<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />




<title>Medicare Drug Spending</title>

<script src="data:application/x-javascript;base64,/*! jQuery v1.11.3 | (c) 2005, 2015 jQuery Foundation, Inc. | jquery.org/license */
!function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=c.slice,e=c.concat,f=c.push,g=c.indexOf,h={},i=h.toString,j=h.hasOwnProperty,k={},l="1.11.3",m=function(a,b){return new m.fn.init(a,b)},n=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,o=/^-ms-/,p=/-([\da-z])/gi,q=function(a,b){return b.toUpperCase()};m.fn=m.prototype={jquery:l,constructor:m,selector:"",length:0,toArray:function(){return d.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:d.call(this)},pushStack:function(a){var b=m.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a,b){return m.each(this,a,b)},map:function(a){return this.pushStack(m.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(d.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c?[this[c]]:[])},end:function(){return this.prevObject||this.constructor(null)},push:f,sort:c.sort,splice:c.splice},m.extend=m.fn.extend=function(){var a,b,c,d,e,f,g=arguments[0]||{},h=1,i=arguments.length,j=!1;for("boolean"==typeof g&&(j=g,g=arguments[h]||{},h++),"object"==typeof g||m.isFunction(g)||(g={}),h===i&&(g=this,h--);i>h;h++)if(null!=(e=arguments[h]))for(d in e)a=g[d],c=e[d],g!==c&&(j&&c&&(m.isPlainObject(c)||(b=m.isArray(c)))?(b?(b=!1,f=a&&m.isArray(a)?a:[]):f=a&&m.isPlainObject(a)?a:{},g[d]=m.extend(j,f,c)):void 0!==c&&(g[d]=c));return g},m.extend({expando:"jQuery"+(l+Math.random()).replace(/\D/g,""),isReady:!0,error:function(a){throw new Error(a)},noop:function(){},isFunction:function(a){return"function"===m.type(a)},isArray:Array.isArray||function(a){return"array"===m.type(a)},isWindow:function(a){return null!=a&&a==a.window},isNumeric:function(a){return!m.isArray(a)&&a-parseFloat(a)+1>=0},isEmptyObject:function(a){var b;for(b in a)return!1;return!0},isPlainObject:function(a){var b;if(!a||"object"!==m.type(a)||a.nodeType||m.isWindow(a))return!1;try{if(a.constructor&&!j.call(a,"constructor")&&!j.call(a.constructor.prototype,"isPrototypeOf"))return!1}catch(c){return!1}if(k.ownLast)for(b in a)return j.call(a,b);for(b in a);return void 0===b||j.call(a,b)},type:function(a){return null==a?a+"":"object"==typeof a||"function"==typeof a?h[i.call(a)]||"object":typeof a},globalEval:function(b){b&&m.trim(b)&&(a.execScript||function(b){a.eval.call(a,b)})(b)},camelCase:function(a){return a.replace(o,"ms-").replace(p,q)},nodeName:function(a,b){return a.nodeName&&a.nodeName.toLowerCase()===b.toLowerCase()},each:function(a,b,c){var d,e=0,f=a.length,g=r(a);if(c){if(g){for(;f>e;e++)if(d=b.apply(a[e],c),d===!1)break}else for(e in a)if(d=b.apply(a[e],c),d===!1)break}else if(g){for(;f>e;e++)if(d=b.call(a[e],e,a[e]),d===!1)break}else for(e in a)if(d=b.call(a[e],e,a[e]),d===!1)break;return a},trim:function(a){return null==a?"":(a+"").replace(n,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(r(Object(a))?m.merge(c,"string"==typeof a?[a]:a):f.call(c,a)),c},inArray:function(a,b,c){var d;if(b){if(g)return g.call(b,a,c);for(d=b.length,c=c?0>c?Math.max(0,d+c):c:0;d>c;c++)if(c in b&&b[c]===a)return c}return-1},merge:function(a,b){var c=+b.length,d=0,e=a.length;while(c>d)a[e++]=b[d++];if(c!==c)while(void 0!==b[d])a[e++]=b[d++];return a.length=e,a},grep:function(a,b,c){for(var d,e=[],f=0,g=a.length,h=!c;g>f;f++)d=!b(a[f],f),d!==h&&e.push(a[f]);return e},map:function(a,b,c){var d,f=0,g=a.length,h=r(a),i=[];if(h)for(;g>f;f++)d=b(a[f],f,c),null!=d&&i.push(d);else for(f in a)d=b(a[f],f,c),null!=d&&i.push(d);return e.apply([],i)},guid:1,proxy:function(a,b){var c,e,f;return"string"==typeof b&&(f=a[b],b=a,a=f),m.isFunction(a)?(c=d.call(arguments,2),e=function(){return a.apply(b||this,c.concat(d.call(arguments)))},e.guid=a.guid=a.guid||m.guid++,e):void 0},now:function(){return+new Date},support:k}),m.each("Boolean Number String Function Array Date RegExp Object Error".split(" "),function(a,b){h["[object "+b+"]"]=b.toLowerCase()});function r(a){var b="length"in a&&a.length,c=m.type(a);return"function"===c||m.isWindow(a)?!1:1===a.nodeType&&b?!0:"array"===c||0===b||"number"==typeof b&&b>0&&b-1 in a}var s=function(a){var b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u="sizzle"+1*new Date,v=a.document,w=0,x=0,y=ha(),z=ha(),A=ha(),B=function(a,b){return a===b&&(l=!0),0},C=1<<31,D={}.hasOwnProperty,E=[],F=E.pop,G=E.push,H=E.push,I=E.slice,J=function(a,b){for(var c=0,d=a.length;d>c;c++)if(a[c]===b)return c;return-1},K="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",L="[\\x20\\t\\r\\n\\f]",M="(?:\\\\.|[\\w-]|[^\\x00-\\xa0])+",N=M.replace("w","w#"),O="\\["+L+"*("+M+")(?:"+L+"*([*^$|!~]?=)"+L+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+N+"))|)"+L+"*\\]",P=":("+M+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+O+")*)|.*)\\)|)",Q=new RegExp(L+"+","g"),R=new RegExp("^"+L+"+|((?:^|[^\\\\])(?:\\\\.)*)"+L+"+$","g"),S=new RegExp("^"+L+"*,"+L+"*"),T=new RegExp("^"+L+"*([>+~]|"+L+")"+L+"*"),U=new RegExp("="+L+"*([^\\]'\"]*?)"+L+"*\\]","g"),V=new RegExp(P),W=new RegExp("^"+N+"$"),X={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\.("+M+")"),TAG:new RegExp("^("+M.replace("w","w*")+")"),ATTR:new RegExp("^"+O),PSEUDO:new RegExp("^"+P),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+L+"*(even|odd|(([+-]|)(\\d*)n|)"+L+"*(?:([+-]|)"+L+"*(\\d+)|))"+L+"*\\)|)","i"),bool:new RegExp("^(?:"+K+")$","i"),needsContext:new RegExp("^"+L+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+L+"*((?:-\\d)?\\d*)"+L+"*\\)|)(?=[^-]|$)","i")},Y=/^(?:input|select|textarea|button)$/i,Z=/^h\d$/i,$=/^[^{]+\{\s*\[native \w/,_=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,aa=/[+~]/,ba=/'|\\/g,ca=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|.)","ig"),da=function(a,b,c){var d="0x"+b-65536;return d!==d||c?b:0>d?String.fromCharCode(d+65536):String.fromCharCode(d>>10|55296,1023&d|56320)},ea=function(){m()};try{H.apply(E=I.call(v.childNodes),v.childNodes),E[v.childNodes.length].nodeType}catch(fa){H={apply:E.length?function(a,b){G.apply(a,I.call(b))}:function(a,b){var c=a.length,d=0;while(a[c++]=b[d++]);a.length=c-1}}}function ga(a,b,d,e){var f,h,j,k,l,o,r,s,w,x;if((b?b.ownerDocument||b:v)!==n&&m(b),b=b||n,d=d||[],k=b.nodeType,"string"!=typeof a||!a||1!==k&&9!==k&&11!==k)return d;if(!e&&p){if(11!==k&&(f=_.exec(a)))if(j=f[1]){if(9===k){if(h=b.getElementById(j),!h||!h.parentNode)return d;if(h.id===j)return d.push(h),d}else if(b.ownerDocument&&(h=b.ownerDocument.getElementById(j))&&t(b,h)&&h.id===j)return d.push(h),d}else{if(f[2])return H.apply(d,b.getElementsByTagName(a)),d;if((j=f[3])&&c.getElementsByClassName)return H.apply(d,b.getElementsByClassName(j)),d}if(c.qsa&&(!q||!q.test(a))){if(s=r=u,w=b,x=1!==k&&a,1===k&&"object"!==b.nodeName.toLowerCase()){o=g(a),(r=b.getAttribute("id"))?s=r.replace(ba,"\\$&"):b.setAttribute("id",s),s="[id='"+s+"'] ",l=o.length;while(l--)o[l]=s+ra(o[l]);w=aa.test(a)&&pa(b.parentNode)||b,x=o.join(",")}if(x)try{return H.apply(d,w.querySelectorAll(x)),d}catch(y){}finally{r||b.removeAttribute("id")}}}return i(a.replace(R,"$1"),b,d,e)}function ha(){var a=[];function b(c,e){return a.push(c+" ")>d.cacheLength&&delete b[a.shift()],b[c+" "]=e}return b}function ia(a){return a[u]=!0,a}function ja(a){var b=n.createElement("div");try{return!!a(b)}catch(c){return!1}finally{b.parentNode&&b.parentNode.removeChild(b),b=null}}function ka(a,b){var c=a.split("|"),e=a.length;while(e--)d.attrHandle[c[e]]=b}function la(a,b){var c=b&&a,d=c&&1===a.nodeType&&1===b.nodeType&&(~b.sourceIndex||C)-(~a.sourceIndex||C);if(d)return d;if(c)while(c=c.nextSibling)if(c===b)return-1;return a?1:-1}function ma(a){return function(b){var c=b.nodeName.toLowerCase();return"input"===c&&b.type===a}}function na(a){return function(b){var c=b.nodeName.toLowerCase();return("input"===c||"button"===c)&&b.type===a}}function oa(a){return ia(function(b){return b=+b,ia(function(c,d){var e,f=a([],c.length,b),g=f.length;while(g--)c[e=f[g]]&&(c[e]=!(d[e]=c[e]))})})}function pa(a){return a&&"undefined"!=typeof a.getElementsByTagName&&a}c=ga.support={},f=ga.isXML=function(a){var b=a&&(a.ownerDocument||a).documentElement;return b?"HTML"!==b.nodeName:!1},m=ga.setDocument=function(a){var b,e,g=a?a.ownerDocument||a:v;return g!==n&&9===g.nodeType&&g.documentElement?(n=g,o=g.documentElement,e=g.defaultView,e&&e!==e.top&&(e.addEventListener?e.addEventListener("unload",ea,!1):e.attachEvent&&e.attachEvent("onunload",ea)),p=!f(g),c.attributes=ja(function(a){return a.className="i",!a.getAttribute("className")}),c.getElementsByTagName=ja(function(a){return a.appendChild(g.createComment("")),!a.getElementsByTagName("*").length}),c.getElementsByClassName=$.test(g.getElementsByClassName),c.getById=ja(function(a){return o.appendChild(a).id=u,!g.getElementsByName||!g.getElementsByName(u).length}),c.getById?(d.find.ID=function(a,b){if("undefined"!=typeof b.getElementById&&p){var c=b.getElementById(a);return c&&c.parentNode?[c]:[]}},d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){return a.getAttribute("id")===b}}):(delete d.find.ID,d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){var c="undefined"!=typeof a.getAttributeNode&&a.getAttributeNode("id");return c&&c.value===b}}),d.find.TAG=c.getElementsByTagName?function(a,b){return"undefined"!=typeof b.getElementsByTagName?b.getElementsByTagName(a):c.qsa?b.querySelectorAll(a):void 0}:function(a,b){var c,d=[],e=0,f=b.getElementsByTagName(a);if("*"===a){while(c=f[e++])1===c.nodeType&&d.push(c);return d}return f},d.find.CLASS=c.getElementsByClassName&&function(a,b){return p?b.getElementsByClassName(a):void 0},r=[],q=[],(c.qsa=$.test(g.querySelectorAll))&&(ja(function(a){o.appendChild(a).innerHTML="<a id='"+u+"'></a><select id='"+u+"-\f]' msallowcapture=''><option selected=''></option></select>",a.querySelectorAll("[msallowcapture^='']").length&&q.push("[*^$]="+L+"*(?:''|\"\")"),a.querySelectorAll("[selected]").length||q.push("\\["+L+"*(?:value|"+K+")"),a.querySelectorAll("[id~="+u+"-]").length||q.push("~="),a.querySelectorAll(":checked").length||q.push(":checked"),a.querySelectorAll("a#"+u+"+*").length||q.push(".#.+[+~]")}),ja(function(a){var b=g.createElement("input");b.setAttribute("type","hidden"),a.appendChild(b).setAttribute("name","D"),a.querySelectorAll("[name=d]").length&&q.push("name"+L+"*[*^$|!~]?="),a.querySelectorAll(":enabled").length||q.push(":enabled",":disabled"),a.querySelectorAll("*,:x"),q.push(",.*:")})),(c.matchesSelector=$.test(s=o.matches||o.webkitMatchesSelector||o.mozMatchesSelector||o.oMatchesSelector||o.msMatchesSelector))&&ja(function(a){c.disconnectedMatch=s.call(a,"div"),s.call(a,"[s!='']:x"),r.push("!=",P)}),q=q.length&&new RegExp(q.join("|")),r=r.length&&new RegExp(r.join("|")),b=$.test(o.compareDocumentPosition),t=b||$.test(o.contains)?function(a,b){var c=9===a.nodeType?a.documentElement:a,d=b&&b.parentNode;return a===d||!(!d||1!==d.nodeType||!(c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===g||a.ownerDocument===v&&t(v,a)?-1:b===g||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,h=[a],i=[b];if(!e||!f)return a===g?-1:b===g?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return la(a,b);c=a;while(c=c.parentNode)h.unshift(c);c=b;while(c=c.parentNode)i.unshift(c);while(h[d]===i[d])d++;return d?la(h[d],i[d]):h[d]===v?-1:i[d]===v?1:0},g):n},ga.matches=function(a,b){return ga(a,null,null,b)},ga.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(U,"='$1']"),!(!c.matchesSelector||!p||r&&r.test(b)||q&&q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return ga(b,n,null,[a]).length>0},ga.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},ga.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},ga.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},ga.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=ga.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=ga.selectors={cacheLength:50,createPseudo:ia,match:X,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ca,da),a[3]=(a[3]||a[4]||a[5]||"").replace(ca,da),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)?(a[3]||ga.error(a[0]),a[4]=+(a[4]?a[5]+(a[6]||1):2*("even"===a[3]||"odd"===a[3])),a[5]=+(a[7]+a[8]||"odd"===a[3])):a[3]&&ga.error(a[0]),a},PSEUDO:function(a){var b,c=!a[6]&&a[2];return X.CHILD.test(a[0])?null:(a[3]?a[2]=a[4]||a[5]||"":c&&V.test(c)&&(b=g(c,!0))&&(b=c.indexOf(")",c.length-b)-c.length)&&(a[0]=a[0].slice(0,b),a[2]=c.slice(0,b)),a.slice(0,3))}},filter:{TAG:function(a){var b=a.replace(ca,da).toLowerCase();return"*"===a?function(){return!0}:function(a){return a.nodeName&&a.nodeName.toLowerCase()===b}},CLASS:function(a){var b=y[a+" "];return b||(b=new RegExp("(^|"+L+")"+a+"("+L+"|$)"))&&y(a,function(a){return b.test("string"==typeof a.className&&a.className||"undefined"!=typeof a.getAttribute&&a.getAttribute("class")||"")})},ATTR:function(a,b,c){return function(d){var e=ga.attr(d,a);return null==e?"!="===b:b?(e+="","="===b?e===c:"!="===b?e!==c:"^="===b?c&&0===e.indexOf(c):"*="===b?c&&e.indexOf(c)>-1:"$="===b?c&&e.slice(-c.length)===c:"~="===b?(" "+e.replace(Q," ")+" ").indexOf(c)>-1:"|="===b?e===c||e.slice(0,c.length+1)===c+"-":!1):!0}},CHILD:function(a,b,c,d,e){var f="nth"!==a.slice(0,3),g="last"!==a.slice(-4),h="of-type"===b;return 1===d&&0===e?function(a){return!!a.parentNode}:function(b,c,i){var j,k,l,m,n,o,p=f!==g?"nextSibling":"previousSibling",q=b.parentNode,r=h&&b.nodeName.toLowerCase(),s=!i&&!h;if(q){if(f){while(p){l=b;while(l=l[p])if(h?l.nodeName.toLowerCase()===r:1===l.nodeType)return!1;o=p="only"===a&&!o&&"nextSibling"}return!0}if(o=[g?q.firstChild:q.lastChild],g&&s){k=q[u]||(q[u]={}),j=k[a]||[],n=j[0]===w&&j[1],m=j[0]===w&&j[2],l=n&&q.childNodes[n];while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if(1===l.nodeType&&++m&&l===b){k[a]=[w,n,m];break}}else if(s&&(j=(b[u]||(b[u]={}))[a])&&j[0]===w)m=j[1];else while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if((h?l.nodeName.toLowerCase()===r:1===l.nodeType)&&++m&&(s&&((l[u]||(l[u]={}))[a]=[w,m]),l===b))break;return m-=e,m===d||m%d===0&&m/d>=0}}},PSEUDO:function(a,b){var c,e=d.pseudos[a]||d.setFilters[a.toLowerCase()]||ga.error("unsupported pseudo: "+a);return e[u]?e(b):e.length>1?(c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ia(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=!(c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ia(function(a){var b=[],c=[],d=h(a.replace(R,"$1"));return d[u]?ia(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=!(b[h]=f))}):function(a,e,f){return b[0]=a,d(b,null,f,c),b[0]=null,!c.pop()}}),has:ia(function(a){return function(b){return ga(a,b).length>0}}),contains:ia(function(a){return a=a.replace(ca,da),function(b){return(b.textContent||b.innerText||e(b)).indexOf(a)>-1}}),lang:ia(function(a){return W.test(a||"")||ga.error("unsupported lang: "+a),a=a.replace(ca,da).toLowerCase(),function(b){var c;do if(c=p?b.lang:b.getAttribute("xml:lang")||b.getAttribute("lang"))return c=c.toLowerCase(),c===a||0===c.indexOf(a+"-");while((b=b.parentNode)&&1===b.nodeType);return!1}}),target:function(b){var c=a.location&&a.location.hash;return c&&c.slice(1)===b.id},root:function(a){return a===o},focus:function(a){return a===n.activeElement&&(!n.hasFocus||n.hasFocus())&&!!(a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&!!a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Z.test(a.nodeName)},input:function(a){return Y.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:oa(function(){return[0]}),last:oa(function(a,b){return[b-1]}),eq:oa(function(a,b,c){return[0>c?c+b:c]}),even:oa(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:oa(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:oa(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:oa(function(a,b,c){for(var d=0>c?c+b:c;++d<b;)a.push(d);return a})}},d.pseudos.nth=d.pseudos.eq;for(b in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})d.pseudos[b]=ma(b);for(b in{submit:!0,reset:!0})d.pseudos[b]=na(b);function qa(){}qa.prototype=d.filters=d.pseudos,d.setFilters=new qa,g=ga.tokenize=function(a,b){var c,e,f,g,h,i,j,k=z[a+" "];if(k)return b?0:k.slice(0);h=a,i=[],j=d.preFilter;while(h){(!c||(e=S.exec(h)))&&(e&&(h=h.slice(e[0].length)||h),i.push(f=[])),c=!1,(e=T.exec(h))&&(c=e.shift(),f.push({value:c,type:e[0].replace(R," ")}),h=h.slice(c.length));for(g in d.filter)!(e=X[g].exec(h))||j[g]&&!(e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?ga.error(a):z(a,i).slice(0)};function ra(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function sa(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(i=b[u]||(b[u]={}),(h=i[d])&&h[0]===w&&h[1]===f)return j[2]=h[2];if(i[d]=j,j[2]=a(b,c,g))return!0}}}function ta(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ua(a,b,c){for(var d=0,e=b.length;e>d;d++)ga(a,b[d],c);return c}function va(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(!c||c(f,d,e))&&(g.push(f),j&&b.push(h));return g}function wa(a,b,c,d,e,f){return d&&!d[u]&&(d=wa(d)),e&&!e[u]&&(e=wa(e,f)),ia(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ua(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:va(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=va(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=!(g[j]=l))}}else r=va(r===g?r.splice(o,r.length):r),e?e(null,g,r,i):H.apply(g,r)})}function xa(a){for(var b,c,e,f=a.length,g=d.relative[a[0].type],h=g||d.relative[" "],i=g?1:0,k=sa(function(a){return a===b},h,!0),l=sa(function(a){return J(b,a)>-1},h,!0),m=[function(a,c,d){var e=!g&&(d||c!==j)||((b=c).nodeType?k(a,c,d):l(a,c,d));return b=null,e}];f>i;i++)if(c=d.relative[a[i].type])m=[sa(ta(m),c)];else{if(c=d.filter[a[i].type].apply(null,a[i].matches),c[u]){for(e=++i;f>e;e++)if(d.relative[a[e].type])break;return wa(i>1&&ta(m),i>1&&ra(a.slice(0,i-1).concat({value:" "===a[i-2].type?"*":""})).replace(R,"$1"),c,e>i&&xa(a.slice(i,e)),f>e&&xa(a=a.slice(e)),f>e&&ra(a))}m.push(c)}return ta(m)}function ya(a,b){var c=b.length>0,e=a.length>0,f=function(f,g,h,i,k){var l,m,o,p=0,q="0",r=f&&[],s=[],t=j,u=f||e&&d.find.TAG("*",k),v=w+=null==t?1:Math.random()||.1,x=u.length;for(k&&(j=g!==n&&g);q!==x&&null!=(l=u[q]);q++){if(e&&l){m=0;while(o=a[m++])if(o(l,g,h)){i.push(l);break}k&&(w=v)}c&&((l=!o&&l)&&p--,f&&r.push(l))}if(p+=q,c&&q!==p){m=0;while(o=b[m++])o(r,s,g,h);if(f){if(p>0)while(q--)r[q]||s[q]||(s[q]=F.call(i));s=va(s)}H.apply(i,s),k&&!f&&s.length>0&&p+b.length>1&&ga.uniqueSort(i)}return k&&(w=v,j=t),r};return c?ia(f):f}return h=ga.compile=function(a,b){var c,d=[],e=[],f=A[a+" "];if(!f){b||(b=g(a)),c=b.length;while(c--)f=xa(b[c]),f[u]?d.push(f):e.push(f);f=A(a,ya(e,d)),f.selector=a}return f},i=ga.select=function(a,b,e,f){var i,j,k,l,m,n="function"==typeof a&&a,o=!f&&g(a=n.selector||a);if(e=e||[],1===o.length){if(j=o[0]=o[0].slice(0),j.length>2&&"ID"===(k=j[0]).type&&c.getById&&9===b.nodeType&&p&&d.relative[j[1].type]){if(b=(d.find.ID(k.matches[0].replace(ca,da),b)||[])[0],!b)return e;n&&(b=b.parentNode),a=a.slice(j.shift().value.length)}i=X.needsContext.test(a)?0:j.length;while(i--){if(k=j[i],d.relative[l=k.type])break;if((m=d.find[l])&&(f=m(k.matches[0].replace(ca,da),aa.test(j[0].type)&&pa(b.parentNode)||b))){if(j.splice(i,1),a=f.length&&ra(j),!a)return H.apply(e,f),e;break}}}return(n||h(a,o))(f,b,!p,e,aa.test(a)&&pa(b.parentNode)||b),e},c.sortStable=u.split("").sort(B).join("")===u,c.detectDuplicates=!!l,m(),c.sortDetached=ja(function(a){return 1&a.compareDocumentPosition(n.createElement("div"))}),ja(function(a){return a.innerHTML="<a href='#'></a>","#"===a.firstChild.getAttribute("href")})||ka("type|href|height|width",function(a,b,c){return c?void 0:a.getAttribute(b,"type"===b.toLowerCase()?1:2)}),c.attributes&&ja(function(a){return a.innerHTML="<input/>",a.firstChild.setAttribute("value",""),""===a.firstChild.getAttribute("value")})||ka("value",function(a,b,c){return c||"input"!==a.nodeName.toLowerCase()?void 0:a.defaultValue}),ja(function(a){return null==a.getAttribute("disabled")})||ka(K,function(a,b,c){var d;return c?void 0:a[b]===!0?b.toLowerCase():(d=a.getAttributeNode(b))&&d.specified?d.value:null}),ga}(a);m.find=s,m.expr=s.selectors,m.expr[":"]=m.expr.pseudos,m.unique=s.uniqueSort,m.text=s.getText,m.isXMLDoc=s.isXML,m.contains=s.contains;var t=m.expr.match.needsContext,u=/^<(\w+)\s*\/?>(?:<\/\1>|)$/,v=/^.[^:#\[\.,]*$/;function w(a,b,c){if(m.isFunction(b))return m.grep(a,function(a,d){return!!b.call(a,d,a)!==c});if(b.nodeType)return m.grep(a,function(a){return a===b!==c});if("string"==typeof b){if(v.test(b))return m.filter(b,a,c);b=m.filter(b,a)}return m.grep(a,function(a){return m.inArray(a,b)>=0!==c})}m.filter=function(a,b,c){var d=b[0];return c&&(a=":not("+a+")"),1===b.length&&1===d.nodeType?m.find.matchesSelector(d,a)?[d]:[]:m.find.matches(a,m.grep(b,function(a){return 1===a.nodeType}))},m.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(m(a).filter(function(){for(b=0;e>b;b++)if(m.contains(d[b],this))return!0}));for(b=0;e>b;b++)m.find(a,d[b],c);return c=this.pushStack(e>1?m.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(w(this,a||[],!1))},not:function(a){return this.pushStack(w(this,a||[],!0))},is:function(a){return!!w(this,"string"==typeof a&&t.test(a)?m(a):a||[],!1).length}});var x,y=a.document,z=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]*))$/,A=m.fn.init=function(a,b){var c,d;if(!a)return this;if("string"==typeof a){if(c="<"===a.charAt(0)&&">"===a.charAt(a.length-1)&&a.length>=3?[null,a,null]:z.exec(a),!c||!c[1]&&b)return!b||b.jquery?(b||x).find(a):this.constructor(b).find(a);if(c[1]){if(b=b instanceof m?b[0]:b,m.merge(this,m.parseHTML(c[1],b&&b.nodeType?b.ownerDocument||b:y,!0)),u.test(c[1])&&m.isPlainObject(b))for(c in b)m.isFunction(this[c])?this[c](b[c]):this.attr(c,b[c]);return this}if(d=y.getElementById(c[2]),d&&d.parentNode){if(d.id!==c[2])return x.find(a);this.length=1,this[0]=d}return this.context=y,this.selector=a,this}return a.nodeType?(this.context=this[0]=a,this.length=1,this):m.isFunction(a)?"undefined"!=typeof x.ready?x.ready(a):a(m):(void 0!==a.selector&&(this.selector=a.selector,this.context=a.context),m.makeArray(a,this))};A.prototype=m.fn,x=m(y);var B=/^(?:parents|prev(?:Until|All))/,C={children:!0,contents:!0,next:!0,prev:!0};m.extend({dir:function(a,b,c){var d=[],e=a[b];while(e&&9!==e.nodeType&&(void 0===c||1!==e.nodeType||!m(e).is(c)))1===e.nodeType&&d.push(e),e=e[b];return d},sibling:function(a,b){for(var c=[];a;a=a.nextSibling)1===a.nodeType&&a!==b&&c.push(a);return c}}),m.fn.extend({has:function(a){var b,c=m(a,this),d=c.length;return this.filter(function(){for(b=0;d>b;b++)if(m.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=t.test(a)||"string"!=typeof a?m(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&m.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?m.unique(f):f)},index:function(a){return a?"string"==typeof a?m.inArray(this[0],m(a)):m.inArray(a.jquery?a[0]:a,this):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(a,b){return this.pushStack(m.unique(m.merge(this.get(),m(a,b))))},addBack:function(a){return this.add(null==a?this.prevObject:this.prevObject.filter(a))}});function D(a,b){do a=a[b];while(a&&1!==a.nodeType);return a}m.each({parent:function(a){var b=a.parentNode;return b&&11!==b.nodeType?b:null},parents:function(a){return m.dir(a,"parentNode")},parentsUntil:function(a,b,c){return m.dir(a,"parentNode",c)},next:function(a){return D(a,"nextSibling")},prev:function(a){return D(a,"previousSibling")},nextAll:function(a){return m.dir(a,"nextSibling")},prevAll:function(a){return m.dir(a,"previousSibling")},nextUntil:function(a,b,c){return m.dir(a,"nextSibling",c)},prevUntil:function(a,b,c){return m.dir(a,"previousSibling",c)},siblings:function(a){return m.sibling((a.parentNode||{}).firstChild,a)},children:function(a){return m.sibling(a.firstChild)},contents:function(a){return m.nodeName(a,"iframe")?a.contentDocument||a.contentWindow.document:m.merge([],a.childNodes)}},function(a,b){m.fn[a]=function(c,d){var e=m.map(this,b,c);return"Until"!==a.slice(-5)&&(d=c),d&&"string"==typeof d&&(e=m.filter(d,e)),this.length>1&&(C[a]||(e=m.unique(e)),B.test(a)&&(e=e.reverse())),this.pushStack(e)}});var E=/\S+/g,F={};function G(a){var b=F[a]={};return m.each(a.match(E)||[],function(a,c){b[c]=!0}),b}m.Callbacks=function(a){a="string"==typeof a?F[a]||G(a):m.extend({},a);var b,c,d,e,f,g,h=[],i=!a.once&&[],j=function(l){for(c=a.memory&&l,d=!0,f=g||0,g=0,e=h.length,b=!0;h&&e>f;f++)if(h[f].apply(l[0],l[1])===!1&&a.stopOnFalse){c=!1;break}b=!1,h&&(i?i.length&&j(i.shift()):c?h=[]:k.disable())},k={add:function(){if(h){var d=h.length;!function f(b){m.each(b,function(b,c){var d=m.type(c);"function"===d?a.unique&&k.has(c)||h.push(c):c&&c.length&&"string"!==d&&f(c)})}(arguments),b?e=h.length:c&&(g=d,j(c))}return this},remove:function(){return h&&m.each(arguments,function(a,c){var d;while((d=m.inArray(c,h,d))>-1)h.splice(d,1),b&&(e>=d&&e--,f>=d&&f--)}),this},has:function(a){return a?m.inArray(a,h)>-1:!(!h||!h.length)},empty:function(){return h=[],e=0,this},disable:function(){return h=i=c=void 0,this},disabled:function(){return!h},lock:function(){return i=void 0,c||k.disable(),this},locked:function(){return!i},fireWith:function(a,c){return!h||d&&!i||(c=c||[],c=[a,c.slice?c.slice():c],b?i.push(c):j(c)),this},fire:function(){return k.fireWith(this,arguments),this},fired:function(){return!!d}};return k},m.extend({Deferred:function(a){var b=[["resolve","done",m.Callbacks("once memory"),"resolved"],["reject","fail",m.Callbacks("once memory"),"rejected"],["notify","progress",m.Callbacks("memory")]],c="pending",d={state:function(){return c},always:function(){return e.done(arguments).fail(arguments),this},then:function(){var a=arguments;return m.Deferred(function(c){m.each(b,function(b,f){var g=m.isFunction(a[b])&&a[b];e[f[1]](function(){var a=g&&g.apply(this,arguments);a&&m.isFunction(a.promise)?a.promise().done(c.resolve).fail(c.reject).progress(c.notify):c[f[0]+"With"](this===d?c.promise():this,g?[a]:arguments)})}),a=null}).promise()},promise:function(a){return null!=a?m.extend(a,d):d}},e={};return d.pipe=d.then,m.each(b,function(a,f){var g=f[2],h=f[3];d[f[1]]=g.add,h&&g.add(function(){c=h},b[1^a][2].disable,b[2][2].lock),e[f[0]]=function(){return e[f[0]+"With"](this===e?d:this,arguments),this},e[f[0]+"With"]=g.fireWith}),d.promise(e),a&&a.call(e,e),e},when:function(a){var b=0,c=d.call(arguments),e=c.length,f=1!==e||a&&m.isFunction(a.promise)?e:0,g=1===f?a:m.Deferred(),h=function(a,b,c){return function(e){b[a]=this,c[a]=arguments.length>1?d.call(arguments):e,c===i?g.notifyWith(b,c):--f||g.resolveWith(b,c)}},i,j,k;if(e>1)for(i=new Array(e),j=new Array(e),k=new Array(e);e>b;b++)c[b]&&m.isFunction(c[b].promise)?c[b].promise().done(h(b,k,c)).fail(g.reject).progress(h(b,j,i)):--f;return f||g.resolveWith(k,c),g.promise()}});var H;m.fn.ready=function(a){return m.ready.promise().done(a),this},m.extend({isReady:!1,readyWait:1,holdReady:function(a){a?m.readyWait++:m.ready(!0)},ready:function(a){if(a===!0?!--m.readyWait:!m.isReady){if(!y.body)return setTimeout(m.ready);m.isReady=!0,a!==!0&&--m.readyWait>0||(H.resolveWith(y,[m]),m.fn.triggerHandler&&(m(y).triggerHandler("ready"),m(y).off("ready")))}}});function I(){y.addEventListener?(y.removeEventListener("DOMContentLoaded",J,!1),a.removeEventListener("load",J,!1)):(y.detachEvent("onreadystatechange",J),a.detachEvent("onload",J))}function J(){(y.addEventListener||"load"===event.type||"complete"===y.readyState)&&(I(),m.ready())}m.ready.promise=function(b){if(!H)if(H=m.Deferred(),"complete"===y.readyState)setTimeout(m.ready);else if(y.addEventListener)y.addEventListener("DOMContentLoaded",J,!1),a.addEventListener("load",J,!1);else{y.attachEvent("onreadystatechange",J),a.attachEvent("onload",J);var c=!1;try{c=null==a.frameElement&&y.documentElement}catch(d){}c&&c.doScroll&&!function e(){if(!m.isReady){try{c.doScroll("left")}catch(a){return setTimeout(e,50)}I(),m.ready()}}()}return H.promise(b)};var K="undefined",L;for(L in m(k))break;k.ownLast="0"!==L,k.inlineBlockNeedsLayout=!1,m(function(){var a,b,c,d;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="display:inline;margin:0;border:0;padding:1px;width:1px;zoom:1",k.inlineBlockNeedsLayout=a=3===b.offsetWidth,a&&(c.style.zoom=1)),c.removeChild(d))}),function(){var a=y.createElement("div");if(null==k.deleteExpando){k.deleteExpando=!0;try{delete a.test}catch(b){k.deleteExpando=!1}}a=null}(),m.acceptData=function(a){var b=m.noData[(a.nodeName+" ").toLowerCase()],c=+a.nodeType||1;return 1!==c&&9!==c?!1:!b||b!==!0&&a.getAttribute("classid")===b};var M=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,N=/([A-Z])/g;function O(a,b,c){if(void 0===c&&1===a.nodeType){var d="data-"+b.replace(N,"-$1").toLowerCase();if(c=a.getAttribute(d),"string"==typeof c){try{c="true"===c?!0:"false"===c?!1:"null"===c?null:+c+""===c?+c:M.test(c)?m.parseJSON(c):c}catch(e){}m.data(a,b,c)}else c=void 0}return c}function P(a){var b;for(b in a)if(("data"!==b||!m.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;

return!0}function Q(a,b,d,e){if(m.acceptData(a)){var f,g,h=m.expando,i=a.nodeType,j=i?m.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||m.guid++:h),j[k]||(j[k]=i?{}:{toJSON:m.noop}),("object"==typeof b||"function"==typeof b)&&(e?j[k]=m.extend(j[k],b):j[k].data=m.extend(j[k].data,b)),g=j[k],e||(g.data||(g.data={}),g=g.data),void 0!==d&&(g[m.camelCase(b)]=d),"string"==typeof b?(f=g[b],null==f&&(f=g[m.camelCase(b)])):f=g,f}}function R(a,b,c){if(m.acceptData(a)){var d,e,f=a.nodeType,g=f?m.cache:a,h=f?a[m.expando]:m.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){m.isArray(b)?b=b.concat(m.map(b,m.camelCase)):b in d?b=[b]:(b=m.camelCase(b),b=b in d?[b]:b.split(" ")),e=b.length;while(e--)delete d[b[e]];if(c?!P(d):!m.isEmptyObject(d))return}(c||(delete g[h].data,P(g[h])))&&(f?m.cleanData([a],!0):k.deleteExpando||g!=g.window?delete g[h]:g[h]=null)}}}m.extend({cache:{},noData:{"applet ":!0,"embed ":!0,"object ":"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000"},hasData:function(a){return a=a.nodeType?m.cache[a[m.expando]]:a[m.expando],!!a&&!P(a)},data:function(a,b,c){return Q(a,b,c)},removeData:function(a,b){return R(a,b)},_data:function(a,b,c){return Q(a,b,c,!0)},_removeData:function(a,b){return R(a,b,!0)}}),m.fn.extend({data:function(a,b){var c,d,e,f=this[0],g=f&&f.attributes;if(void 0===a){if(this.length&&(e=m.data(f),1===f.nodeType&&!m._data(f,"parsedAttrs"))){c=g.length;while(c--)g[c]&&(d=g[c].name,0===d.indexOf("data-")&&(d=m.camelCase(d.slice(5)),O(f,d,e[d])));m._data(f,"parsedAttrs",!0)}return e}return"object"==typeof a?this.each(function(){m.data(this,a)}):arguments.length>1?this.each(function(){m.data(this,a,b)}):f?O(f,a,m.data(f,a)):void 0},removeData:function(a){return this.each(function(){m.removeData(this,a)})}}),m.extend({queue:function(a,b,c){var d;return a?(b=(b||"fx")+"queue",d=m._data(a,b),c&&(!d||m.isArray(c)?d=m._data(a,b,m.makeArray(c)):d.push(c)),d||[]):void 0},dequeue:function(a,b){b=b||"fx";var c=m.queue(a,b),d=c.length,e=c.shift(),f=m._queueHooks(a,b),g=function(){m.dequeue(a,b)};"inprogress"===e&&(e=c.shift(),d--),e&&("fx"===b&&c.unshift("inprogress"),delete f.stop,e.call(a,g,f)),!d&&f&&f.empty.fire()},_queueHooks:function(a,b){var c=b+"queueHooks";return m._data(a,c)||m._data(a,c,{empty:m.Callbacks("once memory").add(function(){m._removeData(a,b+"queue"),m._removeData(a,c)})})}}),m.fn.extend({queue:function(a,b){var c=2;return"string"!=typeof a&&(b=a,a="fx",c--),arguments.length<c?m.queue(this[0],a):void 0===b?this:this.each(function(){var c=m.queue(this,a,b);m._queueHooks(this,a),"fx"===a&&"inprogress"!==c[0]&&m.dequeue(this,a)})},dequeue:function(a){return this.each(function(){m.dequeue(this,a)})},clearQueue:function(a){return this.queue(a||"fx",[])},promise:function(a,b){var c,d=1,e=m.Deferred(),f=this,g=this.length,h=function(){--d||e.resolveWith(f,[f])};"string"!=typeof a&&(b=a,a=void 0),a=a||"fx";while(g--)c=m._data(f[g],a+"queueHooks"),c&&c.empty&&(d++,c.empty.add(h));return h(),e.promise(b)}});var S=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,T=["Top","Right","Bottom","Left"],U=function(a,b){return a=b||a,"none"===m.css(a,"display")||!m.contains(a.ownerDocument,a)},V=m.access=function(a,b,c,d,e,f,g){var h=0,i=a.length,j=null==c;if("object"===m.type(c)){e=!0;for(h in c)m.access(a,b,h,c[h],!0,f,g)}else if(void 0!==d&&(e=!0,m.isFunction(d)||(g=!0),j&&(g?(b.call(a,d),b=null):(j=b,b=function(a,b,c){return j.call(m(a),c)})),b))for(;i>h;h++)b(a[h],c,g?d:d.call(a[h],h,b(a[h],c)));return e?a:j?b.call(a):i?b(a[0],c):f},W=/^(?:checkbox|radio)$/i;!function(){var a=y.createElement("input"),b=y.createElement("div"),c=y.createDocumentFragment();if(b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",k.leadingWhitespace=3===b.firstChild.nodeType,k.tbody=!b.getElementsByTagName("tbody").length,k.htmlSerialize=!!b.getElementsByTagName("link").length,k.html5Clone="<:nav></:nav>"!==y.createElement("nav").cloneNode(!0).outerHTML,a.type="checkbox",a.checked=!0,c.appendChild(a),k.appendChecked=a.checked,b.innerHTML="<textarea>x</textarea>",k.noCloneChecked=!!b.cloneNode(!0).lastChild.defaultValue,c.appendChild(b),b.innerHTML="<input type='radio' checked='checked' name='t'/>",k.checkClone=b.cloneNode(!0).cloneNode(!0).lastChild.checked,k.noCloneEvent=!0,b.attachEvent&&(b.attachEvent("onclick",function(){k.noCloneEvent=!1}),b.cloneNode(!0).click()),null==k.deleteExpando){k.deleteExpando=!0;try{delete b.test}catch(d){k.deleteExpando=!1}}}(),function(){var b,c,d=y.createElement("div");for(b in{submit:!0,change:!0,focusin:!0})c="on"+b,(k[b+"Bubbles"]=c in a)||(d.setAttribute(c,"t"),k[b+"Bubbles"]=d.attributes[c].expando===!1);d=null}();var X=/^(?:input|select|textarea)$/i,Y=/^key/,Z=/^(?:mouse|pointer|contextmenu)|click/,$=/^(?:focusinfocus|focusoutblur)$/,_=/^([^.]*)(?:\.(.+)|)$/;function aa(){return!0}function ba(){return!1}function ca(){try{return y.activeElement}catch(a){}}m.event={global:{},add:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m._data(a);if(r){c.handler&&(i=c,c=i.handler,e=i.selector),c.guid||(c.guid=m.guid++),(g=r.events)||(g=r.events={}),(k=r.handle)||(k=r.handle=function(a){return typeof m===K||a&&m.event.triggered===a.type?void 0:m.event.dispatch.apply(k.elem,arguments)},k.elem=a),b=(b||"").match(E)||[""],h=b.length;while(h--)f=_.exec(b[h])||[],o=q=f[1],p=(f[2]||"").split(".").sort(),o&&(j=m.event.special[o]||{},o=(e?j.delegateType:j.bindType)||o,j=m.event.special[o]||{},l=m.extend({type:o,origType:q,data:d,handler:c,guid:c.guid,selector:e,needsContext:e&&m.expr.match.needsContext.test(e),namespace:p.join(".")},i),(n=g[o])||(n=g[o]=[],n.delegateCount=0,j.setup&&j.setup.call(a,d,p,k)!==!1||(a.addEventListener?a.addEventListener(o,k,!1):a.attachEvent&&a.attachEvent("on"+o,k))),j.add&&(j.add.call(a,l),l.handler.guid||(l.handler.guid=c.guid)),e?n.splice(n.delegateCount++,0,l):n.push(l),m.event.global[o]=!0);a=null}},remove:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m.hasData(a)&&m._data(a);if(r&&(k=r.events)){b=(b||"").match(E)||[""],j=b.length;while(j--)if(h=_.exec(b[j])||[],o=q=h[1],p=(h[2]||"").split(".").sort(),o){l=m.event.special[o]||{},o=(d?l.delegateType:l.bindType)||o,n=k[o]||[],h=h[2]&&new RegExp("(^|\\.)"+p.join("\\.(?:.*\\.|)")+"(\\.|$)"),i=f=n.length;while(f--)g=n[f],!e&&q!==g.origType||c&&c.guid!==g.guid||h&&!h.test(g.namespace)||d&&d!==g.selector&&("**"!==d||!g.selector)||(n.splice(f,1),g.selector&&n.delegateCount--,l.remove&&l.remove.call(a,g));i&&!n.length&&(l.teardown&&l.teardown.call(a,p,r.handle)!==!1||m.removeEvent(a,o,r.handle),delete k[o])}else for(o in k)m.event.remove(a,o+b[j],c,d,!0);m.isEmptyObject(k)&&(delete r.handle,m._removeData(a,"events"))}},trigger:function(b,c,d,e){var f,g,h,i,k,l,n,o=[d||y],p=j.call(b,"type")?b.type:b,q=j.call(b,"namespace")?b.namespace.split("."):[];if(h=l=d=d||y,3!==d.nodeType&&8!==d.nodeType&&!$.test(p+m.event.triggered)&&(p.indexOf(".")>=0&&(q=p.split("."),p=q.shift(),q.sort()),g=p.indexOf(":")<0&&"on"+p,b=b[m.expando]?b:new m.Event(p,"object"==typeof b&&b),b.isTrigger=e?2:3,b.namespace=q.join("."),b.namespace_re=b.namespace?new RegExp("(^|\\.)"+q.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,b.result=void 0,b.target||(b.target=d),c=null==c?[b]:m.makeArray(c,[b]),k=m.event.special[p]||{},e||!k.trigger||k.trigger.apply(d,c)!==!1)){if(!e&&!k.noBubble&&!m.isWindow(d)){for(i=k.delegateType||p,$.test(i+p)||(h=h.parentNode);h;h=h.parentNode)o.push(h),l=h;l===(d.ownerDocument||y)&&o.push(l.defaultView||l.parentWindow||a)}n=0;while((h=o[n++])&&!b.isPropagationStopped())b.type=n>1?i:k.bindType||p,f=(m._data(h,"events")||{})[b.type]&&m._data(h,"handle"),f&&f.apply(h,c),f=g&&h[g],f&&f.apply&&m.acceptData(h)&&(b.result=f.apply(h,c),b.result===!1&&b.preventDefault());if(b.type=p,!e&&!b.isDefaultPrevented()&&(!k._default||k._default.apply(o.pop(),c)===!1)&&m.acceptData(d)&&g&&d[p]&&!m.isWindow(d)){l=d[g],l&&(d[g]=null),m.event.triggered=p;try{d[p]()}catch(r){}m.event.triggered=void 0,l&&(d[g]=l)}return b.result}},dispatch:function(a){a=m.event.fix(a);var b,c,e,f,g,h=[],i=d.call(arguments),j=(m._data(this,"events")||{})[a.type]||[],k=m.event.special[a.type]||{};if(i[0]=a,a.delegateTarget=this,!k.preDispatch||k.preDispatch.call(this,a)!==!1){h=m.event.handlers.call(this,a,j),b=0;while((f=h[b++])&&!a.isPropagationStopped()){a.currentTarget=f.elem,g=0;while((e=f.handlers[g++])&&!a.isImmediatePropagationStopped())(!a.namespace_re||a.namespace_re.test(e.namespace))&&(a.handleObj=e,a.data=e.data,c=((m.event.special[e.origType]||{}).handle||e.handler).apply(f.elem,i),void 0!==c&&(a.result=c)===!1&&(a.preventDefault(),a.stopPropagation()))}return k.postDispatch&&k.postDispatch.call(this,a),a.result}},handlers:function(a,b){var c,d,e,f,g=[],h=b.delegateCount,i=a.target;if(h&&i.nodeType&&(!a.button||"click"!==a.type))for(;i!=this;i=i.parentNode||this)if(1===i.nodeType&&(i.disabled!==!0||"click"!==a.type)){for(e=[],f=0;h>f;f++)d=b[f],c=d.selector+" ",void 0===e[c]&&(e[c]=d.needsContext?m(c,this).index(i)>=0:m.find(c,this,null,[i]).length),e[c]&&e.push(d);e.length&&g.push({elem:i,handlers:e})}return h<b.length&&g.push({elem:this,handlers:b.slice(h)}),g},fix:function(a){if(a[m.expando])return a;var b,c,d,e=a.type,f=a,g=this.fixHooks[e];g||(this.fixHooks[e]=g=Z.test(e)?this.mouseHooks:Y.test(e)?this.keyHooks:{}),d=g.props?this.props.concat(g.props):this.props,a=new m.Event(f),b=d.length;while(b--)c=d[b],a[c]=f[c];return a.target||(a.target=f.srcElement||y),3===a.target.nodeType&&(a.target=a.target.parentNode),a.metaKey=!!a.metaKey,g.filter?g.filter(a,f):a},props:"altKey bubbles cancelable ctrlKey currentTarget eventPhase metaKey relatedTarget shiftKey target timeStamp view which".split(" "),fixHooks:{},keyHooks:{props:"char charCode key keyCode".split(" "),filter:function(a,b){return null==a.which&&(a.which=null!=b.charCode?b.charCode:b.keyCode),a}},mouseHooks:{props:"button buttons clientX clientY fromElement offsetX offsetY pageX pageY screenX screenY toElement".split(" "),filter:function(a,b){var c,d,e,f=b.button,g=b.fromElement;return null==a.pageX&&null!=b.clientX&&(d=a.target.ownerDocument||y,e=d.documentElement,c=d.body,a.pageX=b.clientX+(e&&e.scrollLeft||c&&c.scrollLeft||0)-(e&&e.clientLeft||c&&c.clientLeft||0),a.pageY=b.clientY+(e&&e.scrollTop||c&&c.scrollTop||0)-(e&&e.clientTop||c&&c.clientTop||0)),!a.relatedTarget&&g&&(a.relatedTarget=g===a.target?b.toElement:g),a.which||void 0===f||(a.which=1&f?1:2&f?3:4&f?2:0),a}},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==ca()&&this.focus)try{return this.focus(),!1}catch(a){}},delegateType:"focusin"},blur:{trigger:function(){return this===ca()&&this.blur?(this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return m.nodeName(this,"input")&&"checkbox"===this.type&&this.click?(this.click(),!1):void 0},_default:function(a){return m.nodeName(a.target,"a")}},beforeunload:{postDispatch:function(a){void 0!==a.result&&a.originalEvent&&(a.originalEvent.returnValue=a.result)}}},simulate:function(a,b,c,d){var e=m.extend(new m.Event,c,{type:a,isSimulated:!0,originalEvent:{}});d?m.event.trigger(e,null,b):m.event.dispatch.call(b,e),e.isDefaultPrevented()&&c.preventDefault()}},m.removeEvent=y.removeEventListener?function(a,b,c){a.removeEventListener&&a.removeEventListener(b,c,!1)}:function(a,b,c){var d="on"+b;a.detachEvent&&(typeof a[d]===K&&(a[d]=null),a.detachEvent(d,c))},m.Event=function(a,b){return this instanceof m.Event?(a&&a.type?(this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?aa:ba):this.type=a,b&&m.extend(this,b),this.timeStamp=a&&a.timeStamp||m.now(),void(this[m.expando]=!0)):new m.Event(a,b)},m.Event.prototype={isDefaultPrevented:ba,isPropagationStopped:ba,isImmediatePropagationStopped:ba,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=aa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=aa,a&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=aa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},m.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){m.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return(!e||e!==d&&!m.contains(d,e))&&(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),k.submitBubbles||(m.event.special.submit={setup:function(){return m.nodeName(this,"form")?!1:void m.event.add(this,"click._submit keypress._submit",function(a){var b=a.target,c=m.nodeName(b,"input")||m.nodeName(b,"button")?b.form:void 0;c&&!m._data(c,"submitBubbles")&&(m.event.add(c,"submit._submit",function(a){a._submit_bubble=!0}),m._data(c,"submitBubbles",!0))})},postDispatch:function(a){a._submit_bubble&&(delete a._submit_bubble,this.parentNode&&!a.isTrigger&&m.event.simulate("submit",this.parentNode,a,!0))},teardown:function(){return m.nodeName(this,"form")?!1:void m.event.remove(this,"._submit")}}),k.changeBubbles||(m.event.special.change={setup:function(){return X.test(this.nodeName)?(("checkbox"===this.type||"radio"===this.type)&&(m.event.add(this,"propertychange._change",function(a){"checked"===a.originalEvent.propertyName&&(this._just_changed=!0)}),m.event.add(this,"click._change",function(a){this._just_changed&&!a.isTrigger&&(this._just_changed=!1),m.event.simulate("change",this,a,!0)})),!1):void m.event.add(this,"beforeactivate._change",function(a){var b=a.target;X.test(b.nodeName)&&!m._data(b,"changeBubbles")&&(m.event.add(b,"change._change",function(a){!this.parentNode||a.isSimulated||a.isTrigger||m.event.simulate("change",this.parentNode,a,!0)}),m._data(b,"changeBubbles",!0))})},handle:function(a){var b=a.target;return this!==b||a.isSimulated||a.isTrigger||"radio"!==b.type&&"checkbox"!==b.type?a.handleObj.handler.apply(this,arguments):void 0},teardown:function(){return m.event.remove(this,"._change"),!X.test(this.nodeName)}}),k.focusinBubbles||m.each({focus:"focusin",blur:"focusout"},function(a,b){var c=function(a){m.event.simulate(b,a.target,m.event.fix(a),!0)};m.event.special[b]={setup:function(){var d=this.ownerDocument||this,e=m._data(d,b);e||d.addEventListener(a,c,!0),m._data(d,b,(e||0)+1)},teardown:function(){var d=this.ownerDocument||this,e=m._data(d,b)-1;e?m._data(d,b,e):(d.removeEventListener(a,c,!0),m._removeData(d,b))}}}),m.fn.extend({on:function(a,b,c,d,e){var f,g;if("object"==typeof a){"string"!=typeof b&&(c=c||b,b=void 0);for(f in a)this.on(f,b,c,a[f],e);return this}if(null==c&&null==d?(d=b,c=b=void 0):null==d&&("string"==typeof b?(d=c,c=void 0):(d=c,c=b,b=void 0)),d===!1)d=ba;else if(!d)return this;return 1===e&&(g=d,d=function(a){return m().off(a),g.apply(this,arguments)},d.guid=g.guid||(g.guid=m.guid++)),this.each(function(){m.event.add(this,a,d,c,b)})},one:function(a,b,c,d){return this.on(a,b,c,d,1)},off:function(a,b,c){var d,e;if(a&&a.preventDefault&&a.handleObj)return d=a.handleObj,m(a.delegateTarget).off(d.namespace?d.origType+"."+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return(b===!1||"function"==typeof b)&&(c=b,b=void 0),c===!1&&(c=ba),this.each(function(){m.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){m.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?m.event.trigger(a,b,c,!0):void 0}});function da(a){var b=ea.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}var ea="abbr|article|aside|audio|bdi|canvas|data|datalist|details|figcaption|figure|footer|header|hgroup|mark|meter|nav|output|progress|section|summary|time|video",fa=/ jQuery\d+="(?:null|\d+)"/g,ga=new RegExp("<(?:"+ea+")[\\s/>]","i"),ha=/^\s+/,ia=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:]+)[^>]*)\/>/gi,ja=/<([\w:]+)/,ka=/<tbody/i,la=/<|&#?\w+;/,ma=/<(?:script|style|link)/i,na=/checked\s*(?:[^=]|=\s*.checked.)/i,oa=/^$|\/(?:java|ecma)script/i,pa=/^true\/(.*)/,qa=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g,ra={option:[1,"<select multiple='multiple'>","</select>"],legend:[1,"<fieldset>","</fieldset>"],area:[1,"<map>","</map>"],param:[1,"<object>","</object>"],thead:[1,"<table>","</table>"],tr:[2,"<table><tbody>","</tbody></table>"],col:[2,"<table><tbody></tbody><colgroup>","</colgroup></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:k.htmlSerialize?[0,"",""]:[1,"X<div>","</div>"]},sa=da(y),ta=sa.appendChild(y.createElement("div"));ra.optgroup=ra.option,ra.tbody=ra.tfoot=ra.colgroup=ra.caption=ra.thead,ra.th=ra.td;function ua(a,b){var c,d,e=0,f=typeof a.getElementsByTagName!==K?a.getElementsByTagName(b||"*"):typeof a.querySelectorAll!==K?a.querySelectorAll(b||"*"):void 0;if(!f)for(f=[],c=a.childNodes||a;null!=(d=c[e]);e++)!b||m.nodeName(d,b)?f.push(d):m.merge(f,ua(d,b));return void 0===b||b&&m.nodeName(a,b)?m.merge([a],f):f}function va(a){W.test(a.type)&&(a.defaultChecked=a.checked)}function wa(a,b){return m.nodeName(a,"table")&&m.nodeName(11!==b.nodeType?b:b.firstChild,"tr")?a.getElementsByTagName("tbody")[0]||a.appendChild(a.ownerDocument.createElement("tbody")):a}function xa(a){return a.type=(null!==m.find.attr(a,"type"))+"/"+a.type,a}function ya(a){var b=pa.exec(a.type);return b?a.type=b[1]:a.removeAttribute("type"),a}function za(a,b){for(var c,d=0;null!=(c=a[d]);d++)m._data(c,"globalEval",!b||m._data(b[d],"globalEval"))}function Aa(a,b){if(1===b.nodeType&&m.hasData(a)){var c,d,e,f=m._data(a),g=m._data(b,f),h=f.events;if(h){delete g.handle,g.events={};for(c in h)for(d=0,e=h[c].length;e>d;d++)m.event.add(b,c,h[c][d])}g.data&&(g.data=m.extend({},g.data))}}function Ba(a,b){var c,d,e;if(1===b.nodeType){if(c=b.nodeName.toLowerCase(),!k.noCloneEvent&&b[m.expando]){e=m._data(b);for(d in e.events)m.removeEvent(b,d,e.handle);b.removeAttribute(m.expando)}"script"===c&&b.text!==a.text?(xa(b).text=a.text,ya(b)):"object"===c?(b.parentNode&&(b.outerHTML=a.outerHTML),k.html5Clone&&a.innerHTML&&!m.trim(b.innerHTML)&&(b.innerHTML=a.innerHTML)):"input"===c&&W.test(a.type)?(b.defaultChecked=b.checked=a.checked,b.value!==a.value&&(b.value=a.value)):"option"===c?b.defaultSelected=b.selected=a.defaultSelected:("input"===c||"textarea"===c)&&(b.defaultValue=a.defaultValue)}}m.extend({clone:function(a,b,c){var d,e,f,g,h,i=m.contains(a.ownerDocument,a);if(k.html5Clone||m.isXMLDoc(a)||!ga.test("<"+a.nodeName+">")?f=a.cloneNode(!0):(ta.innerHTML=a.outerHTML,ta.removeChild(f=ta.firstChild)),!(k.noCloneEvent&&k.noCloneChecked||1!==a.nodeType&&11!==a.nodeType||m.isXMLDoc(a)))for(d=ua(f),h=ua(a),g=0;null!=(e=h[g]);++g)d[g]&&Ba(e,d[g]);if(b)if(c)for(h=h||ua(a),d=d||ua(f),g=0;null!=(e=h[g]);g++)Aa(e,d[g]);else Aa(a,f);return d=ua(f,"script"),d.length>0&&za(d,!i&&ua(a,"script")),d=h=e=null,f},buildFragment:function(a,b,c,d){for(var e,f,g,h,i,j,l,n=a.length,o=da(b),p=[],q=0;n>q;q++)if(f=a[q],f||0===f)if("object"===m.type(f))m.merge(p,f.nodeType?[f]:f);else if(la.test(f)){h=h||o.appendChild(b.createElement("div")),i=(ja.exec(f)||["",""])[1].toLowerCase(),l=ra[i]||ra._default,h.innerHTML=l[1]+f.replace(ia,"<$1></$2>")+l[2],e=l[0];while(e--)h=h.lastChild;if(!k.leadingWhitespace&&ha.test(f)&&p.push(b.createTextNode(ha.exec(f)[0])),!k.tbody){f="table"!==i||ka.test(f)?"<table>"!==l[1]||ka.test(f)?0:h:h.firstChild,e=f&&f.childNodes.length;while(e--)m.nodeName(j=f.childNodes[e],"tbody")&&!j.childNodes.length&&f.removeChild(j)}m.merge(p,h.childNodes),h.textContent="";while(h.firstChild)h.removeChild(h.firstChild);h=o.lastChild}else p.push(b.createTextNode(f));h&&o.removeChild(h),k.appendChecked||m.grep(ua(p,"input"),va),q=0;while(f=p[q++])if((!d||-1===m.inArray(f,d))&&(g=m.contains(f.ownerDocument,f),h=ua(o.appendChild(f),"script"),g&&za(h),c)){e=0;while(f=h[e++])oa.test(f.type||"")&&c.push(f)}return h=null,o},cleanData:function(a,b){for(var d,e,f,g,h=0,i=m.expando,j=m.cache,l=k.deleteExpando,n=m.event.special;null!=(d=a[h]);h++)if((b||m.acceptData(d))&&(f=d[i],g=f&&j[f])){if(g.events)for(e in g.events)n[e]?m.event.remove(d,e):m.removeEvent(d,e,g.handle);j[f]&&(delete j[f],l?delete d[i]:typeof d.removeAttribute!==K?d.removeAttribute(i):d[i]=null,c.push(f))}}}),m.fn.extend({text:function(a){return V(this,function(a){return void 0===a?m.text(this):this.empty().append((this[0]&&this[0].ownerDocument||y).createTextNode(a))},null,a,arguments.length)},append:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.appendChild(a)}})},prepend:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.insertBefore(a,b.firstChild)}})},before:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this)})},after:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this.nextSibling)})},remove:function(a,b){for(var c,d=a?m.filter(a,this):this,e=0;null!=(c=d[e]);e++)b||1!==c.nodeType||m.cleanData(ua(c)),c.parentNode&&(b&&m.contains(c.ownerDocument,c)&&za(ua(c,"script")),c.parentNode.removeChild(c));return this},empty:function(){for(var a,b=0;null!=(a=this[b]);b++){1===a.nodeType&&m.cleanData(ua(a,!1));while(a.firstChild)a.removeChild(a.firstChild);a.options&&m.nodeName(a,"select")&&(a.options.length=0)}return this},clone:function(a,b){return a=null==a?!1:a,b=null==b?a:b,this.map(function(){return m.clone(this,a,b)})},html:function(a){return V(this,function(a){var b=this[0]||{},c=0,d=this.length;if(void 0===a)return 1===b.nodeType?b.innerHTML.replace(fa,""):void 0;if(!("string"!=typeof a||ma.test(a)||!k.htmlSerialize&&ga.test(a)||!k.leadingWhitespace&&ha.test(a)||ra[(ja.exec(a)||["",""])[1].toLowerCase()])){a=a.replace(ia,"<$1></$2>");try{for(;d>c;c++)b=this[c]||{},1===b.nodeType&&(m.cleanData(ua(b,!1)),b.innerHTML=a);b=0}catch(e){}}b&&this.empty().append(a)},null,a,arguments.length)},replaceWith:function(){var a=arguments[0];return this.domManip(arguments,function(b){a=this.parentNode,m.cleanData(ua(this)),a&&a.replaceChild(b,this)}),a&&(a.length||a.nodeType)?this:this.remove()},detach:function(a){return this.remove(a,!0)},domManip:function(a,b){a=e.apply([],a);var c,d,f,g,h,i,j=0,l=this.length,n=this,o=l-1,p=a[0],q=m.isFunction(p);if(q||l>1&&"string"==typeof p&&!k.checkClone&&na.test(p))return this.each(function(c){var d=n.eq(c);q&&(a[0]=p.call(this,c,d.html())),d.domManip(a,b)});if(l&&(i=m.buildFragment(a,this[0].ownerDocument,!1,this),c=i.firstChild,1===i.childNodes.length&&(i=c),c)){for(g=m.map(ua(i,"script"),xa),f=g.length;l>j;j++)d=i,j!==o&&(d=m.clone(d,!0,!0),f&&m.merge(g,ua(d,"script"))),b.call(this[j],d,j);if(f)for(h=g[g.length-1].ownerDocument,m.map(g,ya),j=0;f>j;j++)d=g[j],oa.test(d.type||"")&&!m._data(d,"globalEval")&&m.contains(h,d)&&(d.src?m._evalUrl&&m._evalUrl(d.src):m.globalEval((d.text||d.textContent||d.innerHTML||"").replace(qa,"")));i=c=null}return this}}),m.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(a,b){m.fn[a]=function(a){for(var c,d=0,e=[],g=m(a),h=g.length-1;h>=d;d++)c=d===h?this:this.clone(!0),m(g[d])[b](c),f.apply(e,c.get());return this.pushStack(e)}});var Ca,Da={};function Ea(b,c){var d,e=m(c.createElement(b)).appendTo(c.body),f=a.getDefaultComputedStyle&&(d=a.getDefaultComputedStyle(e[0]))?d.display:m.css(e[0],"display");return e.detach(),f}function Fa(a){var b=y,c=Da[a];return c||(c=Ea(a,b),"none"!==c&&c||(Ca=(Ca||m("<iframe frameborder='0' width='0' height='0'/>")).appendTo(b.documentElement),b=(Ca[0].contentWindow||Ca[0].contentDocument).document,b.write(),b.close(),c=Ea(a,b),Ca.detach()),Da[a]=c),c}!function(){var a;k.shrinkWrapBlocks=function(){if(null!=a)return a;a=!1;var b,c,d;return c=y.getElementsByTagName("body")[0],c&&c.style?(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:1px;width:1px;zoom:1",b.appendChild(y.createElement("div")).style.width="5px",a=3!==b.offsetWidth),c.removeChild(d),a):void 0}}();var Ga=/^margin/,Ha=new RegExp("^("+S+")(?!px)[a-z%]+$","i"),Ia,Ja,Ka=/^(top|right|bottom|left)$/;a.getComputedStyle?(Ia=function(b){return b.ownerDocument.defaultView.opener?b.ownerDocument.defaultView.getComputedStyle(b,null):a.getComputedStyle(b,null)},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c.getPropertyValue(b)||c[b]:void 0,c&&(""!==g||m.contains(a.ownerDocument,a)||(g=m.style(a,b)),Ha.test(g)&&Ga.test(b)&&(d=h.width,e=h.minWidth,f=h.maxWidth,h.minWidth=h.maxWidth=h.width=g,g=c.width,h.width=d,h.minWidth=e,h.maxWidth=f)),void 0===g?g:g+""}):y.documentElement.currentStyle&&(Ia=function(a){return a.currentStyle},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c[b]:void 0,null==g&&h&&h[b]&&(g=h[b]),Ha.test(g)&&!Ka.test(b)&&(d=h.left,e=a.runtimeStyle,f=e&&e.left,f&&(e.left=a.currentStyle.left),h.left="fontSize"===b?"1em":g,g=h.pixelLeft+"px",h.left=d,f&&(e.left=f)),void 0===g?g:g+""||"auto"});function La(a,b){return{get:function(){var c=a();if(null!=c)return c?void delete this.get:(this.get=b).apply(this,arguments)}}}!function(){var b,c,d,e,f,g,h;if(b=y.createElement("div"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=d&&d.style){c.cssText="float:left;opacity:.5",k.opacity="0.5"===c.opacity,k.cssFloat=!!c.cssFloat,b.style.backgroundClip="content-box",b.cloneNode(!0).style.backgroundClip="",k.clearCloneStyle="content-box"===b.style.backgroundClip,k.boxSizing=""===c.boxSizing||""===c.MozBoxSizing||""===c.WebkitBoxSizing,m.extend(k,{reliableHiddenOffsets:function(){return null==g&&i(),g},boxSizingReliable:function(){return null==f&&i(),f},pixelPosition:function(){return null==e&&i(),e},reliableMarginRight:function(){return null==h&&i(),h}});function i(){var b,c,d,i;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),b.style.cssText="-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;display:block;margin-top:1%;top:1%;border:1px;padding:1px;width:4px;position:absolute",e=f=!1,h=!0,a.getComputedStyle&&(e="1%"!==(a.getComputedStyle(b,null)||{}).top,f="4px"===(a.getComputedStyle(b,null)||{width:"4px"}).width,i=b.appendChild(y.createElement("div")),i.style.cssText=b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:0",i.style.marginRight=i.style.width="0",b.style.width="1px",h=!parseFloat((a.getComputedStyle(i,null)||{}).marginRight),b.removeChild(i)),b.innerHTML="<table><tr><td></td><td>t</td></tr></table>",i=b.getElementsByTagName("td"),i[0].style.cssText="margin:0;border:0;padding:0;display:none",g=0===i[0].offsetHeight,g&&(i[0].style.display="",i[1].style.display="none",g=0===i[0].offsetHeight),c.removeChild(d))}}}(),m.swap=function(a,b,c,d){var e,f,g={};for(f in b)g[f]=a.style[f],a.style[f]=b[f];e=c.apply(a,d||[]);for(f in b)a.style[f]=g[f];return e};var Ma=/alpha\([^)]*\)/i,Na=/opacity\s*=\s*([^)]*)/,Oa=/^(none|table(?!-c[ea]).+)/,Pa=new RegExp("^("+S+")(.*)$","i"),Qa=new RegExp("^([+-])=("+S+")","i"),Ra={position:"absolute",visibility:"hidden",display:"block"},Sa={letterSpacing:"0",fontWeight:"400"},Ta=["Webkit","O","Moz","ms"];function Ua(a,b){if(b in a)return b;var c=b.charAt(0).toUpperCase()+b.slice(1),d=b,e=Ta.length;while(e--)if(b=Ta[e]+c,b in a)return b;return d}function Va(a,b){for(var c,d,e,f=[],g=0,h=a.length;h>g;g++)d=a[g],d.style&&(f[g]=m._data(d,"olddisplay"),c=d.style.display,b?(f[g]||"none"!==c||(d.style.display=""),""===d.style.display&&U(d)&&(f[g]=m._data(d,"olddisplay",Fa(d.nodeName)))):(e=U(d),(c&&"none"!==c||!e)&&m._data(d,"olddisplay",e?c:m.css(d,"display"))));for(g=0;h>g;g++)d=a[g],d.style&&(b&&"none"!==d.style.display&&""!==d.style.display||(d.style.display=b?f[g]||"":"none"));return a}function Wa(a,b,c){var d=Pa.exec(b);return d?Math.max(0,d[1]-(c||0))+(d[2]||"px"):b}function Xa(a,b,c,d,e){for(var f=c===(d?"border":"content")?4:"width"===b?1:0,g=0;4>f;f+=2)"margin"===c&&(g+=m.css(a,c+T[f],!0,e)),d?("content"===c&&(g-=m.css(a,"padding"+T[f],!0,e)),"margin"!==c&&(g-=m.css(a,"border"+T[f]+"Width",!0,e))):(g+=m.css(a,"padding"+T[f],!0,e),"padding"!==c&&(g+=m.css(a,"border"+T[f]+"Width",!0,e)));return g}function Ya(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ia(a),g=k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Ja(a,b,f),(0>e||null==e)&&(e=a.style[b]),Ha.test(e))return e;d=g&&(k.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+Xa(a,b,c||(g?"border":"content"),d,f)+"px"}m.extend({cssHooks:{opacity:{get:function(a,b){if(b){var c=Ja(a,"opacity");return""===c?"1":c}}}},cssNumber:{columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{"float":k.cssFloat?"cssFloat":"styleFloat"},style:function(a,b,c,d){if(a&&3!==a.nodeType&&8!==a.nodeType&&a.style){var e,f,g,h=m.camelCase(b),i=a.style;if(b=m.cssProps[h]||(m.cssProps[h]=Ua(i,h)),g=m.cssHooks[b]||m.cssHooks[h],void 0===c)return g&&"get"in g&&void 0!==(e=g.get(a,!1,d))?e:i[b];if(f=typeof c,"string"===f&&(e=Qa.exec(c))&&(c=(e[1]+1)*e[2]+parseFloat(m.css(a,b)),f="number"),null!=c&&c===c&&("number"!==f||m.cssNumber[h]||(c+="px"),k.clearCloneStyle||""!==c||0!==b.indexOf("background")||(i[b]="inherit"),!(g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=m.camelCase(b);return b=m.cssProps[h]||(m.cssProps[h]=Ua(a.style,h)),g=m.cssHooks[b]||m.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Ja(a,b,d)),"normal"===f&&b in Sa&&(f=Sa[b]),""===c||c?(e=parseFloat(f),c===!0||m.isNumeric(e)?e||0:f):f}}),m.each(["height","width"],function(a,b){m.cssHooks[b]={get:function(a,c,d){return c?Oa.test(m.css(a,"display"))&&0===a.offsetWidth?m.swap(a,Ra,function(){return Ya(a,b,d)}):Ya(a,b,d):void 0},set:function(a,c,d){var e=d&&Ia(a);return Wa(a,c,d?Xa(a,b,d,k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,e),e):0)}}}),k.opacity||(m.cssHooks.opacity={get:function(a,b){return Na.test((b&&a.currentStyle?a.currentStyle.filter:a.style.filter)||"")?.01*parseFloat(RegExp.$1)+"":b?"1":""},set:function(a,b){var c=a.style,d=a.currentStyle,e=m.isNumeric(b)?"alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===m.trim(f.replace(Ma,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Ma.test(f)?f.replace(Ma,e):f+" "+e)}}),m.cssHooks.marginRight=La(k.reliableMarginRight,function(a,b){return b?m.swap(a,{display:"inline-block"},Ja,[a,"marginRight"]):void 0}),m.each({margin:"",padding:"",border:"Width"},function(a,b){m.cssHooks[a+b]={expand:function(c){for(var d=0,e={},f="string"==typeof c?c.split(" "):[c];4>d;d++)e[a+T[d]+b]=f[d]||f[d-2]||f[0];return e}},Ga.test(a)||(m.cssHooks[a+b].set=Wa)}),m.fn.extend({css:function(a,b){return V(this,function(a,b,c){var d,e,f={},g=0;if(m.isArray(b)){for(d=Ia(a),e=b.length;e>g;g++)f[b[g]]=m.css(a,b[g],!1,d);return f}return void 0!==c?m.style(a,b,c):m.css(a,b)},a,b,arguments.length>1)},show:function(){return Va(this,!0)},hide:function(){return Va(this)},toggle:function(a){return"boolean"==typeof a?a?this.show():this.hide():this.each(function(){U(this)?m(this).show():m(this).hide()})}});function Za(a,b,c,d,e){
return new Za.prototype.init(a,b,c,d,e)}m.Tween=Za,Za.prototype={constructor:Za,init:function(a,b,c,d,e,f){this.elem=a,this.prop=c,this.easing=e||"swing",this.options=b,this.start=this.now=this.cur(),this.end=d,this.unit=f||(m.cssNumber[c]?"":"px")},cur:function(){var a=Za.propHooks[this.prop];return a&&a.get?a.get(this):Za.propHooks._default.get(this)},run:function(a){var b,c=Za.propHooks[this.prop];return this.options.duration?this.pos=b=m.easing[this.easing](a,this.options.duration*a,0,1,this.options.duration):this.pos=b=a,this.now=(this.end-this.start)*b+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),c&&c.set?c.set(this):Za.propHooks._default.set(this),this}},Za.prototype.init.prototype=Za.prototype,Za.propHooks={_default:{get:function(a){var b;return null==a.elem[a.prop]||a.elem.style&&null!=a.elem.style[a.prop]?(b=m.css(a.elem,a.prop,""),b&&"auto"!==b?b:0):a.elem[a.prop]},set:function(a){m.fx.step[a.prop]?m.fx.step[a.prop](a):a.elem.style&&(null!=a.elem.style[m.cssProps[a.prop]]||m.cssHooks[a.prop])?m.style(a.elem,a.prop,a.now+a.unit):a.elem[a.prop]=a.now}}},Za.propHooks.scrollTop=Za.propHooks.scrollLeft={set:function(a){a.elem.nodeType&&a.elem.parentNode&&(a.elem[a.prop]=a.now)}},m.easing={linear:function(a){return a},swing:function(a){return.5-Math.cos(a*Math.PI)/2}},m.fx=Za.prototype.init,m.fx.step={};var $a,_a,ab=/^(?:toggle|show|hide)$/,bb=new RegExp("^(?:([+-])=|)("+S+")([a-z%]*)$","i"),cb=/queueHooks$/,db=[ib],eb={"*":[function(a,b){var c=this.createTween(a,b),d=c.cur(),e=bb.exec(b),f=e&&e[3]||(m.cssNumber[a]?"":"px"),g=(m.cssNumber[a]||"px"!==f&&+d)&&bb.exec(m.css(c.elem,a)),h=1,i=20;if(g&&g[3]!==f){f=f||g[3],e=e||[],g=+d||1;do h=h||".5",g/=h,m.style(c.elem,a,g+f);while(h!==(h=c.cur()/d)&&1!==h&&--i)}return e&&(g=c.start=+g||+d||0,c.unit=f,c.end=e[1]?g+(e[1]+1)*e[2]:+e[2]),c}]};function fb(){return setTimeout(function(){$a=void 0}),$a=m.now()}function gb(a,b){var c,d={height:a},e=0;for(b=b?1:0;4>e;e+=2-b)c=T[e],d["margin"+c]=d["padding"+c]=a;return b&&(d.opacity=d.width=a),d}function hb(a,b,c){for(var d,e=(eb[b]||[]).concat(eb["*"]),f=0,g=e.length;g>f;f++)if(d=e[f].call(c,b,a))return d}function ib(a,b,c){var d,e,f,g,h,i,j,l,n=this,o={},p=a.style,q=a.nodeType&&U(a),r=m._data(a,"fxshow");c.queue||(h=m._queueHooks(a,"fx"),null==h.unqueued&&(h.unqueued=0,i=h.empty.fire,h.empty.fire=function(){h.unqueued||i()}),h.unqueued++,n.always(function(){n.always(function(){h.unqueued--,m.queue(a,"fx").length||h.empty.fire()})})),1===a.nodeType&&("height"in b||"width"in b)&&(c.overflow=[p.overflow,p.overflowX,p.overflowY],j=m.css(a,"display"),l="none"===j?m._data(a,"olddisplay")||Fa(a.nodeName):j,"inline"===l&&"none"===m.css(a,"float")&&(k.inlineBlockNeedsLayout&&"inline"!==Fa(a.nodeName)?p.zoom=1:p.display="inline-block")),c.overflow&&(p.overflow="hidden",k.shrinkWrapBlocks()||n.always(function(){p.overflow=c.overflow[0],p.overflowX=c.overflow[1],p.overflowY=c.overflow[2]}));for(d in b)if(e=b[d],ab.exec(e)){if(delete b[d],f=f||"toggle"===e,e===(q?"hide":"show")){if("show"!==e||!r||void 0===r[d])continue;q=!0}o[d]=r&&r[d]||m.style(a,d)}else j=void 0;if(m.isEmptyObject(o))"inline"===("none"===j?Fa(a.nodeName):j)&&(p.display=j);else{r?"hidden"in r&&(q=r.hidden):r=m._data(a,"fxshow",{}),f&&(r.hidden=!q),q?m(a).show():n.done(function(){m(a).hide()}),n.done(function(){var b;m._removeData(a,"fxshow");for(b in o)m.style(a,b,o[b])});for(d in o)g=hb(q?r[d]:0,d,n),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function jb(a,b){var c,d,e,f,g;for(c in a)if(d=m.camelCase(c),e=b[d],f=a[c],m.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=m.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function kb(a,b,c){var d,e,f=0,g=db.length,h=m.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=$a||fb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:m.extend({},b),opts:m.extend(!0,{specialEasing:{}},c),originalProperties:b,originalOptions:c,startTime:$a||fb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=m.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b?h.resolveWith(a,[j,b]):h.rejectWith(a,[j,b]),this}}),k=j.props;for(jb(k,j.opts.specialEasing);g>f;f++)if(d=db[f].call(j,a,k,j.opts))return d;return m.map(k,hb,j),m.isFunction(j.opts.start)&&j.opts.start.call(a,j),m.fx.timer(m.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}m.Animation=m.extend(kb,{tweener:function(a,b){m.isFunction(a)?(b=a,a=["*"]):a=a.split(" ");for(var c,d=0,e=a.length;e>d;d++)c=a[d],eb[c]=eb[c]||[],eb[c].unshift(b)},prefilter:function(a,b){b?db.unshift(a):db.push(a)}}),m.speed=function(a,b,c){var d=a&&"object"==typeof a?m.extend({},a):{complete:c||!c&&b||m.isFunction(a)&&a,duration:a,easing:c&&b||b&&!m.isFunction(b)&&b};return d.duration=m.fx.off?0:"number"==typeof d.duration?d.duration:d.duration in m.fx.speeds?m.fx.speeds[d.duration]:m.fx.speeds._default,(null==d.queue||d.queue===!0)&&(d.queue="fx"),d.old=d.complete,d.complete=function(){m.isFunction(d.old)&&d.old.call(this),d.queue&&m.dequeue(this,d.queue)},d},m.fn.extend({fadeTo:function(a,b,c,d){return this.filter(U).css("opacity",0).show().end().animate({opacity:b},a,c,d)},animate:function(a,b,c,d){var e=m.isEmptyObject(a),f=m.speed(b,c,d),g=function(){var b=kb(this,m.extend({},a),f);(e||m._data(this,"finish"))&&b.stop(!0)};return g.finish=g,e||f.queue===!1?this.each(g):this.queue(f.queue,g)},stop:function(a,b,c){var d=function(a){var b=a.stop;delete a.stop,b(c)};return"string"!=typeof a&&(c=b,b=a,a=void 0),b&&a!==!1&&this.queue(a||"fx",[]),this.each(function(){var b=!0,e=null!=a&&a+"queueHooks",f=m.timers,g=m._data(this);if(e)g[e]&&g[e].stop&&d(g[e]);else for(e in g)g[e]&&g[e].stop&&cb.test(e)&&d(g[e]);for(e=f.length;e--;)f[e].elem!==this||null!=a&&f[e].queue!==a||(f[e].anim.stop(c),b=!1,f.splice(e,1));(b||!c)&&m.dequeue(this,a)})},finish:function(a){return a!==!1&&(a=a||"fx"),this.each(function(){var b,c=m._data(this),d=c[a+"queue"],e=c[a+"queueHooks"],f=m.timers,g=d?d.length:0;for(c.finish=!0,m.queue(this,a,[]),e&&e.stop&&e.stop.call(this,!0),b=f.length;b--;)f[b].elem===this&&f[b].queue===a&&(f[b].anim.stop(!0),f.splice(b,1));for(b=0;g>b;b++)d[b]&&d[b].finish&&d[b].finish.call(this);delete c.finish})}}),m.each(["toggle","show","hide"],function(a,b){var c=m.fn[b];m.fn[b]=function(a,d,e){return null==a||"boolean"==typeof a?c.apply(this,arguments):this.animate(gb(b,!0),a,d,e)}}),m.each({slideDown:gb("show"),slideUp:gb("hide"),slideToggle:gb("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(a,b){m.fn[a]=function(a,c,d){return this.animate(b,a,c,d)}}),m.timers=[],m.fx.tick=function(){var a,b=m.timers,c=0;for($a=m.now();c<b.length;c++)a=b[c],a()||b[c]!==a||b.splice(c--,1);b.length||m.fx.stop(),$a=void 0},m.fx.timer=function(a){m.timers.push(a),a()?m.fx.start():m.timers.pop()},m.fx.interval=13,m.fx.start=function(){_a||(_a=setInterval(m.fx.tick,m.fx.interval))},m.fx.stop=function(){clearInterval(_a),_a=null},m.fx.speeds={slow:600,fast:200,_default:400},m.fn.delay=function(a,b){return a=m.fx?m.fx.speeds[a]||a:a,b=b||"fx",this.queue(b,function(b,c){var d=setTimeout(b,a);c.stop=function(){clearTimeout(d)}})},function(){var a,b,c,d,e;b=y.createElement("div"),b.setAttribute("className","t"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=y.createElement("select"),e=c.appendChild(y.createElement("option")),a=b.getElementsByTagName("input")[0],d.style.cssText="top:1px",k.getSetAttribute="t"!==b.className,k.style=/top/.test(d.getAttribute("style")),k.hrefNormalized="/a"===d.getAttribute("href"),k.checkOn=!!a.value,k.optSelected=e.selected,k.enctype=!!y.createElement("form").enctype,c.disabled=!0,k.optDisabled=!e.disabled,a=y.createElement("input"),a.setAttribute("value",""),k.input=""===a.getAttribute("value"),a.value="t",a.setAttribute("type","radio"),k.radioValue="t"===a.value}();var lb=/\r/g;m.fn.extend({val:function(a){var b,c,d,e=this[0];{if(arguments.length)return d=m.isFunction(a),this.each(function(c){var e;1===this.nodeType&&(e=d?a.call(this,c,m(this).val()):a,null==e?e="":"number"==typeof e?e+="":m.isArray(e)&&(e=m.map(e,function(a){return null==a?"":a+""})),b=m.valHooks[this.type]||m.valHooks[this.nodeName.toLowerCase()],b&&"set"in b&&void 0!==b.set(this,e,"value")||(this.value=e))});if(e)return b=m.valHooks[e.type]||m.valHooks[e.nodeName.toLowerCase()],b&&"get"in b&&void 0!==(c=b.get(e,"value"))?c:(c=e.value,"string"==typeof c?c.replace(lb,""):null==c?"":c)}}}),m.extend({valHooks:{option:{get:function(a){var b=m.find.attr(a,"value");return null!=b?b:m.trim(m.text(a))}},select:{get:function(a){for(var b,c,d=a.options,e=a.selectedIndex,f="select-one"===a.type||0>e,g=f?null:[],h=f?e+1:d.length,i=0>e?h:f?e:0;h>i;i++)if(c=d[i],!(!c.selected&&i!==e||(k.optDisabled?c.disabled:null!==c.getAttribute("disabled"))||c.parentNode.disabled&&m.nodeName(c.parentNode,"optgroup"))){if(b=m(c).val(),f)return b;g.push(b)}return g},set:function(a,b){var c,d,e=a.options,f=m.makeArray(b),g=e.length;while(g--)if(d=e[g],m.inArray(m.valHooks.option.get(d),f)>=0)try{d.selected=c=!0}catch(h){d.scrollHeight}else d.selected=!1;return c||(a.selectedIndex=-1),e}}}}),m.each(["radio","checkbox"],function(){m.valHooks[this]={set:function(a,b){return m.isArray(b)?a.checked=m.inArray(m(a).val(),b)>=0:void 0}},k.checkOn||(m.valHooks[this].get=function(a){return null===a.getAttribute("value")?"on":a.value})});var mb,nb,ob=m.expr.attrHandle,pb=/^(?:checked|selected)$/i,qb=k.getSetAttribute,rb=k.input;m.fn.extend({attr:function(a,b){return V(this,m.attr,a,b,arguments.length>1)},removeAttr:function(a){return this.each(function(){m.removeAttr(this,a)})}}),m.extend({attr:function(a,b,c){var d,e,f=a.nodeType;if(a&&3!==f&&8!==f&&2!==f)return typeof a.getAttribute===K?m.prop(a,b,c):(1===f&&m.isXMLDoc(a)||(b=b.toLowerCase(),d=m.attrHooks[b]||(m.expr.match.bool.test(b)?nb:mb)),void 0===c?d&&"get"in d&&null!==(e=d.get(a,b))?e:(e=m.find.attr(a,b),null==e?void 0:e):null!==c?d&&"set"in d&&void 0!==(e=d.set(a,c,b))?e:(a.setAttribute(b,c+""),c):void m.removeAttr(a,b))},removeAttr:function(a,b){var c,d,e=0,f=b&&b.match(E);if(f&&1===a.nodeType)while(c=f[e++])d=m.propFix[c]||c,m.expr.match.bool.test(c)?rb&&qb||!pb.test(c)?a[d]=!1:a[m.camelCase("default-"+c)]=a[d]=!1:m.attr(a,c,""),a.removeAttribute(qb?c:d)},attrHooks:{type:{set:function(a,b){if(!k.radioValue&&"radio"===b&&m.nodeName(a,"input")){var c=a.value;return a.setAttribute("type",b),c&&(a.value=c),b}}}}}),nb={set:function(a,b,c){return b===!1?m.removeAttr(a,c):rb&&qb||!pb.test(c)?a.setAttribute(!qb&&m.propFix[c]||c,c):a[m.camelCase("default-"+c)]=a[c]=!0,c}},m.each(m.expr.match.bool.source.match(/\w+/g),function(a,b){var c=ob[b]||m.find.attr;ob[b]=rb&&qb||!pb.test(b)?function(a,b,d){var e,f;return d||(f=ob[b],ob[b]=e,e=null!=c(a,b,d)?b.toLowerCase():null,ob[b]=f),e}:function(a,b,c){return c?void 0:a[m.camelCase("default-"+b)]?b.toLowerCase():null}}),rb&&qb||(m.attrHooks.value={set:function(a,b,c){return m.nodeName(a,"input")?void(a.defaultValue=b):mb&&mb.set(a,b,c)}}),qb||(mb={set:function(a,b,c){var d=a.getAttributeNode(c);return d||a.setAttributeNode(d=a.ownerDocument.createAttribute(c)),d.value=b+="","value"===c||b===a.getAttribute(c)?b:void 0}},ob.id=ob.name=ob.coords=function(a,b,c){var d;return c?void 0:(d=a.getAttributeNode(b))&&""!==d.value?d.value:null},m.valHooks.button={get:function(a,b){var c=a.getAttributeNode(b);return c&&c.specified?c.value:void 0},set:mb.set},m.attrHooks.contenteditable={set:function(a,b,c){mb.set(a,""===b?!1:b,c)}},m.each(["width","height"],function(a,b){m.attrHooks[b]={set:function(a,c){return""===c?(a.setAttribute(b,"auto"),c):void 0}}})),k.style||(m.attrHooks.style={get:function(a){return a.style.cssText||void 0},set:function(a,b){return a.style.cssText=b+""}});var sb=/^(?:input|select|textarea|button|object)$/i,tb=/^(?:a|area)$/i;m.fn.extend({prop:function(a,b){return V(this,m.prop,a,b,arguments.length>1)},removeProp:function(a){return a=m.propFix[a]||a,this.each(function(){try{this[a]=void 0,delete this[a]}catch(b){}})}}),m.extend({propFix:{"for":"htmlFor","class":"className"},prop:function(a,b,c){var d,e,f,g=a.nodeType;if(a&&3!==g&&8!==g&&2!==g)return f=1!==g||!m.isXMLDoc(a),f&&(b=m.propFix[b]||b,e=m.propHooks[b]),void 0!==c?e&&"set"in e&&void 0!==(d=e.set(a,c,b))?d:a[b]=c:e&&"get"in e&&null!==(d=e.get(a,b))?d:a[b]},propHooks:{tabIndex:{get:function(a){var b=m.find.attr(a,"tabindex");return b?parseInt(b,10):sb.test(a.nodeName)||tb.test(a.nodeName)&&a.href?0:-1}}}}),k.hrefNormalized||m.each(["href","src"],function(a,b){m.propHooks[b]={get:function(a){return a.getAttribute(b,4)}}}),k.optSelected||(m.propHooks.selected={get:function(a){var b=a.parentNode;return b&&(b.selectedIndex,b.parentNode&&b.parentNode.selectedIndex),null}}),m.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){m.propFix[this.toLowerCase()]=this}),k.enctype||(m.propFix.enctype="encoding");var ub=/[\t\r\n\f]/g;m.fn.extend({addClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j="string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).addClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):" ")){f=0;while(e=b[f++])d.indexOf(" "+e+" ")<0&&(d+=e+" ");g=m.trim(d),c.className!==g&&(c.className=g)}return this},removeClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j=0===arguments.length||"string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).removeClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):"")){f=0;while(e=b[f++])while(d.indexOf(" "+e+" ")>=0)d=d.replace(" "+e+" "," ");g=a?m.trim(d):"",c.className!==g&&(c.className=g)}return this},toggleClass:function(a,b){var c=typeof a;return"boolean"==typeof b&&"string"===c?b?this.addClass(a):this.removeClass(a):this.each(m.isFunction(a)?function(c){m(this).toggleClass(a.call(this,c,this.className,b),b)}:function(){if("string"===c){var b,d=0,e=m(this),f=a.match(E)||[];while(b=f[d++])e.hasClass(b)?e.removeClass(b):e.addClass(b)}else(c===K||"boolean"===c)&&(this.className&&m._data(this,"__className__",this.className),this.className=this.className||a===!1?"":m._data(this,"__className__")||"")})},hasClass:function(a){for(var b=" "+a+" ",c=0,d=this.length;d>c;c++)if(1===this[c].nodeType&&(" "+this[c].className+" ").replace(ub," ").indexOf(b)>=0)return!0;return!1}}),m.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){m.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),m.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)},bind:function(a,b,c){return this.on(a,null,b,c)},unbind:function(a,b){return this.off(a,null,b)},delegate:function(a,b,c,d){return this.on(b,a,c,d)},undelegate:function(a,b,c){return 1===arguments.length?this.off(a,"**"):this.off(b,a||"**",c)}});var vb=m.now(),wb=/\?/,xb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(?:[eE][+-]?\d+|)/g;m.parseJSON=function(b){if(a.JSON&&a.JSON.parse)return a.JSON.parse(b+"");var c,d=null,e=m.trim(b+"");return e&&!m.trim(e.replace(xb,function(a,b,e,f){return c&&b&&(d=0),0===d?a:(c=e||b,d+=!f-!e,"")}))?Function("return "+e)():m.error("Invalid JSON: "+b)},m.parseXML=function(b){var c,d;if(!b||"string"!=typeof b)return null;try{a.DOMParser?(d=new DOMParser,c=d.parseFromString(b,"text/xml")):(c=new ActiveXObject("Microsoft.XMLDOM"),c.async="false",c.loadXML(b))}catch(e){c=void 0}return c&&c.documentElement&&!c.getElementsByTagName("parsererror").length||m.error("Invalid XML: "+b),c};var yb,zb,Ab=/#.*$/,Bb=/([?&])_=[^&]*/,Cb=/^(.*?):[ \t]*([^\r\n]*)\r?$/gm,Db=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Eb=/^(?:GET|HEAD)$/,Fb=/^\/\//,Gb=/^([\w.+-]+:)(?:\/\/(?:[^\/?#]*@|)([^\/?#:]*)(?::(\d+)|)|)/,Hb={},Ib={},Jb="*/".concat("*");try{zb=location.href}catch(Kb){zb=y.createElement("a"),zb.href="",zb=zb.href}yb=Gb.exec(zb.toLowerCase())||[];function Lb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(E)||[];if(m.isFunction(c))while(d=f[e++])"+"===d.charAt(0)?(d=d.slice(1)||"*",(a[d]=a[d]||[]).unshift(c)):(a[d]=a[d]||[]).push(c)}}function Mb(a,b,c,d){var e={},f=a===Ib;function g(h){var i;return e[h]=!0,m.each(a[h]||[],function(a,h){var j=h(b,c,d);return"string"!=typeof j||f||e[j]?f?!(i=j):void 0:(b.dataTypes.unshift(j),g(j),!1)}),i}return g(b.dataTypes[0])||!e["*"]&&g("*")}function Nb(a,b){var c,d,e=m.ajaxSettings.flatOptions||{};for(d in b)void 0!==b[d]&&((e[d]?a:c||(c={}))[d]=b[d]);return c&&m.extend(!0,a,c),a}function Ob(a,b,c){var d,e,f,g,h=a.contents,i=a.dataTypes;while("*"===i[0])i.shift(),void 0===e&&(e=a.mimeType||b.getResponseHeader("Content-Type"));if(e)for(g in h)if(h[g]&&h[g].test(e)){i.unshift(g);break}if(i[0]in c)f=i[0];else{for(g in c){if(!i[0]||a.converters[g+" "+i[0]]){f=g;break}d||(d=g)}f=f||d}return f?(f!==i[0]&&i.unshift(f),c[f]):void 0}function Pb(a,b,c,d){var e,f,g,h,i,j={},k=a.dataTypes.slice();if(k[1])for(g in a.converters)j[g.toLowerCase()]=a.converters[g];f=k.shift();while(f)if(a.responseFields[f]&&(c[a.responseFields[f]]=b),!i&&d&&a.dataFilter&&(b=a.dataFilter(b,a.dataType)),i=f,f=k.shift())if("*"===f)f=i;else if("*"!==i&&i!==f){if(g=j[i+" "+f]||j["* "+f],!g)for(e in j)if(h=e.split(" "),h[1]===f&&(g=j[i+" "+h[0]]||j["* "+h[0]])){g===!0?g=j[e]:j[e]!==!0&&(f=h[0],k.unshift(h[1]));break}if(g!==!0)if(g&&a["throws"])b=g(b);else try{b=g(b)}catch(l){return{state:"parsererror",error:g?l:"No conversion from "+i+" to "+f}}}return{state:"success",data:b}}m.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:zb,type:"GET",isLocal:Db.test(yb[1]),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Jb,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/xml/,html:/html/,json:/json/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":m.parseJSON,"text xml":m.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(a,b){return b?Nb(Nb(a,m.ajaxSettings),b):Nb(m.ajaxSettings,a)},ajaxPrefilter:Lb(Hb),ajaxTransport:Lb(Ib),ajax:function(a,b){"object"==typeof a&&(b=a,a=void 0),b=b||{};var c,d,e,f,g,h,i,j,k=m.ajaxSetup({},b),l=k.context||k,n=k.context&&(l.nodeType||l.jquery)?m(l):m.event,o=m.Deferred(),p=m.Callbacks("once memory"),q=k.statusCode||{},r={},s={},t=0,u="canceled",v={readyState:0,getResponseHeader:function(a){var b;if(2===t){if(!j){j={};while(b=Cb.exec(f))j[b[1].toLowerCase()]=b[2]}b=j[a.toLowerCase()]}return null==b?null:b},getAllResponseHeaders:function(){return 2===t?f:null},setRequestHeader:function(a,b){var c=a.toLowerCase();return t||(a=s[c]=s[c]||a,r[a]=b),this},overrideMimeType:function(a){return t||(k.mimeType=a),this},statusCode:function(a){var b;if(a)if(2>t)for(b in a)q[b]=[q[b],a[b]];else v.always(a[v.status]);return this},abort:function(a){var b=a||u;return i&&i.abort(b),x(0,b),this}};if(o.promise(v).complete=p.add,v.success=v.done,v.error=v.fail,k.url=((a||k.url||zb)+"").replace(Ab,"").replace(Fb,yb[1]+"//"),k.type=b.method||b.type||k.method||k.type,k.dataTypes=m.trim(k.dataType||"*").toLowerCase().match(E)||[""],null==k.crossDomain&&(c=Gb.exec(k.url.toLowerCase()),k.crossDomain=!(!c||c[1]===yb[1]&&c[2]===yb[2]&&(c[3]||("http:"===c[1]?"80":"443"))===(yb[3]||("http:"===yb[1]?"80":"443")))),k.data&&k.processData&&"string"!=typeof k.data&&(k.data=m.param(k.data,k.traditional)),Mb(Hb,k,b,v),2===t)return v;h=m.event&&k.global,h&&0===m.active++&&m.event.trigger("ajaxStart"),k.type=k.type.toUpperCase(),k.hasContent=!Eb.test(k.type),e=k.url,k.hasContent||(k.data&&(e=k.url+=(wb.test(e)?"&":"?")+k.data,delete k.data),k.cache===!1&&(k.url=Bb.test(e)?e.replace(Bb,"$1_="+vb++):e+(wb.test(e)?"&":"?")+"_="+vb++)),k.ifModified&&(m.lastModified[e]&&v.setRequestHeader("If-Modified-Since",m.lastModified[e]),m.etag[e]&&v.setRequestHeader("If-None-Match",m.etag[e])),(k.data&&k.hasContent&&k.contentType!==!1||b.contentType)&&v.setRequestHeader("Content-Type",k.contentType),v.setRequestHeader("Accept",k.dataTypes[0]&&k.accepts[k.dataTypes[0]]?k.accepts[k.dataTypes[0]]+("*"!==k.dataTypes[0]?", "+Jb+"; q=0.01":""):k.accepts["*"]);for(d in k.headers)v.setRequestHeader(d,k.headers[d]);if(k.beforeSend&&(k.beforeSend.call(l,v,k)===!1||2===t))return v.abort();u="abort";for(d in{success:1,error:1,complete:1})v[d](k[d]);if(i=Mb(Ib,k,b,v)){v.readyState=1,h&&n.trigger("ajaxSend",[v,k]),k.async&&k.timeout>0&&(g=setTimeout(function(){v.abort("timeout")},k.timeout));try{t=1,i.send(r,x)}catch(w){if(!(2>t))throw w;x(-1,w)}}else x(-1,"No Transport");function x(a,b,c,d){var j,r,s,u,w,x=b;2!==t&&(t=2,g&&clearTimeout(g),i=void 0,f=d||"",v.readyState=a>0?4:0,j=a>=200&&300>a||304===a,c&&(u=Ob(k,v,c)),u=Pb(k,u,v,j),j?(k.ifModified&&(w=v.getResponseHeader("Last-Modified"),w&&(m.lastModified[e]=w),w=v.getResponseHeader("etag"),w&&(m.etag[e]=w)),204===a||"HEAD"===k.type?x="nocontent":304===a?x="notmodified":(x=u.state,r=u.data,s=u.error,j=!s)):(s=x,(a||!x)&&(x="error",0>a&&(a=0))),v.status=a,v.statusText=(b||x)+"",j?o.resolveWith(l,[r,x,v]):o.rejectWith(l,[v,x,s]),v.statusCode(q),q=void 0,h&&n.trigger(j?"ajaxSuccess":"ajaxError",[v,k,j?r:s]),p.fireWith(l,[v,x]),h&&(n.trigger("ajaxComplete",[v,k]),--m.active||m.event.trigger("ajaxStop")))}return v},getJSON:function(a,b,c){return m.get(a,b,c,"json")},getScript:function(a,b){return m.get(a,void 0,b,"script")}}),m.each(["get","post"],function(a,b){m[b]=function(a,c,d,e){return m.isFunction(c)&&(e=e||d,d=c,c=void 0),m.ajax({url:a,type:b,dataType:e,data:c,success:d})}}),m._evalUrl=function(a){return m.ajax({url:a,type:"GET",dataType:"script",async:!1,global:!1,"throws":!0})},m.fn.extend({wrapAll:function(a){if(m.isFunction(a))return this.each(function(b){m(this).wrapAll(a.call(this,b))});if(this[0]){var b=m(a,this[0].ownerDocument).eq(0).clone(!0);this[0].parentNode&&b.insertBefore(this[0]),b.map(function(){var a=this;while(a.firstChild&&1===a.firstChild.nodeType)a=a.firstChild;return a}).append(this)}return this},wrapInner:function(a){return this.each(m.isFunction(a)?function(b){m(this).wrapInner(a.call(this,b))}:function(){var b=m(this),c=b.contents();c.length?c.wrapAll(a):b.append(a)})},wrap:function(a){var b=m.isFunction(a);return this.each(function(c){m(this).wrapAll(b?a.call(this,c):a)})},unwrap:function(){return this.parent().each(function(){m.nodeName(this,"body")||m(this).replaceWith(this.childNodes)}).end()}}),m.expr.filters.hidden=function(a){return a.offsetWidth<=0&&a.offsetHeight<=0||!k.reliableHiddenOffsets()&&"none"===(a.style&&a.style.display||m.css(a,"display"))},m.expr.filters.visible=function(a){return!m.expr.filters.hidden(a)};var Qb=/%20/g,Rb=/\[\]$/,Sb=/\r?\n/g,Tb=/^(?:submit|button|image|reset|file)$/i,Ub=/^(?:input|select|textarea|keygen)/i;function Vb(a,b,c,d){var e;if(m.isArray(b))m.each(b,function(b,e){c||Rb.test(a)?d(a,e):Vb(a+"["+("object"==typeof e?b:"")+"]",e,c,d)});else if(c||"object"!==m.type(b))d(a,b);else for(e in b)Vb(a+"["+e+"]",b[e],c,d)}m.param=function(a,b){var c,d=[],e=function(a,b){b=m.isFunction(b)?b():null==b?"":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=m.ajaxSettings&&m.ajaxSettings.traditional),m.isArray(a)||a.jquery&&!m.isPlainObject(a))m.each(a,function(){e(this.name,this.value)});else for(c in a)Vb(c,a[c],b,e);return d.join("&").replace(Qb,"+")},m.fn.extend({serialize:function(){return m.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=m.prop(this,"elements");return a?m.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!m(this).is(":disabled")&&Ub.test(this.nodeName)&&!Tb.test(a)&&(this.checked||!W.test(a))}).map(function(a,b){var c=m(this).val();return null==c?null:m.isArray(c)?m.map(c,function(a){return{name:b.name,value:a.replace(Sb,"\r\n")}}):{name:b.name,value:c.replace(Sb,"\r\n")}}).get()}}),m.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return!this.isLocal&&/^(get|post|head|put|delete|options)$/i.test(this.type)&&Zb()||$b()}:Zb;var Wb=0,Xb={},Yb=m.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in Xb)Xb[a](void 0,!0)}),k.cors=!!Yb&&"withCredentials"in Yb,Yb=k.ajax=!!Yb,Yb&&m.ajaxTransport(function(a){if(!a.crossDomain||k.cors){var b;return{send:function(c,d){var e,f=a.xhr(),g=++Wb;if(f.open(a.type,a.url,a.async,a.username,a.password),a.xhrFields)for(e in a.xhrFields)f[e]=a.xhrFields[e];a.mimeType&&f.overrideMimeType&&f.overrideMimeType(a.mimeType),a.crossDomain||c["X-Requested-With"]||(c["X-Requested-With"]="XMLHttpRequest");for(e in c)void 0!==c[e]&&f.setRequestHeader(e,c[e]+"");f.send(a.hasContent&&a.data||null),b=function(c,e){var h,i,j;if(b&&(e||4===f.readyState))if(delete Xb[g],b=void 0,f.onreadystatechange=m.noop,e)4!==f.readyState&&f.abort();else{j={},h=f.status,"string"==typeof f.responseText&&(j.text=f.responseText);try{i=f.statusText}catch(k){i=""}h||!a.isLocal||a.crossDomain?1223===h&&(h=204):h=j.text?200:404}j&&d(h,i,j,f.getAllResponseHeaders())},a.async?4===f.readyState?setTimeout(b):f.onreadystatechange=Xb[g]=b:b()},abort:function(){b&&b(void 0,!0)}}}});function Zb(){try{return new a.XMLHttpRequest}catch(b){}}function $b(){try{return new a.ActiveXObject("Microsoft.XMLHTTP")}catch(b){}}m.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/(?:java|ecma)script/},converters:{"text script":function(a){return m.globalEval(a),a}}}),m.ajaxPrefilter("script",function(a){void 0===a.cache&&(a.cache=!1),a.crossDomain&&(a.type="GET",a.global=!1)}),m.ajaxTransport("script",function(a){if(a.crossDomain){var b,c=y.head||m("head")[0]||y.documentElement;return{send:function(d,e){b=y.createElement("script"),b.async=!0,a.scriptCharset&&(b.charset=a.scriptCharset),b.src=a.url,b.onload=b.onreadystatechange=function(a,c){(c||!b.readyState||/loaded|complete/.test(b.readyState))&&(b.onload=b.onreadystatechange=null,b.parentNode&&b.parentNode.removeChild(b),b=null,c||e(200,"success"))},c.insertBefore(b,c.firstChild)},abort:function(){b&&b.onload(void 0,!0)}}}});var _b=[],ac=/(=)\?(?=&|$)|\?\?/;m.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var a=_b.pop()||m.expando+"_"+vb++;return this[a]=!0,a}}),m.ajaxPrefilter("json jsonp",function(b,c,d){var e,f,g,h=b.jsonp!==!1&&(ac.test(b.url)?"url":"string"==typeof b.data&&!(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&ac.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=m.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(ac,"$1"+e):b.jsonp!==!1&&(b.url+=(wb.test(b.url)?"&":"?")+b.jsonp+"="+e),b.converters["script json"]=function(){return g||m.error(e+" was not called"),g[0]},b.dataTypes[0]="json",f=a[e],a[e]=function(){g=arguments},d.always(function(){a[e]=f,b[e]&&(b.jsonpCallback=c.jsonpCallback,_b.push(e)),g&&m.isFunction(f)&&f(g[0]),g=f=void 0}),"script"):void 0}),m.parseHTML=function(a,b,c){if(!a||"string"!=typeof a)return null;"boolean"==typeof b&&(c=b,b=!1),b=b||y;var d=u.exec(a),e=!c&&[];return d?[b.createElement(d[1])]:(d=m.buildFragment([a],b,e),e&&e.length&&m(e).remove(),m.merge([],d.childNodes))};var bc=m.fn.load;m.fn.load=function(a,b,c){if("string"!=typeof a&&bc)return bc.apply(this,arguments);var d,e,f,g=this,h=a.indexOf(" ");return h>=0&&(d=m.trim(a.slice(h,a.length)),a=a.slice(0,h)),m.isFunction(b)?(c=b,b=void 0):b&&"object"==typeof b&&(f="POST"),g.length>0&&m.ajax({url:a,type:f,dataType:"html",data:b}).done(function(a){e=arguments,g.html(d?m("<div>").append(m.parseHTML(a)).find(d):a)}).complete(c&&function(a,b){g.each(c,e||[a.responseText,b,a])}),this},m.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(a,b){m.fn[b]=function(a){return this.on(b,a)}}),m.expr.filters.animated=function(a){return m.grep(m.timers,function(b){return a===b.elem}).length};var cc=a.document.documentElement;function dc(a){return m.isWindow(a)?a:9===a.nodeType?a.defaultView||a.parentWindow:!1}m.offset={setOffset:function(a,b,c){var d,e,f,g,h,i,j,k=m.css(a,"position"),l=m(a),n={};"static"===k&&(a.style.position="relative"),h=l.offset(),f=m.css(a,"top"),i=m.css(a,"left"),j=("absolute"===k||"fixed"===k)&&m.inArray("auto",[f,i])>-1,j?(d=l.position(),g=d.top,e=d.left):(g=parseFloat(f)||0,e=parseFloat(i)||0),m.isFunction(b)&&(b=b.call(a,c,h)),null!=b.top&&(n.top=b.top-h.top+g),null!=b.left&&(n.left=b.left-h.left+e),"using"in b?b.using.call(a,n):l.css(n)}},m.fn.extend({offset:function(a){if(arguments.length)return void 0===a?this:this.each(function(b){m.offset.setOffset(this,a,b)});var b,c,d={top:0,left:0},e=this[0],f=e&&e.ownerDocument;if(f)return b=f.documentElement,m.contains(b,e)?(typeof e.getBoundingClientRect!==K&&(d=e.getBoundingClientRect()),c=dc(f),{top:d.top+(c.pageYOffset||b.scrollTop)-(b.clientTop||0),left:d.left+(c.pageXOffset||b.scrollLeft)-(b.clientLeft||0)}):d},position:function(){if(this[0]){var a,b,c={top:0,left:0},d=this[0];return"fixed"===m.css(d,"position")?b=d.getBoundingClientRect():(a=this.offsetParent(),b=this.offset(),m.nodeName(a[0],"html")||(c=a.offset()),c.top+=m.css(a[0],"borderTopWidth",!0),c.left+=m.css(a[0],"borderLeftWidth",!0)),{top:b.top-c.top-m.css(d,"marginTop",!0),left:b.left-c.left-m.css(d,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var a=this.offsetParent||cc;while(a&&!m.nodeName(a,"html")&&"static"===m.css(a,"position"))a=a.offsetParent;return a||cc})}}),m.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(a,b){var c=/Y/.test(b);m.fn[a]=function(d){return V(this,function(a,d,e){var f=dc(a);return void 0===e?f?b in f?f[b]:f.document.documentElement[d]:a[d]:void(f?f.scrollTo(c?m(f).scrollLeft():e,c?e:m(f).scrollTop()):a[d]=e)},a,d,arguments.length,null)}}),m.each(["top","left"],function(a,b){m.cssHooks[b]=La(k.pixelPosition,function(a,c){return c?(c=Ja(a,b),Ha.test(c)?m(a).position()[b]+"px":c):void 0})}),m.each({Height:"height",Width:"width"},function(a,b){m.each({padding:"inner"+a,content:b,"":"outer"+a},function(c,d){m.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0?"margin":"border");return V(this,function(b,c,d){var e;return m.isWindow(b)?b.document.documentElement["client"+a]:9===b.nodeType?(e=b.documentElement,Math.max(b.body["scroll"+a],e["scroll"+a],b.body["offset"+a],e["offset"+a],e["client"+a])):void 0===d?m.css(b,c,g):m.style(b,c,d,g)},b,f?d:void 0,f,null)}})}),m.fn.size=function(){return this.length},m.fn.andSelf=m.fn.addBack,"function"==typeof define&&define.amd&&define("jquery",[],function(){return m});var ec=a.jQuery,fc=a.$;return m.noConflict=function(b){return a.$===m&&(a.$=fc),b&&a.jQuery===m&&(a.jQuery=ec),m},typeof b===K&&(a.jQuery=a.$=m),m});
"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="data:text/css;charset=utf-8,html%7Bfont%2Dfamily%3Asans%2Dserif%3B%2Dwebkit%2Dtext%2Dsize%2Dadjust%3A100%25%3B%2Dms%2Dtext%2Dsize%2Dadjust%3A100%25%7Dbody%7Bmargin%3A0%7Darticle%2Caside%2Cdetails%2Cfigcaption%2Cfigure%2Cfooter%2Cheader%2Chgroup%2Cmain%2Cmenu%2Cnav%2Csection%2Csummary%7Bdisplay%3Ablock%7Daudio%2Ccanvas%2Cprogress%2Cvideo%7Bdisplay%3Ainline%2Dblock%3Bvertical%2Dalign%3Abaseline%7Daudio%3Anot%28%5Bcontrols%5D%29%7Bdisplay%3Anone%3Bheight%3A0%7D%5Bhidden%5D%2Ctemplate%7Bdisplay%3Anone%7Da%7Bbackground%2Dcolor%3Atransparent%7Da%3Aactive%2Ca%3Ahover%7Boutline%3A0%7Dabbr%5Btitle%5D%7Bborder%2Dbottom%3A1px%20dotted%7Db%2Cstrong%7Bfont%2Dweight%3A700%7Ddfn%7Bfont%2Dstyle%3Aitalic%7Dh1%7Bmargin%3A%2E67em%200%3Bfont%2Dsize%3A2em%7Dmark%7Bcolor%3A%23000%3Bbackground%3A%23ff0%7Dsmall%7Bfont%2Dsize%3A80%25%7Dsub%2Csup%7Bposition%3Arelative%3Bfont%2Dsize%3A75%25%3Bline%2Dheight%3A0%3Bvertical%2Dalign%3Abaseline%7Dsup%7Btop%3A%2D%2E5em%7Dsub%7Bbottom%3A%2D%2E25em%7Dimg%7Bborder%3A0%7Dsvg%3Anot%28%3Aroot%29%7Boverflow%3Ahidden%7Dfigure%7Bmargin%3A1em%2040px%7Dhr%7Bheight%3A0%3B%2Dwebkit%2Dbox%2Dsizing%3Acontent%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Acontent%2Dbox%3Bbox%2Dsizing%3Acontent%2Dbox%7Dpre%7Boverflow%3Aauto%7Dcode%2Ckbd%2Cpre%2Csamp%7Bfont%2Dfamily%3Amonospace%2Cmonospace%3Bfont%2Dsize%3A1em%7Dbutton%2Cinput%2Coptgroup%2Cselect%2Ctextarea%7Bmargin%3A0%3Bfont%3Ainherit%3Bcolor%3Ainherit%7Dbutton%7Boverflow%3Avisible%7Dbutton%2Cselect%7Btext%2Dtransform%3Anone%7Dbutton%2Chtml%20input%5Btype%3Dbutton%5D%2Cinput%5Btype%3Dreset%5D%2Cinput%5Btype%3Dsubmit%5D%7B%2Dwebkit%2Dappearance%3Abutton%3Bcursor%3Apointer%7Dbutton%5Bdisabled%5D%2Chtml%20input%5Bdisabled%5D%7Bcursor%3Adefault%7Dbutton%3A%3A%2Dmoz%2Dfocus%2Dinner%2Cinput%3A%3A%2Dmoz%2Dfocus%2Dinner%7Bpadding%3A0%3Bborder%3A0%7Dinput%7Bline%2Dheight%3Anormal%7Dinput%5Btype%3Dcheckbox%5D%2Cinput%5Btype%3Dradio%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%3Bpadding%3A0%7Dinput%5Btype%3Dnumber%5D%3A%3A%2Dwebkit%2Dinner%2Dspin%2Dbutton%2Cinput%5Btype%3Dnumber%5D%3A%3A%2Dwebkit%2Douter%2Dspin%2Dbutton%7Bheight%3Aauto%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Acontent%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Acontent%2Dbox%3Bbox%2Dsizing%3Acontent%2Dbox%3B%2Dwebkit%2Dappearance%3Atextfield%7Dinput%5Btype%3Dsearch%5D%3A%3A%2Dwebkit%2Dsearch%2Dcancel%2Dbutton%2Cinput%5Btype%3Dsearch%5D%3A%3A%2Dwebkit%2Dsearch%2Ddecoration%7B%2Dwebkit%2Dappearance%3Anone%7Dfieldset%7Bpadding%3A%2E35em%20%2E625em%20%2E75em%3Bmargin%3A0%202px%3Bborder%3A1px%20solid%20silver%7Dlegend%7Bpadding%3A0%3Bborder%3A0%7Dtextarea%7Boverflow%3Aauto%7Doptgroup%7Bfont%2Dweight%3A700%7Dtable%7Bborder%2Dspacing%3A0%3Bborder%2Dcollapse%3Acollapse%7Dtd%2Cth%7Bpadding%3A0%7D%40media%20print%7B%2A%2C%3Aafter%2C%3Abefore%7Bcolor%3A%23000%21important%3Btext%2Dshadow%3Anone%21important%3Bbackground%3A0%200%21important%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%21important%3Bbox%2Dshadow%3Anone%21important%7Da%2Ca%3Avisited%7Btext%2Ddecoration%3Aunderline%7Da%5Bhref%5D%3Aafter%7Bcontent%3A%22%20%28%22%20attr%28href%29%20%22%29%22%7Dabbr%5Btitle%5D%3Aafter%7Bcontent%3A%22%20%28%22%20attr%28title%29%20%22%29%22%7Da%5Bhref%5E%3D%22javascript%3A%22%5D%3Aafter%2Ca%5Bhref%5E%3D%22%23%22%5D%3Aafter%7Bcontent%3A%22%22%7Dblockquote%2Cpre%7Bborder%3A1px%20solid%20%23999%3Bpage%2Dbreak%2Dinside%3Aavoid%7Dthead%7Bdisplay%3Atable%2Dheader%2Dgroup%7Dimg%2Ctr%7Bpage%2Dbreak%2Dinside%3Aavoid%7Dimg%7Bmax%2Dwidth%3A100%25%21important%7Dh2%2Ch3%2Cp%7Borphans%3A3%3Bwidows%3A3%7Dh2%2Ch3%7Bpage%2Dbreak%2Dafter%3Aavoid%7D%2Enavbar%7Bdisplay%3Anone%7D%2Ebtn%3E%2Ecaret%2C%2Edropup%3E%2Ebtn%3E%2Ecaret%7Bborder%2Dtop%2Dcolor%3A%23000%21important%7D%2Elabel%7Bborder%3A1px%20solid%20%23000%7D%2Etable%7Bborder%2Dcollapse%3Acollapse%21important%7D%2Etable%20td%2C%2Etable%20th%7Bbackground%2Dcolor%3A%23fff%21important%7D%2Etable%2Dbordered%20td%2C%2Etable%2Dbordered%20th%7Bborder%3A1px%20solid%20%23ddd%21important%7D%7D%40font%2Dface%7Bfont%2Dfamily%3A%27Glyphicons%20Halflings%27%3Bsrc%3Aurl%28data%3Aapplication%2Fvnd%2Ems%2Dfontobject%3Bbase64%2Cn04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ%2FLAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM%2FSEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ%2BpexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h%2Fv4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs%2BLWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy%2BpRYVKGVS%2F1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr%2FCm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB%2BlSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX%2BVSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G%2BKspT%2FFupEGGafCCwxSe6ZUa%2B073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B%2FEnCYu%2FTgCGmr7bMh8GfYL%2BBfcLvB0gRagC09w9elfldaIy%2FhNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4%2FBO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r%2BvnsV%2B372uf1xBLq4qU%2F45fTuqaAP%2BpssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ%2BAzok7B7O%2Ff6J8AzYBySZQB%2FQHYUSA%2BEeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ%2BPKRWyFHHmg1Wi%2F6xzUgA0LREoKJChwnQa9B%2B5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl%2BKdDPbI6Ag4vLr%2BhjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq%2BMhrGxDLak0PrwYzSXtcuyhXEhwOYofiW%2BEcI%2Fjw8P6IY6ed%2BetAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji%2BzDbo8x8HyIRUbXnwUcklFv51fvTymiV%2BMXLSmGH9d9%2BaXpD5X6lao41anWGig7IwIdnoBY2ht%2FpO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi%2B7u%2FjpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf%2B61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP%2FOfKnlk%2FLkaid%2FO2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu%2FgFtuW0wR4cgd%2BZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ%2BHW06H%2Btx%2BbQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543%2FFV6klQ6Tv1OoZGXLv0igKrl%2FCmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF%2F0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5%2FxTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ%2F1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb%2FVeyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6%2FxM%2B4Y67ngNBknxIPwuppgIhFcwJyr6EIj%2BLzNj%2FmfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h%2FC%2FPkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn%2FpdpgHKNGrGIdkRK%2BKPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho%2BEIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA%2Bq%2Fj9m3LM%2FO7WJka4tSidVCjsvo2lQ%2F2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3%2F5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho%2FbcwQdeboqfQartuU3CsCf%2BcXkgYAqp%2F0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid%2FNIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A%2BTRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC%2BJE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW%2FWDHA60cYFaI%2FPjpzquUqdaYGcIq%2BmLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC%2B1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A%2BP%2FoFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E%2FvwOiKxRtCWsDM%2BeTHUrmwrCK5BIfMzGkD%2B0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3%2FkFutpQGNc3pCR7gvC4sgwbupDu3DyEN%2BW6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc%2Bh1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0%2BbC5zgpGz7Io%2BmjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO%2FENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn%2B3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif%2BpZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx%2Fk3QgnAFSq27%2F2i4GEBA%2BUvTJKK%2F9eISNvG46Em5RZfjTYLdeD8kdXHyrwId%2FDQZUaMCY4gGbke2C8vfjgV%2FY9kkRQOJIn%2FxM9INZSpiBnqX0Q9GlQPpPKAyO5y%2BW5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W%2FN6l54qOynCqD3DpWQ%2BmpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE%2B7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv%2F8lbTIkkYpqKM9VOhp65ktYk%2BQ46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI%2BejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5%2B7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu%2Bvtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY%2FiOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v%2B6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ%2FqDQK%2BbfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam%2BWpHG%2B0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3%2BJ1eCBay8IYZ0wQRKGAqvCuZ%2FUgbQPyllosq%2BXtfKIZOzmeJqRazpmmoP%2F76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t%2FI4Jktu0XSgifO2ozFOiwd%2F0SssJDn0dn4xqk4GDTTKX73%2FwQyBLdqgJ%2BWx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy%2FqqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh%2FwkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml%2FR4yrzow1Q2A5G%2Bkzo%2FRhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj%2FUMMc34IBqTKLDTp76WzL%2FdMjCxK7MjhiGjeYAC%2Fkj%2FjY%2FRde7hpSM1xChrog6yZ7OWTuD56xBJnGFE%2BpT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G%2B9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36%2FdBySis4m9%2FDR8izaLJW6bWCkVgm5T%2Bius3ZXq4xI%2BGnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te%2Fr4dPYMCl5qtiHNTn%2BTPbh1jCBHH%2BdMJNhwNgs3nT%2BOhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF%2BuRIWyXjQMAs2chdpaKPNaB%2BkSezYt0%2BCA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6%2FTzoA1%2FZBG9bIUVHLAbi%2FkdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh%2Bepgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF%2BzkJHIA7PwCDk1gGVmGUZSSoPhNf%2BTklauz98QofOlCIQ%2FtCD4dosHYPqtPCXB3agggQQIqQJsSkB%2Bqn0rkQ1toJjON%2FOtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU%2BTQ6NIw3ej%2BAtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb%2B%2BW6Uk4q6F7%2Frg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK%2BEfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l%2BwM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l%2BDMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg%2BEWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb%2BMw76Qy29iQ5up%2FX7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa%2FxnsMYcIO%2FvEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz%2FChp%2FVlpj2P7jJQmQRwGnltkTV5dbF9fE3%2FfxoSqTROgq9wFUlbuYzYcasE0ouzBo%2BdDCDzxKAfhbAZYxQiHrLzV2iVexnDX%2FQnT1fsT%2Fxuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR%2BCtGdkPwYN2o7DOw%2FVGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO%2Ff9Qua%2BpDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD%2FprQ84B1pVGkIpVUAHCG%2Biz3Bn3qm2AVrYcYWhock4jso5%2BJ7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk%2BUILT7%2BVoX5mdxxA5fS42gISQVi%2FHTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8%2F6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk%2FwdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt%2BSu9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ%2FBfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk%2Fgc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B%2F%2FlHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO%2BCvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd%2Fp1gi%2F07h8qfwHrByuSxglc9cI4QIg2oqvC%2Fqm0i7tjPLTgDhoWTAKDO2ONW5oe%2B%2FeKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2%2Fj4ODUwRkqrtBBCrDsDpt8jhZdXoy%2F1BCqw3sSGhgGGy0a5Jw6BP%2FTExoCmNFYjZl248A0osgPyGEmRA%2BfAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd%2FocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE%2FEZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ%2FUgd%2FJZQK8lvAm43uDRAbyW8gZ%2BZGq0EVerVGUKUSm%2FIdn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ%2BQATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm%2BoOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724%2BzUQ7%2BvkCpZB%2BpGA562hYQiDxHVWOq0oDQl%2FQsoiY%2BcuI7iWq%2FZIBtHcXJ7kks%2Bh2fCNUPA82BzjnqktNts%2BRLdk1VSu%2BtqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy%2F44XYXdI5noQoRcvjZ1RMPACRqYg2V1%2BOwOepcOknRLLFdYgTkT5UApt%2FJhLM3jeFYprZV%2BZow2g8fP%2BU68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr%2FA1SY9dXFz4RjzoU9ExfJCmx%2FI9FKEGT3n2cmzl2X42L3Jh%2BAbQq6sA%2BSs1kitoa4TAYgKHaoybHUDJ51oETdeI%2F9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB%2BUn44zExFE4vLytcu5NwpWrUxO%2F0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL%2BBDqMyaN3RJPh%2Fanbx%2BIv%2BqgQdAa3M9Z5JmvYlh4qop%2BHo1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs%2Bgs37sFvi0PPVvA5dnCBgILTwoKd%2F%2BDoL9F6inlM7H4rOTzD79KJgKlZO%2FZgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno%2BgBoKVXgIL%2FVI8dB1O5o%2FR3Suez%2FgD7M781ShjKpIIORM%2FnxG%2BjjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4%2FQftDbEn%2BAucIr1oxrLabRj9q4ae0%2BfXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd%2BeNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz%2F6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT%2BmAUmiYbV3YQVqFVp9dorv%2BTsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp%2BxJyYLv1OsxQCZwTB4a8BZ%2F5EdxTBJthApqyfd9u3ifr%2FWILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj%2Fqn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9%2BW8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4%2FYtowhEmTs0vrvlD%2FCrisnoBNDAcUi%2FteY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O%2F4DcgV%2FdZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk%2BtgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb%2Fn7qwhvGnrHuf5bX6Vh%2Fn3xffU3PeHdR%2BFA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E%2BYbfL0adwNtHP7dT7t7b46DVZIkzaRJOM%2BS6KcrzYVg%2BT3wSRFRQashjfU18NutrKa%2F7PXbtuJvpIjbgPeqd%2BpjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir%2F8tNXJ%2FOsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG%2BFZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx%2FGdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD%2FQi%2FEmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4%2FasthNMK5UQKCOhU97oaOYNGsTah%2BjfCKsZnTRn5TbhFX8ghg8CBYt%2FBjeYYYUrtUZ5jVij%2Fop7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM%2B3SW6Opll%2FwgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy%2BQbSKVJcqkia%2BGvDefFwMOmgnD7h81TUtMn%2BmRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d%2FQK7Cr4uoCeOQ7%2F8JfKT77KiDzLImESHw%2F0wf73QeHu74hxv7uihi4fTX%2BXEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo%2FoVH5ww5OzLFsiTPDns7fS6EURSSWd%2F92BxMYQ8sBaH%2Bj%2BwthQPdVgDGpTfi%2BJQIWMD8xKqULliRH01rTeyF8x8q%2FGBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE%2B%2F7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV%2FyTDRRP8Y2ww5RO6d2D94o%2B6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt%2Bkqdae76ViWe3STan69yaF9%2BfESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw%2FA1zEdjWquIsQXXGIVEH0thC5M%2BW9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF%2BRVmI8L4HUYk4x%2B67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8%2Fp5qIQrEo%2FH%2B1l%2F0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud%2BtJUfdaZ4CWNijzZtlRa8%2BCkmO%2FEwHYfPZFU%2FhzjFWH7vnzHRMo%2BaF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce%2F%2B%2F9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs%2FGWJS6SwEN%2FULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e%2BG2zor8l%2BYaMxSEomDdLHGcD6YVQPegTaA74H8%2BV4WvJkFUrjMLGLlvSZQWvi8%2FQA7yzQ8GPno%2F%2F5SJHRP%2FOqKObPCo81s%2F%2B6WgLqykYpGAgQZhVDEBPXWgU%2FWzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M%2BGWn6ASobIWC%2BLbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg%2Fkpf3%2BCnAXKiMgIE8Jk%2FMhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo%2BRJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B%2BSkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE%2BVMd3b1fhCynD0pQNhCG6%2FWCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp%2FYbHjo%2B%2B7%2FWj8S4YNa%2BZdqAw1hDrKWFXv9%2BzaXpf8ZTDSbiqsxnwN%2FCzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m%2FNCW%2FHILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO%2B5EJ7Z6bCiRoPedRZ%2FP0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn%2FLvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl%2B11PoFYnNv2HwAODeNRkHj%2B8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij%2BbsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur%2FeWHjiB7SOVdqMAVmpBvfRiebsFjger7DC%2B8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l%2BkXRZ0KLZaGsFSIdQz%2FHXDxf3%2FTE30%2BDgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH%2BRptvRMVRaahu4cySjS3P5wxAUCPkmn%2BrhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik%2FzbrTQk5KmgxCg%2Ff45L0jywebOWUYFJQAJia7XzCV0x89rpp%2Ff3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl%2B5tfUWZNwBpEPXghzbBggYCw%2Fdhy0ntds2yeHCDKkF%2FYxQjNIL%2FF%2F37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD%2BqNOhwMlfARQUdJ2tUX%2BMNJqOwIciWalZsmEjt07tfa8ma4cji9sqz%2BQ9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe%2BjGDiNJQLWnfx%2BdrTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf%2Fbkvo8PLVBsZl152y5S8%2BHRDfZIMCbYZ1WDp4yrdchOJw8k6R%2B%2F2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB%2BM4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5%2FiYp3ZdrCf7fL%2Ben%2BsIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv%2BNRiJc8JAKqqgCA%2FPNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN%2FhCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj%2BbYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5%2FzBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8%2Fi%2BjHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2%2BJrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk%2BMz7wwstg6RFZb%2BTZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm%2F7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk%2B9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx%2BwhVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC%2BXYuqMBMUun5YezKbRKmEPwuK%2BCLzijPEQgfhahQswBBLfg%2FGBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX%2BRCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk%2F4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug%2FAbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM%2BZu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX%2FpcsfwXbLze2%2BD%2Bu33OGBoJyAAL3jn3RuEcdp5If8O%2Ba4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT%2B%2Btm%2BhaBCikRUUMrMhYKZJKYoVuv%2FbsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV%2FDMUxd9uFZmBfKXMCn%2FSqkWJyKPnT6lq%2B4zBZni6fYRByJn6OK%2BOgPBGRAJluwGSk4wxjOOzyce%2FPKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO%2FcEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm%2BbddRQu5F9s0XftGEJ9JSuSk%2BZachCbdU45fEqbugzTIUokwoAKvpUQF%2FCvLbWW5BNQFqFkJg2f30E%2F48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J%2B1pT0tLkvFVZaNzfhs%2FKd3%2BA9YsImlO4XK4vpCo%2FelHQi%2F9gkFg07xxnuXLt21unCIpDV%2BbbRxb7FC6nWYTsMFF8%2B1LUg4JFjVt3vqbuhHmDKbgQ4e%2BRGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB%2FKVijd1ARWkFEf3yiUw1v%2FWaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G%2BZManTqDLPjyrOse7WiiwOJCG%2BJ0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj%2F6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j%2FN46f%2BS2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb%2F0jQbaHJ2YRK8A%2Bls6WMhWmpCXYG5jqapGs5%2FeOJErxi2%2F2KWVHiPellTgh%2FfNl%2F2KYPKb7DUcAg%2BmCOPQFCiU9Mq%2FWLcU1xxC8aLePFZZlE%2BPCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh%2FnFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW%2BoKFLvpyvTBMM69tN1Ydwv1LIEhHsC%2BueVG%2Bw%2BkyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw%2BH%2FAuOx%2BaH%2BtBL88H57D0MsqyiZxhOEQkF%2F8DR1d2hSPMj%2FsNOa5rxcUnBgH8ictv2J%2Bcb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd%2FPjMMtQfyDNZsOPd6XcAsnBE%2FmRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl%2FXPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG%2FVanIvcwycVA7%2BBE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP%2FMVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX%2F5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c%2FF1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J%2F5wkjpkre727p5PTRX5FGrSBIfJqhJE%2FIS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug%2BoRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U%2F5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7%2FBQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN%2BnA7pvF78%2FRII5ZHA09OAiE%2F66MF6HQ%2BqVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe%2BhXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz%2BJV%2F4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB%2BK3wBP%2FineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q%2F9uocGsx41O4IZhViw%2F2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY%2FcQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE%2Fom7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi%2FcaHSM3FPRGRf7dB7YC%2BcD2ho6oL2zGDCkjlf%2FDFoQVl8GS%2F56wur3rdV6ggtzZW60MRB3g%2BU1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg%2FgBQIZMG%2FYcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK%2FG7F3mUc3GOAKqh60zM0v34v%2BELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND%2B%2FGTk6M56Ig4yMsU6LUW1EWE%2BfIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP%2FIoRIZ%2FF6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg%2FRrPD%2Fd3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl%2BMu4xf0ezqeXD2PtPDnwMPo86sbwDV%2B9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD%2FOwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d%2FUfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH%2B14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC%2BOA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6%2BvAUUBoGhY3CT2tgwehdPqU%2F4Q7ZLYvhRl%2FogOvR9O2%2BwkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn%2FdFSWBWzQ%2FVYk%2BGezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n%2FyJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET%2FHh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j%2BDXfpi12m1RbzYLg9J2wFergEwOxFyD0%2FJstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT%2FcUP6pE%2FmujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB%2BHEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu%2BvqQ02%2BKpJBjaLt9ye1Ab%2BBbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC%2BUwkXOoAjneU%2FxHplMQo2cXUlrVNqJYczgYlaOEczVCs%2FOCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38%2BxsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9%2Bb8fH6%2Bb8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj%2F0Q7PFUcC8hDrxESWdfgFRm%2B7vvWbkEppHB4T%2F1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y%2Bg3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR%2FRrs%2FJLKXgEx%2BqkmeDlFOD1%2FyTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW%2Bxz%2B5FElFxWB28VjYIGZ0Yd%2B5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ%2BlT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ%2B2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1%2BJpI9psyNYIFuJogZa0%2F1AhOWdlHQxdAgbwacsHqPZo8u%2FngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2%2BRdM%2BMAaYaZ0Y%2FADkbNCZuAyAVQa2OcXOeICmDn9Q%2FeFkDeFQg5MgHEDXq%2FtVjj%2Bjtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2%2FBc0UxvseQCO2pQ2i%2BKrfhu%2FWeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt%2FU0Wf%2BphiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7%2BExseJauyqo30hs%2B1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j%2Fe1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la%2FQCTiVelFnU6O%2FGCvykqS%2FwZJDhKN9gBtSOp%2F1SP5VRgJcoVj%2Bkmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn%2B8p6%2BvBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H%2BgDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D%2FGvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P%2BjAgN5TB3haSifDcApp6yymEi6Ij%2FGsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x%2FpChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11%2Fyxyw0UnGig3MFdZklN5FI%2FqiT65T%2BjOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5%2BbqWiAYiAv6Jsf79%2FVUs4cIl%2Bn6%2BWOjcgB%2F2l5TreoAV2717JzZbQIR0W1cl%2FdEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW%2FPhoawJDrGAP0JYWHgAVUByo%2FbGdiv2T2EMg8gsS14%2FrAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq%2BSCcTSx5NDtbFwNlh8VhjGGDu7JG5%2FTAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9%2BogD8Kk%2FW7QoRN1UWPqM4%2BxdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c%2B4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS%2Bo3F8YVVeikw13w%2BOEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX%2B%2B7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9%2FO53DYi%2F5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD%2BP8sNh6e%2BXYHJXT%2FlkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp%2BpT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS%2F2ToPjqkaq62%2F7WFG8advGlRRqxB9diP07JrXowKR9tpRa%2BjGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq%2Bnsp3YMuXt%2FGkXxLx%2FP6%2BZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar%2BgMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud%2BYlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl%2Fzh575R5rsrmRnKAzq4POFdgbYBuEviM4%2BLVC15ssLNFghbTtHWerS1hDt5s4qkLUha%2FqpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI%2ByjEldJfSo4y0QhG4i4IwkRFGcjWY8%2BEzgYYJUK7BXQksLxAww%2FYYWBMhJILB9e8ePEJ4OP7z%2B4%2FwOQDl64iOYDp26DaONPxpKtBxq%2FaTzRGarm3VkPYTLJKx6Z%2FMw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ%2BlPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k%2FUuGkNpP1DBI5ch%2FEehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv%2BJ41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI%2BHYexTUevLUeta4%2FDqKrbMVS%2BYqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ%2B%2BKkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9%2FWx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k%2F90B8%2ByRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB%2FmQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go%2Fn6j0cS%2Ba2gEU8gIHJ%2BBwfgZX4GL%2BBd%2FgW34FZ%2BBS%2FgUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh%2FF062yJ7AAAAEDAWAAABWhJ%2BKPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg%29%3Bsrc%3Aurl%28data%3Aapplication%2Fvnd%2Ems%2Dfontobject%3Bbase64%2Cn04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ%2FLAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM%2FSEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ%2BpexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h%2Fv4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs%2BLWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy%2BpRYVKGVS%2F1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr%2FCm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB%2BlSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX%2BVSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G%2BKspT%2FFupEGGafCCwxSe6ZUa%2B073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B%2FEnCYu%2FTgCGmr7bMh8GfYL%2BBfcLvB0gRagC09w9elfldaIy%2FhNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4%2FBO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r%2BvnsV%2B372uf1xBLq4qU%2F45fTuqaAP%2BpssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ%2BAzok7B7O%2Ff6J8AzYBySZQB%2FQHYUSA%2BEeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ%2BPKRWyFHHmg1Wi%2F6xzUgA0LREoKJChwnQa9B%2B5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl%2BKdDPbI6Ag4vLr%2BhjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq%2BMhrGxDLak0PrwYzSXtcuyhXEhwOYofiW%2BEcI%2Fjw8P6IY6ed%2BetAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji%2BzDbo8x8HyIRUbXnwUcklFv51fvTymiV%2BMXLSmGH9d9%2BaXpD5X6lao41anWGig7IwIdnoBY2ht%2FpO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi%2B7u%2FjpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf%2B61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP%2FOfKnlk%2FLkaid%2FO2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu%2FgFtuW0wR4cgd%2BZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ%2BHW06H%2Btx%2BbQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543%2FFV6klQ6Tv1OoZGXLv0igKrl%2FCmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF%2F0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5%2FxTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ%2F1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb%2FVeyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6%2FxM%2B4Y67ngNBknxIPwuppgIhFcwJyr6EIj%2BLzNj%2FmfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h%2FC%2FPkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn%2FpdpgHKNGrGIdkRK%2BKPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho%2BEIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA%2Bq%2Fj9m3LM%2FO7WJka4tSidVCjsvo2lQ%2F2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3%2F5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho%2FbcwQdeboqfQartuU3CsCf%2BcXkgYAqp%2F0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid%2FNIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A%2BTRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC%2BJE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW%2FWDHA60cYFaI%2FPjpzquUqdaYGcIq%2BmLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC%2B1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A%2BP%2FoFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E%2FvwOiKxRtCWsDM%2BeTHUrmwrCK5BIfMzGkD%2B0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3%2FkFutpQGNc3pCR7gvC4sgwbupDu3DyEN%2BW6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc%2Bh1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0%2BbC5zgpGz7Io%2BmjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO%2FENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn%2B3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif%2BpZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx%2Fk3QgnAFSq27%2F2i4GEBA%2BUvTJKK%2F9eISNvG46Em5RZfjTYLdeD8kdXHyrwId%2FDQZUaMCY4gGbke2C8vfjgV%2FY9kkRQOJIn%2FxM9INZSpiBnqX0Q9GlQPpPKAyO5y%2BW5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W%2FN6l54qOynCqD3DpWQ%2BmpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE%2B7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv%2F8lbTIkkYpqKM9VOhp65ktYk%2BQ46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI%2BejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5%2B7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu%2Bvtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY%2FiOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v%2B6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ%2FqDQK%2BbfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam%2BWpHG%2B0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3%2BJ1eCBay8IYZ0wQRKGAqvCuZ%2FUgbQPyllosq%2BXtfKIZOzmeJqRazpmmoP%2F76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t%2FI4Jktu0XSgifO2ozFOiwd%2F0SssJDn0dn4xqk4GDTTKX73%2FwQyBLdqgJ%2BWx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy%2FqqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh%2FwkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml%2FR4yrzow1Q2A5G%2Bkzo%2FRhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj%2FUMMc34IBqTKLDTp76WzL%2FdMjCxK7MjhiGjeYAC%2Fkj%2FjY%2FRde7hpSM1xChrog6yZ7OWTuD56xBJnGFE%2BpT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G%2B9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36%2FdBySis4m9%2FDR8izaLJW6bWCkVgm5T%2Bius3ZXq4xI%2BGnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te%2Fr4dPYMCl5qtiHNTn%2BTPbh1jCBHH%2BdMJNhwNgs3nT%2BOhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF%2BuRIWyXjQMAs2chdpaKPNaB%2BkSezYt0%2BCA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6%2FTzoA1%2FZBG9bIUVHLAbi%2FkdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh%2Bepgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF%2BzkJHIA7PwCDk1gGVmGUZSSoPhNf%2BTklauz98QofOlCIQ%2FtCD4dosHYPqtPCXB3agggQQIqQJsSkB%2Bqn0rkQ1toJjON%2FOtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU%2BTQ6NIw3ej%2BAtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb%2B%2BW6Uk4q6F7%2Frg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK%2BEfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l%2BwM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l%2BDMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg%2BEWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb%2BMw76Qy29iQ5up%2FX7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa%2FxnsMYcIO%2FvEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz%2FChp%2FVlpj2P7jJQmQRwGnltkTV5dbF9fE3%2FfxoSqTROgq9wFUlbuYzYcasE0ouzBo%2BdDCDzxKAfhbAZYxQiHrLzV2iVexnDX%2FQnT1fsT%2Fxuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR%2BCtGdkPwYN2o7DOw%2FVGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO%2Ff9Qua%2BpDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD%2FprQ84B1pVGkIpVUAHCG%2Biz3Bn3qm2AVrYcYWhock4jso5%2BJ7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk%2BUILT7%2BVoX5mdxxA5fS42gISQVi%2FHTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8%2F6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk%2FwdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt%2BSu9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ%2FBfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk%2Fgc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B%2F%2FlHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO%2BCvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd%2Fp1gi%2F07h8qfwHrByuSxglc9cI4QIg2oqvC%2Fqm0i7tjPLTgDhoWTAKDO2ONW5oe%2B%2FeKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2%2Fj4ODUwRkqrtBBCrDsDpt8jhZdXoy%2F1BCqw3sSGhgGGy0a5Jw6BP%2FTExoCmNFYjZl248A0osgPyGEmRA%2BfAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd%2FocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE%2FEZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ%2FUgd%2FJZQK8lvAm43uDRAbyW8gZ%2BZGq0EVerVGUKUSm%2FIdn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ%2BQATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm%2BoOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724%2BzUQ7%2BvkCpZB%2BpGA562hYQiDxHVWOq0oDQl%2FQsoiY%2BcuI7iWq%2FZIBtHcXJ7kks%2Bh2fCNUPA82BzjnqktNts%2BRLdk1VSu%2BtqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy%2F44XYXdI5noQoRcvjZ1RMPACRqYg2V1%2BOwOepcOknRLLFdYgTkT5UApt%2FJhLM3jeFYprZV%2BZow2g8fP%2BU68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr%2FA1SY9dXFz4RjzoU9ExfJCmx%2FI9FKEGT3n2cmzl2X42L3Jh%2BAbQq6sA%2BSs1kitoa4TAYgKHaoybHUDJ51oETdeI%2F9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB%2BUn44zExFE4vLytcu5NwpWrUxO%2F0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL%2BBDqMyaN3RJPh%2Fanbx%2BIv%2BqgQdAa3M9Z5JmvYlh4qop%2BHo1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs%2Bgs37sFvi0PPVvA5dnCBgILTwoKd%2F%2BDoL9F6inlM7H4rOTzD79KJgKlZO%2FZgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno%2BgBoKVXgIL%2FVI8dB1O5o%2FR3Suez%2FgD7M781ShjKpIIORM%2FnxG%2BjjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4%2FQftDbEn%2BAucIr1oxrLabRj9q4ae0%2BfXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd%2BeNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz%2F6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT%2BmAUmiYbV3YQVqFVp9dorv%2BTsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp%2BxJyYLv1OsxQCZwTB4a8BZ%2F5EdxTBJthApqyfd9u3ifr%2FWILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj%2Fqn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9%2BW8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4%2FYtowhEmTs0vrvlD%2FCrisnoBNDAcUi%2FteY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O%2F4DcgV%2FdZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk%2BtgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb%2Fn7qwhvGnrHuf5bX6Vh%2Fn3xffU3PeHdR%2BFA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E%2BYbfL0adwNtHP7dT7t7b46DVZIkzaRJOM%2BS6KcrzYVg%2BT3wSRFRQashjfU18NutrKa%2F7PXbtuJvpIjbgPeqd%2BpjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir%2F8tNXJ%2FOsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG%2BFZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx%2FGdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD%2FQi%2FEmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4%2FasthNMK5UQKCOhU97oaOYNGsTah%2BjfCKsZnTRn5TbhFX8ghg8CBYt%2FBjeYYYUrtUZ5jVij%2Fop7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM%2B3SW6Opll%2FwgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy%2BQbSKVJcqkia%2BGvDefFwMOmgnD7h81TUtMn%2BmRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d%2FQK7Cr4uoCeOQ7%2F8JfKT77KiDzLImESHw%2F0wf73QeHu74hxv7uihi4fTX%2BXEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo%2FoVH5ww5OzLFsiTPDns7fS6EURSSWd%2F92BxMYQ8sBaH%2Bj%2BwthQPdVgDGpTfi%2BJQIWMD8xKqULliRH01rTeyF8x8q%2FGBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE%2B%2F7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV%2FyTDRRP8Y2ww5RO6d2D94o%2B6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt%2Bkqdae76ViWe3STan69yaF9%2BfESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw%2FA1zEdjWquIsQXXGIVEH0thC5M%2BW9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF%2BRVmI8L4HUYk4x%2B67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8%2Fp5qIQrEo%2FH%2B1l%2F0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud%2BtJUfdaZ4CWNijzZtlRa8%2BCkmO%2FEwHYfPZFU%2FhzjFWH7vnzHRMo%2BaF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce%2F%2B%2F9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs%2FGWJS6SwEN%2FULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e%2BG2zor8l%2BYaMxSEomDdLHGcD6YVQPegTaA74H8%2BV4WvJkFUrjMLGLlvSZQWvi8%2FQA7yzQ8GPno%2F%2F5SJHRP%2FOqKObPCo81s%2F%2B6WgLqykYpGAgQZhVDEBPXWgU%2FWzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M%2BGWn6ASobIWC%2BLbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg%2Fkpf3%2BCnAXKiMgIE8Jk%2FMhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo%2BRJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B%2BSkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE%2BVMd3b1fhCynD0pQNhCG6%2FWCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp%2FYbHjo%2B%2B7%2FWj8S4YNa%2BZdqAw1hDrKWFXv9%2BzaXpf8ZTDSbiqsxnwN%2FCzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m%2FNCW%2FHILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO%2B5EJ7Z6bCiRoPedRZ%2FP0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn%2FLvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl%2B11PoFYnNv2HwAODeNRkHj%2B8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij%2BbsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur%2FeWHjiB7SOVdqMAVmpBvfRiebsFjger7DC%2B8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l%2BkXRZ0KLZaGsFSIdQz%2FHXDxf3%2FTE30%2BDgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH%2BRptvRMVRaahu4cySjS3P5wxAUCPkmn%2BrhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik%2FzbrTQk5KmgxCg%2Ff45L0jywebOWUYFJQAJia7XzCV0x89rpp%2Ff3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl%2B5tfUWZNwBpEPXghzbBggYCw%2Fdhy0ntds2yeHCDKkF%2FYxQjNIL%2FF%2F37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD%2BqNOhwMlfARQUdJ2tUX%2BMNJqOwIciWalZsmEjt07tfa8ma4cji9sqz%2BQ9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe%2BjGDiNJQLWnfx%2BdrTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf%2Fbkvo8PLVBsZl152y5S8%2BHRDfZIMCbYZ1WDp4yrdchOJw8k6R%2B%2F2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB%2BM4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5%2FiYp3ZdrCf7fL%2Ben%2BsIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv%2BNRiJc8JAKqqgCA%2FPNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN%2FhCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj%2BbYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5%2FzBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8%2Fi%2BjHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2%2BJrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk%2BMz7wwstg6RFZb%2BTZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm%2F7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk%2B9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx%2BwhVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC%2BXYuqMBMUun5YezKbRKmEPwuK%2BCLzijPEQgfhahQswBBLfg%2FGBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX%2BRCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk%2F4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug%2FAbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM%2BZu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX%2FpcsfwXbLze2%2BD%2Bu33OGBoJyAAL3jn3RuEcdp5If8O%2Ba4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT%2B%2Btm%2BhaBCikRUUMrMhYKZJKYoVuv%2FbsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV%2FDMUxd9uFZmBfKXMCn%2FSqkWJyKPnT6lq%2B4zBZni6fYRByJn6OK%2BOgPBGRAJluwGSk4wxjOOzyce%2FPKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO%2FcEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm%2BbddRQu5F9s0XftGEJ9JSuSk%2BZachCbdU45fEqbugzTIUokwoAKvpUQF%2FCvLbWW5BNQFqFkJg2f30E%2F48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J%2B1pT0tLkvFVZaNzfhs%2FKd3%2BA9YsImlO4XK4vpCo%2FelHQi%2F9gkFg07xxnuXLt21unCIpDV%2BbbRxb7FC6nWYTsMFF8%2B1LUg4JFjVt3vqbuhHmDKbgQ4e%2BRGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB%2FKVijd1ARWkFEf3yiUw1v%2FWaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G%2BZManTqDLPjyrOse7WiiwOJCG%2BJ0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj%2F6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j%2FN46f%2BS2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb%2F0jQbaHJ2YRK8A%2Bls6WMhWmpCXYG5jqapGs5%2FeOJErxi2%2F2KWVHiPellTgh%2FfNl%2F2KYPKb7DUcAg%2BmCOPQFCiU9Mq%2FWLcU1xxC8aLePFZZlE%2BPCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh%2FnFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW%2BoKFLvpyvTBMM69tN1Ydwv1LIEhHsC%2BueVG%2Bw%2BkyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw%2BH%2FAuOx%2BaH%2BtBL88H57D0MsqyiZxhOEQkF%2F8DR1d2hSPMj%2FsNOa5rxcUnBgH8ictv2J%2Bcb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd%2FPjMMtQfyDNZsOPd6XcAsnBE%2FmRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl%2FXPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG%2FVanIvcwycVA7%2BBE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP%2FMVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX%2F5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c%2FF1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J%2F5wkjpkre727p5PTRX5FGrSBIfJqhJE%2FIS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug%2BoRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U%2F5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7%2FBQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN%2BnA7pvF78%2FRII5ZHA09OAiE%2F66MF6HQ%2BqVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe%2BhXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz%2BJV%2F4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB%2BK3wBP%2FineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q%2F9uocGsx41O4IZhViw%2F2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY%2FcQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE%2Fom7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi%2FcaHSM3FPRGRf7dB7YC%2BcD2ho6oL2zGDCkjlf%2FDFoQVl8GS%2F56wur3rdV6ggtzZW60MRB3g%2BU1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg%2FgBQIZMG%2FYcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK%2FG7F3mUc3GOAKqh60zM0v34v%2BELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND%2B%2FGTk6M56Ig4yMsU6LUW1EWE%2BfIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP%2FIoRIZ%2FF6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg%2FRrPD%2Fd3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl%2BMu4xf0ezqeXD2PtPDnwMPo86sbwDV%2B9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD%2FOwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d%2FUfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH%2B14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC%2BOA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6%2BvAUUBoGhY3CT2tgwehdPqU%2F4Q7ZLYvhRl%2FogOvR9O2%2BwkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn%2FdFSWBWzQ%2FVYk%2BGezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n%2FyJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET%2FHh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j%2BDXfpi12m1RbzYLg9J2wFergEwOxFyD0%2FJstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT%2FcUP6pE%2FmujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB%2BHEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu%2BvqQ02%2BKpJBjaLt9ye1Ab%2BBbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC%2BUwkXOoAjneU%2FxHplMQo2cXUlrVNqJYczgYlaOEczVCs%2FOCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38%2BxsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9%2Bb8fH6%2Bb8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj%2F0Q7PFUcC8hDrxESWdfgFRm%2B7vvWbkEppHB4T%2F1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y%2Bg3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR%2FRrs%2FJLKXgEx%2BqkmeDlFOD1%2FyTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW%2Bxz%2B5FElFxWB28VjYIGZ0Yd%2B5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ%2BlT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ%2B2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1%2BJpI9psyNYIFuJogZa0%2F1AhOWdlHQxdAgbwacsHqPZo8u%2FngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2%2BRdM%2BMAaYaZ0Y%2FADkbNCZuAyAVQa2OcXOeICmDn9Q%2FeFkDeFQg5MgHEDXq%2FtVjj%2Bjtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2%2FBc0UxvseQCO2pQ2i%2BKrfhu%2FWeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt%2FU0Wf%2BphiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7%2BExseJauyqo30hs%2B1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j%2Fe1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la%2FQCTiVelFnU6O%2FGCvykqS%2FwZJDhKN9gBtSOp%2F1SP5VRgJcoVj%2Bkmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn%2B8p6%2BvBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H%2BgDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D%2FGvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P%2BjAgN5TB3haSifDcApp6yymEi6Ij%2FGsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x%2FpChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11%2Fyxyw0UnGig3MFdZklN5FI%2FqiT65T%2BjOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5%2BbqWiAYiAv6Jsf79%2FVUs4cIl%2Bn6%2BWOjcgB%2F2l5TreoAV2717JzZbQIR0W1cl%2FdEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW%2FPhoawJDrGAP0JYWHgAVUByo%2FbGdiv2T2EMg8gsS14%2FrAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq%2BSCcTSx5NDtbFwNlh8VhjGGDu7JG5%2FTAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9%2BogD8Kk%2FW7QoRN1UWPqM4%2BxdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c%2B4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS%2Bo3F8YVVeikw13w%2BOEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX%2B%2B7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9%2FO53DYi%2F5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD%2BP8sNh6e%2BXYHJXT%2FlkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp%2BpT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS%2F2ToPjqkaq62%2F7WFG8advGlRRqxB9diP07JrXowKR9tpRa%2BjGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq%2Bnsp3YMuXt%2FGkXxLx%2FP6%2BZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar%2BgMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud%2BYlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl%2Fzh575R5rsrmRnKAzq4POFdgbYBuEviM4%2BLVC15ssLNFghbTtHWerS1hDt5s4qkLUha%2FqpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI%2ByjEldJfSo4y0QhG4i4IwkRFGcjWY8%2BEzgYYJUK7BXQksLxAww%2FYYWBMhJILB9e8ePEJ4OP7z%2B4%2FwOQDl64iOYDp26DaONPxpKtBxq%2FaTzRGarm3VkPYTLJKx6Z%2FMw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ%2BlPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k%2FUuGkNpP1DBI5ch%2FEehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv%2BJ41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI%2BHYexTUevLUeta4%2FDqKrbMVS%2BYqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ%2B%2BKkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9%2FWx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k%2F90B8%2ByRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB%2FmQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go%2Fn6j0cS%2Ba2gEU8gIHJ%2BBwfgZX4GL%2BBd%2FgW34FZ%2BBS%2FgUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh%2FF062yJ7AAAAEDAWAAABWhJ%2BKPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg%29%20format%28%27embedded%2Dopentype%27%29%2Curl%28data%3Aapplication%2Fx%2Dfont%2Dwoff%3Bbase64%2Cd09GRgABAAAAAFuAAA8AAAAAsVwAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAABGRlRNAAABWAAAABwAAAAcbSqX3EdERUYAAAF0AAAAHwAAACABRAAET1MvMgAAAZQAAABFAAAAYGe5a4ljbWFwAAAB3AAAAsAAAAZy2q3jgWN2dCAAAAScAAAABAAAAAQAKAL4Z2FzcAAABKAAAAAIAAAACP%2F%2FAANnbHlmAAAEqAAATRcAAJSkfV3Cb2hlYWQAAFHAAAAANAAAADYFTS%2FYaGhlYQAAUfQAAAAcAAAAJApEBBFobXR4AABSEAAAAU8AAAN00scgYGxvY2EAAFNgAAACJwAAAjBv%2B5XObWF4cAAAVYgAAAAgAAAAIAFqANhuYW1lAABVqAAAAZ4AAAOisyygm3Bvc3QAAFdIAAAELQAACtG6o%2BU1d2ViZgAAW3gAAAAGAAAABsMYVFAAAAABAAAAAMw9os8AAAAA0HaBdQAAAADQdnOXeNpjYGRgYOADYgkGEGBiYGRgZBQDkixgHgMABUgASgB42mNgZulmnMDAysDCzMN0gYGBIQpCMy5hMGLaAeQDpRCACYkd6h3ux%2BDAoPD%2FP%2FOB%2FwJAdSIM1UBhRiQlCgyMADGWCwwAAAB42u2UP2hTQRzHf5ekaVPExv6JjW3fvTQ0sa3QLA5xylBLgyBx0gzSWEUaXbIoBBQyCQGHLqXUqYNdtIIgIg5FHJxEtwqtpbnfaV1E1KFaSvX5vVwGEbW6OPngk8%2FvvXfv7pt3v4SImojIDw6BViKxRgIVBaZwVdSv%2BxvXA%2BIuzqcog2cOkkvDNE8Lbqs74k64i%2B5Sf3u8Z2AnIRLbyVCyTflVSEXVoEqrrMqrgiqqsqqqWQ5xlAc5zWOc5TwXucxVnuE5HdQhHdFRHdNJndZZndeFLc%2FzsKJLQ%2FWV6BcrCdWkwspVKZVROaw0qUqqoqZZcJhdTnGGxznHBS5xhad5VhNWCuturBTXKZ3RObuS98pb9c57k6ql9rp2v1as5deb1r6s9q1GV2IrHSt73T631424YXzjgPwqt%2BRn%2BVG%2BlRvyirwsS%2FKCPCfPytPypDwhj8mjctRZd9acF86y89x55jxxHjkPnXstXfbt%2FpNjj%2FnwXW%2BcHa6%2FSYvZ7yEwbDYazDcIgoUGzY3h2HtqgUcs1AFPWKgTXrRQF7xkoQhRf7uF9hPFeyzUTTSwY6EoUUJY6AC8bSGMS4Ys1Au3WaiPSGGsMtkdGH2rzJgYHAaYjxIwQqtB1CnYkEZ9BM6ALOpROAfyqI%2FDBQudgidBETXuqRIooz4DV0AV9UV4GsyivkTEyMMmw1UYGdhkuAYjA5sMGMvIwCbDDRgZeAz1TXgcmDy3YeRhk%2BcOjCxsMjyAkYFNhscwMrDJ8BQ2886gXoaRhedQvyTSkDZ7uA6HLLQBI5vGntAbGHugTc53cMxC7%2BE4SKL%2BACOzNpk3YWTWJid%2BiRo5NXIKM3fBItAPW55FdJLY3FeHBDr90606JCIU9Jk%2BMs3%2FY%2F8L8jUq3y79bJ%2F0%2F%2BROoP4v9v%2F4%2Fmj%2Bi7HBXUd0%2FelU6IHfHt8Aj9EPGAAoAvgAAAAB%2F%2F8AAnjaxb0JfBvVtTA%2BdxaN1hltI1m2ZVuSJVneLVlSHCdy9oTEWchqtrBEJRAgCYEsQNhC2EsbWmpI2dqkQBoSYgKlpaQthVL0yusrpW77aEubfq%2Fly%2BujvJampSTW5Dvnzmi1E%2Bjr%2F%2F3%2BXmbu3Llz77nnbuece865DMu0MAy5jGtiOEZkOp8lTNeUwyLP%2FDH%2BrEH41ZTDHAtB5lkOowWMPiwayNiUwwTjE46AI5xwhFrINPXYn%2F7ENY0dbWHfZAiTZbL8ID%2FInAd5xz2NpIH4STpDGonHIJNE3OP1KG4ISaSNeBuITAyRLgIxoiEUhFAnmUpEiXSRSGqAQEw0kuyFUIb0k2gnGSApyBFi0il2SI5YLGb5MdFjXCey4mNHzQ7WwLGEdZiPPgYR64we8THZHAt%2BwnT84D%2Fx8YTpGPgheKH4CMEDVF9xBOIeP3EbQgGH29BGgpGkIxCMTCW9qUTA0Zsir%2BQUP1mt%2BP2KusevwIO6Bx%2FIaj8%2FOD5O0VNrZW2EsqZBWbO1skRiEKE0DdlKKaSVO5VAuRpqk8VQJAqY7ydxaK44YJvrO2EWjOoDBoFYzQbDNkON%2BUbiKoRkywMWWf1j4bEY2iIY1AeMgvmEz%2FkVo9v4FSc%2FaMZMrFbjl4zWLL0%2BY5FlyzNlEVYDudJohg8gPUP7kcB%2Fmn%2BG6cd%2B5PV4Q72dXCgocWJADBgUuDTwiXiGSyZo14HOEQ2lE6k0XDIEusexDzZOMXwt1Dutz%2BtqmxTvlskNWXXUQIbhaurum9GrePqm9Yaeabjkiqf%2BbUvzDOvb2Y1E%2BEX2DnemcTP%2FzLcuu7xjQXdAtjR0Lo5n4%2FHs%2FGtntMlysHt%2B29NXbH6se%2F%2FWbFcyu%2Br28H0MwzI30DYeYTLMXIA2EG8QlHpAsyS0EfEToR0a3utIxFPJ3kiIHCCrZ66b0e2xEmL1dM9YN%2FMwS5p01N5jMX%2FBLKt%2F1R83l0LyC29M6%2BiYxo%2FUNg%2FEF7c2WyyW5tYl8WnhWg2%2FhyySbD5UhnDyS7OcU0dnrFw%2BDfGdI7v4QfYIIzOMq9hFtY55gmvC7jZ2FK7sEdrn6IXBuucYhjsGdQ8z0yEbWkkczjjsE5hNAIZrPx2zOLZDmKNXcXtg7EMqidAEEWg%2BSJCBBNwxvxJfc%2FbZa%2BKKf%2BxoKZybnq5vaqpPTye7CiF%2BZFjxZ8%2F7Qij0hfOG%2FcowPA1rT1l4ymWnrKmxxqfErTVrpgwPlz1kC%2BOy8NMDz6c%2BIO38K%2Fx0xkPnLW8Kx6qGAoQdL%2BTD9V9rb%2B%2Fctn%2F%2Ftrxz8dUrZrD%2Fzk%2FferF0cNt1BzctmX2FZPXt%2FjnFCQNz4Ah%2FiKllGiCMs1w5Lkg0kiEwj6VTXCDKsX9rMpnvIj9pcDecXAIXMnqn2dTUbN6w0XQ9ue6FV%2FnnXCH7S3lPWGltVcLsH75ub3ab7A8M28caNrIeOr3o5Q0yFsYL80xaa0EY%2FUEczV7icUMY5pnelAkmUAXmHYjvFWFGxuqlSaow3OM%2B%2FiYY7%2Fl%2FhVELF4EjRqNR%2FbvRbOY%2BDUGzGR%2FOh3EqmE%2FugIQQguGt%2FeMYz%2F%2BL0cimjeZfQDI3phXMbMQsqH%2BCjwVz%2Fhf4idHovgVmB8gLvjbicDcC%2FNypP536E%2F9N%2FpuMibExdohBmNwyiaZdJGoigos7GpF222xrfnZhML%2F7Z%2BylaqP63Hr%2Bm7bdUkQ6%2F2cXqdfmvwixY%2Bs2ksXFeXcE%2BiX0Z%2BIow76DBNgjJ7TOdUK18iPsPflfQD%2BDPsZG2Aj9VmKMMJ4fYRrhIaxhTDR0Elh2vA6h%2FAE6xUb29mj3sjmL72petXjejPy%2Boel60M99tFduCI59N3221xe7apOvxs6aHs7vab1IqY2tv7q2xsHeHGml%2FcV06u%2F8S%2FxTjJ%2BJYc0bWEX0ukW6YmIbGkJRMdjJ9mYIH5QIdJF4hvRGyK7cC7ctImQRcUET99fGXOoft35GYLMQu%2Bg2smnkgZUrH8AL%2F9Si217IssJ916nv14ZrJrvdxLkQvrvtBcjgPC0NXOicO8Qf4mcxPqh3hgUw3DDfdvLJXngg7N3dN2zbPJSaed3OfZnMU7dvmznp3C3bruO%2BNmue0LFsy7S%2B6265%2BfCKFYdvvuW6vmlblnUI8xCXp37CrOZv4B9gauDBlYp7adcUXB5DNCwYImlXOJJKkAdvExXxVvKEYnCo%2B3eIskP9qrrfIYs71CccBjfXRC52udTHHdaP1A1ui%2FVvH1otbrLrpNXBsGX5B89QghDyimlvNB2KfkxZ5C9%2Fem3%2Bd1%2Bd%2F%2FIfFp2%2B2Oxn%2Fs%2B9n%2F79p39S3s8idN6g0yZObwJOgKUpNB3GyU0Ls0PbRzIRq4lcarLKOJBkLRzJQD4j2090XrbA7DW8K3jNF5hlGS5e4V2D17zgss4T20egOJte5iD0bReM9yjTxnQxCRj3c5kFzGJmGbNKmwGw39IJDJcXJZGMkaAB4jyJAKw0jt5IAuIE%2BA%2BU3cVAZZrq9zhDyBrU8oosuxcGNTzCKJfla7JjNVmuSb%2F%2BtuzN2H%2BX4vlB%2BPpdfMXXmuVsNiub1T34SFbjYw5itEvVi0K0Nt9pNJUMI7SLGRhf2xipfCYf8z5OdlGKayOucFeVPeS%2Fdbo3lBrbSMmwUiQN5%2Fed7g0Ds1s17IuZC5kNzM3MZ6EWCa0DtekdJfAxz%2BR%2FOX28sND7yRMTBcf%2B%2Bs8mQCQWHya4qBv%2FufeMoWyslPA9DtMxUknxkH%2FyfTnm2CMYzs%2BCq3r7PxY%2FMXomrvTEsRpfEGHa%2BWN8E1AHjElb7d06ddA7oK%2F%2B5Mdsv9EtPms0jv0Z5kf1FqPxWdFtfFr0kHfgDX0Y%2B5PRSG7RUj0tQr7rmfX8DH4G5W28kKeJLtmQsQkuwMP1pk16EV4sl7vrMJATfyUWo%2FGwEco4rh4XFQgaiUX9qxZHrMQqKnz%2Fc2d8b9TysYrAuXpP%2FRf%2FGr8b1qwwc5a%2BeuLa6S6sneNXToG2XrEJi4R5SGs8Sq2S3d97bsfCRaTdaLwKClRHt37mkudvXbjwVrLhuYeGhh56bvfQkHpk2CwvwClqgWwuBfndC3c8dwmstj81KkagcUgbfPY8Zje0W%2F82VPWJHmSq6pP8hPWpotc%2FEexDOK3qU%2BwngPhOCiO9MJRm8TJefjelrzoKnG2Bn%2B1NCUmPE4gHFmBN9jrTigRIpsACrc9Gstg58ULkp9467%2BGf%2FeFnD5%2F31lNrt2967dhrm7bzI%2BVT5m%2BfzKhvf2MzpICEm79Bopkn07lt1762adNr127LwVqQLdJ5%2BlpQDcvHPQtVY5knhYrK6q8%2FJsiP6EuhGZdFdaNszjvpqvc%2BPI0CdjN0AXsFOC3ZfALDJwr4q2Xq%2BGF%2BGNbsxUg5NLLIEXi8otcDQcUts0D8eQ1iVDRAMBTsYiNdRIxE09EIBJO9A2xqgERTaW86BUFn0OD2xFO97FAgFhF6OoQ7prYt4XwSeUgQHiJyDbeke9IdQntciLQ1FlJMaYcUNvZBg%2BFB1ubjlnRNvl3o6IEU2w7fdNPhm%2Fhh%2BFLysUu6%2B%2BDLHkOkrSHYEjH0tEPe7WdD3uyDgvAgK%2Fm4szFFR7ch0toUgBTdWHr7EpaWru6%2B6dmbbnqWEbV2EtxAsXiZAPTtGPSbHsotI2leoM8TePEqgSQprs7AGFf8kuOkPdZPXGb55POAW1d%2FjLST9v5YflasP6v%2FCO7%2BGNAPC2BMZWmsOjp2NNbfHwMCJD%2BLPVL%2BD%2FOYlWEEI%2F9jpPddOFkB5d1GSuKZYggmCCd7JUxD7EXAzxyirYnNDLdDZoFdx14kivkvGc3579Jm36reTTvDgBnaO6vzyQ6chQmlsMoIkIQ2%2BbBDWBud1Va4pcCn8CPqxlh%2FfgtG8IPaPH8C5wk6%2FnZDv69jurV5QhtwE0x2iqOsj9Mx8B9%2F0EaUdiPfOYYDCi%2Fq9jhWRuupMDEU0%2BCtX0sDFxv07T%2FK5niBPqN9%2BtQjgEc31NGCXFeMcCEuQBIc%2FBK4CO78u7EPYvl3yaEfK3vcb6qP1R2tI7vUjVDDUdKubsSrNjYKY1qBEa2P50SJoaXiksIoLiCwnxS6EBuBde87botNfdEWwYvF%2FR0%2Fu5yCqhGeEOR2ynSeyXjt6ka7neyye8kryBSWE52y%2BRBgogrXPZ8E1yIHoHIFUM%2BAbJhE7lbMtt8ApL%2BxmZW7PwbjAO0fAVoXQOuiSP%2FksIVdFZ0aulsamKUzwPZ%2FNYDMJRBPCxsBqLzqHyneXF6Ej9HlIFo7%2Bpg%2BjUb3unRmGpstGkm6etOuDBGA5wCMefp1gTHcdZlvPBXlOslvYTp1cd8UjYLVd%2FJ5awNrIOKLnIt9MD9qdrKrWCvA6ALm3QV9VrsPm60Q7%2BRHJHP%2B2hqfugo%2FMvI2H%2Fmqr4b9tFnKSRY1Y5Ek80Nm%2FWIhr1ikKnxGz9TWXrokf9xwujfvcOTtNTWnxd0F37Y2W79tteBqZ4G5qLCuomw%2BnSr28QESCRVLTyYKILGJOPfcnaIFOsewhRdvv%2BrWa%2FWih0vlbX6Zb75T5C0qNKVFvH1QL%2FvazSWgC2s6oWXXIuUxQelKiJbowuJDQViatLmLijg9CQBMg8WiPgiw3LEeYRmm5f%2BXdnvkDnxLLjMLxtvX74C3OlwPQqx4xwIdpPx38LrlDphiyWUWHWKAzzxurS%2FxTo%2BP5wGFak62ap1PVFFN4v%2Fy%2BxuR39WnIO7lsWfwgVsK17wxrs9K8ltIKuhkw7f%2F6dhK6gQokFKhWX3urrjk%2FrnI0pgfpGMeuQIUaEM7%2BGF5q2iMkCaMQwxxOzcvU0eXbsnS9XknXvP7Gtw5dwPXlFu2ecvSHEZgNDsU6x%2FGdXBYXyOQjzZReSedeEPY6nEv9gJR4oBQJtFO6Kd0fwC6BO4LNHDeBujB6dSNcUQC9zIv2LnAzGk99bUDrdFY%2B9yGFQtEo0GQPNv6vS2drj4%2B1jHbv3aJSMUWP%2BQTZrmbNTjU8wyG%2FiXNNpskybLcJ3CiTF5Ir%2BJYzmJwE0mSVhlxbtbmvweB3ulB6Til5UuUZydpgiFVeobhU0WaBqpJ198d%2B%2FXeNRTZ9%2F1OPfG7%2B2hwzd5W3D%2BhmyjsRcUg%2F%2BCavb%2B%2BVh2ls3L7zT%2FetOnHNxeerv313vzLVqPai4nJv%2BK1FC6040%2F4udw7sAb3laSg0XCkAAs0npBO6VJabS4Elk%2FU%2BD4gTXW%2Bj0wnrMlqNamq4tMIYB87tE10i0FR3LZNhJsb7%2FR561btmes8YBCRkhYNByRtKd55mqTas9FYhJnbRGHuOh3M4QTdgQSqmgRxuzGdSvZGcbMxNQGk5C3ebLjoXIOFM4l%2BWKHmLTJwRv9E8GWJ6dYvf%2FFmEyEGr%2Bgyrr1p5zrgkz0Cw2j94Hv8Jdx7dIVegBSNtgsqGsRQEYiIBoXwD0LNvQ5d7s5Z00QzwNhqZA0b%2BtMG1tQq5nd84uq8R0zPvX35G8uRaze4jcOHzz0w1%2BQ2BIRvf6J6Kgatnrbiem%2BCFvAxfkrndzD9MFPP1GWTUHclpASUkCNAQkpCCcCgDSUDAhDZ%2BCuEkgn8J7i9nMA7pA4lISappxILKfAeSAbIcSDuN2bJcfZILqeO5rLs0MnngSHYRdrHjmaz7JEsEPw51ZqDJDmUIOZIe34WaQeegNsJn1qz8AIpT3yCjyEih%2FxELkuJ0lEMYTLVCiWpo5oYMleMH6USyYJcD%2BuOe%2BkWKpn1Qns34iyYDjkSLvgnZXcgVQNeqINXr48m3iS7cjm8tedyY0f1QvTnHHdsrKby%2F%2BSSbPY8%2FNH6vpl%2FEsq3Ae4ZU1HC44KFiI9o7CEgab%2FRqHbj7s5KAg06s39ZP%2FzxI%2FmVuF%2FTbTSy%2B3Fb8If9%2Fcv7%2Bwt91yy8RfP1QXtW5RzQn7qIiZyuFM5QfJ5E9uVnqT85TanFx0lkP3ukBAMprvsRyi%2FC8NAJL1xbIIirSvnSj4O5netb4JxmNANHPssHAcHMHsFRgEug816gDBeMbdfiuRcghqYcm0%2BXxx%2F5IAEtN3fqFF3LzAXqwoT0PN0OVTNqxo8sxMkd5Ig6k79Zk7VxxX6gMLOZFQgvpW2RrMW1D0BDihaXQ9wVRoBxPLfpknmkeMtoB%2FqM9cRc9IqmMD2XUmdZ7GSRKPUZvChf8BoykriM2MnKYbOHX8R7cLdNCxSFFVQqoYswnlWtlFS2mNkhswVpZiQW1J%2FUKFfipHGlUkM6UKBhMz1istELIHJLMSctu3ugzfaVSOjKvUgc%2FTHK4Sdg2Wscz69leKIkkrwuuWiOe9yGYKQXRumkC3qbRcMwrvhjNXgdZk3RxAUEhuSPvn3nnd%2B%2BU%2F3vlVOmrJzCD8JLxV1OHRjrZifbcFDOuRNTGqdgQm1tSNJ2OcQ04YiEXuxtII1ECSQRoQGYioEsgCfchB4ghAtw7FfJre4WZ9hkVi9MtjuWqtdNDlpMrfEG9fOT6q21okg%2Be4As38MfGquNt7oUws6Ysarj1%2FefE%2Byst86YUVNvDdts3Pv5c8m%2FaP0C%2Bf8%2FQb%2BIMnGq09BgwN01oIOAnAdagI8mBSrqk1gxTDUBOtk2ousEtBH2z4Ir2d3f6k8PXXVlt2qN9RODxRuoJT%2Fv27wm09jRYVc%2Fe%2B%2Biyx2tyzJb%2Fn3J0htXP87eSsQaf2Ly0s6Zmxela88REy1cf4273mI3iXNJ7KxrZibOm9xm6rl4fqy%2Ft27smU8tOfdW2ucBzg2UfmOIVyLIl3kpYlwphDISTXJXsctmiDtN7fNV6zelgxwnWxsVr83Aj%2FS5ki1jL%2Fa0GC6%2B2L6Um%2BaoddlNFuj%2BbJ8mH%2FiaLh8I0%2FU51NspIEfq0dohwyFXKgm4NggwQ4rRhCOUFtxxo8XnitT4cnGfT93IS8FaT85XE3H5LMY4zIEPL1hw443wz%2B1UmhTJyJGxZzw%2BwsKkKZgUiVtKOKMEb2AKHTv61FNc01PQFwKnvsZ%2F9pPA4RKTASWahmh%2B8MxwzHxKy74IRn5LGRjsPUUwTu64UYNY38caqd7HKucZ%2FtHnODtENw%2F2UfHRMaq1UUPDJQ0OKkWCeet5fYOhII1VRz8%2B%2FElg5j4Gxur3J8o2PJ4rg%2B2d08T%2FfwEzSVbyZ9XPro95T477lRKqUSRXQnauHNsISAl27oWi6Fv9z48JMv8r%2FaMMj8onCP%2FDuDZOuN%2BGPPr%2F%2Bp7bx%2B7JlbYdppcNhzKU%2F1Px5aiaGDn%2Fs1iGMaBcleKUo%2Fv9rcxkZj7DBEKOfrayytXNLYiUdBY%2BpleQXdnscKlQcpzuWluxsieeyuXIK6SdxozitWyGOV3vOHHjguyCQ6fpIYy2JwvrQEF%2FQa9Pdf%2FQqOSqCiE%2FEE1%2FXIVKTc2tzWbHnimrEd%2BVyz311Ml3P0GVTj7PD5aDnsvCvH36alEaPMePcMegXs7x8igTu4B9v7G9vTHvhCu%2FkzIdx%2BBxC0ay9zRSvoS0F2lIxI%2BX7klU63I40gLQ3w5ep5na%2BSFnba3z5D64zv%2BQtM4n4ffG3tq4aNHGRfxgrXPMim%2B5487abL7xhdseIRn1KDl%2B7aINixdv0OD%2BJSPwKf5%2BxoP6aiTeQIDVlIhMcL1H5R9PYXvprs3fv2bO7MOplCmweuiq2JRZ1zz%2B9a%2Fv2PH1Hfz9236w%2BZrPXvWfAxlj4NLLHpq3c%2FPQ3uvmvbrjG7fe%2Bo2y%2FcLdtE6VUlXi0ASb1VLUBVSUWSU4HdvAraTyS8xzM8NxvxFkXV6pUVRiJwcgC5zEeht4rwcp7ki0k41G0qlQhG1Vzlq8alEmnFi58caB5Q9vn988MLhqyVlHvLEWjtQFeupdiocF%2FtkkOGPW2ibWaBTkeZ%2FdvPWazXfOnnvL6jkRXpi85sFzZt%2B55ZptW3bl1cCCHZPD06MhySha7UFzjcjbp8fOecFCirzAG%2FyVjBX6OFIaadSjQq1nNhyIe8tVbaaSdHlXIWKacMeuZA1uxS95zILhyrxAdsXTL6m7kNQlx2P9uZf2qhufePFFbpI6%2FOU0WcP99RrCsrwseVot5mtytpf6Y0gm9sdeyKnPQ7onyK4nXlR%2Frg7H95M1upzu89DH6pgUcikoiihJ6NJKmRxV1x%2BMJiOA3YwhDRQrWU0u%2F0rvq0VYXnyCwsLeTJYBq3dAtJDavuzyoVpzZ99Z0%2Ba0uoiFH%2FxcqgDR7rUFeOrUn6Cywb8ZeNMbhLV5ugP9l0zv9UN5b5mFkjzxUcpPJCn3V402pRxtJd2GrnLdhtVk9ZSZh9W91fCSH5B7ofxPiWL%2Bj3D%2FuwhBRdyAyozeZwvQzs79soi%2BBKSnafLviZCcfrpBpLyimfLfTyJtbyruIQKD01tUwJyKEo%2FybaxkSNFUMdMkhQoJyRBQFhnUkDQSXhTM%2B3NmY0EDM7ffLIjqWEGt8lCO6mLia3PukFnghosJD5p5SIho%2FVDkzQfLE%2BIrYoJXkD19pdP7OwG%2FvoIUtagiWiZ4PAFTHHlTVhRZ7dYmPar%2BNJ%2B8JhmR6DFK5DV1foHoLNO%2FpHrvZfmWZ15RQlwvoVDKhCWNK3CCch9lfFBuAqUgpFSShmNaPj%2Bi5%2B%2BWZfKeViJfW5HnUakVL4UCNVkA4%2BETfIqx4B5xSaP2L1yn0zn2ltPn4%2BOqZGmwwEVCaCSqG53ldtL1oLGAhdMLd09MpCCF6tD6ZnAZBY9hDaYsP0jzZ0j5ZjKsF4i1UmLuhbJMCnYJPt5VwFNvmZawXjEvLJqIH8STonZjq7BZ8gKgR20C9MDFqJAX1H64QW2NEup6qgzLP8cvppL%2FNNTOBTCJABOHeWoXzLhw4Wuy7gaBtjKr9kgKq8ZlRYBS32Lpxc8vIhpNDTfyNXWybMJbn2RyQ5EmWc2QF9wmSZ0KYCE%2BcPuYO6b15Uotj2Kd4MItLS7gtFbkTdrFND6pvEZqv5Yv7jXAus7Pg7avo7KDot50NX3CPkP%2BKps8J9%2F3mGQIteY%2FLGPC%2BL7872SPR2br5fy8MtKBMHedGuM28%2FMZmPJMrGgi3Gb1S%2BSi1%2FL%2FzrZwO9XH1ce%2Fz7ZQ1WSoY%2F%2BpMb5FT4ua0Wm%2BJf%2F298nFmChEQ%2BTi71est4mq9VYI6RsymoRJKYidElT2FGnDTZvqtfhGAFTbeqEw68GqtfmbVa%2F1IFO1%2FjdWr%2F8BDRRtQh9XNjubEm4aWVpVonpTGR7PVGc%2BKJNoBIWF7kYi4gUV3r1U6723i6TxUl3n3%2FtM27aZfKb7THiHW9VzFSwHJ05VfK6Ar7kaB0XgPPE0BSkSFKsBUpaLihEWoA9wBt8qirh2VSOkZwXEwyrxZ5jyt2rJmSo9gX7cg6jsEUGJU9z9xJPOEM3uQQxKgkh35DNATnVyrmJ3mbCNyIB%2Fyox4wH1bg2DwN7q9kov4pFqny8oSm3RQbGgJ1QQTs6ZMLilOVYJ9v6Wha3HcJ9jddsXp9YhGUXLXt%2FqMDnvLpPNTXfNa60z5%2FyjXQOMq%2BlNmwh5egpYrdfZQZV9rI47xlRkuyTjpzsmCBSWNkAXVoK8sgYWqQJWbo1RLo6QH0YW6pxqfCnRgkd%2BRiFjUQUQ7poIaYoakgXxwFd9BuuI38H1xBxXSFb%2FpBDIKQFn7YB3dB36l7sG1FLaKiBdp1KxLvfswap%2F30lnVESgNnvjbUoT6w9N%2BXoio0qcYOIM%2Bheg940YimsucQVvli9NEcft2UZwGQwLuilj1fFr1i3NP94X%2BPE7Hpvtj6lBJfJ4R6NvWiaL6MgzWHxiN66DExa%2BdAdAbMYX6HVF8A%2B7rjEZIXAVbDe7PVI9rmN69JOLV1DOSvRPxWNPZBZf%2FNf%2BNy65BhYxxxV%2B77XJ2wfQ389%2FIQPgajXbwMsuAz%2F0IaQcXJavKbRqR2IqyZruXjVC2%2Bhdee%2F5vdnYOedpmVtR3NGXldxSzDSIiBVpkGb9by89UpEPKrSLZmyFDzMab%2FwXl2CNe7s%2FqCtTvWgG5kpBmCBlSzDS%2Fr8N4uwBwohRW63JTS1y32f0TQsPfXVGEHQrV8%2FNCfiOUVirYcBbIeA2%2BiF68rQIo3B%2FS628vYESr79ehzS7Q9LEL9UXmik9XVHb1yBO3Ngvt5935%2Bk1efkV51mzzrM0LL3%2F20avnwMeKuWyOUZg2TasSqZ%2BKcZQiOn1Iu2Vh497ALUVZiCKt%2Fgh6IvTIj1ZLRjWAkpHKOKovNwp00eqPROiAbiNEKieXwMLcXhVJ1%2FuzmLP4tfxaHR59cBdJVG1kTAgl9ze9QKUEQ946Hkb%2BokJ5JRDyf54Axur1D%2BWS49cLr0tTPEu7UmXrxcSr3XNvumv4yXzInXKH4F7Tc7p17Zt%2Bt%2FqW2%2B93k063X7VW6lALxTY7i1nBXMxcxmzQbabxz%2BtJo%2BwijYaIGMNS8AoSMgAPt84DdHOoMPfjXhF%2BkuH1tZvuFQrRCN07xGcXRX9MYxYchDe5BcHj%2BZ4i%2B42WyPc8Xofi7bbZJN5nJLJ5qr6IqRtzqNlM17SpFsnkEyTWoABEjz4JXOQvzWYuwdnV5LNGOwTM5v9r4RpQ8ZXsYodks3o31JBlzbYtNotisnm22MxiwGFXam5oN1n0TA%2FhRvshvTSDwHff4nNzRo9Dum6PaJbMXzDz%2Bx%2BFkj4L4bFNBb1asqsgH7Dyh4DvbkPtf5yMDKzEwyoaESMSNS9P9gJVA3%2FRTlwoMwZvxECFWxIPNw9gi01nOHjP32esZTtmXHnxvZd8ZtakqQ7ekajbXetpNa6ocTVxJtY%2BuSe69OLz77zh5bDR3xjZMzUz6fxrz1nqrZGcHQHfPVefN%2BfiK86LeXj%2BSc5lPKy%2Bk%2FvCUI%2FDaLFYCWHr6nbXuILTIsb5imNKY%2FrCm28fSMxPhkN1XbNMNZGuqwOBhtTSxWuTk6bw0ZaG86b1hKddePOKuBvmiguYBn4T%2FyOqOyGRBt7bKUI1GjioBC8aUKwF7Q319UgcmtFGIzCJGBqwQij0ynDsfdFGc3TS3BlNfJ25xmzniMkpXXTPvCaD3ZaZvyzjmZdudBostmhb0ORZNN2sJBeed1HXkrUsywueQH%2BL0eCPxmsa5ZpgRJSDZ11yDv%2Bjmbd86vxZfc1WcZJ3UkMq1BOOOVtvu%2F%2BpB%2Ben186d3GTwWAw2jheaJs09%2F%2BLNfZft37DALyrNj1wABMuUKbODyTVnT%2FKYbJ3Tpq8IrNh92dkxOj5P%2FYpZx4%2FycyiVcDYdn4JbEoKdQi9054iBKsygLW46FRGxAb0NPNCm8BSNCPjoKcj6EAus4SuP3rB%2BcV99%2FeTF6294dA8%2BTK6v74MHVpYNRt%2FI30e8QGTOOdfGWzzxcy%2B87a7bLjw37rHw1nPzp0KyyRSeZO%2BQQhInt3dYgvycjrPOv%2BT8s1rptaP84VeywdWX2T4ysr0%2F7TLIs6%2Bx9zib56ye1dM9e%2FXsZmePY3NDs9zlnNVt4%2BWgHJbbz3Livg4P9WWgviOMm4kCRT6I8vw0NbUUEnFvOuFKoxQW1gTsvFirsF5pb7qTUCx4i7VmtToveaDxvK9uOaedVvPRpVOnNz0Q6bry7uiSdQ8t7Vy4JQKVS%2BXPplV2ts4bvCwZu%2BKzgITtxepaPRzWdpv74muvv6RO0SorX6cu%2FdqKn%2FXWnrtp%2FZragz13DUCl5myiFW2Ycvb0PtsXnU%2Btx8pvLFbUspLX68mdegwmOif%2FNPDONajTGoUh6tU56HBJCTBASVvNUB5VIiKpc9kd7kludodSFz7xQbiOmMk5dOYk56gzL6uaf7N8a6MQOHm0ae6snZpFDfuT3%2FjdYzjzwkXXIVHoXNuCfQslQZqBZjTsoHMqrkE4jaYdgkGz2ATOgB3cPkSukD01DnV3ttb1wx%2B6arPqbkcNAHoFPzKUUQ%2BqL0k97pjbZv1I%2FegC9zTFbrrlFpNdmea%2BgIgfWW3wqkcis8ky5FAcRd1If5nNZrl2FFpungc8wpoCl1BpQV%2FScS%2BzjlASyUTVv%2FAJ46gkJI4bHX4lTnloctxPZE1ckS3%2BjG2fKIjkQFyzuo8jvYQG1OrGvJPSTu%2FnSp9PHNTl4z5hK%2F8gtXVKF6gEKiglgcKiRlCESsQCV5QIlKWKpr34lt%2FwkSx%2FJCmP5%2FcBKQfl%2F5gd%2BrOS%2F%2Bp91%2F%2BYCg5CXK2W4M9fu%2B%2F6xxX%2BvnelVuldIDCG0VQTpU9Dw4pRfei%2B6zWx0MLie0gPbyrkmRU7OwT16JGeyXLHqOLqAfVN1GPlBzWtFNzj0TRTCjogtP1NjIvu5habN5Aoa1k66wGpqriVetJgiGdwDZtKhnN0y4n9sXYnsqGmZfDSR15%2B5NLBlhoDaedEm7sxmpqRija6ZEEg2EAnTiAC8IrmFbGz1q08P9PSkjl%2F5bqzYqT9hMmptEXDgTqP3Wiye%2BsD4Wir4jCeoHbbp5hRfpB7BakUIppIlPCD30dR1GtslDz8OsqbXmejFC%2Fv8wu5X2myq7SJ8Avzv9DFUJySf5uNvq4%2BTi7W9D%2FOZrLChdwxmPNiBRqVjnpK%2FaGxRCDspVYKAW9AN1JANoo8wP4BJUlGqdgw6m1qPQ2QW3%2BOfU5%2FieLS%2FNuKpDU3uf8bcAXyBal5jMR2NEAbPAZt0K3hvxHBEDlUxfIGcD%2BN2gNSNx36nfqlAYow0puatNpRz0e4W2oahKzQHsjf2c16ad%2F3t2KTtPobnX6D8C8pd0MDP%2BKx7wnXqGGlLQcvikMErm6TmfsuxJXbSAxqNjOogJLQBLiKEHAE%2BJGTS3JoEhTrz8%2FCB%2B5YlupJ58aOat8Kv4JvregxwcU5Cp8GFAFm1FyOfto6GS2m1NGTS6CPNKkbsTdCBlnN9onMho55BX8IJZtEQ35lk%2BhtwN5A0V3RCPoD%2FyXAcv6pAtbZczRUA64JmcUf4q7Q89ZHLeJVZ5D1Ps%2Ft%2B0iCT3AHVtZC7JDCXfR7OSb%2FXja5H3zQbZL1B%2BULX1BMTEk3AseSpmnKEK4T9ekMIidUCRQFfcbj7z8gNLvzF7mbhQN8h6ZbRset%2BnQWdS%2FZX3k7WpS8P9sfo0iGS64wV516pOhjI6TZ2dApgI5%2BLhxywYoWxKUrykKJsIoDsR4mSrCTg0egMPnLW%2F3Q5Nn8BZEuzqEI7HK3n0%2BzFmuO3TtWQ5WJoG9YqCD6Gc32SxnbnVPfsxvrFXK2dILl7bLthDp6glhcsfp4bYvbSmj%2FmQ94uBTw0E73x2jbNRCvC6VL6GCFDwU7eWQDcC5FY5s0slieRDwtAbRsbLXbaXAuu14e2OJw1dc6jQ3ZdY8v7rv2%2FBWZLqvFWVvvcmwZkK9f5jS4muO9yR5res4kfkRxhV03L1RfPOiPtYi8pd7jNEsOpyTwxpaY%2FyCZu%2FAmd5Or9uS3DYaeqVOhH7gZN%2F8I%2Fwi1fEuLXvyNivibjuKvN%2B1Nc01HF%2F3h%2Bef%2FsOhox8MPd5SFucPjorQwXT%2BytA8EmA5mamHNFDVhBI5pjZbQpugBNkO8MvRub8KVDKST1Wag7D3xlin1ZF7LFP%2F79nbvCXFOY%2BPUjrT7%2FotsPXXZ4exdPzuhZuL5LUXVAn7k7PbhG89uz3b41X01gbjP1xwlu5rrvvf9%2Bpbs6E%2FVu7Nk642%2FPYRaAiUBdrmO6CDTBLPQFA1ur0uXoBR1INDMkypKpoTqnSMx5GiEdTEaSHLs0Alvu%2F19%2F5QW9Rv1U1ridT22i%2B53pzumbs%2BXFFXYC%2B%2BCGsTj5JUT%2FGCgRt3n78i2n71FHG4%2Fu6X%2B%2B9%2Braya7os3ZbDmgWfXun44e%2Bu2NZKuGZ0HiF8M4TlMPR%2BEU6rPKRJ8wOU2RFUFLex3egEsz3YqEAq0cqhAAW19dBZIlVzR61tuIdTnpXH7l%2BuXrbjPUyep%2B8cl6aXKWhPHpDcXl9KiTWDNr4mBQc8Tq%2BNzK%2FOKSbsfl79o9G20R%2BbrBXYvUg0rLHhtrc4TN81TTOWSZ0gL1ZVlOYH2ery%2F7XVUjFMbzYpg7UswcqJPQwBd0LKLabJ8IaCr2otcjSkIrGwootKECaUd4XH1%2BSdazRrfddkBU98t1htvWrbjqSqjaCguxrffM%2F5zDCpBALUycmajhd%2BR6ww4SWafuZ5eU%2BtPid4lgd3gt%2Bb%2FY9rQoZNmiXYPXyRHbRs8zX%2Ff4WIFjWZJtUdSD55AP3xtXH%2BZipC0EqdBGDA4CoYEU6gRLGPU11QhkLTBiEYPiqOeQgwTCl9aok1Qr5pFf71qEeNxjy%2F8F0GoqYPv75Yh9j3x4DuJ%2BuEzHRpAq2lMqb%2BqfTdiq6kGtzfOWsv0c7lSeMXDHBDe1MT%2BLUgx0Pg%2Fp87u2UicdIvqQi8DkxhcUwUXCedMpb4NQjwY3npTmgsURJavLwCRyEcN2HfWsDVGfv%2Fu9ZUWUx%2BPYFueUKwaNvbtu%2BXps3eVWbN1GcgVrdMnWJ7WmJz9SD66EBidag0NF1Ukep0t5A7sFCWdhzvYwHv6L%2FBehXuHqfaBwBEU7hfVLcXvS4VQv%2BT%2FvaSIl7cbeMc7ekv9i8S3e1L5xxpvMGcu1EYPbKyCiijjGXcDKckm43PqU2qNWlXusZMiqF82cuVzolUHN9NNR0HZPxFPV9V0wLtvq%2Bk4DqOwVWDlzuQLVdqFiP08cRX7aRlBVfR8cb55bWe5LExnlcsDp1vAP8Q9BucPMk1Ulh4GnN0SAdxcNHv3q9ohx1Ati4S%2FtkWjIDe3hQdkUGrGRaFBiUdiTSkI41UkMuuQHP%2BEaSQYlPQTFWJF03BNPpTu5KFAdkWgDukzsZKMG0Q1TAQQglScOaP%2FdsZ8%2BfP75D%2F9Uu5Gs3FY%2F2SxPld0DHOciXI9gqjcEidXjE%2B3BLosy0OcX3T7O5g65ROGyzQ2BZs7WbZVnO5ydLe32hMwTQ4wnnKXW6XW5LAa7oaXOIHoUl0FgLQLH2by8wSTWeAx2Y5PDazK3BqZbeJZwXGPaYhX87ZNszoDdaRxotXO1nNlpdvAPFWHDm8PqEE0sZxDEqGzxisFNnuCWetPcGrObN0p23tTZwMuRVodSV8%2BLTrOV3eRvzjQZiSjaLYS1WEJe0kNsJlZu9LFun7%2B%2BwW4gRDRbaxw2nrOGm%2BxOj9cmtbp9ZqeTM1m8UXfQQCSTVSQox6pvtjot%2FFpHvIUjJovFEoYvHYV9C5Y%2FxN9OfcalvII37UEhTbTg%2FAQIaPb4Vz6j5u8%2FaViycMod%2FfkDcpu8QZbZoeBi%2FvbzP3XPsZvOubMtaPHkD9jt6%2BU2O7vqU%2F9C9SMvgrXpQNG%2FE0oJxun%2BCiElUa0IKQSUwERxOntKSV7ekcuh9VBZBBo3VUcB58ofKBHCwLyf9qFosz9Ibf8dGqwaBMjRig4SGOZ2UkWI7UiO9OfUPdxOYFApUZyfpY7mgEc5rtNGGk2H1lPhAk1Hp%2FVAMqQEHEUfEYkkUQq1JMdzsX7kklRrTrUi1wMcDjmu1YYfATj7Y%2BpGpPEBXuoQIj8rR9mgCl4C9yqmF7xnVWxGVniNqtpVmXBvQ6iwni5YQ8a1jYrXtc2J13HvgkvqWxuva1sbr%2BP2S5ceKGyBwDv2DbrToe1u6BkAJV7xnVLUaq0sJB8pFqcUIPi3yuwxi4JuLr%2BP30f3OkPQ72aO0xYo3%2FEsmO3QO5qEF8S0qQH0UsKXv0brnl9%2B8M7jF174%2BDsfvPOl1au%2FRL5%2F9DsbNnwHL2pHR1NTRxMZhJtHktOOxLxErPF6YlLvpC9YP73x%2B4ofw%2B3xVdrHcDE0dQQCmCRgvt9b35xINDf1CDcRSfJ%2BpYl%2BSf8YcurfmXP5F%2Fkj6J82jNsrkWiEuhVlgFfyNkB3S5MUzLhoNiwSCYcxQ7Ui4J0Xh7fmqRbaPa1tzujxkBRlsEHy0%2FOM4pYLPb7g9O6BQJN6l9zQ0OGyCaZz0vMTbHOzXfQ7a2tsterTcqxeInODoemdktw%2B1SbVhKwtW9ffe8VKadK0OVuC3bWzyKm5LeddsWTeorWyY9IMtUFutdu5g%2BRn533qkocdvLs2HmhU75br%2FMmWtD8zA3OP2t1ea636jEzqYxJZGAwFiDEd61oTsrRuW3%2F3pYNi3bS%2BRd%2BGjOfVpAPNd6y64Gsz1GaZleWIPoYL%2Fv9mTeQBENVEguiF1aC4YeXxFETw6QyPfn0m9g8IrMFAvKM1EI11DARnbqibHk%2FIojy5rSdgCyZi06y8sS024PeuO4MfwQ5Y9yKRZCqyYaF30vzeHlmUprR21tR0t0yz8KZY66zWuGvxVQB%2F36kP%2BK38t2Hu6NQ9SFJfw0AdpqPEK2qTMpf2VCqJwqPoJezTL824b8akoL%2Bx03nhh%2BoNo5e77psxg9Q5LzebIKD%2BfsY34f2MtB9fk9v5b8PT6tYrgv4kRPwd0q9z3gdJSJ0653KjCYPwCaR5aUY63eW48O%2Fkdo33yxX9wCiMv2QTrk8eGSI6Ag6moG9t2P%2FF7GRNlDjl0gw7pJ5aOXXqyqn8SENnXBmbSwUYLyqJjv3UmY1nKr4t80no0faXsaIEiF%2FBRaIBnItSce4OUif7W6Vm9T9H1X9Vj71BEm%2BRdmIJQST%2FZfVdudUvh9S%2FqqNvqT98g9SQ3lHibZY0mRVHooyDN%2FFHmTgzjdozKw28NwQ0hwN6BCoPKaEk3YtKwNhwRLXuk076CGoZNXDQcRwZvreTZY9EZi%2Bd0s4%2Bztv8iei04JQl6ZbDD2eHV7X4uHuFVfPrOmcs6m6Kr7hssr%2B1VZFcEZ%2FPdJkn1hOs8SXS%2FNFFgqt94PIZzZ3tdaL6Q5vo6piSzdy737pwsX1VyxUrF15iJ4uNkq%2Brbyg1Z%2BO8VsNC1UmcvORPRfxtPrfRwL2p%2FoA1eZp6Z%2FaGffoewaXcA%2FxBlKlQLfhQL%2FoPgBGP3qsA7IQS8qDVNswHKRSheDUvA3Q7MZoRcJMxlEygujn1QdyzfPfq3dEp%2FbXh5e5YXW2Ngfvza0ZF6UgFL%2FE0fTq4LBlvTE2qb%2FKuuzYSXVnjTfM1osvqMHVbm9950quIZlbqaL6YP7jk3kUtA0GnX2nvq53f3WoSsvEdDRnULgo2fN7lNZJgI8%2FVWi33c3bBZnGY05%2Bdm%2B3qc7fNmj4YGKLj2nfqFP%2Bg7jdDlxEV5XsJQZP6hYrS1l0VQr4c69Xueixp90gnZPmE5OF22j%2BSYEWHlZ0K%2FHgsh%2FZtsbh6h2DNRlvv6jJh9XaJaHCZDiUDKNTMkvb8vsqCyf3ZNdSmO0fa0Y4baJTtpbKzuVzeeSI7fCKr2Z0WypapnXJ4gnoWy3PoUIlIQ1TXdqhQJIXp9Wx5fYdpeWh2TY5D%2BYVyKd0jw3iumwi%2FBC3cEy4o83QlZnW79MrCgCjbhWXBlRZVVZZv4rIKpXC01HFlHdHLoeWVl6UVc%2FJ5uGm6CViW5mulYMk%2BHqNYr0AyUPivLg2oMs2MPqtuhHyRyiwvNJej1Br%2BfcLyoAyu8D9B7bgmzUqfFobF5nKnK4%2Bt8MPJkI%2FxHUNWk117jugWF%2BxazTAALQn6%2BUE9lhoI5ApGA%2FiuJOsrlNP28SVVuBVajXmircLel46w2bJS1Q0Ft0KDuikDFL%2F3pYrid1Q4FvofwRIo4R9h2ftSwc6jHAMqLcCql8YPHtlzGoByNXYN6v8hXnRaOhUvx0sVLCexwupGDR4NOYC7PePa5keIPACnuAdD7dEadRuTIiS6Lb7uskb381My5yjzF8lGCjBRqdwrWJCagfB3yCy7XT1i92hbcZ5Ci1FJkgYMDf6n%2BjspIsHFjJrTOdzSMuOa9DbDcj%2FnH9N9bIoGVgzHPWIQuFuYtaMRaq8eCKI0gEF6lPOZjBz3EEvaaxwSUT9U%2F8JbJZPJJLBLolH1La%2FRbF9AbC8JJjv%2FmMnssKjLRBJyqj9QXxNko0Ux%2FX79epfiXkm6fmKwF%2Fen1HLc6LxloXWKvGa5rVCVL83VuiPcDEX%2FK5pTXOxHfx6HHB0t2FI0qI2rCZFTrvPWU67zVuS%2FkTsLnc7IKhFg30e4FOkqNSfH5PtkmUy6Cpiv%2F36k2sbqCeCFNa%2BURpoY0sZoYmCgCr3qgZz6s8I0gP1bYiR%2BD79H56NOz0EVWCTy2%2FfffvSCCx59W7uRV9995eqrX8GLesOXNm360iZ%2BT%2FEl3uZqL%2BFyzSZ8XxpTiI%2FG0nkT4zznFZ0t4ipMz5v4q9ssqbdKUZt6u82knPCrt6PZwsnn0XySVnyPR1ZXAn72yx48bWJsu7apnI3Hy8bygUK5Js32qcytapqgmn95uexccj205vGgJ%2BeuOeG2SORmKZr%2FqKzcx9SFctMJdwMUFZDJITs7dnOp1EKZCxg304Cevyfya%2BvlKqv6aXK1qIj3imL%2BL6hL%2ByvUlFfE0VKZ7E8gBY3M%2F8VoJCFgizH1W6VyC76nH6b7jiibYVxUmVIEspry%2FLgZIlCeP11Z4zs%2FAwvVwtGFEut5S1JY4lfyT0N%2FevOLo%2BrUEgjcqc9IkGpQbv3iW7Co5b%2BKgjvpzYdH85PLcc4X21ouwEGl%2FS4qnUAvoSlXUUhR1eKr2VWFTB%2BGMl6FsiQsVD1R3urlAAIoSn7JQkmiVVCHSpCwDH%2FqPepXQ0Db77CJOAImohB%2BRPWr31ev5g%2FkE%2BzTa4lbvZo8xdWPffQu9yJTPCNB66s%2BzXoJt%2F0L6hSoCuBIoK8fnBGG87OoRckJpLqyWe4YbpGi50g0%2B3I3UD85Oa0fzubfoXxPLbW3FDWzigmyJeM0tQkax7PqTy80%2BUxfUHPlBZIRVNQ%2Bv0xRm8REKPoLmNr0%2BUo48v9GFbXPKylqQ2IKm00QddgyWGMROCTxdLB9nCY8P7j2DjlsV%2F%2Bmfr0C0r%2FNkeXbbpPlOTBBwT0mVz1zx9S%2FwJecBF9Wgv3p032iP2v4VSgfgW2G%2BHUEdEXU6iq4CtpLJfIN9XQG8dwa1VoO8XC2SrPDDyCOQptXgbcPvlAgBfxBoGwftQKeKFrNTASPt3pGGqDt%2FQRasn2kri%2BH6L80MJRsmVYJrAKyDItpJUy3%2F15WYIJqcJ9Q5N%2FLFJ4c3dc1URpWl9hW6mu50MUIelg4ucTPf15zs5DFo1c0VSp1tKB9jkwIyuM45kb%2BIP8gHed%2B6jO3v0KbIknzLy636E8KPTdCuUpB0wLo9JKnAO6pv0vS31EtBha%2FfJemkgLVVnd8KCk4qBTpQ5m7FbifBKrPJcq0pZAFVG%2FXbOFz%2BTcq2MLrcmV28Nmi%2FOHskh82bau0k8eWCaPijQPWQ5lUvslwVCfHkXBMIehqUgtDNLeauH1huvZTbYmw%2BluPjyWoNGEuxRLR7LK5fSyXFUyK7PURQv2v8D3XOt2NJ6liBbmPGOsakw1kbeOs%2B31Wm5qpH%2BiJWSzqdPr2O7zc2TmtnrzCig6bBd%2FvgQmzOlz0STWIlmZEQfupogOZFHUZ7EkUnMn0RrpIMqAgHRJAOjIJ3yGw1I%2FMAp9q9S3Q%2FclADNm1wEeO%2Bxbwg5OIYHZLY3ehG5lJk2xhco%2B6JWybpEVz2wrR6hZyD0QXZbeDVB%2BonmlimpkWprdAs4WEZDSQppsDlcdCBJJESIYFuAtUnC4GIF2C3Uu2Kv7L1bdz6FxtqxpG4TqQOqOUNAJ2HLvPWA2GgDy4O4vaDrtyl6P%2B1fAll%2BSyFcQ28GHqh7fvvf37udylf0fNwhzgz87Y%2Bcf5x9GnF6ygHu18sAbipWeF0YPBgp2GaKeQduxxdEr3SgbH1kvH7tvqSLhedomOvZyts2dw8acu3dY%2Ff%2BucuMtCuP%2Fe4zC4XnH3OLZ8ZuxTWxy8dJfU5dhDeKPSlJy5pn%2F%2B7u3XrJhmr9C5CuleGflGQocKnlAUaRKp0BAHV0ZwUt9VCqk6zYOgRIuMfePJzdmBdpPJ7%2F6B23%2Bf%2Bsp9NMDZevovvfYHG5dGPISQq1DojqNckchVrCcCYz%2FQ0hI0m3NKDRfkgsrnamo%2Bp0CAq1FyvC3a3Nak%2Fs5VX282x9Ufy3E39VAx6o7LpCvO2wK%2Bch9jNqpJCutcIOooKnYWtDK8gTRVYygRQfwgzKM5%2BjP2jOZdx3r32Py7rQUPOzAnoRs95NvRAR0qLGU11Taqu1bUYSzMcWjMEir067JQQHfIrLBHsrgv00%2FWavd8HRLMEEYFSW3HCSNQehnrHztKqHcDyo4VfZ6gPKCR%2BgufwA8GegxUEo4A%2Bgd0BASHiH6jYMLIsUdQJTs%2FC641KN4oCHWolCMLlMfIdtWKScjx7SM5LD9HnfmhrGI0S139UWfUnxgOXdJFW%2BAMcGjKr6eHAttHF5sUoeArYKDcxMSYcKA%2FxUDhPiEOEAPafSIUFArN0r24ynI91EPARDXvIDYyvqZaWeroBOUABQA%2FE%2BDXC7PWafDLQY2oiwpUEyj4RQtVlUp1GrM7In2p2A7VuiOW6otMiGOo5Mrp05ejVuTy6dNX%2Fk%2F7mybZQ0nUmfrbx3U4KueDnlHm5wdh8FFeKnoaKKh%2FTK18StOPhwG9Xo5mqXAxvw%2F79YQwwDR%2BnAKQQ4izVXioB84qcppWB7IqjU45z4CE17OvF1Dw%2BoTFqxtz8dxwtogBnF9MjIl%2Fin%2BK8s3hM9laIn0TiCbTAXL0T798bPXqx36p3chrv0O%2BGC9Xaj48Ecv8U8UEeBvUEsDlTepiU5OvlpeNGvpnKF0RvUooWhIjnx6GeBapXCQYTw9DNg6%2FOC3gZjp76oNTj9Kz6Jqobxb9NDqc08vcKReOpcsQV2K8InXFaXW3aI6Ofr1k48rp7CX7rx%2Bv1UKPsfvzQU0Kc83i2VdILmd2%2FyX55zT9luN2%2BCu4nKfwPcK%2FCvDVU%2BpHh8%2BLaldIf1fA5h3ndT6Fln9%2FW%2F9Ce1vndfvJtnPVO2xhm3qbafHVCN1X363UXHq9xuVD8OSD29Z8pZ5cZrern9cAdGW%2Fuib%2Fud%2BVK0L9a42r6C90kL8KzxwLQw9NkIQJL0ASU8M%2BVG0KsUdgdvpgP%2F6NqqP0%2FgHZFUfGEijZLHpiIgvV5%2FBltrj8Qd7XQd5p4P%2B7tJo30NMO6VGBwahSPMYiaaBYoLY6uEnciyhhh1Z%2FvvacG%2Frjpsvnpzs0B1Id6fmX8119l88XnOxe%2FuGrzzHcdu7UtY3%2B2vmXN5zUyj3ZcPl8p1sZSs6%2FnGXtwrV7Ka0XZdz83fwjjINpZWYw85lL8BRK4nGyIir2RiOsEyipuEcIakpGjWgBjLiHWOgj0Yi34gW1kKPxHt2Na5q%2Blwg1RdRSpFDNzosb44YJXnAfoEOpZW%2F%2F6u1lhYA6leevezbI26zNHO811M2dc5HFxpk4i1jPC0s21%2FBWW5DnPQbn2X1WK43%2FaM2n18DfSoybbNHijFpamzXI31eRibGUOxSu%2FlT96YZlq1Yt20DaSBuG6knw2eusHs5EPBfNmVvHKdaQzcDfz9ZsXmLDWGXy2U5OsYSsIn8CS12jQIyD12KKqZrLPy7mSPdICmd6WGHG8NDZkkHuE4h9TU8FpmUO%2FVjC%2FEinToFyoNDz2p9XD6g78WgQdPG7Z3R0T%2FZ5dTM9lsL8Ktek7szl2L%2BgQwGgwkZHc2g5Su7NvVqwGy2Ua4KSXUwt1X4PaM5paaEu6jQ5zVFyNabxvUksVt2T%2F4VeamYPlLtffdQsk%2B2sUTY%2FzDXl%2F05W53%2FBz9UK3p7LjapZ2ZxOm%2BUlZXrL3HHGqO8%2BwVroDaCTTnTxitMxmiAAYQzVJQH%2Bnj3oIHnPaN6Zq6sNSLjBl8tKgVr2mj%2F9CWi9dnKca8rBQBsd5R1tzVlgrl5pbnPw6kZclCr2CHxMnHohLz%2B3KRQokzALyeIKFU1TNCiayJdoHvDYe7K6mZLm8S3uJ9dojuaJ62%2FqN%2FtjQxnSnhnKPw%2BLNrLi8ZKyJ3x1YhiI1aNAtP6NzCGzYv3DmaGh%2FLvQZnt0evgIhTFV0kE%2FPYxAnOHhCQUZdCWY5JWJwMzlAGl1mpNbDU7yyGnhRMILsYhH3VRAijrPcBU8%2FCj1Y9NY6cnGVW0CjTLaz7E3epvaT%2FLtTV72Rs%2B0WVVmd0dz%2FMGTI5F0OsIviaqDlbbO5X6xT3PeXbXHRtf%2Fz%2Bfdka%2BeKPr8KF7IF4vBsT9MFPuPJMBTBMq9hQxXelQ%2Bbewnf18ap4Ib%2BmSMrtDU5zqlD8QANa5MBGh%2FOwOvSDfcV2d66mfEWsbGWmIz6nsyZDWQSmqmxDneYyvjHPmRXHZxeueyRGLZzvRioKnGto9nIPkibAJA16adcOZRQr1iAP3bUyBR7T4RgAWTKxhkCYFwshq%2B7iV9r0whk50cmRcTg4fy5x4OmmNkHndIA2%2BYuMbmE9dwGYB4KFTsvnDE6Ah47r%2FfE3AYI%2BoXADpkdlENcZ8OZEEf8FFGZNxMs6ZLpG3SUFLL7Q2kcFU%2FA%2FJsw%2BvWDa%2F7emewLaoeibaF1B9qUNnuqWK3%2BUfXYVL1v%2FomD15xxeDkPnXTOKSVcCbDGtOu0YQNpGAP7U1HU58UrqGu8xIbHtkQ3LVhb7Dx46ET3Ffcm1q0YcOizNmf3bC3VjWfAcpSv3MyTlgJ23FHQgmgvk%2Bgk8pL0mcCDOn08MDAQlf%2B%2FSlTZ1z12fnqntOhbOTL9%2FZdevbAPN%2Byby1f%2FuUtC%2Fixm8ZBo59LTXEW060hGrTDplNprWd58fwB%2Fb%2FE27BdS%2Fs7U%2BrGVCeQ46nzaw9QccnmZerGZZs3Yw9aVHt%2BKh6HN4ti6lxIhT%2FwahnZtWwzlY9QHQ2c79C%2BdxzvVDKy8GqKWQERO9YAKbpsDUTLdWV5dE8PVPjvj9pqw7ah%2FPFVtkit7aj6G5xY9mfJrCz1j1e0BcnPol4UjtrCdbahIVtd2HaURujnFJR8CuOuUUfhrGhgKKgjCYNSvCc1WKlEp8wHUaAYynFNyzZn%2B2MnYv36dbMDBTonl%2FT%2Fma5IKAyEGz%2B4eRnVtaX6tss2o34u8mWorFtuFgm4A6qK%2Fyp%2FgLEBVat5WnPDdKA574ubuFJ%2FIUfZ%2FY2Nt6mN%2BZNNTSTaeI56gKwkXerTe9DDHUw8%2FH35FY3nNN7GGuBKWhrV9ep%2B0k1WjNWVaHkW1yA%2BQHWNu8rtBw2a5YXuE40rs7%2FGA%2Bj09V3hA98yRnFPOGr8ltGlsFdD%2F7tRce3LH6Trcneuiy7K7J3khKu%2B3qUaXPWaX7T6%2FKfj9BX2eZq2XAcZT79u1ClJzUtHUqfqSMWBcZS43Ena0cUGLgpkKxB1QM%2B0Fxz10wgg6r5rltnFpH05pepUq3Y2HfYqeKRntmUFNz%2BXmcOs1H31U6cC6RTVLfCg7RNBF1UF2%2FwBgu0fFQtPEU1sSg3VcNsR7dWq3af87tUFn1l3ltXpaJxpNvtcZkH2WmMst3JqRpxUH%2BWC0E1qOGtP66s1MYv%2BVLu8%2FXFXvV%2FZbunYYBeVN64ls0ur6NzpV9xzlmQwB5qC4Tq70WC0tk8dWJXeHvkD0h9zJOM0vD86%2F1NJMaIAolctvlByferCsqOKDKceOfUu1PsmoFCamV5mCrMUOCi6V6FJosMF22AcrKJgQDVhfYh6tepp%2FlYgvnCEAbJQ1L0rOpajEmRcasMiPfxhgGoVo4rwreQpV6fUJHH2e8fa1s2c13Apl1b89a58ozdoap2sjgLN9uISl7P1DrulyeIkt0zr6JjWocoPOZsaXPb6jtqBblsgsaRre2xHi4nELm0MhG1%2Bx1SXwLpFi53b%2BaHRYo%2FIrbZtuWAKu5cSEXfybnnmUCaXGTpQr0xK2O2WWY76f%2BnAjNVf7nCZHU5XqIkTnpt6VtvsFlPXg1031g%2FVRdpkkyVpD7jnmax88QwDvg%2F66NnMRdRXTcGTmQc3cuINwN5IQqi0yzb%2BYFVHuVqI5s4ADfg5oE4ybDLd28mFSFmYvRoomsWXEdLU2Wl3GJy93ZNb%2Fd5gqmNaqJZSO1l6PVRy0nZIj%2F45EetjLguh1rLqR%2BSK0hO6NrsqcNX8zoUdjQYDJ7tb4os6%2Bi%2BY0qpY2AWlnLRDWdGFTfGY1gV0zNAtJ7pdo24se0D88AwLY%2FgZmE9iuP4V5v7CSR%2FRThaHLh%2BUeBkXwU6BC7lGOevK65udTv%2BtS%2FPfW7qj3ljTcj3b9OkbV85t8xsMj7Ddj7DGpthZKwKPvso%2Fc%2F1K9aLE12fMWLV1y1D9ua8lyJdWXr%2FbG%2BnoCFutf%2FmLILe39ITUV4igr3876fpX5g2zeB52sWnIL4fXHlgeUzOx5QfIvJQyrKQE9wHUqVq%2BPEaOrz0wVvNbJZVSfsuMzxN4l9PkedFzw9V5Dj%2BnzpgoT4ZxCxJfC5RWLc74YVHxKlExCYt0JAOMatREhHBSCAtSfod6x6Ls8HCWECLwXZ9nd5Dz1T24JUdWs6fU3%2B%2BfcnT49Qe%2BkBs%2BwdsMZgPXMp3U5S958snPP%2FEE7bvkOPCuTUDTUQ%2FUzirLhML9yPahoe1D5Fj5jWsaoveyP00PehdUAHk%2FseDVWsvDWXXXsyn%2F4wfpXc2V3%2FQxli3jl%2F5hj%2F83avSCfpTNxOEKLmTjxOEKuxgNlsQn0xgct724mhynupNW1Ph6o3RYS3%2F%2B2TJrzLlkFz%2Bip3qCHKf6eqW02QJLjBYuuj4sobhCWqa%2FYHGEHpcnumuWSOhxeaL7sOakNR6vvmo%2BYcfFA8UFXEPZf9UjyudIOyNwx%2Fi90DdsujS%2FFX2UAwvWSVK4NxaMhAGw3oowp%2Fuc8CTi7D2rBgZWwb%2F60faR7SPsEbjkXy4G0XaqhXPwe2cePjxjxuHD6ssQuR1fq6PF0E%2Bo2t1nePTn8TUmxz%2FA3crMoCc7egESuoTHYc7mYdg6etORoOhR7BBGD%2BqJopELrl4S6cJNRtEAsLP%2FOdvnJq0Wo0GolY2Et9VFB2Kf%2B4bZvVyxfOMz3WdFfSIryj6DwWghre7aQbdiDrkTL3A3vNDuDpk93HqXwam%2BbWmUJZfNn5ozKV5Pmmq8PF%2FjVY%2B2Tlk2M2RzSXKjmbQ4RZcQavEYrN%2F9rlXwtIQqzxQNMzPPfHYLvuPoO9TbT8bpGw5CQPGd%2BSyX%2FCyf0Vxjd2R9NmsunnXYa8xGHzn%2BsSfM5J0y0DZEXWWxkXjcR75KBLNLHi7XvX2G8VOrf4Ykg0AMdBESIpo7MgAfyakA6rkqpI6UjNs0px7cMV%2BD5BF49Tez1VGnYmq0WIijp985m4Sn2gJR9b07riPPFo97OYbUZbxJCpot7H%2FlpZBicglCPN7WOfJkcHqc3ElWqvvz%2F1E6bIQrG%2Btz6WkM1SM9FBTR7FSs8KyBBytSmNEoquJNFN5EQyTiCrnKDx1h58yxCepPHU5nxGoxEQeeOZi2m80DxNxncVhr6BmEfUarxejw%2BWSiHhWk19bSY7aKR5MsteblJpfTLtjimBouXsm3d3djjYM%2BwEW0El9dM%2FueVRWIsXwe43R7SgbVZqrnqoJ1X%2FkuF7pcgf8duv4q6vayV5U9zMV91GxO59UUjW8rHV6u799WzKMT7umRCXbYUKM%2BfoaCcwgaoqZUtmodV3p%2BX7akb4dnU9B9La38RPFUG2SCC90tVA4XwEFhyOpZZrUCsgWYHsczLFBBVGNtstoN1bw0Z%2BO4fYIbvZVt4EUcJEKOhHeincWqONw%2Bq6w5Go%2BWGOSR7LhKV%2BKBqbBPpfUvOf9QqkpDyVhBeyyZQGMsdA5FBUqvFMtUyGq9vjnsAJU4UcrxldP1CCaofyDkSAifoP5QwWx%2BSyUGxp75BzGAvtG7uQ38LehlyEQMeh0TeE6Bm7tYdXqdkt0uOb3kfYlNwmOdDyacOq%2FqlFo1v%2BPTmTi3E%2FglC9W11b34A22zmLzvb231Q0L2Bgg60OTW4YdstO%2BYOJnO38TtpH7zy9ymokWyA79qlVSn38HtpFlImFnhu3b4boNWXklOXV0Iwo7lQ1hrZyPFcwtjwFP7iEKSHSSJw509kh8kj6pr%2BH1jR7km9vcvqN9657vffefkv%2BfKxge1X%2B7RdjYUPIESN7gTvRkB%2FRMYtEkaVkdHApmdBPpnKmz0n1xSWFOyVIuLrinZwpoCRe6kyiVZoHX088F%2BUX4%2BWKS4iBTP0IWxGtZgOdMaV4KTayqHQF%2FVihBwTbgDXTCmKoOBJeNhwJMzEVjtjIFLuU38fPR7hqNG1JS7g%2FqRCuy3vmQ3W9Vu8qbVbP%2BSzazGRJH83MzP90Ck2m31mMjP8TiLn5uwD2Ugr2PFvPQjB5BnSJvQxGQZZEB%2BLopqzGzDbMmbkAPkZVJjeO5FzOSBKCgJze2ZS4Gemc9twrwY6u9H61iUQTcRvtdT9RW3tRxAWwFs2tcuJRnI6xjmBdWjbgFNRHMHiF1uHYBfUR%2Fut5Ug2jXAaT96%2B9RH%2FFToRwIzGbKmVJ1AZQnoabSB1yyIg7ByAridHApPMjyw0OiV6RjSbCuzwLAvFizBliWJua1tsuAgvNPbmljYbpt8lkWam7b3XZiOiKJskMOtmfScnsbPW208knwjuXrXK4Q1iKIgNyYXXDVT9C2Ye%2F78GQ5BEEXfFdde2RwauOysdJNL5AzCy84ard%2FnGAVN8alecnFdgu5Gbd5DJTL%2BhHZK0vApVy3OfU8XTSJg1TlssivsPYUlIqvn66PzrVTymCc4wgF6SDNR0pDf%2B9Gp%2BVnsUH5WtpHYsuhOaey8zdwLN47V8MTbm78g687%2BP3cx6tcAeNpjYGRgYGBk8s0%2FzBIfz2%2FzlUGeZQNQhOFCWfF0GP0%2F8P8c1jusIkAuBwMTSBQAYwQM6HjaY2BkYGAV%2Bd8KJgP%2FXWG9wwAUQQGLAYqPBl942n1TvUoDQRCe1VM8kWARjNrZGIurBAsRBIuA2vkAFsJiKTYW4guIjT5ARMgTxCLoA1hcb5OgDyGHrY7f7M65e8fpLF%2B%2B2W%2FnZ2eTmGfaIJi5I0qGDlZZcD51QzTTJirZPAI9JIwVA%2BwT8L5nOdMaV0AuMJ%2BicRHq8of6LSD18fzq8ds7xjpwBnQiSI9V5QVl6NwPvgM15NXn%2FAtWZyj3W0HjEXitOc%2FdIdbetPdFTZ%2BP6t%2BX7xU0%2Fk6GJtOe1%2FB3arN0%2Fpmz1J4UZc%2BD6ExwjD7vioeGd5HvhvU%2BR%2BDZcGZ6YBPNfAi0G97iBPwFXqph2cW8%2BD7kjMfwtinHb6kLb6Wygk3cZytSEoptGrlScdHtLPeri1JKueACMZfU1ViJG1Sq5E43dIt7SZZFl1zuRhb%2FGOs44xFVDbrJzB5tYs35OmaXTrEmkv0DajnMWQB42mNgYNCCwk0MLxheMPrhgUuY2JiUmOqY2pjWMD1hdmPOY%2B5hPsLCwWLEksSyiOUOawzrLrYiti%2FsCuxJ7Kc45DiSOPZxmnG2cG7jvMelweXDNYXrEbcBdxf3KR4OngheLd443g18fHwZfFv4NfiX8T8TEBIIEZggsEpQS7BMcJsQl5CFUI3QAWEp4RLhCyJaIldEbURXiJ4RYxEzE0sQ2yD2TzxIfJkEk4SeRJbENIkNEg8k%2FklqSGZITpE8InlL8p2UmVSG1A6pb9Jx0ltkjGSmyDySlZF1kc2RnSK7R%2FaZnJ5cmdwB%2BST5SwpuCvsUjRTLFHcoOShNU9qhzKespGyhXKV8SPmBCpOKgUqcyjSVR6omqgmqe9RE1OrUnqkHqO9R%2F6FholGgsUZzgeYZLTUtL60WbS7tKh0OnQydXTpvdGV0O3S%2F6Gnopekt0ruhz6fvpl%2Bnv0n%2Fh4GdQYvBJUMhwwTDdYYvjFSM4oxmGd0zVjK2M84w3mYiYZJgssLkkqmO6TzTF2Z2ZjVmd8ylzP3MJ5lfsRCwcLJoszhhyWXpZdlhecZKxirHapbVPesF1ndsJGwCbBbZ%2FLA1sn1jZ2XXY3fFXsM%2Bz36V%2FS8HD4cGh2OOTI51ThJOK5zeOUs4OzmXOS9wPuUi4JLgss7lm2uU6zY3NrcSty1u39zN3Mvct7l%2F8xDzMPLw88jyaPM44ynkaeEZ59niucqLyUvPKwgAn3OqOQAAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAHjarZK9TgJBEMf%2Fd6CRaAyRhMLqCgsbL4ciglTGRPEjSiSKlnLycXJ86CEniU%2FhM9jYWPgIFkYfwd6nsDD%2Bd1mBIIUx3mZnfzs3MzszuwDCeIYG8UUwQxmAFgxxPeeuyxrmcaNYxzTuFAewi0fFQSTxqXgM11pC8TgS2oPiCUS1d8Uh8ofiSczpYcVT5LjiCPlY8Qui%2BncOr7D02y6%2FBTCrP%2Fm%2Bb5bdTrPi2I26Z9qNGtbRQBMdXMJBGRW0YOCecxEWYoiTCvxrYBunqHPdoX2bLOyrMKlZg8thDETw5K7Itci1TXlGy0124QRZZLDFU%2FexhxztMozlosTpMH6ZPge0L%2BOKGnFKjJ4WRwppHPL0PP3SI2P9jLQwFOu3GRhDfkeyDo%2F%2FG7IHgzllZQxLdquvrdCyBVvat3seJlYo06gxapUxhU2JWnFygR03sSxnEkvcpf5Y5eibGq315TDp7fKWm8zbUVl71Aqq%2FZtNnlkWmLnQtno9ycvXYbA6W2pF3aKfCayyC0Ja7Fr%2FPW70%2FHO4YM0OKxFvzf0C1MyPjwAAeNpt1VWUU2cYRuHsgxenQt1d8%2F3JOUnqAyR1d%2FcCLQVKO22pu7tQd3d3d3d3d3cXmGzumrWy3pWLs%2FNdPDMpZaWu1783l1Lpf14MnfzO6FbqVupfGkD30iR60JNe9KYP09CXfvRnAAMZxGCGMG3pW6ZjemZgKDMyEzMzC7MyG7MzB3MyF3MzD%2FMyH%2FOzAAuyEAuzCIuyGIuzBGWCRIUqOQU16jRYkqVYmmVYluVYng6GMZwRNGmxAiuyEiuzCquyGquzBmuyFmuzDuuyHuuzARuyERuzCZuyGZuzBVuyFVuzDduyHdszklGMZgd2ZAw7MZZxjGdnJrALu9LJbuzOHkxkT%2FZib%2FZhX%2FZjfw7gQA7iYA7hUA7jcI7gSI7iaI7hWI7jeE7gRE7iZE5hEqdyGqdzBmdyFmdzDudyHudzARdyERdzCZdyGZdzBVdyFVdzDddyHddzAzdyEzdzC7dyG7dzB3dyF3dzD%2FdyH%2FfzAA%2FyEA%2FzCI%2FyGI%2FzBE%2FyFE%2FzDM%2FyHM%2FzAi%2FyEi%2FzCq%2FyGq%2FzBm%2FyFm%2FzDu%2FyHu%2FzAR%2FyER%2FzCZ%2FyGZ%2FzBV%2FyFV%2FzDd%2FyHd%2FzAz%2FyEz%2FzC7%2FyG7%2FzB3%2FyF3%2FzD%2F9mpYwsy7pl3bMeWc%2BsV9Y765NNk%2FXN%2BmX9swHZwGxQNjgb0nPkmInjR0V7Uq%2FOsaPL5Y7ylE3l8tQNN7kVt%2BrmbuHW3LrbcDvam1rtzVvdm50TxrU%2FDBvRtZUY1rV5a3jXFn550Wo%2FXDNWK3dFmh7X9LimxzU9qulRTY9qelTTo5rlKLt2wk7YiaprL%2ByFvbAX9pK9ZC%2FZS%2FaSvWQv2Uv2kr1kr2KvYq9ir2KvYq9ir2KvYq9ir2Kvaq9qr2qvaq9qr2qvaq9qr2qvai%2B3l9vL7eX2cnu5vdxebi%2B3l9sr7BV2CjuFncJOYaewU9gp7NTs1LyrZq9mr2avZq9mr2avZq9mr26vbq9ur26vbq9ur26vbq9ur26vYa9hr2GvYa9hr2GvYa%2FR7oXuQ%2Feh%2B2j%2FUU7e3C3cqc%2FV3fYdof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D92H7kP3ofvQfeg%2BdB%2B6D92H7kP3ofvQfRT29B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6D%2F2H%2FkP%2Fof%2FQf%2Bg%2F9B%2F6j6nuG3Ya7U5q%2F0hN3nCTW3Grbu4Wrs%2FrP%2Bk%2F6T%2FpP%2Bk%2F6T%2FpP%2Bk%2B6T7pPek86TzpPOk86TzpOuk66TrpOuk66TrpOlWmPu%2F36zrpOuk66TrpOuk66TrpOvl%2FPek76TvpO%2Bk76TvpO%2Bk76TvpO%2Bk76TvpO7V9t%2BqtVs%2FOaOURU6bo6PgPt6rZbwAAAAABVFDDFwAA%29%20format%28%27woff%27%29%2Curl%28data%3Aapplication%2Fx%2Dfont%2Dtruetype%3Bbase64%2CAAEAAAAPAIAAAwBwRkZUTW0ql9wAAAD8AAAAHEdERUYBRAAEAAABGAAAACBPUy8yZ7lriQAAATgAAABgY21hcNqt44EAAAGYAAAGcmN2dCAAKAL4AAAIDAAAAARnYXNw%2F%2F8AAwAACBAAAAAIZ2x5Zn1dwm8AAAgYAACUpGhlYWQFTS%2FYAACcvAAAADZoaGVhCkQEEQAAnPQAAAAkaG10eNLHIGAAAJ0YAAADdGxvY2Fv%2B5XOAACgjAAAAjBtYXhwAWoA2AAAorwAAAAgbmFtZbMsoJsAAKLcAAADonBvc3S6o%2BU1AACmgAAACtF3ZWJmwxhUUAAAsVQAAAAGAAAAAQAAAADMPaLPAAAAANB2gXUAAAAA0HZzlwABAAAADgAAABgAAAAAAAIAAQABARYAAQAEAAAAAgAAAAMEiwGQAAUABAMMAtAAAABaAwwC0AAAAaQAMgK4AAAAAAUAAAAAAAAAAAAAAAIAAAAAAAAAAAAAAFVLV04AQAAg%2F%2F8DwP8QAAAFFAB7AAAAAQAAAAAAAAAAAAAAIAABAAAABQAAAAMAAAAsAAAACgAAAdwAAQAAAAAEaAADAAEAAAAsAAMACgAAAdwABAGwAAAAaABAAAUAKAAgACsAoAClIAogLyBfIKwgvSISIxsl%2FCYBJvonCScP4APgCeAZ4CngOeBJ4FngYOBp4HngieCX4QnhGeEp4TnhRuFJ4VnhaeF54YnhleGZ4gbiCeIW4hniIeIn4jniSeJZ4mD4%2F%2F%2F%2FAAAAIAAqAKAApSAAIC8gXyCsIL0iEiMbJfwmASb6JwknD%2BAB4AXgEOAg4DDgQOBQ4GDgYuBw4IDgkOEB4RDhIOEw4UDhSOFQ4WDhcOGA4ZDhl%2BIA4gniEOIY4iHiI%2BIw4kDiUOJg%2BP%2F%2F%2F%2F%2Fj%2F9r%2FZv9i4Ajf5N%2B132nfWd4F3P3aHdoZ2SHZE9kOIB0gHCAWIBAgCiAEH%2F4f%2BB%2F3H%2FEf6x%2FlH3wfdh9wH2ofZB9jH10fVx9RH0sfRR9EHt4e3B7WHtUezh7NHsUevx65HrMIFQABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADAAAAAACjAAAAAAAAAA1AAAAIAAAACAAAAADAAAAKgAAACsAAAAEAAAAoAAAAKAAAAAGAAAApQAAAKUAAAAHAAAgAAAAIAoAAAAIAAAgLwAAIC8AAAATAAAgXwAAIF8AAAAUAAAgrAAAIKwAAAAVAAAgvQAAIL0AAAAWAAAiEgAAIhIAAAAXAAAjGwAAIxsAAAAYAAAl%2FAAAJfwAAAAZAAAmAQAAJgEAAAAaAAAm%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%2FAADiUAAA4lkAAAEJAADiYAAA4mAAAAETAAD4%2FwAA%2BP8AAAEUAAH1EQAB9REAAAEVAAH2qgAB9qoAAAEWAAYCCgAAAAABAAABAAAAAAAAAAAAAAAAAAAAAQACAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQAAAAAAAwAAAAAAAAAAAAAAAAAAAAAAAAAEAAUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAVAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAKAL4AAAAAf%2F%2FAAIAAgAoAAABaAMgAAMABwAusQEALzyyBwQA7TKxBgXcPLIDAgDtMgCxAwAvPLIFBADtMrIHBgH8PLIBAgDtMjMRIRElMxEjKAFA%2Fujw8AMg%2FOAoAtAAAQBkAGQETARMAFsAAAEyFh8BHgEdATc%2BAR8BFgYPATMyFhcWFRQGDwEOASsBFx4BDwEGJi8BFRQGBwYjIiYvAS4BPQEHDgEvASY2PwEjIiYnJjU0Nj8BPgE7AScuAT8BNhYfATU0Njc2AlgPJgsLCg%2BeBxYIagcCB57gChECBgMCAQIRCuCeBwIHaggWB54PCikiDyYLCwoPngcWCGoHAgee4AoRAgYDAgECEQrgngcCB2oIFgeeDwopBEwDAgECEQrgngcCB2oIFgeeDwopIg8mCwsKD54HFghqBwIHnuAKEQIGAwIBAhEK4J4HAgdqCBYHng8KKSIPJgsLCg%2BeBxYIagcCB57gChECBgAAAAABAAAAAARMBEwAIwAAATMyFhURITIWHQEUBiMhERQGKwEiJjURISImPQE0NjMhETQ2AcLIFR0BXhUdHRX%2Boh0VyBUd%2FqIVHR0VAV4dBEwdFf6iHRXIFR3%2BohUdHRUBXh0VyBUdAV4VHQAAAAABAHAAAARABEwARQAAATMyFgcBBgchMhYPAQ4BKwEVITIWDwEOASsBFRQGKwEiJj0BISImPwE%2BATsBNSEiJj8BPgE7ASYnASY2OwEyHwEWMj8BNgM5%2BgoFCP6UBgUBDAoGBngGGAp9ARMKBgZ4BhgKfQ8LlAsP%2Fu0KBgZ4BhgKff7tCgYGeAYYCnYFBv6UCAUK%2BhkSpAgUCKQSBEwKCP6UBgwMCKAIDGQMCKAIDK4LDw8LrgwIoAgMZAwIoAgMDAYBbAgKEqQICKQSAAABAGQABQSMBK4AOwAAATIXFhcjNC4DIyIOAwchByEGFSEHIR4EMzI%2BAzUzBgcGIyInLgEnIzczNjcjNzM%2BATc2AujycDwGtSM0QDkXEys4MjAPAXtk%2FtQGAZZk%2FtQJMDlCNBUWOUA0I64eYmunznYkQgzZZHABBdpkhhQ%2BH3UErr1oaS1LMCEPCx4uTzJkMjJkSnRCKw8PIjBKK6trdZ4wqndkLzVkV4UljQAAAgB7AAAETASwAD4ARwAAASEyHgUVHAEVFA4FKwEHITIWDwEOASsBFRQGKwEiJj0BISImPwE%2BATsBNSEiJj8BPgE7ARE0NhcRMzI2NTQmIwGsAV5DakIwFgwBAQwWMEJqQ7ICASAKBgZ4BhgKigsKlQoP%2FvUKBgZ4BhgKdf71CgYGeAYYCnUPtstALS1ABLAaJD8yTyokCwsLJCpQMkAlGmQMCKAIDK8LDg8KrwwIoAgMZAwIoAgMAdsKD8j%2B1EJWVEAAAAEAyAGQBEwCvAAPAAATITIWHQEUBiMhIiY9ATQ2%2BgMgFR0dFfzgFR0dArwdFcgVHR0VyBUdAAAAAgDIAAAD6ASwACUAQQAAARUUBisBFRQGBx4BHQEzMhYdASE1NDY7ATU0NjcuAT0BIyImPQEXFRQWFx4BFAYHDgEdASE1NCYnLgE0Njc%2BAT0BA%2BgdFTJjUVFjMhUd%2FOAdFTJjUVFjMhUdyEE3HCAgHDdBAZBBNxwgIBw3QQSwlhUdZFuVIyOVW5YdFZaWFR2WW5UjI5VbZB0VlshkPGMYDDI8MgwYYzyWljxjGAwyPDIMGGM8ZAAAAAEAAAAAAAAAAAAAAAAxAAAB%2F%2FIBLATCBEEAFgAAATIWFzYzMhYVFAYjISImNTQ2NyY1NDYB9261LCwueKqqeP0ST3FVQgLYBEF3YQ6teHmtclBFaw4MGZnXAAAAAgAAAGQEsASvABoAHgAAAB4BDwEBMzIWHQEhNTQ2OwEBJyY%2BARYfATc2AyEnAwL2IAkKiAHTHhQe%2B1AeFB4B1IcKCSAkCm9wCXoBebbDBLMTIxC7%2FRYlFSoqFSUC6rcQJBQJEJSWEPwecAIWAAAAAAQAAABkBLAETAALABcAIwA3AAATITIWBwEGIicBJjYXARYUBwEGJjURNDYJATYWFREUBicBJjQHARYGIyEiJjcBNjIfARYyPwE2MhkEfgoFCP3MCBQI%2FcwIBQMBCAgI%2FvgICgoDjAEICAoKCP74CFwBbAgFCvuCCgUIAWwIFAikCBQIpAgUBEwKCP3JCAgCNwgK2v74CBQI%2FvgIBQoCJgoF%2FvABCAgFCv3aCgUIAQgIFID%2BlAgKCggBbAgIpAgIpAgAAAAD%2F%2FD%2F8AS6BLoACQANABAAAAAyHwEWFA8BJzcTAScJAQUTA%2BAmDpkNDWPWXyL9mdYCZv4f%2FrNuBLoNmQ4mDlzWYP50%2FZrWAmb8anABTwAAAAEAAAAABLAEsAAPAAABETMyFh0BITU0NjsBEQEhArz6FR384B0V%2Bv4MBLACiv3aHRUyMhUdAiYCJgAAAAEADgAIBEwEnAAfAAABJTYWFREUBgcGLgE2NzYXEQURFAYHBi4BNjc2FxE0NgFwAoUnMFNGT4gkV09IQv2oWEFPiCRXT0hCHQP5ow8eIvzBN1EXGSltchkYEAIJm%2F2iKmAVGilucRoYEQJ%2FJioAAAACAAn%2F%2BAS7BKcAHQApAAAAMh4CFQcXFAcBFgYPAQYiJwEGIycHIi4CND4BBCIOARQeATI%2BATQmAZDItoNOAQFOARMXARY7GikT%2Fu13jgUCZLaDTk6DAXKwlFZWlLCUVlYEp06DtmQCBY15%2Fu4aJRg6FBQBEk0BAU6Dtsi2g1tWlLCUVlaUsJQAAQBkAFgErwREABkAAAE%2BAh4CFRQOAwcuBDU0PgIeAQKJMHt4dVg2Q3mEqD4%2Bp4V4Qzhadnh5A7VESAUtU3ZAOXmAf7JVVbJ%2FgHk5QHZTLQVIAAAAAf%2FTAF4EewSUABgAAAETNjIXEyEyFgcFExYGJyUFBiY3EyUmNjMBl4MHFQeBAaUVBhH%2BqoIHDxH%2Bqf6qEQ8Hgv6lEQYUAyABYRMT%2Fp8RDPn%2BbxQLDPb3DAsUAZD7DBEAAv%2FTAF4EewSUABgAIgAAARM2MhcTITIWBwUTFgYnJQUGJjcTJSY2MwUjFwc3Fyc3IycBl4MHFQeBAaUVBhH%2BqoIHDxH%2Bqf6qEQ8Hgv6lEQYUAfPwxUrBw0rA6k4DIAFhExP%2BnxEM%2Bf5vFAsM9vcMCxQBkPsMEWSO4ouM5YzTAAABAAAAAASwBLAAJgAAATIWHQEUBiMVFBYXBR4BHQEUBiMhIiY9ATQ2NyU%2BAT0BIiY9ATQ2Alh8sD4mDAkBZgkMDwr7ggoPDAkBZgkMJj6wBLCwfPouaEsKFwbmBRcKXQoPDwpdChcF5gYXCktoLvp8sAAAAA0AAAAABLAETAAPABMAIwAnACsALwAzADcARwBLAE8AUwBXAAATITIWFREUBiMhIiY1ETQ2FxUzNSkBIgYVERQWMyEyNjURNCYzFTM1BRUzNSEVMzUFFTM1IRUzNQchIgYVERQWMyEyNjURNCYFFTM1IRUzNQUVMzUhFTM1GQR%2BCg8PCvuCCg8PVWQCo%2F3aCg8PCgImCg8Pc2T8GGQDIGT8GGQDIGTh%2FdoKDw8KAiYKDw%2F872QDIGT8GGQDIGQETA8K%2B%2BYKDw8KBBoKD2RkZA8K%2FqIKDw8KAV4KD2RkyGRkZGTIZGRkZGQPCv6iCg8PCgFeCg9kZGRkZMhkZGRkAAAEAAAAAARMBEwADwAfAC8APwAAEyEyFhURFAYjISImNRE0NikBMhYVERQGIyEiJjURNDYBITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NjIBkBUdHRX%2BcBUdHQJtAZAVHR0V%2FnAVHR39vQGQFR0dFf5wFR0dAm0BkBUdHRX%2BcBUdHQRMHRX%2BcBUdHRUBkBUdHRX%2BcBUdHRUBkBUd%2FagdFf5wFR0dFQGQFR0dFf5wFR0dFQGQFR0AAAkAAAAABEwETAAPAB8ALwA%2FAE8AXwBvAH8AjwAAEzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2MsgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR0ETB0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHf5wHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUd%2FnAdFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0ABgAAAAAEsARMAA8AHwAvAD8ATwBfAAATMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYyyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHQRMHRXIFR0dFcgVHR0VyBUdHRXIFR3%2BcB0VyBUdHRXIFR0dFcgVHR0VyBUd%2FnAdFcgVHR0VyBUdHRXIFR0dFcgVHQAAAAABACYALAToBCAAFwAACQE2Mh8BFhQHAQYiJwEmND8BNjIfARYyAdECOwgUB7EICPzxBxUH%2FoAICLEHFAirBxYB3QI7CAixBxQI%2FPAICAGACBQHsQgIqwcAAQBuAG4EQgRCACMAAAEXFhQHCQEWFA8BBiInCQEGIi8BJjQ3CQEmND8BNjIXCQE2MgOIsggI%2FvUBCwgIsggVB%2F70%2FvQHFQiyCAgBC%2F71CAiyCBUHAQwBDAcVBDuzCBUH%2FvT%2B9AcVCLIICAEL%2FvUICLIIFQcBDAEMBxUIsggI%2FvUBDAcAAwAX%2F%2BsExQSZABkAJQBJAAAAMh4CFRQHARYUDwEGIicBBiMiLgI0PgEEIg4BFB4BMj4BNCYFMzIWHQEzMhYdARQGKwEVFAYrASImPQEjIiY9ATQ2OwE1NDYBmcSzgk1OASwICG0HFQj%2B1HeOYrSBTU2BAW%2BzmFhYmLOZWFj%2BvJYKD0sKDw8KSw8KlgoPSwoPDwpLDwSZTYKzYo15%2FtUIFQhsCAgBK01NgbTEs4JNWJmzmFhYmLOZIw8KSw8KlgoPSwoPDwpLDwqWCg9LCg8AAAMAF%2F%2FrBMUEmQAZACUANQAAADIeAhUUBwEWFA8BBiInAQYjIi4CND4BBCIOARQeATI%2BATQmBSEyFh0BFAYjISImPQE0NgGZxLOCTU4BLAgIbQcVCP7Ud45itIFNTYEBb7OYWFiYs5lYWP5YAV4KDw8K%2FqIKDw8EmU2Cs2KNef7VCBUIbAgIAStNTYG0xLOCTViZs5hYWJizmYcPCpYKDw8KlgoPAAAAAAIAFwAXBJkEsAAPAC0AAAEzMhYVERQGKwEiJjURNDYFNRYSFRQOAiIuAjU0EjcVDgEVFB4BMj4BNTQmAiZkFR0dFWQVHR0BD6fSW5vW6tabW9KnZ3xyxejFcnwEsB0V%2FnAVHR0VAZAVHeGmPv7ZuHXWm1tbm9Z1uAEnPqY3yHh0xXJyxXR4yAAEAGQAAASwBLAADwAfAC8APwAAATMyFhURFAYrASImNRE0NgEzMhYVERQGKwEiJjURNDYBMzIWFREUBisBIiY1ETQ2BTMyFh0BFAYrASImPQE0NgQBlgoPDwqWCg8P%2Ft6WCg8PCpYKDw%2F%2B3pYKDw8KlgoPD%2F7elgoPDwqWCg8PBLAPCvuCCg8PCgR%2BCg%2F%2BcA8K%2FRIKDw8KAu4KD%2F7UDwr%2BPgoPDwoBwgoPyA8K%2BgoPDwr6Cg8AAAAAAgAaABsElgSWAEcATwAAATIfAhYfATcWFwcXFh8CFhUUDwIGDwEXBgcnBwYPAgYjIi8CJi8BByYnNycmLwImNTQ%2FAjY%2FASc2Nxc3Nj8CNhIiBhQWMjY0AlghKSYFMS0Fhj0rUAMZDgGYBQWYAQ8YA1AwOIYFLDIFJisfISkmBTEtBYY8LFADGQ0ClwYGlwINGQNQLzqFBS0xBSYreLJ%2BfrJ%2BBJYFmAEOGQJQMDmGBSwxBiYrHiIoJgYxLAWGPSxRAxkOApcFBZcCDhkDUTA5hgUtMAYmKiAhKCYGMC0Fhj0sUAIZDgGYBf6ZfrF%2BfrEABwBkAAAEsAUUABMAFwAhACUAKQAtADEAAAEhMhYdASEyFh0BITU0NjMhNTQ2FxUhNQERFAYjISImNREXETMRMxEzETMRMxEzETMRAfQBLCk7ARMKD%2Fu0DwoBEzspASwBLDsp%2FUQpO2RkZGRkZGRkBRQ7KWQPCktLCg9kKTtkZGT%2B1PzgKTs7KQMgZP1EArz9RAK8%2FUQCvP1EArwAAQAMAAAFCATRAB8AABMBNjIXARYGKwERFAYrASImNREhERQGKwEiJjURIyImEgJsCBUHAmAIBQqvDwr6Cg%2F%2B1A8K%2BgoPrwoFAmoCYAcH%2FaAICv3BCg8PCgF3%2FokKDw8KAj8KAAIAZAAAA%2BgEsAARABcAAAERFBYzIREUBiMhIiY1ETQ2MwEjIiY9AQJYOykBLB0V%2FOAVHR0VA1L6FR0EsP5wKTv9dhUdHRUETBUd%2FnAdFfoAAwAXABcEmQSZAA8AGwAwAAAAMh4CFA4CIi4CND4BBCIOARQeATI%2BATQmBTMyFhURMzIWHQEUBisBIiY1ETQ2AePq1ptbW5vW6tabW1ubAb%2FoxXJyxejFcnL%2BfDIKD68KDw8K%2BgoPDwSZW5vW6tabW1ub1urWmztyxejFcnLF6MUNDwr%2B7Q8KMgoPDwoBXgoPAAAAAAL%2FnAAABRQEsAALAA8AACkBAyMDIQEzAzMDMwEDMwMFFP3mKfIp%2FeYBr9EVohTQ%2Fp4b4BsBkP5wBLD%2B1AEs%2FnD%2B1AEsAAAAAAIAZAAABLAEsAAVAC8AAAEzMhYVETMyFgcBBiInASY2OwERNDYBMzIWFREUBiMhIiY1ETQ2OwEyFh0BITU0NgImyBUdvxQLDf65DSYN%2FrkNCxS%2FHQJUMgoPDwr75goPDwoyCg8DhA8EsB0V%2Fj4XEP5wEBABkBAXAcIVHfzgDwr%2BogoPDwoBXgoPDwqvrwoPAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgUzMhYVETMyFgcDBiInAyY2OwERNDYB4%2BrWm1tbm9bq1ptbW5sBv%2BjFcnLF6MVycv58lgoPiRUKDd8NJg3fDQoViQ8EmVub1urWm1tbm9bq1ps7csXoxXJyxejFDQ8K%2Fu0XEP7tEBABExAXARMKDwAAAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JiUTFgYrAREUBisBIiY1ESMiJjcTNjIB4%2BrWm1tbm9bq1ptbW5sBv%2BjFcnLF6MVycv7n3w0KFYkPCpYKD4kVCg3fDSYEmVub1urWm1tbm9bq1ps7csXoxXJyxejFAf7tEBf%2B7QoPDwoBExcQARMQAAAAAAIAAAAABLAEsAAZADkAABMhMhYXExYVERQGBwYjISImJyY1EzQ3Ez4BBSEiBgcDBhY7ATIWHwEeATsBMjY%2FAT4BOwEyNicDLgHhAu4KEwO6BwgFDBn7tAweAgYBB7kDEwKX%2FdQKEgJXAgwKlgoTAiYCEwr6ChMCJgITCpYKDAJXAhIEsA4K%2FXQYGf5XDB4CBggEDRkBqRkYAowKDsgOC%2F4%2BCw4OCpgKDg4KmAoODgsBwgsOAAMAFwAXBJkEmQAPABsAJwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgUXFhQPAQYmNRE0NgHj6tabW1ub1urWm1tbmwG%2F6MVycsXoxXJy%2Fov9ERH9EBgYBJlbm9bq1ptbW5vW6tabO3LF6MVycsXoxV2%2BDCQMvgwLFQGQFQsAAQAXABcEmQSwACgAAAE3NhYVERQGIyEiJj8BJiMiDgEUHgEyPgE1MxQOAiIuAjQ%2BAjMyA7OHBwsPCv6WCwQHhW2BdMVycsXoxXKWW5vW6tabW1ub1nXABCSHBwQL%2FpYKDwsHhUxyxejFcnLFdHXWm1tbm9bq1ptbAAAAAAIAFwABBJkEsAAaADUAAAE3NhYVERQGIyEiJj8BJiMiDgEVIzQ%2BAjMyEzMUDgIjIicHBiY1ETQ2MyEyFg8BFjMyPgEDs4cHCw8L%2FpcLBAeGboF0xXKWW5vWdcDrllub1nXAnIYHCw8LAWgKBQiFboJ0xXIEJIcHBAv%2BlwsPCweGS3LFdHXWm1v9v3XWm1t2hggFCgFoCw8LB4VMcsUAAAAKAGQAAASwBLAADwAfAC8APwBPAF8AbwB%2FAI8AnwAAEyEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0NgczMhYdARQGKwEiJj0BNDYzITIWHQEUBiMhIiY9ATQ2BzMyFh0BFAYrASImPQE0NjMhMhYdARQGIyEiJj0BNDYHMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0Nn0EGgoPDwr75goPDwPA%2FK4KDw8KA1IKDw%2F9CDIKDw8KMgoPD9IBwgoPDwr%2BPgoPD74yCg8PCjIKDw%2FSAcIKDw8K%2Fj4KDw%2B%2BMgoPDwoyCg8P0gHCCg8PCv4%2BCg8PvjIKDw8KMgoPD9IBwgoPDwr%2BPgoPDwSwDwr7ggoPDwoEfgoPyA8K%2FK4KDw8KA1IKD2QPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKDwAAAAACAAAAAARMBLAAGQAjAAABNTQmIyEiBh0BIyIGFREUFjMhMjY1ETQmIyE1NDY7ATIWHQEDhHVT%2FtRSdmQpOzspA4QpOzsp%2FageFMgUHgMgyFN1dlLIOyn9qCk7OykCWCk7lhUdHRWWAAIAZAAABEwETAAJADcAABMzMhYVESMRNDYFMhcWFREUBw4DIyIuAScuAiMiBwYjIicmNRE%2BATc2HgMXHgIzMjc2fTIKD2QPA8AEBRADIUNAMRwaPyonKSxHHlVLBwgGBQ4WeDsXKC4TOQQpLUUdZ1AHBEwPCvvNBDMKDzACBhH%2BWwYGO1AkDQ0ODg8PDzkFAwcPAbY3VwMCAwsGFAEODg5XCAAAAwAAAAAEsASXACEAMQBBAAAAMh4CFREUBisBIiY1ETQuASAOARURFAYrASImNRE0PgEDMzIWFREUBisBIiY1ETQ2ITMyFhURFAYrASImNRE0NgHk6N6jYw8KMgoPjeT%2B%2BuSNDwoyCg9joyqgCAwMCKAIDAwCYKAIDAwIoAgMDASXY6PedP7UCg8PCgEsf9FyctF%2F%2FtQKDw8KASx03qP9wAwI%2FjQIDAwIAcwIDAwI%2FjQIDAwIAcwIDAAAAAACAAAA0wRHA90AFQA5AAABJTYWFREUBiclJisBIiY1ETQ2OwEyBTc2Mh8BFhQPARcWFA8BBiIvAQcGIi8BJjQ%2FAScmND8BNjIXAUEBAgkMDAn%2B%2FhUZ%2BgoPDwr6GQJYeAcUByIHB3h4BwciBxQHeHgHFAciBwd3dwcHIgcUBwMurAYHCv0SCgcGrA4PCgFeCg%2BEeAcHIgcUB3h4BxQHIgcHd3cHByIHFAd4eAcUByIICAAAAAACAAAA0wNyA90AFQAvAAABJTYWFREUBiclJisBIiY1ETQ2OwEyJTMWFxYVFAcGDwEiLwEuATc2NTQnJjY%2FATYBQQECCQwMCf7%2BFRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcDLqwGBwr9EgoHBqwODwoBXgoPZAEJgaGafwkBAQYXBxMIZ36EaggUBxYFAAAAAAMAAADEBGID7AAbADEASwAAATMWFxYVFAYHBgcjIi8BLgE3NjU0JicmNj8BNgUlNhYVERQGJyUmKwEiJjURNDY7ATIlMxYXFhUUBwYPASIvAS4BNzY1NCcmNj8BNgPHAwsGh0RABwoDCQcqCAIGbzs3BgIJKgf9ggECCQwMCf7%2BFRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcD7AEJs9lpy1QJAQYiBhQIlrJarEcJFAYhBb6sBgcK%2FRIKBwasDg8KAV4KD2QBCYGhmn8JAQEGFwcTCGd%2BhGoIFQYWBQAAAAANAAAAAASwBLAACQAVABkAHQAhACUALQA7AD8AQwBHAEsATwAAATMVIxUhFSMRIQEjFTMVIREjESM1IQURIREhESERBSM1MwUjNTMBMxEhETM1MwEzFSMVIzUjNTM1IzUhBREhEQcjNTMFIzUzASM1MwUhNSEB9GRk%2FnBkAfQCvMjI%2FtTIZAJY%2B7QBLAGQASz84GRkArxkZP1EyP4MyGQB9MhkyGRkyAEs%2FUQBLGRkZAOEZGT%2BDGRkAfT%2B1AEsA4RkZGQCWP4MZMgBLAEsyGT%2B1AEs%2FtQBLMhkZGT%2BDP4MAfRk%2FtRkZGRkyGTI%2FtQBLMhkZGT%2B1GRkZAAAAAAJAAAAAASwBLAAAwAHAAsADwATABcAGwAfACMAADcjETMTIxEzASMRMxMjETMBIxEzASE1IRcjNTMXIzUzBSM1M2RkZMhkZAGQyMjIZGQBLMjI%2FOD%2B1AEsyGRkyGRkASzIyMgD6PwYA%2Bj8GAPo%2FBgD6PwYA%2Bj7UGRkW1tbW1sAAAIAAAAKBKYEsAANABUAAAkBFhQHAQYiJwETNDYzBCYiBhQWMjYB9AKqCAj%2BMAgUCP1WAQ8KAUM7Uzs7UzsEsP1WCBQI%2FjAICAKqAdsKD807O1Q7OwAAAAADAAAACgXSBLAADQAZACEAAAkBFhQHAQYiJwETNDYzIQEWFAcBBiIvAQkBBCYiBhQWMjYB9AKqCAj%2BMAgUCP1WAQ8KAwYCqggI%2FjAIFAg4Aaj9RP7TO1M7O1M7BLD9VggUCP4wCAgCqgHbCg%2F9VggUCP4wCAg4AaoCvM07O1Q7OwAAAAABAGQAAASwBLAAJgAAASEyFREUDwEGJjURNCYjISIPAQYWMyEyFhURFAYjISImNRE0PwE2ASwDOUsSQAgKDwr9RBkSQAgFCgK8Cg8PCvyuCg8SixIEsEv8fBkSQAgFCgO2Cg8SQAgKDwr8SgoPDwoDzxkSixIAAAABAMj%2F%2FwRMBLAACgAAEyEyFhURCQERNDb6AyAVHf4%2B%2Fj4dBLAdFfuCAbz%2BQwR%2FFR0AAAAAAwAAAAAEsASwABUARQBVAAABISIGBwMGHwEeATMhMjY%2FATYnAy4BASMiBg8BDgEjISImLwEuASsBIgYVERQWOwEyNj0BNDYzITIWHQEUFjsBMjY1ETQmASEiBg8BBhYzITI2LwEuAQM2%2FkQLEAFOBw45BhcKAcIKFwY%2BDgdTARABVpYKFgROBBYK%2FdoKFgROBBYKlgoPDwqWCg8PCgLuCg8PCpYKDw%2F%2Bsf4MChMCJgILCgJYCgsCJgITBLAPCv7TGBVsCQwMCWwVGAEtCg%2F%2BcA0JnAkNDQmcCQ0PCv12Cg8PCpYKDw8KlgoPDwoCigoP%2FagOCpgKDg4KmAoOAAAAAAQAAABkBLAETAAdACEAKQAxAAABMzIeAh8BMzIWFREUBiMhIiY1ETQ2OwE%2BBAEVMzUEIgYUFjI2NCQyFhQGIiY0AfTIOF00JAcGlik7Oyn8GCk7OymWAgknM10ByGT%2Bz76Hh76H%2Fu9WPDxWPARMKTs7FRQ7Kf2oKTs7KQJYKTsIG0U1K%2F7UZGRGh76Hh74IPFY8PFYAAAAAAgA1AAAEsASvACAAIwAACQEWFx4BHwEVITUyNi8BIQYHBh4CMxUhNTY3PgE%2FAQEDIQMCqQGBFCgSJQkK%2Fl81LBFS%2Fnk6IgsJKjIe%2FpM4HAwaBwcBj6wBVKIEr%2FwaMioTFQECQkJXLd6RWSIuHAxCQhgcDCUNDQPu%2FVoByQAAAAADAGQAAAPwBLAAJwAyADsAAAEeBhUUDgMjITU%2BATURNC4EJzUFMh4CFRQOAgclMzI2NTQuAisBETMyNjU0JisBAvEFEzUwOyodN1htbDD%2BDCk7AQYLFyEaAdc5dWM%2BHy0tEP6Pi05pESpTPnbYUFJ9Xp8CgQEHGB0zOlIuQ3VONxpZBzMoAzsYFBwLEAkHRwEpSXNDM1s6KwkxYUopOzQb%2FK5lUFqBAAABAMgAAANvBLAAGQAAARcOAQcDBhYXFSE1NjcTNjQuBCcmJzUDbQJTQgeECSxK%2Fgy6Dq0DAw8MHxUXDQYEsDkTNSj8uTEoBmFhEFIDQBEaExAJCwYHAwI5AAAAAAL%2FtQAABRQEsAAlAC8AAAEjNC4FKwERFBYfARUhNTI%2BAzURIyIOBRUjESEFIxEzByczESM3BRQyCAsZEyYYGcgyGRn%2BcAQOIhoWyBkYJhMZCwgyA%2Bj7m0tLfX1LS30DhBUgFQ4IAwH8rhYZAQJkZAEFCRUOA1IBAwgOFSAVASzI%2FOCnpwMgpwACACH%2FtQSPBLAAJQAvAAABIzQuBSsBERQWHwEVITUyPgM1ESMiDgUVIxEhEwc1IRUnNxUhNQRMMggLGRMmGBnIMhkZ%2FnAEDiIaFsgZGCYTGQsIMgPoQ6f84KenAyADhBUgFQ4IAwH9dhYZAQJkZAEFCRUOAooBAwgOFSAVASz7gn1LS319S0sABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyAlgVHR0V%2FagVHR0VA%2BgVHR0V%2FBgVHR0VAyAVHR0V%2FOAVHR0VBEwVHR0V%2B7QVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYDITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NgMhMhYdARQGIyEiJj0BNDb6ArwVHR0V%2FUQVHR2zBEwVHR0V%2B7QVHR3dArwVHR0V%2FUQVHR2zBEwVHR0V%2B7QVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AAAE1NDYzITIWHQEUBiMhIiYBNTQ2MyEyFh0BFAYjISImEzU0NjMhMhYdARQGIyEiJgE1NDYzITIWHQEUBiMhIiYB9B0VAlgVHR0V%2FagVHf5wHRUD6BUdHRX8GBUdyB0VAyAVHR0V%2FOAVHf7UHRUETBUdHRX7tBUdA7ZkFR0dFWQVHR3%2B6WQVHR0VZBUdHf7pZBUdHRVkFR0d%2FulkFR0dFWQVHR0AAAQAAAAABLAETAAPAB8ALwA%2FAAATITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2MgRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dBEwdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdAAgAAAAABLAETAAPAB8ALwA%2FAE8AXwBvAH8AABMzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2MmQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR3%2B6WQVHR0VZBUdHQFBAyAVHR0V%2FOAVHR0ETB0VZBUdHRVkFR0dFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdHRVkFR0dFWQVHf7UHRVkFR0dFWQVHR0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0dFWQVHR0VZBUdAAAG%2F5wAAASwBEwAAwATACMAKgA6AEoAACEjETsCMhYdARQGKwEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2BQc1IzUzNQUhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2AZBkZJZkFR0dFWQVHR0VAfQVHR0V%2FgwVHR3%2B%2BqfIyAHCASwVHR0V%2FtQVHR0VAlgVHR0V%2FagVHR0ETB0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR36fUtkS68dFWQVHR0VZBUd%2FtQdFWQVHR0VZBUdAAAABgAAAAAFFARMAA8AEwAjACoAOgBKAAATMzIWHQEUBisBIiY9ATQ2ASMRMwEhMhYdARQGIyEiJj0BNDYFMxUjFSc3BSEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyZBUdHRVkFR0dA2dkZPyuAfQVHR0V%2FgwVHR0EL8jIp6f75gEsFR0dFf7UFR0dFQJYFR0dFf2oFR0dBEwdFWQVHR0VZBUd%2B7QETP7UHRVkFR0dFWQVHchkS319rx0VZBUdHRVkFR3%2B1B0VZBUdHRVkFR0AAAAAAgAAAMgEsAPoAA8AEgAAEyEyFhURFAYjISImNRE0NgkCSwLuHywsH%2F0SHywsBIT%2B1AEsA%2BgsH%2F12HywsHwKKHyz9RAEsASwAAwAAAAAEsARMAA8AFwAfAAATITIWFREUBiMhIiY1ETQ2FxE3BScBExEEMhYUBiImNCwEWBIaGhL7qBIaGkr3ASpKASXs%2FNJwTk5wTgRMGhL8DBIaGhID9BIaZP0ftoOcAT7%2B4AH0dE5vT09vAAAAAAIA2wAFBDYEkQAWAB4AAAEyHgEVFAcOAQ8BLgQnJjU0PgIWIgYUFjI2NAKIdcZzRkWyNjYJIV5YbSk8RHOft7eCgreCBJF4ynVzj23pPz4IIWZomEiEdVijeUjDgriBgbgAAAACABcAFwSZBJkADwAXAAAAMh4CFA4CIi4CND4BAREiDgEUHgEB4%2BrWm1tbm9bq1ptbW5sBS3TFcnLFBJlbm9bq1ptbW5vW6tab%2FG8DVnLF6MVyAAACAHUAAwPfBQ8AGgA1AAABHgYVFA4DBy4DNTQ%2BBQMOAhceBBcWNj8BNiYnLgInJjc2IyYCKhVJT1dOPiUzVnB9P1SbfEokP0xXUEm8FykoAwEbITEcExUWAgYCCQkFEikMGiACCAgFD0iPdXdzdYdFR4BeRiYEBTpjl1lFh3ZzeHaQ%2Ff4hS4I6JUEnIw4IBwwQIgoYBwQQQSlZtgsBAAAAAwAAAAAEywRsAAwAKgAvAAABNz4CHgEXHgEPAiUhMhcHISIGFREUFjMhMjY9ATcRFAYjISImNRE0NgkBBzcBA%2BhsAgYUFR0OFgoFBmz9BQGQMje7%2FpApOzspAfQpO8i7o%2F5wpbm5Azj%2BlqE3AWMD9XMBAgIEDw4WKgsKc8gNuzsp%2FgwpOzsptsj%2BtKW5uaUBkKW5%2Ftf%2BljKqAWMAAgAAAAAEkwRMABsANgAAASEGByMiBhURFBYzITI2NTcVFAYjISImNRE0NgUBFhQHAQYmJzUmDgMHPgY3NT4BAV4BaaQ0wyk7OykB9Ck7yLml%2FnClubkCfwFTCAj%2BrAcLARo5ZFRYGgouOUlARioTAQsETJI2Oyn%2BDCk7OymZZ6W5uaUBkKW5G%2F7TBxUH%2Fs4GBAnLAQINFjAhO2JBNB0UBwHSCgUAAAAAAgAAAAAEnQRMAB0ANQAAASEyFwchIgYVERQWMyEyNj0BNxUUBiMhIiY1ETQ2CQE2Mh8BFhQHAQYiLwEmND8BNjIfARYyAV4BXjxDsv6jKTs7KQH0KTvIuaX%2BcKW5uQHKAYsHFQdlBwf97QcVB%2FgHB2UHFQdvCBQETBexOyn%2BDCk7OylFyNulubmlAZCluf4zAYsHB2UHFQf97AcH%2BAcVB2UHB28HAAAAAQAKAAoEpgSmADsAAAkBNjIXARYGKwEVMzU0NhcBFhQHAQYmPQEjFTMyFgcBBiInASY2OwE1IxUUBicBJjQ3ATYWHQEzNSMiJgE%2BAQgIFAgBBAcFCqrICggBCAgI%2FvgICsiqCgUH%2FvwIFAj%2B%2BAgFCq%2FICgj%2B%2BAgIAQgICsivCgUDlgEICAj%2B%2BAgKyK0KBAf%2B%2FAcVB%2F73BwQKrcgKCP74CAgBCAgKyK0KBAcBCQcVBwEEBwQKrcgKAAEAyAAAA4QETAAZAAATMzIWFREBNhYVERQGJwERFAYrASImNRE0NvpkFR0B0A8VFQ%2F%2BMB0VZBUdHQRMHRX%2BSgHFDggV%2FBgVCA4Bxf5KFR0dFQPoFR0AAAABAAAAAASwBEwAIwAAEzMyFhURATYWFREBNhYVERQGJwERFAYnAREUBisBIiY1ETQ2MmQVHQHQDxUB0A8VFQ%2F%2BMBUP%2FjAdFWQVHR0ETB0V%2FkoBxQ4IFf5KAcUOCBX8GBUIDgHF%2FkoVCA4Bxf5KFR0dFQPoFR0AAAABAJ0AGQSwBDMAFQAAAREUBicBERQGJwEmNDcBNhYVEQE2FgSwFQ%2F%2BMBUP%2FhQPDwHsDxUB0A8VBBr8GBUIDgHF%2FkoVCA4B4A4qDgHgDggV%2FkoBxQ4IAAAAAQDIABYEMwQ2AAsAABMBFhQHAQYmNRE0NvMDLhIS%2FNISGRkEMv4OCx4L%2Fg4LDhUD6BUOAAIAyABkA4QD6AAPAB8AABMzMhYVERQGKwEiJjURNDYhMzIWFREUBisBIiY1ETQ2%2BsgVHR0VyBUdHQGlyBUdHRXIFR0dA%2BgdFfzgFR0dFQMgFR0dFfzgFR0dFQMgFR0AAAEAyABkBEwD6AAPAAABERQGIyEiJjURNDYzITIWBEwdFfzgFR0dFQMgFR0DtvzgFR0dFQMgFR0dAAAAAAEAAAAZBBMEMwAVAAABETQ2FwEWFAcBBiY1EQEGJjURNDYXAfQVDwHsDw%2F%2BFA8V%2FjAPFRUPAmQBthUIDv4gDioO%2FiAOCBUBtv47DggVA%2BgVCA4AAAH%2F%2FgACBLMETwAjAAABNzIWFRMUBiMHIiY1AwEGJjUDAQYmNQM0NhcBAzQ2FwEDNDYEGGQUHgUdFWQVHQL%2BMQ4VAv4yDxUFFQ8B0gIVDwHSAh0ETgEdFfwYFR0BHRUBtf46DwkVAbX%2BOQ4JFAPoFQkP%2Fj4BthQJDv49AbYVHQAAAQEsAAAD6ARMABkAAAEzMhYVERQGKwEiJjURAQYmNRE0NhcBETQ2A1JkFR0dFWQVHf4wDxUVDwHQHQRMHRX8GBUdHRUBtv47DggVA%2BgVCA7%2BOwG2FR0AAAIAZADIBLAESAALABsAAAkBFgYjISImNwE2MgEhMhYdARQGIyEiJj0BNDYCrgH1DwkW%2B%2B4WCQ8B9Q8q%2FfcD6BUdHRX8GBUdHQQ5%2FeQPFhYPAhwP%2FUgdFWQVHR0VZBUdAAEAiP%2F8A3UESgAFAAAJAgcJAQN1%2FqABYMX92AIoA4T%2Bn%2F6fxgIoAiYAAAAAAQE7%2F%2FwEKARKAAUAAAkBJwkBNwQo%2FdnGAWH%2Bn8YCI%2F3ZxgFhAWHGAAIAFwAXBJkEmQAPADMAAAAyHgIUDgIiLgI0PgEFIyIGHQEjIgYdARQWOwEVFBY7ATI2PQEzMjY9ATQmKwE1NCYB4%2BrWm1tbm9bq1ptbW5sBfWQVHZYVHR0Vlh0VZBUdlhUdHRWWHQSZW5vW6tabW1ub1urWm7odFZYdFWQVHZYVHR0Vlh0VZBUdlhUdAAAAAAIAFwAXBJkEmQAPAB8AAAAyHgIUDgIiLgI0PgEBISIGHQEUFjMhMjY9ATQmAePq1ptbW5vW6tabW1ubAkX%2BDBUdHRUB9BUdHQSZW5vW6tabW1ub1urWm%2F5%2BHRVkFR0dFWQVHQACABcAFwSZBJkADwAzAAAAMh4CFA4CIi4CND4BBCIPAScmIg8BBhQfAQcGFB8BFjI%2FARcWMj8BNjQvATc2NC8BAePq1ptbW5vW6tabW1ubAeUZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0JCXh4CQmNBJlbm9bq1ptbW5vW6tabrQl4eAkJjQkZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0AAgAXABcEmQSZAA8AJAAAADIeAhQOAiIuAjQ%2BAQEnJiIPAQYUHwEWMjcBNjQvASYiBwHj6tabW1ub1urWm1tbmwEVVAcVCIsHB%2FIHFQcBdwcHiwcVBwSZW5vW6tabW1ub1urWm%2F4xVQcHiwgUCPEICAF3BxUIiwcHAAAAAAMAFwAXBJkEmQAPADsASwAAADIeAhQOAiIuAjQ%2BAQUiDgMVFDsBFjc%2BATMyFhUUBgciDgUHBhY7ATI%2BAzU0LgMTIyIGHQEUFjsBMjY9ATQmAePq1ptbW5vW6tabW1ubAT8dPEIyIRSDHgUGHR8UFw4TARkOGhITDAIBDQ6tBx4oIxgiM0Q8OpYKDw8KlgoPDwSZW5vW6tabW1ub1urWm5ELHi9PMhkFEBQQFRIXFgcIBw4UHCoZCBEQKDhcNi9IKhsJ%2FeMPCpYKDw8KlgoPAAADABcAFwSZBJkADwAfAD4AAAAyHgIUDgIiLgI0PgEFIyIGHQEUFjsBMjY9ATQmAyMiBh0BFBY7ARUjIgYdARQWMyEyNj0BNCYrARE0JgHj6tabW1ub1urWm1tbmwGWlgoPDwqWCg8PCvoKDw8KS0sKDw8KAV4KDw8KSw8EmVub1urWm1tbm9bq1ptWDwqWCg8PCpYKD%2F7UDwoyCg%2FIDwoyCg8PCjIKDwETCg8AAgAAAAAEsASwAC8AXwAAATMyFh0BHgEXMzIWHQEUBisBDgEHFRQGKwEiJj0BLgEnIyImPQE0NjsBPgE3NTQ2ExUUBisBIiY9AQ4BBzMyFh0BFAYrAR4BFzU0NjsBMhYdAT4BNyMiJj0BNDY7AS4BAg2WCg9nlxvCCg8PCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw%2B5DwqWCg9EZheoCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmBLAPCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw8KlgoPZ5cbwgoP%2Fs2oCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmRA8KlgoPRGYAAwAXABcEmQSZAA8AGwA%2FAAAAMh4CFA4CIi4CND4BBCIOARQeATI%2BATQmBxcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyAePq1ptbW5vW6tabW1ubAb%2FoxXJyxejFcnKaQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwdABxUHfHwHFQSZW5vW6tabW1ub1urWmztyxejFcnLF6MVaQAcVB3x8BxUHQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwAAAAMAFwAXBJkEmQAPABsAMAAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgcXFhQHAQYiLwEmND8BNjIfATc2MgHj6tabW1ub1urWm1tbmwG%2F6MVycsXoxXJyg2oHB%2F7ACBQIyggIagcVB0%2FFBxUEmVub1urWm1tbm9bq1ps7csXoxXJyxejFfWoHFQf%2BvwcHywcVB2oICE%2FFBwAAAAMAFwAXBJkEmQAPABgAIQAAADIeAhQOAiIuAjQ%2BAQUiDgEVFBcBJhcBFjMyPgE1NAHj6tabW1ub1urWm1tbmwFLdMVyQQJLafX9uGhzdMVyBJlbm9bq1ptbW5vW6tabO3LFdHhpAktB0P24PnLFdHMAAAAAAQAXAFMEsAP5ABUAABMBNhYVESEyFh0BFAYjIREUBicBJjQnAgoQFwImFR0dFf3aFxD99hACRgGrDQoV%2Ft0dFcgVHf7dFQoNAasNJgAAAAABAAAAUwSZA%2FkAFQAACQEWFAcBBiY1ESEiJj0BNDYzIRE0NgJ%2FAgoQEP32EBf92hUdHRUCJhcD8f5VDSYN%2FlUNChUBIx0VyBUdASMVCgAAAAEAtwAABF0EmQAVAAAJARYGIyERFAYrASImNREhIiY3ATYyAqoBqw0KFf7dHRXIFR3%2B3RUKDQGrDSYEif32EBf92hUdHRUCJhcQAgoQAAAAAQC3ABcEXQSwABUAAAEzMhYVESEyFgcBBiInASY2MyERNDYCJsgVHQEjFQoN%2FlUNJg3%2BVQ0KFQEjHQSwHRX92hcQ%2FfYQEAIKEBcCJhUdAAABAAAAtwSZBF0AFwAACQEWFAcBBiY1EQ4DBz4ENxE0NgJ%2FAgoQEP32EBdesKWBJAUsW4fHfhcEVf5VDSYN%2FlUNChUBIwIkRHVNabGdcUYHAQYVCgACAAAAAASwBLAAFQArAAABITIWFREUBi8BBwYiLwEmND8BJyY2ASEiJjURNDYfATc2Mh8BFhQPARcWBgNSASwVHRUOXvkIFAhqBwf5Xg4I%2FiH%2B1BUdFQ5e%2BQgUCGoHB%2FleDggEsB0V%2FtQVCA5e%2BQcHaggUCPleDhX7UB0VASwVCA5e%2BQcHaggUCPleDhUAAAACAEkASQRnBGcAFQArAAABFxYUDwEXFgYjISImNRE0Nh8BNzYyASEyFhURFAYvAQcGIi8BJjQ%2FAScmNgP2agcH%2BV4OCBX%2B1BUdFQ5e%2BQgU%2FQwBLBUdFQ5e%2BQgUCGoHB%2FleDggEYGoIFAj5Xg4VHRUBLBUIDl75B%2F3xHRX%2B1BUIDl75BwdqCBQI%2BV4OFQAAAAADABcAFwSZBJkADwAfAC8AAAAyHgIUDgIiLgI0PgEFIyIGFxMeATsBMjY3EzYmAyMiBh0BFBY7ATI2PQE0JgHj6tabW1ub1urWm1tbmwGz0BQYBDoEIxQ2FCMEOgQYMZYKDw8KlgoPDwSZW5vW6tabW1ub1urWm7odFP7SFB0dFAEuFB3%2BDA8KlgoPDwqWCg8AAAAABQAAAAAEsASwAEkAVQBhAGgAbwAAATIWHwEWHwEWFxY3Nj8BNjc2MzIWHwEWHwIeATsBMhYdARQGKwEiBh0BIREjESE1NCYrASImPQE0NjsBMjY1ND8BNjc%2BBAUHBhY7ATI2LwEuAQUnJgYPAQYWOwEyNhMhIiY1ESkBERQGIyERAQQJFAUFFhbEFQ8dCAsmxBYXERUXMA0NDgQZCAEPCj0KDw8KMgoP%2FnDI%2FnAPCjIKDw8KPQsOCRkFDgIGFRYfAp2mBwQK2woKAzMDEP41sQgQAzMDCgrnCwMe%2FokKDwGQAlgPCv6JBLAEAgIKDXYNCxUJDRZ2DQoHIREQFRh7LAkLDwoyCg8PCq8BLP7UrwoPDwoyCg8GBQQwgBkUAwgWEQ55ogcKDgqVCgSqnQcECo8KDgr8cg8KAXf%2BiQoPAZAAAAAAAgAAAAwErwSmACsASQAAATYWFQYCDgQuAScmByYOAQ8BBiY1NDc%2BATc%2BAScuAT4BNz4GFyYGBw4BDwEOBAcOARY2Nz4CNz4DNz4BBI0IGgItQmxhi2KORDg9EQQRMxuZGhYqCFUYEyADCQIQOjEnUmFch3vAJQgdHyaiPT44XHRZUhcYDhItIRmKcVtGYWtbKRYEBKYDEwiy%2Ft3IlVgxEQgLCwwBAQIbG5kYEyJAJghKFRE8Hzdff4U%2FM0o1JSMbL0QJGCYvcSEhHjZST2c1ODwEJygeW0AxJUBff1UyFAABAF0AHgRyBM8ATwAAAQ4BHgQXLgc%2BATceAwYHDgQHBicmNzY3PgQuAScWDgMmJy4BJyY%2BBDcGHgM3PgEuAicmPgMCjScfCic4R0IgBBsKGAoQAwEJEg5gikggBhANPkpTPhZINx8SBgsNJysiCRZOQQoVNU1bYC9QZwICBAUWITsoCAYdJzIYHw8YIiYHDyJJYlkEz0OAZVxEOSQMBzgXOB42IzElKRIqg5Gnl0o3Z0c6IAYWCwYNAwQFIDhHXGF1OWiqb0sdBxUknF0XNTQ8PEUiNWNROBYJDS5AQVUhVZloUSkAAAAAA%2F%2FcAGoE1ARGABsAPwBRAAAAMh4FFA4FIi4FND4EBSYGFxYVFAYiJjU0NzYmBwYHDgEXHgQyPgM3NiYnJgUHDgEXFhcWNj8BNiYnJicuAQIGpJ17bk85HBw6T257naKde25POhwcOU9uewIPDwYIGbD4sBcIBw5GWg0ECxYyWl%2BDiINfWjIWCwQMWv3%2FIw8JCSU4EC0OIw4DDywtCyIERi1JXGJcSSpJXGJcSS0tSVxiXEkqSVxiXEncDwYTOT58sLB8OzcTBg9FcxAxEiRGXkQxMEVeRSQSMRF1HiQPLxJEMA0EDyIPJQ8sSRIEAAAABP%2FcAAAE1ASwABQAJwA7AEwAACEjNy4ENTQ%2BBTMyFzczEzceARUUDgMHNz4BNzYmJyYlBgcOARceBBc3LgE1NDc2JhcHDgEXFhcWNj8CJyYnLgECUJQfW6l2WSwcOU9ue51SPUEglCYvbIknUGqYUi5NdiYLBAw2%2FVFGWg0ECxIqSExoNSlrjxcIB3wjDwkJJTgQLQ4MFgMsLQsieBRhdHpiGxVJXGJcSS0Pef5StVXWNBpacm5jGq0xiD8SMRFGckVzEDESHjxRQTkNmhKnbjs3EwZwJA8vEkQwDQQPC1YELEkSBAAAAAP%2FngAABRIEqwALABgAKAAAJwE2FhcBFgYjISImJSE1NDY7ATIWHQEhAQczMhYPAQ4BKwEiJi8BJjZaAoIUOBQCghUbJfryJRsBCgFZDwqWCg8BWf5DaNAUGAQ6BCMUNhQjBDoEGGQEKh8FIfvgIEdEhEsKDw8KSwLT3x0U%2FBQdHRT8FB0AAAABAGQAFQSwBLAAKAAAADIWFREBHgEdARQGJyURFh0BFAYvAQcGJj0BNDcRBQYmPQE0NjcBETQCTHxYAWsPFhgR%2FplkGhPNzRMaZP6ZERgWDwFrBLBYPv6t%2FrsOMRQpFA0M%2Bf75XRRAFRAJgIAJEBVAFF0BB%2FkMDRQpFDEOAUUBUz4AAAARAAAAAARMBLAAHQAnACsALwAzADcAOwA%2FAEMARwBLAE8AUwBXAFsAXwBjAAABMzIWHQEzMhYdASE1NDY7ATU0NjsBMhYdASE1NDYBERQGIyEiJjURFxUzNTMVMzUzFTM1MxUzNTMVMzUFFTM1MxUzNTMVMzUzFTM1MxUzNQUVMzUzFTM1MxUzNTMVMzUzFTM1A1JkFR0yFR37tB0VMh0VZBUdAfQdAQ8dFfwYFR1kZGRkZGRkZGRk%2FHxkZGRkZGRkZGT8fGRkZGRkZGRkZASwHRUyHRWWlhUdMhUdHRUyMhUd%2FnD9EhUdHRUC7shkZGRkZGRkZGRkyGRkZGRkZGRkZGTIZGRkZGRkZGRkZAAAAAMAAAAZBXcElwAZACUANwAAARcWFA8BBiY9ASMBISImPQE0NjsBATM1NDYBBycjIiY9ATQ2MyEBFxYUDwEGJj0BIyc3FzM1NDYEb%2FkPD%2FkOFZ%2F9qP7dFR0dFdECWPEV%2FamNetEVHR0VASMDGvkPD%2FkOFfG1jXqfFQSN5g4qDuYOCBWW%2FagdFWQVHQJYlhUI%2FpiNeh0VZBUd%2Fk3mDioO5g4IFZa1jXqWFQgAAAABAAAAAASwBEwAEgAAEyEyFhURFAYjIQERIyImNRE0NmQD6Ck7Oyn9rP7QZCk7OwRMOyn9qCk7%2FtQBLDspAlgpOwAAAAMAZAAABEwEsAAJABMAPwAAEzMyFh0BITU0NiEzMhYdASE1NDYBERQOBSIuBTURIRUUFRwBHgYyPgYmNTQ9AZbIFR3%2B1B0C0cgVHf7UHQEPBhgoTGacwJxmTCgYBgEsAwcNFB8nNkI2Jx8TDwUFAQSwHRX6%2BhUdHRX6%2BhUd%2FnD%2B1ClJalZcPigoPlxWakkpASz6CRIVKyclIRsWEAgJEBccISUnKhURCPoAAAAB%2F%2F8A1ARMA8IABQAAAQcJAScBBEzG%2Fp%2F%2Bn8UCJwGbxwFh%2Fp%2FHAicAAQAAAO4ETQPcAAUAAAkCNwkBBE392v3ZxgFhAWEDFf3ZAifH%2Fp8BYQAAAAAC%2F1EAZAVfA%2BgAFAApAAABITIWFREzMhYPAQYiLwEmNjsBESElFxYGKwERIRchIiY1ESMiJj8BNjIBlALqFR2WFQgO5g4qDuYOCBWW%2FoP%2BHOYOCBWWAYHX%2FRIVHZYVCA7mDioD6B0V%2FdkVDvkPD%2FkOFQGRuPkOFf5wyB0VAiYVDvkPAAABAAYAAASeBLAAMAAAEzMyFh8BITIWBwMOASMhFyEyFhQGKwEVFAYiJj0BIRUUBiImPQEjIiYvAQMjIiY0NjheERwEJgOAGB4FZAUsIf2HMAIXFR0dFTIdKh3%2B1B0qHR8SHQYFyTYUHh4EsBYQoiUY%2FiUVK8gdKh0yFR0dFTIyFR0dFTIUCQoDwR0qHQAAAAACAAAAAASwBEwACwAPAAABFSE1MzQ2MyEyFhUFIREhBLD7UMg7KQEsKTv9RASw%2B1AD6GRkKTs7Kcj84AACAAAAAAXcBEwADAAQAAATAxEzNDYzITIWFSEVBQEhAcjIyDspASwqOgH0ASz%2B1PtQASwDIP5wAlgpOzspyGT9RAK8AAEBRQAAA2sErwAbAAABFxYGKwERMzIWDwEGIi8BJjY7AREjIiY%2FATYyAnvmDggVlpYVCA7mDioO5g4IFZaWFQgO5g4qBKD5DhX9pxUO%2BQ8P%2BQ4VAlkVDvkPAAAAAQABAUQErwNrABsAAAEXFhQPAQYmPQEhFRQGLwEmND8BNhYdASE1NDYDqPkODvkPFf2oFQ%2F5Dg75DxUCWBUDYOUPKQ%2FlDwkUl5cUCQ%2FlDykP5Q8JFZWVFQkAAAAEAAAAAASwBLAACQAZAB0AIQAAAQMuASMhIgYHAwUhIgYdARQWMyEyNj0BNCYFNTMVMzUzFQSRrAUkFP1gFCQFrAQt%2FBgpOzspA%2BgpOzv%2Bq2RkZAGQAtwXLSgV%2FR1kOylkKTs7KWQpO8hkZGRkAAAAA%2F%2BcAGQEsARMAAsAIwAxAAAAMhYVERQGIiY1ETQDJSMTFgYjIisBIiYnAj0BNDU0PgE7ASUBFSIuAz0BND4CNwRpKh0dKh1k%2FV0mLwMRFQUCVBQdBDcCCwzIAqP8GAQOIhoWFR0dCwRMHRX8rhUdHRUDUhX8mcj%2B7BAIHBUBUQ76AgQQDw36%2FtT6AQsTKRwyGigUDAEAAAACAEoAAARmBLAALAA1AAABMzIWDwEeARcTFzMyFhQGBw4EIyIuBC8BLgE0NjsBNxM%2BATcnJjYDFjMyNw4BIiYCKV4UEgYSU3oPP3YRExwaEggeZGqfTzl0XFU%2BLwwLEhocExF2Pw96UxIGEyQyNDUxDDdGOASwFRMlE39N%2FrmtHSkoBwQLHBYSCg4REg4FBAgoKR2tAUdNfhQgExr7vgYGMT09AAEAFAAUBJwEnAAXAAABNwcXBxcHFycHJwcnBzcnNyc3Jxc3FzcDIOBO6rS06k7gLZubLeBO6rS06k7gLZubA7JO4C2bmy3gTuq0tOpO4C2bmy3gTuq0tAADAAAAZASwBLAAIQAtAD0AAAEzMhYdAQchMhYdARQHAw4BKwEiJi8BIyImNRE0PwI%2BARcPAREzFzMTNSE3NQEzMhYVERQGKwEiJjURNDYCijIoPBwBSCg8He4QLBf6B0YfHz0tNxSRYA0xG2SWZIjW%2Bv4%2BMv12ZBUdHRVkFR0dBLBRLJZ9USxkLR3%2BqBghMhkZJCcBkCQbxMYcKGTU1f6JZAF3feGv%2FtQdFf4MFR0dFQH0FR0AAAAAAwAAAAAEsARMACAAMAA8AAABMzIWFxMWHQEUBiMhFh0BFAYrASImLwImNRE0NjsBNgUzMhYVERQGKwEiJjURNDYhByMRHwEzNSchNQMCWPoXLBDuHTwo%2FrgcPCgyGzENYJEUNy09fP3pZBUdHRVkFR0dAl%2BIZJZkMjIBwvoETCEY%2FqgdLWQsUXYHlixRKBzGxBskAZAnJGRkHRX%2BDBUdHRUB9BUdZP6J1dSv4X0BdwADAAAAZAUOBE8AGwA3AEcAAAElNh8BHgEPASEyFhQGKwEDDgEjISImNRE0NjcXERchEz4BOwEyNiYjISoDLgQnJj8BJwUzMhYVERQGKwEiJjURNDYBZAFrHxZuDQEMVAEuVGxuVGqDBhsP%2FqoHphwOOmQBJYMGGw%2FLFRMSFv44AgoCCQMHAwUDAQwRklb9T2QVHR0VZBUdHQNp5hAWcA0mD3lMkE7%2BrRUoog0CDRElCkj%2BCVkBUxUoMjIBAgIDBQIZFrdT5B0V%2FgwVHR0VAfQVHQAAAAP%2FnABkBLAETwAdADYARgAAAQUeBBURFAYjISImJwMjIiY0NjMhJyY2PwE2BxcWBw4FKgIjIRUzMhYXEyE3ESUFMzIWFREUBisBIiY1ETQ2AdsBbgIIFBANrAf%2Bqg8bBoNqVW1sVAEuVQsBDW4WSpIRDAIDBQMHAwkDCgH%2BJd0PHAaCASZq%2FqoCUGQVHR0VZBUdHQRP5gEFEBEXC%2F3zDaIoFQFTTpBMeQ8mDXAWrrcWGQIFAwICAWQoFf6tWQH37OQdFf4MFR0dFQH0FR0AAAADAGEAAARMBQ4AGwA3AEcAAAAyFh0BBR4BFREUBiMhIiYvAQMmPwE%2BAR8BETQXNTQmBhURHAMOBAcGLwEHEyE3ESUuAQMhMhYdARQGIyEiJj0BNDYB3pBOAVMVKKIN%2FfMRJQoJ5hAWcA0mD3nGMjIBAgIDBQIZFrdT7AH3Wf6tFSiWAfQVHR0V%2FgwVHR0FDm5UaoMGGw%2F%2BqgemHA4OAWsfFm4NAQxUAS5U1ssVExIW%2FjgCCgIJAwcDBQMBDBGSVv6tZAElgwYb%2FQsdFWQVHR0VZBUdAAP%2F%2FQAGA%2BgFFAAPAC0ASQAAASEyNj0BNCYjISIGHQEUFgEVFAYiJjURBwYmLwEmNxM%2BBDMhMhYVERQGBwEDFzc2Fx4FHAIVERQWNj0BNDY3JREnAV4B9BUdHRX%2BDBUdHQEPTpBMeQ8mDXAWEOYBBRARFwsCDQ2iKBX9iexTtxYZAgUDAgIBMjIoFQFTWQRMHRVkFR0dFWQVHfzmalRubFQBLlQMAQ1uFh8BawIIEw8Mpgf%2Bqg8bBgHP%2Fq1WkhEMAQMFAwcDCQIKAv44FhITFcsPGwaDASVkAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBJSYGHQEhIgYdARQWMyEVFBY3JTY0AeLs1ptbW5vW7NabW1ubAob%2B7RAX%2Fu0KDw8KARMXEAETEASaW5vW7NabW1ub1uzWm%2F453w0KFYkPCpYKD4kVCg3fDSYAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgENAQYUFwUWNj0BITI2PQE0JiMhNTQmAeLs1ptbW5vW7NabW1ubASX%2B7RAQARMQFwETCg8PCv7tFwSaW5vW7NabW1ub1uzWm%2BjfDSYN3w0KFYkPCpYKD4kVCgAAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBAyYiBwMGFjsBERQWOwEyNjURMzI2AeLs1ptbW5vW7NabW1ubAkvfDSYN3w0KFYkPCpYKD4kVCgSaW5vW7NabW1ub1uzWm%2F5AARMQEP7tEBf%2B7QoPDwoBExcAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEFIyIGFREjIgYXExYyNxM2JisBETQmAeLs1ptbW5vW7NabW1ubAZeWCg%2BJFQoN3w0mDd8NChWJDwSaW5vW7NabW1ub1uzWm7sPCv7tFxD%2B7RAQARMQFwETCg8AAAMAGAAYBJgEmAAPAJYApgAAADIeAhQOAiIuAjQ%2BASUOAwcGJgcOAQcGFgcOAQcGFgcUFgcyHgEXHgIXHgI3Fg4BFx4CFxQGFBcWNz4CNy4BJy4BJyIOAgcGJyY2NS4BJzYuAQYHBicmNzY3HgIXHgMfAT4CJyY%2BATc%2BAzcmNzIWMjY3LgMnND4CJiceAT8BNi4CJwYHFB4BFS4CJz4BNxYyPgEB5OjVm1xcm9Xo1ZtcXJsBZA8rHDoKDz0PFD8DAxMBAzEFCRwGIgEMFhkHECIvCxU%2FOR0HFBkDDRQjEwcFaHUeISQDDTAMD0UREi4oLBAzDwQBBikEAQMLGhIXExMLBhAGKBsGBxYVEwYFAgsFAwMNFwQGCQcYFgYQCCARFwkKKiFBCwQCAQMDHzcLDAUdLDgNEiEQEgg%2FKhADGgMKEgoRBJhcm9Xo1ZtcXJvV6NWbEQwRBwkCAwYFBycPCxcHInIWInYcCUcYChQECA4QBAkuHgQPJioRFRscBAcSCgwCch0kPiAIAQcHEAsBAgsLIxcBMQENCQIPHxkCFBkdHB4QBgEBBwoMGBENBAMMJSAQEhYXDQ4qFBkKEhIDCQsXJxQiBgEOCQwHAQ0DBAUcJAwSCwRnETIoAwEJCwsLJQcKDBEAAAAAAQAAAAIErwSFABYAAAE2FwUXNxYGBw4BJwEGIi8BJjQ3ASY2AvSkjv79kfsGUE08hjv9rA8rD28PDwJYIk8EhVxliuh%2BWYcrIgsW%2FawQEG4PKxACV2XJAAYAAABgBLAErAAPABMAIwAnADcAOwAAEyEyFh0BFAYjISImPQE0NgUjFTMFITIWHQEUBiMhIiY9ATQ2BSEVIQUhMhYdARQGIyEiJj0BNDYFIRUhZAPoKTs7KfwYKTs7BBHIyPwYA%2BgpOzsp%2FBgpOzsEEf4MAfT8GAPoKTs7KfwYKTs7BBH%2B1AEsBKw7KWQpOzspZCk7ZGTIOylkKTs7KWQpO2RkyDspZCk7OylkKTtkZAAAAAIAZAAABEwEsAALABEAABMhMhYUBiMhIiY0NgERBxEBIZYDhBUdHRX8fBUdHQI7yP6iA4QEsB0qHR0qHf1E%2FtTIAfQB9AAAAAMAAABkBLAEsAAXABsAJQAAATMyFh0BITIWFREhNSMVIRE0NjMhNTQ2FxUzNQEVFAYjISImPQEB9MgpOwEsKTv%2BDMj%2BDDspASw7KcgB9Dsp%2FBgpOwSwOylkOyn%2BcGRkAZApO2QpO2RkZP1EyCk7OynIAAAABAAAAAAEsASwABUAKwBBAFcAABMhMhYPARcWFA8BBiIvAQcGJjURNDYpATIWFREUBi8BBwYiLwEmND8BJyY2ARcWFA8BFxYGIyEiJjURNDYfATc2MgU3NhYVERQGIyEiJj8BJyY0PwE2MhcyASwVCA5exwcHaggUCMdeDhUdAzUBLBUdFQ5exwgUCGoHB8deDgj%2BL2oHB8deDggV%2FtQVHRUOXscIFALLXg4VHRX%2B1BUIDl7HBwdqCBQIBLAVDl7HCBQIagcHx14OCBUBLBUdHRX%2B1BUIDl7HBwdqCBQIx14OFf0maggUCMdeDhUdFQEsFQgOXscHzl4OCBX%2B1BUdFQ5exwgUCGoHBwAAAAYAAAAABKgEqAAPABsAIwA7AEMASwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JiQyFhQGIiY0JDIWFAYjIicHFhUUBiImNTQ2PwImNTQEMhYUBiImNCQyFhQGIiY0Advy3Z9fX5%2Fd8t2gXl6gAcbgv29vv%2BC%2Fb2%2F%2BLS0gIC0gAUwtICAWDg83ETNIMykfegEJ%2FoctICAtIAIdLSAgLSAEqF%2Bf3fLdoF5eoN3y3Z9Xb7%2Fgv29vv%2BC%2FBiAtISEtICAtIQqRFxwkMzMkIDEFfgEODhekIC0gIC0gIC0gIC0AAf%2FYAFoEuQS8AFsAACUBNjc2JicmIyIOAwcABw4EFx4BMzI3ATYnLgEjIgcGBwEOASY0NwA3PgEzMhceARcWBgcOBgcGIyImJyY2NwE2NzYzMhceARcWBgcBDgEnLgECIgHVWwgHdl8WGSJBMD8hIP6IDx4eLRMNBQlZN0ozAiQkEAcdEhoYDRr%2Bqw8pHA4BRyIjQS4ODyw9DQ4YIwwod26La1YOOEBGdiIwGkQB%2F0coW2tQSE5nDxE4Qv4eDyoQEAOtAdZbZWKbEQQUGjIhH%2F6JDxsdNSg3HT5CMwIkJCcQFBcMGv6uDwEcKQ4BTSIjIQEINykvYyMLKnhuiWZMBxtAOU6%2BRAH%2FSBg3ISSGV121Qv4kDwIPDyYAAAACAGQAWASvBEQAGQBEAAABPgIeAhUUDgMHLgQ1ND4CHgEFIg4DIi4DIyIGFRQeAhcWFx4EMj4DNzY3PgQ1NCYCiTB7eHVYNkN5hKg%2BPqeFeEM4WnZ4eQEjIT8yLSohJyktPyJDbxtBMjMPBw86KzEhDSIzKUAMBAgrKT8dF2oDtURIBS1TdkA5eYB%2FslVVsn%2BAeTlAdlMtBUgtJjY1JiY1NiZvTRc4SjQxDwcOPCouGBgwKEALBAkpKkQqMhNPbQACADn%2F8gR3BL4AFwAuAAAAMh8BFhUUBg8BJi8BNycBFwcvASY0NwEDNxYfARYUBwEGIi8BJjQ%2FARYfAQcXAQKru0KNQjgiHR8uEl%2F3%2FnvUaRONQkIBGxJpCgmNQkL%2B5UK6Qo1CQjcdLhJf9wGFBL5CjUJeKmsiHTUuEl%2F4%2FnvUahKNQrpCARv%2BRmkICY1CukL%2B5UJCjUK7Qjc3LxFf%2BAGFAAAAAAMAyAAAA%2BgEsAARABUAHQAAADIeAhURFAYjISImNRE0PgEHESERACIGFBYyNjQCBqqaZDo7Kf2oKTs8Zj4CWP7%2FVj09Vj0EsB4uMhX8Ryk7OykDuRUzLar9RAK8%2FRY9Vj09VgABAAAAAASwBLAAFgAACQEWFAYiLwEBEScBBRMBJyEBJyY0NjIDhgEbDx0qDiT%2B6dT%2BzP7oywEz0gEsAQsjDx0qBKH%2B5g8qHQ8j%2FvX%2B1NL%2BzcsBGAE01AEXJA4qHQAAAAADAScAEQQJBOAAMgBAAEsAAAEVHgQXIy4DJxEXHgQVFAYHFSM1JicuASczHgEXEScuBDU0PgI3NRkBDgMVFB4DFxYXET4ENC4CArwmRVI8LAKfBA0dMydAIjxQNyiym2SWVygZA4sFV0obLkJOMCAyVWg6HSoqFQ4TJhkZCWgWKTEiGBkzNwTgTgUTLD9pQiQuLBsH%2Fs0NBxMtPGQ%2Bi6oMTU8QVyhrVk1iEAFPCA4ZLzlYNkZwSCoGTf4SARIEDh02Jh0rGRQIBgPQ%2FsoCCRYgNEM0JRkAAAABAGQAZgOUBK0ASgAAATIeARUjNC4CIyIGBwYVFB4BFxYXMxUjFgYHBgc%2BATM2FjMyNxcOAyMiLgEHDgEPASc%2BBTc%2BAScjNTMmJy4CPgE3NgIxVJlemSc8OxolVBQpGxoYBgPxxQgVFS02ImIWIIwiUzUyHzY4HCAXanQmJ1YYFzcEGAcTDBEJMAwk3aYXFQcKAg4tJGEErVCLTig%2FIhIdFSw5GkowKgkFZDKCHj4yCg8BIh6TExcIASIfBAMaDAuRAxAFDQsRCjePR2QvORQrREFMIVgAAAACABn%2F%2FwSXBLAADwAfAAABMzIWDwEGIi8BJjY7AREzBRcWBisBESMRIyImPwE2MgGQlhUIDuYOKg7mDggVlsgCF%2BYOCBWWyJYVCA7mDioBLBYO%2Bg8P%2Bg4WA4QQ%2BQ4V%2FHwDhBUO%2BQ8AAAQAGf%2F%2FA%2BgEsAAHABcAGwAlAAABIzUjFSMRIQEzMhYPAQYiLwEmNjsBETMFFTM1EwczFSE1NyM1IQPoZGRkASz9qJYVCA7mDioO5g4IFZbIAZFkY8jI%2FtTIyAEsArxkZAH0%2FHwWDvoPD%2FoOFgOEZMjI%2FRL6ZJb6ZAAAAAAEABn%2F%2FwPoBLAADwAZACEAJQAAATMyFg8BBiIvASY2OwERMwUHMxUhNTcjNSERIzUjFSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAljIyP7UyMgBLGRkZAEsx2QBLBYO%2Bg8P%2Bg4WA4SW%2BmSW%2BmT7UGRkAfRkyMgAAAAEABn%2F%2FwRMBLAADwAVABsAHwAAATMyFg8BBiIvASY2OwERMwEjESM1MxMjNSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAlhkZMhkZMgBLMdkASwWDvoPD%2FoOFgOE%2FgwBkGT7UGQBkGTIyAAAAAAEABn%2F%2FwRMBLAADwAVABkAHwAAATMyFg8BBiIvASY2OwERMwEjNSMRIQcVMzUDIxEjNTMBkJYVCA7mDioO5g4IFZbIArxkyAEsx2QBZGTIASwWDvoPD%2FoOFgOE%2FgxkAZBkyMj7tAGQZAAAAAAFABn%2F%2FwSwBLAADwATABcAGwAfAAABMzIWDwEGIi8BJjY7AREzBSM1MxMhNSETITUhEyE1IQGQlhUIDuYOKg7mDggVlsgB9MjIZP7UASxk%2FnABkGT%2BDAH0ASwWDvoPD%2FoOFgOEyMj%2BDMj%2BDMj%2BDMgABQAZ%2F%2F8EsASwAA8AEwAXABsAHwAAATMyFg8BBiIvASY2OwERMwUhNSEDITUhAyE1IQMjNTMBkJYVCA7mDioO5g4IFZbIAyD%2BDAH0ZP5wAZBk%2FtQBLGTIyAEsFg76Dw%2F6DhYDhMjI%2FgzI%2FgzI%2FgzIAAIAAAAABEwETAAPAB8AAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmAV4BkKK8u6P%2BcKW5uQJn%2FgwpOzspAfQpOzsETLuj%2FnClubmlAZClucg7Kf4MKTs7KQH0KTsAAAAAAwAAAAAETARMAA8AHwArAAABITIWFREUBiMhIiY1ETQ2BSEiBhURFBYzITI2NRE0JgUXFhQPAQYmNRE0NgFeAZClubml%2FnCju7wCZP4MKTs7KQH0KTs7%2Fm%2F9ERH9EBgYBEy5pf5wpbm5pQGQo7vIOyn%2BDCk7OykB9Ck7gr4MJAy%2BDAsVAZAVCwAAAAADAAAAAARMBEwADwAfACsAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFg8BBiIvASY2AV4BkKO7uaX%2BcKW5uQJn%2FgwpOzspAfQpOzv%2BFQGQFQsMvgwkDL4MCwRMvKL%2BcKW5uaUBkKO7yDsp%2FgwpOzspAfQpO8gYEP0REf0QGAAAAAMAAAAABEwETAAPAB8AKwAAASEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFFxYGIyEiJj8BNjIBXgGQpbm5pf5wo7u5Amf%2BDCk7OykB9Ck7O%2F77vgwLFf5wFQsMvgwkBEy5pf5wo7u8ogGQpbnIOyn%2BDCk7OykB9Ck7z%2F0QGBgQ%2FREAAAAAAgAAAAAFFARMAB8ANQAAASEyFhURFAYjISImPQE0NjMhMjY1ETQmIyEiJj0BNDYHARYUBwEGJj0BIyImPQE0NjsBNTQ2AiYBkKW5uaX%2BcBUdHRUBwik7Oyn%2BPhUdHb8BRBAQ%2FrwQFvoVHR0V%2BhYETLml%2FnCluR0VZBUdOykB9Ck7HRVkFR3p%2FuQOJg7%2B5A4KFZYdFcgVHZYVCgAAAQDZAAID1wSeACMAAAEXFgcGAgclMhYHIggBBwYrAScmNz4BPwEhIicmNzYANjc2MwMZCQgDA5gCASwYEQ4B%2Fvf%2B8wQMDgkJCQUCUCcn%2FtIXCAoQSwENuwUJEASeCQoRC%2F5TBwEjEv7K%2FsUFDwgLFQnlbm4TFRRWAS%2FTBhAAAAACAAAAAAT%2BBEwAHwA1AAABITIWHQEUBiMhIgYVERQWMyEyFh0BFAYjISImNRE0NgUBFhQHAQYmPQEjIiY9ATQ2OwE1NDYBXgGQFR0dFf4%2BKTs7KQHCFR0dFf5wpbm5AvEBRBAQ%2FrwQFvoVHR0V%2BhYETB0VZBUdOyn%2BDCk7HRVkFR25pQGQpbnp%2FuQOJg7%2B5A4KFZYdFcgVHZYVCgACAAAAAASwBLAAFQAxAAABITIWFREUBi8BAQYiLwEmNDcBJyY2ASMiBhURFBYzITI2PQE3ERQGIyEiJjURNDYzIQLuAZAVHRUObf7IDykPjQ8PAThtDgj%2B75wpOzspAfQpO8i7o%2F5wpbm5pQEsBLAdFf5wFQgObf7IDw%2BNDykPAThtDhX%2B1Dsp%2FgwpOzsplMj%2B1qW5uaUBkKW5AAADAA4ADgSiBKIADwAbACMAAAAyHgIUDgIiLgI0PgEEIg4BFB4BMj4BNCYEMhYUBiImNAHh7tmdXV2d2e7ZnV1dnQHD5sJxccLmwnFx%2FnugcnKgcgSiXZ3Z7tmdXV2d2e7ZnUdxwubCcXHC5sJzcqBycqAAAAMAAAAABEwEsAAVAB8AIwAAATMyFhURMzIWBwEGIicBJjY7ARE0NgEhMhYdASE1NDYFFTM1AcLIFR31FAoO%2FoEOJw3%2BhQ0JFfod%2FoUD6BUd%2B7QdA2dkBLAdFf6iFg%2F%2BVg8PAaoPFgFeFR38fB0V%2BvoVHWQyMgAAAAMAAAAABEwErAAVAB8AIwAACQEWBisBFRQGKwEiJj0BIyImNwE%2BAQEhMhYdASE1NDYFFTM1AkcBeg4KFfQiFsgUGPoUCw4Bfw4n%2FfkD6BUd%2B7QdA2dkBJ7%2BTQ8g%2BhQeHRX6IQ8BrxAC%2FH8dFfr6FR1kMjIAAwAAAAAETARLABQAHgAiAAAJATYyHwEWFAcBBiInASY0PwE2MhcDITIWHQEhNTQ2BRUzNQGMAXEHFQeLBwf98wcVB%2F7cBweLCBUH1APoFR37tB0DZ2QC0wFxBweLCBUH%2FfMICAEjCBQIiwcH%2FdIdFfr6FR1kMjIABAAAAAAETASbAAkAGQAjACcAABM3NjIfAQcnJjQFNzYWFQMOASMFIiY%2FASc3ASEyFh0BITU0NgUVMzWHjg4qDk3UTQ4CFtIOFQIBHRX9qxUIDtCa1P49A%2BgVHfu0HQNnZAP%2Fjg4OTdRMDyqa0g4IFf2pFB4BFQ7Qm9T9Oh0V%2BvoVHWQyMgAAAAQAAAAABEwEsAAPABkAIwAnAAABBR4BFRMUBi8BByc3JyY2EwcGIi8BJjQ%2FAQEhMhYdASE1NDYFFTM1AV4CVxQeARUO0JvUm9IOCMNMDyoOjg4OTf76A%2BgVHfu0HQNnZASwAgEdFf2rFQgO0JrUmtIOFf1QTQ4Ojg4qDk3%2BWB0V%2BvoVHWQyMgACAAT%2F7ASwBK8ABQAIAAAlCQERIQkBFQEEsP4d%2Fsb%2BcQSs%2FTMCq2cBFP5xAacDHPz55gO5AAAAAAIAAABkBEwEsAAVABkAAAERFAYrAREhESMiJjURNDY7AREhETMHIzUzBEwdFZb9RJYVHR0V%2BgH0ZMhkZAPo%2FK4VHQGQ%2FnAdFQPoFB7%2B1AEsyMgAAAMAAABFBN0EsAAWABoALwAAAQcBJyYiDwEhESMiJjURNDY7AREhETMHIzUzARcWFAcBBiIvASY0PwE2Mh8BATYyBEwC%2FtVfCRkJlf7IlhUdHRX6AfRkyGRkAbBqBwf%2BXAgUCMoICGoHFQdPASkHFQPolf7VXwkJk%2F5wHRUD6BQe%2FtQBLMjI%2Fc5qBxUH%2FlsHB8sHFQdqCAhPASkHAAMAAAANBQcEsAAWABoAPgAAAREHJy4BBwEhESMiJjURNDY7AREhETMHIzUzARcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyBExnhg8lEP72%2FreWFR0dFfoB9GTIZGQB9kYPD4ODDw9GDykPg4MPKQ9GDw%2BDgw8PRg8pD4ODDykD6P7zZ4YPAw7%2B9v5wHRUD6BQe%2FtQBLMjI%2FYxGDykPg4MPKQ9GDw%2BDgw8PRg8pD4ODDykPRg8Pg4MPAAADAAAAFQSXBLAAFQAZAC8AAAERISIGHQEhESMiJjURNDY7AREhETMHIzUzEzMyFh0BMzIWDwEGIi8BJjY7ATU0NgRM%2FqIVHf4MlhUdHRX6AfRkyGRklmQVHZYVCA7mDioO5g4IFZYdA%2Bj%2B1B0Vlv5wHRUD6BQe%2FtQBLMjI%2FagdFfoVDuYODuYOFfoVHQAAAAADAAAAAASXBLAAFQAZAC8AAAERJyYiBwEhESMiJjURNDY7AREhETMHIzUzExcWBisBFRQGKwEiJj0BIyImPwE2MgRMpQ4qDv75%2Fm6WFR0dFfoB9GTIZGTr5g4IFZYdFWQVHZYVCA7mDioD6P5wpQ8P%2Fvf%2BcB0VA%2BgUHv7UASzIyP2F5Q8V%2BhQeHhT6FQ%2FlDwADAAAAyASwBEwACQATABcAABMhMhYdASE1NDYBERQGIyEiJjURExUhNTIETBUd%2B1AdBJMdFfu0FR1kAZAETB0VlpYVHf7U%2FdoVHR0VAib%2B1MjIAAAGAAMAfQStBJcADwAZAB0ALQAxADsAAAEXFhQPAQYmPQEhNSE1NDYBIyImPQE0NjsBFyM1MwE3NhYdASEVIRUUBi8BJjQFIzU7AjIWHQEUBisBA6f4Dg74DhX%2BcAGQFf0vMhUdHRUyyGRk%2FoL3DhUBkP5wFQ73DwOBZGRkMxQdHRQzBI3mDioO5g4IFZbIlhUI%2FoUdFWQVHcjI%2FcvmDggVlsiWFQgO5g4qecgdFWQVHQAAAAACAGQAAASwBLAAFgBRAAABJTYWFREUBisBIiY1ES4ENRE0NiUyFh8BERQOAg8BERQGKwEiJjURLgQ1ETQ%2BAzMyFh8BETMRPAE%2BAjMyFh8BETMRND4DA14BFBklHRXIFR0EDiIaFiX%2B4RYZAgEVHR0LCh0VyBUdBA4iGhYBBwoTDRQZAgNkBQkVDxcZAQFkAQUJFQQxdBIUH%2FuuFR0dFQGNAQgbHzUeAWcfRJEZDA3%2BPhw%2FMSkLC%2F5BFR0dFQG%2FBA8uLkAcAcICBxENCxkMDf6iAV4CBxENCxkMDf6iAV4CBxENCwABAGQAAASwBEwAMwAAARUiDgMVERQWHwEVITUyNjURIREUFjMVITUyPgM1ETQmLwE1IRUiBhURIRE0JiM1BLAEDiIaFjIZGf5wSxn%2BDBlL%2FnAEDiIaFjIZGQGQSxkB9BlLBEw4AQUKFA78iBYZAQI4OA0lAYr%2BdiUNODgBBQoUDgN4FhkBAjg4DSX%2BdgGKJQ04AAAABgAAAAAETARMAAwAHAAgACQAKAA0AAABITIWHQEjBTUnITchBSEyFhURFAYjISImNRE0NhcVITUBBTUlBRUhNQUVFAYjIQchJyE3MwKjAXcVHWn%2B2cj%2BcGQBd%2F4lASwpOzsp%2FtQpOzspASwCvP5wAZD8GAEsArwdFf6JZP6JZAGQyGkD6B0VlmJiyGTIOyn%2BDCk7OykB9Ck7ZMjI%2FveFo4XGyMhm%2BBUdZGTIAAEAEAAQBJ8EnwAmAAATNzYWHwEWBg8BHgEXNz4BHwEeAQ8BBiIuBicuBTcRohEuDosOBhF3ZvyNdxEzE8ATBxGjAw0uMUxPZWZ4O0p3RjITCwED76IRBhPCFDERdo78ZXYRBA6IDi8RogEECBUgNUNjO0qZfHNVQBAAAAACAAAAAASwBEwAIwBBAAAAMh4EHwEVFAYvAS4BPQEmIAcVFAYPAQYmPQE%2BBRIyHgIfARUBHgEdARQGIyEiJj0BNDY3ATU0PgIB%2FLimdWQ%2FLAkJHRTKFB2N%2FsKNHRTKFB0DDTE7ZnTKcFImFgEBAW0OFR0V%2B7QVHRUOAW0CFiYETBUhKCgiCgrIFRgDIgMiFZIYGJIVIgMiAxgVyAQNJyQrIP7kExwcCgoy%2FtEPMhTUFR0dFdQUMg8BLzIEDSEZAAADAAAAAASwBLAADQAdACcAAAEHIScRMxUzNTMVMzUzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYETMj9qMjIyMjIyPyuArwVHR0VDIn8SokMFR0dswRMFR37UB0CvMjIAfTIyMjI%2FOAdKh1kZB0qHf7UHRUyMhUdAAAAAwBkAAAEsARMAAkAEwAdAAABIyIGFREhETQmASMiBhURIRE0JgEhETQ2OwEyFhUCvGQpOwEsOwFnZCk7ASw7%2FRv%2B1DspZCk7BEw7KfwYA%2BgpO%2F7UOyn9RAK8KTv84AGQKTs7KQAAAAAF%2F5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQURByMRMwcRMxHIArx8sLB8%2FUR8sLAYA4T%2BDMjI%2FtTIyAEsAZBkyMhkZARMsHz%2BDHywsHwB9HywyP1EArzIZP7UZGQBLGT%2B1GQB9GT%2B1AEsAAAABf%2BcAAAEsARMAA8AEwAfACUAKQAAEyEyFhURFAYjISImNRE0NhcRIREBIzUjFSMRMxUzNTMFEQcjETMHETMRyAK8fLCwfP1EfLCwGAOE%2FgxkZGRkZGQBkGTIyGRkBEywfP4MfLCwfAH0fLDI%2FUQCvP2oyMgB9MjIZP7UZAH0ZP7UASwABP%2BcAAAEsARMAA8AEwAbACMAABMhMhYVERQGIyEiJjURNDYXESERBSMRMxUhESEFIxEzFSERIcgCvHywsHz9RHywsBgDhP4MyMj%2B1AEsAZDIyP7UASwETLB8%2Fgx8sLB8AfR8sMj9RAK8yP7UZAH0ZP7UZAH0AAAABP%2BcAAAEsARMAA8AEwAWABkAABMhMhYVERQGIyEiJjURNDYXESERAS0BDQERyAK8fLCwfP1EfLCwGAOE%2Fgz%2B1AEsAZD%2B1ARMsHz%2BDHywsHwB9HywyP1EArz%2BDJaWlpYBLAAAAAX%2FnAAABLAETAAPABMAFwAgACkAABMhMhYVERQGIyEiJjURNDYXESERAyERIQcjIgYVFBY7AQERMzI2NTQmI8gCvHywsHz9RHywsBgDhGT9RAK8ZIImOTYpgv4Mgik2OSYETLB8%2Fgx8sLB8AfR8sMj9RAK8%2FagB9GRWQUFUASz%2B1FRBQVYAAAAF%2F5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQEjESM1MwMjNTPIArx8sLB8%2FUR8sLAYA4T%2BDMjI%2FtTIyAEsAZBkZMjIZGQETLB8%2Fgx8sLB8AfR8sMj9RAK8yGT%2B1GRkASz%2BDAGQZP4MZAAG%2F5wAAASwBEwADwATABkAHwAjACcAABMhMhYVERQGIyEiJjURNDYXESERBTMRIREzASMRIzUzBRUzNQEjNTPIArx8sLB8%2FUR8sLAYA4T9RMj%2B1GQCWGRkyP2oZAEsZGQETLB8%2Fgx8sLB8AfR8sMj9RAK8yP5wAfT%2BDAGQZMjIyP7UZAAF%2F5wAAASwBEwADwATABwAIgAmAAATITIWFREUBiMhIiY1ETQ2FxEhEQEHIzU3NSM1IQEjESM1MwMjNTPIArx8sLB8%2FUR8sLAYA4T%2BDMdkx8gBLAGQZGTIx2RkBEywfP4MfLCwfAH0fLDI%2FUQCvP5wyDLIlmT%2BDAGQZP4MZAAAAAMACQAJBKcEpwAPABsAJQAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgchFSEVISc1NyEB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWz%2B1AEs%2FtRkZAEsBKdentvw255eXp7b8NueTHHC5MJxccLkwtDIZGTIZAAAAAAEAAkACQSnBKcADwAbACcAKwAAADIeAhQOAiIuAjQ%2BAQQiDgEUHgEyPgE0JgcVBxcVIycjFSMRIQcVMzUB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWwyZGRklmQBLMjIBKdentvw255eXp7b8NueTHHC5MJxccLkwtBkMmQyZGQBkGRkZAAAAv%2Fy%2F50EwgRBACAANgAAATIWFzYzMhYUBisBNTQmIyEiBh0BIyImNTQ2NyY1ND4BEzMyFhURMzIWDwEGIi8BJjY7ARE0NgH3brUsLC54qqp4gB0V%2FtQVHd5QcFZBAmKqepYKD4kVCg3fDSYN3w0KFYkPBEF3YQ6t8a36FR0dFfpzT0VrDhMSZKpi%2FbMPCv7tFxD0EBD0EBcBEwoPAAAAAAL%2F8v%2BcBMMEQQAcADMAAAEyFhc2MzIWFxQGBwEmIgcBIyImNTQ2NyY1ND4BExcWBisBERQGKwEiJjURIyImNzY3NjIB9m62LCsueaoBeFr%2Bhg0lDf6DCU9xVkECYqnm3w0KFYkPCpYKD4kVCg3HGBMZBEF3YQ%2BteGOkHAFoEBD%2Bk3NPRWsOExNkqWP9kuQQF%2F7tCg8PCgETFxDMGBMAAAABAGQAAARMBG0AGAAAJTUhATMBMwkBMwEzASEVIyIGHQEhNTQmIwK8AZD%2B8qr%2B8qr%2B1P7Uqv7yqv7yAZAyFR0BkB0VZGQBLAEsAU3%2Bs%2F7U%2FtRkHRUyMhUdAAAAAAEAeQAABDcEmwAvAAABMhYXHgEVFAYHFhUUBiMiJxUyFh0BITU0NjM1BiMiJjU0Ny4BNTQ2MzIXNCY1NDYCWF6TGll7OzIJaUo3LRUd%2FtQdFS03SmkELzlpSgUSAqMEm3FZBoNaPWcfHRpKaR77HRUyMhUd%2Bx5pShIUFVg1SmkCAhAFdKMAAAAGACcAFASJBJwAEQAqAEIASgBiAHsAAAEWEgIHDgEiJicmAhI3PgEyFgUiBw4BBwYWHwEWMzI3Njc2Nz4BLwEmJyYXIgcOAQcGFh8BFjMyNz4BNz4BLwEmJyYWJiIGFBYyNjciBw4BBw4BHwEWFxYzMjc%2BATc2Ji8BJhciBwYHBgcOAR8BFhcWMzI3PgE3NiYvASYD8m9PT29T2dzZU29PT29T2dzZ%2Fj0EBHmxIgQNDCQDBBcGG0dGYAsNAwkDCwccBAVQdRgEDA0iBAQWBhJROQwMAwkDCwf5Y4xjY4xjVhYGElE6CwwDCQMLBwgEBVB1GAQNDCIEjRcGG0dGYAsNAwkDCwcIBAR5sSIEDQwkAwPyb%2F7V%2FtVvU1dXU28BKwErb1NXVxwBIrF5DBYDCQEWYEZHGwMVDCMNBgSRAhh1UA0WAwkBFTpREgMVCyMMBwT6Y2OMY2MVFTpREQQVCyMMBwQCGHVQDRYDCQEkFmBGRxsDFQwjDQYEASKxeQwWAwkBAAAABQBkAAAD6ASwAAwADwAWABwAIgAAASERIzUhFSERNDYzIQEjNQMzByczNTMDISImNREFFRQGKwECvAEstP6s%2FoQPCgI%2FASzIZKLU1KJktP51Cg8DhA8KwwMg%2FoTIyALzCg%2F%2B1Mj84NTUyP4MDwoBi8jDCg8AAAAABQBkAAAD6ASwAAkADAATABoAIQAAASERCQERNDYzIQEjNRMjFSM1IzcDISImPQEpARUUBisBNQK8ASz%2Bov3aDwoCPwEsyD6iZKLUqv6dCg8BfAIIDwqbAyD9%2BAFe%2FdoERwoP%2FtTI%2FHzIyNT%2BZA8KNzcKD1AAAAAAAwAAAAAEsAP0AAgAGQAfAAABIxUzFyERIzcFMzIeAhUhFSEDETM0PgIBMwMhASEEiqJkZP7UotT9EsgbGiEOASz9qMhkDiEaAnPw8PzgASwB9AMgyGQBLNTUBBErJGT%2BogHCJCsRBP5w%2FnAB9AAAAAMAAAAABEwETAAZADIAOQAAATMyFh0BMzIWHQEUBiMhIiY9ATQ2OwE1NDYFNTIWFREUBiMhIic3ARE0NjMVFBYzITI2AQc1IzUzNQKKZBUdMhUdHRX%2B1BUdHRUyHQFzKTs7Kf2oARP2%2Fro7KVg%2BASw%2BWP201MjIBEwdFTIdFWQVHR0VZBUdMhUd%2BpY7KfzgKTsE9gFGAUQpO5Y%2BWFj95tSiZKIAAwBkAAAEvARMABkANgA9AAABMzIWHQEzMhYdARQGIyEiJj0BNDY7ATU0NgU1MhYVESMRMxQOAiMhIiY1ETQ2MxUUFjMhMjYBBzUjNTM1AcJkFR0yFR0dFf7UFR0dFTIdAXMpO8jIDiEaG%2F2oKTs7KVg%2BASw%2BWAGc1MjIBEwdFTIdFWQVHR0VZBUdMhUd%2BpY7Kf4M%2FtQkKxEEOykDICk7lj5YWP3m1KJkogAAAAP%2FogAABRYE1AALABsAHwAACQEWBiMhIiY3ATYyEyMiBhcTHgE7ATI2NxM2JgMVMzUCkgJ9FyAs%2BwQsIBcCfRZARNAUGAQ6BCMUNhQjBDoEGODIBK37sCY3NyYEUCf%2BTB0U%2FtIUHR0UAS4UHf4MZGQAAAAACQAAAAAETARMAA8AHwAvAD8ATwBfAG8AfwCPAAABMzIWHQEUBisBIiY9ATQ2EzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBqfoKDw8K%2BgoPDwr6Cg8PCvoKDw8BmvoKDw8K%2BgoPD%2Fzq%2BgoPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K%2BgoPD%2Fzq%2BgoPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K%2BgoPDwRMDwqWCg8PCpYKD%2F7UDwqWCg8PCpYKDw8KlgoPDwqWCg%2F%2B1A8KlgoPDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKD%2F7UDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKDw8KlgoPAAAAAwAAAAAEsAUUABkAKQAzAAABMxUjFSEyFg8BBgchJi8BJjYzITUjNTM1MwEhMhYUBisBFyE3IyImNDYDITIWHQEhNTQ2ArxkZAFePjEcQiko%2FPwoKUIcMT4BXmRkyP4%2BArwVHR0VDIn8SooNFR0dswRMFR37UB0EsMhkTzeEUzMzU4Q3T2TIZPx8HSodZGQdKh3%2B1B0VMjIVHQAABAAAAAAEsAUUAAUAGQArADUAAAAyFhUjNAchFhUUByEyFg8BIScmNjMhJjU0AyEyFhQGKwEVBSElNSMiJjQ2AyEyFh0BITU0NgIwUDnCPAE6EgMBSCkHIq%2F9WrIiCikBSAOvArwVHR0VlgET%2FEoBE5YVHR2zBEwVHftQHQUUOykpjSUmCBEhFpGRFiERCCb%2BlR0qHcjIyMgdKh39qB0VMjIVHQAEAAAAAASwBJ0ABwAUACQALgAAADIWFAYiJjQTMzIWFRQXITY1NDYzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYCDZZqapZqty4iKyf%2BvCcrI%2F7NArwVHR0VDYr8SokMFR0dswRMFR37UB0EnWqWamqW%2Fus5Okxra0w6Of5yHSodZGQdKh3%2B1B0VMjIVHQAEAAAAAASwBRQADwAcACwANgAAATIeARUUBiImNTQ3FzcnNhMzMhYVFBchNjU0NjMBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYL1szb5xvIpBvoyIfLiIrJ%2F68Jysj%2Fs0CvBUdHRUNivxKiQwVHR2zBEwVHftQHQUUa4s2Tm9vTj5Rj2%2BjGv4KOTpMa2tMOjn%2Bch0qHWRkHSod%2FtQdFTIyFR0AAAADAAAAAASwBRIAEgAiACwAAAEFFSEUHgMXIS4BNTQ%2BAjcBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYASz%2B1CU%2FP00T%2Fe48PUJtj0r%2BogK8FR0dFQ2K%2FEqJDBUdHbMETBUd%2B1AdBLChizlmUT9IGVO9VFShdksE%2FH4dKh1kZB0qHf7UHRUyMhUdAAIAyAAAA%2BgFFAAPACkAAAAyFh0BHgEdASE1NDY3NTQDITIWFyMVMxUjFTMVIxUzFAYjISImNRE0NgIvUjsuNv5wNi5kAZA2XBqsyMjIyMh1U%2F5wU3V1BRQ7KU4aXDYyMjZcGk4p%2Fkc2LmRkZGRkU3V1UwGQU3UAAAMAZP%2F%2FBEwETAAPAC8AMwAAEyEyFhURFAYjISImNRE0NgMhMhYdARQGIyEXFhQGIi8BIQcGIiY0PwEhIiY9ATQ2BQchJ5YDhBUdHRX8fBUdHQQDtgoPDwr%2B5eANGiUNWP30Vw0mGg3g%2Ft8KDw8BqmQBRGQETB0V%2FgwVHR0VAfQVHf1EDwoyCg%2FgDSUbDVhYDRslDeAPCjIKD2RkZAAAAAAEAAAAAASwBEwAGQAjAC0ANwAAEyEyFh0BIzQmKwEiBhUjNCYrASIGFSM1NDYDITIWFREhETQ2ExUUBisBIiY9ASEVFAYrASImPQHIAyBTdWQ7KfopO2Q7KfopO2R1EQPoKTv7UDvxHRVkFR0D6B0VZBUdBEx1U8gpOzspKTs7KchTdf4MOyn%2B1AEsKTv%2BDDIVHR0VMjIVHR0VMgADAAEAAASpBKwADQARABsAAAkBFhQPASEBJjQ3ATYyCQMDITIWHQEhNTQ2AeACqh8fg%2F4f%2FfsgIAEnH1n%2BrAFWAS%2F%2Bq6IDIBUd%2FHwdBI39VR9ZH4MCBh9ZHwEoH%2F5u%2FqoBMAFV%2FBsdFTIyFR0AAAAAAgCPAAAEIQSwABcALwAAAQMuASMhIgYHAwYWMyEVFBYyNj0BMzI2AyE1NDY7ATU0NjsBETMRMzIWHQEzMhYVBCG9CCcV%2FnAVJwi9CBMVAnEdKh19FROo%2Fa0dFTIdFTDILxUdMhUdAocB%2BhMcHBP%2BBhMclhUdHRWWHP2MMhUdMhUdASz%2B1B0VMh0VAAAEAAAAAASwBLAADQAQAB8AIgAAASERFAYjIREBNTQ2MyEBIzUBIREUBiMhIiY1ETQ2MyEBIzUDhAEsDwr%2Bif7UDwoBdwEsyP2oASwPCv12Cg8PCgF3ASzIAyD9wQoPAk8BLFQKD%2F7UyP4M%2FcEKDw8KA7YKD%2F7UyAAC%2F5wAZAUUBEcARgBWAAABMzIeAhcWFxY2NzYnJjc%2BARYXFgcOASsBDgEPAQ4BKwEiJj8BBisBIicHDgErASImPwEmLwEuAT0BNDY7ATY3JyY2OwE2BSMiBh0BFBY7ATI2PQE0JgHkw0uOakkMEhEfQwoKGRMKBQ8XDCkCA1Y9Pgc4HCcDIhVkFRgDDDEqwxgpCwMiFWQVGAMaVCyfExwdFXwLLW8QBxXLdAFF%2BgoPDwr6Cg8PBEdBa4pJDgYKISAiJRsQCAYIDCw9P1c3fCbqFB0dFEYOCEAUHR0UnUplNQcmFTIVHVdPXw4TZV8PCjIKDw8KMgoPAAb%2FnP%2FmBRQEfgAJACQANAA8AFIAYgAAASU2Fh8BFgYPASUzMhYfASEyFh0BFAYHBQYmJyYjISImPQE0NhcjIgYdARQ7ATI2NTQmJyYEIgYUFjI2NAE3PgEeARceAT8BFxYGDwEGJi8BJjYlBwYfAR4BPwE2Jy4BJy4BAoEBpxMuDiAOAxCL%2FCtqQ0geZgM3FR0cE%2F0fFyIJKjr%2B1D5YWLlQExIqhhALIAsSAYBALS1ALf4PmBIgHhMQHC0aPzANITNQL3wpgigJASlmHyElDR0RPRMFAhQHCxADhPcICxAmDyoNeMgiNtQdFTIVJgeEBBQPQ1g%2ByD5YrBwVODMQEAtEERzJLUAtLUD%2B24ITChESEyMgAwWzPUkrRSgJL5cvfRxYGyYrDwkLNRAhFEgJDAQAAAAAAwBkAAAEOQSwAFEAYABvAAABMzIWHQEeARcWDgIPATIeBRUUDgUjFRQGKwEiJj0BIxUUBisBIiY9ASMiJj0BNDY7AREjIiY9ATQ2OwE1NDY7ATIWHQEzNTQ2AxUhMj4CNTc0LgMjARUhMj4CNTc0LgMjAnGWCg9PaAEBIC4uEBEGEjQwOiodFyI2LUAjGg8KlgoPZA8KlgoPrwoPDwpLSwoPDwqvDwqWCg9kD9cBBxwpEwsBAQsTKRz%2B%2BQFrHCkTCwEBCxMpHASwDwptIW1KLk0tHwYGAw8UKDJOLTtdPCoVCwJLCg8PCktLCg8PCksPCpYKDwJYDwqWCg9LCg8PCktLCg%2F%2B1MgVHR0LCgQOIhoW%2FnDIFR0dCwoEDiIaFgAAAwAEAAIEsASuABcAKQAsAAATITIWFREUBg8BDgEjISImJy4CNRE0NgQiDgQPARchNy4FAyMT1AMMVnokEhIdgVL9xFKCHAgYKHoCIIx9VkcrHQYGnAIwnAIIIClJVSGdwwSuelb%2BYDO3QkJXd3ZYHFrFMwGgVnqZFyYtLSUMDPPzBQ8sKDEj%2FsIBBQACAMgAAAOEBRQADwAZAAABMzIWFREUBiMhIiY1ETQ2ARUUBisBIiY9AQHblmesVCn%2BPilUrAFINhWWFTYFFKxn%2FgwpVFQpAfRnrPwY4RU2NhXhAAACAMgAAAOEBRQADwAZAAABMxQWMxEUBiMhIiY1ETQ2ARUUBisBIiY9AQHbYLOWVCn%2BPilUrAFINhWWFTYFFJaz%2FkIpVFQpAfRnrPwY4RU2NhXhAAACAAAAFAUOBBoAFAAaAAAJASUHFRcVJwc1NzU0Jj4CPwEnCQEFJTUFJQUO%2FYL%2Bhk5klpZkAQEBBQQvkwKCAVz%2Bov6iAV4BXgL%2F%2FuWqPOCWx5SVyJb6BA0GCgYDKEEBG%2F1ipqaTpaUAAAMAZAH0BLADIAAHAA8AFwAAEjIWFAYiJjQkMhYUBiImNCQyFhQGIiY0vHxYWHxYAeh8WFh8WAHofFhYfFgDIFh8WFh8WFh8WFh8WFh8WFh8AAAAAAMBkAAAArwETAAHAA8AFwAAADIWFAYiJjQSMhYUBiImNBIyFhQGIiY0Aeh8WFh8WFh8WFh8WFh8WFh8WARMWHxYWHz%2ByFh8WFh8%2FshYfFhYfAAAAAMAZABkBEwETAAPAB8ALwAAEyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2fQO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PBEwPCpYKDw8KlgoP%2FnAPCpYKDw8KlgoP%2FnAPCpYKDw8KlgoPAAAABAAAAAAEsASwAA8AHwAvADMAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFhURFAYjISImNRE0NhcVITUBXgH0ory7o%2F4Mpbm5Asv9qCk7OykCWCk7O%2F2xAfQVHR0V%2FgwVHR1HAZAEsLuj%2FgylubmlAfSlucg7Kf2oKTs7KQJYKTtkHRX%2B1BUdHRUBLBUdZMjIAAAAAAEAZABkBLAETAA7AAATITIWFAYrARUzMhYUBisBFTMyFhQGKwEVMzIWFAYjISImNDY7ATUjIiY0NjsBNSMiJjQ2OwE1IyImNDaWA%2BgVHR0VMjIVHR0VMjIVHR0VMjIVHR0V%2FBgVHR0VMjIVHR0VMjIVHR0VMjIVHR0ETB0qHcgdKh3IHSodyB0qHR0qHcgdKh3IHSodyB0qHQAAAAYBLAAFA%2BgEowAHAA0AEwAZAB8AKgAAAR4BBgcuATYBMhYVIiYlFAYjNDYBMhYVIiYlFAYjNDYDFRQGIiY9ARYzMgKKVz8%2FV1c%2FP%2F75fLB8sAK8sHyw%2FcB8sHywArywfLCwHSodKAMRBKNDsrJCQrKy%2FsCwfLB8fLB8sP7UsHywfHywfLD%2B05AVHR0VjgQAAAH%2FtQDIBJQDgQBCAAABNzYXAR4BBw4BKwEyFRQOBCsBIhE0NyYiBxYVECsBIi4DNTQzIyImJyY2NwE2HwEeAQ4BLwEHIScHBi4BNgLpRRkUASoLCAYFGg8IAQQNGyc%2FKZK4ChRUFQu4jjBJJxkHAgcPGQYGCAsBKhQaTBQVCiMUM7YDe7YsFCMKFgNuEwYS%2FtkLHw8OEw0dNkY4MhwBIBgXBAQYF%2F7gKjxTQyMNEw4PHwoBKBIHEwUjKBYGDMHBDAUWKCMAAAAAAgAAAAAEsASwACUAQwAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjNC4DKwERFBYXMxUjNTI1ESMiDgMVIzUhBLAyCAsZEyYYGcgyGRn%2BcAQOIhoWyBkYJhMZCwgyA%2Bj9RBkIChgQEWQZDQzIMmQREBgKCBkB9AOEFSAVDggDAfyuFhkBAmRkAQUJFQ4DUgEDCA4VIBUBLP0SDxMKBQH%2BVwsNATIyGQGpAQUKEw%2BWAAAAAAMAAAAABEwErgAdACAAMAAAATUiJy4BLwEBIwEGBw4BDwEVITUiJj8BIRcWBiMVARsBARUUBiMhIiY9ATQ2MyEyFgPoGR4OFgUE%2Ft9F%2FtQSFQkfCwsBETE7EkUBJT0NISf%2B7IZ5AbEdFfwYFR0dFQPoFR0BLDIgDiIKCwLr%2FQ4jFQkTBQUyMisusKYiQTIBhwFW%2Fqr942QVHR0VZBUdHQADAAAAAASwBLAADwBHAEoAABMhMhYVERQGIyEiJjURNDYFIyIHAQYHBgcGHQEUFjMhMjY9ATQmIyInJj8BIRcWBwYjIgYdARQWMyEyNj0BNCYnIicmJyMBJhMjEzIETBUdHRX7tBUdHQJGRg0F%2FtUREhImDAsJAREIDAwINxAKCj8BCjkLEQwYCAwMCAE5CAwLCBEZGQ8B%2FuAFDsVnBLAdFfu0FR0dFQRMFR1SDP0PIBMSEAUNMggMDAgyCAwXDhmjmR8YEQwIMggMDAgyBwwBGRskAuwM%2FgUBCAAABAAAAAAEsASwAAMAEwAjACcAAAEhNSEFITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NhcRIREEsPtQBLD7ggGQFR0dFf5wFR0dAm0BkBUdHRX%2BcBUdHUcBLARMZMgdFfx8FR0dFQOEFR0dFf5wFR0dFQGQFR1k%2FtQBLAAEAAAAAASwBLAADwAfACMAJwAAEyEyFhURFAYjISImNRE0NgEhMhYVERQGIyEiJjURNDYXESEREyE1ITIBkBUdHRX%2BcBUdHQJtAZAVHR0V%2FnAVHR1HASzI%2B1AEsASwHRX8fBUdHRUDhBUd%2FgwdFf5wFR0dFQGQFR1k%2FtQBLP2oZAAAAAACAAAAZASwA%2BgAJwArAAATITIWFREzNTQ2MyEyFh0BMxUjFRQGIyEiJj0BIxEUBiMhIiY1ETQ2AREhETIBkBUdZB0VAZAVHWRkHRX%2BcBUdZB0V%2FnAVHR0CnwEsA%2BgdFf6ilhUdHRWWZJYVHR0Vlv6iFR0dFQMgFR3%2B1P7UASwAAAQAAAAABLAEsAADABMAFwAnAAAzIxEzFyEyFhURFAYjISImNRE0NhcRIREBITIWFREUBiMhIiY1ETQ2ZGRklgGQFR0dFf5wFR0dRwEs%2FqIDhBUdHRX8fBUdHQSwZB0V%2FnAVHR0VAZAVHWT%2B1AEs%2FgwdFf5wFR0dFQGQFR0AAAAAAgBkAAAETASwACcAKwAAATMyFhURFAYrARUhMhYVERQGIyEiJjURNDYzITUjIiY1ETQ2OwE1MwcRIRECWJYVHR0VlgHCFR0dFfx8FR0dFQFelhUdHRWWZMgBLARMHRX%2BcBUdZB0V%2FnAVHR0VAZAVHWQdFQGQFR1kyP7UASwAAAAEAAAAAASwBLAAAwATABcAJwAAISMRMwUhMhYVERQGIyEiJjURNDYXESERASEyFhURFAYjISImNRE0NgSwZGT9dgGQFR0dFf5wFR0dRwEs%2FK4DhBUdHRX8fBUdHQSwZB0V%2FnAVHR0VAZAVHWT%2B1AEs%2FgwdFf5wFR0dFQGQFR0AAAEBLAAwA28EgAAPAAAJAQYjIiY1ETQ2MzIXARYUA2H%2BEhcSDhAQDhIXAe4OAjX%2BEhcbGQPoGRsX%2FhIOKgAAAAABAUEAMgOEBH4ACwAACQE2FhURFAYnASY0AU8B7h0qKh3%2BEg4CewHuHREp%2FBgpER0B7g4qAAAAAAEAMgFBBH4DhAALAAATITIWBwEGIicBJjZkA%2BgpER3%2BEg4qDv4SHREDhCod%2FhIODgHuHSoAAAAAAQAyASwEfgNvAAsAAAkBFgYjISImNwE2MgJ7Ae4dESn8GCkRHQHuDioDYf4SHSoqHQHuDgAAAAACAAgAAASwBCgABgAKAAABFQE1LQE1ASE1IQK8%2FUwBnf5jBKj84AMgAuW2%2Fr3dwcHd%2B9jIAAAAAAIAAABkBLAEsAALADEAAAEjFTMVIREzNSM1IQEzND4FOwERFAYPARUhNSIuAzURMzIeBRUzESEEsMjI%2FtTIyAEs%2B1AyCAsZEyYYGWQyGRkBkAQOIhoWZBkYJhMZCwgy%2FOADhGRkASxkZP4MFSAVDggDAf3aFhkBAmRkAQUJFQ4CJgEDCA4VIBUBLAAAAgAAAAAETAPoACUAMQAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjFTMVIREzNSM1IQMgMggLGRMmGBlkMhkZ%2FnAEDiIaFmQZGCYTGQsIMgMgASzIyP7UyMgBLAK8FSAVDggDAf3aFhkCAWRkAQUJFQ4CJgEDCA4VIBUBLPzgZGQBLGRkAAABAMgAZgNyBEoAEgAAATMyFgcJARYGKwEiJwEmNDcBNgK9oBAKDP4wAdAMChCgDQr%2BKQcHAdcKBEoWDP4w%2FjAMFgkB1wgUCAHXCQAAAQE%2BAGYD6ARKABIAAAEzMhcBFhQHAQYrASImNwkBJjYBU6ANCgHXBwf%2BKQoNoBAKDAHQ%2FjAMCgRKCf4pCBQI%2FikJFgwB0AHQDBYAAAEAZgDIBEoDcgASAAAAFh0BFAcBBiInASY9ATQ2FwkBBDQWCf4pCBQI%2FikJFgwB0AHQA3cKEKANCv4pBwcB1woNoBAKDP4wAdAAAAABAGYBPgRKA%2BgAEgAACQEWHQEUBicJAQYmPQE0NwE2MgJqAdcJFgz%2BMP4wDBYJAdcIFAPh%2FikKDaAQCgwB0P4wDAoQoA0KAdcHAAAAAgDZ%2F%2FkEPQSwAAUAOgAAARQGIzQ2BTMyFh8BNjc%2BAh4EBgcOBgcGIiYjIgYiJy4DLwEuAT4EHgEXJyY2A%2BiwfLD%2BVmQVJgdPBQsiKFAzRyorDwURAQQSFyozTSwNOkkLDkc3EDlfNyYHBw8GDyUqPjdGMR%2BTDA0EsHywfLDIHBPCAQIGBwcFDx81S21DBxlLR1xKQhEFBQcHGWt0bCQjP2hJNyATBwMGBcASGAAAAAACAMgAFQOEBLAAFgAaAAATITIWFREUBisBEQcGJjURIyImNRE0NhcVITX6AlgVHR0Vlv8TGpYVHR2rASwEsB0V%2FnAVHf4MsgkQFQKKHRUBkBUdZGRkAAAAAgDIABkETASwAA4AEgAAEyEyFhURBRElIREjETQ2ARU3NfoC7ic9%2FUQCWP1EZB8BDWQEsFEs%2FFt1A7Z9%2FBgEARc0%2FV1kFGQAAQAAAAECTW%2FDBF9fDzz1AB8EsAAAAADQdnOXAAAAANB2c5f%2FUf%2BcBdwFFAAAAAgAAgAAAAAAAAABAAAFFP%2BFAAAFFP9R%2FtQF3AABAAAAAAAAAAAAAAAAAAAAowG4ACgAAAAAAZAAAASwAAAEsABkBLAAAASwAAAEsABwAooAAAUUAAACigAABRQAAAGxAAABRQAAANgAAADYAAAAogAAAQQAAABIAAABBAAAAUUAAASwAGQEsAB7BLAAyASwAMgB9AAABLD%2F8gSwAAAEsAAABLD%2F8ASwAAAEsAAOBLAACQSwAGQEsP%2FTBLD%2F0wSwAAAEsAAABLAAAASwAAAEsAAABLAAJgSwAG4EsAAXBLAAFwSwABcEsABkBLAAGgSwAGQEsAAMBLAAZASwABcEsP%2BcBLAAZASwABcEsAAXBLAAAASwABcEsAAXBLAAFwSwAGQEsAAABLAAZASwAAAEsAAABLAAAASwAAAEsAAABLAAAASwAAAEsAAABLAAZASwAMgEsAAABLAAAASwADUEsABkBLAAyASw%2F7UEsAAhBLAAAASwAAAEsAAABLAAAASwAAAEsP%2BcBLAAAASwAAAEsAAABLAA2wSwABcEsAB1BLAAAASwAAAEsAAABLAACgSwAMgEsAAABLAAnQSwAMgEsADIBLAAyASwAAAEsP%2F%2BBLABLASwAGQEsACIBLABOwSwABcEsAAXBLAAFwSwABcEsAAXBLAAFwSwAAAEsAAXBLAAFwSwABcEsAAXBLAAAASwALcEsAC3BLAAAASwAAAEsABJBLAAFwSwAAAEsAAABLAAXQSw%2F9wEsP%2FcBLD%2FnwSwAGQEsAAABLAAAASwAAAEsABkBLD%2F%2FwSwAAAEsP9RBLAABgSwAAAEsAAABLABRQSwAAEEsAAABLD%2FnASwAEoEsAAUBLAAAASwAAAEsAAABLD%2FnASwAGEEsP%2F9BLAAFgSwABYEsAAWBLAAFgSwABgEsAAABMQAAASwAGQAAAAAAAD%2F2ABkADkAyAAAAScAZAAZABkAGQAZABkAGQAZAAAAAAAAAAAAAADZAAAAAAAOAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAMAZABkAAAAEAAAAAAAZP%2Bc%2F5z%2FnP%2Bc%2F5z%2FnP%2Bc%2F5wACQAJ%2F%2FL%2F8gBkAHkAJwBkAGQAAAAAAGT%2FogAAAAAAAAAAAAAAAADIAGQAAAABAI8AAP%2Bc%2F5wAZAAEAMgAyAAAAGQBkABkAAAAZAEs%2F7UAAAAAAAAAAAAAAAAAAABkAAABLAFBADIAMgAIAAAAAADIAT4AZgBmANkAyADIAAAAKgAqACoAKgCyAOgA6AFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BpAIGAiICfgKGAqwC5ANGA24DjAPEBAgEMgRiBKIE3AVcBboGcgb0ByAHYgfKCB4IYgi%2BCTYJhAm2Cd4KKApMCpQK4gswC4oLygwIDFgNKg1eDbAODg5oDrQPKA%2BmD%2BYQEhBUEJAQqhEqEXYRthIKEjgSfBLAExoTdBPQFCoU1BU8FagVzBYEFjYWYBawFv4XUhemGAIYLhhqGJYYsBjgGP4ZKBloGZQZxBnaGe4aNhpoGrga9hteG7QcMhyUHOIdHB1EHWwdlB28HeYeLh52HsAfYh%2FSIEYgviEyIXYhuCJAIpYiuCMOIyIjOCN6I8Ij4CQCJDAkXiSWJOIlNCVgJbwmFCZ%2BJuYnUCe8J%2FgoNChwKKwpoCnMKiYqSiqEKworeiwILGgsuizsLRwtiC30LiguZi6iLtgvDi9GL34vsi%2F4MD4whDDSMRIxYDGuMegyJDJeMpoy3jMiMz4zaDO2NBg0YDSoNNI1LDWeNeg2PjZ8Ntw3GjdON5I31DgQOEI4hjjIOQo5SjmIOcw6HDpsOpo63jugO9w8GDxQPKI8%2BD0yPew%2BOj6MPtQ%2FKD9uP6o%2F%2BkBIQIBAxkECQX5CGEKoQu5DGENCQ3ZDoEPKRBBEYESuRPZFWkW2RgZGdEa0RvZHNkd2R7ZH9kgWSDJITkhqSIZIzEkSSThJXkmESapKAkouSlIAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAAAAABAAxgABAAAAAAATABIAAAADAAEECQAAAGoAEgADAAEECQABACgAfAADAAEECQACAA4ApAADAAEECQADAEwAsgADAAEECQAEADgA%2FgADAAEECQAFAHgBNgADAAEECQAGADYBrgADAAEECQAIABYB5AADAAEECQAJABYB%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%2FtQAyAAAAAAAAAAAAAAAAAAAAAAAAAAABFwAAAQIBAwADAA0ADgEEAJYBBQEGAQcBCAEJAQoBCwEMAQ0BDgEPARABEQESARMA7wEUARUBFgEXARgBGQEaARsBHAEdAR4BHwEgASEBIgEjASQBJQEmAScBKAEpASoBKwEsAS0BLgEvATABMQEyATMBNAE1ATYBNwE4ATkBOgE7ATwBPQE%2BAT8BQAFBAUIBQwFEAUUBRgFHAUgBSQFKAUsBTAFNAU4BTwFQAVEBUgFTAVQBVQFWAVcBWAFZAVoBWwFcAV0BXgFfAWABYQFiAWMBZAFlAWYBZwFoAWkBagFrAWwBbQFuAW8BcAFxAXIBcwF0AXUBdgF3AXgBeQF6AXsBfAF9AX4BfwGAAYEBggGDAYQBhQGGAYcBiAGJAYoBiwGMAY0BjgGPAZABkQGSAZMBlAGVAZYBlwGYAZkBmgGbAZwBnQGeAZ8BoAGhAaIBowGkAaUBpgGnAagBqQGqAasBrAGtAa4BrwGwAbEBsgGzAbQBtQG2AbcBuAG5AboBuwG8Ab0BvgG%2FAcABwQHCAcMBxAHFAcYBxwHIAckBygHLAcwBzQHOAc8B0AHRAdIB0wHUAdUB1gHXAdgB2QHaAdsB3AHdAd4B3wHgAeEB4gHjAeQB5QHmAecB6AHpAeoB6wHsAe0B7gHvAfAB8QHyAfMB9AH1AfYB9wH4AfkB%2BgH7AfwB%2FQH%2BAf8CAAIBAgICAwIEAgUCBgIHAggCCQIKAgsCDAINAg4CDwIQAhECEgZnbHlwaDEGZ2x5cGgyB3VuaTAwQTAHdW5pMjAwMAd1bmkyMDAxB3VuaTIwMDIHdW5pMjAwMwd1bmkyMDA0B3VuaTIwMDUHdW5pMjAwNgd1bmkyMDA3B3VuaTIwMDgHdW5pMjAwOQd1bmkyMDBBB3VuaTIwMkYHdW5pMjA1RgRFdXJvB3VuaTIwQkQHdW5pMjMxQgd1bmkyNUZDB3VuaTI2MDEHdW5pMjZGQQd1bmkyNzA5B3VuaTI3MEYHdW5pRTAwMQd1bmlFMDAyB3VuaUUwMDMHdW5pRTAwNQd1bmlFMDA2B3VuaUUwMDcHdW5pRTAwOAd1bmlFMDA5B3VuaUUwMTAHdW5pRTAxMQd1bmlFMDEyB3VuaUUwMTMHdW5pRTAxNAd1bmlFMDE1B3VuaUUwMTYHdW5pRTAxNwd1bmlFMDE4B3VuaUUwMTkHdW5pRTAyMAd1bmlFMDIxB3VuaUUwMjIHdW5pRTAyMwd1bmlFMDI0B3VuaUUwMjUHdW5pRTAyNgd1bmlFMDI3B3VuaUUwMjgHdW5pRTAyOQd1bmlFMDMwB3VuaUUwMzEHdW5pRTAzMgd1bmlFMDMzB3VuaUUwMzQHdW5pRTAzNQd1bmlFMDM2B3VuaUUwMzcHdW5pRTAzOAd1bmlFMDM5B3VuaUUwNDAHdW5pRTA0MQd1bmlFMDQyB3VuaUUwNDMHdW5pRTA0NAd1bmlFMDQ1B3VuaUUwNDYHdW5pRTA0Nwd1bmlFMDQ4B3VuaUUwNDkHdW5pRTA1MAd1bmlFMDUxB3VuaUUwNTIHdW5pRTA1Mwd1bmlFMDU0B3VuaUUwNTUHdW5pRTA1Ngd1bmlFMDU3B3VuaUUwNTgHdW5pRTA1OQd1bmlFMDYwB3VuaUUwNjIHdW5pRTA2Mwd1bmlFMDY0B3VuaUUwNjUHdW5pRTA2Ngd1bmlFMDY3B3VuaUUwNjgHdW5pRTA2OQd1bmlFMDcwB3VuaUUwNzEHdW5pRTA3Mgd1bmlFMDczB3VuaUUwNzQHdW5pRTA3NQd1bmlFMDc2B3VuaUUwNzcHdW5pRTA3OAd1bmlFMDc5B3VuaUUwODAHdW5pRTA4MQd1bmlFMDgyB3VuaUUwODMHdW5pRTA4NAd1bmlFMDg1B3VuaUUwODYHdW5pRTA4Nwd1bmlFMDg4B3VuaUUwODkHdW5pRTA5MAd1bmlFMDkxB3VuaUUwOTIHdW5pRTA5Mwd1bmlFMDk0B3VuaUUwOTUHdW5pRTA5Ngd1bmlFMDk3B3VuaUUxMDEHdW5pRTEwMgd1bmlFMTAzB3VuaUUxMDQHdW5pRTEwNQd1bmlFMTA2B3VuaUUxMDcHdW5pRTEwOAd1bmlFMTA5B3VuaUUxMTAHdW5pRTExMQd1bmlFMTEyB3VuaUUxMTMHdW5pRTExNAd1bmlFMTE1B3VuaUUxMTYHdW5pRTExNwd1bmlFMTE4B3VuaUUxMTkHdW5pRTEyMAd1bmlFMTIxB3VuaUUxMjIHdW5pRTEyMwd1bmlFMTI0B3VuaUUxMjUHdW5pRTEyNgd1bmlFMTI3B3VuaUUxMjgHdW5pRTEyOQd1bmlFMTMwB3VuaUUxMzEHdW5pRTEzMgd1bmlFMTMzB3VuaUUxMzQHdW5pRTEzNQd1bmlFMTM2B3VuaUUxMzcHdW5pRTEzOAd1bmlFMTM5B3VuaUUxNDAHdW5pRTE0MQd1bmlFMTQyB3VuaUUxNDMHdW5pRTE0NAd1bmlFMTQ1B3VuaUUxNDYHdW5pRTE0OAd1bmlFMTQ5B3VuaUUxNTAHdW5pRTE1MQd1bmlFMTUyB3VuaUUxNTMHdW5pRTE1NAd1bmlFMTU1B3VuaUUxNTYHdW5pRTE1Nwd1bmlFMTU4B3VuaUUxNTkHdW5pRTE2MAd1bmlFMTYxB3VuaUUxNjIHdW5pRTE2Mwd1bmlFMTY0B3VuaUUxNjUHdW5pRTE2Ngd1bmlFMTY3B3VuaUUxNjgHdW5pRTE2OQd1bmlFMTcwB3VuaUUxNzEHdW5pRTE3Mgd1bmlFMTczB3VuaUUxNzQHdW5pRTE3NQd1bmlFMTc2B3VuaUUxNzcHdW5pRTE3OAd1bmlFMTc5B3VuaUUxODAHdW5pRTE4MQd1bmlFMTgyB3VuaUUxODMHdW5pRTE4NAd1bmlFMTg1B3VuaUUxODYHdW5pRTE4Nwd1bmlFMTg4B3VuaUUxODkHdW5pRTE5MAd1bmlFMTkxB3VuaUUxOTIHdW5pRTE5Mwd1bmlFMTk0B3VuaUUxOTUHdW5pRTE5Nwd1bmlFMTk4B3VuaUUxOTkHdW5pRTIwMAd1bmlFMjAxB3VuaUUyMDIHdW5pRTIwMwd1bmlFMjA0B3VuaUUyMDUHdW5pRTIwNgd1bmlFMjA5B3VuaUUyMTAHdW5pRTIxMQd1bmlFMjEyB3VuaUUyMTMHdW5pRTIxNAd1bmlFMjE1B3VuaUUyMTYHdW5pRTIxOAd1bmlFMjE5B3VuaUUyMjEHdW5pRTIyMwd1bmlFMjI0B3VuaUUyMjUHdW5pRTIyNgd1bmlFMjI3B3VuaUUyMzAHdW5pRTIzMQd1bmlFMjMyB3VuaUUyMzMHdW5pRTIzNAd1bmlFMjM1B3VuaUUyMzYHdW5pRTIzNwd1bmlFMjM4B3VuaUUyMzkHdW5pRTI0MAd1bmlFMjQxB3VuaUUyNDIHdW5pRTI0Mwd1bmlFMjQ0B3VuaUUyNDUHdW5pRTI0Ngd1bmlFMjQ3B3VuaUUyNDgHdW5pRTI0OQd1bmlFMjUwB3VuaUUyNTEHdW5pRTI1Mgd1bmlFMjUzB3VuaUUyNTQHdW5pRTI1NQd1bmlFMjU2B3VuaUUyNTcHdW5pRTI1OAd1bmlFMjU5B3VuaUUyNjAHdW5pRjhGRgZ1MUY1MTEGdTFGNkFBAAAAAAFUUMMXAAA%3D%29%20format%28%27truetype%27%29%2Curl%28data%3Aimage%2Fsvg%2Bxml%3Bbase64%2CPD94bWwgdmVyc2lvbj0iMS4wIiBzdGFuZGFsb25lPSJubyI%2FPgo8IURPQ1RZUEUgc3ZnIFBVQkxJQyAiLS8vVzNDLy9EVEQgU1ZHIDEuMS8vRU4iICJodHRwOi8vd3d3LnczLm9yZy9HcmFwaGljcy9TVkcvMS4xL0RURC9zdmcxMS5kdGQiID4KPHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPgo8bWV0YWRhdGE%2BPC9tZXRhZGF0YT4KPGRlZnM%2BCjxmb250IGlkPSJnbHlwaGljb25zX2hhbGZsaW5nc3JlZ3VsYXIiIGhvcml6LWFkdi14PSIxMjAwIiA%2BCjxmb250LWZhY2UgdW5pdHMtcGVyLWVtPSIxMjAwIiBhc2NlbnQ9Ijk2MCIgZGVzY2VudD0iLTI0MCIgLz4KPG1pc3NpbmctZ2x5cGggaG9yaXotYWR2LXg9IjUwMCIgLz4KPGdseXBoIGhvcml6LWFkdi14PSIwIiAvPgo8Z2x5cGggaG9yaXotYWR2LXg9IjQwMCIgLz4KPGdseXBoIHVuaWNvZGU9IiAiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDAzOyIgaG9yaXotYWR2LXg9IjEzMDAiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDA0OyIgaG9yaXotYWR2LXg9IjQzMyIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeDIwMDU7IiBob3Jpei1hZHYteD0iMzI1IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAwNjsiIGhvcml6LWFkdi14PSIyMTYiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDA3OyIgaG9yaXotYWR2LXg9IjIxNiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeDIwMDg7IiBob3Jpei1hZHYteD0iMTYyIiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAwOTsiIGhvcml6LWFkdi14PSIyNjAiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMDBhOyIgaG9yaXotYWR2LXg9IjcyIiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjAyZjsiIGhvcml6LWFkdi14PSIyNjAiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3gyMGJkOyIgZD0iTTQyOCAxMjAwaDM1MHE2NyAwIDEyMCAtMTN0ODYgLTMxdDU3IC00OS41dDM1IC01Ni41dDE3IC02NC41dDYuNSAtNjAuNXQwLjUgLTU3di0xNi41di0xNi41cTAgLTM2IC0wLjUgLTU3dC02LjUgLTYxdC0xNyAtNjV0LTM1IC01N3QtNTcgLTUwLjV0LTg2IC0zMS41dC0xMjAgLTEzaC0xNzhsLTIgLTEwMGgyODhxMTAgMCAxMyAtNnQtMyAtMTRsLTEyMCAtMTYwcS02IC04IC0xOCAtMTR0LTIyIC02aC0xMzh2LTE3NXEwIC0xMSAtNS41IC0xOCB0LTE1LjUgLTdoLTE0OXEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41djE3NWgtMjY3cS0xMCAwIC0xMyA2dDMgMTRsMTIwIDE2MHE2IDggMTggMTR0MjIgNmgxMTd2MTAwaC0yNjdxLTEwIDAgLTEzIDZ0MyAxNGwxMjAgMTYwcTYgOCAxOCAxNHQyMiA2aDExN3Y0NzVxMCAxMCA3LjUgMTcuNXQxNy41IDcuNXpNNjAwIDEwMDB2LTMwMGgyMDNxNjQgMCA4Ni41IDMzdDIyLjUgMTE5cTAgODQgLTIyLjUgMTE2dC04Ni41IDMyaC0yMDN6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjIxMjsiIGQ9Ik0yNTAgNzAwaDgwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMjAwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC04MDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djIwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4MjMxYjsiIGQ9Ik0xMDAwIDEyMDB2LTE1MHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNTB2LTEwMHEwIC05MSAtNDkuNSAtMTY1LjV0LTEzMC41IC0xMDkuNXE4MSAtMzUgMTMwLjUgLTEwOS41dDQ5LjUgLTE2NS41di0xNTBoNTBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTE1MGgtODAwdjE1MHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjVoNTB2MTUwcTAgOTEgNDkuNSAxNjUuNXQxMzAuNSAxMDkuNXEtODEgMzUgLTEzMC41IDEwOS41IHQtNDkuNSAxNjUuNXYxMDBoLTUwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxNTBoODAwek00MDAgMTAwMHYtMTAwcTAgLTYwIDMyLjUgLTEwOS41dDg3LjUgLTczLjVxMjggLTEyIDQ0IC0zN3QxNiAtNTV0LTE2IC01NXQtNDQgLTM3cS01NSAtMjQgLTg3LjUgLTczLjV0LTMyLjUgLTEwOS41di0xNTBoNDAwdjE1MHEwIDYwIC0zMi41IDEwOS41dC04Ny41IDczLjVxLTI4IDEyIC00NCAzN3QtMTYgNTV0MTYgNTV0NDQgMzcgcTU1IDI0IDg3LjUgNzMuNXQzMi41IDEwOS41djEwMGgtNDAweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeDI1ZmM7IiBob3Jpei1hZHYteD0iNTAwIiBkPSJNMCAweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeDI2MDE7IiBkPSJNNTAzIDEwODlxMTEwIDAgMjAwLjUgLTU5LjV0MTM0LjUgLTE1Ni41cTQ0IDE0IDkwIDE0cTEyMCAwIDIwNSAtODYuNXQ4NSAtMjA2LjVxMCAtMTIxIC04NSAtMjA3LjV0LTIwNSAtODYuNWgtNzUwcS03OSAwIC0xMzUuNSA1N3QtNTYuNSAxMzdxMCA2OSA0Mi41IDEyMi41dDEwOC41IDY3LjVxLTIgMTIgLTIgMzdxMCAxNTMgMTA4IDI2MC41dDI2MCAxMDcuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3gyNmZhOyIgZD0iTTc3NCAxMTkzLjVxMTYgLTkuNSAyMC41IC0yN3QtNS41IC0zMy41bC0xMzYgLTE4N2w0NjcgLTc0NmgzMHEyMCAwIDM1IC0xOC41dDE1IC0zOS41di00MmgtMTIwMHY0MnEwIDIxIDE1IDM5LjV0MzUgMTguNWgzMGw0NjggNzQ2bC0xMzUgMTgzcS0xMCAxNiAtNS41IDM0dDIwLjUgMjh0MzQgNS41dDI4IC0yMC41bDExMSAtMTQ4bDExMiAxNTBxOSAxNiAyNyAyMC41dDM0IC01ek02MDAgMjAwaDM3N2wtMTgyIDExMmwtMTk1IDUzNHYtNjQ2eiAiIC8%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDI0OyIgZD0iTTEzMDAgMGgtNTM4bC00MSA0MDBoLTI0MmwtNDEgLTQwMGgtNTM4bDQzMSAxMjAwaDIwOWwtMjEgLTMwMGgxNjJsLTIwIDMwMGgyMDh6TTUxNSA4MDBsLTI3IC0zMDBoMjI0bC0yNyAzMDBoLTE3MHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDI1OyIgZD0iTTU1MCAxMjAwaDIwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtNDUwaDE5MXEyMCAwIDI1LjUgLTExLjV0LTcuNSAtMjcuNWwtMzI3IC00MDBxLTEzIC0xNiAtMzIgLTE2dC0zMiAxNmwtMzI3IDQwMHEtMTMgMTYgLTcuNSAyNy41dDI1LjUgMTEuNWgxOTF2NDUwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNMTEyNSA0MDBoNTBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di0zNTBxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41IGgtMTA1MHEtMTAgMCAtMTcuNSA3LjV0LTcuNSAxNy41djM1MHEwIDEwIDcuNSAxNy41dDE3LjUgNy41aDUwcTEwIDAgMTcuNSAtNy41dDcuNSAtMTcuNXYtMTc1aDkwMHYxNzVxMCAxMCA3LjUgMTcuNXQxNy41IDcuNXoiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDI4OyIgZD0iTTIyNSAxMjAwaDc1MHExMCAwIDE5LjUgLTd0MTIuNSAtMTdsMTg2IC02NTJxNyAtMjQgNyAtNDl2LTQyNXEwIC0xMiAtNCAtMjd0LTkgLTE3cS0xMiAtNiAtMzcgLTZoLTExMDBxLTEyIDAgLTI3IDR0LTE3IDhxLTYgMTMgLTYgMzhsMSA0MjVxMCAyNSA3IDQ5bDE4NSA2NTJxMyAxMCAxMi41IDE3dDE5LjUgN3pNODc4IDEwMDBoLTU1NnEtMTAgMCAtMTkgLTd0LTExIC0xOGwtODcgLTQ1MHEtMiAtMTEgNCAtMTh0MTYgLTdoMTUwIHExMCAwIDE5LjUgLTd0MTEuNSAtMTdsMzggLTE1MnEyIC0xMCAxMS41IC0xN3QxOS41IC03aDI1MHExMCAwIDE5LjUgN3QxMS41IDE3bDM4IDE1MnEyIDEwIDExLjUgMTd0MTkuNSA3aDE1MHExMCAwIDE2IDd0NCAxOGwtODcgNDUwcS0yIDExIC0xMSAxOHQtMTkgN3oiIC8%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQyOyIgZD0iTTUwMCAxMjAwbDY4MiAtNjgycTggLTggOCAtMTh0LTggLTE4bC00NjQgLTQ2NHEtOCAtOCAtMTggLTh0LTE4IDhsLTY4MiA2ODJsMSA0NzVxMCAxMCA3LjUgMTcuNXQxNy41IDcuNWg0NzR6TTgwMCAxMjAwbDY4MiAtNjgycTggLTggOCAtMTh0LTggLTE4bC00NjQgLTQ2NHEtOCAtOCAtMTggLTh0LTE4IDhsLTU2IDU2bDQyNCA0MjZsLTcwMCA3MDBoMTUwek0zMTkuNSAxMDI0LjVxLTI5LjUgMjkuNSAtNzEgMjkuNXQtNzEgLTI5LjUgdC0yOS41IC03MS41dDI5LjUgLTcxLjV0NzEgLTI5LjV0NzEgMjkuNXQyOS41IDcxLjV0LTI5LjUgNzEuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQzOyIgZD0iTTMwMCAxMjAwaDgyNXE3NSAwIDc1IC03NXYtOTAwcTAgLTI1IC0xOCAtNDNsLTY0IC02NHEtOCAtOCAtMTMgLTUuNXQtNSAxMi41djk1MHEwIDEwIC03LjUgMTcuNXQtMTcuNSA3LjVoLTcwMHEtMjUgMCAtNDMgLTE4bC02NCAtNjRxLTggLTggLTUuNSAtMTN0MTIuNSAtNWg3MDBxMTAgMCAxNy41IC03LjV0Ny41IC0xNy41di05NTBxMCAtMTAgLTcuNSAtMTcuNXQtMTcuNSAtNy41aC04NTBxLTEwIDAgLTE3LjUgNy41dC03LjUgMTcuNXY5NzUgcTAgMjUgMTggNDNsMTM5IDEzOXExOCAxOCA0MyAxOHoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDQ5OyIgZD0iTTg3NyAxMjAwbDIgLTU3cS04MyAtMTkgLTExNiAtNDUuNXQtNDAgLTY2LjVsLTEzMiAtODM5cS05IC00OSAxMyAtNjl0OTYgLTI2di05N2gtNTAwdjk3cTE4NiAxNiAyMDAgOThsMTczIDgzMnEzIDE3IDMgMzB0LTEuNSAyMi41dC05IDE3LjV0LTEzLjUgMTIuNXQtMjEuNSAxMHQtMjYgOC41dC0zMy41IDEwcS0xMyAzIC0xOSA1djU3aDQyNXoiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDU0OyIgZD0iTTUwMCA5NTB2MTAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNWg2MDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtNjAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXpNMTAwIDY1MHYxMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41aDEwMDBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMTAwMCBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41ek0zMDAgMzUwdjEwMHEwIDIxIDE0LjUgMzUuNXQzNS41IDE0LjVoODAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0xMDBxMCAtMjEgLTE0LjUgLTM1LjV0LTM1LjUgLTE0LjVoLTgwMHEtMjEgMCAtMzUuNSAxNC41dC0xNC41IDM1LjV6TTAgNTB2MTAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNWgxMTAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0xMDAgcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDY3OyIgZD0iTTM1MCAxMTAwaDM1MHE2MCAwIDEyNyAtMjNsLTE3OCAtMTc3aC0zNDlxLTQxIDAgLTcwLjUgLTI5LjV0LTI5LjUgLTcwLjV2LTUwMHEwIC00MSAyOS41IC03MC41dDcwLjUgLTI5LjVoNTAwcTQxIDAgNzAuNSAyOS41dDI5LjUgNzAuNXY2OWwyMDAgMjAwdi0yMTlxMCAtMTY1IC05Mi41IC0yNTcuNXQtMjU3LjUgLTkyLjVoLTQwMHEtMTY1IDAgLTI1Ny41IDkyLjV0LTkyLjUgMjU3LjV2NDAwcTAgMTY1IDkyLjUgMjU3LjV0MjU3LjUgOTIuNXogTTY0MyA2MzlsMzk1IDM5NXE3IDcgMTcuNSA3dDE3LjUgLTdsMTAxIC0xMDFxNyAtNyA3IC0xNy41dC03IC0xNy41bC01MzEgLTUzMnEtNyAtNyAtMTcuNSAtN3QtMTcuNSA3bC0yNDggMjQ4cS03IDcgLTcgMTcuNXQ3IDE3LjVsMTAxIDEwMXE3IDcgMTcuNSA3dDE3LjUgLTdsMTExIC0xMTFxOCAtNyAxOCAtN3QxOCA3eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwNjg7IiBkPSJNMzE4IDkxOGwyNjQgMjY0cTggOCAxOCA4dDE4IC04bDI2MCAtMjY0cTcgLTggNC41IC0xM3QtMTIuNSAtNWgtMTcwdi0yMDBoMjAwdjE3M3EwIDEwIDUgMTJ0MTMgLTVsMjY0IC0yNjBxOCAtNyA4IC0xNy41dC04IC0xNy41bC0yNjQgLTI2NXEtOCAtNyAtMTMgLTV0LTUgMTJ2MTczaC0yMDB2LTIwMGgxNzBxMTAgMCAxMi41IC01dC00LjUgLTEzbC0yNjAgLTI2NHEtOCAtOCAtMTggLTh0LTE4IDhsLTI2NCAyNjRxLTggOCAtNS41IDEzIHQxMi41IDVoMTc1djIwMGgtMjAwdi0xNzNxMCAtMTAgLTUgLTEydC0xMyA1bC0yNjQgMjY1cS04IDcgLTggMTcuNXQ4IDE3LjVsMjY0IDI2MHE4IDcgMTMgNXQ1IC0xMnYtMTczaDIwMHYyMDBoLTE3NXEtMTAgMCAtMTIuNSA1dDUuNSAxM3oiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDY5OyIgZD0iTTI1MCAxMTAwaDEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtNDM4bDQ2NCA0NTNxMTUgMTQgMjUuNSAxMHQxMC41IC0yNXYtMTAwMHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ2NCA0NTN2LTQzOHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMTAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDcwOyIgZD0iTTUwIDExMDBoMTAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di00MzhsNDY0IDQ1M3ExNSAxNCAyNS41IDEwdDEwLjUgLTI1di00MzhsNDY0IDQ1M3ExNSAxNCAyNS41IDEwdDEwLjUgLTI1di0xMDAwcTAgLTIxIC0xMC41IC0yNXQtMjUuNSAxMGwtNDY0IDQ1M3YtNDM4cTAgLTIxIC0xMC41IC0yNXQtMjUuNSAxMGwtNDY0IDQ1M3YtNDM4cTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMDBxLTIxIDAgLTM1LjUgMTQuNSB0LTE0LjUgMzUuNXYxMDAwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDcxOyIgZD0iTTEyMDAgMTA1MHYtMTAwMHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ2NCA0NTN2LTQzOHEwIC0yMSAtMTAuNSAtMjV0LTI1LjUgMTBsLTQ5MiA0ODBxLTE1IDE0IC0xNSAzNXQxNSAzNWw0OTIgNDgwcTE1IDE0IDI1LjUgMTB0MTAuNSAtMjV2LTQzOGw0NjQgNDUzcTE1IDE0IDI1LjUgMTB0MTAuNSAtMjV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTA3MjsiIGQ9Ik0yNDMgMTA3NGw4MTQgLTQ5OHExOCAtMTEgMTggLTI2dC0xOCAtMjZsLTgxNCAtNDk4cS0xOCAtMTEgLTMwLjUgLTR0LTEyLjUgMjh2MTAwMHEwIDIxIDEyLjUgMjh0MzAuNSAtNHoiIC8%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDc5OyIgZD0iTTg4NSA5MDBsLTM1MiAtMzUzbDM1MiAtMzUzbC0xOTcgLTE5OGwtNTUyIDU1Mmw1NTIgNTUweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUwODA7IiBkPSJNMTA2NCA1NDdsLTU1MSAtNTUxbC0xOTggMTk4bDM1MyAzNTNsLTM1MyAzNTNsMTk4IDE5OHoiIC8%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%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMDk2OyIgZD0iTTg1MCAxMjAwaDMwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtMzAwcTAgLTIxIC0xMC41IC0yNXQtMjQuNSAxMGwtOTQgOTRsLTI0OSAtMjQ5cS04IC03IC0xOCAtN3QtMTggN2wtMTA2IDEwNnEtNyA4IC03IDE4dDcgMThsMjQ5IDI0OWwtOTQgOTRxLTE0IDE0IC0xMCAyNC41dDI1IDEwLjV6TTM1MCAwaC0zMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djMwMHEwIDIxIDEwLjUgMjV0MjQuNSAtMTBsOTQgLTk0bDI0OSAyNDkgcTggNyAxOCA3dDE4IC03bDEwNiAtMTA2cTcgLTggNyAtMTh0LTcgLTE4bC0yNDkgLTI0OWw5NCAtOTRxMTQgLTE0IDEwIC0yNC41dC0yNSAtMTAuNXoiIC8%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTYyOyIgZD0iTTc5MyAxMTgybDkgLTlxOCAtMTAgNSAtMjdxLTMgLTExIC03OSAtMjI1LjV0LTc4IC0yMjEuNWwzMDAgMXEyNCAwIDMyLjUgLTE3LjV0LTUuNSAtMzUuNXEtMSAwIC0xMzMuNSAtMTU1dC0yNjcgLTMxMi41dC0xMzguNSAtMTYyLjVxLTEyIC0xNSAtMjYgLTE1aC05bC05IDhxLTkgMTEgLTQgMzJxMiA5IDQyIDEyMy41dDc5IDIyNC41bDM5IDExMGgtMzAycS0yMyAwIC0zMSAxOXEtMTAgMjEgNiA0MXE3NSA4NiAyMDkuNSAyMzcuNSB0MjI4IDI1N3Q5OC41IDExMS41cTkgMTYgMjUgMTZoOXoiIC8%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTgwOyIgZD0iTTEyMDAgMTEwMHYtNTZxLTQgMCAtMTEgLTAuNXQtMjQgLTN0LTMwIC03LjV0LTI0IC0xNXQtMTEgLTI0di04ODhxMCAtMjIgMjUgLTM0LjV0NTAgLTEzLjVsMjUgLTJ2LTU2aC00MDB2NTZxNzUgMCA4Ny41IDYuNXQxMi41IDQzLjV2Mzk0aC01MDB2LTM5NHEwIC0zNyAxMi41IC00My41dDg3LjUgLTYuNXYtNTZoLTQwMHY1NnE0IDAgMTEgMC41dDI0IDN0MzAgNy41dDI0IDE1dDExIDI0djg4OHEwIDIyIC0yNSAzNC41dC01MCAxMy41IGwtMjUgMnY1Nmg0MDB2LTU2cS03NSAwIC04Ny41IC02LjV0LTEyLjUgLTQzLjV2LTM5NGg1MDB2Mzk0cTAgMzcgLTEyLjUgNDMuNXQtODcuNSA2LjV2NTZoNDAweiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUxODE7IiBkPSJNNjc1IDEwMDBoMzc1cTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di0xNTBoLTEwNWwtMjk1IC05OHY5OGwtMjAwIDIwMGgtNDAwbDEwMCAxMDBoMzc1ek0xMDAgOTAwaDMwMHE0MSAwIDcwLjUgLTI5LjV0MjkuNSAtNzAuNXYtNTAwcTAgLTQxIC0yOS41IC03MC41dC03MC41IC0yOS41aC0zMDBxLTQxIDAgLTcwLjUgMjkuNXQtMjkuNSA3MC41djUwMHEwIDQxIDI5LjUgNzAuNXQ3MC41IDI5LjV6TTEwMCA4MDB2LTIwMGgzMDB2MjAwIGgtMzAwek0xMTAwIDUzNWwtNDAwIC0xMzN2MTYzbDQwMCAxMzN2LTE2M3pNMTAwIDUwMHYtMjAwaDMwMHYyMDBoLTMwMHpNMTEwMCAzOTh2LTI0OHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMzc1bC0xMDAgLTEwMGgtMzc1bC0xMDAgMTAwaDQwMGwyMDAgMjAwaDEwNXoiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMTg4OyIgZD0iTTIwMCAxMTAwaDcwMHExMjQgMCAyMTIgLTg4dDg4IC0yMTJ2LTUwMHEwIC0xMjQgLTg4IC0yMTJ0LTIxMiAtODhoLTcwMHEtMTI0IDAgLTIxMiA4OHQtODggMjEydjUwMHEwIDEyNCA4OCAyMTJ0MjEyIDg4ek0xMDAgOTAwdi03MDBoOTAwdjcwMGgtOTAwek01MDAgNzAwaC0yMDB2LTMwMGgyMDB2LTEwMGgtMzAwdjUwMGgzMDB2LTEwMHpNOTAwIDcwMGgtMjAwdi0zMDBoMjAwdi0xMDBoLTMwMHY1MDBoMzAwdi0xMDB6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTE4OTsiIGQ9Ik0yMDAgMTEwMGg3MDBxMTI0IDAgMjEyIC04OHQ4OCAtMjEydi01MDBxMCAtMTI0IC04OCAtMjEydC0yMTIgLTg4aC03MDBxLTEyNCAwIC0yMTIgODh0LTg4IDIxMnY1MDBxMCAxMjQgODggMjEydDIxMiA4OHpNMTAwIDkwMHYtNzAwaDkwMHY3MDBoLTkwMHpNNTAwIDQwMGwtMzAwIDE1MGwzMDAgMTUwdi0zMDB6TTkwMCA1NTBsLTMwMCAtMTUwdjMwMHoiIC8%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjA2OyIgZD0iTTQ1MCAxMTAwaDEwMHEyMSAwIDM1LjUgLTE0LjV0MTQuNSAtMzUuNXYtNTBoNTBxMjEgMCAzNS41IC0xNC41dDE0LjUgLTM1LjV2LTEwMHEwIC0yMSAtMTQuNSAtMzUuNXQtMzUuNSAtMTQuNWgtMzAwcS0yMSAwIC0zNS41IDE0LjV0LTE0LjUgMzUuNXYxMDBxMCAyMSAxNC41IDM1LjV0MzUuNSAxNC41aDUwdjUwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXpNODAwIDg1MHYxNTBxNDEgMCA3MC41IC0yOS41dDI5LjUgLTcwLjV2LTUwMCBoLTIwMHYtMzAwaDIwMHEwIC0zNiAtNyAtNTcuNXQtMjMuNSAtMzB0LTI5LjUgLTEwLjV0LTQwIC0yaC02MDBxLTQxIDAgLTcwLjUgMjkuNXQtMjkuNSA3MC41djgwMHEwIDQxIDI5LjUgNzAuNXQ3MC41IDI5LjV2LTE1MHEwIC02MiA0NCAtMTA2dDEwNiAtNDRoMzAwcTYyIDAgMTA2IDQ0dDQ0IDEwNnpNMTIxMiAyNTBsLTIxMiAtMjEydjE2MmgtMjAwdjEwMGgyMDB2MTYyeiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyMDk7IiBkPSJNNjU4IDExOTdsNjM3IC0xMTA0cTIzIC0zOCA3IC02NS41dC02MCAtMjcuNWgtMTI3NnEtNDQgMCAtNjAgMjcuNXQ3IDY1LjVsNjM3IDExMDRxMjIgMzkgNTQgMzl0NTQgLTM5ek03MDQgODAwaC0yMDhxLTIwIDAgLTMyIC0xNC41dC04IC0zNC41bDU4IC0zMDJxNCAtMjAgMjEuNSAtMzQuNXQzNy41IC0xNC41aDU0cTIwIDAgMzcuNSAxNC41dDIxLjUgMzQuNWw1OCAzMDJxNCAyMCAtOCAzNC41dC0zMiAxNC41ek01MDAgMzAwdi0xMDBoMjAwIHYxMDBoLTIwMHoiIC8%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjE5OyIgZD0iTTIwMCAxMTAwaDgwMHE4MyAwIDE0MS41IC01OC41dDU4LjUgLTE0MS41di0yMDBoLTEwMHEwIDQxIC0yOS41IDcwLjV0LTcwLjUgMjkuNWgtMjUwcS00MSAwIC03MC41IC0yOS41dC0yOS41IC03MC41aC0xMDBxMCA0MSAtMjkuNSA3MC41dC03MC41IDI5LjVoLTI1MHEtNDEgMCAtNzAuNSAtMjkuNXQtMjkuNSAtNzAuNWgtMTAwdjIwMHEwIDgzIDU4LjUgMTQxLjV0MTQxLjUgNTguNXpNMTAwIDYwMGgxMDAwcTQxIDAgNzAuNSAtMjkuNSB0MjkuNSAtNzAuNXYtMzAwaC0xMjAwdjMwMHEwIDQxIDI5LjUgNzAuNXQ3MC41IDI5LjV6TTMwMCAxMDB2LTUwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djUwaDIwMHpNMTEwMCAxMDB2LTUwcTAgLTIxIC0xNC41IC0zNS41dC0zNS41IC0xNC41aC0xMDBxLTIxIDAgLTM1LjUgMTQuNXQtMTQuNSAzNS41djUwaDIwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjIxOyIgZD0iTTQ4MCAxMTY1bDY4MiAtNjgzcTMxIC0zMSAzMSAtNzUuNXQtMzEgLTc1LjVsLTEzMSAtMTMxaC00ODFsLTUxNyA1MThxLTMyIDMxIC0zMiA3NS41dDMyIDc1LjVsMjk1IDI5NnEzMSAzMSA3NS41IDMxdDc2LjUgLTMxek0xMDggNzk0bDM0MiAtMzQybDMwMyAzMDRsLTM0MSAzNDF6TTI1MCAxMDBoODAwcTIxIDAgMzUuNSAtMTQuNXQxNC41IC0zNS41di01MGgtOTAwdjUwcTAgMjEgMTQuNSAzNS41dDM1LjUgMTQuNXoiIC8%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%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%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%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%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%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%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%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%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUwOyIgZD0iTTg2NSA1NjVsLTQ5NCAtNDk0cS0yMyAtMjMgLTQxIC0yM3EtMTQgMCAtMjIgMTMuNXQtOCAzOC41djEwMDBxMCAyNSA4IDM4LjV0MjIgMTMuNXExOCAwIDQxIC0yM2w0OTQgLTQ5NHExNCAtMTQgMTQgLTM1dC0xNCAtMzV6IiAvPgo8Z2x5cGggdW5pY29kZT0iJiN4ZTI1MTsiIGQ9Ik0zMzUgNjM1bDQ5NCA0OTRxMjkgMjkgNTAgMjAuNXQyMSAtNDkuNXYtMTAwMHEwIC00MSAtMjEgLTQ5LjV0LTUwIDIwLjVsLTQ5NCA0OTRxLTE0IDE0IC0xNCAzNXQxNCAzNXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUyOyIgZD0iTTEwMCA5MDBoMTAwMHE0MSAwIDQ5LjUgLTIxdC0yMC41IC01MGwtNDk0IC00OTRxLTE0IC0xNCAtMzUgLTE0dC0zNSAxNGwtNDk0IDQ5NHEtMjkgMjkgLTIwLjUgNTB0NDkuNSAyMXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjUzOyIgZD0iTTYzNSA4NjVsNDk0IC00OTRxMjkgLTI5IDIwLjUgLTUwdC00OS41IC0yMWgtMTAwMHEtNDEgMCAtNDkuNSAyMXQyMC41IDUwbDQ5NCA0OTRxMTQgMTQgMzUgMTR0MzUgLTE0eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyNTQ7IiBkPSJNNzAwIDc0MXYtMTgybC02OTIgLTMyM3YyMjFsNDEzIDE5M2wtNDEzIDE5M3YyMjF6TTEyMDAgMGgtODAwdjIwMGg4MDB2LTIwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU1OyIgZD0iTTEyMDAgOTAwaC0yMDB2LTEwMGgyMDB2LTEwMGgtMzAwdjMwMGgyMDB2MTAwaC0yMDB2MTAwaDMwMHYtMzAwek0wIDcwMGg1MHEwIDIxIDQgMzd0OS41IDI2LjV0MTggMTcuNXQyMiAxMXQyOC41IDUuNXQzMSAydDM3IDAuNWgxMDB2LTU1MHEwIC0yMiAtMjUgLTM0LjV0LTUwIC0xMy41bC0yNSAtMnYtMTAwaDQwMHYxMDBxLTQgMCAtMTEgMC41dC0yNCAzdC0zMCA3dC0yNCAxNXQtMTEgMjQuNXY1NTBoMTAwcTI1IDAgMzcgLTAuNXQzMSAtMiB0MjguNSAtNS41dDIyIC0xMXQxOCAtMTcuNXQ5LjUgLTI2LjV0NCAtMzdoNTB2MzAwaC04MDB2LTMwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU2OyIgZD0iTTgwMCA3MDBoLTUwcTAgMjEgLTQgMzd0LTkuNSAyNi41dC0xOCAxNy41dC0yMiAxMXQtMjguNSA1LjV0LTMxIDJ0LTM3IDAuNWgtMTAwdi01NTBxMCAtMjIgMjUgLTM0LjV0NTAgLTE0LjVsMjUgLTF2LTEwMGgtNDAwdjEwMHE0IDAgMTEgMC41dDI0IDN0MzAgN3QyNCAxNXQxMSAyNC41djU1MGgtMTAwcS0yNSAwIC0zNyAtMC41dC0zMSAtMnQtMjguNSAtNS41dC0yMiAtMTF0LTE4IC0xNy41dC05LjUgLTI2LjV0LTQgLTM3aC01MHYzMDAgaDgwMHYtMzAwek0xMTAwIDIwMGgtMjAwdi0xMDBoMjAwdi0xMDBoLTMwMHYzMDBoMjAwdjEwMGgtMjAwdjEwMGgzMDB2LTMwMHoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU3OyIgZD0iTTcwMSAxMDk4aDE2MHExNiAwIDIxIC0xMXQtNyAtMjNsLTQ2NCAtNDY0bDQ2NCAtNDY0cTEyIC0xMiA3IC0yM3QtMjEgLTExaC0xNjBxLTEzIDAgLTIzIDlsLTQ3MSA0NzFxLTcgOCAtNyAxOHQ3IDE4bDQ3MSA0NzFxMTAgOSAyMyA5eiIgLz4KPGdseXBoIHVuaWNvZGU9IiYjeGUyNTg7IiBkPSJNMzM5IDEwOThoMTYwcTEzIDAgMjMgLTlsNDcxIC00NzFxNyAtOCA3IC0xOHQtNyAtMThsLTQ3MSAtNDcxcS0xMCAtOSAtMjMgLTloLTE2MHEtMTYgMCAtMjEgMTF0NyAyM2w0NjQgNDY0bC00NjQgNDY0cS0xMiAxMiAtNyAyM3QyMSAxMXoiIC8%2BCjxnbHlwaCB1bmljb2RlPSImI3hlMjU5OyIgZD0iTTEwODcgODgycTExIC01IDExIC0yMXYtMTYwcTAgLTEzIC05IC0yM2wtNDcxIC00NzFxLTggLTcgLTE4IC03dC0xOCA3bC00NzEgNDcxcS05IDEwIC05IDIzdjE2MHEwIDE2IDExIDIxdDIzIC03bDQ2NCAtNDY0bDQ2NCA0NjRxMTIgMTIgMjMgN3oiIC8%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%2BCjwvZGVmcz48L3N2Zz4g%29%20format%28%27svg%27%29%7D%2Eglyphicon%7Bposition%3Arelative%3Btop%3A1px%3Bdisplay%3Ainline%2Dblock%3Bfont%2Dfamily%3A%27Glyphicons%20Halflings%27%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3B%2Dwebkit%2Dfont%2Dsmoothing%3Aantialiased%3B%2Dmoz%2Dosx%2Dfont%2Dsmoothing%3Agrayscale%7D%2Eglyphicon%2Dasterisk%3Abefore%7Bcontent%3A%22%5C2a%22%7D%2Eglyphicon%2Dplus%3Abefore%7Bcontent%3A%22%5C2b%22%7D%2Eglyphicon%2Deur%3Abefore%2C%2Eglyphicon%2Deuro%3Abefore%7Bcontent%3A%22%5C20ac%22%7D%2Eglyphicon%2Dminus%3Abefore%7Bcontent%3A%22%5C2212%22%7D%2Eglyphicon%2Dcloud%3Abefore%7Bcontent%3A%22%5C2601%22%7D%2Eglyphicon%2Denvelope%3Abefore%7Bcontent%3A%22%5C2709%22%7D%2Eglyphicon%2Dpencil%3Abefore%7Bcontent%3A%22%5C270f%22%7D%2Eglyphicon%2Dglass%3Abefore%7Bcontent%3A%22%5Ce001%22%7D%2Eglyphicon%2Dmusic%3Abefore%7Bcontent%3A%22%5Ce002%22%7D%2Eglyphicon%2Dsearch%3Abefore%7Bcontent%3A%22%5Ce003%22%7D%2Eglyphicon%2Dheart%3Abefore%7Bcontent%3A%22%5Ce005%22%7D%2Eglyphicon%2Dstar%3Abefore%7Bcontent%3A%22%5Ce006%22%7D%2Eglyphicon%2Dstar%2Dempty%3Abefore%7Bcontent%3A%22%5Ce007%22%7D%2Eglyphicon%2Duser%3Abefore%7Bcontent%3A%22%5Ce008%22%7D%2Eglyphicon%2Dfilm%3Abefore%7Bcontent%3A%22%5Ce009%22%7D%2Eglyphicon%2Dth%2Dlarge%3Abefore%7Bcontent%3A%22%5Ce010%22%7D%2Eglyphicon%2Dth%3Abefore%7Bcontent%3A%22%5Ce011%22%7D%2Eglyphicon%2Dth%2Dlist%3Abefore%7Bcontent%3A%22%5Ce012%22%7D%2Eglyphicon%2Dok%3Abefore%7Bcontent%3A%22%5Ce013%22%7D%2Eglyphicon%2Dremove%3Abefore%7Bcontent%3A%22%5Ce014%22%7D%2Eglyphicon%2Dzoom%2Din%3Abefore%7Bcontent%3A%22%5Ce015%22%7D%2Eglyphicon%2Dzoom%2Dout%3Abefore%7Bcontent%3A%22%5Ce016%22%7D%2Eglyphicon%2Doff%3Abefore%7Bcontent%3A%22%5Ce017%22%7D%2Eglyphicon%2Dsignal%3Abefore%7Bcontent%3A%22%5Ce018%22%7D%2Eglyphicon%2Dcog%3Abefore%7Bcontent%3A%22%5Ce019%22%7D%2Eglyphicon%2Dtrash%3Abefore%7Bcontent%3A%22%5Ce020%22%7D%2Eglyphicon%2Dhome%3Abefore%7Bcontent%3A%22%5Ce021%22%7D%2Eglyphicon%2Dfile%3Abefore%7Bcontent%3A%22%5Ce022%22%7D%2Eglyphicon%2Dtime%3Abefore%7Bcontent%3A%22%5Ce023%22%7D%2Eglyphicon%2Droad%3Abefore%7Bcontent%3A%22%5Ce024%22%7D%2Eglyphicon%2Ddownload%2Dalt%3Abefore%7Bcontent%3A%22%5Ce025%22%7D%2Eglyphicon%2Ddownload%3Abefore%7Bcontent%3A%22%5Ce026%22%7D%2Eglyphicon%2Dupload%3Abefore%7Bcontent%3A%22%5Ce027%22%7D%2Eglyphicon%2Dinbox%3Abefore%7Bcontent%3A%22%5Ce028%22%7D%2Eglyphicon%2Dplay%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce029%22%7D%2Eglyphicon%2Drepeat%3Abefore%7Bcontent%3A%22%5Ce030%22%7D%2Eglyphicon%2Drefresh%3Abefore%7Bcontent%3A%22%5Ce031%22%7D%2Eglyphicon%2Dlist%2Dalt%3Abefore%7Bcontent%3A%22%5Ce032%22%7D%2Eglyphicon%2Dlock%3Abefore%7Bcontent%3A%22%5Ce033%22%7D%2Eglyphicon%2Dflag%3Abefore%7Bcontent%3A%22%5Ce034%22%7D%2Eglyphicon%2Dheadphones%3Abefore%7Bcontent%3A%22%5Ce035%22%7D%2Eglyphicon%2Dvolume%2Doff%3Abefore%7Bcontent%3A%22%5Ce036%22%7D%2Eglyphicon%2Dvolume%2Ddown%3Abefore%7Bcontent%3A%22%5Ce037%22%7D%2Eglyphicon%2Dvolume%2Dup%3Abefore%7Bcontent%3A%22%5Ce038%22%7D%2Eglyphicon%2Dqrcode%3Abefore%7Bcontent%3A%22%5Ce039%22%7D%2Eglyphicon%2Dbarcode%3Abefore%7Bcontent%3A%22%5Ce040%22%7D%2Eglyphicon%2Dtag%3Abefore%7Bcontent%3A%22%5Ce041%22%7D%2Eglyphicon%2Dtags%3Abefore%7Bcontent%3A%22%5Ce042%22%7D%2Eglyphicon%2Dbook%3Abefore%7Bcontent%3A%22%5Ce043%22%7D%2Eglyphicon%2Dbookmark%3Abefore%7Bcontent%3A%22%5Ce044%22%7D%2Eglyphicon%2Dprint%3Abefore%7Bcontent%3A%22%5Ce045%22%7D%2Eglyphicon%2Dcamera%3Abefore%7Bcontent%3A%22%5Ce046%22%7D%2Eglyphicon%2Dfont%3Abefore%7Bcontent%3A%22%5Ce047%22%7D%2Eglyphicon%2Dbold%3Abefore%7Bcontent%3A%22%5Ce048%22%7D%2Eglyphicon%2Ditalic%3Abefore%7Bcontent%3A%22%5Ce049%22%7D%2Eglyphicon%2Dtext%2Dheight%3Abefore%7Bcontent%3A%22%5Ce050%22%7D%2Eglyphicon%2Dtext%2Dwidth%3Abefore%7Bcontent%3A%22%5Ce051%22%7D%2Eglyphicon%2Dalign%2Dleft%3Abefore%7Bcontent%3A%22%5Ce052%22%7D%2Eglyphicon%2Dalign%2Dcenter%3Abefore%7Bcontent%3A%22%5Ce053%22%7D%2Eglyphicon%2Dalign%2Dright%3Abefore%7Bcontent%3A%22%5Ce054%22%7D%2Eglyphicon%2Dalign%2Djustify%3Abefore%7Bcontent%3A%22%5Ce055%22%7D%2Eglyphicon%2Dlist%3Abefore%7Bcontent%3A%22%5Ce056%22%7D%2Eglyphicon%2Dindent%2Dleft%3Abefore%7Bcontent%3A%22%5Ce057%22%7D%2Eglyphicon%2Dindent%2Dright%3Abefore%7Bcontent%3A%22%5Ce058%22%7D%2Eglyphicon%2Dfacetime%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce059%22%7D%2Eglyphicon%2Dpicture%3Abefore%7Bcontent%3A%22%5Ce060%22%7D%2Eglyphicon%2Dmap%2Dmarker%3Abefore%7Bcontent%3A%22%5Ce062%22%7D%2Eglyphicon%2Dadjust%3Abefore%7Bcontent%3A%22%5Ce063%22%7D%2Eglyphicon%2Dtint%3Abefore%7Bcontent%3A%22%5Ce064%22%7D%2Eglyphicon%2Dedit%3Abefore%7Bcontent%3A%22%5Ce065%22%7D%2Eglyphicon%2Dshare%3Abefore%7Bcontent%3A%22%5Ce066%22%7D%2Eglyphicon%2Dcheck%3Abefore%7Bcontent%3A%22%5Ce067%22%7D%2Eglyphicon%2Dmove%3Abefore%7Bcontent%3A%22%5Ce068%22%7D%2Eglyphicon%2Dstep%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce069%22%7D%2Eglyphicon%2Dfast%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce070%22%7D%2Eglyphicon%2Dbackward%3Abefore%7Bcontent%3A%22%5Ce071%22%7D%2Eglyphicon%2Dplay%3Abefore%7Bcontent%3A%22%5Ce072%22%7D%2Eglyphicon%2Dpause%3Abefore%7Bcontent%3A%22%5Ce073%22%7D%2Eglyphicon%2Dstop%3Abefore%7Bcontent%3A%22%5Ce074%22%7D%2Eglyphicon%2Dforward%3Abefore%7Bcontent%3A%22%5Ce075%22%7D%2Eglyphicon%2Dfast%2Dforward%3Abefore%7Bcontent%3A%22%5Ce076%22%7D%2Eglyphicon%2Dstep%2Dforward%3Abefore%7Bcontent%3A%22%5Ce077%22%7D%2Eglyphicon%2Deject%3Abefore%7Bcontent%3A%22%5Ce078%22%7D%2Eglyphicon%2Dchevron%2Dleft%3Abefore%7Bcontent%3A%22%5Ce079%22%7D%2Eglyphicon%2Dchevron%2Dright%3Abefore%7Bcontent%3A%22%5Ce080%22%7D%2Eglyphicon%2Dplus%2Dsign%3Abefore%7Bcontent%3A%22%5Ce081%22%7D%2Eglyphicon%2Dminus%2Dsign%3Abefore%7Bcontent%3A%22%5Ce082%22%7D%2Eglyphicon%2Dremove%2Dsign%3Abefore%7Bcontent%3A%22%5Ce083%22%7D%2Eglyphicon%2Dok%2Dsign%3Abefore%7Bcontent%3A%22%5Ce084%22%7D%2Eglyphicon%2Dquestion%2Dsign%3Abefore%7Bcontent%3A%22%5Ce085%22%7D%2Eglyphicon%2Dinfo%2Dsign%3Abefore%7Bcontent%3A%22%5Ce086%22%7D%2Eglyphicon%2Dscreenshot%3Abefore%7Bcontent%3A%22%5Ce087%22%7D%2Eglyphicon%2Dremove%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce088%22%7D%2Eglyphicon%2Dok%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce089%22%7D%2Eglyphicon%2Dban%2Dcircle%3Abefore%7Bcontent%3A%22%5Ce090%22%7D%2Eglyphicon%2Darrow%2Dleft%3Abefore%7Bcontent%3A%22%5Ce091%22%7D%2Eglyphicon%2Darrow%2Dright%3Abefore%7Bcontent%3A%22%5Ce092%22%7D%2Eglyphicon%2Darrow%2Dup%3Abefore%7Bcontent%3A%22%5Ce093%22%7D%2Eglyphicon%2Darrow%2Ddown%3Abefore%7Bcontent%3A%22%5Ce094%22%7D%2Eglyphicon%2Dshare%2Dalt%3Abefore%7Bcontent%3A%22%5Ce095%22%7D%2Eglyphicon%2Dresize%2Dfull%3Abefore%7Bcontent%3A%22%5Ce096%22%7D%2Eglyphicon%2Dresize%2Dsmall%3Abefore%7Bcontent%3A%22%5Ce097%22%7D%2Eglyphicon%2Dexclamation%2Dsign%3Abefore%7Bcontent%3A%22%5Ce101%22%7D%2Eglyphicon%2Dgift%3Abefore%7Bcontent%3A%22%5Ce102%22%7D%2Eglyphicon%2Dleaf%3Abefore%7Bcontent%3A%22%5Ce103%22%7D%2Eglyphicon%2Dfire%3Abefore%7Bcontent%3A%22%5Ce104%22%7D%2Eglyphicon%2Deye%2Dopen%3Abefore%7Bcontent%3A%22%5Ce105%22%7D%2Eglyphicon%2Deye%2Dclose%3Abefore%7Bcontent%3A%22%5Ce106%22%7D%2Eglyphicon%2Dwarning%2Dsign%3Abefore%7Bcontent%3A%22%5Ce107%22%7D%2Eglyphicon%2Dplane%3Abefore%7Bcontent%3A%22%5Ce108%22%7D%2Eglyphicon%2Dcalendar%3Abefore%7Bcontent%3A%22%5Ce109%22%7D%2Eglyphicon%2Drandom%3Abefore%7Bcontent%3A%22%5Ce110%22%7D%2Eglyphicon%2Dcomment%3Abefore%7Bcontent%3A%22%5Ce111%22%7D%2Eglyphicon%2Dmagnet%3Abefore%7Bcontent%3A%22%5Ce112%22%7D%2Eglyphicon%2Dchevron%2Dup%3Abefore%7Bcontent%3A%22%5Ce113%22%7D%2Eglyphicon%2Dchevron%2Ddown%3Abefore%7Bcontent%3A%22%5Ce114%22%7D%2Eglyphicon%2Dretweet%3Abefore%7Bcontent%3A%22%5Ce115%22%7D%2Eglyphicon%2Dshopping%2Dcart%3Abefore%7Bcontent%3A%22%5Ce116%22%7D%2Eglyphicon%2Dfolder%2Dclose%3Abefore%7Bcontent%3A%22%5Ce117%22%7D%2Eglyphicon%2Dfolder%2Dopen%3Abefore%7Bcontent%3A%22%5Ce118%22%7D%2Eglyphicon%2Dresize%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce119%22%7D%2Eglyphicon%2Dresize%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce120%22%7D%2Eglyphicon%2Dhdd%3Abefore%7Bcontent%3A%22%5Ce121%22%7D%2Eglyphicon%2Dbullhorn%3Abefore%7Bcontent%3A%22%5Ce122%22%7D%2Eglyphicon%2Dbell%3Abefore%7Bcontent%3A%22%5Ce123%22%7D%2Eglyphicon%2Dcertificate%3Abefore%7Bcontent%3A%22%5Ce124%22%7D%2Eglyphicon%2Dthumbs%2Dup%3Abefore%7Bcontent%3A%22%5Ce125%22%7D%2Eglyphicon%2Dthumbs%2Ddown%3Abefore%7Bcontent%3A%22%5Ce126%22%7D%2Eglyphicon%2Dhand%2Dright%3Abefore%7Bcontent%3A%22%5Ce127%22%7D%2Eglyphicon%2Dhand%2Dleft%3Abefore%7Bcontent%3A%22%5Ce128%22%7D%2Eglyphicon%2Dhand%2Dup%3Abefore%7Bcontent%3A%22%5Ce129%22%7D%2Eglyphicon%2Dhand%2Ddown%3Abefore%7Bcontent%3A%22%5Ce130%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dright%3Abefore%7Bcontent%3A%22%5Ce131%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dleft%3Abefore%7Bcontent%3A%22%5Ce132%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Dup%3Abefore%7Bcontent%3A%22%5Ce133%22%7D%2Eglyphicon%2Dcircle%2Darrow%2Ddown%3Abefore%7Bcontent%3A%22%5Ce134%22%7D%2Eglyphicon%2Dglobe%3Abefore%7Bcontent%3A%22%5Ce135%22%7D%2Eglyphicon%2Dwrench%3Abefore%7Bcontent%3A%22%5Ce136%22%7D%2Eglyphicon%2Dtasks%3Abefore%7Bcontent%3A%22%5Ce137%22%7D%2Eglyphicon%2Dfilter%3Abefore%7Bcontent%3A%22%5Ce138%22%7D%2Eglyphicon%2Dbriefcase%3Abefore%7Bcontent%3A%22%5Ce139%22%7D%2Eglyphicon%2Dfullscreen%3Abefore%7Bcontent%3A%22%5Ce140%22%7D%2Eglyphicon%2Ddashboard%3Abefore%7Bcontent%3A%22%5Ce141%22%7D%2Eglyphicon%2Dpaperclip%3Abefore%7Bcontent%3A%22%5Ce142%22%7D%2Eglyphicon%2Dheart%2Dempty%3Abefore%7Bcontent%3A%22%5Ce143%22%7D%2Eglyphicon%2Dlink%3Abefore%7Bcontent%3A%22%5Ce144%22%7D%2Eglyphicon%2Dphone%3Abefore%7Bcontent%3A%22%5Ce145%22%7D%2Eglyphicon%2Dpushpin%3Abefore%7Bcontent%3A%22%5Ce146%22%7D%2Eglyphicon%2Dusd%3Abefore%7Bcontent%3A%22%5Ce148%22%7D%2Eglyphicon%2Dgbp%3Abefore%7Bcontent%3A%22%5Ce149%22%7D%2Eglyphicon%2Dsort%3Abefore%7Bcontent%3A%22%5Ce150%22%7D%2Eglyphicon%2Dsort%2Dby%2Dalphabet%3Abefore%7Bcontent%3A%22%5Ce151%22%7D%2Eglyphicon%2Dsort%2Dby%2Dalphabet%2Dalt%3Abefore%7Bcontent%3A%22%5Ce152%22%7D%2Eglyphicon%2Dsort%2Dby%2Dorder%3Abefore%7Bcontent%3A%22%5Ce153%22%7D%2Eglyphicon%2Dsort%2Dby%2Dorder%2Dalt%3Abefore%7Bcontent%3A%22%5Ce154%22%7D%2Eglyphicon%2Dsort%2Dby%2Dattributes%3Abefore%7Bcontent%3A%22%5Ce155%22%7D%2Eglyphicon%2Dsort%2Dby%2Dattributes%2Dalt%3Abefore%7Bcontent%3A%22%5Ce156%22%7D%2Eglyphicon%2Dunchecked%3Abefore%7Bcontent%3A%22%5Ce157%22%7D%2Eglyphicon%2Dexpand%3Abefore%7Bcontent%3A%22%5Ce158%22%7D%2Eglyphicon%2Dcollapse%2Ddown%3Abefore%7Bcontent%3A%22%5Ce159%22%7D%2Eglyphicon%2Dcollapse%2Dup%3Abefore%7Bcontent%3A%22%5Ce160%22%7D%2Eglyphicon%2Dlog%2Din%3Abefore%7Bcontent%3A%22%5Ce161%22%7D%2Eglyphicon%2Dflash%3Abefore%7Bcontent%3A%22%5Ce162%22%7D%2Eglyphicon%2Dlog%2Dout%3Abefore%7Bcontent%3A%22%5Ce163%22%7D%2Eglyphicon%2Dnew%2Dwindow%3Abefore%7Bcontent%3A%22%5Ce164%22%7D%2Eglyphicon%2Drecord%3Abefore%7Bcontent%3A%22%5Ce165%22%7D%2Eglyphicon%2Dsave%3Abefore%7Bcontent%3A%22%5Ce166%22%7D%2Eglyphicon%2Dopen%3Abefore%7Bcontent%3A%22%5Ce167%22%7D%2Eglyphicon%2Dsaved%3Abefore%7Bcontent%3A%22%5Ce168%22%7D%2Eglyphicon%2Dimport%3Abefore%7Bcontent%3A%22%5Ce169%22%7D%2Eglyphicon%2Dexport%3Abefore%7Bcontent%3A%22%5Ce170%22%7D%2Eglyphicon%2Dsend%3Abefore%7Bcontent%3A%22%5Ce171%22%7D%2Eglyphicon%2Dfloppy%2Ddisk%3Abefore%7Bcontent%3A%22%5Ce172%22%7D%2Eglyphicon%2Dfloppy%2Dsaved%3Abefore%7Bcontent%3A%22%5Ce173%22%7D%2Eglyphicon%2Dfloppy%2Dremove%3Abefore%7Bcontent%3A%22%5Ce174%22%7D%2Eglyphicon%2Dfloppy%2Dsave%3Abefore%7Bcontent%3A%22%5Ce175%22%7D%2Eglyphicon%2Dfloppy%2Dopen%3Abefore%7Bcontent%3A%22%5Ce176%22%7D%2Eglyphicon%2Dcredit%2Dcard%3Abefore%7Bcontent%3A%22%5Ce177%22%7D%2Eglyphicon%2Dtransfer%3Abefore%7Bcontent%3A%22%5Ce178%22%7D%2Eglyphicon%2Dcutlery%3Abefore%7Bcontent%3A%22%5Ce179%22%7D%2Eglyphicon%2Dheader%3Abefore%7Bcontent%3A%22%5Ce180%22%7D%2Eglyphicon%2Dcompressed%3Abefore%7Bcontent%3A%22%5Ce181%22%7D%2Eglyphicon%2Dearphone%3Abefore%7Bcontent%3A%22%5Ce182%22%7D%2Eglyphicon%2Dphone%2Dalt%3Abefore%7Bcontent%3A%22%5Ce183%22%7D%2Eglyphicon%2Dtower%3Abefore%7Bcontent%3A%22%5Ce184%22%7D%2Eglyphicon%2Dstats%3Abefore%7Bcontent%3A%22%5Ce185%22%7D%2Eglyphicon%2Dsd%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce186%22%7D%2Eglyphicon%2Dhd%2Dvideo%3Abefore%7Bcontent%3A%22%5Ce187%22%7D%2Eglyphicon%2Dsubtitles%3Abefore%7Bcontent%3A%22%5Ce188%22%7D%2Eglyphicon%2Dsound%2Dstereo%3Abefore%7Bcontent%3A%22%5Ce189%22%7D%2Eglyphicon%2Dsound%2Ddolby%3Abefore%7Bcontent%3A%22%5Ce190%22%7D%2Eglyphicon%2Dsound%2D5%2D1%3Abefore%7Bcontent%3A%22%5Ce191%22%7D%2Eglyphicon%2Dsound%2D6%2D1%3Abefore%7Bcontent%3A%22%5Ce192%22%7D%2Eglyphicon%2Dsound%2D7%2D1%3Abefore%7Bcontent%3A%22%5Ce193%22%7D%2Eglyphicon%2Dcopyright%2Dmark%3Abefore%7Bcontent%3A%22%5Ce194%22%7D%2Eglyphicon%2Dregistration%2Dmark%3Abefore%7Bcontent%3A%22%5Ce195%22%7D%2Eglyphicon%2Dcloud%2Ddownload%3Abefore%7Bcontent%3A%22%5Ce197%22%7D%2Eglyphicon%2Dcloud%2Dupload%3Abefore%7Bcontent%3A%22%5Ce198%22%7D%2Eglyphicon%2Dtree%2Dconifer%3Abefore%7Bcontent%3A%22%5Ce199%22%7D%2Eglyphicon%2Dtree%2Ddeciduous%3Abefore%7Bcontent%3A%22%5Ce200%22%7D%2Eglyphicon%2Dcd%3Abefore%7Bcontent%3A%22%5Ce201%22%7D%2Eglyphicon%2Dsave%2Dfile%3Abefore%7Bcontent%3A%22%5Ce202%22%7D%2Eglyphicon%2Dopen%2Dfile%3Abefore%7Bcontent%3A%22%5Ce203%22%7D%2Eglyphicon%2Dlevel%2Dup%3Abefore%7Bcontent%3A%22%5Ce204%22%7D%2Eglyphicon%2Dcopy%3Abefore%7Bcontent%3A%22%5Ce205%22%7D%2Eglyphicon%2Dpaste%3Abefore%7Bcontent%3A%22%5Ce206%22%7D%2Eglyphicon%2Dalert%3Abefore%7Bcontent%3A%22%5Ce209%22%7D%2Eglyphicon%2Dequalizer%3Abefore%7Bcontent%3A%22%5Ce210%22%7D%2Eglyphicon%2Dking%3Abefore%7Bcontent%3A%22%5Ce211%22%7D%2Eglyphicon%2Dqueen%3Abefore%7Bcontent%3A%22%5Ce212%22%7D%2Eglyphicon%2Dpawn%3Abefore%7Bcontent%3A%22%5Ce213%22%7D%2Eglyphicon%2Dbishop%3Abefore%7Bcontent%3A%22%5Ce214%22%7D%2Eglyphicon%2Dknight%3Abefore%7Bcontent%3A%22%5Ce215%22%7D%2Eglyphicon%2Dbaby%2Dformula%3Abefore%7Bcontent%3A%22%5Ce216%22%7D%2Eglyphicon%2Dtent%3Abefore%7Bcontent%3A%22%5C26fa%22%7D%2Eglyphicon%2Dblackboard%3Abefore%7Bcontent%3A%22%5Ce218%22%7D%2Eglyphicon%2Dbed%3Abefore%7Bcontent%3A%22%5Ce219%22%7D%2Eglyphicon%2Dapple%3Abefore%7Bcontent%3A%22%5Cf8ff%22%7D%2Eglyphicon%2Derase%3Abefore%7Bcontent%3A%22%5Ce221%22%7D%2Eglyphicon%2Dhourglass%3Abefore%7Bcontent%3A%22%5C231b%22%7D%2Eglyphicon%2Dlamp%3Abefore%7Bcontent%3A%22%5Ce223%22%7D%2Eglyphicon%2Dduplicate%3Abefore%7Bcontent%3A%22%5Ce224%22%7D%2Eglyphicon%2Dpiggy%2Dbank%3Abefore%7Bcontent%3A%22%5Ce225%22%7D%2Eglyphicon%2Dscissors%3Abefore%7Bcontent%3A%22%5Ce226%22%7D%2Eglyphicon%2Dbitcoin%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dbtc%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dxbt%3Abefore%7Bcontent%3A%22%5Ce227%22%7D%2Eglyphicon%2Dyen%3Abefore%7Bcontent%3A%22%5C00a5%22%7D%2Eglyphicon%2Djpy%3Abefore%7Bcontent%3A%22%5C00a5%22%7D%2Eglyphicon%2Druble%3Abefore%7Bcontent%3A%22%5C20bd%22%7D%2Eglyphicon%2Drub%3Abefore%7Bcontent%3A%22%5C20bd%22%7D%2Eglyphicon%2Dscale%3Abefore%7Bcontent%3A%22%5Ce230%22%7D%2Eglyphicon%2Dice%2Dlolly%3Abefore%7Bcontent%3A%22%5Ce231%22%7D%2Eglyphicon%2Dice%2Dlolly%2Dtasted%3Abefore%7Bcontent%3A%22%5Ce232%22%7D%2Eglyphicon%2Deducation%3Abefore%7Bcontent%3A%22%5Ce233%22%7D%2Eglyphicon%2Doption%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce234%22%7D%2Eglyphicon%2Doption%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce235%22%7D%2Eglyphicon%2Dmenu%2Dhamburger%3Abefore%7Bcontent%3A%22%5Ce236%22%7D%2Eglyphicon%2Dmodal%2Dwindow%3Abefore%7Bcontent%3A%22%5Ce237%22%7D%2Eglyphicon%2Doil%3Abefore%7Bcontent%3A%22%5Ce238%22%7D%2Eglyphicon%2Dgrain%3Abefore%7Bcontent%3A%22%5Ce239%22%7D%2Eglyphicon%2Dsunglasses%3Abefore%7Bcontent%3A%22%5Ce240%22%7D%2Eglyphicon%2Dtext%2Dsize%3Abefore%7Bcontent%3A%22%5Ce241%22%7D%2Eglyphicon%2Dtext%2Dcolor%3Abefore%7Bcontent%3A%22%5Ce242%22%7D%2Eglyphicon%2Dtext%2Dbackground%3Abefore%7Bcontent%3A%22%5Ce243%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dtop%3Abefore%7Bcontent%3A%22%5Ce244%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dbottom%3Abefore%7Bcontent%3A%22%5Ce245%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dhorizontal%3Abefore%7Bcontent%3A%22%5Ce246%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dleft%3Abefore%7Bcontent%3A%22%5Ce247%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dvertical%3Abefore%7Bcontent%3A%22%5Ce248%22%7D%2Eglyphicon%2Dobject%2Dalign%2Dright%3Abefore%7Bcontent%3A%22%5Ce249%22%7D%2Eglyphicon%2Dtriangle%2Dright%3Abefore%7Bcontent%3A%22%5Ce250%22%7D%2Eglyphicon%2Dtriangle%2Dleft%3Abefore%7Bcontent%3A%22%5Ce251%22%7D%2Eglyphicon%2Dtriangle%2Dbottom%3Abefore%7Bcontent%3A%22%5Ce252%22%7D%2Eglyphicon%2Dtriangle%2Dtop%3Abefore%7Bcontent%3A%22%5Ce253%22%7D%2Eglyphicon%2Dconsole%3Abefore%7Bcontent%3A%22%5Ce254%22%7D%2Eglyphicon%2Dsuperscript%3Abefore%7Bcontent%3A%22%5Ce255%22%7D%2Eglyphicon%2Dsubscript%3Abefore%7Bcontent%3A%22%5Ce256%22%7D%2Eglyphicon%2Dmenu%2Dleft%3Abefore%7Bcontent%3A%22%5Ce257%22%7D%2Eglyphicon%2Dmenu%2Dright%3Abefore%7Bcontent%3A%22%5Ce258%22%7D%2Eglyphicon%2Dmenu%2Ddown%3Abefore%7Bcontent%3A%22%5Ce259%22%7D%2Eglyphicon%2Dmenu%2Dup%3Abefore%7Bcontent%3A%22%5Ce260%22%7D%2A%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7D%3Aafter%2C%3Abefore%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7Dhtml%7Bfont%2Dsize%3A10px%3B%2Dwebkit%2Dtap%2Dhighlight%2Dcolor%3Argba%280%2C0%2C0%2C0%29%7Dbody%7Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23fff%7Dbutton%2Cinput%2Cselect%2Ctextarea%7Bfont%2Dfamily%3Ainherit%3Bfont%2Dsize%3Ainherit%3Bline%2Dheight%3Ainherit%7Da%7Bcolor%3A%23337ab7%3Btext%2Ddecoration%3Anone%7Da%3Afocus%2Ca%3Ahover%7Bcolor%3A%2323527c%3Btext%2Ddecoration%3Aunderline%7Da%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7Dfigure%7Bmargin%3A0%7Dimg%7Bvertical%2Dalign%3Amiddle%7D%2Ecarousel%2Dinner%3E%2Eitem%3Ea%3Eimg%2C%2Ecarousel%2Dinner%3E%2Eitem%3Eimg%2C%2Eimg%2Dresponsive%2C%2Ethumbnail%20a%3Eimg%2C%2Ethumbnail%3Eimg%7Bdisplay%3Ablock%3Bmax%2Dwidth%3A100%25%3Bheight%3Aauto%7D%2Eimg%2Drounded%7Bborder%2Dradius%3A6px%7D%2Eimg%2Dthumbnail%7Bdisplay%3Ainline%2Dblock%3Bmax%2Dwidth%3A100%25%3Bheight%3Aauto%3Bpadding%3A4px%3Bline%2Dheight%3A1%2E42857143%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dtransition%3Aall%20%2E2s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3Aall%20%2E2s%20ease%2Din%2Dout%3Btransition%3Aall%20%2E2s%20ease%2Din%2Dout%7D%2Eimg%2Dcircle%7Bborder%2Dradius%3A50%25%7Dhr%7Bmargin%2Dtop%3A20px%3Bmargin%2Dbottom%3A20px%3Bborder%3A0%3Bborder%2Dtop%3A1px%20solid%20%23eee%7D%2Esr%2Donly%7Bposition%3Aabsolute%3Bwidth%3A1px%3Bheight%3A1px%3Bpadding%3A0%3Bmargin%3A%2D1px%3Boverflow%3Ahidden%3Bclip%3Arect%280%2C0%2C0%2C0%29%3Bborder%3A0%7D%2Esr%2Donly%2Dfocusable%3Aactive%2C%2Esr%2Donly%2Dfocusable%3Afocus%7Bposition%3Astatic%3Bwidth%3Aauto%3Bheight%3Aauto%3Bmargin%3A0%3Boverflow%3Avisible%3Bclip%3Aauto%7D%5Brole%3Dbutton%5D%7Bcursor%3Apointer%7D%2Eh1%2C%2Eh2%2C%2Eh3%2C%2Eh4%2C%2Eh5%2C%2Eh6%2Ch1%2Ch2%2Ch3%2Ch4%2Ch5%2Ch6%7Bfont%2Dfamily%3Ainherit%3Bfont%2Dweight%3A500%3Bline%2Dheight%3A1%2E1%3Bcolor%3Ainherit%7D%2Eh1%20%2Esmall%2C%2Eh1%20small%2C%2Eh2%20%2Esmall%2C%2Eh2%20small%2C%2Eh3%20%2Esmall%2C%2Eh3%20small%2C%2Eh4%20%2Esmall%2C%2Eh4%20small%2C%2Eh5%20%2Esmall%2C%2Eh5%20small%2C%2Eh6%20%2Esmall%2C%2Eh6%20small%2Ch1%20%2Esmall%2Ch1%20small%2Ch2%20%2Esmall%2Ch2%20small%2Ch3%20%2Esmall%2Ch3%20small%2Ch4%20%2Esmall%2Ch4%20small%2Ch5%20%2Esmall%2Ch5%20small%2Ch6%20%2Esmall%2Ch6%20small%7Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3Bcolor%3A%23777%7D%2Eh1%2C%2Eh2%2C%2Eh3%2Ch1%2Ch2%2Ch3%7Bmargin%2Dtop%3A20px%3Bmargin%2Dbottom%3A10px%7D%2Eh1%20%2Esmall%2C%2Eh1%20small%2C%2Eh2%20%2Esmall%2C%2Eh2%20small%2C%2Eh3%20%2Esmall%2C%2Eh3%20small%2Ch1%20%2Esmall%2Ch1%20small%2Ch2%20%2Esmall%2Ch2%20small%2Ch3%20%2Esmall%2Ch3%20small%7Bfont%2Dsize%3A65%25%7D%2Eh4%2C%2Eh5%2C%2Eh6%2Ch4%2Ch5%2Ch6%7Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Eh4%20%2Esmall%2C%2Eh4%20small%2C%2Eh5%20%2Esmall%2C%2Eh5%20small%2C%2Eh6%20%2Esmall%2C%2Eh6%20small%2Ch4%20%2Esmall%2Ch4%20small%2Ch5%20%2Esmall%2Ch5%20small%2Ch6%20%2Esmall%2Ch6%20small%7Bfont%2Dsize%3A75%25%7D%2Eh1%2Ch1%7Bfont%2Dsize%3A36px%7D%2Eh2%2Ch2%7Bfont%2Dsize%3A30px%7D%2Eh3%2Ch3%7Bfont%2Dsize%3A24px%7D%2Eh4%2Ch4%7Bfont%2Dsize%3A18px%7D%2Eh5%2Ch5%7Bfont%2Dsize%3A14px%7D%2Eh6%2Ch6%7Bfont%2Dsize%3A12px%7Dp%7Bmargin%3A0%200%2010px%7D%2Elead%7Bmargin%2Dbottom%3A20px%3Bfont%2Dsize%3A16px%3Bfont%2Dweight%3A300%3Bline%2Dheight%3A1%2E4%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Elead%7Bfont%2Dsize%3A21px%7D%7D%2Esmall%2Csmall%7Bfont%2Dsize%3A85%25%7D%2Emark%2Cmark%7Bpadding%3A%2E2em%3Bbackground%2Dcolor%3A%23fcf8e3%7D%2Etext%2Dleft%7Btext%2Dalign%3Aleft%7D%2Etext%2Dright%7Btext%2Dalign%3Aright%7D%2Etext%2Dcenter%7Btext%2Dalign%3Acenter%7D%2Etext%2Djustify%7Btext%2Dalign%3Ajustify%7D%2Etext%2Dnowrap%7Bwhite%2Dspace%3Anowrap%7D%2Etext%2Dlowercase%7Btext%2Dtransform%3Alowercase%7D%2Etext%2Duppercase%7Btext%2Dtransform%3Auppercase%7D%2Etext%2Dcapitalize%7Btext%2Dtransform%3Acapitalize%7D%2Etext%2Dmuted%7Bcolor%3A%23777%7D%2Etext%2Dprimary%7Bcolor%3A%23337ab7%7Da%2Etext%2Dprimary%3Afocus%2Ca%2Etext%2Dprimary%3Ahover%7Bcolor%3A%23286090%7D%2Etext%2Dsuccess%7Bcolor%3A%233c763d%7Da%2Etext%2Dsuccess%3Afocus%2Ca%2Etext%2Dsuccess%3Ahover%7Bcolor%3A%232b542c%7D%2Etext%2Dinfo%7Bcolor%3A%2331708f%7Da%2Etext%2Dinfo%3Afocus%2Ca%2Etext%2Dinfo%3Ahover%7Bcolor%3A%23245269%7D%2Etext%2Dwarning%7Bcolor%3A%238a6d3b%7Da%2Etext%2Dwarning%3Afocus%2Ca%2Etext%2Dwarning%3Ahover%7Bcolor%3A%2366512c%7D%2Etext%2Ddanger%7Bcolor%3A%23a94442%7Da%2Etext%2Ddanger%3Afocus%2Ca%2Etext%2Ddanger%3Ahover%7Bcolor%3A%23843534%7D%2Ebg%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%7Da%2Ebg%2Dprimary%3Afocus%2Ca%2Ebg%2Dprimary%3Ahover%7Bbackground%2Dcolor%3A%23286090%7D%2Ebg%2Dsuccess%7Bbackground%2Dcolor%3A%23dff0d8%7Da%2Ebg%2Dsuccess%3Afocus%2Ca%2Ebg%2Dsuccess%3Ahover%7Bbackground%2Dcolor%3A%23c1e2b3%7D%2Ebg%2Dinfo%7Bbackground%2Dcolor%3A%23d9edf7%7Da%2Ebg%2Dinfo%3Afocus%2Ca%2Ebg%2Dinfo%3Ahover%7Bbackground%2Dcolor%3A%23afd9ee%7D%2Ebg%2Dwarning%7Bbackground%2Dcolor%3A%23fcf8e3%7Da%2Ebg%2Dwarning%3Afocus%2Ca%2Ebg%2Dwarning%3Ahover%7Bbackground%2Dcolor%3A%23f7ecb5%7D%2Ebg%2Ddanger%7Bbackground%2Dcolor%3A%23f2dede%7Da%2Ebg%2Ddanger%3Afocus%2Ca%2Ebg%2Ddanger%3Ahover%7Bbackground%2Dcolor%3A%23e4b9b9%7D%2Epage%2Dheader%7Bpadding%2Dbottom%3A9px%3Bmargin%3A40px%200%2020px%3Bborder%2Dbottom%3A1px%20solid%20%23eee%7Dol%2Cul%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A10px%7Dol%20ol%2Col%20ul%2Cul%20ol%2Cul%20ul%7Bmargin%2Dbottom%3A0%7D%2Elist%2Dunstyled%7Bpadding%2Dleft%3A0%3Blist%2Dstyle%3Anone%7D%2Elist%2Dinline%7Bpadding%2Dleft%3A0%3Bmargin%2Dleft%3A%2D5px%3Blist%2Dstyle%3Anone%7D%2Elist%2Dinline%3Eli%7Bdisplay%3Ainline%2Dblock%3Bpadding%2Dright%3A5px%3Bpadding%2Dleft%3A5px%7Ddl%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A20px%7Ddd%2Cdt%7Bline%2Dheight%3A1%2E42857143%7Ddt%7Bfont%2Dweight%3A700%7Ddd%7Bmargin%2Dleft%3A0%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Edl%2Dhorizontal%20dt%7Bfloat%3Aleft%3Bwidth%3A160px%3Boverflow%3Ahidden%3Bclear%3Aleft%3Btext%2Dalign%3Aright%3Btext%2Doverflow%3Aellipsis%3Bwhite%2Dspace%3Anowrap%7D%2Edl%2Dhorizontal%20dd%7Bmargin%2Dleft%3A180px%7D%7Dabbr%5Bdata%2Doriginal%2Dtitle%5D%2Cabbr%5Btitle%5D%7Bcursor%3Ahelp%3Bborder%2Dbottom%3A1px%20dotted%20%23777%7D%2Einitialism%7Bfont%2Dsize%3A90%25%3Btext%2Dtransform%3Auppercase%7Dblockquote%7Bpadding%3A10px%2020px%3Bmargin%3A0%200%2020px%3Bfont%2Dsize%3A17%2E5px%3Bborder%2Dleft%3A5px%20solid%20%23eee%7Dblockquote%20ol%3Alast%2Dchild%2Cblockquote%20p%3Alast%2Dchild%2Cblockquote%20ul%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%7Dblockquote%20%2Esmall%2Cblockquote%20footer%2Cblockquote%20small%7Bdisplay%3Ablock%3Bfont%2Dsize%3A80%25%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23777%7Dblockquote%20%2Esmall%3Abefore%2Cblockquote%20footer%3Abefore%2Cblockquote%20small%3Abefore%7Bcontent%3A%27%5C2014%20%5C00A0%27%7D%2Eblockquote%2Dreverse%2Cblockquote%2Epull%2Dright%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A0%3Btext%2Dalign%3Aright%3Bborder%2Dright%3A5px%20solid%20%23eee%3Bborder%2Dleft%3A0%7D%2Eblockquote%2Dreverse%20%2Esmall%3Abefore%2C%2Eblockquote%2Dreverse%20footer%3Abefore%2C%2Eblockquote%2Dreverse%20small%3Abefore%2Cblockquote%2Epull%2Dright%20%2Esmall%3Abefore%2Cblockquote%2Epull%2Dright%20footer%3Abefore%2Cblockquote%2Epull%2Dright%20small%3Abefore%7Bcontent%3A%27%27%7D%2Eblockquote%2Dreverse%20%2Esmall%3Aafter%2C%2Eblockquote%2Dreverse%20footer%3Aafter%2C%2Eblockquote%2Dreverse%20small%3Aafter%2Cblockquote%2Epull%2Dright%20%2Esmall%3Aafter%2Cblockquote%2Epull%2Dright%20footer%3Aafter%2Cblockquote%2Epull%2Dright%20small%3Aafter%7Bcontent%3A%27%5C00A0%20%5C2014%27%7Daddress%7Bmargin%2Dbottom%3A20px%3Bfont%2Dstyle%3Anormal%3Bline%2Dheight%3A1%2E42857143%7Dcode%2Ckbd%2Cpre%2Csamp%7Bfont%2Dfamily%3Amonospace%7Dcode%7Bpadding%3A2px%204px%3Bfont%2Dsize%3A90%25%3Bcolor%3A%23c7254e%3Bbackground%2Dcolor%3A%23f9f2f4%3Bborder%2Dradius%3A4px%7Dkbd%7Bpadding%3A2px%204px%3Bfont%2Dsize%3A90%25%3Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23333%3Bborder%2Dradius%3A3px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E25%29%3Bbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E25%29%7Dkbd%20kbd%7Bpadding%3A0%3Bfont%2Dsize%3A100%25%3Bfont%2Dweight%3A700%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7Dpre%7Bdisplay%3Ablock%3Bpadding%3A9%2E5px%3Bmargin%3A0%200%2010px%3Bfont%2Dsize%3A13px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bword%2Dbreak%3Abreak%2Dall%3Bword%2Dwrap%3Abreak%2Dword%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%7Dpre%20code%7Bpadding%3A0%3Bfont%2Dsize%3Ainherit%3Bcolor%3Ainherit%3Bwhite%2Dspace%3Apre%2Dwrap%3Bbackground%2Dcolor%3Atransparent%3Bborder%2Dradius%3A0%7D%2Epre%2Dscrollable%7Bmax%2Dheight%3A340px%3Boverflow%2Dy%3Ascroll%7D%2Econtainer%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Econtainer%7Bwidth%3A750px%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Econtainer%7Bwidth%3A970px%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Econtainer%7Bwidth%3A1170px%7D%7D%2Econtainer%2Dfluid%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%2Erow%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%2Ecol%2Dlg%2D1%2C%2Ecol%2Dlg%2D10%2C%2Ecol%2Dlg%2D11%2C%2Ecol%2Dlg%2D12%2C%2Ecol%2Dlg%2D2%2C%2Ecol%2Dlg%2D3%2C%2Ecol%2Dlg%2D4%2C%2Ecol%2Dlg%2D5%2C%2Ecol%2Dlg%2D6%2C%2Ecol%2Dlg%2D7%2C%2Ecol%2Dlg%2D8%2C%2Ecol%2Dlg%2D9%2C%2Ecol%2Dmd%2D1%2C%2Ecol%2Dmd%2D10%2C%2Ecol%2Dmd%2D11%2C%2Ecol%2Dmd%2D12%2C%2Ecol%2Dmd%2D2%2C%2Ecol%2Dmd%2D3%2C%2Ecol%2Dmd%2D4%2C%2Ecol%2Dmd%2D5%2C%2Ecol%2Dmd%2D6%2C%2Ecol%2Dmd%2D7%2C%2Ecol%2Dmd%2D8%2C%2Ecol%2Dmd%2D9%2C%2Ecol%2Dsm%2D1%2C%2Ecol%2Dsm%2D10%2C%2Ecol%2Dsm%2D11%2C%2Ecol%2Dsm%2D12%2C%2Ecol%2Dsm%2D2%2C%2Ecol%2Dsm%2D3%2C%2Ecol%2Dsm%2D4%2C%2Ecol%2Dsm%2D5%2C%2Ecol%2Dsm%2D6%2C%2Ecol%2Dsm%2D7%2C%2Ecol%2Dsm%2D8%2C%2Ecol%2Dsm%2D9%2C%2Ecol%2Dxs%2D1%2C%2Ecol%2Dxs%2D10%2C%2Ecol%2Dxs%2D11%2C%2Ecol%2Dxs%2D12%2C%2Ecol%2Dxs%2D2%2C%2Ecol%2Dxs%2D3%2C%2Ecol%2Dxs%2D4%2C%2Ecol%2Dxs%2D5%2C%2Ecol%2Dxs%2D6%2C%2Ecol%2Dxs%2D7%2C%2Ecol%2Dxs%2D8%2C%2Ecol%2Dxs%2D9%7Bposition%3Arelative%3Bmin%2Dheight%3A1px%3Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%7D%2Ecol%2Dxs%2D1%2C%2Ecol%2Dxs%2D10%2C%2Ecol%2Dxs%2D11%2C%2Ecol%2Dxs%2D12%2C%2Ecol%2Dxs%2D2%2C%2Ecol%2Dxs%2D3%2C%2Ecol%2Dxs%2D4%2C%2Ecol%2Dxs%2D5%2C%2Ecol%2Dxs%2D6%2C%2Ecol%2Dxs%2D7%2C%2Ecol%2Dxs%2D8%2C%2Ecol%2Dxs%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dxs%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dxs%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dxs%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dxs%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dxs%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dxs%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dxs%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dxs%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dxs%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dxs%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dxs%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dxs%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dxs%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dxs%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dxs%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dxs%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dxs%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dxs%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dxs%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dxs%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dxs%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dxs%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dxs%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dxs%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dxs%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dxs%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dxs%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dxs%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Ecol%2Dsm%2D1%2C%2Ecol%2Dsm%2D10%2C%2Ecol%2Dsm%2D11%2C%2Ecol%2Dsm%2D12%2C%2Ecol%2Dsm%2D2%2C%2Ecol%2Dsm%2D3%2C%2Ecol%2Dsm%2D4%2C%2Ecol%2Dsm%2D5%2C%2Ecol%2Dsm%2D6%2C%2Ecol%2Dsm%2D7%2C%2Ecol%2Dsm%2D8%2C%2Ecol%2Dsm%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dsm%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dsm%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dsm%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dsm%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dsm%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dsm%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dsm%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dsm%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dsm%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dsm%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dsm%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dsm%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dsm%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dsm%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dsm%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dsm%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dsm%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dsm%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dsm%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dsm%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dsm%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dsm%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dsm%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dsm%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dsm%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dsm%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dsm%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dsm%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Ecol%2Dmd%2D1%2C%2Ecol%2Dmd%2D10%2C%2Ecol%2Dmd%2D11%2C%2Ecol%2Dmd%2D12%2C%2Ecol%2Dmd%2D2%2C%2Ecol%2Dmd%2D3%2C%2Ecol%2Dmd%2D4%2C%2Ecol%2Dmd%2D5%2C%2Ecol%2Dmd%2D6%2C%2Ecol%2Dmd%2D7%2C%2Ecol%2Dmd%2D8%2C%2Ecol%2Dmd%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dmd%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dmd%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dmd%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dmd%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dmd%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dmd%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dmd%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dmd%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dmd%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dmd%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dmd%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dmd%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dmd%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dmd%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dmd%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dmd%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dmd%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dmd%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dmd%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dmd%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dmd%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dmd%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dmd%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dmd%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dmd%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dmd%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dmd%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dmd%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Ecol%2Dlg%2D1%2C%2Ecol%2Dlg%2D10%2C%2Ecol%2Dlg%2D11%2C%2Ecol%2Dlg%2D12%2C%2Ecol%2Dlg%2D2%2C%2Ecol%2Dlg%2D3%2C%2Ecol%2Dlg%2D4%2C%2Ecol%2Dlg%2D5%2C%2Ecol%2Dlg%2D6%2C%2Ecol%2Dlg%2D7%2C%2Ecol%2Dlg%2D8%2C%2Ecol%2Dlg%2D9%7Bfloat%3Aleft%7D%2Ecol%2Dlg%2D12%7Bwidth%3A100%25%7D%2Ecol%2Dlg%2D11%7Bwidth%3A91%2E66666667%25%7D%2Ecol%2Dlg%2D10%7Bwidth%3A83%2E33333333%25%7D%2Ecol%2Dlg%2D9%7Bwidth%3A75%25%7D%2Ecol%2Dlg%2D8%7Bwidth%3A66%2E66666667%25%7D%2Ecol%2Dlg%2D7%7Bwidth%3A58%2E33333333%25%7D%2Ecol%2Dlg%2D6%7Bwidth%3A50%25%7D%2Ecol%2Dlg%2D5%7Bwidth%3A41%2E66666667%25%7D%2Ecol%2Dlg%2D4%7Bwidth%3A33%2E33333333%25%7D%2Ecol%2Dlg%2D3%7Bwidth%3A25%25%7D%2Ecol%2Dlg%2D2%7Bwidth%3A16%2E66666667%25%7D%2Ecol%2Dlg%2D1%7Bwidth%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D12%7Bright%3A100%25%7D%2Ecol%2Dlg%2Dpull%2D11%7Bright%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D10%7Bright%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D9%7Bright%3A75%25%7D%2Ecol%2Dlg%2Dpull%2D8%7Bright%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D7%7Bright%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D6%7Bright%3A50%25%7D%2Ecol%2Dlg%2Dpull%2D5%7Bright%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D4%7Bright%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D3%7Bright%3A25%25%7D%2Ecol%2Dlg%2Dpull%2D2%7Bright%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Dpull%2D1%7Bright%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpull%2D0%7Bright%3Aauto%7D%2Ecol%2Dlg%2Dpush%2D12%7Bleft%3A100%25%7D%2Ecol%2Dlg%2Dpush%2D11%7Bleft%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D10%7Bleft%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D9%7Bleft%3A75%25%7D%2Ecol%2Dlg%2Dpush%2D8%7Bleft%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D7%7Bleft%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D6%7Bleft%3A50%25%7D%2Ecol%2Dlg%2Dpush%2D5%7Bleft%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D4%7Bleft%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D3%7Bleft%3A25%25%7D%2Ecol%2Dlg%2Dpush%2D2%7Bleft%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Dpush%2D1%7Bleft%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Dpush%2D0%7Bleft%3Aauto%7D%2Ecol%2Dlg%2Doffset%2D12%7Bmargin%2Dleft%3A100%25%7D%2Ecol%2Dlg%2Doffset%2D11%7Bmargin%2Dleft%3A91%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D10%7Bmargin%2Dleft%3A83%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D9%7Bmargin%2Dleft%3A75%25%7D%2Ecol%2Dlg%2Doffset%2D8%7Bmargin%2Dleft%3A66%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D7%7Bmargin%2Dleft%3A58%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D6%7Bmargin%2Dleft%3A50%25%7D%2Ecol%2Dlg%2Doffset%2D5%7Bmargin%2Dleft%3A41%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D4%7Bmargin%2Dleft%3A33%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D3%7Bmargin%2Dleft%3A25%25%7D%2Ecol%2Dlg%2Doffset%2D2%7Bmargin%2Dleft%3A16%2E66666667%25%7D%2Ecol%2Dlg%2Doffset%2D1%7Bmargin%2Dleft%3A8%2E33333333%25%7D%2Ecol%2Dlg%2Doffset%2D0%7Bmargin%2Dleft%3A0%7D%7Dtable%7Bbackground%2Dcolor%3Atransparent%7Dcaption%7Bpadding%2Dtop%3A8px%3Bpadding%2Dbottom%3A8px%3Bcolor%3A%23777%3Btext%2Dalign%3Aleft%7Dth%7B%7D%2Etable%7Bwidth%3A100%25%3Bmax%2Dwidth%3A100%25%3Bmargin%2Dbottom%3A20px%7D%2Etable%3Etbody%3Etr%3Etd%2C%2Etable%3Etbody%3Etr%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2C%2Etable%3Etfoot%3Etr%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2C%2Etable%3Ethead%3Etr%3Eth%7Bpadding%3A8px%3Bline%2Dheight%3A1%2E42857143%3Bvertical%2Dalign%3Atop%3Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Etable%3Ethead%3Etr%3Eth%7Bvertical%2Dalign%3Abottom%3Bborder%2Dbottom%3A2px%20solid%20%23ddd%7D%2Etable%3Ecaption%2Bthead%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ecaption%2Bthead%3Etr%3Afirst%2Dchild%3Eth%2C%2Etable%3Ecolgroup%2Bthead%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ecolgroup%2Bthead%3Etr%3Afirst%2Dchild%3Eth%2C%2Etable%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%3Etd%2C%2Etable%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%3Eth%7Bborder%2Dtop%3A0%7D%2Etable%3Etbody%2Btbody%7Bborder%2Dtop%3A2px%20solid%20%23ddd%7D%2Etable%20%2Etable%7Bbackground%2Dcolor%3A%23fff%7D%2Etable%2Dcondensed%3Etbody%3Etr%3Etd%2C%2Etable%2Dcondensed%3Etbody%3Etr%3Eth%2C%2Etable%2Dcondensed%3Etfoot%3Etr%3Etd%2C%2Etable%2Dcondensed%3Etfoot%3Etr%3Eth%2C%2Etable%2Dcondensed%3Ethead%3Etr%3Etd%2C%2Etable%2Dcondensed%3Ethead%3Etr%3Eth%7Bpadding%3A5px%7D%2Etable%2Dbordered%7Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dbordered%3Etbody%3Etr%3Etd%2C%2Etable%2Dbordered%3Etbody%3Etr%3Eth%2C%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%2C%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%2C%2Etable%2Dbordered%3Ethead%3Etr%3Etd%2C%2Etable%2Dbordered%3Ethead%3Etr%3Eth%7Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dbordered%3Ethead%3Etr%3Etd%2C%2Etable%2Dbordered%3Ethead%3Etr%3Eth%7Bborder%2Dbottom%2Dwidth%3A2px%7D%2Etable%2Dstriped%3Etbody%3Etr%3Anth%2Dof%2Dtype%28odd%29%7Bbackground%2Dcolor%3A%23f9f9f9%7D%2Etable%2Dhover%3Etbody%3Etr%3Ahover%7Bbackground%2Dcolor%3A%23f5f5f5%7Dtable%20col%5Bclass%2A%3Dcol%2D%5D%7Bposition%3Astatic%3Bdisplay%3Atable%2Dcolumn%3Bfloat%3Anone%7Dtable%20td%5Bclass%2A%3Dcol%2D%5D%2Ctable%20th%5Bclass%2A%3Dcol%2D%5D%7Bposition%3Astatic%3Bdisplay%3Atable%2Dcell%3Bfloat%3Anone%7D%2Etable%3Etbody%3Etr%2Eactive%3Etd%2C%2Etable%3Etbody%3Etr%2Eactive%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Eactive%2C%2Etable%3Etbody%3Etr%3Eth%2Eactive%2C%2Etable%3Etfoot%3Etr%2Eactive%3Etd%2C%2Etable%3Etfoot%3Etr%2Eactive%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Eactive%2C%2Etable%3Etfoot%3Etr%3Eth%2Eactive%2C%2Etable%3Ethead%3Etr%2Eactive%3Etd%2C%2Etable%3Ethead%3Etr%2Eactive%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Eactive%2C%2Etable%3Ethead%3Etr%3Eth%2Eactive%7Bbackground%2Dcolor%3A%23f5f5f5%7D%2Etable%2Dhover%3Etbody%3Etr%2Eactive%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Eactive%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Eactive%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Eactive%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Eactive%3Ahover%7Bbackground%2Dcolor%3A%23e8e8e8%7D%2Etable%3Etbody%3Etr%2Esuccess%3Etd%2C%2Etable%3Etbody%3Etr%2Esuccess%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Esuccess%2C%2Etable%3Etbody%3Etr%3Eth%2Esuccess%2C%2Etable%3Etfoot%3Etr%2Esuccess%3Etd%2C%2Etable%3Etfoot%3Etr%2Esuccess%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Esuccess%2C%2Etable%3Etfoot%3Etr%3Eth%2Esuccess%2C%2Etable%3Ethead%3Etr%2Esuccess%3Etd%2C%2Etable%3Ethead%3Etr%2Esuccess%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Esuccess%2C%2Etable%3Ethead%3Etr%3Eth%2Esuccess%7Bbackground%2Dcolor%3A%23dff0d8%7D%2Etable%2Dhover%3Etbody%3Etr%2Esuccess%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Esuccess%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Esuccess%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Esuccess%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Esuccess%3Ahover%7Bbackground%2Dcolor%3A%23d0e9c6%7D%2Etable%3Etbody%3Etr%2Einfo%3Etd%2C%2Etable%3Etbody%3Etr%2Einfo%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Einfo%2C%2Etable%3Etbody%3Etr%3Eth%2Einfo%2C%2Etable%3Etfoot%3Etr%2Einfo%3Etd%2C%2Etable%3Etfoot%3Etr%2Einfo%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Einfo%2C%2Etable%3Etfoot%3Etr%3Eth%2Einfo%2C%2Etable%3Ethead%3Etr%2Einfo%3Etd%2C%2Etable%3Ethead%3Etr%2Einfo%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Einfo%2C%2Etable%3Ethead%3Etr%3Eth%2Einfo%7Bbackground%2Dcolor%3A%23d9edf7%7D%2Etable%2Dhover%3Etbody%3Etr%2Einfo%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Einfo%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Einfo%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Einfo%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Einfo%3Ahover%7Bbackground%2Dcolor%3A%23c4e3f3%7D%2Etable%3Etbody%3Etr%2Ewarning%3Etd%2C%2Etable%3Etbody%3Etr%2Ewarning%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Ewarning%2C%2Etable%3Etbody%3Etr%3Eth%2Ewarning%2C%2Etable%3Etfoot%3Etr%2Ewarning%3Etd%2C%2Etable%3Etfoot%3Etr%2Ewarning%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Ewarning%2C%2Etable%3Etfoot%3Etr%3Eth%2Ewarning%2C%2Etable%3Ethead%3Etr%2Ewarning%3Etd%2C%2Etable%3Ethead%3Etr%2Ewarning%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Ewarning%2C%2Etable%3Ethead%3Etr%3Eth%2Ewarning%7Bbackground%2Dcolor%3A%23fcf8e3%7D%2Etable%2Dhover%3Etbody%3Etr%2Ewarning%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Ewarning%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Ewarning%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Ewarning%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Ewarning%3Ahover%7Bbackground%2Dcolor%3A%23faf2cc%7D%2Etable%3Etbody%3Etr%2Edanger%3Etd%2C%2Etable%3Etbody%3Etr%2Edanger%3Eth%2C%2Etable%3Etbody%3Etr%3Etd%2Edanger%2C%2Etable%3Etbody%3Etr%3Eth%2Edanger%2C%2Etable%3Etfoot%3Etr%2Edanger%3Etd%2C%2Etable%3Etfoot%3Etr%2Edanger%3Eth%2C%2Etable%3Etfoot%3Etr%3Etd%2Edanger%2C%2Etable%3Etfoot%3Etr%3Eth%2Edanger%2C%2Etable%3Ethead%3Etr%2Edanger%3Etd%2C%2Etable%3Ethead%3Etr%2Edanger%3Eth%2C%2Etable%3Ethead%3Etr%3Etd%2Edanger%2C%2Etable%3Ethead%3Etr%3Eth%2Edanger%7Bbackground%2Dcolor%3A%23f2dede%7D%2Etable%2Dhover%3Etbody%3Etr%2Edanger%3Ahover%3Etd%2C%2Etable%2Dhover%3Etbody%3Etr%2Edanger%3Ahover%3Eth%2C%2Etable%2Dhover%3Etbody%3Etr%3Ahover%3E%2Edanger%2C%2Etable%2Dhover%3Etbody%3Etr%3Etd%2Edanger%3Ahover%2C%2Etable%2Dhover%3Etbody%3Etr%3Eth%2Edanger%3Ahover%7Bbackground%2Dcolor%3A%23ebcccc%7D%2Etable%2Dresponsive%7Bmin%2Dheight%3A%2E01%25%3Boverflow%2Dx%3Aauto%7D%40media%20screen%20and%20%28max%2Dwidth%3A767px%29%7B%2Etable%2Dresponsive%7Bwidth%3A100%25%3Bmargin%2Dbottom%3A15px%3Boverflow%2Dy%3Ahidden%3B%2Dms%2Doverflow%2Dstyle%3A%2Dms%2Dautohiding%2Dscrollbar%3Bborder%3A1px%20solid%20%23ddd%7D%2Etable%2Dresponsive%3E%2Etable%7Bmargin%2Dbottom%3A0%7D%2Etable%2Dresponsive%3E%2Etable%3Etbody%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Etbody%3Etr%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%3Etfoot%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Etfoot%3Etr%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%3Ethead%3Etr%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%3Ethead%3Etr%3Eth%7Bwhite%2Dspace%3Anowrap%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%7Bborder%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%7Bborder%2Dleft%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%7Bborder%2Dright%3A0%7D%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%7Dfieldset%7Bmin%2Dwidth%3A0%3Bpadding%3A0%3Bmargin%3A0%3Bborder%3A0%7Dlegend%7Bdisplay%3Ablock%3Bwidth%3A100%25%3Bpadding%3A0%3Bmargin%2Dbottom%3A20px%3Bfont%2Dsize%3A21px%3Bline%2Dheight%3Ainherit%3Bcolor%3A%23333%3Bborder%3A0%3Bborder%2Dbottom%3A1px%20solid%20%23e5e5e5%7Dlabel%7Bdisplay%3Ainline%2Dblock%3Bmax%2Dwidth%3A100%25%3Bmargin%2Dbottom%3A5px%3Bfont%2Dweight%3A700%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dbox%2Dsizing%3Aborder%2Dbox%3B%2Dmoz%2Dbox%2Dsizing%3Aborder%2Dbox%3Bbox%2Dsizing%3Aborder%2Dbox%7Dinput%5Btype%3Dcheckbox%5D%2Cinput%5Btype%3Dradio%5D%7Bmargin%3A4px%200%200%3Bmargin%2Dtop%3A1px%5C9%3Bline%2Dheight%3Anormal%7Dinput%5Btype%3Dfile%5D%7Bdisplay%3Ablock%7Dinput%5Btype%3Drange%5D%7Bdisplay%3Ablock%3Bwidth%3A100%25%7Dselect%5Bmultiple%5D%2Cselect%5Bsize%5D%7Bheight%3Aauto%7Dinput%5Btype%3Dfile%5D%3Afocus%2Cinput%5Btype%3Dcheckbox%5D%3Afocus%2Cinput%5Btype%3Dradio%5D%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7Doutput%7Bdisplay%3Ablock%3Bpadding%2Dtop%3A7px%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23555%7D%2Eform%2Dcontrol%7Bdisplay%3Ablock%3Bwidth%3A100%25%3Bheight%3A34px%3Bpadding%3A6px%2012px%3Bfont%2Dsize%3A14px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23fff%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3B%2Dwebkit%2Dtransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2C%2Dwebkit%2Dbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%3B%2Do%2Dtransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2Cbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%3Btransition%3Aborder%2Dcolor%20ease%2Din%2Dout%20%2E15s%2Cbox%2Dshadow%20ease%2Din%2Dout%20%2E15s%7D%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%2366afe9%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%208px%20rgba%28102%2C175%2C233%2C%2E6%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%208px%20rgba%28102%2C175%2C233%2C%2E6%29%7D%2Eform%2Dcontrol%3A%3A%2Dmoz%2Dplaceholder%7Bcolor%3A%23999%3Bopacity%3A1%7D%2Eform%2Dcontrol%3A%2Dms%2Dinput%2Dplaceholder%7Bcolor%3A%23999%7D%2Eform%2Dcontrol%3A%3A%2Dwebkit%2Dinput%2Dplaceholder%7Bcolor%3A%23999%7D%2Eform%2Dcontrol%5Bdisabled%5D%2C%2Eform%2Dcontrol%5Breadonly%5D%2Cfieldset%5Bdisabled%5D%20%2Eform%2Dcontrol%7Bbackground%2Dcolor%3A%23eee%3Bopacity%3A1%7D%2Eform%2Dcontrol%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Eform%2Dcontrol%7Bcursor%3Anot%2Dallowed%7Dtextarea%2Eform%2Dcontrol%7Bheight%3Aauto%7Dinput%5Btype%3Dsearch%5D%7B%2Dwebkit%2Dappearance%3Anone%7D%40media%20screen%20and%20%28%2Dwebkit%2Dmin%2Ddevice%2Dpixel%2Dratio%3A0%29%7Binput%5Btype%3Ddate%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Dtime%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Eform%2Dcontrol%2Cinput%5Btype%3Dmonth%5D%2Eform%2Dcontrol%7Bline%2Dheight%3A34px%7D%2Einput%2Dgroup%2Dsm%20input%5Btype%3Ddate%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Dtime%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Ddatetime%2Dlocal%5D%2C%2Einput%2Dgroup%2Dsm%20input%5Btype%3Dmonth%5D%2Cinput%5Btype%3Ddate%5D%2Einput%2Dsm%2Cinput%5Btype%3Dtime%5D%2Einput%2Dsm%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Einput%2Dsm%2Cinput%5Btype%3Dmonth%5D%2Einput%2Dsm%7Bline%2Dheight%3A30px%7D%2Einput%2Dgroup%2Dlg%20input%5Btype%3Ddate%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Dtime%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Ddatetime%2Dlocal%5D%2C%2Einput%2Dgroup%2Dlg%20input%5Btype%3Dmonth%5D%2Cinput%5Btype%3Ddate%5D%2Einput%2Dlg%2Cinput%5Btype%3Dtime%5D%2Einput%2Dlg%2Cinput%5Btype%3Ddatetime%2Dlocal%5D%2Einput%2Dlg%2Cinput%5Btype%3Dmonth%5D%2Einput%2Dlg%7Bline%2Dheight%3A46px%7D%7D%2Eform%2Dgroup%7Bmargin%2Dbottom%3A15px%7D%2Echeckbox%2C%2Eradio%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Echeckbox%20label%2C%2Eradio%20label%7Bmin%2Dheight%3A20px%3Bpadding%2Dleft%3A20px%3Bmargin%2Dbottom%3A0%3Bfont%2Dweight%3A400%3Bcursor%3Apointer%7D%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Echeckbox%2Dinline%20input%5Btype%3Dcheckbox%5D%2C%2Eradio%20input%5Btype%3Dradio%5D%2C%2Eradio%2Dinline%20input%5Btype%3Dradio%5D%7Bposition%3Aabsolute%3Bmargin%2Dtop%3A4px%5C9%3Bmargin%2Dleft%3A%2D20px%7D%2Echeckbox%2B%2Echeckbox%2C%2Eradio%2B%2Eradio%7Bmargin%2Dtop%3A%2D5px%7D%2Echeckbox%2Dinline%2C%2Eradio%2Dinline%7Bposition%3Arelative%3Bdisplay%3Ainline%2Dblock%3Bpadding%2Dleft%3A20px%3Bmargin%2Dbottom%3A0%3Bfont%2Dweight%3A400%3Bvertical%2Dalign%3Amiddle%3Bcursor%3Apointer%7D%2Echeckbox%2Dinline%2B%2Echeckbox%2Dinline%2C%2Eradio%2Dinline%2B%2Eradio%2Dinline%7Bmargin%2Dtop%3A0%3Bmargin%2Dleft%3A10px%7Dfieldset%5Bdisabled%5D%20input%5Btype%3Dcheckbox%5D%2Cfieldset%5Bdisabled%5D%20input%5Btype%3Dradio%5D%2Cinput%5Btype%3Dcheckbox%5D%2Edisabled%2Cinput%5Btype%3Dcheckbox%5D%5Bdisabled%5D%2Cinput%5Btype%3Dradio%5D%2Edisabled%2Cinput%5Btype%3Dradio%5D%5Bdisabled%5D%7Bcursor%3Anot%2Dallowed%7D%2Echeckbox%2Dinline%2Edisabled%2C%2Eradio%2Dinline%2Edisabled%2Cfieldset%5Bdisabled%5D%20%2Echeckbox%2Dinline%2Cfieldset%5Bdisabled%5D%20%2Eradio%2Dinline%7Bcursor%3Anot%2Dallowed%7D%2Echeckbox%2Edisabled%20label%2C%2Eradio%2Edisabled%20label%2Cfieldset%5Bdisabled%5D%20%2Echeckbox%20label%2Cfieldset%5Bdisabled%5D%20%2Eradio%20label%7Bcursor%3Anot%2Dallowed%7D%2Eform%2Dcontrol%2Dstatic%7Bmin%2Dheight%3A34px%3Bpadding%2Dtop%3A7px%3Bpadding%2Dbottom%3A7px%3Bmargin%2Dbottom%3A0%7D%2Eform%2Dcontrol%2Dstatic%2Einput%2Dlg%2C%2Eform%2Dcontrol%2Dstatic%2Einput%2Dsm%7Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%2Einput%2Dsm%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7Dselect%2Einput%2Dsm%7Bheight%3A30px%3Bline%2Dheight%3A30px%7Dselect%5Bmultiple%5D%2Einput%2Dsm%2Ctextarea%2Einput%2Dsm%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Eform%2Dgroup%2Dsm%20select%2Eform%2Dcontrol%7Bheight%3A30px%3Bline%2Dheight%3A30px%7D%2Eform%2Dgroup%2Dsm%20select%5Bmultiple%5D%2Eform%2Dcontrol%2C%2Eform%2Dgroup%2Dsm%20textarea%2Eform%2Dcontrol%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%2Dstatic%7Bheight%3A30px%3Bmin%2Dheight%3A32px%3Bpadding%3A6px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%7D%2Einput%2Dlg%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7Dselect%2Einput%2Dlg%7Bheight%3A46px%3Bline%2Dheight%3A46px%7Dselect%5Bmultiple%5D%2Einput%2Dlg%2Ctextarea%2Einput%2Dlg%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7D%2Eform%2Dgroup%2Dlg%20select%2Eform%2Dcontrol%7Bheight%3A46px%3Bline%2Dheight%3A46px%7D%2Eform%2Dgroup%2Dlg%20select%5Bmultiple%5D%2Eform%2Dcontrol%2C%2Eform%2Dgroup%2Dlg%20textarea%2Eform%2Dcontrol%7Bheight%3Aauto%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%2Dstatic%7Bheight%3A46px%3Bmin%2Dheight%3A38px%3Bpadding%3A11px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%7D%2Ehas%2Dfeedback%7Bposition%3Arelative%7D%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%7Bpadding%2Dright%3A42%2E5px%7D%2Eform%2Dcontrol%2Dfeedback%7Bposition%3Aabsolute%3Btop%3A0%3Bright%3A0%3Bz%2Dindex%3A2%3Bdisplay%3Ablock%3Bwidth%3A34px%3Bheight%3A34px%3Bline%2Dheight%3A34px%3Btext%2Dalign%3Acenter%3Bpointer%2Devents%3Anone%7D%2Eform%2Dgroup%2Dlg%20%2Eform%2Dcontrol%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dgroup%2Dlg%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dlg%2B%2Eform%2Dcontrol%2Dfeedback%7Bwidth%3A46px%3Bheight%3A46px%3Bline%2Dheight%3A46px%7D%2Eform%2Dgroup%2Dsm%20%2Eform%2Dcontrol%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dgroup%2Dsm%2B%2Eform%2Dcontrol%2Dfeedback%2C%2Einput%2Dsm%2B%2Eform%2Dcontrol%2Dfeedback%7Bwidth%3A30px%3Bheight%3A30px%3Bline%2Dheight%3A30px%7D%2Ehas%2Dsuccess%20%2Echeckbox%2C%2Ehas%2Dsuccess%20%2Echeckbox%2Dinline%2C%2Ehas%2Dsuccess%20%2Econtrol%2Dlabel%2C%2Ehas%2Dsuccess%20%2Ehelp%2Dblock%2C%2Ehas%2Dsuccess%20%2Eradio%2C%2Ehas%2Dsuccess%20%2Eradio%2Dinline%2C%2Ehas%2Dsuccess%2Echeckbox%20label%2C%2Ehas%2Dsuccess%2Echeckbox%2Dinline%20label%2C%2Ehas%2Dsuccess%2Eradio%20label%2C%2Ehas%2Dsuccess%2Eradio%2Dinline%20label%7Bcolor%3A%233c763d%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%233c763d%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%232b542c%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%2367b168%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%2367b168%7D%2Ehas%2Dsuccess%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%233c763d%7D%2Ehas%2Dsuccess%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%233c763d%7D%2Ehas%2Dwarning%20%2Echeckbox%2C%2Ehas%2Dwarning%20%2Echeckbox%2Dinline%2C%2Ehas%2Dwarning%20%2Econtrol%2Dlabel%2C%2Ehas%2Dwarning%20%2Ehelp%2Dblock%2C%2Ehas%2Dwarning%20%2Eradio%2C%2Ehas%2Dwarning%20%2Eradio%2Dinline%2C%2Ehas%2Dwarning%2Echeckbox%20label%2C%2Ehas%2Dwarning%2Echeckbox%2Dinline%20label%2C%2Ehas%2Dwarning%2Eradio%20label%2C%2Ehas%2Dwarning%2Eradio%2Dinline%20label%7Bcolor%3A%238a6d3b%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%238a6d3b%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%2366512c%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23c0a16b%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23c0a16b%7D%2Ehas%2Dwarning%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%238a6d3b%7D%2Ehas%2Dwarning%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%238a6d3b%7D%2Ehas%2Derror%20%2Echeckbox%2C%2Ehas%2Derror%20%2Echeckbox%2Dinline%2C%2Ehas%2Derror%20%2Econtrol%2Dlabel%2C%2Ehas%2Derror%20%2Ehelp%2Dblock%2C%2Ehas%2Derror%20%2Eradio%2C%2Ehas%2Derror%20%2Eradio%2Dinline%2C%2Ehas%2Derror%2Echeckbox%20label%2C%2Ehas%2Derror%2Echeckbox%2Dinline%20label%2C%2Ehas%2Derror%2Eradio%20label%2C%2Ehas%2Derror%2Eradio%2Dinline%20label%7Bcolor%3A%23a94442%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%7Bborder%2Dcolor%3A%23a94442%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%3Afocus%7Bborder%2Dcolor%3A%23843534%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23ce8483%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E075%29%2C0%200%206px%20%23ce8483%7D%2Ehas%2Derror%20%2Einput%2Dgroup%2Daddon%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23a94442%7D%2Ehas%2Derror%20%2Eform%2Dcontrol%2Dfeedback%7Bcolor%3A%23a94442%7D%2Ehas%2Dfeedback%20label%7E%2Eform%2Dcontrol%2Dfeedback%7Btop%3A25px%7D%2Ehas%2Dfeedback%20label%2Esr%2Donly%7E%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%2Ehelp%2Dblock%7Bdisplay%3Ablock%3Bmargin%2Dtop%3A5px%3Bmargin%2Dbottom%3A10px%3Bcolor%3A%23737373%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dinline%20%2Eform%2Dgroup%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Eform%2Dcontrol%7Bdisplay%3Ainline%2Dblock%3Bwidth%3Aauto%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Eform%2Dcontrol%2Dstatic%7Bdisplay%3Ainline%2Dblock%7D%2Eform%2Dinline%20%2Einput%2Dgroup%7Bdisplay%3Ainline%2Dtable%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Daddon%2C%2Eform%2Dinline%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Dbtn%7Bwidth%3Aauto%7D%2Eform%2Dinline%20%2Einput%2Dgroup%3E%2Eform%2Dcontrol%7Bwidth%3A100%25%7D%2Eform%2Dinline%20%2Econtrol%2Dlabel%7Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Echeckbox%2C%2Eform%2Dinline%20%2Eradio%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Eform%2Dinline%20%2Echeckbox%20label%2C%2Eform%2Dinline%20%2Eradio%20label%7Bpadding%2Dleft%3A0%7D%2Eform%2Dinline%20%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Eform%2Dinline%20%2Eradio%20input%5Btype%3Dradio%5D%7Bposition%3Arelative%3Bmargin%2Dleft%3A0%7D%2Eform%2Dinline%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%7D%2Eform%2Dhorizontal%20%2Echeckbox%2C%2Eform%2Dhorizontal%20%2Echeckbox%2Dinline%2C%2Eform%2Dhorizontal%20%2Eradio%2C%2Eform%2Dhorizontal%20%2Eradio%2Dinline%7Bpadding%2Dtop%3A7px%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%7D%2Eform%2Dhorizontal%20%2Echeckbox%2C%2Eform%2Dhorizontal%20%2Eradio%7Bmin%2Dheight%3A27px%7D%2Eform%2Dhorizontal%20%2Eform%2Dgroup%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A7px%3Bmargin%2Dbottom%3A0%3Btext%2Dalign%3Aright%7D%7D%2Eform%2Dhorizontal%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Bright%3A15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Eform%2Dgroup%2Dlg%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A14%2E33px%3Bfont%2Dsize%3A18px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Eform%2Dhorizontal%20%2Eform%2Dgroup%2Dsm%20%2Econtrol%2Dlabel%7Bpadding%2Dtop%3A6px%3Bfont%2Dsize%3A12px%7D%7D%2Ebtn%7Bdisplay%3Ainline%2Dblock%3Bpadding%3A6px%2012px%3Bmargin%2Dbottom%3A0%3Bfont%2Dsize%3A14px%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%3B%2Dms%2Dtouch%2Daction%3Amanipulation%3Btouch%2Daction%3Amanipulation%3Bcursor%3Apointer%3B%2Dwebkit%2Duser%2Dselect%3Anone%3B%2Dmoz%2Duser%2Dselect%3Anone%3B%2Dms%2Duser%2Dselect%3Anone%3Buser%2Dselect%3Anone%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Ebtn%2Eactive%2Efocus%2C%2Ebtn%2Eactive%3Afocus%2C%2Ebtn%2Efocus%2C%2Ebtn%3Aactive%2Efocus%2C%2Ebtn%3Aactive%3Afocus%2C%2Ebtn%3Afocus%7Boutline%3Athin%20dotted%3Boutline%3A5px%20auto%20%2Dwebkit%2Dfocus%2Dring%2Dcolor%3Boutline%2Doffset%3A%2D2px%7D%2Ebtn%2Efocus%2C%2Ebtn%3Afocus%2C%2Ebtn%3Ahover%7Bcolor%3A%23333%3Btext%2Ddecoration%3Anone%7D%2Ebtn%2Eactive%2C%2Ebtn%3Aactive%7Bbackground%2Dimage%3Anone%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%3Bbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%7D%2Ebtn%2Edisabled%2C%2Ebtn%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Ebtn%7Bcursor%3Anot%2Dallowed%3Bfilter%3Aalpha%28opacity%3D65%29%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%3Bopacity%3A%2E65%7Da%2Ebtn%2Edisabled%2Cfieldset%5Bdisabled%5D%20a%2Ebtn%7Bpointer%2Devents%3Anone%7D%2Ebtn%2Ddefault%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ccc%7D%2Ebtn%2Ddefault%2Efocus%2C%2Ebtn%2Ddefault%3Afocus%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%238c8c8c%7D%2Ebtn%2Ddefault%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%23adadad%7D%2Ebtn%2Ddefault%2Eactive%2C%2Ebtn%2Ddefault%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23e6e6e6%3Bborder%2Dcolor%3A%23adadad%7D%2Ebtn%2Ddefault%2Eactive%2Efocus%2C%2Ebtn%2Ddefault%2Eactive%3Afocus%2C%2Ebtn%2Ddefault%2Eactive%3Ahover%2C%2Ebtn%2Ddefault%3Aactive%2Efocus%2C%2Ebtn%2Ddefault%3Aactive%3Afocus%2C%2Ebtn%2Ddefault%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23d4d4d4%3Bborder%2Dcolor%3A%238c8c8c%7D%2Ebtn%2Ddefault%2Eactive%2C%2Ebtn%2Ddefault%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddefault%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Ddefault%2Edisabled%2C%2Ebtn%2Ddefault%2Edisabled%2Eactive%2C%2Ebtn%2Ddefault%2Edisabled%2Efocus%2C%2Ebtn%2Ddefault%2Edisabled%3Aactive%2C%2Ebtn%2Ddefault%2Edisabled%3Afocus%2C%2Ebtn%2Ddefault%2Edisabled%3Ahover%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Ddefault%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Ddefault%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddefault%3Ahover%7Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ccc%7D%2Ebtn%2Ddefault%20%2Ebadge%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23333%7D%2Ebtn%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%232e6da4%7D%2Ebtn%2Dprimary%2Efocus%2C%2Ebtn%2Dprimary%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23122b40%7D%2Ebtn%2Dprimary%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23204d74%7D%2Ebtn%2Dprimary%2Eactive%2C%2Ebtn%2Dprimary%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23286090%3Bborder%2Dcolor%3A%23204d74%7D%2Ebtn%2Dprimary%2Eactive%2Efocus%2C%2Ebtn%2Dprimary%2Eactive%3Afocus%2C%2Ebtn%2Dprimary%2Eactive%3Ahover%2C%2Ebtn%2Dprimary%3Aactive%2Efocus%2C%2Ebtn%2Dprimary%3Aactive%3Afocus%2C%2Ebtn%2Dprimary%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23204d74%3Bborder%2Dcolor%3A%23122b40%7D%2Ebtn%2Dprimary%2Eactive%2C%2Ebtn%2Dprimary%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dprimary%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dprimary%2Edisabled%2C%2Ebtn%2Dprimary%2Edisabled%2Eactive%2C%2Ebtn%2Dprimary%2Edisabled%2Efocus%2C%2Ebtn%2Dprimary%2Edisabled%3Aactive%2C%2Ebtn%2Dprimary%2Edisabled%3Afocus%2C%2Ebtn%2Dprimary%2Edisabled%3Ahover%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dprimary%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dprimary%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dprimary%3Ahover%7Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%232e6da4%7D%2Ebtn%2Dprimary%20%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dsuccess%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%235cb85c%3Bborder%2Dcolor%3A%234cae4c%7D%2Ebtn%2Dsuccess%2Efocus%2C%2Ebtn%2Dsuccess%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23255625%7D%2Ebtn%2Dsuccess%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23398439%7D%2Ebtn%2Dsuccess%2Eactive%2C%2Ebtn%2Dsuccess%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23449d44%3Bborder%2Dcolor%3A%23398439%7D%2Ebtn%2Dsuccess%2Eactive%2Efocus%2C%2Ebtn%2Dsuccess%2Eactive%3Afocus%2C%2Ebtn%2Dsuccess%2Eactive%3Ahover%2C%2Ebtn%2Dsuccess%3Aactive%2Efocus%2C%2Ebtn%2Dsuccess%3Aactive%3Afocus%2C%2Ebtn%2Dsuccess%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23398439%3Bborder%2Dcolor%3A%23255625%7D%2Ebtn%2Dsuccess%2Eactive%2C%2Ebtn%2Dsuccess%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dsuccess%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dsuccess%2Edisabled%2C%2Ebtn%2Dsuccess%2Edisabled%2Eactive%2C%2Ebtn%2Dsuccess%2Edisabled%2Efocus%2C%2Ebtn%2Dsuccess%2Edisabled%3Aactive%2C%2Ebtn%2Dsuccess%2Edisabled%3Afocus%2C%2Ebtn%2Dsuccess%2Edisabled%3Ahover%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dsuccess%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dsuccess%3Ahover%7Bbackground%2Dcolor%3A%235cb85c%3Bborder%2Dcolor%3A%234cae4c%7D%2Ebtn%2Dsuccess%20%2Ebadge%7Bcolor%3A%235cb85c%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dinfo%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%235bc0de%3Bborder%2Dcolor%3A%2346b8da%7D%2Ebtn%2Dinfo%2Efocus%2C%2Ebtn%2Dinfo%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%231b6d85%7D%2Ebtn%2Dinfo%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%23269abc%7D%2Ebtn%2Dinfo%2Eactive%2C%2Ebtn%2Dinfo%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331b0d5%3Bborder%2Dcolor%3A%23269abc%7D%2Ebtn%2Dinfo%2Eactive%2Efocus%2C%2Ebtn%2Dinfo%2Eactive%3Afocus%2C%2Ebtn%2Dinfo%2Eactive%3Ahover%2C%2Ebtn%2Dinfo%3Aactive%2Efocus%2C%2Ebtn%2Dinfo%3Aactive%3Afocus%2C%2Ebtn%2Dinfo%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23269abc%3Bborder%2Dcolor%3A%231b6d85%7D%2Ebtn%2Dinfo%2Eactive%2C%2Ebtn%2Dinfo%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dinfo%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dinfo%2Edisabled%2C%2Ebtn%2Dinfo%2Edisabled%2Eactive%2C%2Ebtn%2Dinfo%2Edisabled%2Efocus%2C%2Ebtn%2Dinfo%2Edisabled%3Aactive%2C%2Ebtn%2Dinfo%2Edisabled%3Afocus%2C%2Ebtn%2Dinfo%2Edisabled%3Ahover%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dinfo%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dinfo%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dinfo%3Ahover%7Bbackground%2Dcolor%3A%235bc0de%3Bborder%2Dcolor%3A%2346b8da%7D%2Ebtn%2Dinfo%20%2Ebadge%7Bcolor%3A%235bc0de%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dwarning%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23f0ad4e%3Bborder%2Dcolor%3A%23eea236%7D%2Ebtn%2Dwarning%2Efocus%2C%2Ebtn%2Dwarning%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23985f0d%7D%2Ebtn%2Dwarning%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23d58512%7D%2Ebtn%2Dwarning%2Eactive%2C%2Ebtn%2Dwarning%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ec971f%3Bborder%2Dcolor%3A%23d58512%7D%2Ebtn%2Dwarning%2Eactive%2Efocus%2C%2Ebtn%2Dwarning%2Eactive%3Afocus%2C%2Ebtn%2Dwarning%2Eactive%3Ahover%2C%2Ebtn%2Dwarning%3Aactive%2Efocus%2C%2Ebtn%2Dwarning%3Aactive%3Afocus%2C%2Ebtn%2Dwarning%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23d58512%3Bborder%2Dcolor%3A%23985f0d%7D%2Ebtn%2Dwarning%2Eactive%2C%2Ebtn%2Dwarning%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Dwarning%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Dwarning%2Edisabled%2C%2Ebtn%2Dwarning%2Edisabled%2Eactive%2C%2Ebtn%2Dwarning%2Edisabled%2Efocus%2C%2Ebtn%2Dwarning%2Edisabled%3Aactive%2C%2Ebtn%2Dwarning%2Edisabled%3Afocus%2C%2Ebtn%2Dwarning%2Edisabled%3Ahover%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Dwarning%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dwarning%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dwarning%3Ahover%7Bbackground%2Dcolor%3A%23f0ad4e%3Bborder%2Dcolor%3A%23eea236%7D%2Ebtn%2Dwarning%20%2Ebadge%7Bcolor%3A%23f0ad4e%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Ddanger%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23d9534f%3Bborder%2Dcolor%3A%23d43f3a%7D%2Ebtn%2Ddanger%2Efocus%2C%2Ebtn%2Ddanger%3Afocus%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23761c19%7D%2Ebtn%2Ddanger%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23ac2925%7D%2Ebtn%2Ddanger%2Eactive%2C%2Ebtn%2Ddanger%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23c9302c%3Bborder%2Dcolor%3A%23ac2925%7D%2Ebtn%2Ddanger%2Eactive%2Efocus%2C%2Ebtn%2Ddanger%2Eactive%3Afocus%2C%2Ebtn%2Ddanger%2Eactive%3Ahover%2C%2Ebtn%2Ddanger%3Aactive%2Efocus%2C%2Ebtn%2Ddanger%3Aactive%3Afocus%2C%2Ebtn%2Ddanger%3Aactive%3Ahover%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%2Efocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%3Afocus%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23ac2925%3Bborder%2Dcolor%3A%23761c19%7D%2Ebtn%2Ddanger%2Eactive%2C%2Ebtn%2Ddanger%3Aactive%2C%2Eopen%3E%2Edropdown%2Dtoggle%2Ebtn%2Ddanger%7Bbackground%2Dimage%3Anone%7D%2Ebtn%2Ddanger%2Edisabled%2C%2Ebtn%2Ddanger%2Edisabled%2Eactive%2C%2Ebtn%2Ddanger%2Edisabled%2Efocus%2C%2Ebtn%2Ddanger%2Edisabled%3Aactive%2C%2Ebtn%2Ddanger%2Edisabled%3Afocus%2C%2Ebtn%2Ddanger%2Edisabled%3Ahover%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2Eactive%2C%2Ebtn%2Ddanger%5Bdisabled%5D%2Efocus%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Aactive%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Ddanger%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Eactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%2Efocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Aactive%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Ddanger%3Ahover%7Bbackground%2Dcolor%3A%23d9534f%3Bborder%2Dcolor%3A%23d43f3a%7D%2Ebtn%2Ddanger%20%2Ebadge%7Bcolor%3A%23d9534f%3Bbackground%2Dcolor%3A%23fff%7D%2Ebtn%2Dlink%7Bfont%2Dweight%3A400%3Bcolor%3A%23337ab7%3Bborder%2Dradius%3A0%7D%2Ebtn%2Dlink%2C%2Ebtn%2Dlink%2Eactive%2C%2Ebtn%2Dlink%3Aactive%2C%2Ebtn%2Dlink%5Bdisabled%5D%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%7Bbackground%2Dcolor%3Atransparent%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Ebtn%2Dlink%2C%2Ebtn%2Dlink%3Aactive%2C%2Ebtn%2Dlink%3Afocus%2C%2Ebtn%2Dlink%3Ahover%7Bborder%2Dcolor%3Atransparent%7D%2Ebtn%2Dlink%3Afocus%2C%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%2323527c%3Btext%2Ddecoration%3Aunderline%3Bbackground%2Dcolor%3Atransparent%7D%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23777%3Btext%2Ddecoration%3Anone%7D%2Ebtn%2Dgroup%2Dlg%3E%2Ebtn%2C%2Ebtn%2Dlg%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7D%2Ebtn%2Dgroup%2Dsm%3E%2Ebtn%2C%2Ebtn%2Dsm%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Ebtn%2Dgroup%2Dxs%3E%2Ebtn%2C%2Ebtn%2Dxs%7Bpadding%3A1px%205px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7D%2Ebtn%2Dblock%7Bdisplay%3Ablock%3Bwidth%3A100%25%7D%2Ebtn%2Dblock%2B%2Ebtn%2Dblock%7Bmargin%2Dtop%3A5px%7Dinput%5Btype%3Dbutton%5D%2Ebtn%2Dblock%2Cinput%5Btype%3Dreset%5D%2Ebtn%2Dblock%2Cinput%5Btype%3Dsubmit%5D%2Ebtn%2Dblock%7Bwidth%3A100%25%7D%2Efade%7Bopacity%3A0%3B%2Dwebkit%2Dtransition%3Aopacity%20%2E15s%20linear%3B%2Do%2Dtransition%3Aopacity%20%2E15s%20linear%3Btransition%3Aopacity%20%2E15s%20linear%7D%2Efade%2Ein%7Bopacity%3A1%7D%2Ecollapse%7Bdisplay%3Anone%7D%2Ecollapse%2Ein%7Bdisplay%3Ablock%7Dtr%2Ecollapse%2Ein%7Bdisplay%3Atable%2Drow%7Dtbody%2Ecollapse%2Ein%7Bdisplay%3Atable%2Drow%2Dgroup%7D%2Ecollapsing%7Bposition%3Arelative%3Bheight%3A0%3Boverflow%3Ahidden%3B%2Dwebkit%2Dtransition%2Dtiming%2Dfunction%3Aease%3B%2Do%2Dtransition%2Dtiming%2Dfunction%3Aease%3Btransition%2Dtiming%2Dfunction%3Aease%3B%2Dwebkit%2Dtransition%2Dduration%3A%2E35s%3B%2Do%2Dtransition%2Dduration%3A%2E35s%3Btransition%2Dduration%3A%2E35s%3B%2Dwebkit%2Dtransition%2Dproperty%3Aheight%2Cvisibility%3B%2Do%2Dtransition%2Dproperty%3Aheight%2Cvisibility%3Btransition%2Dproperty%3Aheight%2Cvisibility%7D%2Ecaret%7Bdisplay%3Ainline%2Dblock%3Bwidth%3A0%3Bheight%3A0%3Bmargin%2Dleft%3A2px%3Bvertical%2Dalign%3Amiddle%3Bborder%2Dtop%3A4px%20dashed%3Bborder%2Dtop%3A4px%20solid%5C9%3Bborder%2Dright%3A4px%20solid%20transparent%3Bborder%2Dleft%3A4px%20solid%20transparent%7D%2Edropdown%2C%2Edropup%7Bposition%3Arelative%7D%2Edropdown%2Dtoggle%3Afocus%7Boutline%3A0%7D%2Edropdown%2Dmenu%7Bposition%3Aabsolute%3Btop%3A100%25%3Bleft%3A0%3Bz%2Dindex%3A1000%3Bdisplay%3Anone%3Bfloat%3Aleft%3Bmin%2Dwidth%3A160px%3Bpadding%3A5px%200%3Bmargin%3A2px%200%200%3Bfont%2Dsize%3A14px%3Btext%2Dalign%3Aleft%3Blist%2Dstyle%3Anone%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23ccc%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E15%29%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%206px%2012px%20rgba%280%2C0%2C0%2C%2E175%29%3Bbox%2Dshadow%3A0%206px%2012px%20rgba%280%2C0%2C0%2C%2E175%29%7D%2Edropdown%2Dmenu%2Epull%2Dright%7Bright%3A0%3Bleft%3Aauto%7D%2Edropdown%2Dmenu%20%2Edivider%7Bheight%3A1px%3Bmargin%3A9px%200%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23e5e5e5%7D%2Edropdown%2Dmenu%3Eli%3Ea%7Bdisplay%3Ablock%3Bpadding%3A3px%2020px%3Bclear%3Aboth%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23333%3Bwhite%2Dspace%3Anowrap%7D%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23262626%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%7D%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23337ab7%3Boutline%3A0%7D%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23777%7D%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3Atransparent%3Bbackground%2Dimage%3Anone%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28enabled%3Dfalse%29%7D%2Eopen%3E%2Edropdown%2Dmenu%7Bdisplay%3Ablock%7D%2Eopen%3Ea%7Boutline%3A0%7D%2Edropdown%2Dmenu%2Dright%7Bright%3A0%3Bleft%3Aauto%7D%2Edropdown%2Dmenu%2Dleft%7Bright%3Aauto%3Bleft%3A0%7D%2Edropdown%2Dheader%7Bdisplay%3Ablock%3Bpadding%3A3px%2020px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23777%3Bwhite%2Dspace%3Anowrap%7D%2Edropdown%2Dbackdrop%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A990%7D%2Epull%2Dright%3E%2Edropdown%2Dmenu%7Bright%3A0%3Bleft%3Aauto%7D%2Edropup%20%2Ecaret%2C%2Enavbar%2Dfixed%2Dbottom%20%2Edropdown%20%2Ecaret%7Bcontent%3A%22%22%3Bborder%2Dtop%3A0%3Bborder%2Dbottom%3A4px%20dashed%3Bborder%2Dbottom%3A4px%20solid%5C9%7D%2Edropup%20%2Edropdown%2Dmenu%2C%2Enavbar%2Dfixed%2Dbottom%20%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bbottom%3A100%25%3Bmargin%2Dbottom%3A2px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dright%20%2Edropdown%2Dmenu%7Bright%3A0%3Bleft%3Aauto%7D%2Enavbar%2Dright%20%2Edropdown%2Dmenu%2Dleft%7Bright%3Aauto%3Bleft%3A0%7D%7D%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%7Bposition%3Arelative%3Bdisplay%3Ainline%2Dblock%3Bvertical%2Dalign%3Amiddle%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2C%2Ebtn%2Dgroup%3E%2Ebtn%7Bposition%3Arelative%3Bfloat%3Aleft%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Eactive%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Aactive%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Afocus%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Ahover%2C%2Ebtn%2Dgroup%3E%2Ebtn%2Eactive%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Aactive%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Afocus%2C%2Ebtn%2Dgroup%3E%2Ebtn%3Ahover%7Bz%2Dindex%3A2%7D%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%2C%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%20%2Ebtn%2Dgroup%2B%2Ebtn%2C%2Ebtn%2Dgroup%20%2Ebtn%2Dgroup%2B%2Ebtn%2Dgroup%7Bmargin%2Dleft%3A%2D1px%7D%2Ebtn%2Dtoolbar%7Bmargin%2Dleft%3A%2D5px%7D%2Ebtn%2Dtoolbar%20%2Ebtn%2C%2Ebtn%2Dtoolbar%20%2Ebtn%2Dgroup%2C%2Ebtn%2Dtoolbar%20%2Einput%2Dgroup%7Bfloat%3Aleft%7D%2Ebtn%2Dtoolbar%3E%2Ebtn%2C%2Ebtn%2Dtoolbar%3E%2Ebtn%2Dgroup%2C%2Ebtn%2Dtoolbar%3E%2Einput%2Dgroup%7Bmargin%2Dleft%3A5px%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Afirst%2Dchild%7Bmargin%2Dleft%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%2C%2Ebtn%2Dgroup%3E%2Edropdown%2Dtoggle%3Anot%28%3Afirst%2Dchild%29%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%7Bfloat%3Aleft%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%3Alast%2Dchild%2C%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Edropdown%2Dtoggle%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dgroup%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%20%2Edropdown%2Dtoggle%3Aactive%2C%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%7Boutline%3A0%7D%2Ebtn%2Dgroup%3E%2Ebtn%2B%2Edropdown%2Dtoggle%7Bpadding%2Dright%3A8px%3Bpadding%2Dleft%3A8px%7D%2Ebtn%2Dgroup%3E%2Ebtn%2Dlg%2B%2Edropdown%2Dtoggle%7Bpadding%2Dright%3A12px%3Bpadding%2Dleft%3A12px%7D%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%7B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%3Bbox%2Dshadow%3Ainset%200%203px%205px%20rgba%280%2C0%2C0%2C%2E125%29%7D%2Ebtn%2Dgroup%2Eopen%20%2Edropdown%2Dtoggle%2Ebtn%2Dlink%7B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Ebtn%20%2Ecaret%7Bmargin%2Dleft%3A0%7D%2Ebtn%2Dlg%20%2Ecaret%7Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Edropup%20%2Ebtn%2Dlg%20%2Ecaret%7Bborder%2Dwidth%3A0%205px%205px%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3E%2Ebtn%7Bdisplay%3Ablock%3Bfloat%3Anone%3Bwidth%3A100%25%3Bmax%2Dwidth%3A100%25%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3E%2Ebtn%7Bfloat%3Anone%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2B%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2B%2Ebtn%2Dgroup%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2B%2Ebtn%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%2B%2Ebtn%2Dgroup%7Bmargin%2Dtop%3A%2D1px%3Bmargin%2Dleft%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%7Bborder%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%3Alast%2Dchild%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Afirst%2Dchild%3Anot%28%3Alast%2Dchild%29%3E%2Edropdown%2Dtoggle%7Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Alast%2Dchild%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Ebtn%2Dgroup%2Djustified%7Bdisplay%3Atable%3Bwidth%3A100%25%3Btable%2Dlayout%3Afixed%3Bborder%2Dcollapse%3Aseparate%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2C%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%7Bdisplay%3Atable%2Dcell%3Bfloat%3Anone%3Bwidth%3A1%25%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%20%2Ebtn%7Bwidth%3A100%25%7D%2Ebtn%2Dgroup%2Djustified%3E%2Ebtn%2Dgroup%20%2Edropdown%2Dmenu%7Bleft%3Aauto%7D%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%20input%5Btype%3Dcheckbox%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%20input%5Btype%3Dradio%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%2Dgroup%3E%2Ebtn%20input%5Btype%3Dcheckbox%5D%2C%5Bdata%2Dtoggle%3Dbuttons%5D%3E%2Ebtn%2Dgroup%3E%2Ebtn%20input%5Btype%3Dradio%5D%7Bposition%3Aabsolute%3Bclip%3Arect%280%2C0%2C0%2C0%29%3Bpointer%2Devents%3Anone%7D%2Einput%2Dgroup%7Bposition%3Arelative%3Bdisplay%3Atable%3Bborder%2Dcollapse%3Aseparate%7D%2Einput%2Dgroup%5Bclass%2A%3Dcol%2D%5D%7Bfloat%3Anone%3Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%7Bposition%3Arelative%3Bz%2Dindex%3A2%3Bfloat%3Aleft%3Bwidth%3A100%25%3Bmargin%2Dbottom%3A0%7D%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A46px%3Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%3Bborder%2Dradius%3A6px%7Dselect%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Cselect%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Cselect%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A46px%3Bline%2Dheight%3A46px%7Dselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Eform%2Dcontrol%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Daddon%2Ctextarea%2Einput%2Dgroup%2Dlg%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3Aauto%7D%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A30px%3Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%3Bborder%2Dradius%3A3px%7Dselect%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Cselect%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Cselect%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3A30px%3Bline%2Dheight%3A30px%7Dselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Cselect%5Bmultiple%5D%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Eform%2Dcontrol%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Daddon%2Ctextarea%2Einput%2Dgroup%2Dsm%3E%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bheight%3Aauto%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dbtn%7Bdisplay%3Atable%2Dcell%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%2C%2Einput%2Dgroup%2Daddon%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%2C%2Einput%2Dgroup%2Dbtn%3Anot%28%3Afirst%2Dchild%29%3Anot%28%3Alast%2Dchild%29%7Bborder%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%2C%2Einput%2Dgroup%2Dbtn%7Bwidth%3A1%25%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%7D%2Einput%2Dgroup%2Daddon%7Bpadding%3A6px%2012px%3Bfont%2Dsize%3A14px%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%3Bcolor%3A%23555%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23eee%3Bborder%3A1px%20solid%20%23ccc%3Bborder%2Dradius%3A4px%7D%2Einput%2Dgroup%2Daddon%2Einput%2Dsm%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bborder%2Dradius%3A3px%7D%2Einput%2Dgroup%2Daddon%2Einput%2Dlg%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bborder%2Dradius%3A6px%7D%2Einput%2Dgroup%2Daddon%20input%5Btype%3Dcheckbox%5D%2C%2Einput%2Dgroup%2Daddon%20input%5Btype%3Dradio%5D%7Bmargin%2Dtop%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Afirst%2Dchild%2C%2Einput%2Dgroup%2Daddon%3Afirst%2Dchild%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Edropdown%2Dtoggle%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%3Anot%28%3Alast%2Dchild%29%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%3Anot%28%3Alast%2Dchild%29%3Anot%28%2Edropdown%2Dtoggle%29%7Bborder%2Dtop%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%3Afirst%2Dchild%7Bborder%2Dright%3A0%7D%2Einput%2Dgroup%20%2Eform%2Dcontrol%3Alast%2Dchild%2C%2Einput%2Dgroup%2Daddon%3Alast%2Dchild%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%3Anot%28%3Afirst%2Dchild%29%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%3Anot%28%3Afirst%2Dchild%29%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Edropdown%2Dtoggle%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Einput%2Dgroup%2Daddon%3Alast%2Dchild%7Bborder%2Dleft%3A0%7D%2Einput%2Dgroup%2Dbtn%7Bposition%3Arelative%3Bfont%2Dsize%3A0%3Bwhite%2Dspace%3Anowrap%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%7Bposition%3Arelative%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%2B%2Ebtn%7Bmargin%2Dleft%3A%2D1px%7D%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Aactive%2C%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Afocus%2C%2Einput%2Dgroup%2Dbtn%3E%2Ebtn%3Ahover%7Bz%2Dindex%3A2%7D%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Afirst%2Dchild%3E%2Ebtn%2Dgroup%7Bmargin%2Dright%3A%2D1px%7D%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2C%2Einput%2Dgroup%2Dbtn%3Alast%2Dchild%3E%2Ebtn%2Dgroup%7Bz%2Dindex%3A2%3Bmargin%2Dleft%3A%2D1px%7D%2Enav%7Bpadding%2Dleft%3A0%3Bmargin%2Dbottom%3A0%3Blist%2Dstyle%3Anone%7D%2Enav%3Eli%7Bposition%3Arelative%3Bdisplay%3Ablock%7D%2Enav%3Eli%3Ea%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bpadding%3A10px%2015px%7D%2Enav%3Eli%3Ea%3Afocus%2C%2Enav%3Eli%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23eee%7D%2Enav%3Eli%2Edisabled%3Ea%7Bcolor%3A%23777%7D%2Enav%3Eli%2Edisabled%3Ea%3Afocus%2C%2Enav%3Eli%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23777%3Btext%2Ddecoration%3Anone%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3Atransparent%7D%2Enav%20%2Eopen%3Ea%2C%2Enav%20%2Eopen%3Ea%3Afocus%2C%2Enav%20%2Eopen%3Ea%3Ahover%7Bbackground%2Dcolor%3A%23eee%3Bborder%2Dcolor%3A%23337ab7%7D%2Enav%20%2Enav%2Ddivider%7Bheight%3A1px%3Bmargin%3A9px%200%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23e5e5e5%7D%2Enav%3Eli%3Ea%3Eimg%7Bmax%2Dwidth%3Anone%7D%2Enav%2Dtabs%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%7D%2Enav%2Dtabs%3Eli%7Bfloat%3Aleft%3Bmargin%2Dbottom%3A%2D1px%7D%2Enav%2Dtabs%3Eli%3Ea%7Bmargin%2Dright%3A2px%3Bline%2Dheight%3A1%2E42857143%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%3Eli%3Ea%3Ahover%7Bborder%2Dcolor%3A%23eee%20%23eee%20%23ddd%7D%2Enav%2Dtabs%3Eli%2Eactive%3Ea%2C%2Enav%2Dtabs%3Eli%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%3Eli%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bcursor%3Adefault%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dbottom%2Dcolor%3Atransparent%7D%2Enav%2Dtabs%2Enav%2Djustified%7Bwidth%3A100%25%3Bborder%2Dbottom%3A0%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%7Bfloat%3Anone%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A5px%3Btext%2Dalign%3Acenter%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Enav%2Djustified%3Eli%7Bdisplay%3Atable%2Dcell%3Bwidth%3A1%25%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A0%7D%7D%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dright%3A0%3Bborder%2Dradius%3A4px%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%3A1px%20solid%20%23ddd%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Enav%2Djustified%3Eli%3Ea%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Enav%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%2Dbottom%2Dcolor%3A%23fff%7D%7D%2Enav%2Dpills%3Eli%7Bfloat%3Aleft%7D%2Enav%2Dpills%3Eli%3Ea%7Bborder%2Dradius%3A4px%7D%2Enav%2Dpills%3Eli%2Bli%7Bmargin%2Dleft%3A2px%7D%2Enav%2Dpills%3Eli%2Eactive%3Ea%2C%2Enav%2Dpills%3Eli%2Eactive%3Ea%3Afocus%2C%2Enav%2Dpills%3Eli%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%7D%2Enav%2Dstacked%3Eli%7Bfloat%3Anone%7D%2Enav%2Dstacked%3Eli%2Bli%7Bmargin%2Dtop%3A2px%3Bmargin%2Dleft%3A0%7D%2Enav%2Djustified%7Bwidth%3A100%25%7D%2Enav%2Djustified%3Eli%7Bfloat%3Anone%7D%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A5px%3Btext%2Dalign%3Acenter%7D%2Enav%2Djustified%3E%2Edropdown%20%2Edropdown%2Dmenu%7Btop%3Aauto%3Bleft%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Djustified%3Eli%7Bdisplay%3Atable%2Dcell%3Bwidth%3A1%25%7D%2Enav%2Djustified%3Eli%3Ea%7Bmargin%2Dbottom%3A0%7D%7D%2Enav%2Dtabs%2Djustified%7Bborder%2Dbottom%3A0%7D%2Enav%2Dtabs%2Djustified%3Eli%3Ea%7Bmargin%2Dright%3A0%3Bborder%2Dradius%3A4px%7D%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%3A1px%20solid%20%23ddd%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enav%2Dtabs%2Djustified%3Eli%3Ea%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%204px%200%200%7D%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Afocus%2C%2Enav%2Dtabs%2Djustified%3E%2Eactive%3Ea%3Ahover%7Bborder%2Dbottom%2Dcolor%3A%23fff%7D%7D%2Etab%2Dcontent%3E%2Etab%2Dpane%7Bdisplay%3Anone%7D%2Etab%2Dcontent%3E%2Eactive%7Bdisplay%3Ablock%7D%2Enav%2Dtabs%20%2Edropdown%2Dmenu%7Bmargin%2Dtop%3A%2D1px%3Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Enavbar%7Bposition%3Arelative%3Bmin%2Dheight%3A50px%3Bmargin%2Dbottom%3A20px%3Bborder%3A1px%20solid%20transparent%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%7Bborder%2Dradius%3A4px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dheader%7Bfloat%3Aleft%7D%7D%2Enavbar%2Dcollapse%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%3Boverflow%2Dx%3Avisible%3B%2Dwebkit%2Doverflow%2Dscrolling%3Atouch%3Bborder%2Dtop%3A1px%20solid%20transparent%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%7D%2Enavbar%2Dcollapse%2Ein%7Boverflow%2Dy%3Aauto%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dcollapse%7Bwidth%3Aauto%3Bborder%2Dtop%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Enavbar%2Dcollapse%2Ecollapse%7Bdisplay%3Ablock%21important%3Bheight%3Aauto%21important%3Bpadding%2Dbottom%3A0%3Boverflow%3Avisible%21important%7D%2Enavbar%2Dcollapse%2Ein%7Boverflow%2Dy%3Avisible%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dstatic%2Dtop%20%2Enavbar%2Dcollapse%7Bpadding%2Dright%3A0%3Bpadding%2Dleft%3A0%7D%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%7Bmax%2Dheight%3A340px%7D%40media%20%28max%2Ddevice%2Dwidth%3A480px%29%20and%20%28orientation%3Alandscape%29%7B%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dfixed%2Dtop%20%2Enavbar%2Dcollapse%7Bmax%2Dheight%3A200px%7D%7D%2Econtainer%2Dfluid%3E%2Enavbar%2Dcollapse%2C%2Econtainer%2Dfluid%3E%2Enavbar%2Dheader%2C%2Econtainer%3E%2Enavbar%2Dcollapse%2C%2Econtainer%3E%2Enavbar%2Dheader%7Bmargin%2Dright%3A%2D15px%3Bmargin%2Dleft%3A%2D15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Econtainer%2Dfluid%3E%2Enavbar%2Dcollapse%2C%2Econtainer%2Dfluid%3E%2Enavbar%2Dheader%2C%2Econtainer%3E%2Enavbar%2Dcollapse%2C%2Econtainer%3E%2Enavbar%2Dheader%7Bmargin%2Dright%3A0%3Bmargin%2Dleft%3A0%7D%7D%2Enavbar%2Dstatic%2Dtop%7Bz%2Dindex%3A1000%3Bborder%2Dwidth%3A0%200%201px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dstatic%2Dtop%7Bborder%2Dradius%3A0%7D%7D%2Enavbar%2Dfixed%2Dbottom%2C%2Enavbar%2Dfixed%2Dtop%7Bposition%3Afixed%3Bright%3A0%3Bleft%3A0%3Bz%2Dindex%3A1030%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dfixed%2Dbottom%2C%2Enavbar%2Dfixed%2Dtop%7Bborder%2Dradius%3A0%7D%7D%2Enavbar%2Dfixed%2Dtop%7Btop%3A0%3Bborder%2Dwidth%3A0%200%201px%7D%2Enavbar%2Dfixed%2Dbottom%7Bbottom%3A0%3Bmargin%2Dbottom%3A0%3Bborder%2Dwidth%3A1px%200%200%7D%2Enavbar%2Dbrand%7Bfloat%3Aleft%3Bheight%3A50px%3Bpadding%3A15px%2015px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A20px%7D%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Dbrand%3Ahover%7Btext%2Ddecoration%3Anone%7D%2Enavbar%2Dbrand%3Eimg%7Bdisplay%3Ablock%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%3E%2Econtainer%20%2Enavbar%2Dbrand%2C%2Enavbar%3E%2Econtainer%2Dfluid%20%2Enavbar%2Dbrand%7Bmargin%2Dleft%3A%2D15px%7D%7D%2Enavbar%2Dtoggle%7Bposition%3Arelative%3Bfloat%3Aright%3Bpadding%3A9px%2010px%3Bmargin%2Dtop%3A8px%3Bmargin%2Dright%3A15px%3Bmargin%2Dbottom%3A8px%3Bbackground%2Dcolor%3Atransparent%3Bbackground%2Dimage%3Anone%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Enavbar%2Dtoggle%3Afocus%7Boutline%3A0%7D%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bdisplay%3Ablock%3Bwidth%3A22px%3Bheight%3A2px%3Bborder%2Dradius%3A1px%7D%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%2B%2Eicon%2Dbar%7Bmargin%2Dtop%3A4px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dtoggle%7Bdisplay%3Anone%7D%7D%2Enavbar%2Dnav%7Bmargin%3A7%2E5px%20%2D15px%7D%2Enavbar%2Dnav%3Eli%3Ea%7Bpadding%2Dtop%3A10px%3Bpadding%2Dbottom%3A10px%3Bline%2Dheight%3A20px%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%7Bposition%3Astatic%3Bfloat%3Anone%3Bwidth%3Aauto%3Bmargin%2Dtop%3A0%3Bbackground%2Dcolor%3Atransparent%3Bborder%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%20%2Edropdown%2Dheader%2C%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bpadding%3A5px%2015px%205px%2025px%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bline%2Dheight%3A20px%7D%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bbackground%2Dimage%3Anone%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dnav%7Bfloat%3Aleft%3Bmargin%3A0%7D%2Enavbar%2Dnav%3Eli%7Bfloat%3Aleft%7D%2Enavbar%2Dnav%3Eli%3Ea%7Bpadding%2Dtop%3A15px%3Bpadding%2Dbottom%3A15px%7D%7D%2Enavbar%2Dform%7Bpadding%3A10px%2015px%3Bmargin%2Dtop%3A8px%3Bmargin%2Dright%3A%2D15px%3Bmargin%2Dbottom%3A8px%3Bmargin%2Dleft%3A%2D15px%3Bborder%2Dtop%3A1px%20solid%20transparent%3Bborder%2Dbottom%3A1px%20solid%20transparent%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%2C0%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%2C0%201px%200%20rgba%28255%2C255%2C255%2C%2E1%29%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dform%20%2Eform%2Dgroup%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Eform%2Dcontrol%7Bdisplay%3Ainline%2Dblock%3Bwidth%3Aauto%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Eform%2Dcontrol%2Dstatic%7Bdisplay%3Ainline%2Dblock%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%7Bdisplay%3Ainline%2Dtable%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Eform%2Dcontrol%2C%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Daddon%2C%2Enavbar%2Dform%20%2Einput%2Dgroup%20%2Einput%2Dgroup%2Dbtn%7Bwidth%3Aauto%7D%2Enavbar%2Dform%20%2Einput%2Dgroup%3E%2Eform%2Dcontrol%7Bwidth%3A100%25%7D%2Enavbar%2Dform%20%2Econtrol%2Dlabel%7Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Echeckbox%2C%2Enavbar%2Dform%20%2Eradio%7Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bvertical%2Dalign%3Amiddle%7D%2Enavbar%2Dform%20%2Echeckbox%20label%2C%2Enavbar%2Dform%20%2Eradio%20label%7Bpadding%2Dleft%3A0%7D%2Enavbar%2Dform%20%2Echeckbox%20input%5Btype%3Dcheckbox%5D%2C%2Enavbar%2Dform%20%2Eradio%20input%5Btype%3Dradio%5D%7Bposition%3Arelative%3Bmargin%2Dleft%3A0%7D%2Enavbar%2Dform%20%2Ehas%2Dfeedback%20%2Eform%2Dcontrol%2Dfeedback%7Btop%3A0%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dform%20%2Eform%2Dgroup%7Bmargin%2Dbottom%3A5px%7D%2Enavbar%2Dform%20%2Eform%2Dgroup%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dform%7Bwidth%3Aauto%3Bpadding%2Dtop%3A0%3Bpadding%2Dbottom%3A0%3Bmargin%2Dright%3A0%3Bmargin%2Dleft%3A0%3Bborder%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3Anone%3Bbox%2Dshadow%3Anone%7D%7D%2Enavbar%2Dnav%3Eli%3E%2Edropdown%2Dmenu%7Bmargin%2Dtop%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Enavbar%2Dfixed%2Dbottom%20%2Enavbar%2Dnav%3Eli%3E%2Edropdown%2Dmenu%7Bmargin%2Dbottom%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A0%3Bborder%2Dbottom%2Dleft%2Dradius%3A0%7D%2Enavbar%2Dbtn%7Bmargin%2Dtop%3A8px%3Bmargin%2Dbottom%3A8px%7D%2Enavbar%2Dbtn%2Ebtn%2Dsm%7Bmargin%2Dtop%3A10px%3Bmargin%2Dbottom%3A10px%7D%2Enavbar%2Dbtn%2Ebtn%2Dxs%7Bmargin%2Dtop%3A14px%3Bmargin%2Dbottom%3A14px%7D%2Enavbar%2Dtext%7Bmargin%2Dtop%3A15px%3Bmargin%2Dbottom%3A15px%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dtext%7Bfloat%3Aleft%3Bmargin%2Dright%3A15px%3Bmargin%2Dleft%3A15px%7D%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Enavbar%2Dleft%7Bfloat%3Aleft%21important%7D%2Enavbar%2Dright%7Bfloat%3Aright%21important%3Bmargin%2Dright%3A%2D15px%7D%2Enavbar%2Dright%7E%2Enavbar%2Dright%7Bmargin%2Dright%3A0%7D%7D%2Enavbar%2Ddefault%7Bbackground%2Dcolor%3A%23f8f8f8%3Bborder%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dbrand%3Ahover%7Bcolor%3A%235e5e5e%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtext%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3Eli%3Ea%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23ccc%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%7Bborder%2Dcolor%3A%23ddd%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%3Ahover%7Bbackground%2Dcolor%3A%23ddd%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bbackground%2Dcolor%3A%23888%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dform%7Bborder%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23333%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23555%3Bbackground%2Dcolor%3A%23e7e7e7%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Ddefault%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23ccc%3Bbackground%2Dcolor%3Atransparent%7D%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dlink%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Enavbar%2Dlink%3Ahover%7Bcolor%3A%23333%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%7Bcolor%3A%23777%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Afocus%2C%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23333%7D%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Ddefault%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23ccc%7D%2Enavbar%2Dinverse%7Bbackground%2Dcolor%3A%23222%3Bborder%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dbrand%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtext%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3Eli%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23444%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%7Bborder%2Dcolor%3A%23333%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%3Ahover%7Bbackground%2Dcolor%3A%23333%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dtoggle%20%2Eicon%2Dbar%7Bbackground%2Dcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dcollapse%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dform%7Bborder%2Dcolor%3A%23101010%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%3E%2Eopen%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edropdown%2Dheader%7Bborder%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%20%2Edivider%7Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3Eli%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3Atransparent%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Eactive%3Ea%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23080808%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Afocus%2C%2Enavbar%2Dinverse%20%2Enavbar%2Dnav%20%2Eopen%20%2Edropdown%2Dmenu%3E%2Edisabled%3Ea%3Ahover%7Bcolor%3A%23444%3Bbackground%2Dcolor%3Atransparent%7D%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dlink%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Enavbar%2Dlink%3Ahover%7Bcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%7Bcolor%3A%239d9d9d%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Afocus%2C%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23fff%7D%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%5Bdisabled%5D%3Afocus%2C%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%5Bdisabled%5D%3Ahover%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Afocus%2Cfieldset%5Bdisabled%5D%20%2Enavbar%2Dinverse%20%2Ebtn%2Dlink%3Ahover%7Bcolor%3A%23444%7D%2Ebreadcrumb%7Bpadding%3A8px%2015px%3Bmargin%2Dbottom%3A20px%3Blist%2Dstyle%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dradius%3A4px%7D%2Ebreadcrumb%3Eli%7Bdisplay%3Ainline%2Dblock%7D%2Ebreadcrumb%3Eli%2Bli%3Abefore%7Bpadding%3A0%205px%3Bcolor%3A%23ccc%3Bcontent%3A%22%2F%5C00a0%22%7D%2Ebreadcrumb%3E%2Eactive%7Bcolor%3A%23777%7D%2Epagination%7Bdisplay%3Ainline%2Dblock%3Bpadding%2Dleft%3A0%3Bmargin%3A20px%200%3Bborder%2Dradius%3A4px%7D%2Epagination%3Eli%7Bdisplay%3Ainline%7D%2Epagination%3Eli%3Ea%2C%2Epagination%3Eli%3Espan%7Bposition%3Arelative%3Bfloat%3Aleft%3Bpadding%3A6px%2012px%3Bmargin%2Dleft%3A%2D1px%3Bline%2Dheight%3A1%2E42857143%3Bcolor%3A%23337ab7%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%7D%2Epagination%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%3Eli%3Afirst%2Dchild%3Espan%7Bmargin%2Dleft%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7D%2Epagination%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dright%2Dradius%3A4px%7D%2Epagination%3Eli%3Ea%3Afocus%2C%2Epagination%3Eli%3Ea%3Ahover%2C%2Epagination%3Eli%3Espan%3Afocus%2C%2Epagination%3Eli%3Espan%3Ahover%7Bz%2Dindex%3A3%3Bcolor%3A%2323527c%3Bbackground%2Dcolor%3A%23eee%3Bborder%2Dcolor%3A%23ddd%7D%2Epagination%3E%2Eactive%3Ea%2C%2Epagination%3E%2Eactive%3Ea%3Afocus%2C%2Epagination%3E%2Eactive%3Ea%3Ahover%2C%2Epagination%3E%2Eactive%3Espan%2C%2Epagination%3E%2Eactive%3Espan%3Afocus%2C%2Epagination%3E%2Eactive%3Espan%3Ahover%7Bz%2Dindex%3A2%3Bcolor%3A%23fff%3Bcursor%3Adefault%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Epagination%3E%2Edisabled%3Ea%2C%2Epagination%3E%2Edisabled%3Ea%3Afocus%2C%2Epagination%3E%2Edisabled%3Ea%3Ahover%2C%2Epagination%3E%2Edisabled%3Espan%2C%2Epagination%3E%2Edisabled%3Espan%3Afocus%2C%2Epagination%3E%2Edisabled%3Espan%3Ahover%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23fff%3Bborder%2Dcolor%3A%23ddd%7D%2Epagination%2Dlg%3Eli%3Ea%2C%2Epagination%2Dlg%3Eli%3Espan%7Bpadding%3A10px%2016px%3Bfont%2Dsize%3A18px%3Bline%2Dheight%3A1%2E3333333%7D%2Epagination%2Dlg%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%2Dlg%3Eli%3Afirst%2Dchild%3Espan%7Bborder%2Dtop%2Dleft%2Dradius%3A6px%3Bborder%2Dbottom%2Dleft%2Dradius%3A6px%7D%2Epagination%2Dlg%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%2Dlg%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A6px%3Bborder%2Dbottom%2Dright%2Dradius%3A6px%7D%2Epagination%2Dsm%3Eli%3Ea%2C%2Epagination%2Dsm%3Eli%3Espan%7Bpadding%3A5px%2010px%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A1%2E5%7D%2Epagination%2Dsm%3Eli%3Afirst%2Dchild%3Ea%2C%2Epagination%2Dsm%3Eli%3Afirst%2Dchild%3Espan%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epagination%2Dsm%3Eli%3Alast%2Dchild%3Ea%2C%2Epagination%2Dsm%3Eli%3Alast%2Dchild%3Espan%7Bborder%2Dtop%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%7D%2Epager%7Bpadding%2Dleft%3A0%3Bmargin%3A20px%200%3Btext%2Dalign%3Acenter%3Blist%2Dstyle%3Anone%7D%2Epager%20li%7Bdisplay%3Ainline%7D%2Epager%20li%3Ea%2C%2Epager%20li%3Espan%7Bdisplay%3Ainline%2Dblock%3Bpadding%3A5px%2014px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A15px%7D%2Epager%20li%3Ea%3Afocus%2C%2Epager%20li%3Ea%3Ahover%7Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23eee%7D%2Epager%20%2Enext%3Ea%2C%2Epager%20%2Enext%3Espan%7Bfloat%3Aright%7D%2Epager%20%2Eprevious%3Ea%2C%2Epager%20%2Eprevious%3Espan%7Bfloat%3Aleft%7D%2Epager%20%2Edisabled%3Ea%2C%2Epager%20%2Edisabled%3Ea%3Afocus%2C%2Epager%20%2Edisabled%3Ea%3Ahover%2C%2Epager%20%2Edisabled%3Espan%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23fff%7D%2Elabel%7Bdisplay%3Ainline%3Bpadding%3A%2E2em%20%2E6em%20%2E3em%3Bfont%2Dsize%3A75%25%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Abaseline%3Bborder%2Dradius%3A%2E25em%7Da%2Elabel%3Afocus%2Ca%2Elabel%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%7D%2Elabel%3Aempty%7Bdisplay%3Anone%7D%2Ebtn%20%2Elabel%7Bposition%3Arelative%3Btop%3A%2D1px%7D%2Elabel%2Ddefault%7Bbackground%2Dcolor%3A%23777%7D%2Elabel%2Ddefault%5Bhref%5D%3Afocus%2C%2Elabel%2Ddefault%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%235e5e5e%7D%2Elabel%2Dprimary%7Bbackground%2Dcolor%3A%23337ab7%7D%2Elabel%2Dprimary%5Bhref%5D%3Afocus%2C%2Elabel%2Dprimary%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23286090%7D%2Elabel%2Dsuccess%7Bbackground%2Dcolor%3A%235cb85c%7D%2Elabel%2Dsuccess%5Bhref%5D%3Afocus%2C%2Elabel%2Dsuccess%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23449d44%7D%2Elabel%2Dinfo%7Bbackground%2Dcolor%3A%235bc0de%7D%2Elabel%2Dinfo%5Bhref%5D%3Afocus%2C%2Elabel%2Dinfo%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%2331b0d5%7D%2Elabel%2Dwarning%7Bbackground%2Dcolor%3A%23f0ad4e%7D%2Elabel%2Dwarning%5Bhref%5D%3Afocus%2C%2Elabel%2Dwarning%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23ec971f%7D%2Elabel%2Ddanger%7Bbackground%2Dcolor%3A%23d9534f%7D%2Elabel%2Ddanger%5Bhref%5D%3Afocus%2C%2Elabel%2Ddanger%5Bhref%5D%3Ahover%7Bbackground%2Dcolor%3A%23c9302c%7D%2Ebadge%7Bdisplay%3Ainline%2Dblock%3Bmin%2Dwidth%3A10px%3Bpadding%3A3px%207px%3Bfont%2Dsize%3A12px%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bwhite%2Dspace%3Anowrap%3Bvertical%2Dalign%3Amiddle%3Bbackground%2Dcolor%3A%23777%3Bborder%2Dradius%3A10px%7D%2Ebadge%3Aempty%7Bdisplay%3Anone%7D%2Ebtn%20%2Ebadge%7Bposition%3Arelative%3Btop%3A%2D1px%7D%2Ebtn%2Dgroup%2Dxs%3E%2Ebtn%20%2Ebadge%2C%2Ebtn%2Dxs%20%2Ebadge%7Btop%3A0%3Bpadding%3A1px%205px%7Da%2Ebadge%3Afocus%2Ca%2Ebadge%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%7D%2Elist%2Dgroup%2Ditem%2Eactive%3E%2Ebadge%2C%2Enav%2Dpills%3E%2Eactive%3Ea%3E%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Elist%2Dgroup%2Ditem%3E%2Ebadge%7Bfloat%3Aright%7D%2Elist%2Dgroup%2Ditem%3E%2Ebadge%2B%2Ebadge%7Bmargin%2Dright%3A5px%7D%2Enav%2Dpills%3Eli%3Ea%3E%2Ebadge%7Bmargin%2Dleft%3A3px%7D%2Ejumbotron%7Bpadding%2Dtop%3A30px%3Bpadding%2Dbottom%3A30px%3Bmargin%2Dbottom%3A30px%3Bcolor%3Ainherit%3Bbackground%2Dcolor%3A%23eee%7D%2Ejumbotron%20%2Eh1%2C%2Ejumbotron%20h1%7Bcolor%3Ainherit%7D%2Ejumbotron%20p%7Bmargin%2Dbottom%3A15px%3Bfont%2Dsize%3A21px%3Bfont%2Dweight%3A200%7D%2Ejumbotron%3Ehr%7Bborder%2Dtop%2Dcolor%3A%23d5d5d5%7D%2Econtainer%20%2Ejumbotron%2C%2Econtainer%2Dfluid%20%2Ejumbotron%7Bborder%2Dradius%3A6px%7D%2Ejumbotron%20%2Econtainer%7Bmax%2Dwidth%3A100%25%7D%40media%20screen%20and%20%28min%2Dwidth%3A768px%29%7B%2Ejumbotron%7Bpadding%2Dtop%3A48px%3Bpadding%2Dbottom%3A48px%7D%2Econtainer%20%2Ejumbotron%2C%2Econtainer%2Dfluid%20%2Ejumbotron%7Bpadding%2Dright%3A60px%3Bpadding%2Dleft%3A60px%7D%2Ejumbotron%20%2Eh1%2C%2Ejumbotron%20h1%7Bfont%2Dsize%3A63px%7D%7D%2Ethumbnail%7Bdisplay%3Ablock%3Bpadding%3A4px%3Bmargin%2Dbottom%3A20px%3Bline%2Dheight%3A1%2E42857143%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dtransition%3Aborder%20%2E2s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3Aborder%20%2E2s%20ease%2Din%2Dout%3Btransition%3Aborder%20%2E2s%20ease%2Din%2Dout%7D%2Ethumbnail%20a%3Eimg%2C%2Ethumbnail%3Eimg%7Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7Da%2Ethumbnail%2Eactive%2Ca%2Ethumbnail%3Afocus%2Ca%2Ethumbnail%3Ahover%7Bborder%2Dcolor%3A%23337ab7%7D%2Ethumbnail%20%2Ecaption%7Bpadding%3A9px%3Bcolor%3A%23333%7D%2Ealert%7Bpadding%3A15px%3Bmargin%2Dbottom%3A20px%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%7D%2Ealert%20h4%7Bmargin%2Dtop%3A0%3Bcolor%3Ainherit%7D%2Ealert%20%2Ealert%2Dlink%7Bfont%2Dweight%3A700%7D%2Ealert%3Ep%2C%2Ealert%3Eul%7Bmargin%2Dbottom%3A0%7D%2Ealert%3Ep%2Bp%7Bmargin%2Dtop%3A5px%7D%2Ealert%2Ddismissable%2C%2Ealert%2Ddismissible%7Bpadding%2Dright%3A35px%7D%2Ealert%2Ddismissable%20%2Eclose%2C%2Ealert%2Ddismissible%20%2Eclose%7Bposition%3Arelative%3Btop%3A%2D2px%3Bright%3A%2D21px%3Bcolor%3Ainherit%7D%2Ealert%2Dsuccess%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%23d6e9c6%7D%2Ealert%2Dsuccess%20hr%7Bborder%2Dtop%2Dcolor%3A%23c9e2b3%7D%2Ealert%2Dsuccess%20%2Ealert%2Dlink%7Bcolor%3A%232b542c%7D%2Ealert%2Dinfo%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%3Bborder%2Dcolor%3A%23bce8f1%7D%2Ealert%2Dinfo%20hr%7Bborder%2Dtop%2Dcolor%3A%23a6e1ec%7D%2Ealert%2Dinfo%20%2Ealert%2Dlink%7Bcolor%3A%23245269%7D%2Ealert%2Dwarning%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%23faebcc%7D%2Ealert%2Dwarning%20hr%7Bborder%2Dtop%2Dcolor%3A%23f7e1b5%7D%2Ealert%2Dwarning%20%2Ealert%2Dlink%7Bcolor%3A%2366512c%7D%2Ealert%2Ddanger%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23ebccd1%7D%2Ealert%2Ddanger%20hr%7Bborder%2Dtop%2Dcolor%3A%23e4b9c0%7D%2Ealert%2Ddanger%20%2Ealert%2Dlink%7Bcolor%3A%23843534%7D%40%2Dwebkit%2Dkeyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%40%2Do%2Dkeyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%40keyframes%20progress%2Dbar%2Dstripes%7Bfrom%7Bbackground%2Dposition%3A40px%200%7Dto%7Bbackground%2Dposition%3A0%200%7D%7D%2Eprogress%7Bheight%3A20px%3Bmargin%2Dbottom%3A20px%3Boverflow%3Ahidden%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%202px%20rgba%280%2C0%2C0%2C%2E1%29%3Bbox%2Dshadow%3Ainset%200%201px%202px%20rgba%280%2C0%2C0%2C%2E1%29%7D%2Eprogress%2Dbar%7Bfloat%3Aleft%3Bwidth%3A0%3Bheight%3A100%25%3Bfont%2Dsize%3A12px%3Bline%2Dheight%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23337ab7%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E15%29%3Bbox%2Dshadow%3Ainset%200%20%2D1px%200%20rgba%280%2C0%2C0%2C%2E15%29%3B%2Dwebkit%2Dtransition%3Awidth%20%2E6s%20ease%3B%2Do%2Dtransition%3Awidth%20%2E6s%20ease%3Btransition%3Awidth%20%2E6s%20ease%7D%2Eprogress%2Dbar%2Dstriped%2C%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3B%2Dwebkit%2Dbackground%2Dsize%3A40px%2040px%3Bbackground%2Dsize%3A40px%2040px%7D%2Eprogress%2Dbar%2Eactive%2C%2Eprogress%2Eactive%20%2Eprogress%2Dbar%7B%2Dwebkit%2Danimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%3B%2Do%2Danimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%3Banimation%3Aprogress%2Dbar%2Dstripes%202s%20linear%20infinite%7D%2Eprogress%2Dbar%2Dsuccess%7Bbackground%2Dcolor%3A%235cb85c%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dsuccess%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Dinfo%7Bbackground%2Dcolor%3A%235bc0de%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dinfo%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Dwarning%7Bbackground%2Dcolor%3A%23f0ad4e%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Dwarning%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Eprogress%2Dbar%2Ddanger%7Bbackground%2Dcolor%3A%23d9534f%7D%2Eprogress%2Dstriped%20%2Eprogress%2Dbar%2Ddanger%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%3Bbackground%2Dimage%3Alinear%2Dgradient%2845deg%2Crgba%28255%2C255%2C255%2C%2E15%29%2025%25%2Ctransparent%2025%25%2Ctransparent%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2050%25%2Crgba%28255%2C255%2C255%2C%2E15%29%2075%25%2Ctransparent%2075%25%2Ctransparent%29%7D%2Emedia%7Bmargin%2Dtop%3A15px%7D%2Emedia%3Afirst%2Dchild%7Bmargin%2Dtop%3A0%7D%2Emedia%2C%2Emedia%2Dbody%7Boverflow%3Ahidden%3Bzoom%3A1%7D%2Emedia%2Dbody%7Bwidth%3A10000px%7D%2Emedia%2Dobject%7Bdisplay%3Ablock%7D%2Emedia%2Dobject%2Eimg%2Dthumbnail%7Bmax%2Dwidth%3Anone%7D%2Emedia%2Dright%2C%2Emedia%3E%2Epull%2Dright%7Bpadding%2Dleft%3A10px%7D%2Emedia%2Dleft%2C%2Emedia%3E%2Epull%2Dleft%7Bpadding%2Dright%3A10px%7D%2Emedia%2Dbody%2C%2Emedia%2Dleft%2C%2Emedia%2Dright%7Bdisplay%3Atable%2Dcell%3Bvertical%2Dalign%3Atop%7D%2Emedia%2Dmiddle%7Bvertical%2Dalign%3Amiddle%7D%2Emedia%2Dbottom%7Bvertical%2Dalign%3Abottom%7D%2Emedia%2Dheading%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A5px%7D%2Emedia%2Dlist%7Bpadding%2Dleft%3A0%3Blist%2Dstyle%3Anone%7D%2Elist%2Dgroup%7Bpadding%2Dleft%3A0%3Bmargin%2Dbottom%3A20px%7D%2Elist%2Dgroup%2Ditem%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bpadding%3A10px%2015px%3Bmargin%2Dbottom%3A%2D1px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20%23ddd%7D%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A4px%3Bborder%2Dtop%2Dright%2Dradius%3A4px%7D%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%7Bmargin%2Dbottom%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A4px%3Bborder%2Dbottom%2Dleft%2Dradius%3A4px%7Da%2Elist%2Dgroup%2Ditem%2Cbutton%2Elist%2Dgroup%2Ditem%7Bcolor%3A%23555%7Da%2Elist%2Dgroup%2Ditem%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3A%23333%7Da%2Elist%2Dgroup%2Ditem%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%3Ahover%7Bcolor%3A%23555%3Btext%2Ddecoration%3Anone%3Bbackground%2Dcolor%3A%23f5f5f5%7Dbutton%2Elist%2Dgroup%2Ditem%7Bwidth%3A100%25%3Btext%2Dalign%3Aleft%7D%2Elist%2Dgroup%2Ditem%2Edisabled%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%7Bcolor%3A%23777%3Bcursor%3Anot%2Dallowed%3Bbackground%2Dcolor%3A%23eee%7D%2Elist%2Dgroup%2Ditem%2Edisabled%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7D%2Elist%2Dgroup%2Ditem%2Edisabled%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Edisabled%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dtext%7Bcolor%3A%23777%7D%2Elist%2Dgroup%2Ditem%2Eactive%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%7Bz%2Dindex%3A2%3Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%3E%2Esmall%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dheading%3Esmall%7Bcolor%3Ainherit%7D%2Elist%2Dgroup%2Ditem%2Eactive%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Afocus%20%2Elist%2Dgroup%2Ditem%2Dtext%2C%2Elist%2Dgroup%2Ditem%2Eactive%3Ahover%20%2Elist%2Dgroup%2Ditem%2Dtext%7Bcolor%3A%23c7ddef%7D%2Elist%2Dgroup%2Ditem%2Dsuccess%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%7Bcolor%3A%233c763d%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%3Ahover%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23d0e9c6%7Da%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dsuccess%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%233c763d%3Bborder%2Dcolor%3A%233c763d%7D%2Elist%2Dgroup%2Ditem%2Dinfo%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%7Bcolor%3A%2331708f%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%3Ahover%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23c4e3f3%7Da%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dinfo%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%2331708f%3Bborder%2Dcolor%3A%2331708f%7D%2Elist%2Dgroup%2Ditem%2Dwarning%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%7Bcolor%3A%238a6d3b%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%3Ahover%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23faf2cc%7Da%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Dwarning%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%238a6d3b%3Bborder%2Dcolor%3A%238a6d3b%7D%2Elist%2Dgroup%2Ditem%2Ddanger%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%7Bcolor%3A%23a94442%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%20%2Elist%2Dgroup%2Ditem%2Dheading%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%20%2Elist%2Dgroup%2Ditem%2Dheading%7Bcolor%3Ainherit%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%3Ahover%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23ebcccc%7Da%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Afocus%2Ca%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Ahover%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Afocus%2Cbutton%2Elist%2Dgroup%2Ditem%2Ddanger%2Eactive%3Ahover%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23a94442%3Bborder%2Dcolor%3A%23a94442%7D%2Elist%2Dgroup%2Ditem%2Dheading%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A5px%7D%2Elist%2Dgroup%2Ditem%2Dtext%7Bmargin%2Dbottom%3A0%3Bline%2Dheight%3A1%2E3%7D%2Epanel%7Bmargin%2Dbottom%3A20px%3Bbackground%2Dcolor%3A%23fff%3Bborder%3A1px%20solid%20transparent%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%3Bbox%2Dshadow%3A0%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%7D%2Epanel%2Dbody%7Bpadding%3A15px%7D%2Epanel%2Dheading%7Bpadding%3A10px%2015px%3Bborder%2Dbottom%3A1px%20solid%20transparent%3Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%2Dheading%3E%2Edropdown%20%2Edropdown%2Dtoggle%7Bcolor%3Ainherit%7D%2Epanel%2Dtitle%7Bmargin%2Dtop%3A0%3Bmargin%2Dbottom%3A0%3Bfont%2Dsize%3A16px%3Bcolor%3Ainherit%7D%2Epanel%2Dtitle%3E%2Esmall%2C%2Epanel%2Dtitle%3E%2Esmall%3Ea%2C%2Epanel%2Dtitle%3Ea%2C%2Epanel%2Dtitle%3Esmall%2C%2Epanel%2Dtitle%3Esmall%3Ea%7Bcolor%3Ainherit%7D%2Epanel%2Dfooter%7Bpadding%3A10px%2015px%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dtop%3A1px%20solid%20%23ddd%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Elist%2Dgroup%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%7Bmargin%2Dbottom%3A0%7D%2Epanel%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%7Bborder%2Dwidth%3A1px%200%3Bborder%2Dradius%3A0%7D%2Epanel%3E%2Elist%2Dgroup%3Afirst%2Dchild%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%3Afirst%2Dchild%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%3A0%3Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Elist%2Dgroup%3Alast%2Dchild%20%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%2C%2Epanel%3E%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%3Alast%2Dchild%20%2Elist%2Dgroup%2Ditem%3Alast%2Dchild%7Bborder%2Dbottom%3A0%3Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A0%3Bborder%2Dtop%2Dright%2Dradius%3A0%7D%2Epanel%2Dheading%2B%2Elist%2Dgroup%20%2Elist%2Dgroup%2Ditem%3Afirst%2Dchild%7Bborder%2Dtop%2Dwidth%3A0%7D%2Elist%2Dgroup%2B%2Epanel%2Dfooter%7Bborder%2Dtop%2Dwidth%3A0%7D%2Epanel%3E%2Epanel%2Dcollapse%3E%2Etable%2C%2Epanel%3E%2Etable%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%7Bmargin%2Dbottom%3A0%7D%2Epanel%3E%2Epanel%2Dcollapse%3E%2Etable%20caption%2C%2Epanel%3E%2Etable%20caption%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%20caption%7Bpadding%2Dright%3A15px%3Bpadding%2Dleft%3A15px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%3Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Afirst%2Dchild%7Bborder%2Dtop%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Afirst%2Dchild%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Afirst%2Dchild%3Ethead%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%3Alast%2Dchild%7Bborder%2Dtop%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%3Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Afirst%2Dchild%7Bborder%2Dbottom%2Dleft%2Dradius%3A3px%7D%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3Alast%2Dchild%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etbody%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20td%3Alast%2Dchild%2C%2Epanel%3E%2Etable%3Alast%2Dchild%3Etfoot%3Alast%2Dchild%3Etr%3Alast%2Dchild%20th%3Alast%2Dchild%7Bborder%2Dbottom%2Dright%2Dradius%3A3px%7D%2Epanel%3E%2Epanel%2Dbody%2B%2Etable%2C%2Epanel%3E%2Epanel%2Dbody%2B%2Etable%2Dresponsive%2C%2Epanel%3E%2Etable%2B%2Epanel%2Dbody%2C%2Epanel%3E%2Etable%2Dresponsive%2B%2Epanel%2Dbody%7Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Epanel%3E%2Etable%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20td%2C%2Epanel%3E%2Etable%3Etbody%3Afirst%2Dchild%3Etr%3Afirst%2Dchild%20th%7Bborder%2Dtop%3A0%7D%2Epanel%3E%2Etable%2Dbordered%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%7Bborder%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Afirst%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Afirst%2Dchild%7Bborder%2Dleft%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Eth%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Etd%3Alast%2Dchild%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Eth%3Alast%2Dchild%7Bborder%2Dright%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Afirst%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Ethead%3Etr%3Afirst%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etbody%3Etr%3Alast%2Dchild%3Eth%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Etd%2C%2Epanel%3E%2Etable%2Dresponsive%3E%2Etable%2Dbordered%3Etfoot%3Etr%3Alast%2Dchild%3Eth%7Bborder%2Dbottom%3A0%7D%2Epanel%3E%2Etable%2Dresponsive%7Bmargin%2Dbottom%3A0%3Bborder%3A0%7D%2Epanel%2Dgroup%7Bmargin%2Dbottom%3A20px%7D%2Epanel%2Dgroup%20%2Epanel%7Bmargin%2Dbottom%3A0%3Bborder%2Dradius%3A4px%7D%2Epanel%2Dgroup%20%2Epanel%2B%2Epanel%7Bmargin%2Dtop%3A5px%7D%2Epanel%2Dgroup%20%2Epanel%2Dheading%7Bborder%2Dbottom%3A0%7D%2Epanel%2Dgroup%20%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Elist%2Dgroup%2C%2Epanel%2Dgroup%20%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%3A1px%20solid%20%23ddd%7D%2Epanel%2Dgroup%20%2Epanel%2Dfooter%7Bborder%2Dtop%3A0%7D%2Epanel%2Dgroup%20%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%20%2Epanel%2Dbody%7Bborder%2Dbottom%3A1px%20solid%20%23ddd%7D%2Epanel%2Ddefault%7Bborder%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%7Bcolor%3A%23333%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23ddd%7D%2Epanel%2Ddefault%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23f5f5f5%3Bbackground%2Dcolor%3A%23333%7D%2Epanel%2Ddefault%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23ddd%7D%2Epanel%2Dprimary%7Bborder%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%7Bcolor%3A%23fff%3Bbackground%2Dcolor%3A%23337ab7%3Bborder%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23337ab7%7D%2Epanel%2Dprimary%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23337ab7%3Bbackground%2Dcolor%3A%23fff%7D%2Epanel%2Dprimary%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23337ab7%7D%2Epanel%2Dsuccess%7Bborder%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%7Bcolor%3A%233c763d%3Bbackground%2Dcolor%3A%23dff0d8%3Bborder%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23dff0d8%3Bbackground%2Dcolor%3A%233c763d%7D%2Epanel%2Dsuccess%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23d6e9c6%7D%2Epanel%2Dinfo%7Bborder%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%7Bcolor%3A%2331708f%3Bbackground%2Dcolor%3A%23d9edf7%3Bborder%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dinfo%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23d9edf7%3Bbackground%2Dcolor%3A%2331708f%7D%2Epanel%2Dinfo%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23bce8f1%7D%2Epanel%2Dwarning%7Bborder%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%7Bcolor%3A%238a6d3b%3Bbackground%2Dcolor%3A%23fcf8e3%3Bborder%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23faebcc%7D%2Epanel%2Dwarning%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23fcf8e3%3Bbackground%2Dcolor%3A%238a6d3b%7D%2Epanel%2Dwarning%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23faebcc%7D%2Epanel%2Ddanger%7Bborder%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%7Bcolor%3A%23a94442%3Bbackground%2Dcolor%3A%23f2dede%3Bborder%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dtop%2Dcolor%3A%23ebccd1%7D%2Epanel%2Ddanger%3E%2Epanel%2Dheading%20%2Ebadge%7Bcolor%3A%23f2dede%3Bbackground%2Dcolor%3A%23a94442%7D%2Epanel%2Ddanger%3E%2Epanel%2Dfooter%2B%2Epanel%2Dcollapse%3E%2Epanel%2Dbody%7Bborder%2Dbottom%2Dcolor%3A%23ebccd1%7D%2Eembed%2Dresponsive%7Bposition%3Arelative%3Bdisplay%3Ablock%3Bheight%3A0%3Bpadding%3A0%3Boverflow%3Ahidden%7D%2Eembed%2Dresponsive%20%2Eembed%2Dresponsive%2Ditem%2C%2Eembed%2Dresponsive%20embed%2C%2Eembed%2Dresponsive%20iframe%2C%2Eembed%2Dresponsive%20object%2C%2Eembed%2Dresponsive%20video%7Bposition%3Aabsolute%3Btop%3A0%3Bbottom%3A0%3Bleft%3A0%3Bwidth%3A100%25%3Bheight%3A100%25%3Bborder%3A0%7D%2Eembed%2Dresponsive%2D16by9%7Bpadding%2Dbottom%3A56%2E25%25%7D%2Eembed%2Dresponsive%2D4by3%7Bpadding%2Dbottom%3A75%25%7D%2Ewell%7Bmin%2Dheight%3A20px%3Bpadding%3A19px%3Bmargin%2Dbottom%3A20px%3Bbackground%2Dcolor%3A%23f5f5f5%3Bborder%3A1px%20solid%20%23e3e3e3%3Bborder%2Dradius%3A4px%3B%2Dwebkit%2Dbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%3Bbox%2Dshadow%3Ainset%200%201px%201px%20rgba%280%2C0%2C0%2C%2E05%29%7D%2Ewell%20blockquote%7Bborder%2Dcolor%3A%23ddd%3Bborder%2Dcolor%3Argba%280%2C0%2C0%2C%2E15%29%7D%2Ewell%2Dlg%7Bpadding%3A24px%3Bborder%2Dradius%3A6px%7D%2Ewell%2Dsm%7Bpadding%3A9px%3Bborder%2Dradius%3A3px%7D%2Eclose%7Bfloat%3Aright%3Bfont%2Dsize%3A21px%3Bfont%2Dweight%3A700%3Bline%2Dheight%3A1%3Bcolor%3A%23000%3Btext%2Dshadow%3A0%201px%200%20%23fff%3Bfilter%3Aalpha%28opacity%3D20%29%3Bopacity%3A%2E2%7D%2Eclose%3Afocus%2C%2Eclose%3Ahover%7Bcolor%3A%23000%3Btext%2Ddecoration%3Anone%3Bcursor%3Apointer%3Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7Dbutton%2Eclose%7B%2Dwebkit%2Dappearance%3Anone%3Bpadding%3A0%3Bcursor%3Apointer%3Bbackground%3A0%200%3Bborder%3A0%7D%2Emodal%2Dopen%7Boverflow%3Ahidden%7D%2Emodal%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A1050%3Bdisplay%3Anone%3Boverflow%3Ahidden%3B%2Dwebkit%2Doverflow%2Dscrolling%3Atouch%3Boutline%3A0%7D%2Emodal%2Efade%20%2Emodal%2Ddialog%7B%2Dwebkit%2Dtransition%3A%2Dwebkit%2Dtransform%20%2E3s%20ease%2Dout%3B%2Do%2Dtransition%3A%2Do%2Dtransform%20%2E3s%20ease%2Dout%3Btransition%3Atransform%20%2E3s%20ease%2Dout%3B%2Dwebkit%2Dtransform%3Atranslate%280%2C%2D25%25%29%3B%2Dms%2Dtransform%3Atranslate%280%2C%2D25%25%29%3B%2Do%2Dtransform%3Atranslate%280%2C%2D25%25%29%3Btransform%3Atranslate%280%2C%2D25%25%29%7D%2Emodal%2Ein%20%2Emodal%2Ddialog%7B%2Dwebkit%2Dtransform%3Atranslate%280%2C0%29%3B%2Dms%2Dtransform%3Atranslate%280%2C0%29%3B%2Do%2Dtransform%3Atranslate%280%2C0%29%3Btransform%3Atranslate%280%2C0%29%7D%2Emodal%2Dopen%20%2Emodal%7Boverflow%2Dx%3Ahidden%3Boverflow%2Dy%3Aauto%7D%2Emodal%2Ddialog%7Bposition%3Arelative%3Bwidth%3Aauto%3Bmargin%3A10px%7D%2Emodal%2Dcontent%7Bposition%3Arelative%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23999%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E2%29%3Bborder%2Dradius%3A6px%3Boutline%3A0%3B%2Dwebkit%2Dbox%2Dshadow%3A0%203px%209px%20rgba%280%2C0%2C0%2C%2E5%29%3Bbox%2Dshadow%3A0%203px%209px%20rgba%280%2C0%2C0%2C%2E5%29%7D%2Emodal%2Dbackdrop%7Bposition%3Afixed%3Btop%3A0%3Bright%3A0%3Bbottom%3A0%3Bleft%3A0%3Bz%2Dindex%3A1040%3Bbackground%2Dcolor%3A%23000%7D%2Emodal%2Dbackdrop%2Efade%7Bfilter%3Aalpha%28opacity%3D0%29%3Bopacity%3A0%7D%2Emodal%2Dbackdrop%2Ein%7Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7D%2Emodal%2Dheader%7Bmin%2Dheight%3A16%2E43px%3Bpadding%3A15px%3Bborder%2Dbottom%3A1px%20solid%20%23e5e5e5%7D%2Emodal%2Dheader%20%2Eclose%7Bmargin%2Dtop%3A%2D2px%7D%2Emodal%2Dtitle%7Bmargin%3A0%3Bline%2Dheight%3A1%2E42857143%7D%2Emodal%2Dbody%7Bposition%3Arelative%3Bpadding%3A15px%7D%2Emodal%2Dfooter%7Bpadding%3A15px%3Btext%2Dalign%3Aright%3Bborder%2Dtop%3A1px%20solid%20%23e5e5e5%7D%2Emodal%2Dfooter%20%2Ebtn%2B%2Ebtn%7Bmargin%2Dbottom%3A0%3Bmargin%2Dleft%3A5px%7D%2Emodal%2Dfooter%20%2Ebtn%2Dgroup%20%2Ebtn%2B%2Ebtn%7Bmargin%2Dleft%3A%2D1px%7D%2Emodal%2Dfooter%20%2Ebtn%2Dblock%2B%2Ebtn%2Dblock%7Bmargin%2Dleft%3A0%7D%2Emodal%2Dscrollbar%2Dmeasure%7Bposition%3Aabsolute%3Btop%3A%2D9999px%3Bwidth%3A50px%3Bheight%3A50px%3Boverflow%3Ascroll%7D%40media%20%28min%2Dwidth%3A768px%29%7B%2Emodal%2Ddialog%7Bwidth%3A600px%3Bmargin%3A30px%20auto%7D%2Emodal%2Dcontent%7B%2Dwebkit%2Dbox%2Dshadow%3A0%205px%2015px%20rgba%280%2C0%2C0%2C%2E5%29%3Bbox%2Dshadow%3A0%205px%2015px%20rgba%280%2C0%2C0%2C%2E5%29%7D%2Emodal%2Dsm%7Bwidth%3A300px%7D%7D%40media%20%28min%2Dwidth%3A992px%29%7B%2Emodal%2Dlg%7Bwidth%3A900px%7D%7D%2Etooltip%7Bposition%3Aabsolute%3Bz%2Dindex%3A1070%3Bdisplay%3Ablock%3Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A12px%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Aleft%3Btext%2Dalign%3Astart%3Btext%2Ddecoration%3Anone%3Btext%2Dshadow%3Anone%3Btext%2Dtransform%3Anone%3Bletter%2Dspacing%3Anormal%3Bword%2Dbreak%3Anormal%3Bword%2Dspacing%3Anormal%3Bword%2Dwrap%3Anormal%3Bwhite%2Dspace%3Anormal%3Bfilter%3Aalpha%28opacity%3D0%29%3Bopacity%3A0%3Bline%2Dbreak%3Aauto%7D%2Etooltip%2Ein%7Bfilter%3Aalpha%28opacity%3D90%29%3Bopacity%3A%2E9%7D%2Etooltip%2Etop%7Bpadding%3A5px%200%3Bmargin%2Dtop%3A%2D3px%7D%2Etooltip%2Eright%7Bpadding%3A0%205px%3Bmargin%2Dleft%3A3px%7D%2Etooltip%2Ebottom%7Bpadding%3A5px%200%3Bmargin%2Dtop%3A3px%7D%2Etooltip%2Eleft%7Bpadding%3A0%205px%3Bmargin%2Dleft%3A%2D3px%7D%2Etooltip%2Dinner%7Bmax%2Dwidth%3A200px%3Bpadding%3A3px%208px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Bbackground%2Dcolor%3A%23000%3Bborder%2Dradius%3A4px%7D%2Etooltip%2Darrow%7Bposition%3Aabsolute%3Bwidth%3A0%3Bheight%3A0%3Bborder%2Dcolor%3Atransparent%3Bborder%2Dstyle%3Asolid%7D%2Etooltip%2Etop%20%2Etooltip%2Darrow%7Bbottom%3A0%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Etop%2Dleft%20%2Etooltip%2Darrow%7Bright%3A5px%3Bbottom%3A0%3Bmargin%2Dbottom%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Etop%2Dright%20%2Etooltip%2Darrow%7Bbottom%3A0%3Bleft%3A5px%3Bmargin%2Dbottom%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%200%3Bborder%2Dtop%2Dcolor%3A%23000%7D%2Etooltip%2Eright%20%2Etooltip%2Darrow%7Btop%3A50%25%3Bleft%3A0%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A5px%205px%205px%200%3Bborder%2Dright%2Dcolor%3A%23000%7D%2Etooltip%2Eleft%20%2Etooltip%2Darrow%7Btop%3A50%25%3Bright%3A0%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A5px%200%205px%205px%3Bborder%2Dleft%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%20%2Etooltip%2Darrow%7Btop%3A0%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%2Dleft%20%2Etooltip%2Darrow%7Btop%3A0%3Bright%3A5px%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Etooltip%2Ebottom%2Dright%20%2Etooltip%2Darrow%7Btop%3A0%3Bleft%3A5px%3Bmargin%2Dtop%3A%2D5px%3Bborder%2Dwidth%3A0%205px%205px%3Bborder%2Dbottom%2Dcolor%3A%23000%7D%2Epopover%7Bposition%3Aabsolute%3Btop%3A0%3Bleft%3A0%3Bz%2Dindex%3A1060%3Bdisplay%3Anone%3Bmax%2Dwidth%3A276px%3Bpadding%3A1px%3Bfont%2Dfamily%3A%22Helvetica%20Neue%22%2CHelvetica%2CArial%2Csans%2Dserif%3Bfont%2Dsize%3A14px%3Bfont%2Dstyle%3Anormal%3Bfont%2Dweight%3A400%3Bline%2Dheight%3A1%2E42857143%3Btext%2Dalign%3Aleft%3Btext%2Dalign%3Astart%3Btext%2Ddecoration%3Anone%3Btext%2Dshadow%3Anone%3Btext%2Dtransform%3Anone%3Bletter%2Dspacing%3Anormal%3Bword%2Dbreak%3Anormal%3Bword%2Dspacing%3Anormal%3Bword%2Dwrap%3Anormal%3Bwhite%2Dspace%3Anormal%3Bbackground%2Dcolor%3A%23fff%3B%2Dwebkit%2Dbackground%2Dclip%3Apadding%2Dbox%3Bbackground%2Dclip%3Apadding%2Dbox%3Bborder%3A1px%20solid%20%23ccc%3Bborder%3A1px%20solid%20rgba%280%2C0%2C0%2C%2E2%29%3Bborder%2Dradius%3A6px%3B%2Dwebkit%2Dbox%2Dshadow%3A0%205px%2010px%20rgba%280%2C0%2C0%2C%2E2%29%3Bbox%2Dshadow%3A0%205px%2010px%20rgba%280%2C0%2C0%2C%2E2%29%3Bline%2Dbreak%3Aauto%7D%2Epopover%2Etop%7Bmargin%2Dtop%3A%2D10px%7D%2Epopover%2Eright%7Bmargin%2Dleft%3A10px%7D%2Epopover%2Ebottom%7Bmargin%2Dtop%3A10px%7D%2Epopover%2Eleft%7Bmargin%2Dleft%3A%2D10px%7D%2Epopover%2Dtitle%7Bpadding%3A8px%2014px%3Bmargin%3A0%3Bfont%2Dsize%3A14px%3Bbackground%2Dcolor%3A%23f7f7f7%3Bborder%2Dbottom%3A1px%20solid%20%23ebebeb%3Bborder%2Dradius%3A5px%205px%200%200%7D%2Epopover%2Dcontent%7Bpadding%3A9px%2014px%7D%2Epopover%3E%2Earrow%2C%2Epopover%3E%2Earrow%3Aafter%7Bposition%3Aabsolute%3Bdisplay%3Ablock%3Bwidth%3A0%3Bheight%3A0%3Bborder%2Dcolor%3Atransparent%3Bborder%2Dstyle%3Asolid%7D%2Epopover%3E%2Earrow%7Bborder%2Dwidth%3A11px%7D%2Epopover%3E%2Earrow%3Aafter%7Bcontent%3A%22%22%3Bborder%2Dwidth%3A10px%7D%2Epopover%2Etop%3E%2Earrow%7Bbottom%3A%2D11px%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D11px%3Bborder%2Dtop%2Dcolor%3A%23999%3Bborder%2Dtop%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Epopover%2Etop%3E%2Earrow%3Aafter%7Bbottom%3A1px%3Bmargin%2Dleft%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dtop%2Dcolor%3A%23fff%3Bborder%2Dbottom%2Dwidth%3A0%7D%2Epopover%2Eright%3E%2Earrow%7Btop%3A50%25%3Bleft%3A%2D11px%3Bmargin%2Dtop%3A%2D11px%3Bborder%2Dright%2Dcolor%3A%23999%3Bborder%2Dright%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%3Bborder%2Dleft%2Dwidth%3A0%7D%2Epopover%2Eright%3E%2Earrow%3Aafter%7Bbottom%3A%2D10px%3Bleft%3A1px%3Bcontent%3A%22%20%22%3Bborder%2Dright%2Dcolor%3A%23fff%3Bborder%2Dleft%2Dwidth%3A0%7D%2Epopover%2Ebottom%3E%2Earrow%7Btop%3A%2D11px%3Bleft%3A50%25%3Bmargin%2Dleft%3A%2D11px%3Bborder%2Dtop%2Dwidth%3A0%3Bborder%2Dbottom%2Dcolor%3A%23999%3Bborder%2Dbottom%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%7D%2Epopover%2Ebottom%3E%2Earrow%3Aafter%7Btop%3A1px%3Bmargin%2Dleft%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dtop%2Dwidth%3A0%3Bborder%2Dbottom%2Dcolor%3A%23fff%7D%2Epopover%2Eleft%3E%2Earrow%7Btop%3A50%25%3Bright%3A%2D11px%3Bmargin%2Dtop%3A%2D11px%3Bborder%2Dright%2Dwidth%3A0%3Bborder%2Dleft%2Dcolor%3A%23999%3Bborder%2Dleft%2Dcolor%3Argba%280%2C0%2C0%2C%2E25%29%7D%2Epopover%2Eleft%3E%2Earrow%3Aafter%7Bright%3A1px%3Bbottom%3A%2D10px%3Bcontent%3A%22%20%22%3Bborder%2Dright%2Dwidth%3A0%3Bborder%2Dleft%2Dcolor%3A%23fff%7D%2Ecarousel%7Bposition%3Arelative%7D%2Ecarousel%2Dinner%7Bposition%3Arelative%3Bwidth%3A100%25%3Boverflow%3Ahidden%7D%2Ecarousel%2Dinner%3E%2Eitem%7Bposition%3Arelative%3Bdisplay%3Anone%3B%2Dwebkit%2Dtransition%3A%2E6s%20ease%2Din%2Dout%20left%3B%2Do%2Dtransition%3A%2E6s%20ease%2Din%2Dout%20left%3Btransition%3A%2E6s%20ease%2Din%2Dout%20left%7D%2Ecarousel%2Dinner%3E%2Eitem%3Ea%3Eimg%2C%2Ecarousel%2Dinner%3E%2Eitem%3Eimg%7Bline%2Dheight%3A1%7D%40media%20all%20and%20%28transform%2D3d%29%2C%28%2Dwebkit%2Dtransform%2D3d%29%7B%2Ecarousel%2Dinner%3E%2Eitem%7B%2Dwebkit%2Dtransition%3A%2Dwebkit%2Dtransform%20%2E6s%20ease%2Din%2Dout%3B%2Do%2Dtransition%3A%2Do%2Dtransform%20%2E6s%20ease%2Din%2Dout%3Btransition%3Atransform%20%2E6s%20ease%2Din%2Dout%3B%2Dwebkit%2Dbackface%2Dvisibility%3Ahidden%3Bbackface%2Dvisibility%3Ahidden%3B%2Dwebkit%2Dperspective%3A1000px%3Bperspective%3A1000px%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2Eright%2C%2Ecarousel%2Dinner%3E%2Eitem%2Enext%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%28100%25%2C0%2C0%29%3Btransform%3Atranslate3d%28100%25%2C0%2C0%29%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eitem%2Eprev%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%28%2D100%25%2C0%2C0%29%3Btransform%3Atranslate3d%28%2D100%25%2C0%2C0%29%7D%2Ecarousel%2Dinner%3E%2Eitem%2Eactive%2C%2Ecarousel%2Dinner%3E%2Eitem%2Enext%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eitem%2Eprev%2Eright%7Bleft%3A0%3B%2Dwebkit%2Dtransform%3Atranslate3d%280%2C0%2C0%29%3Btransform%3Atranslate3d%280%2C0%2C0%29%7D%7D%2Ecarousel%2Dinner%3E%2Eactive%2C%2Ecarousel%2Dinner%3E%2Enext%2C%2Ecarousel%2Dinner%3E%2Eprev%7Bdisplay%3Ablock%7D%2Ecarousel%2Dinner%3E%2Eactive%7Bleft%3A0%7D%2Ecarousel%2Dinner%3E%2Enext%2C%2Ecarousel%2Dinner%3E%2Eprev%7Bposition%3Aabsolute%3Btop%3A0%3Bwidth%3A100%25%7D%2Ecarousel%2Dinner%3E%2Enext%7Bleft%3A100%25%7D%2Ecarousel%2Dinner%3E%2Eprev%7Bleft%3A%2D100%25%7D%2Ecarousel%2Dinner%3E%2Enext%2Eleft%2C%2Ecarousel%2Dinner%3E%2Eprev%2Eright%7Bleft%3A0%7D%2Ecarousel%2Dinner%3E%2Eactive%2Eleft%7Bleft%3A%2D100%25%7D%2Ecarousel%2Dinner%3E%2Eactive%2Eright%7Bleft%3A100%25%7D%2Ecarousel%2Dcontrol%7Bposition%3Aabsolute%3Btop%3A0%3Bbottom%3A0%3Bleft%3A0%3Bwidth%3A15%25%3Bfont%2Dsize%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Btext%2Dshadow%3A0%201px%202px%20rgba%280%2C0%2C0%2C%2E6%29%3Bfilter%3Aalpha%28opacity%3D50%29%3Bopacity%3A%2E5%7D%2Ecarousel%2Dcontrol%2Eleft%7Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bbackground%2Dimage%3A%2Dwebkit%2Dgradient%28linear%2Cleft%20top%2Cright%20top%2Cfrom%28rgba%280%2C0%2C0%2C%2E5%29%29%2Cto%28rgba%280%2C0%2C0%2C%2E0001%29%29%29%3Bbackground%2Dimage%3Alinear%2Dgradient%28to%20right%2Crgba%280%2C0%2C0%2C%2E5%29%200%2Crgba%280%2C0%2C0%2C%2E0001%29%20100%25%29%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28startColorstr%3D%27%2380000000%27%2C%20endColorstr%3D%27%2300000000%27%2C%20GradientType%3D1%29%3Bbackground%2Drepeat%3Arepeat%2Dx%7D%2Ecarousel%2Dcontrol%2Eright%7Bright%3A0%3Bleft%3Aauto%3Bbackground%2Dimage%3A%2Dwebkit%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bbackground%2Dimage%3A%2Do%2Dlinear%2Dgradient%28left%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bbackground%2Dimage%3A%2Dwebkit%2Dgradient%28linear%2Cleft%20top%2Cright%20top%2Cfrom%28rgba%280%2C0%2C0%2C%2E0001%29%29%2Cto%28rgba%280%2C0%2C0%2C%2E5%29%29%29%3Bbackground%2Dimage%3Alinear%2Dgradient%28to%20right%2Crgba%280%2C0%2C0%2C%2E0001%29%200%2Crgba%280%2C0%2C0%2C%2E5%29%20100%25%29%3Bfilter%3Aprogid%3ADXImageTransform%2EMicrosoft%2Egradient%28startColorstr%3D%27%2300000000%27%2C%20endColorstr%3D%27%2380000000%27%2C%20GradientType%3D1%29%3Bbackground%2Drepeat%3Arepeat%2Dx%7D%2Ecarousel%2Dcontrol%3Afocus%2C%2Ecarousel%2Dcontrol%3Ahover%7Bcolor%3A%23fff%3Btext%2Ddecoration%3Anone%3Bfilter%3Aalpha%28opacity%3D90%29%3Boutline%3A0%3Bopacity%3A%2E9%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bposition%3Aabsolute%3Btop%3A50%25%3Bz%2Dindex%3A5%3Bdisplay%3Ainline%2Dblock%3Bmargin%2Dtop%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bleft%3A50%25%3Bmargin%2Dleft%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%7Bright%3A50%25%3Bmargin%2Dright%3A%2D10px%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bwidth%3A20px%3Bheight%3A20px%3Bfont%2Dfamily%3Aserif%3Bline%2Dheight%3A1%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%3Abefore%7Bcontent%3A%27%5C2039%27%7D%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%3Abefore%7Bcontent%3A%27%5C203a%27%7D%2Ecarousel%2Dindicators%7Bposition%3Aabsolute%3Bbottom%3A10px%3Bleft%3A50%25%3Bz%2Dindex%3A15%3Bwidth%3A60%25%3Bpadding%2Dleft%3A0%3Bmargin%2Dleft%3A%2D30%25%3Btext%2Dalign%3Acenter%3Blist%2Dstyle%3Anone%7D%2Ecarousel%2Dindicators%20li%7Bdisplay%3Ainline%2Dblock%3Bwidth%3A10px%3Bheight%3A10px%3Bmargin%3A1px%3Btext%2Dindent%3A%2D999px%3Bcursor%3Apointer%3Bbackground%2Dcolor%3A%23000%5C9%3Bbackground%2Dcolor%3Argba%280%2C0%2C0%2C0%29%3Bborder%3A1px%20solid%20%23fff%3Bborder%2Dradius%3A10px%7D%2Ecarousel%2Dindicators%20%2Eactive%7Bwidth%3A12px%3Bheight%3A12px%3Bmargin%3A0%3Bbackground%2Dcolor%3A%23fff%7D%2Ecarousel%2Dcaption%7Bposition%3Aabsolute%3Bright%3A15%25%3Bbottom%3A20px%3Bleft%3A15%25%3Bz%2Dindex%3A10%3Bpadding%2Dtop%3A20px%3Bpadding%2Dbottom%3A20px%3Bcolor%3A%23fff%3Btext%2Dalign%3Acenter%3Btext%2Dshadow%3A0%201px%202px%20rgba%280%2C0%2C0%2C%2E6%29%7D%2Ecarousel%2Dcaption%20%2Ebtn%7Btext%2Dshadow%3Anone%7D%40media%20screen%20and%20%28min%2Dwidth%3A768px%29%7B%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bwidth%3A30px%3Bheight%3A30px%3Bmargin%2Dtop%3A%2D15px%3Bfont%2Dsize%3A30px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dleft%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dprev%7Bmargin%2Dleft%3A%2D15px%7D%2Ecarousel%2Dcontrol%20%2Eglyphicon%2Dchevron%2Dright%2C%2Ecarousel%2Dcontrol%20%2Eicon%2Dnext%7Bmargin%2Dright%3A%2D15px%7D%2Ecarousel%2Dcaption%7Bright%3A20%25%3Bleft%3A20%25%3Bpadding%2Dbottom%3A30px%7D%2Ecarousel%2Dindicators%7Bbottom%3A20px%7D%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Aafter%2C%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Abefore%2C%2Ebtn%2Dtoolbar%3Aafter%2C%2Ebtn%2Dtoolbar%3Abefore%2C%2Eclearfix%3Aafter%2C%2Eclearfix%3Abefore%2C%2Econtainer%2Dfluid%3Aafter%2C%2Econtainer%2Dfluid%3Abefore%2C%2Econtainer%3Aafter%2C%2Econtainer%3Abefore%2C%2Edl%2Dhorizontal%20dd%3Aafter%2C%2Edl%2Dhorizontal%20dd%3Abefore%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Aafter%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Abefore%2C%2Emodal%2Dfooter%3Aafter%2C%2Emodal%2Dfooter%3Abefore%2C%2Enav%3Aafter%2C%2Enav%3Abefore%2C%2Enavbar%2Dcollapse%3Aafter%2C%2Enavbar%2Dcollapse%3Abefore%2C%2Enavbar%2Dheader%3Aafter%2C%2Enavbar%2Dheader%3Abefore%2C%2Enavbar%3Aafter%2C%2Enavbar%3Abefore%2C%2Epager%3Aafter%2C%2Epager%3Abefore%2C%2Epanel%2Dbody%3Aafter%2C%2Epanel%2Dbody%3Abefore%2C%2Erow%3Aafter%2C%2Erow%3Abefore%7Bdisplay%3Atable%3Bcontent%3A%22%20%22%7D%2Ebtn%2Dgroup%2Dvertical%3E%2Ebtn%2Dgroup%3Aafter%2C%2Ebtn%2Dtoolbar%3Aafter%2C%2Eclearfix%3Aafter%2C%2Econtainer%2Dfluid%3Aafter%2C%2Econtainer%3Aafter%2C%2Edl%2Dhorizontal%20dd%3Aafter%2C%2Eform%2Dhorizontal%20%2Eform%2Dgroup%3Aafter%2C%2Emodal%2Dfooter%3Aafter%2C%2Enav%3Aafter%2C%2Enavbar%2Dcollapse%3Aafter%2C%2Enavbar%2Dheader%3Aafter%2C%2Enavbar%3Aafter%2C%2Epager%3Aafter%2C%2Epanel%2Dbody%3Aafter%2C%2Erow%3Aafter%7Bclear%3Aboth%7D%2Ecenter%2Dblock%7Bdisplay%3Ablock%3Bmargin%2Dright%3Aauto%3Bmargin%2Dleft%3Aauto%7D%2Epull%2Dright%7Bfloat%3Aright%21important%7D%2Epull%2Dleft%7Bfloat%3Aleft%21important%7D%2Ehide%7Bdisplay%3Anone%21important%7D%2Eshow%7Bdisplay%3Ablock%21important%7D%2Einvisible%7Bvisibility%3Ahidden%7D%2Etext%2Dhide%7Bfont%3A0%2F0%20a%3Bcolor%3Atransparent%3Btext%2Dshadow%3Anone%3Bbackground%2Dcolor%3Atransparent%3Bborder%3A0%7D%2Ehidden%7Bdisplay%3Anone%21important%7D%2Eaffix%7Bposition%3Afixed%7D%40%2Dms%2Dviewport%7Bwidth%3Adevice%2Dwidth%7D%2Evisible%2Dlg%2C%2Evisible%2Dmd%2C%2Evisible%2Dsm%2C%2Evisible%2Dxs%7Bdisplay%3Anone%21important%7D%2Evisible%2Dlg%2Dblock%2C%2Evisible%2Dlg%2Dinline%2C%2Evisible%2Dlg%2Dinline%2Dblock%2C%2Evisible%2Dmd%2Dblock%2C%2Evisible%2Dmd%2Dinline%2C%2Evisible%2Dmd%2Dinline%2Dblock%2C%2Evisible%2Dsm%2Dblock%2C%2Evisible%2Dsm%2Dinline%2C%2Evisible%2Dsm%2Dinline%2Dblock%2C%2Evisible%2Dxs%2Dblock%2C%2Evisible%2Dxs%2Dinline%2C%2Evisible%2Dxs%2Dinline%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dxs%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dxs%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dxs%2Cth%2Evisible%2Dxs%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Evisible%2Dxs%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dsm%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dsm%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dsm%2Cth%2Evisible%2Dsm%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Evisible%2Dsm%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dmd%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dmd%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dmd%2Cth%2Evisible%2Dmd%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Evisible%2Dmd%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dlg%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dlg%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dlg%2Cth%2Evisible%2Dlg%7Bdisplay%3Atable%2Dcell%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Evisible%2Dlg%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20%28max%2Dwidth%3A767px%29%7B%2Ehidden%2Dxs%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A768px%29%20and%20%28max%2Dwidth%3A991px%29%7B%2Ehidden%2Dsm%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A992px%29%20and%20%28max%2Dwidth%3A1199px%29%7B%2Ehidden%2Dmd%7Bdisplay%3Anone%21important%7D%7D%40media%20%28min%2Dwidth%3A1200px%29%7B%2Ehidden%2Dlg%7Bdisplay%3Anone%21important%7D%7D%2Evisible%2Dprint%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%7Bdisplay%3Ablock%21important%7Dtable%2Evisible%2Dprint%7Bdisplay%3Atable%21important%7Dtr%2Evisible%2Dprint%7Bdisplay%3Atable%2Drow%21important%7Dtd%2Evisible%2Dprint%2Cth%2Evisible%2Dprint%7Bdisplay%3Atable%2Dcell%21important%7D%7D%2Evisible%2Dprint%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dblock%7Bdisplay%3Ablock%21important%7D%7D%2Evisible%2Dprint%2Dinline%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dinline%7Bdisplay%3Ainline%21important%7D%7D%2Evisible%2Dprint%2Dinline%2Dblock%7Bdisplay%3Anone%21important%7D%40media%20print%7B%2Evisible%2Dprint%2Dinline%2Dblock%7Bdisplay%3Ainline%2Dblock%21important%7D%7D%40media%20print%7B%2Ehidden%2Dprint%7Bdisplay%3Anone%21important%7D%7D%0A" rel="stylesheet" />
<script src="data:application/x-javascript;base64,/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);"></script>
<script src="data:application/x-javascript;base64,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"></script>
<script src="data:application/x-javascript;base64,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"></script>
<link href="data:text/css;charset=utf-8,%2Epagedtable%20%7B%0Aoverflow%3A%20auto%3B%0Apadding%2Dleft%3A%208px%3B%0Apadding%2Dright%3A%208px%3B%0A%7D%0A%2Epagedtable%2Dwrapper%20%7B%0Aborder%3A%201px%20solid%20%23ccc%3B%0Aborder%2Dradius%3A%204px%3B%0Amargin%2Dbottom%3A%2010px%3B%0A%7D%0A%2Epagedtable%20table%20%7B%0Awidth%3A%20100%25%3B%0Amax%2Dwidth%3A%20100%25%3B%0Amargin%3A%200%3B%0A%7D%0A%2Epagedtable%20th%20%7B%0Apadding%3A%200%205px%200%205px%3B%0Aborder%3A%20none%3B%0Aborder%2Dbottom%3A%202px%20solid%20%23dddddd%3B%0Amin%2Dwidth%3A%2045px%3B%0A%7D%0A%2Epagedtable%2Dempty%20th%20%7B%0Adisplay%3A%20none%3B%0A%7D%0A%2Epagedtable%20td%20%7B%0Apadding%3A%200%204px%200%204px%3B%0A%7D%0A%2Epagedtable%20%2Eeven%20%7B%0Abackground%2Dcolor%3A%20%23fcfcfc%3B%0A%7D%0A%2Epagedtable%2Dpadding%2Dcol%20%7B%0Adisplay%3A%20none%3B%0A%7D%0A%2Epagedtable%20a%20%7B%0A%2Dwebkit%2Dtouch%2Dcallout%3A%20none%3B%0A%2Dwebkit%2Duser%2Dselect%3A%20none%3B%0A%2Dkhtml%2Duser%2Dselect%3A%20none%3B%0A%2Dmoz%2Duser%2Dselect%3A%20none%3B%0A%2Dms%2Duser%2Dselect%3A%20none%3B%0Auser%2Dselect%3A%20none%3B%0A%7D%0A%2Epagedtable%2Dindex%2Dnav%20%7B%0Acursor%3A%20pointer%3B%0Apadding%3A%200%205px%200%205px%3B%0Afloat%3A%20right%3B%0Aborder%3A%200%3B%0A%7D%0A%2Epagedtable%2Dindex%2Dnav%2Ddisabled%20%7B%0Acursor%3A%20default%3B%0Atext%2Ddecoration%3A%20none%3B%0Acolor%3A%20%23999%3B%0A%7D%0Aa%2Epagedtable%2Dindex%2Dnav%2Ddisabled%3Ahover%20%7B%0Atext%2Ddecoration%3A%20none%3B%0Acolor%3A%20%23999%3B%0A%7D%0A%2Epagedtable%2Dindexes%20%7B%0Acursor%3A%20pointer%3B%0Afloat%3A%20right%3B%0Aborder%3A%200%3B%0A%7D%0A%2Epagedtable%2Dindex%2Dcurrent%20%7B%0Acursor%3A%20default%3B%0Atext%2Ddecoration%3A%20none%3B%0Afont%2Dweight%3A%20bold%3B%0Acolor%3A%20%23333%3B%0Aborder%3A%200%3B%0A%7D%0Aa%2Epagedtable%2Dindex%2Dcurrent%3Ahover%20%7B%0Atext%2Ddecoration%3A%20none%3B%0Afont%2Dweight%3A%20bold%3B%0Acolor%3A%20%23333%3B%0A%7D%0A%2Epagedtable%2Dindex%20%7B%0Awidth%3A%2030px%3B%0Adisplay%3A%20inline%2Dblock%3B%0Atext%2Dalign%3A%20center%3B%0Aborder%3A%200%3B%0A%7D%0A%2Epagedtable%2Dindex%2Dseparator%2Dleft%20%7B%0Adisplay%3A%20inline%2Dblock%3B%0Acolor%3A%20%23333%3B%0Afont%2Dsize%3A%209px%3B%0Apadding%3A%200%200%200%200%3B%0Acursor%3A%20default%3B%0A%7D%0A%2Epagedtable%2Dindex%2Dseparator%2Dright%20%7B%0Adisplay%3A%20inline%2Dblock%3B%0Acolor%3A%20%23333%3B%0Afont%2Dsize%3A%209px%3B%0Apadding%3A%200%204px%200%200%3B%0Acursor%3A%20default%3B%0A%7D%0A%2Epagedtable%2Dfooter%20%7B%0Apadding%2Dtop%3A%204px%3B%0Apadding%2Dbottom%3A%205px%3B%0A%7D%0A%2Epagedtable%2Dnot%2Dempty%20%2Epagedtable%2Dfooter%20%7B%0Aborder%2Dtop%3A%202px%20solid%20%23dddddd%3B%0A%7D%0A%2Epagedtable%2Dinfo%20%7B%0Aoverflow%3A%20hidden%3B%0Acolor%3A%20%23999%3B%0Awhite%2Dspace%3A%20nowrap%3B%0Atext%2Doverflow%3A%20ellipsis%3B%0A%7D%0A%2Epagedtable%2Dheader%2Dname%20%7B%0Aoverflow%3A%20hidden%3B%0Atext%2Doverflow%3A%20ellipsis%3B%0A%7D%0A%2Epagedtable%2Dheader%2Dtype%20%7B%0Acolor%3A%20%23999%3B%0Afont%2Dweight%3A%20400%3B%0A%7D%0A%2Epagedtable%2Dna%2Dcell%20%7B%0Afont%2Dstyle%3A%20italic%3B%0Aopacity%3A%200%2E3%3B%0A%7D%0A" rel="stylesheet" />
<script src="data:application/x-javascript;base64,// Production steps of ECMA-262, Edition 5, 15.4.4.18
// Reference: http://es5.github.io/#x15.4.4.18
if (!Array.prototype.forEach) {

  Array.prototype.forEach = function(callback, thisArg) {

    var T, k;

    if (this === null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling toObject() passing the
    // |this| value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get() internal
    // method of O with the argument "length".
    // 3. Let len be toUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If isCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== "function") {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let
    // T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let k be 0
    k = 0;

    // 7. Repeat, while k < len
    while (k < len) {

      var kValue;

      // a. Let Pk be ToString(k).
      //    This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty
      //    internal method of O with argument Pk.
      //    This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        // method of O with argument Pk.
        kValue = O[k];

        // ii. Call the Call internal method of callback with T as
        // the this value and argument list containing kValue, k, and O.
        callback.call(T, kValue, k, O);
      }
      // d. Increase k by 1.
      k++;
    }
    // 8. return undefined
  };
}

// Production steps of ECMA-262, Edition 5, 15.4.4.19
// Reference: http://es5.github.io/#x15.4.4.19
if (!Array.prototype.map) {

  Array.prototype.map = function(callback, thisArg) {

    var T, A, k;

    if (this == null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling ToObject passing the |this|
    //    value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get internal
    //    method of O with the argument "length".
    // 3. Let len be ToUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If IsCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== 'function') {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let A be a new array created as if by the expression new Array(len)
    //    where Array is the standard built-in constructor with that name and
    //    len is the value of len.
    A = new Array(len);

    // 7. Let k be 0
    k = 0;

    // 8. Repeat, while k < len
    while (k < len) {

      var kValue, mappedValue;

      // a. Let Pk be ToString(k).
      //   This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty internal
      //    method of O with argument Pk.
      //   This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        //    method of O with argument Pk.
        kValue = O[k];

        // ii. Let mappedValue be the result of calling the Call internal
        //     method of callback with T as the this value and argument
        //     list containing kValue, k, and O.
        mappedValue = callback.call(T, kValue, k, O);

        // iii. Call the DefineOwnProperty internal method of A with arguments
        // Pk, Property Descriptor
        // { Value: mappedValue,
        //   Writable: true,
        //   Enumerable: true,
        //   Configurable: true },
        // and false.

        // In browsers that support Object.defineProperty, use the following:
        // Object.defineProperty(A, k, {
        //   value: mappedValue,
        //   writable: true,
        //   enumerable: true,
        //   configurable: true
        // });

        // For best browser support, use the following:
        A[k] = mappedValue;
      }
      // d. Increase k by 1.
      k++;
    }

    // 9. return A
    return A;
  };
}

var PagedTable = function (pagedTable) {
  var me = this;

  var source = function(pagedTable) {
    var sourceElems = [].slice.call(pagedTable.children).filter(function(e) {
      return e.hasAttribute("data-pagedtable-source");
    });

    if (sourceElems === null || sourceElems.length !== 1) {
      throw("A single data-pagedtable-source was not found");
    }

    return JSON.parse(sourceElems[0].innerHTML);
  }(pagedTable);

  var options = function(source) {
    var options = typeof(source.options) !== "undefined" &&
      source.options !== null ? source.options : {};

    var columns = typeof(options.columns) !== "undefined" ? options.columns : {};
    var rows = typeof(options.rows) !== "undefined" ? options.rows : {};

    var positiveIntOrNull = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : null;
    };

    return {
      pages: positiveIntOrNull(options.pages),
      rows: {
        min: positiveIntOrNull(rows.min),
        max: positiveIntOrNull(rows.max),
        total: positiveIntOrNull(rows.total)
      },
      columns: {
        min: positiveIntOrNull(columns.min),
        max: positiveIntOrNull(columns.max),
        total: positiveIntOrNull(columns.total)
      }
    };
  }(source);

  var Measurer = function() {

    // set some default initial values that will get adjusted in runtime
    me.measures = {
      padding: 12,
      character: 8,
      height: 15,
      defaults: true
    };

    me.calculate = function(measuresCell) {
      if (!me.measures.defaults)
        return;

      var measuresCellStyle = window.getComputedStyle(measuresCell, null);

      var newPadding = parsePadding(measuresCellStyle.paddingLeft) +
            parsePadding(measuresCellStyle.paddingRight);

      var sampleString = "ABCDEFGHIJ0123456789";
      var newCharacter = Math.ceil(measuresCell.clientWidth / sampleString.length);

      if (newPadding <= 0 || newCharacter <= 0)
        return;

      me.measures.padding = newPadding;
      me.measures.character = newCharacter;
      me.measures.height = measuresCell.clientHeight;
      me.measures.defaults = false;
    };

    return me;
  };

  var Page = function(data, options) {
    var me = this;

    var defaults = {
      max: 7,
      rows: 10
    };

    var totalPages = function() {
      return Math.ceil(data.length / me.rows);
    };

    me.number = 0;
    me.max = options.pages !== null ? options.pages : defaults.max;
    me.visible = me.max;
    me.rows = options.rows.min !== null ? options.rows.min : defaults.rows;
    me.total = totalPages();

    me.setRows = function(newRows) {
      me.rows = newRows;
      me.total = totalPages();
    };

    me.setPageNumber = function(newPageNumber) {
      if (newPageNumber < 0) newPageNumber = 0;
      if (newPageNumber >= me.total) newPageNumber = me.total - 1;

      me.number = newPageNumber;
    };

    me.setVisiblePages = function(visiblePages) {
      me.visible = Math.min(me.max, visiblePages);
      me.setPageNumber(me.number);
    };

    me.getVisiblePageRange = function() {
      var start = me.number - Math.max(Math.floor((me.visible - 1) / 2), 0);
      var end = me.number + Math.floor(me.visible / 2) + 1;
      var pageCount = me.total;

      if (start < 0) {
        var diffToStart = 0 - start;
        start += diffToStart;
        end += diffToStart;
      }

      if (end > pageCount) {
        var diffToEnd = end - pageCount;
        start -= diffToEnd;
        end -= diffToEnd;
      }

      start = start < 0 ? 0 : start;
      end = end >= pageCount ? pageCount : end;

      var first = false;
      var last = false;

      if (start > 0 && me.visible > 1) {
        start = start + 1;
        first = true;
      }

      if (end < pageCount && me.visible > 2) {
        end = end - 1;
        last = true;
      }

      return {
        first: first,
        start: start,
        end: end,
        last: last
      };
    };

    me.getRowStart = function() {
      var rowStart = page.number * page.rows;
      if (rowStart < 0)
        rowStart = 0;

      return rowStart;
    };

    me.getRowEnd = function() {
      var rowStart = me.getRowStart();
      return Math.min(rowStart + me.rows, data.length);
    };

    me.getPaddingRows = function() {
      var rowStart = me.getRowStart();
      var rowEnd = me.getRowEnd();
      return data.length > me.rows ? me.rows - (rowEnd - rowStart) : 0;
    };
  };

  var Columns = function(data, columns, options) {
    var me = this;

    me.defaults = {
      min: 5
    };

    me.number = 0;
    me.visible = 0;
    me.total = columns.length;
    me.subset = [];
    me.padding = 0;
    me.min = options.columns.min !== null ? options.columns.min : me.defaults.min;
    me.max = options.columns.max !== null ? options.columns.max : null;
    me.widths = {};

    var widthsLookAhead = Math.max(100, options.rows.min);
    var paddingColChars = 10;

    me.emptyNames = function() {
      columns.forEach(function(column) {
        if (columns.label !== null && columns.label !== "")
          return false;
      });

      return true;
    };

    var parsePadding = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : 0;
    };

    me.calculateWidths = function(measures) {
      columns.forEach(function(column) {
        var maxChars = column.label.toString().length;
        for (var idxRow = 0; idxRow < Math.min(widthsLookAhead, data.length); idxRow++) {
          maxChars = Math.max(maxChars, data[idxRow][column.name.toString()].length);
        }

        me.widths[column.name] = {
          // width in characters
          chars: maxChars,
          // width for the inner html columns
          inner: maxChars * measures.character,
          // width adding outer styles like padding
          outer: maxChars * measures.character + measures.padding
        };
      });
    };

    me.getWidth = function() {
      var widthOuter = 0;
      for (var idxCol = 0; idxCol < me.subset.length; idxCol++) {
        var columnName = me.subset[idxCol].name;
        widthOuter = widthOuter + me.widths[columnName].outer;
      }

      widthOuter = widthOuter + me.padding * paddingColChars * measurer.measures.character;

      if (me.hasMoreLeftColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      if (me.hasMoreRightColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      return widthOuter;
    };

    me.updateSlice = function() {
      if (me.number + me.visible >= me.total)
        me.number = me.total - me.visible;

      if (me.number < 0) me.number = 0;

      me.subset = columns.slice(me.number, Math.min(me.number + me.visible, me.total));

      me.subset = me.subset.map(function(column) {
        Object.keys(column).forEach(function(colKey) {
          column[colKey] = column[colKey] === null ? "" : column[colKey].toString();
        });

        column.width = null;
        return column;
      });
    };

    me.setVisibleColumns = function(columnNumber, newVisibleColumns, paddingCount) {
      me.number = columnNumber;
      me.visible = newVisibleColumns;
      me.padding = paddingCount;

      me.updateSlice();
    };

    me.incColumnNumber = function(increment) {
      me.number = me.number + increment;
    };

    me.setColumnNumber = function(newNumber) {
      me.number = newNumber;
    };

    me.setPaddingCount = function(newPadding) {
      me.padding = newPadding;
    };

    me.getPaddingCount = function() {
      return me.padding;
    };

    me.hasMoreLeftColumns = function() {
      return me.number > 0;
    };

    me.hasMoreRightColumns = function() {
      return me.number + me.visible < me.total;
    };

    me.updateSlice(0);
    return me;
  };

  var data = source.data;
  var page = new Page(data, options);
  var measurer = new Measurer(data, options);
  var columns = new Columns(data, source.columns, options);

  var table = null;
  var tableDiv = null;
  var header = null;
  var footer = null;
  var tbody = null;

  // Caches pagedTable.clientWidth, specially for webkit
  var cachedPagedTableClientWidth = null;

  var onChangeCallbacks = [];

  var clearSelection = function() {
    if(document.selection && document.selection.empty) {
      document.selection.empty();
    } else if(window.getSelection) {
      var sel = window.getSelection();
      sel.removeAllRanges();
    }
  };

  var columnNavigationWidthPX = 5;

  var renderColumnNavigation = function(increment, backwards) {
    var arrow = document.createElement("div");
    arrow.setAttribute("style",
      "border-top: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-bottom: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-" + (backwards ? "right" : "left") + ": " + columnNavigationWidthPX + "px solid;");

    var header = document.createElement("th");
    header.appendChild(arrow);
    header.setAttribute("style",
      "cursor: pointer;" +
      "vertical-align: middle;" +
      "min-width: " + columnNavigationWidthPX + "px;" +
      "width: " + columnNavigationWidthPX + "px;");

    header.onclick = function() {
      columns.incColumnNumber(backwards ? -1 : increment);

      me.animateColumns(backwards);
      renderFooter();

      clearSelection();
      triggerOnChange();
    };

    return header;
  };

  var maxColumnWidth = function(width) {
    var padding = 80;
    var columnMax = Math.max(cachedPagedTableClientWidth - padding, 0);

    return parseInt(width) > 0 ?
      Math.min(columnMax, parseInt(width)) + "px" :
      columnMax + "px";
  };

  var clearHeader = function() {
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.innerHTML = "";
  };

  var renderHeader = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth;

    var fragment = document.createDocumentFragment();

    header = document.createElement("tr");
    fragment.appendChild(header);

    if (columns.number > 0)
      header.appendChild(renderColumnNavigation(-columns.visible, true));

    columns.subset = columns.subset.map(function(columnData) {
      var column = document.createElement("th");
      column.setAttribute("align", columnData.align);
      column.style.textAlign = columnData.align;

      column.style.maxWidth = maxColumnWidth(null);
      if (columnData.width) {
        column.style.minWidth =
          column.style.maxWidth = maxColumnWidth(columnData.width);
      }

      var columnName = document.createElement("div");
      columnName.setAttribute("class", "pagedtable-header-name");
      if (columnData.label === "") {
        columnName.innerHTML = "&nbsp;";
      }
      else {
        columnName.appendChild(document.createTextNode(columnData.label));
      }
      column.appendChild(columnName);

      var columnType = document.createElement("div");
      columnType.setAttribute("class", "pagedtable-header-type");
      if (columnData.type === "") {
        columnType.innerHTML = "&nbsp;";
      }
      else {
        columnType.appendChild(document.createTextNode("<" + columnData.type + ">"));
      }
      column.appendChild(columnType);

      header.appendChild(column);

      columnData.element = column;

      return columnData;
    });

    for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
      var paddingCol = document.createElement("th");
      paddingCol.setAttribute("class", "pagedtable-padding-col");
      header.appendChild(paddingCol);
    }

    if (columns.number + columns.visible < columns.total)
      header.appendChild(renderColumnNavigation(columns.visible, false));

    if (typeof(clear) == "undefined" || clear) clearHeader();
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.appendChild(fragment);
  };

  me.animateColumns = function(backwards) {
    var thead = pagedTable.querySelectorAll("thead")[0];

    var headerOld = thead.querySelectorAll("tr")[0];
    var tbodyOld = table.querySelectorAll("tbody")[0];

    me.fitColumns(backwards);

    renderHeader(false);

    header.style.opacity = "0";
    header.style.transform = backwards ? "translateX(-30px)" : "translateX(30px)";
    header.style.transition = "transform 200ms linear, opacity 200ms";
    header.style.transitionDelay = "0";

    renderBody(false);

    if (headerOld) {
      headerOld.style.position = "absolute";
      headerOld.style.transform = "translateX(0px)";
      headerOld.style.opacity = "1";
      headerOld.style.transition = "transform 100ms linear, opacity 100ms";
      headerOld.setAttribute("class", "pagedtable-remove-head");
      if (headerOld.style.transitionEnd) {
        headerOld.addEventListener("transitionend", function() {
          var headerOldByClass = thead.querySelector(".pagedtable-remove-head");
          if (headerOldByClass) thead.removeChild(headerOldByClass);
        });
      }
      else {
        thead.removeChild(headerOld);
      }
    }

    if (tbodyOld) table.removeChild(tbodyOld);

    tbody.style.opacity = "0";
    tbody.style.transition = "transform 200ms linear, opacity 200ms";
    tbody.style.transitionDelay = "0ms";

    // force relayout
    window.getComputedStyle(header).opacity;
    window.getComputedStyle(tbody).opacity;

    if (headerOld) {
      headerOld.style.transform = backwards ? "translateX(20px)" : "translateX(-30px)";
      headerOld.style.opacity = "0";
    }

    header.style.transform = "translateX(0px)";
    header.style.opacity = "1";

    tbody.style.opacity = "1";
  }

  me.onChange = function(callback) {
    onChangeCallbacks.push(callback);
  };

  var triggerOnChange = function() {
    onChangeCallbacks.forEach(function(onChange) {
      onChange();
    });
  };

  var clearBody = function() {
    if (tbody) {
      table.removeChild(tbody);
      tbody = null;
    }
  };

  var renderBody = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth

    var fragment = document.createDocumentFragment();

    var pageData = data.slice(page.getRowStart(), page.getRowEnd());

    pageData.forEach(function(dataRow, idxRow) {
      var htmlRow = document.createElement("tr");
      htmlRow.setAttribute("class", (idxRow % 2 !==0) ? "even" : "odd");

      if (columns.hasMoreLeftColumns())
        htmlRow.appendChild(document.createElement("td"));

      columns.subset.forEach(function(columnData) {
        var cellName = columnData.name;
        var dataCell = dataRow[cellName];
        var htmlCell = document.createElement("td");

        if (dataCell === "NA") htmlCell.setAttribute("class", "pagedtable-na-cell");
        if (dataCell === "__NA__") dataCell = "NA";

        var cellText = document.createTextNode(dataCell);
        htmlCell.appendChild(cellText);
        if (dataCell.length > 50) {
          htmlCell.setAttribute("title", dataCell);
        }
        htmlCell.setAttribute("align", columnData.align);
        htmlCell.style.textAlign = columnData.align;
        htmlCell.style.maxWidth = maxColumnWidth(null);
        if (columnData.width) {
          htmlCell.style.minWidth = htmlCell.style.maxWidth = maxColumnWidth(columnData.width);
        }
        htmlRow.appendChild(htmlCell);
      });

      for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
        var paddingCol = document.createElement("td");
        paddingCol.setAttribute("class", "pagedtable-padding-col");
        htmlRow.appendChild(paddingCol);
      }

      if (columns.hasMoreRightColumns())
        htmlRow.appendChild(document.createElement("td"));

      fragment.appendChild(htmlRow);
    });

    for (var idxPadding = 0; idxPadding < page.getPaddingRows(); idxPadding++) {
      var paddingRow = document.createElement("tr");

      var paddingCellRow = document.createElement("td");
      paddingCellRow.innerHTML = "&nbsp;";
      paddingCellRow.setAttribute("colspan", "100%");
      paddingRow.appendChild(paddingCellRow);

      fragment.appendChild(paddingRow);
    }

    if (typeof(clear) == "undefined" || clear) clearBody();
    tbody = document.createElement("tbody");
    tbody.appendChild(fragment);

    table.appendChild(tbody);
  };

  var getLabelInfo = function() {
    var pageStart = page.getRowStart();
    var pageEnd = page.getRowEnd();
    var totalRows = data.length;

    var totalRowsLabel = options.rows.total ? options.rows.total : totalRows;
    var totalRowsLabelFormat = totalRowsLabel.toString().replace(/(\d)(?=(\d\d\d)+(?!\d))/g, '$1,');

    var infoText = (pageStart + 1) + "-" + pageEnd + " of " + totalRowsLabelFormat + " rows";
    if (totalRows < page.rows) {
      infoText = totalRowsLabel + " row" + (totalRows != 1 ? "s" : "");
    }
    if (columns.total > columns.visible) {
      var totalColumnsLabel = options.columns.total ? options.columns.total : columns.total;

      infoText = infoText + " | " + (columns.number + 1) + "-" +
        (Math.min(columns.number + columns.visible, columns.total)) +
        " of " + totalColumnsLabel + " columns";
    }

    return infoText;
  };

  var clearFooter = function() {
    footer = pagedTable.querySelectorAll("div.pagedtable-footer")[0];
    footer.innerHTML = "";

    return footer;
  };

  var createPageLink = function(idxPage) {
    var pageLink = document.createElement("a");
    pageLinkClass = idxPage === page.number ? "pagedtable-index pagedtable-index-current" : "pagedtable-index";
    pageLink.setAttribute("class", pageLinkClass);
    pageLink.setAttribute("data-page-index", idxPage);
    pageLink.onclick = function() {
      page.setPageNumber(parseInt(this.getAttribute("data-page-index")));
      renderBody();
      renderFooter();

      triggerOnChange();
    };

    pageLink.appendChild(document.createTextNode(idxPage + 1));

    return pageLink;
  }

  var renderFooter = function() {
    footer = clearFooter();

    var next = document.createElement("a");
    next.appendChild(document.createTextNode("Next"));
    next.onclick = function() {
      page.setPageNumber(page.number + 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(next);

    var pageNumbers = document.createElement("div");
    pageNumbers.setAttribute("class", "pagedtable-indexes");

    var pageRange = page.getVisiblePageRange();

    if (pageRange.first) {
      var pageLink = createPageLink(0);
      pageNumbers.appendChild(pageLink);

      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-left");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);
    }

    for (var idxPage = pageRange.start; idxPage < pageRange.end; idxPage++) {
      var pageLink = createPageLink(idxPage);

      pageNumbers.appendChild(pageLink);
    }

    if (pageRange.last) {
      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-right");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);

      var pageLink = createPageLink(page.total - 1);
      pageNumbers.appendChild(pageLink);
    }

    if (data.length > page.rows) footer.appendChild(pageNumbers);

    var previous = document.createElement("a");
    previous.appendChild(document.createTextNode("Previous"));
    previous.onclick = function() {
      page.setPageNumber(page.number - 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(previous);

    var infoLabel = document.createElement("div");
    infoLabel.setAttribute("class", "pagedtable-info");
    infoLabel.setAttribute("title", getLabelInfo());
    infoLabel.appendChild(document.createTextNode(getLabelInfo()));
    footer.appendChild(infoLabel);

    var enabledClass = "pagedtable-index-nav";
    var disabledClass = "pagedtable-index-nav pagedtable-index-nav-disabled";
    previous.setAttribute("class", page.number <= 0 ? disabledClass : enabledClass);
    next.setAttribute("class", (page.number + 1) * page.rows >= data.length ? disabledClass : enabledClass);
  };

  var measuresCell = null;

  var renderMeasures = function() {
    var measuresTable = document.createElement("table");
    measuresTable.style.visibility = "hidden";
    measuresTable.style.position = "absolute";
    measuresTable.style.whiteSpace = "nowrap";
    measuresTable.style.height = "auto";
    measuresTable.style.width = "auto";

    var measuresRow = document.createElement("tr");
    measuresTable.appendChild(measuresRow);

    measuresCell = document.createElement("td");
    var sampleString = "ABCDEFGHIJ0123456789";
    measuresCell.appendChild(document.createTextNode(sampleString));

    measuresRow.appendChild(measuresCell);

    tableDiv.appendChild(measuresTable);
  }

  me.init = function() {
    tableDiv = document.createElement("div");
    pagedTable.appendChild(tableDiv);
    var pagedTableClass = data.length > 0 ?
      "pagedtable pagedtable-not-empty" :
      "pagedtable pagedtable-empty";

    if (columns.total == 0 || (columns.emptyNames() && data.length == 0)) {
      pagedTableClass = pagedTableClass + " pagedtable-empty-columns";
    }

    tableDiv.setAttribute("class", pagedTableClass);

    renderMeasures();
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    table = document.createElement("table");
    table.setAttribute("cellspacing", "0");
    table.setAttribute("class", "table table-condensed");
    tableDiv.appendChild(table);

    table.appendChild(document.createElement("thead"));

    var footerDiv = document.createElement("div");
    footerDiv.setAttribute("class", "pagedtable-footer");
    tableDiv.appendChild(footerDiv);

    // if the host has not yet provided horizontal space, render hidden
    if (tableDiv.clientWidth <= 0) {
      tableDiv.style.opacity = "0";
    }

    me.render();

    // retry seizing columns later if the host has not provided space
    var retries = 100;
    function retryFit() {
      retries = retries - 1;
      if (retries > 0) {
        if (tableDiv.clientWidth <= 0) {
          setTimeout(retryFit, 100);
        } else {
          me.render();
          triggerOnChange();
        }
      }
    }
    if (tableDiv.clientWidth <= 0) {
      retryFit();
    }
  };

  var registerWidths = function() {
    columns.subset = columns.subset.map(function(column) {
      column.width = columns.widths[column.name].inner;
      return column;
    });
  };

  var parsePadding = function(value) {
    return parseInt(value) >= 0 ? parseInt(value) : 0;
  };

  me.fixedHeight = function() {
    return options.rows.max != null;
  }

  me.fitRows = function() {
    if (me.fixedHeight())
      return;

    measurer.calculate(measuresCell);

    var rows = options.rows.min !== null ? options.rows.min : 0;
    var headerHeight = header !== null && header.offsetHeight > 0 ? header.offsetHeight : 0;
    var footerHeight = footer !== null && footer.offsetHeight > 0 ? footer.offsetHeight : 0;

    if (pagedTable.offsetHeight > 0) {
      var availableHeight = pagedTable.offsetHeight - headerHeight - footerHeight;
      rows = Math.floor((availableHeight) / measurer.measures.height);
    }

    rows = options.rows.min !== null ? Math.max(options.rows.min, rows) : rows;

    page.setRows(rows);
  }

  // The goal of this function is to add as many columns as possible
  // starting from left-to-right, when the right most limit is reached
  // it tries to add columns from the left as well.
  //
  // When startBackwards is true columns are added from right-to-left
  me.fitColumns = function(startBackwards) {
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    if (tableDiv.clientWidth > 0) {
      tableDiv.style.opacity = 1;
    }

    var visibleColumns = tableDiv.clientWidth <= 0 ? Math.max(columns.min, 1) : 1;
    var columnNumber = columns.number;
    var paddingCount = 0;

    // track a list of added columns as we build the visible ones to allow us
    // to remove columns when they don't fit anymore.
    var columnHistory = [];

    var lastTableHeight = 0;
    var backwards = startBackwards;

    var tableDivStyle = window.getComputedStyle(tableDiv, null);
    var tableDivPadding = parsePadding(tableDivStyle.paddingLeft) +
      parsePadding(tableDivStyle.paddingRight);

    var addPaddingCol = false;
    var currentWidth = 0;

    while (true) {
      columns.setVisibleColumns(columnNumber, visibleColumns, paddingCount);
      currentWidth = columns.getWidth();

      if (tableDiv.clientWidth - tableDivPadding < currentWidth) {
        break;
      }

      columnHistory.push({
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
      });

      if (columnHistory.length > 100) {
        console.error("More than 100 tries to fit columns, aborting");
        break;
      }

      if (columns.max !== null &&
        columns.visible + columns.getPaddingCount() >= columns.max) {
        break;
      }

      // if we run out of right-columns
      if (!backwards && columnNumber + columns.visible >= columns.total) {
        // if we started adding right-columns, try adding left-columns
        if (!startBackwards && columnNumber > 0) {
          backwards = true;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // if we run out of left-columns
      if (backwards && columnNumber == 0) {
        // if we started adding left-columns, try adding right-columns
        if (startBackwards && columnNumber + columns.visible < columns.total) {
          backwards = false;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // when moving backwards try fitting left columns first
      if (backwards && columnNumber > 0) {
        columnNumber = columnNumber - 1;
      }

      if (columnNumber + visibleColumns < columns.total) {
        visibleColumns = visibleColumns + 1;
      }
    }

    var lastRenderableColumn = {
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
    };

    if (columnHistory.length > 0) {
      lastRenderableColumn = columnHistory[columnHistory.length - 1];
    }

    columns.setVisibleColumns(
      lastRenderableColumn.columnNumber,
      lastRenderableColumn.visibleColumns,
      lastRenderableColumn.paddingCount);

    if (pagedTable.offsetWidth > 0) {
      page.setVisiblePages(Math.max(Math.ceil(1.0 * (pagedTable.offsetWidth - 250) / 40), 2));
    }

    registerWidths();
  };

  me.fit = function(startBackwards) {
    me.fitRows();
    me.fitColumns(startBackwards);
  }

  me.render = function() {
    me.fitColumns(false);

    // render header/footer to measure height accurately
    renderHeader();
    renderFooter();

    me.fitRows();
    renderBody();

    // re-render footer to match new rows
    renderFooter();
  }

  var resizeLastWidth = -1;
  var resizeLastHeight = -1;
  var resizeNewWidth = -1;
  var resizeNewHeight = -1;
  var resizePending = false;

  me.resize = function(newWidth, newHeight) {

    function resizeDelayed() {
      resizePending = false;

      if (
        (resizeNewWidth !== resizeLastWidth) ||
        (!me.fixedHeight() && resizeNewHeight !== resizeLastHeight)
      ) {
        resizeLastWidth = resizeNewWidth;
        resizeLastHeight = resizeNewHeight;

        setTimeout(resizeDelayed, 200);
        resizePending = true;
      } else {
        me.render();
        triggerOnChange();

        resizeLastWidth = -1;
        resizeLastHeight = -1;
      }
    }

    resizeNewWidth = newWidth;
    resizeNewHeight = newHeight;

    if (!resizePending) resizeDelayed();
  };
};

var PagedTableDoc;
(function (PagedTableDoc) {
  var allPagedTables = [];

  PagedTableDoc.initAll = function() {
    allPagedTables = [];

    var pagedTables = [].slice.call(document.querySelectorAll('[data-pagedtable="false"],[data-pagedtable=""]'));
    pagedTables.forEach(function(pagedTable, idx) {
      pagedTable.setAttribute("data-pagedtable", "true");
      pagedTable.setAttribute("pagedtable-page", 0);
      pagedTable.setAttribute("class", "pagedtable-wrapper");

      var pagedTableInstance = new PagedTable(pagedTable);
      pagedTableInstance.init();

      allPagedTables.push(pagedTableInstance);
    });
  };

  PagedTableDoc.resizeAll = function() {
    allPagedTables.forEach(function(pagedTable) {
      pagedTable.render();
    });
  };

  window.addEventListener("resize", PagedTableDoc.resizeAll);

  return PagedTableDoc;
})(PagedTableDoc || (PagedTableDoc = {}));

window.onload = function() {
  PagedTableDoc.initAll();
};
"></script>
<script src="data:application/x-javascript;base64,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"></script>
<script src="data:application/x-javascript;base64,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"></script>
<script src="data:application/x-javascript;base64,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"></script>
<script src="data:application/x-javascript;base64,Cgp3aW5kb3cuaW5pdGlhbGl6ZVNvdXJjZUVtYmVkID0gZnVuY3Rpb24oZmlsZW5hbWUpIHsKICAkKCIjcm1kLWRvd25sb2FkLXNvdXJjZSIpLmNsaWNrKGZ1bmN0aW9uKCkgewogICAgdmFyIHNyYyA9IHdpbmRvdy5hdG9iKCQoIiNybWQtc291cmNlLWNvZGUiKS5odG1sKCkpOwogICAgdmFyIGJsb2IgPSBuZXcgQmxvYihbc3JjXSwge3R5cGU6ICJ0ZXh0L3gtci1tYXJrZG93biJ9KTsKICAgIHNhdmVBcyhibG9iLCBmaWxlbmFtZSk7CiAgfSk7Cn07Cg=="></script>
<link href="data:text/css;charset=utf-8,pre%20%2Eoperator%2C%0Apre%20%2Eparen%20%7B%0Acolor%3A%20rgb%28104%2C%20118%2C%20135%29%0A%7D%0Apre%20%2Eliteral%20%7B%0Acolor%3A%20rgb%2888%2C%2072%2C%20246%29%0A%7D%0Apre%20%2Enumber%20%7B%0Acolor%3A%20rgb%280%2C%200%2C%20205%29%3B%0A%7D%0Apre%20%2Ecomment%20%7B%0Acolor%3A%20rgb%2876%2C%20136%2C%20107%29%3B%0A%7D%0Apre%20%2Ekeyword%20%7B%0Acolor%3A%20rgb%280%2C%200%2C%20255%29%3B%0A%7D%0Apre%20%2Eidentifier%20%7B%0Acolor%3A%20rgb%280%2C%200%2C%200%29%3B%0A%7D%0Apre%20%2Estring%20%7B%0Acolor%3A%20rgb%283%2C%20106%2C%207%29%3B%0A%7D%0A" rel="stylesheet" />
<script src="data:application/x-javascript;base64,var hljs=new function(){function m(p){return p.replace(/&/gm,"&amp;").replace(/</gm,"&lt;")}function f(r,q,p){return RegExp(q,"m"+(r.cI?"i":"")+(p?"g":""))}function b(r){for(var p=0;p<r.childNodes.length;p++){var q=r.childNodes[p];if(q.nodeName=="CODE"){return q}if(!(q.nodeType==3&&q.nodeValue.match(/\s+/))){break}}}function h(t,s){var p="";for(var r=0;r<t.childNodes.length;r++){if(t.childNodes[r].nodeType==3){var q=t.childNodes[r].nodeValue;if(s){q=q.replace(/\n/g,"")}p+=q}else{if(t.childNodes[r].nodeName=="BR"){p+="\n"}else{p+=h(t.childNodes[r])}}}if(/MSIE [678]/.test(navigator.userAgent)){p=p.replace(/\r/g,"\n")}return p}function a(s){var r=s.className.split(/\s+/);r=r.concat(s.parentNode.className.split(/\s+/));for(var q=0;q<r.length;q++){var p=r[q].replace(/^language-/,"");if(e[p]){return p}}}function c(q){var p=[];(function(s,t){for(var r=0;r<s.childNodes.length;r++){if(s.childNodes[r].nodeType==3){t+=s.childNodes[r].nodeValue.length}else{if(s.childNodes[r].nodeName=="BR"){t+=1}else{if(s.childNodes[r].nodeType==1){p.push({event:"start",offset:t,node:s.childNodes[r]});t=arguments.callee(s.childNodes[r],t);p.push({event:"stop",offset:t,node:s.childNodes[r]})}}}}return t})(q,0);return p}function k(y,w,x){var q=0;var z="";var s=[];function u(){if(y.length&&w.length){if(y[0].offset!=w[0].offset){return(y[0].offset<w[0].offset)?y:w}else{return w[0].event=="start"?y:w}}else{return y.length?y:w}}function t(D){var A="<"+D.nodeName.toLowerCase();for(var B=0;B<D.attributes.length;B++){var C=D.attributes[B];A+=" "+C.nodeName.toLowerCase();if(C.value!==undefined&&C.value!==false&&C.value!==null){A+='="'+m(C.value)+'"'}}return A+">"}while(y.length||w.length){var v=u().splice(0,1)[0];z+=m(x.substr(q,v.offset-q));q=v.offset;if(v.event=="start"){z+=t(v.node);s.push(v.node)}else{if(v.event=="stop"){var p,r=s.length;do{r--;p=s[r];z+=("</"+p.nodeName.toLowerCase()+">")}while(p!=v.node);s.splice(r,1);while(r<s.length){z+=t(s[r]);r++}}}}return z+m(x.substr(q))}function j(){function q(x,y,v){if(x.compiled){return}var u;var s=[];if(x.k){x.lR=f(y,x.l||hljs.IR,true);for(var w in x.k){if(!x.k.hasOwnProperty(w)){continue}if(x.k[w] instanceof Object){u=x.k[w]}else{u=x.k;w="keyword"}for(var r in u){if(!u.hasOwnProperty(r)){continue}x.k[r]=[w,u[r]];s.push(r)}}}if(!v){if(x.bWK){x.b="\\b("+s.join("|")+")\\s"}x.bR=f(y,x.b?x.b:"\\B|\\b");if(!x.e&&!x.eW){x.e="\\B|\\b"}if(x.e){x.eR=f(y,x.e)}}if(x.i){x.iR=f(y,x.i)}if(x.r===undefined){x.r=1}if(!x.c){x.c=[]}x.compiled=true;for(var t=0;t<x.c.length;t++){if(x.c[t]=="self"){x.c[t]=x}q(x.c[t],y,false)}if(x.starts){q(x.starts,y,false)}}for(var p in e){if(!e.hasOwnProperty(p)){continue}q(e[p].dM,e[p],true)}}function d(B,C){if(!j.called){j();j.called=true}function q(r,M){for(var L=0;L<M.c.length;L++){if((M.c[L].bR.exec(r)||[null])[0]==r){return M.c[L]}}}function v(L,r){if(D[L].e&&D[L].eR.test(r)){return 1}if(D[L].eW){var M=v(L-1,r);return M?M+1:0}return 0}function w(r,L){return L.i&&L.iR.test(r)}function K(N,O){var M=[];for(var L=0;L<N.c.length;L++){M.push(N.c[L].b)}var r=D.length-1;do{if(D[r].e){M.push(D[r].e)}r--}while(D[r+1].eW);if(N.i){M.push(N.i)}return f(O,M.join("|"),true)}function p(M,L){var N=D[D.length-1];if(!N.t){N.t=K(N,E)}N.t.lastIndex=L;var r=N.t.exec(M);return r?[M.substr(L,r.index-L),r[0],false]:[M.substr(L),"",true]}function z(N,r){var L=E.cI?r[0].toLowerCase():r[0];var M=N.k[L];if(M&&M instanceof Array){return M}return false}function F(L,P){L=m(L);if(!P.k){return L}var r="";var O=0;P.lR.lastIndex=0;var M=P.lR.exec(L);while(M){r+=L.substr(O,M.index-O);var N=z(P,M);if(N){x+=N[1];r+='<span class="'+N[0]+'">'+M[0]+"</span>"}else{r+=M[0]}O=P.lR.lastIndex;M=P.lR.exec(L)}return r+L.substr(O,L.length-O)}function J(L,M){if(M.sL&&e[M.sL]){var r=d(M.sL,L);x+=r.keyword_count;return r.value}else{return F(L,M)}}function I(M,r){var L=M.cN?'<span class="'+M.cN+'">':"";if(M.rB){y+=L;M.buffer=""}else{if(M.eB){y+=m(r)+L;M.buffer=""}else{y+=L;M.buffer=r}}D.push(M);A+=M.r}function G(N,M,Q){var R=D[D.length-1];if(Q){y+=J(R.buffer+N,R);return false}var P=q(M,R);if(P){y+=J(R.buffer+N,R);I(P,M);return P.rB}var L=v(D.length-1,M);if(L){var O=R.cN?"</span>":"";if(R.rE){y+=J(R.buffer+N,R)+O}else{if(R.eE){y+=J(R.buffer+N,R)+O+m(M)}else{y+=J(R.buffer+N+M,R)+O}}while(L>1){O=D[D.length-2].cN?"</span>":"";y+=O;L--;D.length--}var r=D[D.length-1];D.length--;D[D.length-1].buffer="";if(r.starts){I(r.starts,"")}return R.rE}if(w(M,R)){throw"Illegal"}}var E=e[B];var D=[E.dM];var A=0;var x=0;var y="";try{var s,u=0;E.dM.buffer="";do{s=p(C,u);var t=G(s[0],s[1],s[2]);u+=s[0].length;if(!t){u+=s[1].length}}while(!s[2]);if(D.length>1){throw"Illegal"}return{r:A,keyword_count:x,value:y}}catch(H){if(H=="Illegal"){return{r:0,keyword_count:0,value:m(C)}}else{throw H}}}function g(t){var p={keyword_count:0,r:0,value:m(t)};var r=p;for(var q in e){if(!e.hasOwnProperty(q)){continue}var s=d(q,t);s.language=q;if(s.keyword_count+s.r>r.keyword_count+r.r){r=s}if(s.keyword_count+s.r>p.keyword_count+p.r){r=p;p=s}}if(r.language){p.second_best=r}return p}function i(r,q,p){if(q){r=r.replace(/^((<[^>]+>|\t)+)/gm,function(t,w,v,u){return w.replace(/\t/g,q)})}if(p){r=r.replace(/\n/g,"<br>")}return r}function n(t,w,r){var x=h(t,r);var v=a(t);var y,s;if(v){y=d(v,x)}else{return}var q=c(t);if(q.length){s=document.createElement("pre");s.innerHTML=y.value;y.value=k(q,c(s),x)}y.value=i(y.value,w,r);var u=t.className;if(!u.match("(\\s|^)(language-)?"+v+"(\\s|$)")){u=u?(u+" "+v):v}if(/MSIE [678]/.test(navigator.userAgent)&&t.tagName=="CODE"&&t.parentNode.tagName=="PRE"){s=t.parentNode;var p=document.createElement("div");p.innerHTML="<pre><code>"+y.value+"</code></pre>";t=p.firstChild.firstChild;p.firstChild.cN=s.cN;s.parentNode.replaceChild(p.firstChild,s)}else{t.innerHTML=y.value}t.className=u;t.result={language:v,kw:y.keyword_count,re:y.r};if(y.second_best){t.second_best={language:y.second_best.language,kw:y.second_best.keyword_count,re:y.second_best.r}}}function o(){if(o.called){return}o.called=true;var r=document.getElementsByTagName("pre");for(var p=0;p<r.length;p++){var q=b(r[p]);if(q){n(q,hljs.tabReplace)}}}function l(){if(window.addEventListener){window.addEventListener("DOMContentLoaded",o,false);window.addEventListener("load",o,false)}else{if(window.attachEvent){window.attachEvent("onload",o)}else{window.onload=o}}}var e={};this.LANGUAGES=e;this.highlight=d;this.highlightAuto=g;this.fixMarkup=i;this.highlightBlock=n;this.initHighlighting=o;this.initHighlightingOnLoad=l;this.IR="[a-zA-Z][a-zA-Z0-9_]*";this.UIR="[a-zA-Z_][a-zA-Z0-9_]*";this.NR="\\b\\d+(\\.\\d+)?";this.CNR="\\b(0[xX][a-fA-F0-9]+|(\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)";this.BNR="\\b(0b[01]+)";this.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|\\.|-|-=|/|/=|:|;|<|<<|<<=|<=|=|==|===|>|>=|>>|>>=|>>>|>>>=|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~";this.ER="(?![\\s\\S])";this.BE={b:"\\\\.",r:0};this.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[this.BE],r:0};this.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[this.BE],r:0};this.CLCM={cN:"comment",b:"//",e:"$"};this.CBLCLM={cN:"comment",b:"/\\*",e:"\\*/"};this.HCM={cN:"comment",b:"#",e:"$"};this.NM={cN:"number",b:this.NR,r:0};this.CNM={cN:"number",b:this.CNR,r:0};this.BNM={cN:"number",b:this.BNR,r:0};this.inherit=function(r,s){var p={};for(var q in r){p[q]=r[q]}if(s){for(var q in s){p[q]=s[q]}}return p}}();hljs.LANGUAGES.bash=function(){var e={"true":1,"false":1};var b={cN:"variable",b:"\\$([a-zA-Z0-9_]+)\\b"};var a={cN:"variable",b:"\\$\\{(([^}])|(\\\\}))+\\}",c:[hljs.CNM]};var f={cN:"string",b:'"',e:'"',i:"\\n",c:[hljs.BE,b,a],r:0};var c={cN:"string",b:"'",e:"'",c:[{b:"''"}],r:0};var d={cN:"test_condition",b:"",e:"",c:[f,c,b,a,hljs.CNM],k:{literal:e},r:0};return{dM:{k:{keyword:{"if":1,then:1,"else":1,fi:1,"for":1,"break":1,"continue":1,"while":1,"in":1,"do":1,done:1,echo:1,exit:1,"return":1,set:1,declare:1},literal:e},c:[{cN:"shebang",b:"(#!\\/bin\\/bash)|(#!\\/bin\\/sh)",r:10},b,a,hljs.HCM,hljs.CNM,f,c,hljs.inherit(d,{b:"\\[ ",e:" \\]",r:0}),hljs.inherit(d,{b:"\\[\\[ ",e:" \\]\\]"})]}}}();hljs.LANGUAGES.cpp=function(){var a={keyword:{"false":1,"int":1,"float":1,"while":1,"private":1,"char":1,"catch":1,"export":1,virtual:1,operator:2,sizeof:2,dynamic_cast:2,typedef:2,const_cast:2,"const":1,struct:1,"for":1,static_cast:2,union:1,namespace:1,unsigned:1,"long":1,"throw":1,"volatile":2,"static":1,"protected":1,bool:1,template:1,mutable:1,"if":1,"public":1,friend:2,"do":1,"return":1,"goto":1,auto:1,"void":2,"enum":1,"else":1,"break":1,"new":1,extern:1,using:1,"true":1,"class":1,asm:1,"case":1,typeid:1,"short":1,reinterpret_cast:2,"default":1,"double":1,register:1,explicit:1,signed:1,typename:1,"try":1,"this":1,"switch":1,"continue":1,wchar_t:1,inline:1,"delete":1,alignof:1,char16_t:1,char32_t:1,constexpr:1,decltype:1,noexcept:1,nullptr:1,static_assert:1,thread_local:1,restrict:1,_Bool:1,complex:1},built_in:{std:1,string:1,cin:1,cout:1,cerr:1,clog:1,stringstream:1,istringstream:1,ostringstream:1,auto_ptr:1,deque:1,list:1,queue:1,stack:1,vector:1,map:1,set:1,bitset:1,multiset:1,multimap:1,unordered_set:1,unordered_map:1,unordered_multiset:1,unordered_multimap:1,array:1,shared_ptr:1}};return{dM:{k:a,i:"</",c:[hljs.CLCM,hljs.CBLCLM,hljs.QSM,{cN:"string",b:"'\\\\?.",e:"'",i:"."},{cN:"number",b:"\\b(\\d+(\\.\\d*)?|\\.\\d+)(u|U|l|L|ul|UL|f|F)"},hljs.CNM,{cN:"preprocessor",b:"#",e:"$"},{cN:"stl_container",b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:a,r:10,c:["self"]}]}}}();hljs.LANGUAGES.css=function(){var a={cN:"function",b:hljs.IR+"\\(",e:"\\)",c:[{eW:true,eE:true,c:[hljs.NM,hljs.ASM,hljs.QSM]}]};return{cI:true,dM:{i:"[=/|']",c:[hljs.CBLCLM,{cN:"id",b:"\\#[A-Za-z0-9_-]+"},{cN:"class",b:"\\.[A-Za-z0-9_-]+",r:0},{cN:"attr_selector",b:"\\[",e:"\\]",i:"$"},{cN:"pseudo",b:":(:)?[a-zA-Z0-9\\_\\-\\+\\(\\)\\\"\\']+"},{cN:"at_rule",b:"@(font-face|page)",l:"[a-z-]+",k:{"font-face":1,page:1}},{cN:"at_rule",b:"@",e:"[{;]",eE:true,k:{"import":1,page:1,media:1,charset:1},c:[a,hljs.ASM,hljs.QSM,hljs.NM]},{cN:"tag",b:hljs.IR,r:0},{cN:"rules",b:"{",e:"}",i:"[^\\s]",r:0,c:[hljs.CBLCLM,{cN:"rule",b:"[^\\s]",rB:true,e:";",eW:true,c:[{cN:"attribute",b:"[A-Z\\_\\.\\-]+",e:":",eE:true,i:"[^\\s]",starts:{cN:"value",eW:true,eE:true,c:[a,hljs.NM,hljs.QSM,hljs.ASM,hljs.CBLCLM,{cN:"hexcolor",b:"\\#[0-9A-F]+"},{cN:"important",b:"!important"}]}}]}]}]}}}();hljs.LANGUAGES.ini={cI:true,dM:{i:"[^\\s]",c:[{cN:"comment",b:";",e:"$"},{cN:"title",b:"^\\[",e:"\\]"},{cN:"setting",b:"^[a-z0-9_\\[\\]]+[ \\t]*=[ \\t]*",e:"$",c:[{cN:"value",eW:true,k:{on:1,off:1,"true":1,"false":1,yes:1,no:1},c:[hljs.QSM,hljs.NM]}]}]}};hljs.LANGUAGES.perl=function(){var d={getpwent:1,getservent:1,quotemeta:1,msgrcv:1,scalar:1,kill:1,dbmclose:1,undef:1,lc:1,ma:1,syswrite:1,tr:1,send:1,umask:1,sysopen:1,shmwrite:1,vec:1,qx:1,utime:1,local:1,oct:1,semctl:1,localtime:1,readpipe:1,"do":1,"return":1,format:1,read:1,sprintf:1,dbmopen:1,pop:1,getpgrp:1,not:1,getpwnam:1,rewinddir:1,qq:1,fileno:1,qw:1,endprotoent:1,wait:1,sethostent:1,bless:1,s:0,opendir:1,"continue":1,each:1,sleep:1,endgrent:1,shutdown:1,dump:1,chomp:1,connect:1,getsockname:1,die:1,socketpair:1,close:1,flock:1,exists:1,index:1,shmget:1,sub:1,"for":1,endpwent:1,redo:1,lstat:1,msgctl:1,setpgrp:1,abs:1,exit:1,select:1,print:1,ref:1,gethostbyaddr:1,unshift:1,fcntl:1,syscall:1,"goto":1,getnetbyaddr:1,join:1,gmtime:1,symlink:1,semget:1,splice:1,x:0,getpeername:1,recv:1,log:1,setsockopt:1,cos:1,last:1,reverse:1,gethostbyname:1,getgrnam:1,study:1,formline:1,endhostent:1,times:1,chop:1,length:1,gethostent:1,getnetent:1,pack:1,getprotoent:1,getservbyname:1,rand:1,mkdir:1,pos:1,chmod:1,y:0,substr:1,endnetent:1,printf:1,next:1,open:1,msgsnd:1,readdir:1,use:1,unlink:1,getsockopt:1,getpriority:1,rindex:1,wantarray:1,hex:1,system:1,getservbyport:1,endservent:1,"int":1,chr:1,untie:1,rmdir:1,prototype:1,tell:1,listen:1,fork:1,shmread:1,ucfirst:1,setprotoent:1,"else":1,sysseek:1,link:1,getgrgid:1,shmctl:1,waitpid:1,unpack:1,getnetbyname:1,reset:1,chdir:1,grep:1,split:1,require:1,caller:1,lcfirst:1,until:1,warn:1,"while":1,values:1,shift:1,telldir:1,getpwuid:1,my:1,getprotobynumber:1,"delete":1,and:1,sort:1,uc:1,defined:1,srand:1,accept:1,"package":1,seekdir:1,getprotobyname:1,semop:1,our:1,rename:1,seek:1,"if":1,q:0,chroot:1,sysread:1,setpwent:1,no:1,crypt:1,getc:1,chown:1,sqrt:1,write:1,setnetent:1,setpriority:1,foreach:1,tie:1,sin:1,msgget:1,map:1,stat:1,getlogin:1,unless:1,elsif:1,truncate:1,exec:1,keys:1,glob:1,tied:1,closedir:1,ioctl:1,socket:1,readlink:1,"eval":1,xor:1,readline:1,binmode:1,setservent:1,eof:1,ord:1,bind:1,alarm:1,pipe:1,atan2:1,getgrent:1,exp:1,time:1,push:1,setgrent:1,gt:1,lt:1,or:1,ne:1,m:0};var f={cN:"subst",b:"[$@]\\{",e:"\\}",k:d,r:10};var c={cN:"variable",b:"\\$\\d"};var b={cN:"variable",b:"[\\$\\%\\@\\*](\\^\\w\\b|#\\w+(\\:\\:\\w+)*|[^\\s\\w{]|{\\w+}|\\w+(\\:\\:\\w*)*)"};var h=[hljs.BE,f,c,b];var g={b:"->",c:[{b:hljs.IR},{b:"{",e:"}"}]};var e={cN:"comment",b:"^(__END__|__DATA__)",e:"\\n$",r:5};var a=[c,b,hljs.HCM,e,g,{cN:"string",b:"q[qwxr]?\\s*\\(",e:"\\)",c:h,r:5},{cN:"string",b:"q[qwxr]?\\s*\\[",e:"\\]",c:h,r:5},{cN:"string",b:"q[qwxr]?\\s*\\{",e:"\\}",c:h,r:5},{cN:"string",b:"q[qwxr]?\\s*\\|",e:"\\|",c:h,r:5},{cN:"string",b:"q[qwxr]?\\s*\\<",e:"\\>",c:h,r:5},{cN:"string",b:"qw\\s+q",e:"q",c:h,r:5},{cN:"string",b:"'",e:"'",c:[hljs.BE],r:0},{cN:"string",b:'"',e:'"',c:h,r:0},{cN:"string",b:"`",e:"`",c:[hljs.BE]},{cN:"string",b:"{\\w+}",r:0},{cN:"string",b:"-?\\w+\\s*\\=\\>",r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"("+hljs.RSR+"|\\b(split|return|print|reverse|grep)\\b)\\s*",k:{split:1,"return":1,print:1,reverse:1,grep:1},r:0,c:[hljs.HCM,e,{cN:"regexp",b:"(s|tr|y)/(\\\\.|[^/])*/(\\\\.|[^/])*/[a-z]*",r:10},{cN:"regexp",b:"(m|qr)?/",e:"/[a-z]*",c:[hljs.BE],r:0}]},{cN:"sub",b:"\\bsub\\b",e:"(\\s*\\(.*?\\))?[;{]",k:{sub:1},r:5},{cN:"operator",b:"-\\w\\b",r:0},{cN:"pod",b:"\\=\\w",e:"\\=cut"}];f.c=a;g.c[1].c=a;return{dM:{k:d,c:a}}}();hljs.LANGUAGES.python=function(){var b=[{cN:"string",b:"(u|b)?r?'''",e:"'''",r:10},{cN:"string",b:'(u|b)?r?"""',e:'"""',r:10},{cN:"string",b:"(u|r|ur)'",e:"'",c:[hljs.BE],r:10},{cN:"string",b:'(u|r|ur)"',e:'"',c:[hljs.BE],r:10},{cN:"string",b:"(b|br)'",e:"'",c:[hljs.BE]},{cN:"string",b:'(b|br)"',e:'"',c:[hljs.BE]}].concat([hljs.ASM,hljs.QSM]);var d={cN:"title",b:hljs.UIR};var c={cN:"params",b:"\\(",e:"\\)",c:b.concat([hljs.CNM])};var a={bWK:true,e:":",i:"[${]",c:[d,c],r:10};return{dM:{k:{keyword:{and:1,elif:1,is:1,global:1,as:1,"in":1,"if":1,from:1,raise:1,"for":1,except:1,"finally":1,print:1,"import":1,pass:1,"return":1,exec:1,"else":1,"break":1,not:1,"with":1,"class":1,assert:1,yield:1,"try":1,"while":1,"continue":1,del:1,or:1,def:1,lambda:1,nonlocal:10},built_in:{None:1,True:1,False:1,Ellipsis:1,NotImplemented:1}},i:"(</|->|\\?)",c:b.concat([hljs.HCM,hljs.inherit(a,{cN:"function",k:{def:1}}),hljs.inherit(a,{cN:"class",k:{"class":1}}),hljs.CNM,{cN:"decorator",b:"@",e:"$"}])}}}();hljs.LANGUAGES.r={dM:{c:[hljs.HCM,{cN:"number",b:"\\b0[xX][0-9a-fA-F]+[Li]?\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\b\\d+(?:[eE][+\\-]?\\d*)?L\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\b\\d+\\.(?!\\d)(?:i\\b)?",e:hljs.IMMEDIATE_RE,r:1},{cN:"number",b:"\\b\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"keyword",b:"(?:tryCatch|library|setGeneric|setGroupGeneric)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\.\\.\\.",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\.\\.\\d+(?![\\w.])",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"\\b(?:function)",e:hljs.IMMEDIATE_RE,r:2},{cN:"keyword",b:"(?:if|in|break|next|repeat|else|for|return|switch|while|try|stop|warning|require|attach|detach|source|setMethod|setClass)\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"literal",b:"(?:NA|NA_integer_|NA_real_|NA_character_|NA_complex_)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"literal",b:"(?:NULL|TRUE|FALSE|T|F|Inf|NaN)\\b",e:hljs.IMMEDIATE_RE,r:1},{cN:"identifier",b:"[a-zA-Z.][a-zA-Z0-9._]*\\b",e:hljs.IMMEDIATE_RE,r:0},{cN:"operator",b:"<\\-(?!\\s*\\d)",e:hljs.IMMEDIATE_RE,r:2},{cN:"operator",b:"\\->|<\\-",e:hljs.IMMEDIATE_RE,r:1},{cN:"operator",b:"%%|~",e:hljs.IMMEDIATE_RE},{cN:"operator",b:">=|<=|==|!=|\\|\\||&&|=|\\+|\\-|\\*|/|\\^|>|<|!|&|\\||\\$|:",e:hljs.IMMEDIATE_RE,r:0},{cN:"operator",b:"%",e:"%",i:"\\n",r:1},{cN:"identifier",b:"`",e:"`",r:0},{cN:"string",b:'"',e:'"',c:[hljs.BE],r:0},{cN:"string",b:"'",e:"'",c:[hljs.BE],r:0},{cN:"paren",b:"[[({\\])}]",e:hljs.IMMEDIATE_RE,r:0}]}};hljs.LANGUAGES.ruby=function(){var a="[a-zA-Z_][a-zA-Z0-9_]*(\\!|\\?)?";var j="[a-zA-Z_]\\w*[!?=]?|[-+~]\\@|<<|>>|=~|===?|<=>|[<>]=?|\\*\\*|[-/+%^&*~`|]|\\[\\]=?";var f={keyword:{and:1,"false":1,then:1,defined:1,module:1,"in":1,"return":1,redo:1,"if":1,BEGIN:1,retry:1,end:1,"for":1,"true":1,self:1,when:1,next:1,until:1,"do":1,begin:1,unless:1,END:1,rescue:1,nil:1,"else":1,"break":1,undef:1,not:1,"super":1,"class":1,"case":1,require:1,yield:1,alias:1,"while":1,ensure:1,elsif:1,or:1,def:1},keymethods:{__id__:1,__send__:1,abort:1,abs:1,"all?":1,allocate:1,ancestors:1,"any?":1,arity:1,assoc:1,at:1,at_exit:1,autoload:1,"autoload?":1,"between?":1,binding:1,binmode:1,"block_given?":1,call:1,callcc:1,caller:1,capitalize:1,"capitalize!":1,casecmp:1,"catch":1,ceil:1,center:1,chomp:1,"chomp!":1,chop:1,"chop!":1,chr:1,"class":1,class_eval:1,"class_variable_defined?":1,class_variables:1,clear:1,clone:1,close:1,close_read:1,close_write:1,"closed?":1,coerce:1,collect:1,"collect!":1,compact:1,"compact!":1,concat:1,"const_defined?":1,const_get:1,const_missing:1,const_set:1,constants:1,count:1,crypt:1,"default":1,default_proc:1,"delete":1,"delete!":1,delete_at:1,delete_if:1,detect:1,display:1,div:1,divmod:1,downcase:1,"downcase!":1,downto:1,dump:1,dup:1,each:1,each_byte:1,each_index:1,each_key:1,each_line:1,each_pair:1,each_value:1,each_with_index:1,"empty?":1,entries:1,eof:1,"eof?":1,"eql?":1,"equal?":1,"eval":1,exec:1,exit:1,"exit!":1,extend:1,fail:1,fcntl:1,fetch:1,fileno:1,fill:1,find:1,find_all:1,first:1,flatten:1,"flatten!":1,floor:1,flush:1,for_fd:1,foreach:1,fork:1,format:1,freeze:1,"frozen?":1,fsync:1,getc:1,gets:1,global_variables:1,grep:1,gsub:1,"gsub!":1,"has_key?":1,"has_value?":1,hash:1,hex:1,id:1,include:1,"include?":1,included_modules:1,index:1,indexes:1,indices:1,induced_from:1,inject:1,insert:1,inspect:1,instance_eval:1,instance_method:1,instance_methods:1,"instance_of?":1,"instance_variable_defined?":1,instance_variable_get:1,instance_variable_set:1,instance_variables:1,"integer?":1,intern:1,invert:1,ioctl:1,"is_a?":1,isatty:1,"iterator?":1,join:1,"key?":1,keys:1,"kind_of?":1,lambda:1,last:1,length:1,lineno:1,ljust:1,load:1,local_variables:1,loop:1,lstrip:1,"lstrip!":1,map:1,"map!":1,match:1,max:1,"member?":1,merge:1,"merge!":1,method:1,"method_defined?":1,method_missing:1,methods:1,min:1,module_eval:1,modulo:1,name:1,nesting:1,"new":1,next:1,"next!":1,"nil?":1,nitems:1,"nonzero?":1,object_id:1,oct:1,open:1,pack:1,partition:1,pid:1,pipe:1,pop:1,popen:1,pos:1,prec:1,prec_f:1,prec_i:1,print:1,printf:1,private_class_method:1,private_instance_methods:1,"private_method_defined?":1,private_methods:1,proc:1,protected_instance_methods:1,"protected_method_defined?":1,protected_methods:1,public_class_method:1,public_instance_methods:1,"public_method_defined?":1,public_methods:1,push:1,putc:1,puts:1,quo:1,raise:1,rand:1,rassoc:1,read:1,read_nonblock:1,readchar:1,readline:1,readlines:1,readpartial:1,rehash:1,reject:1,"reject!":1,remainder:1,reopen:1,replace:1,require:1,"respond_to?":1,reverse:1,"reverse!":1,reverse_each:1,rewind:1,rindex:1,rjust:1,round:1,rstrip:1,"rstrip!":1,scan:1,seek:1,select:1,send:1,set_trace_func:1,shift:1,singleton_method_added:1,singleton_methods:1,size:1,sleep:1,slice:1,"slice!":1,sort:1,"sort!":1,sort_by:1,split:1,sprintf:1,squeeze:1,"squeeze!":1,srand:1,stat:1,step:1,store:1,strip:1,"strip!":1,sub:1,"sub!":1,succ:1,"succ!":1,sum:1,superclass:1,swapcase:1,"swapcase!":1,sync:1,syscall:1,sysopen:1,sysread:1,sysseek:1,system:1,syswrite:1,taint:1,"tainted?":1,tell:1,test:1,"throw":1,times:1,to_a:1,to_ary:1,to_f:1,to_hash:1,to_i:1,to_int:1,to_io:1,to_proc:1,to_s:1,to_str:1,to_sym:1,tr:1,"tr!":1,tr_s:1,"tr_s!":1,trace_var:1,transpose:1,trap:1,truncate:1,"tty?":1,type:1,ungetc:1,uniq:1,"uniq!":1,unpack:1,unshift:1,untaint:1,untrace_var:1,upcase:1,"upcase!":1,update:1,upto:1,"value?":1,values:1,values_at:1,warn:1,write:1,write_nonblock:1,"zero?":1,zip:1}};var c={cN:"yardoctag",b:"@[A-Za-z]+"};var k=[{cN:"comment",b:"#",e:"$",c:[c]},{cN:"comment",b:"^\\=begin",e:"^\\=end",c:[c],r:10},{cN:"comment",b:"^__END__",e:"\\n$"}];var d={cN:"subst",b:"#\\{",e:"}",l:a,k:f};var i=[hljs.BE,d];var b=[{cN:"string",b:"'",e:"'",c:i,r:0},{cN:"string",b:'"',e:'"',c:i,r:0},{cN:"string",b:"%[qw]?\\(",e:"\\)",c:i,r:10},{cN:"string",b:"%[qw]?\\[",e:"\\]",c:i,r:10},{cN:"string",b:"%[qw]?{",e:"}",c:i,r:10},{cN:"string",b:"%[qw]?<",e:">",c:i,r:10},{cN:"string",b:"%[qw]?/",e:"/",c:i,r:10},{cN:"string",b:"%[qw]?%",e:"%",c:i,r:10},{cN:"string",b:"%[qw]?-",e:"-",c:i,r:10},{cN:"string",b:"%[qw]?\\|",e:"\\|",c:i,r:10}];var h={cN:"function",b:"\\bdef\\s+",e:" |$|;",l:a,k:f,c:[{cN:"title",b:j,l:a,k:f},{cN:"params",b:"\\(",e:"\\)",l:a,k:f}].concat(k)};var g={cN:"identifier",b:a,l:a,k:f,r:0};var e=k.concat(b.concat([{cN:"class",b:"\\b(class|module)\\b",e:"$|;",k:{"class":1,module:1},c:[{cN:"title",b:"[A-Za-z_]\\w*(::\\w+)*(\\?|\\!)?",r:0},{cN:"inheritance",b:"<\\s*",c:[{cN:"parent",b:"("+hljs.IR+"::)?"+hljs.IR}]}].concat(k)},h,{cN:"constant",b:"(::)?([A-Z]\\w*(::)?)+",r:0},{cN:"symbol",b:":",c:b.concat([g]),r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{cN:"number",b:"\\?\\w"},{cN:"variable",b:"(\\$\\W)|((\\$|\\@\\@?)(\\w+))"},g,{b:"("+hljs.RSR+")\\s*",c:k.concat([{cN:"regexp",b:"/",e:"/[a-z]*",i:"\\n",c:[hljs.BE]}]),r:0}]));d.c=e;h.c[1].c=e;return{dM:{l:a,k:f,c:e}}}();hljs.LANGUAGES.scala=function(){var b={cN:"annotation",b:"@[A-Za-z]+"};var a={cN:"string",b:'u?r?"""',e:'"""',r:10};return{dM:{k:{type:1,yield:1,lazy:1,override:1,def:1,"with":1,val:1,"var":1,"false":1,"true":1,sealed:1,"abstract":1,"private":1,trait:1,object:1,"null":1,"if":1,"for":1,"while":1,"throw":1,"finally":1,"protected":1,"extends":1,"import":1,"final":1,"return":1,"else":1,"break":1,"new":1,"catch":1,"super":1,"class":1,"case":1,"package":1,"default":1,"try":1,"this":1,match:1,"continue":1,"throws":1},c:[{cN:"javadoc",b:"/\\*\\*",e:"\\*/",c:[{cN:"javadoctag",b:"@[A-Za-z]+"}],r:10},hljs.CLCM,hljs.CBLCLM,hljs.ASM,hljs.QSM,a,{cN:"class",b:"((case )?class |object |trait )",e:"({|$)",i:":",k:{"case":1,"class":1,trait:1,object:1},c:[{bWK:true,k:{"extends":1,"with":1},r:10},{cN:"title",b:hljs.UIR},{cN:"params",b:"\\(",e:"\\)",c:[hljs.ASM,hljs.QSM,a,b]}]},hljs.CNM,b]}}}();hljs.LANGUAGES.sql={cI:true,dM:{i:"[^\\s]",c:[{cN:"operator",b:"(begin|start|commit|rollback|savepoint|lock|alter|create|drop|rename|call|delete|do|handler|insert|load|replace|select|truncate|update|set|show|pragma|grant)\\b",e:";|"+hljs.ER,k:{keyword:{all:1,partial:1,global:1,month:1,current_timestamp:1,using:1,go:1,revoke:1,smallint:1,indicator:1,"end-exec":1,disconnect:1,zone:1,"with":1,character:1,assertion:1,to:1,add:1,current_user:1,usage:1,input:1,local:1,alter:1,match:1,collate:1,real:1,then:1,rollback:1,get:1,read:1,timestamp:1,session_user:1,not:1,integer:1,bit:1,unique:1,day:1,minute:1,desc:1,insert:1,execute:1,like:1,ilike:2,level:1,decimal:1,drop:1,"continue":1,isolation:1,found:1,where:1,constraints:1,domain:1,right:1,national:1,some:1,module:1,transaction:1,relative:1,second:1,connect:1,escape:1,close:1,system_user:1,"for":1,deferred:1,section:1,cast:1,current:1,sqlstate:1,allocate:1,intersect:1,deallocate:1,numeric:1,"public":1,preserve:1,full:1,"goto":1,initially:1,asc:1,no:1,key:1,output:1,collation:1,group:1,by:1,union:1,session:1,both:1,last:1,language:1,constraint:1,column:1,of:1,space:1,foreign:1,deferrable:1,prior:1,connection:1,unknown:1,action:1,commit:1,view:1,or:1,first:1,into:1,"float":1,year:1,primary:1,cascaded:1,except:1,restrict:1,set:1,references:1,names:1,table:1,outer:1,open:1,select:1,size:1,are:1,rows:1,from:1,prepare:1,distinct:1,leading:1,create:1,only:1,next:1,inner:1,authorization:1,schema:1,corresponding:1,option:1,declare:1,precision:1,immediate:1,"else":1,timezone_minute:1,external:1,varying:1,translation:1,"true":1,"case":1,exception:1,join:1,hour:1,"default":1,"double":1,scroll:1,value:1,cursor:1,descriptor:1,values:1,dec:1,fetch:1,procedure:1,"delete":1,and:1,"false":1,"int":1,is:1,describe:1,"char":1,as:1,at:1,"in":1,varchar:1,"null":1,trailing:1,any:1,absolute:1,current_time:1,end:1,grant:1,privileges:1,when:1,cross:1,check:1,write:1,current_date:1,pad:1,begin:1,temporary:1,exec:1,time:1,update:1,catalog:1,user:1,sql:1,date:1,on:1,identity:1,timezone_hour:1,natural:1,whenever:1,interval:1,work:1,order:1,cascade:1,diagnostics:1,nchar:1,having:1,left:1,call:1,"do":1,handler:1,load:1,replace:1,truncate:1,start:1,lock:1,show:1,pragma:1},aggregate:{count:1,sum:1,min:1,max:1,avg:1}},c:[{cN:"string",b:"'",e:"'",c:[hljs.BE,{b:"''"}],r:0},{cN:"string",b:'"',e:'"',c:[hljs.BE,{b:'""'}],r:0},{cN:"string",b:"`",e:"`",c:[hljs.BE]},hljs.CNM]},hljs.CBLCLM,{cN:"comment",b:"--",e:"$"}]}};hljs.LANGUAGES.stan={dM:{c:[hljs.HCM,hljs.CLCM,hljs.QSM,hljs.CNM,{cN:"operator",b:"(?:<-|~|\\|\\||&&|==|!=|<=?|>=?|\\+|-|\\.?/|\\\\|\\^|\\^|!|'|%|:|,|;|=)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"paren",b:"[[({\\])}]",e:hljs.IMMEDIATE_RE,r:0},{cN:"function",b:"(?:Phi|Phi_approx|abs|acos|acosh|append_col|append_row|asin|asinh|atan|atan2|atanh|bernoulli_ccdf_log|bernoulli_cdf|bernoulli_cdf_log|bernoulli_log|bernoulli_logit_log|bernoulli_rng|bessel_first_kind|bessel_second_kind|beta_binomial_ccdf_log|beta_binomial_cdf|beta_binomial_cdf_log|beta_binomial_log|beta_binomial_rng|beta_ccdf_log|beta_cdf|beta_cdf_log|beta_log|beta_rng|binary_log_loss|binomial_ccdf_log|binomial_cdf|binomial_cdf_log|binomial_coefficient_log|binomial_log|binomial_logit_log|binomial_rng|block|categorical_log|categorical_logit_log|categorical_rng|cauchy_ccdf_log|cauchy_cdf|cauchy_cdf_log|cauchy_log|cauchy_rng|cbrt|ceil|chi_square_ccdf_log|chi_square_cdf|chi_square_cdf_log|chi_square_log|chi_square_rng|cholesky_decompose|col|cols|columns_dot_product|columns_dot_self|cos|cosh|crossprod|csr_extract_u|csr_extract_v|csr_extract_w|csr_matrix_times_vector|csr_to_dense_matrix|cumulative_sum|determinant|diag_matrix|diag_post_multiply|diag_pre_multiply|diagonal|digamma|dims|dirichlet_log|dirichlet_rng|distance|dot_product|dot_self|double_exponential_ccdf_log|double_exponential_cdf|double_exponential_cdf_log|double_exponential_log|double_exponential_rng|e|eigenvalues_sym|eigenvectors_sym|erf|erfc|exp|exp2|exp_mod_normal_ccdf_log|exp_mod_normal_cdf|exp_mod_normal_cdf_log|exp_mod_normal_log|exp_mod_normal_rng|expm1|exponential_ccdf_log|exponential_cdf|exponential_cdf_log|exponential_log|exponential_rng|fabs|falling_factorial|fdim|floor|fma|fmax|fmin|fmod|frechet_ccdf_log|frechet_cdf|frechet_cdf_log|frechet_log|frechet_rng|gamma_ccdf_log|gamma_cdf|gamma_cdf_log|gamma_log|gamma_p|gamma_q|gamma_rng|gaussian_dlm_obs_log|get_lp|gumbel_ccdf_log|gumbel_cdf|gumbel_cdf_log|gumbel_log|gumbel_rng|head|hypergeometric_log|hypergeometric_rng|hypot|if_else|int_step|inv|inv_chi_square_ccdf_log|inv_chi_square_cdf|inv_chi_square_cdf_log|inv_chi_square_log|inv_chi_square_rng|inv_cloglog|inv_gamma_ccdf_log|inv_gamma_cdf|inv_gamma_cdf_log|inv_gamma_log|inv_gamma_rng|inv_logit|inv_phi|inv_sqrt|inv_square|inv_wishart_log|inv_wishart_rng|inverse|inverse_spd|is_inf|is_nan|lbeta|lgamma|lkj_corr_cholesky_log|lkj_corr_cholesky_rng|lkj_corr_log|lkj_corr_rng|lmgamma|log|log10|log1m|log1m_exp|log1m_inv_logit|log1p|log1p_exp|log2|log_determinant|log_diff_exp|log_falling_factorial|log_inv_logit|log_mix|log_rising_factorial|log_softmax|log_sum_exp|logistic_ccdf_log|logistic_cdf|logistic_cdf_log|logistic_log|logistic_rng|logit|lognormal_ccdf_log|lognormal_cdf|lognormal_cdf_log|lognormal_log|lognormal_rng|machine_precision|max|mdivide_left_tri_low|mdivide_right_tri_low|mean|min|modified_bessel_first_kind|modified_bessel_second_kind|multi_gp_cholesky_log|multi_gp_log|multi_normal_cholesky_log|multi_normal_cholesky_rng|multi_normal_log|multi_normal_prec_log|multi_normal_rng|multi_student_t_log|multi_student_t_rng|multinomial_log|multinomial_rng|multiply_log|multiply_lower_tri_self_transpose|neg_binomial_2_ccdf_log|neg_binomial_2_cdf|neg_binomial_2_cdf_log|neg_binomial_2_log|neg_binomial_2_log_log|neg_binomial_2_log_rng|neg_binomial_2_rng|neg_binomial_ccdf_log|neg_binomial_cdf|neg_binomial_cdf_log|neg_binomial_log|neg_binomial_rng|negative_infinity|normal_ccdf_log|normal_cdf|normal_cdf_log|normal_log|normal_rng|not_a_number|num_elements|ordered_logistic_log|ordered_logistic_rng|owens_t|pareto_ccdf_log|pareto_cdf|pareto_cdf_log|pareto_log|pareto_rng|pareto_type_2_ccdf_log|pareto_type_2_cdf|pareto_type_2_cdf_log|pareto_type_2_log|pareto_type_2_rng|pi|poisson_ccdf_log|poisson_cdf|poisson_cdf_log|poisson_log|poisson_log_log|poisson_log_rng|poisson_rng|positive_infinity|pow|prod|qr_Q|qr_R|quad_form|quad_form_diag|quad_form_sym|rank|rayleigh_ccdf_log|rayleigh_cdf|rayleigh_cdf_log|rayleigh_log|rayleigh_rng|rep_array|rep_matrix|rep_row_vector|rep_vector|rising_factorial|round|row|rows|rows_dot_product|rows_dot_self|scaled_inv_chi_square_ccdf_log|scaled_inv_chi_square_cdf|scaled_inv_chi_square_cdf_log|scaled_inv_chi_square_log|scaled_inv_chi_square_rng|sd|segment|sin|singular_values|sinh|size|skew_normal_ccdf_log|skew_normal_cdf|skew_normal_cdf_log|skew_normal_log|skew_normal_rng|softmax|sort_asc|sort_desc|sort_indices_asc|sort_indices_desc|sqrt|sqrt2|square|squared_distance|step|student_t_ccdf_log|student_t_cdf|student_t_cdf_log|student_t_log|student_t_rng|sub_col|sub_row|sum|tail|tan|tanh|tcrossprod|tgamma|to_array_1d|to_array_2d|to_matrix|to_row_vector|to_vector|trace|trace_gen_quad_form|trace_quad_form|trigamma|trunc|uniform_ccdf_log|uniform_cdf|uniform_cdf_log|uniform_log|uniform_rng|variance|von_mises_log|von_mises_rng|weibull_ccdf_log|weibull_cdf|weibull_cdf_log|weibull_log|weibull_rng|wiener_log|wishart_log|wishart_rng)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"function",b:"(?:bernoulli|bernoulli_logit|beta|beta_binomial|binomial|binomial_logit|categorical|categorical_logit|cauchy|chi_square|dirichlet|double_exponential|exp_mod_normal|exponential|frechet|gamma|gaussian_dlm_obs|gumbel|hypergeometric|inv_chi_square|inv_gamma|inv_wishart|lkj_corr|lkj_corr_cholesky|logistic|lognormal|multi_gp|multi_gp_cholesky|multi_normal|multi_normal_cholesky|multi_normal_prec|multi_student_t|multinomial|neg_binomial|neg_binomial_2|neg_binomial_2_log|normal|ordered_logistic|pareto|pareto_type_2|poisson|poisson_log|rayleigh|scaled_inv_chi_square|skew_normal|student_t|uniform|von_mises|weibull|wiener|wishart)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"(?:for|in|while|if|then|else|return|lower|upper|print|increment_log_prob|integrate_ode|reject)\\b",e:hljs.IMMEDIATE_RE,r:10},{cN:"keyword",b:"(?:int|real|vector|simplex|unit_vector|ordered|positive_ordered|row_vector|matrix|cholesky_factor_cov|cholesky_factor_corr|corr_matrix|cov_matrix|void)\\b",e:hljs.IMMEDIATE_RE,r:5},{cN:"keyword",b:"(?:functions|data|transformed\\s+data|parameters|transformed\\s+parameters|model|generated\\s+quantities)\\b",e:hljs.IMMEDIATE_RE,r:5}]}};hljs.LANGUAGES.xml=function(){var b="[A-Za-z0-9\\._:-]+";var a={eW:true,c:[{cN:"attribute",b:b,r:0},{b:'="',rB:true,e:'"',c:[{cN:"value",b:'"',eW:true}]},{b:"='",rB:true,e:"'",c:[{cN:"value",b:"'",eW:true}]},{b:"=",c:[{cN:"value",b:"[^\\s/>]+"}]}]};return{cI:true,dM:{c:[{cN:"pi",b:"<\\?",e:"\\?>",r:10},{cN:"doctype",b:"<!DOCTYPE",e:">",r:10,c:[{b:"\\[",e:"\\]"}]},{cN:"comment",b:"<!--",e:"-->",r:10},{cN:"cdata",b:"<\\!\\[CDATA\\[",e:"\\]\\]>",r:10},{cN:"tag",b:"<style(?=\\s|>|$)",e:">",k:{title:{style:1}},c:[a],starts:{cN:"css",e:"</style>",rE:true,sL:"css"}},{cN:"tag",b:"<script(?=\\s|>|$)",e:">",k:{title:{script:1}},c:[a],starts:{cN:"javascript",e:"<\/script>",rE:true,sL:"javascript"}},{cN:"vbscript",b:"<%",e:"%>",sL:"vbscript"},{cN:"tag",b:"</?",e:"/?>",c:[{cN:"title",b:"[^ />]+"},a]}]}}}();
hljs.initHighlightingOnLoad();

"></script>

<style type="text/css">code{white-space: pre;}</style>
<style type="text/css">
  pre:not([class]) {
    background-color: white;
  }
</style>
<script type="text/javascript">
if (window.hljs && document.readyState && document.readyState === "complete") {
   window.setTimeout(function() {
      hljs.initHighlighting();
   }, 0);
}
</script>



<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
#rmd-source-code {
  display: none;
}
</style>


</head>

<body>

<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
.tabbed-pane {
  padding-top: 12px;
}
button.code-folding-btn:focus {
  outline: none;
}
</style>

<style type="text/css">
.kable-table {
  border: 1px solid #ccc;
  border-radius: 4px;
  overflow: auto;
  padding-left: 8px;
  padding-right: 8px;
  margin-bottom: 20px;
  max-height: 350px;
}

.kable-table table {
  margin-bottom: 0px;
}

.kable-table table>thead>tr>th {
  border: none;
  border-bottom: 2px solid #dddddd;
}

.kable-table table>thead {
  background-color: #fff;
}
</style>


<div class="container-fluid main-container">

<!-- tabsets -->
<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});
</script>

<!-- code folding -->
<style type="text/css">
.code-folding-btn { margin-bottom: 4px; }
</style>
<script>
$(document).ready(function () {
  window.initializeSourceEmbed("explore_drugspending.Rmd");
  window.initializeCodeFolding("show" === "show");
});
</script>






<div class="fluid-row" id="header">

<div class="btn-group pull-right">
<button type="button" class="btn btn-default btn-xs dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"><span>Code</span> <span class="caret"></span></button>
<ul class="dropdown-menu" style="min-width: 50px;">
<li><a id="rmd-show-all-code" href="#">Show All Code</a></li>
<li><a id="rmd-hide-all-code" href="#">Hide All Code</a></li>
<li role="separator" class="divider"></li>
<li><a id="rmd-download-source" href="#">Download Rmd</a></li>
</ul>
</div>



<h1 class="title toc-ignore">Medicare Drug Spending</h1>

</div>


<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxubGlicmFyeShmZWF0aGVyKVxubGlicmFyeSh0aWR5dmVyc2UpXG5saWJyYXJ5KGpzb25saXRlKVxuYGBgIn0= -->
<pre class="r"><code>library(feather)
library(tidyverse)
library(jsonlite)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>## -- Spending data --------------------------------------------------------------------------------
## Read in drug names (brand + generic)
drugnames &lt;- read_feather('data/drugnames.feather')
## Function to add a column with spending year to a data frame
add_drug_year &lt;- function(df, yr){
  mutate(df, drug_year = yr)
}
drug.years &lt;- 2011:2015
## Read in each year's data set, add year and drug names, and combine into a single data.frame
spending.data &lt;- map(paste0('data/spending-', drug.years, '.feather'), read_feather) %&gt;%
  map2(drug.years, add_drug_year) %&gt;%
  map(bind_cols, drugnames) %&gt;%
  bind_rows()</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuc3BlbmRpbmcuZGF0YVxuYGBgIn0= -->
<pre class="r"><code>spending.data</code></pre>
<!-- rnb-source-end -->
<!-- rnb-frame-begin {"metadata":{"classes":["tbl_df","tbl","data.frame"],"ncol":13,"nrow":22490},"rdf":"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"} -->
<div data-pagedtable>
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["claim_count"],"name":[1],"type":["dbl"],"align":["right"]},{"label":["total_spending"],"name":[2],"type":["dbl"],"align":["right"]},{"label":["user_count"],"name":[3],"type":["dbl"],"align":["right"]},{"label":["total_spending_per_user"],"name":[4],"type":["dbl"],"align":["right"]},{"label":["unit_count"],"name":[5],"type":["dbl"],"align":["right"]},{"label":["unit_cost_wavg"],"name":[6],"type":["dbl"],"align":["right"]},{"label":["user_count_non_lowincome"],"name":[7],"type":["dbl"],"align":["right"]},{"label":["out_of_pocket_avg_non_lowincome"],"name":[8],"type":["dbl"],"align":["right"]},{"label":["user_count_lowincome"],"name":[9],"type":["dbl"],"align":["right"]},{"label":["out_of_pocket_avg_lowincome"],"name":[10],"type":["dbl"],"align":["right"]},{"label":["drug_year"],"name":[11],"type":["int"],"align":["right"]},{"label":["drugname_brand"],"name":[12],"type":["chr"],"align":["left"]},{"label":["drugname_generic"],"name":[13],"type":["chr"],"align":["left"]}],"data":[{"1":"24","2":"1.569190e+03","3":"16","4":"9.807438e+01","5":"5.170000e+03","6":"3.035184e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"10 WASH","13":"SULFACETAMIDE SODIUM"},{"1":"2472","2":"5.766673e+04","3":"893","4":"6.457641e+01","5":"2.931600e+05","6":"1.967660e-01","7":"422","8":"4.234720e+01","9":"471","10":"7.54585987","11":"2011","12":"1ST TIER UNIFINE PENTIPS","13":"PEN NEEDLE, DIABETIC"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"1ST TIER UNIFINE PENTIPS PLUS","13":"PEN NEEDLE, DIABETIC"},{"1":"12","2":"3.501000e+02","3":"11","4":"3.182727e+01","5":"4.970000e+02","6":"7.044266e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"60PSE-400GFN-20DM","13":"GUAIFENESIN/DM/PSEUDOEPHEDRINE"},{"1":"11","2":"9.003260e+03","3":"NA","4":"NA","5":"2.980000e+02","6":"3.021228e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"8-MOP","13":"METHOXSALEN"},{"1":"30","2":"2.128600e+02","3":"29","4":"7.340000e+00","5":"4.510000e+02","6":"4.719734e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"A-B OTIC","13":"ANTIPYRINE/BENZOCAINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ABACAVIR","13":"ABACAVIR SULFATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ABACAVIR-LAMIVUDINE-ZIDOVUDINE","13":"ABACAVIR/LAMIVUDINE/ZIDOVUDINE"},{"1":"363","2":"4.555661e+05","3":"97","4":"4.696558e+03","5":"4.902700e+04","6":"9.292147e+00","7":"49","8":"4.020480e+02","9":"48","10":"6.41250000","11":"2011","12":"ABELCET","13":"AMPHOTERICIN B LIPID COMPLEX"},{"1":"2447965","2":"1.469661e+09","3":"360675","4":"4.074752e+03","5":"7.747481e+07","6":"1.921862e+01","7":"57408","8":"4.660259e+02","9":"303267","10":"23.08279714","11":"2011","12":"ABILIFY","13":"ARIPIPRAZOLE"},{"1":"4677","2":"3.929706e+06","3":"961","4":"4.089184e+03","5":"1.893515e+05","6":"2.075390e+01","7":"83","8":"4.398764e+02","9":"878","10":"22.16558087","11":"2011","12":"ABILIFY DISCMELT","13":"ARIPIPRAZOLE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ABILIFY MAINTENA","13":"ARIPIPRAZOLE"},{"1":"233","2":"9.507034e+05","3":"51","4":"1.864124e+04","5":"9.750000e+02","6":"9.750804e+02","7":"14","8":"1.262687e+03","9":"37","10":"4.60540541","11":"2011","12":"ABRAXANE","13":"PACLITAXEL PROTEIN-BOUND"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ABSORICA","13":"ISOTRETINOIN"},{"1":"82","2":"1.238138e+05","3":"32","4":"3.869182e+03","5":"5.458000e+03","6":"2.128904e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ABSTRAL","13":"FENTANYL CITRATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ACAMPROSATE CALCIUM","13":"ACAMPROSATE CALCIUM"},{"1":"432","2":"8.953996e+04","3":"289","4":"3.098269e+02","5":"2.160100e+04","6":"4.145166e+00","7":"134","8":"1.041386e+02","9":"155","10":"5.48451613","11":"2011","12":"ACANYA","13":"CLINDAMYCIN PHOS/BENZOYL PEROX"},{"1":"171071","2":"1.169336e+07","3":"32843","4":"3.560382e+02","5":"1.884502e+07","6":"6.200326e-01","7":"15297","8":"6.696805e+01","9":"17546","10":"7.40393366","11":"2011","12":"ACARBOSE","13":"ACARBOSE"},{"1":"21924","2":"2.619497e+06","3":"6409","4":"4.087217e+02","5":"1.436161e+06","6":"1.823579e+00","7":"2871","8":"1.797795e+02","9":"3538","10":"13.27503957","11":"2011","12":"ACCOLATE","13":"ZAFIRLUKAST"},{"1":"120","2":"7.415180e+03","3":"90","4":"8.239089e+01","5":"1.292100e+04","6":"5.736624e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ACCUNEB","13":"ALBUTEROL SULFATE"},{"1":"8052","2":"7.678249e+05","3":"1786","4":"4.299132e+02","5":"4.381766e+05","6":"1.752397e+00","7":"1259","8":"2.421045e+02","9":"527","10":"22.96529412","11":"2011","12":"ACCUPRIL","13":"QUINAPRIL HCL"},{"1":"870","2":"8.047508e+04","3":"209","4":"3.850482e+02","5":"4.682000e+04","6":"1.716690e+00","7":"145","8":"2.520863e+02","9":"64","10":"16.45843750","11":"2011","12":"ACCURETIC","13":"QUINAPRIL/HYDROCHLOROTHIAZIDE"},{"1":"889","2":"1.618152e+04","3":"326","4":"4.963656e+01","5":"7.726200e+04","6":"2.093435e-01","7":"76","8":"1.250711e+01","9":"250","10":"8.11608000","11":"2011","12":"ACCUSURE","13":"SYRING W-NDL,DISP,INSUL,0.5 ML"},{"1":"768","2":"1.354321e+04","3":"269","4":"5.034651e+01","5":"6.404600e+04","6":"2.111381e-01","7":"125","8":"1.012672e+01","9":"144","10":"9.57361111","11":"2011","12":"ACCUSURE","13":"SYRINGE AND NEEDLE,INSULIN,1ML"},{"1":"127745","2":"3.499407e+06","3":"20981","4":"1.667894e+02","5":"9.501688e+06","6":"3.698131e-01","7":"17349","8":"5.950967e+01","9":"3632","10":"12.22938877","11":"2011","12":"ACEBUTOLOL HCL","13":"ACEBUTOLOL HCL"},{"1":"2605","2":"2.878742e+05","3":"685","4":"4.202543e+02","5":"1.200940e+05","6":"2.386485e+00","7":"507","8":"2.371859e+02","9":"178","10":"18.83617978","11":"2011","12":"ACEON","13":"PERINDOPRIL ERBUMINE"},{"1":"4997","2":"4.845722e+05","3":"1582","4":"3.063035e+02","5":"3.400650e+05","6":"1.424940e+00","7":"635","8":"1.051835e+02","9":"947","10":"6.95561774","11":"2011","12":"ACETAMINOPH-CAFF-DIHYDROCODEIN","13":"DHCODEINE BT/ACETAMINOPHN/CAFF"},{"1":"2803822","2":"3.753617e+07","3":"1192417","4":"3.147906e+01","5":"1.722670e+08","6":"2.256168e-01","7":"600518","8":"1.358333e+01","9":"591899","10":"3.23540401","11":"2011","12":"ACETAMINOPHEN-CODEINE","13":"ACETAMINOPHEN WITH CODEINE"},{"1":"4607","2":"8.549517e+05","3":"3546","4":"2.411031e+02","5":"5.992600e+04","6":"1.426679e+01","7":"2050","8":"3.041462e+01","9":"1496","10":"2.88216578","11":"2011","12":"ACETASOL HC","13":"ACETIC ACID/HYDROCORTISONE"},{"1":"225803","2":"1.289488e+07","3":"73929","4":"1.744225e+02","5":"1.290460e+07","6":"1.149070e+00","7":"43674","8":"2.913826e+01","9":"30255","10":"5.02575045","11":"2011","12":"ACETAZOLAMIDE","13":"ACETAZOLAMIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ACETAZOLAMIDE SODIUM","13":"ACETAZOLAMIDE SODIUM"},{"1":"44440","2":"1.267348e+06","3":"22923","4":"5.528720e+01","5":"3.018925e+07","6":"1.186918e+00","7":"11382","8":"1.008842e+01","9":"11541","10":"1.75480981","11":"2011","12":"ACETIC ACID","13":"ACETIC ACID"},{"1":"5859","2":"3.684252e+05","3":"4271","4":"8.626204e+01","5":"3.606810e+05","6":"1.021471e+00","7":"2615","8":"1.094416e+01","9":"1656","10":"1.67549517","11":"2011","12":"ACETIC ACID-ALUMINUM","13":"ACETIC ACID/ALUMINUM ACETATE"},{"1":"35634","2":"1.555543e+06","3":"14055","4":"1.106754e+02","5":"2.464842e+06","6":"6.331998e-01","7":"5865","8":"1.512438e+01","9":"8190","10":"0.96385470","11":"2011","12":"ACETYLCYSTEINE","13":"ACETYLCYSTEINE"},{"1":"229","2":"8.237440e+03","3":"136","4":"6.056941e+01","5":"2.369000e+04","6":"3.477180e-01","7":"111","8":"2.569396e+01","9":"25","10":"2.48160000","11":"2011","12":"ACID JELLY","13":"ACETIC AC/RICINOLEIC/OXYQUINOL"},{"1":"404412","2":"1.318898e+08","3":"88282","4":"1.493960e+03","5":"1.821615e+07","6":"7.240267e+00","7":"44579","8":"3.156039e+02","9":"43703","10":"21.15239709","11":"2011","12":"ACIPHEX","13":"RABEPRAZOLE SODIUM"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ACIPHEX SPRINKLE","13":"RABEPRAZOLE SODIUM"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ACITRETIN","13":"ACITRETIN"},{"1":"61","2":"4.452640e+03","3":"48","4":"9.276333e+01","5":"2.220000e+03","6":"2.133009e+00","7":"27","8":"3.690333e+01","9":"21","10":"2.41904762","11":"2011","12":"ACLOVATE","13":"ALCLOMETASONE DIPROPIONATE"},{"1":"1611","2":"2.318580e+06","3":"223","4":"1.039722e+04","5":"5.422800e+04","6":"5.390098e+01","7":"89","8":"1.155395e+03","9":"134","10":"23.44746269","11":"2011","12":"ACTEMRA","13":"TOCILIZUMAB"},{"1":"259","2":"7.972280e+03","3":"238","4":"3.349697e+01","5":"3.725000e+02","6":"2.140209e+01","7":"190","8":"1.914726e+01","9":"48","10":"3.78250000","11":"2011","12":"ACTHIB","13":"HAEMOPH B POLY CONJ-TET TOX/PF"},{"1":"2112","2":"4.503237e+04","3":"1715","4":"2.625794e+01","5":"1.449890e+05","6":"3.105916e-01","7":"541","8":"9.435009e+00","9":"1174","10":"1.71459114","11":"2011","12":"ACTICIN","13":"PERMETHRIN"},{"1":"787","2":"4.275251e+05","3":"163","4":"2.622853e+03","5":"8.128600e+04","6":"5.259517e+00","7":"92","8":"5.556543e+02","9":"71","10":"13.38028169","11":"2011","12":"ACTIGALL","13":"URSODIOL"},{"1":"601","2":"4.338257e+06","3":"76","4":"5.708233e+04","5":"5.653500e+03","6":"7.673577e+02","7":"41","8":"3.472235e+03","9":"35","10":"26.87742857","11":"2011","12":"ACTIMMUNE","13":"INTERFERON GAMMA-1B,RECOMB."},{"1":"1118","2":"1.034995e+07","3":"158","4":"6.550600e+04","5":"1.229050e+05","6":"7.751096e+01","7":"41","8":"1.734700e+03","9":"117","10":"22.78376068","11":"2011","12":"ACTIQ","13":"FENTANYL CITRATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ACTIVE OB","13":"PNV NO.66/IRON,CARBONYL/FA/DHA"},{"1":"10536","2":"1.237659e+06","3":"2841","4":"4.356420e+02","5":"4.241941e+05","6":"2.923502e+00","7":"2141","8":"2.857272e+02","9":"700","10":"18.24158571","11":"2011","12":"ACTIVELLA","13":"ESTRADIOL/NORETHINDRONE ACET"},{"1":"1556284","2":"2.423483e+08","3":"311086","4":"7.790395e+02","5":"6.732428e+06","6":"6.143703e+01","7":"189688","8":"2.842613e+02","9":"121398","10":"23.50605982","11":"2011","12":"ACTONEL","13":"RISEDRONATE SODIUM"},{"1":"51","2":"4.818160e+03","3":"27","4":"1.784504e+02","5":"1.376000e+03","6":"3.501570e+00","7":"12","8":"4.721833e+01","9":"15","10":"12.20666667","11":"2011","12":"ACTONEL WITH CALCIUM","13":"RISEDRONATE SOD/CALCIUM CARB"},{"1":"425375","2":"1.233210e+08","3":"77250","4":"1.596388e+03","5":"3.147092e+07","6":"3.918672e+00","7":"38285","8":"3.428253e+02","9":"38965","10":"29.79346644","11":"2011","12":"ACTOPLUS MET","13":"PIOGLITAZONE HCL/METFORMIN HCL"},{"1":"6252","2":"1.845632e+06","3":"2113","4":"8.734654e+02","5":"3.605080e+05","6":"5.507746e+00","7":"1286","8":"2.604875e+02","9":"827","10":"17.54243047","11":"2011","12":"ACTOPLUS MET XR","13":"PIOGLITAZONE HCL/METFORMIN HCL"},{"1":"4484645","2":"1.294152e+09","3":"778712","4":"1.661914e+03","5":"1.845496e+08","6":"7.113681e+00","7":"376150","8":"3.389420e+02","9":"402562","10":"29.91958431","11":"2011","12":"ACTOS","13":"PIOGLITAZONE HCL"},{"1":"50","2":"4.575980e+03","3":"24","4":"1.906658e+02","5":"3.412000e+03","6":"1.341143e+00","7":"13","8":"5.379538e+01","9":"11","10":"4.75636364","11":"2011","12":"ACUFLEX","13":"ACETAMINOPHEN/PHENYLTOLX"},{"1":"3704","2":"4.524195e+05","3":"2141","4":"2.113122e+02","5":"2.169250e+04","6":"2.085603e+01","7":"1075","8":"7.878114e+01","9":"1066","10":"6.32856473","11":"2011","12":"ACULAR","13":"KETOROLAC TROMETHAMINE"},{"1":"6188","2":"7.240996e+05","3":"3663","4":"1.976794e+02","5":"3.356200e+04","6":"2.157498e+01","7":"2294","8":"8.063397e+01","9":"1369","10":"7.23235208","11":"2011","12":"ACULAR LS","13":"KETOROLAC TROMETHAMINE"},{"1":"20719","2":"3.000401e+06","3":"15153","4":"1.980071e+02","5":"7.359165e+05","6":"4.077095e+00","7":"11079","8":"7.386418e+01","9":"4074","10":"7.48627148","11":"2011","12":"ACUVAIL","13":"KETOROLAC TROMETHAMINE/PF"},{"1":"1042311","2":"2.275148e+07","3":"434279","4":"5.238909e+01","5":"6.168427e+07","6":"3.910866e-01","7":"272649","8":"1.808335e+01","9":"161630","10":"3.17152577","11":"2011","12":"ACYCLOVIR","13":"ACYCLOVIR"},{"1":"338","2":"8.535864e+04","3":"168","4":"5.080871e+02","5":"1.019469e+05","6":"9.041454e-01","7":"67","8":"6.944373e+01","9":"101","10":"1.42475248","11":"2011","12":"ACYCLOVIR SODIUM","13":"ACYCLOVIR SODIUM"},{"1":"2121","2":"5.191764e+05","3":"1158","4":"4.483388e+02","5":"9.852000e+04","6":"5.269756e+00","7":"700","8":"1.040126e+02","9":"458","10":"8.94102620","11":"2011","12":"ACZONE","13":"DAPSONE"},{"1":"119038","2":"6.021775e+06","3":"118181","4":"5.095384e+01","5":"1.120570e+05","6":"5.659874e+01","7":"97885","8":"2.555673e+01","9":"20296","10":"3.56955853","11":"2011","12":"ADACEL TDAP","13":"DIPH,PERTUSS(ACELL),TET VAC/PF"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADAGEN","13":"PEGADEMASE BOVINE"},{"1":"4725","2":"4.505338e+05","3":"968","4":"4.654274e+02","5":"2.122480e+05","6":"2.146411e+00","7":"606","8":"2.829547e+02","9":"362","10":"22.90187845","11":"2011","12":"ADALAT CC","13":"NIFEDIPINE"},{"1":"5116","2":"8.856399e+05","3":"2869","4":"3.086929e+02","5":"2.433680e+05","6":"3.641914e+00","7":"1221","8":"5.325283e+01","9":"1648","10":"2.69371359","11":"2011","12":"ADAPALENE","13":"ADAPALENE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADCETRIS","13":"BRENTUXIMAB VEDOTIN"},{"1":"25251","2":"3.148848e+07","3":"4068","4":"7.740530e+03","5":"1.536088e+06","6":"2.049914e+01","7":"2146","8":"1.198646e+03","9":"1922","10":"36.40925078","11":"2011","12":"ADCIRCA","13":"TADALAFIL"},{"1":"4952","2":"1.308013e+06","3":"1905","4":"6.866209e+02","5":"3.793670e+05","6":"3.448339e+00","7":"479","8":"2.074377e+02","9":"1426","10":"8.74518934","11":"2011","12":"ADDERALL","13":"DEXTROAMPHETAMINE/AMPHETAMINE"},{"1":"48889","2":"1.476008e+07","3":"12740","4":"1.158562e+03","5":"2.253296e+06","6":"6.555882e+00","7":"2835","8":"2.249894e+02","9":"9905","10":"14.87380919","11":"2011","12":"ADDERALL XR","13":"DEXTROAMPHETAMINE/AMPHETAMINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADEFOVIR DIPIVOXIL","13":"ADEFOVIR DIPIVOXIL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADEMPAS","13":"RIOCIGUAT"},{"1":"21","2":"1.237600e+03","3":"NA","4":"NA","5":"5.720000e+02","6":"2.174480e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADIPEX-P","13":"PHENTERMINE HCL"},{"1":"142","2":"9.547284e+04","3":"105","4":"9.092651e+02","5":"4.286000e+03","6":"2.206644e+01","7":"59","8":"1.179368e+02","9":"46","10":"3.53260870","11":"2011","12":"ADOXA","13":"DOXYCYCLINE MONOHYDRATE"},{"1":"39","2":"5.941950e+03","3":"35","4":"1.697700e+02","5":"6.700000e+01","6":"8.868582e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADRENACLICK","13":"EPINEPHRINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADRENALIN","13":"EPINEPHRINE"},{"1":"149","2":"1.098500e+03","3":"137","4":"8.018248e+00","5":"6.170000e+02","6":"3.110218e+00","7":"65","8":"7.798462e+00","9":"72","10":"1.56000000","11":"2011","12":"ADRENALIN CHLORIDE","13":"EPINEPHRINE"},{"1":"15","2":"4.170200e+02","3":"14","4":"2.978714e+01","5":"4.750000e+02","6":"8.779368e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADRENALIN CHLORIDE","13":"EPINEPHRINE HCL"},{"1":"180","2":"2.340121e+04","3":"73","4":"3.205645e+02","5":"7.872000e+03","6":"1.508708e+01","7":"36","8":"4.855278e+01","9":"37","10":"2.03189189","11":"2011","12":"ADRIAMYCIN","13":"DOXORUBICIN HCL"},{"1":"25","2":"7.280600e+02","3":"17","4":"4.282706e+01","5":"1.340000e+03","6":"5.433284e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADRUCIL","13":"FLUOROURACIL"},{"1":"6168173","2":"1.664866e+09","3":"1402405","4":"1.187150e+03","5":"4.367479e+08","6":"3.813868e+00","7":"664800","8":"2.295039e+02","9":"737605","10":"20.52186539","11":"2011","12":"ADVAIR DISKUS","13":"FLUTICASONE/SALMETEROL"},{"1":"252981","2":"6.863129e+07","3":"74061","4":"9.266860e+02","5":"3.465654e+06","6":"1.980460e+01","7":"34626","8":"1.832741e+02","9":"39435","10":"15.38708863","11":"2011","12":"ADVAIR HFA","13":"FLUTICASONE/SALMETEROL"},{"1":"22","2":"1.239380e+03","3":"NA","4":"NA","5":"3.420000e+03","6":"3.623918e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADVANCED AM/PM","13":"OM-3/CALCIUM/D3/FA/MV CMB 13"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADVANCED DNA MEDICATED COLLECT","13":"LIDOCAINE HCL/GLYCERIN"},{"1":"33250","2":"7.221494e+06","3":"7251","4":"9.959307e+02","5":"1.908640e+06","6":"3.790168e+00","7":"5810","8":"3.553087e+02","9":"1441","10":"24.76973629","11":"2011","12":"ADVICOR","13":"NIACIN/LOVASTATIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADVOCATE PEN NEEDLES","13":"PEN NEEDLE, DIABETIC"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADVOCATE SYRINGES","13":"SYRING W-NDL,DISP,INSUL,0.3 ML"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADVOCATE SYRINGES","13":"SYRING W-NDL,DISP,INSUL,0.5 ML"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ADVOCATE SYRINGES","13":"SYRINGE AND NEEDLE,INSULIN,1ML"},{"1":"149","2":"1.382485e+04","3":"123","4":"1.123972e+02","5":"1.120000e+03","6":"1.234362e+01","7":"59","8":"7.888288e+01","9":"64","10":"7.60000000","11":"2011","12":"AEROBID","13":"FLUNISOLIDE"},{"1":"61","2":"5.512420e+03","3":"50","4":"1.102484e+02","5":"4.490000e+02","6":"1.227710e+01","7":"27","8":"7.889111e+01","9":"23","10":"5.52652174","11":"2011","12":"AEROBID-M","13":"FLUNISOLIDE/MENTHOL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AEROSPAN","13":"FLUNISOLIDE"},{"1":"60897","2":"2.155902e+06","3":"13102","4":"1.645476e+02","5":"2.482808e+06","6":"8.599991e-01","7":"6900","8":"3.567217e+01","9":"6202","10":"5.93453080","11":"2011","12":"AFEDITAB CR","13":"NIFEDIPINE"},{"1":"6076","2":"4.514053e+07","3":"1573","4":"2.869710e+04","5":"1.796820e+05","6":"2.515794e+02","7":"953","8":"2.364999e+03","9":"620","10":"59.49337097","11":"2011","12":"AFINITOR","13":"EVEROLIMUS"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AFINITOR DISPERZ","13":"EVEROLIMUS"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AFREZZA","13":"INSULIN REGULAR, HUMAN"},{"1":"1089190","2":"2.709840e+08","3":"176897","4":"1.531875e+03","5":"7.895770e+07","6":"3.432015e+00","7":"101170","8":"3.820294e+02","9":"75727","10":"32.25016612","11":"2011","12":"AGGRENOX","13":"ASPIRIN/DIPYRIDAMOLE"},{"1":"354","2":"2.730113e+05","3":"69","4":"3.956686e+03","5":"4.324700e+04","6":"6.312838e+00","7":"38","8":"6.712400e+02","9":"31","10":"23.80193548","11":"2011","12":"AGRYLIN","13":"ANAGRELIDE HCL"},{"1":"11","2":"3.721000e+02","3":"NA","4":"NA","5":"2.280000e+02","6":"1.632018e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"A-HYDROCORT","13":"HYDROCORTISONE SOD SUCCINATE"},{"1":"61","2":"1.227880e+03","3":"48","4":"2.558083e+01","5":"6.660000e+03","6":"1.843664e-01","7":"24","8":"2.028542e+01","9":"24","10":"2.89041667","11":"2011","12":"AIMSCO MINI ULTRA-THIN II","13":"PEN NEEDLE, DIABETIC"},{"1":"1000","2":"2.520084e+04","3":"444","4":"5.675865e+01","5":"1.225000e+05","6":"2.056302e-01","7":"152","8":"3.211961e+01","9":"292","10":"6.17191781","11":"2011","12":"AIMSCO ULTRA THIN II","13":"PEN NEEDLE, DIABETIC"},{"1":"687","2":"8.476608e+04","3":"533","4":"1.590358e+02","5":"2.202845e+04","6":"3.848027e+00","7":"333","8":"7.313553e+01","9":"200","10":"5.01900000","11":"2011","12":"AKNE-MYCIN","13":"ERYTHROMYCIN BASE"},{"1":"11","2":"2.889300e+02","3":"NA","4":"NA","5":"3.810000e+02","6":"7.583465e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AKORN BALANCED SALT","13":"BALANCED SALT IRRIG SOLN NO.2"},{"1":"730","2":"6.893650e+03","3":"563","4":"1.224449e+01","5":"2.019000e+03","6":"3.414388e+00","7":"369","8":"7.194173e+00","9":"194","10":"1.99355670","11":"2011","12":"AK-PENTOLATE","13":"CYCLOPENTOLATE HCL"},{"1":"9012","2":"2.186122e+05","3":"5486","4":"3.984911e+01","5":"3.292388e+04","6":"6.639930e+00","7":"2496","8":"1.114073e+01","9":"2990","10":"1.36119064","11":"2011","12":"AK-POLY-BAC","13":"BACITRACIN/POLYMYXIN B SULFATE"},{"1":"12","2":"6.103600e+02","3":"NA","4":"NA","5":"4.135000e+02","6":"1.476082e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AKTEN","13":"LIDOCAINE HCL/PF"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AKYNZEO","13":"NETUPITANT/PALONOSETRON HCL"},{"1":"11","2":"1.028400e+02","3":"11","4":"9.349091e+00","5":"4.982000e+02","6":"2.189352e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALA-CORT","13":"HYDROCORTISONE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALAHIST DHC","13":"PHENYLEPHRINE HCL/DIHYDROCO BT"},{"1":"2392","2":"2.757738e+05","3":"956","4":"2.884664e+02","5":"2.618000e+04","6":"1.053376e+01","7":"444","8":"1.216668e+02","9":"512","10":"8.73371094","11":"2011","12":"ALAMAST","13":"PEMIROLAST POTASSIUM"},{"1":"91","2":"2.718200e+03","3":"62","4":"4.384194e+01","5":"2.992800e+03","6":"9.082465e-01","7":"44","8":"2.260864e+01","9":"18","10":"4.68888889","11":"2011","12":"ALA-SCALP","13":"HYDROCORTISONE"},{"1":"2072","2":"1.753495e+05","3":"1418","4":"1.236597e+02","5":"6.764400e+04","6":"2.592240e+00","7":"776","8":"3.898026e+01","9":"642","10":"5.86271028","11":"2011","12":"ALBENZA","13":"ALBENDAZOLE"},{"1":"15","2":"4.797730e+03","3":"NA","4":"NA","5":"4.130000e+03","6":"1.500576e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALBUMIN (HUMAN)","13":"ALBUMIN HUMAN"},{"1":"43","2":"2.982950e+04","3":"15","4":"1.988633e+03","5":"1.640000e+04","6":"1.818872e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALBUMINAR-25","13":"ALBUMIN HUMAN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALBUMINAR-5","13":"ALBUMIN HUMAN"},{"1":"45","2":"1.621084e+04","3":"14","4":"1.157917e+03","5":"9.895000e+03","6":"1.951059e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALBURX","13":"ALBUMIN HUMAN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALBUTEIN","13":"ALBUMIN HUMAN"},{"1":"1020652","2":"1.873415e+07","3":"298242","4":"6.281527e+01","5":"1.172817e+08","6":"1.942663e-01","7":"64973","8":"2.037415e+01","9":"233269","10":"1.11605340","11":"2011","12":"ALBUTEROL SULFATE","13":"ALBUTEROL SULFATE"},{"1":"15","2":"5.330300e+02","3":"NA","4":"NA","5":"2.250000e+02","6":"2.369022e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALCAINE","13":"PROPARACAINE HCL"},{"1":"34197","2":"1.100650e+06","3":"22196","4":"4.958778e+01","5":"1.412621e+06","6":"7.783343e-01","7":"15877","8":"1.184681e+01","9":"6319","10":"2.30799810","11":"2011","12":"ALCLOMETASONE DIPROPIONATE","13":"ALCLOMETASONE DIPROPIONATE"},{"1":"278","2":"2.833700e+03","3":"135","4":"2.099037e+01","5":"2.910000e+04","6":"9.737801e-02","7":"12","8":"3.292500e+00","9":"123","10":"2.92878049","11":"2011","12":"ALCOHOL PADS","13":"ALCOHOL ANTISEPTIC PADS"},{"1":"90422","2":"5.062065e+05","3":"29603","4":"1.709984e+01","5":"9.785478e+06","6":"5.173038e-02","7":"4977","8":"4.393936e+00","9":"24626","10":"4.15686957","11":"2011","12":"ALCOHOL PREP PADS","13":"ALCOHOL ANTISEPTIC PADS"},{"1":"4815","2":"1.737303e+04","3":"1929","4":"9.006236e+00","5":"5.353000e+05","6":"3.245475e-02","7":"451","8":"2.947938e+00","9":"1478","10":"3.67374154","11":"2011","12":"ALCOHOL PREP SWABS","13":"ALCOHOL ANTISEPTIC PADS"},{"1":"33","2":"1.272800e+02","3":"25","4":"5.091200e+00","5":"4.801000e+03","6":"2.651114e-02","7":"12","8":"1.148333e+00","9":"13","10":"2.52384615","11":"2011","12":"ALCOHOL SWAB","13":"ALCOHOL ANTISEPTIC PADS"},{"1":"88846","2":"3.386106e+05","3":"33211","4":"1.019574e+01","5":"9.806995e+06","6":"3.452745e-02","7":"5009","8":"3.517195e+00","9":"28202","10":"3.72176441","11":"2011","12":"ALCOHOL SWABS","13":"ALCOHOL ANTISEPTIC PADS"},{"1":"1836","2":"5.890670e+03","3":"655","4":"8.993389e+00","5":"2.034620e+05","6":"2.895219e-02","7":"71","8":"4.046761e+00","9":"584","10":"3.78433219","11":"2011","12":"ALCOHOL WIPES","13":"ALCOHOL ANTISEPTIC PADS"},{"1":"33","2":"2.195480e+03","3":"NA","4":"NA","5":"2.409000e+03","6":"9.113657e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALCOHOL,DEHYDRATED","13":"ETHYL ALCOHOL"},{"1":"5055","2":"4.069714e+05","3":"1318","4":"3.087795e+02","5":"2.444245e+05","6":"1.676165e+00","7":"877","8":"1.783154e+02","9":"441","10":"18.81213152","11":"2011","12":"ALDACTAZIDE","13":"SPIRONOLACT/HYDROCHLOROTHIAZID"},{"1":"3624","2":"2.924844e+05","3":"960","4":"3.046713e+02","5":"2.130020e+05","6":"1.324861e+00","7":"646","8":"1.767507e+02","9":"314","10":"13.44869427","11":"2011","12":"ALDACTONE","13":"SPIRONOLACTONE"},{"1":"3739","2":"1.333908e+06","3":"2490","4":"5.357059e+02","5":"6.100425e+04","6":"2.186582e+01","7":"1486","8":"1.053073e+02","9":"1004","10":"7.15820717","11":"2011","12":"ALDARA","13":"IMIQUIMOD"},{"1":"50","2":"3.880390e+03","3":"43","4":"9.024163e+01","5":"7.330000e+03","6":"5.293847e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALDEX D","13":"PHENYLEPHRINE/PYRILAMINE"},{"1":"79","2":"7.985340e+03","3":"58","4":"1.376783e+02","5":"3.237000e+03","6":"2.466895e+00","7":"29","8":"7.912448e+01","9":"29","10":"7.89448276","11":"2011","12":"ALDEX-CT","13":"PHENYLEPHRINE/DIPHENHYDRAMINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALDURAZYME","13":"LARONIDASE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALECENSA","13":"ALECTINIB HYDROCHLORIDE"},{"1":"9685594","2":"1.546331e+08","3":"1868915","4":"8.273952e+01","5":"6.171980e+07","6":"2.601284e+00","7":"1199715","8":"3.877450e+01","9":"669200","10":"6.96610161","11":"2011","12":"ALENDRONATE SODIUM","13":"ALENDRONATE SODIUM"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALEVEER","13":"CAPSAICIN/MENTHOL"},{"1":"89235","2":"7.817604e+06","3":"39922","4":"1.958220e+02","5":"4.324809e+06","6":"1.807618e+00","7":"30634","8":"6.396161e+01","9":"9288","10":"3.74482989","11":"2011","12":"ALFUZOSIN HCL ER","13":"ALFUZOSIN HCL"},{"1":"901","2":"4.127788e+04","3":"446","4":"9.255130e+01","5":"1.655830e+05","6":"2.492882e-01","7":"330","8":"1.550415e+01","9":"116","10":"2.68922414","11":"2011","12":"ALICLEN","13":"SALICYLIC ACID"},{"1":"343","2":"5.870240e+03","3":"152","4":"3.862000e+01","5":"1.953100e+04","6":"3.005601e-01","7":"92","8":"1.687772e+01","9":"60","10":"4.30733333","11":"2011","12":"ALI-FLEX","13":"ACETAMINOPHEN/PHENYLTOLX"},{"1":"1070","2":"4.973477e+06","3":"207","4":"2.402646e+04","5":"4.709000e+03","6":"1.749703e+03","7":"86","8":"1.494577e+03","9":"121","10":"111.68074380","11":"2011","12":"ALIMTA","13":"PEMETREXED DISODIUM"},{"1":"4343","2":"1.639900e+06","3":"3385","4":"4.844609e+02","5":"9.438800e+04","6":"2.016522e+01","7":"2101","8":"9.991209e+01","9":"1284","10":"7.63626947","11":"2011","12":"ALINIA","13":"NITAZOXANIDE"},{"1":"521","2":"9.287977e+04","3":"206","4":"4.508727e+02","5":"1.304900e+04","6":"7.117769e+00","7":"132","8":"1.468063e+02","9":"74","10":"10.88391892","11":"2011","12":"ALKERAN","13":"MELPHALAN"},{"1":"7144","2":"5.618955e+05","3":"3920","4":"1.433407e+02","5":"4.767781e+05","6":"1.867377e+00","7":"1805","8":"7.187128e+01","9":"2115","10":"6.20526241","11":"2011","12":"ALLEGRA","13":"FEXOFENADINE HCL"},{"1":"61","2":"6.668480e+03","3":"44","4":"1.515564e+02","5":"3.799000e+03","6":"1.755325e+00","7":"16","8":"5.824562e+01","9":"28","10":"8.15392857","11":"2011","12":"ALLEGRA ODT","13":"FEXOFENADINE HCL"},{"1":"2980","2":"3.360173e+05","3":"1888","4":"1.779753e+02","5":"1.594240e+05","6":"2.107696e+00","7":"767","8":"7.645209e+01","9":"1121","10":"6.67782337","11":"2011","12":"ALLEGRA-D 12 HOUR","13":"FEXOFENADINE/PSEUDOEPHEDRINE"},{"1":"7745","2":"1.059767e+06","3":"5062","4":"2.093574e+02","5":"2.483770e+05","6":"4.266768e+00","7":"1685","8":"8.023796e+01","9":"3377","10":"6.93798934","11":"2011","12":"ALLEGRA-D 24 HOUR","13":"FEXOFENADINE/PSEUDOEPHEDRINE"},{"1":"13","2":"9.852820e+03","3":"11","4":"8.957109e+02","5":"1.080000e+03","6":"9.122981e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALLERX 10","13":"PSEUDOEPHEDRIN/METHSCOP/CPM/PE"},{"1":"19","2":"1.789796e+04","3":"16","4":"1.118622e+03","5":"1.980000e+03","6":"9.039374e+00","7":"16","8":"NA","9":"0","10":"NA","11":"2011","12":"ALLERX 30","13":"PSEUDOEPHEDRIN/METHSCOP/CPM/PE"},{"1":"48","2":"2.074254e+04","3":"40","4":"5.185635e+02","5":"2.380000e+03","6":"8.715353e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALLERX DF","13":"CHLORPHENIRAMINE/METHSCOPOLAMN"},{"1":"35","2":"1.925524e+04","3":"31","4":"6.211368e+02","5":"2.460000e+03","6":"7.827333e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALLERX DF 30","13":"CHLORPHENIRAMINE/METHSCOPOLAMN"},{"1":"86","2":"3.424588e+04","3":"67","4":"5.111325e+02","5":"3.570000e+03","6":"9.592683e+00","7":"49","8":"1.084949e+02","9":"18","10":"7.21666667","11":"2011","12":"ALLERX PE","13":"CHLOR-MAL/PHENYLEPH/METHSCOP"},{"1":"6132082","2":"4.588371e+07","3":"1144203","4":"4.010103e+01","5":"3.267291e+08","6":"1.429828e-01","7":"756746","8":"2.660751e+01","9":"387457","10":"7.20775172","11":"2011","12":"ALLOPURINOL","13":"ALLOPURINOL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALMOTRIPTAN MALATE","13":"ALMOTRIPTAN MALATE"},{"1":"4781","2":"5.346972e+05","3":"2278","4":"2.347222e+02","5":"2.810000e+04","6":"1.902837e+01","7":"1289","8":"6.865929e+01","9":"989","10":"8.41602629","11":"2011","12":"ALOCRIL","13":"NEDOCROMIL SODIUM"},{"1":"1310","2":"1.409948e+05","3":"615","4":"2.292598e+02","5":"1.490500e+04","6":"9.459564e+00","7":"333","8":"1.210652e+02","9":"282","10":"7.35039007","11":"2011","12":"ALOMIDE","13":"LODOXAMIDE TROMETHAMINE"},{"1":"116","2":"1.805996e+04","3":"83","4":"2.175899e+02","5":"7.200000e+03","6":"2.508328e+00","7":"53","8":"5.629264e+01","9":"30","10":"3.09700000","11":"2011","12":"ALOQUIN","13":"IODOQUINOL/ALOE POLYSACCHAR #1"},{"1":"11302","2":"7.753494e+05","3":"2865","4":"2.706281e+02","5":"1.124370e+05","6":"6.897380e+00","7":"1683","8":"1.761135e+02","9":"1182","10":"14.87868866","11":"2011","12":"ALORA","13":"ESTRADIOL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALOSETRON HCL","13":"ALOSETRON HCL"},{"1":"2003","2":"1.458210e+06","3":"537","4":"2.715475e+03","5":"1.895000e+04","6":"7.695041e+01","7":"226","8":"2.721675e+02","9":"311","10":"17.97681672","11":"2011","12":"ALOXI","13":"PALONOSETRON HCL"},{"1":"826128","2":"9.413150e+07","3":"204217","4":"4.609386e+02","5":"7.118076e+06","6":"1.321484e+01","7":"117019","8":"1.635670e+02","9":"87198","10":"17.29271405","11":"2011","12":"ALPHAGAN P","13":"BRIMONIDINE TARTRATE"},{"1":"1305191","2":"1.185929e+07","3":"263892","4":"4.493993e+01","5":"8.280416e+07","6":"1.422564e-01","7":"208872","8":"1.685794e+01","9":"55020","10":"11.80124464","11":"2011","12":"ALPRAZOLAM","13":"ALPRAZOLAM"},{"1":"4949","2":"2.716504e+05","3":"1117","4":"2.431964e+02","5":"2.630820e+05","6":"1.044065e+00","7":"918","8":"4.448856e+01","9":"199","10":"32.34542714","11":"2011","12":"ALPRAZOLAM ER","13":"ALPRAZOLAM"},{"1":"20","2":"1.237100e+03","3":"17","4":"7.277059e+01","5":"6.000000e+02","6":"2.061833e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALPRAZOLAM INTENSOL","13":"ALPRAZOLAM"},{"1":"711","2":"7.463157e+04","3":"253","4":"2.949864e+02","5":"4.591100e+04","6":"1.608851e+00","7":"215","8":"2.910972e+01","9":"38","10":"21.85421053","11":"2011","12":"ALPRAZOLAM ODT","13":"ALPRAZOLAM"},{"1":"4081","2":"2.600414e+05","3":"929","4":"2.799154e+02","5":"2.134550e+05","6":"1.248647e+00","7":"765","8":"4.877552e+01","9":"164","10":"37.43878049","11":"2011","12":"ALPRAZOLAM XR","13":"ALPRAZOLAM"},{"1":"145","2":"1.767729e+04","3":"72","4":"2.455179e+02","5":"1.005295e+03","6":"1.758833e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALPROSTADIL","13":"ALPROSTADIL"},{"1":"92139","2":"1.208350e+07","3":"45319","4":"2.666321e+02","5":"6.043389e+05","6":"1.999457e+01","7":"23686","8":"7.789841e+01","9":"21633","10":"7.42978274","11":"2011","12":"ALREX","13":"LOTEPREDNOL ETABONATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALSUMA","13":"SUMATRIPTAN SUCCINATE"},{"1":"12484","2":"1.415411e+06","3":"8548","4":"1.655839e+02","5":"2.458465e+05","6":"5.757297e+00","7":"5010","8":"6.838043e+01","9":"3538","10":"6.58348219","11":"2011","12":"ALTABAX","13":"RETAPAMULIN"},{"1":"16484","2":"2.308918e+06","3":"3941","4":"5.858711e+02","5":"9.082130e+05","6":"2.535535e+00","7":"2594","8":"2.658413e+02","9":"1347","10":"21.36140312","11":"2011","12":"ALTACE","13":"RAMIPRIL"},{"1":"759","2":"2.412484e+04","3":"206","4":"1.171109e+02","5":"2.791600e+04","6":"8.641940e-01","7":"17","8":"3.348471e+01","9":"189","10":"3.78650794","11":"2011","12":"ALTAVERA","13":"LEVONORGESTREL-ETHIN ESTRADIOL"},{"1":"6595","2":"2.732291e+06","3":"1640","4":"1.666031e+03","5":"2.844315e+05","6":"9.619911e+00","7":"979","8":"3.556251e+02","9":"661","10":"20.91057489","11":"2011","12":"ALTOPREV","13":"LOVASTATIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALUVEA","13":"UREA"},{"1":"17466","2":"3.614502e+06","3":"5338","4":"6.771267e+02","5":"1.467204e+05","6":"2.463694e+01","7":"3549","8":"2.260618e+02","9":"1789","10":"13.84953046","11":"2011","12":"ALVESCO","13":"CICLESONIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALYACEN","13":"NORETHINDRONE-ETHINYL ESTRAD"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ALZ-NAC","13":"ACETYL/METHYL-B12/LMEFOLATE CA"},{"1":"347791","2":"1.187853e+07","3":"65005","4":"1.827326e+02","5":"2.918996e+07","6":"4.686159e-01","7":"31442","8":"5.005067e+01","9":"33563","10":"5.68909007","11":"2011","12":"AMANTADINE","13":"AMANTADINE HCL"},{"1":"9984","2":"8.655272e+05","3":"2522","4":"3.431908e+02","5":"6.421790e+05","6":"1.346205e+00","7":"1523","8":"1.527922e+02","9":"999","10":"15.77227227","11":"2011","12":"AMARYL","13":"GLIMEPIRIDE"},{"1":"40793","2":"8.160744e+06","3":"10506","4":"7.767698e+02","5":"1.405003e+06","6":"5.808288e+00","7":"5347","8":"2.073240e+02","9":"5159","10":"16.36113782","11":"2011","12":"AMBIEN","13":"ZOLPIDEM TARTRATE"},{"1":"72851","2":"1.458658e+07","3":"20332","4":"7.174198e+02","5":"2.452986e+06","6":"5.947178e+00","7":"9432","8":"2.111111e+02","9":"10900","10":"14.77618716","11":"2011","12":"AMBIEN CR","13":"ZOLPIDEM TARTRATE"},{"1":"194","2":"5.433104e+05","3":"52","4":"1.044828e+04","5":"2.228421e+04","6":"2.438096e+01","7":"26","8":"6.672319e+02","9":"26","10":"16.36730769","11":"2011","12":"AMBISOME","13":"AMPHOTERICIN B LIPOSOME"},{"1":"8578","2":"5.096258e+05","3":"4437","4":"1.148582e+02","5":"9.996653e+05","6":"5.431173e-01","7":"3159","8":"1.873251e+01","9":"1278","10":"3.51048513","11":"2011","12":"AMCINONIDE","13":"AMCINONIDE"},{"1":"1437","2":"4.508994e+05","3":"416","4":"1.083893e+03","5":"1.581800e+04","6":"2.850414e+01","7":"212","8":"2.522000e+02","9":"204","10":"13.54416667","11":"2011","12":"AMERGE","13":"NARATRIPTAN HCL"},{"1":"3862","2":"5.400603e+04","3":"2441","4":"2.212455e+01","5":"2.818013e+04","6":"2.229790e+00","7":"527","8":"8.276717e+00","9":"1914","10":"0.36075235","11":"2011","12":"A-METHAPRED","13":"METHYLPREDNISOLONE SOD SUCC"},{"1":"620","2":"1.333005e+05","3":"491","4":"2.714879e+02","5":"5.638700e+04","6":"2.364030e+00","7":"27","8":"6.933778e+01","9":"464","10":"1.89187500","11":"2011","12":"AMETHIA","13":"L-NORGEST/E.ESTRADION-E.ESTRAD"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMETHIA LO","13":"L-NORGEST/E.ESTRADION-E.ESTRAD"},{"1":"371","2":"2.405434e+04","3":"117","4":"2.055926e+02","5":"1.358000e+04","6":"1.771306e+00","7":"13","8":"5.928385e+01","9":"104","10":"4.59673077","11":"2011","12":"AMETHYST","13":"LEVONORGESTREL-ETHIN ESTRADIOL"},{"1":"93","2":"3.991781e+05","3":"22","4":"1.814446e+04","5":"3.380000e+02","6":"1.181000e+03","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMEVIVE","13":"ALEFACEPT"},{"1":"807","2":"3.666318e+05","3":"427","4":"8.586226e+02","5":"8.553000e+04","6":"4.850770e+00","7":"280","8":"1.981625e+02","9":"147","10":"5.16122449","11":"2011","12":"AMICAR","13":"AMINOCAPROIC ACID"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMIFOSTINE","13":"AMIFOSTINE CRYSTALLINE"},{"1":"6406","2":"3.309450e+05","3":"2834","4":"1.167766e+02","5":"6.476579e+05","6":"5.154975e-01","7":"498","8":"6.102861e+01","9":"2336","10":"1.07835188","11":"2011","12":"AMIKACIN SULFATE","13":"AMIKACIN SULFATE"},{"1":"68004","2":"4.176766e+06","3":"13261","4":"3.149661e+02","5":"4.521275e+06","6":"9.238027e-01","7":"8615","8":"8.131131e+01","9":"4646","10":"8.54372794","11":"2011","12":"AMILORIDE HCL","13":"AMILORIDE HCL"},{"1":"127044","2":"9.308174e+05","3":"24314","4":"3.828319e+01","5":"6.351558e+06","6":"1.465495e-01","7":"18499","8":"2.699827e+01","9":"5815","10":"9.04938951","11":"2011","12":"AMILORIDE-HYDROCHLOROTHIAZIDE","13":"AMILORIDE/HYDROCHLOROTHIAZIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMINO ACIDS","13":"PARENTERAL AMINO ACID 15% NO.1"},{"1":"5145","2":"1.295930e+06","3":"2360","4":"5.491227e+02","5":"7.843575e+05","6":"1.895381e+00","7":"1618","8":"6.575391e+01","9":"742","10":"5.94869272","11":"2011","12":"AMINOCAPROIC ACID","13":"AMINOCAPROIC ACID"},{"1":"3761","2":"3.113850e+04","3":"811","4":"3.839519e+01","5":"3.766165e+05","6":"8.395442e-02","7":"461","8":"2.000573e+01","9":"350","10":"5.73628571","11":"2011","12":"AMINOPHYLLINE","13":"AMINOPHYLLINE"},{"1":"16","2":"1.221190e+03","3":"NA","4":"NA","5":"3.995600e+04","6":"3.056337e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMINOSYN","13":"PARENTERAL AMINO ACID 10% NO.2"},{"1":"148","2":"1.761978e+04","3":"NA","4":"NA","5":"7.200091e+05","6":"2.447161e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMINOSYN II","13":"PARENTERAL AMINO ACID 10% NO.1"},{"1":"229","2":"2.091917e+04","3":"40","4":"5.229792e+02","5":"6.227827e+05","6":"3.358984e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMINOSYN II","13":"PARENTERAL AMINO ACID 15% NO.2"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMINOSYN II","13":"PARENTERAL AMINO ACID 8.5 % #3"},{"1":"1715690","2":"3.836060e+07","3":"366216","4":"1.047486e+02","5":"7.654144e+07","6":"5.018170e-01","7":"235684","8":"3.754179e+01","9":"130532","10":"6.59289883","11":"2011","12":"AMIODARONE HCL","13":"AMIODARONE HCL"},{"1":"356635","2":"8.246465e+07","3":"86063","4":"9.581894e+02","5":"2.144115e+07","6":"3.846119e+00","7":"30273","8":"1.787191e+02","9":"55790","10":"13.65318462","11":"2011","12":"AMITIZA","13":"LUBIPROSTONE"},{"1":"4077101","2":"2.318514e+07","3":"785313","4":"2.952343e+01","5":"2.212150e+08","6":"1.069816e-01","7":"397244","8":"2.060592e+01","9":"388069","10":"6.90573640","11":"2011","12":"AMITRIPTYLINE HCL","13":"AMITRIPTYLINE HCL"},{"1":"25","2":"1.460430e+03","3":"13","4":"1.123408e+02","5":"1.560000e+03","6":"9.543889e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMITRIPTYLINE-CHLORDIAZEPOXIDE","13":"AMITRIP HCL/CHLORDIAZEPOXIDE"},{"1":"27947959","2":"3.831188e+08","3":"4798488","4":"7.984158e+01","5":"1.263562e+09","6":"3.040146e-01","7":"2884071","8":"3.971457e+01","9":"1914417","10":"8.03177140","11":"2011","12":"AMLODIPINE BESYLATE","13":"AMLODIPINE BESYLATE"},{"1":"3202726","2":"2.958348e+08","3":"504870","4":"5.859622e+02","5":"1.431846e+08","6":"2.083583e+00","7":"318578","8":"1.314410e+02","9":"186292","10":"15.03331018","11":"2011","12":"AMLODIPINE BESYLATE-BENAZEPRIL","13":"AMLODIPINE BESYLATE/BENAZEPRIL"},{"1":"4852","2":"1.211925e+06","3":"4824","4":"2.512281e+02","5":"2.512000e+05","6":"4.832041e+00","7":"3624","8":"4.182938e+01","9":"1200","10":"2.60590833","11":"2011","12":"AMLODIPINE-ATORVASTATIN","13":"AMLODIPINE/ATORVASTATIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMLODIPINE-VALSARTAN","13":"AMLODIPINE/VALSARTAN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMLODIPINE-VALSARTAN-HCTZ","13":"AMLODIPINE/VALSARTAN/HCTHIAZID"},{"1":"539663","2":"1.161118e+07","3":"239147","4":"4.855249e+01","5":"1.589931e+08","6":"7.316249e-02","7":"76447","8":"9.065080e+00","9":"162700","10":"2.11235298","11":"2011","12":"AMMONIUM LACTATE","13":"AMMONIUM LACTATE"},{"1":"1215","2":"5.334342e+05","3":"448","4":"1.190701e+03","5":"5.658400e+04","6":"9.393287e+00","7":"217","8":"1.542529e+02","9":"231","10":"7.78051948","11":"2011","12":"AMNESTEEM","13":"ISOTRETINOIN"},{"1":"172349","2":"4.483974e+06","3":"145452","4":"3.082786e+01","5":"3.671345e+06","6":"1.246207e+00","7":"78267","8":"9.152869e+00","9":"67185","10":"1.59630275","11":"2011","12":"AMOX TR-POTASSIUM CLAVULANATE","13":"AMOXICILLIN/POTASSIUM CLAV"},{"1":"15233","2":"7.877111e+05","3":"2193","4":"3.591934e+02","5":"1.081728e+06","6":"7.459183e-01","7":"1166","8":"9.168540e+01","9":"1027","10":"11.64288218","11":"2011","12":"AMOXAPINE","13":"AMOXAPINE"},{"1":"4573213","2":"2.800762e+07","3":"3193300","4":"8.770745e+00","5":"1.161085e+08","6":"2.609674e-01","7":"2008704","8":"5.969676e+00","9":"1184596","10":"1.74673604","11":"2011","12":"AMOXICILLIN","13":"AMOXICILLIN"},{"1":"30456","2":"3.031311e+06","3":"24851","4":"1.219794e+02","5":"9.390160e+05","6":"3.228178e+00","7":"15465","8":"4.032379e+01","9":"9386","10":"2.81503090","11":"2011","12":"AMOXICILLIN-CLAVULANATE POT ER","13":"AMOXICILLIN/POTASSIUM CLAV"},{"1":"2345274","2":"6.390408e+07","3":"1789120","4":"3.571816e+01","5":"5.200390e+07","6":"1.331233e+00","7":"1026464","8":"1.109762e+01","9":"762656","10":"1.84336011","11":"2011","12":"AMOXICILLIN-CLAVULANATE POTASS","13":"AMOXICILLIN/POTASSIUM CLAV"},{"1":"284","2":"1.513790e+03","3":"245","4":"6.178735e+00","5":"1.510800e+04","6":"1.831319e-01","7":"93","8":"3.080430e+00","9":"152","10":"1.05078947","11":"2011","12":"AMOXIL","13":"AMOXICILLIN"},{"1":"1713","2":"6.345142e+04","3":"626","4":"1.013601e+02","5":"1.112680e+05","6":"5.746864e-01","7":"174","8":"3.459718e+01","9":"452","10":"4.72265487","11":"2011","12":"AMPHETAMINE SALT COMBO","13":"DEXTROAMPHETAMINE/AMPHETAMINE"},{"1":"2153","2":"2.948107e+05","3":"846","4":"3.484760e+02","5":"5.215092e+05","6":"5.653031e-01","7":"551","8":"9.454548e+01","9":"295","10":"4.15111864","11":"2011","12":"AMPHOTERICIN B","13":"AMPHOTERICIN B"},{"1":"6047","2":"1.157098e+06","3":"1572","4":"7.360672e+02","5":"1.064172e+06","6":"1.184999e+00","7":"655","8":"2.641839e+02","9":"917","10":"7.17189749","11":"2011","12":"AMPICILLIN SODIUM","13":"AMPICILLIN SODIUM"},{"1":"163540","2":"1.336753e+06","3":"115955","4":"1.152820e+01","5":"5.265649e+06","6":"2.658996e-01","7":"57013","8":"6.293103e+00","9":"58942","10":"1.22094381","11":"2011","12":"AMPICILLIN TRIHYDRATE","13":"AMPICILLIN TRIHYDRATE"},{"1":"7952","2":"1.051559e+06","3":"2250","4":"4.673595e+02","5":"1.430432e+06","6":"8.670788e-01","7":"495","8":"1.393372e+02","9":"1755","10":"2.85365812","11":"2011","12":"AMPICILLIN-SULBACTAM","13":"AMPICILLIN SODIUM/SULBACTAM NA"},{"1":"40470","2":"5.170647e+07","3":"7277","4":"7.105466e+03","5":"2.668262e+06","6":"1.937833e+01","7":"2290","8":"7.121025e+02","9":"4987","10":"15.18872268","11":"2011","12":"AMPYRA","13":"DALFAMPRIDINE"},{"1":"7430","2":"2.644765e+06","3":"3786","4":"6.985645e+02","5":"2.555120e+05","6":"1.035167e+01","7":"1437","8":"1.273828e+02","9":"2349","10":"11.33358450","11":"2011","12":"AMRIX","13":"CYCLOBENZAPRINE HCL"},{"1":"1979","2":"2.273945e+05","3":"713","4":"3.189264e+02","5":"7.415100e+04","6":"3.063801e+00","7":"371","8":"1.295742e+02","9":"342","10":"13.36374269","11":"2011","12":"AMTURNIDE","13":"ALISKIREN/AMLODIPIN/HCTHIAZIDE"},{"1":"27","2":"3.776100e+02","3":"15","4":"2.517400e+01","5":"5.600000e+02","6":"6.743036e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AMYL NITRITE","13":"AMYL NITRITE"},{"1":"28","2":"1.303270e+03","3":"13","4":"1.002515e+02","5":"2.235000e+03","6":"5.831186e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ANABAR","13":"SAL-AMIDE/ACETAMINOPHN/P-TLOX"},{"1":"439","2":"5.976484e+05","3":"90","4":"6.640538e+03","5":"2.365500e+04","6":"2.526520e+01","7":"20","8":"6.702555e+02","9":"70","10":"11.59885714","11":"2011","12":"ANADROL-50","13":"OXYMETHOLONE"},{"1":"448","2":"4.542383e+05","3":"66","4":"6.882398e+03","5":"3.848600e+04","6":"1.179260e+01","7":"19","8":"6.071779e+02","9":"47","10":"10.10489362","11":"2011","12":"ANAFRANIL","13":"CLOMIPRAMINE HCL"},{"1":"45018","2":"4.858907e+06","3":"7481","4":"6.494997e+02","5":"4.758871e+06","6":"1.055008e+00","7":"5395","8":"9.002209e+01","9":"2086","10":"11.76115532","11":"2011","12":"ANAGRELIDE HCL","13":"ANAGRELIDE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ANA-LEX","13":"HYDROCORTISONE/LIDOCAINE/ALOE"},{"1":"16","2":"1.561210e+03","3":"16","4":"9.757563e+01","5":"9.460000e+02","6":"1.650328e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ANALPRAM HC","13":"HYDROCORTISONE/PRAMOXINE"},{"1":"258","2":"7.316325e+04","3":"202","4":"3.621943e+02","5":"1.793000e+04","6":"7.853192e+00","7":"111","8":"8.370730e+01","9":"91","10":"5.16285714","11":"2011","12":"ANAMANTLE HC","13":"LIDOCAINE/HYDROCORTISONE AC"},{"1":"46","2":"1.015541e+04","3":"13","4":"7.811854e+02","5":"4.648000e+03","6":"2.184899e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ANAPROX","13":"NAPROXEN SODIUM"},{"1":"264","2":"6.518248e+04","3":"99","4":"6.584089e+02","5":"1.942000e+04","6":"3.356461e+00","7":"64","8":"1.495089e+02","9":"35","10":"11.68571429","11":"2011","12":"ANAPROX DS","13":"NAPROXEN SODIUM"},{"1":"2401","2":"3.353891e+04","3":"1236","4":"2.713504e+01","5":"1.636090e+05","6":"2.049943e-01","7":"794","8":"1.832698e+01","9":"442","10":"4.28278281","11":"2011","12":"ANASPAZ","13":"HYOSCYAMINE SULFATE"},{"1":"908171","2":"6.375361e+07","3":"159836","4":"3.988689e+02","5":"3.968624e+07","6":"1.606441e+00","7":"113579","8":"7.336403e+01","9":"46257","10":"11.30788032","11":"2011","12":"ANASTROZOLE","13":"ANASTROZOLE"},{"1":"180","2":"1.147423e+06","3":"86","4":"1.334213e+04","5":"2.762200e+04","6":"4.301574e+01","7":"23","8":"1.497335e+03","9":"63","10":"16.17412698","11":"2011","12":"ANCOBON","13":"FLUCYTOSINE"},{"1":"50385","2":"1.646567e+07","3":"15526","4":"1.060522e+03","5":"1.944871e+06","6":"8.595082e+00","7":"8054","8":"2.015062e+02","9":"7472","10":"14.26068790","11":"2011","12":"ANDRODERM","13":"TESTOSTERONE"},{"1":"326338","2":"1.312396e+08","3":"91249","4":"1.438258e+03","5":"6.287791e+07","6":"2.192343e+00","7":"66536","8":"2.494724e+02","9":"24713","10":"19.56979363","11":"2011","12":"ANDROGEL","13":"TESTOSTERONE"},{"1":"1149","2":"6.230228e+05","3":"321","4":"1.940881e+03","5":"5.631400e+04","6":"1.106337e+01","7":"177","8":"3.024381e+02","9":"144","10":"6.61965278","11":"2011","12":"ANDROID","13":"METHYLTESTOSTERONE"},{"1":"1703","2":"3.602587e+05","3":"482","4":"7.474247e+02","5":"9.281800e+04","6":"3.881345e+00","7":"321","8":"2.226250e+02","9":"161","10":"10.41086957","11":"2011","12":"ANDROXY","13":"FLUOXYMESTERONE"},{"1":"1376","2":"1.352556e+05","3":"332","4":"4.073964e+02","5":"5.127600e+04","6":"2.637795e+00","7":"210","8":"2.349986e+02","9":"122","10":"19.23336066","11":"2011","12":"ANGELIQ","13":"DROSPIRENONE/ESTRADIOL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ANIMI-3","13":"OM-3/DHA/EPA/D3/B12/FA/B-6/PHY"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ANIMI-3 WITH VITAMIN D","13":"OM-3/DHA/EPA/D3/B12/FA/B-6/PHY"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ANORO ELLIPTA","13":"UMECLIDINIUM BRM/VILANTEROL TR"},{"1":"13652","2":"1.766200e+06","3":"4272","4":"4.134364e+02","5":"4.448922e+05","6":"4.031616e+00","7":"1268","8":"1.197891e+02","9":"3004","10":"7.88632490","11":"2011","12":"ANTABUSE","13":"DISULFIRAM"},{"1":"64695","2":"1.238141e+07","3":"12729","4":"9.726929e+02","5":"2.650719e+06","6":"4.676830e+00","7":"6028","8":"3.142154e+02","9":"6701","10":"22.49693180","11":"2011","12":"ANTARA","13":"FENOFIBRATE,MICRONIZED"},{"1":"27612","2":"3.249968e+05","3":"24087","4":"1.349262e+01","5":"3.549252e+05","6":"9.156768e-01","7":"13554","8":"5.533043e+00","9":"10533","10":"1.51190354","11":"2011","12":"ANTIPYRINE-BENZOCAINE","13":"ANTIPYRINE/BENZOCAINE"},{"1":"419","2":"3.873310e+04","3":"232","4":"1.669530e+02","5":"2.224800e+04","6":"1.741935e+00","7":"117","8":"9.046282e+01","9":"115","10":"7.39695652","11":"2011","12":"ANTIVERT","13":"MECLIZINE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ANUCORT-HC","13":"HYDROCORTISONE ACETATE"},{"1":"862","2":"7.153428e+04","3":"565","4":"1.266093e+02","5":"2.897275e+04","6":"2.469019e+00","7":"231","8":"5.085606e+01","9":"334","10":"2.13149701","11":"2011","12":"ANUSOL-HC","13":"HYDROCORTISONE"},{"1":"682","2":"6.436260e+05","3":"241","4":"2.670647e+03","5":"1.198750e+04","6":"4.784403e+01","7":"127","8":"1.641084e+02","9":"114","10":"5.51140351","11":"2011","12":"ANZEMET","13":"DOLASETRON MESYLATE"},{"1":"4068","2":"9.273393e+05","3":"2661","4":"3.484928e+02","5":"2.254150e+05","6":"4.113920e+00","7":"1785","8":"6.289898e+01","9":"876","10":"3.34222603","11":"2011","12":"APEXICON E","13":"DIFLORASONE DIACETATE/EMOLL"},{"1":"131","2":"2.769050e+03","3":"105","4":"2.637190e+01","5":"6.940000e+02","6":"3.989986e+00","7":"50","8":"1.679180e+01","9":"55","10":"2.77272727","11":"2011","12":"APHTHASOL","13":"AMLEXANOX"},{"1":"50388","2":"1.009576e+07","3":"13821","4":"7.304651e+02","5":"1.051323e+06","6":"9.604859e+00","7":"6510","8":"2.019998e+02","9":"7311","10":"14.84784845","11":"2011","12":"APIDRA","13":"INSULIN GLULISINE"},{"1":"40282","2":"1.007351e+07","3":"13449","4":"7.490156e+02","5":"8.234500e+05","6":"1.223330e+01","7":"7147","8":"1.980857e+02","9":"6302","10":"15.59932085","11":"2011","12":"APIDRA SOLOSTAR","13":"INSULIN GLULISINE"},{"1":"4640","2":"1.647034e+06","3":"970","4":"1.697973e+03","5":"1.582910e+05","6":"1.050189e+01","7":"383","8":"3.468390e+02","9":"587","10":"18.16829642","11":"2011","12":"APLENZIN","13":"BUPROPION HBR"},{"1":"930","2":"3.253667e+06","3":"246","4":"1.322629e+04","5":"5.812100e+04","6":"5.598093e+01","7":"128","8":"1.261008e+03","9":"118","10":"21.29567797","11":"2011","12":"APOKYN","13":"APOMORPHINE HCL"},{"1":"5468","2":"5.632459e+05","3":"1653","4":"3.407416e+02","5":"3.855200e+04","6":"1.461003e+01","7":"1072","8":"7.679382e+01","9":"581","10":"6.75320138","11":"2011","12":"APRACLONIDINE HCL","13":"APRACLONIDINE HCL"},{"1":"17416","2":"4.572061e+05","3":"2791","4":"1.638144e+02","5":"6.141340e+05","6":"7.444729e-01","7":"210","8":"6.223124e+01","9":"2581","10":"7.16239442","11":"2011","12":"APRI","13":"DESOGESTREL-ETHINYL ESTRADIOL"},{"1":"35798","2":"9.801215e+06","3":"7359","4":"1.331868e+03","5":"4.852828e+06","6":"2.019691e+00","7":"5110","8":"3.291797e+02","9":"2249","10":"27.41728768","11":"2011","12":"APRISO","13":"MESALAMINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"APTIOM","13":"ESLICARBAZEPINE ACETATE"},{"1":"4110","2":"4.579842e+06","3":"479","4":"9.561256e+03","5":"5.056060e+05","6":"9.058124e+00","7":"132","8":"7.226809e+02","9":"347","10":"15.06337176","11":"2011","12":"APTIVUS","13":"TIPRANAVIR"},{"1":"15","2":"1.703805e+04","3":"NA","4":"NA","5":"4.455000e+03","6":"3.824478e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"APTIVUS","13":"TIPRANAVIR/VITAMIN E TPGS"},{"1":"3822","2":"2.343706e+07","3":"260","4":"9.014252e+04","5":"5.065530e+07","6":"4.628229e-01","7":"99","8":"5.871217e+03","9":"161","10":"69.78900621","11":"2011","12":"ARALAST NP","13":"ALPHA-1-PROTEINASE INHIBITOR"},{"1":"21","2":"1.921430e+03","3":"NA","4":"NA","5":"2.960000e+02","6":"6.491318e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARALEN PHOSPHATE","13":"CHLOROQUINE PHOSPHATE"},{"1":"669","2":"2.485001e+04","3":"99","4":"2.510102e+02","5":"2.382800e+04","6":"1.042891e+00","7":"12","8":"6.166667e+01","9":"87","10":"7.81034483","11":"2011","12":"ARANELLE","13":"NORETHINDRONE-ETHINYL ESTRAD"},{"1":"15","2":"1.454380e+04","3":"NA","4":"NA","5":"1.660000e+01","6":"1.020134e+03","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARANESP","13":"DARBEPOETIN ALFA IN ALBUMN SOL"},{"1":"80290","2":"7.241106e+07","3":"15260","4":"4.745155e+03","5":"7.008209e+04","6":"1.142325e+03","7":"3563","8":"5.758538e+02","9":"11697","10":"13.49689664","11":"2011","12":"ARANESP","13":"DARBEPOETIN ALFA IN POLYSORBAT"},{"1":"8305","2":"6.343994e+06","3":"3344","4":"1.897127e+03","5":"3.091835e+05","6":"2.051557e+01","7":"1361","8":"1.778830e+02","9":"1983","10":"10.60738275","11":"2011","12":"ARAVA","13":"LEFLUNOMIDE"},{"1":"1256","2":"4.739408e+04","3":"849","4":"5.582342e+01","5":"7.648000e+04","6":"6.422537e-01","7":"381","8":"1.373861e+01","9":"468","10":"2.40279915","11":"2011","12":"ARBINOXA","13":"CARBINOXAMINE MALEATE"},{"1":"116","2":"2.485874e+06","3":"13","4":"1.912211e+05","5":"4.800000e+02","6":"5.178904e+03","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARCALYST","13":"RILONACEPT"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARCAPTA NEOHALER","13":"INDACATEROL MALEATE"},{"1":"1394","2":"8.250310e+05","3":"1362","4":"6.057496e+02","5":"2.782800e+04","6":"2.964751e+01","7":"1235","8":"9.322221e+01","9":"127","10":"11.99921260","11":"2011","12":"ARESTIN","13":"MINOCYCLINE HCL MICROSPHERES"},{"1":"527378","2":"1.461742e+08","3":"155748","4":"9.385300e+02","5":"1.815720e+07","6":"8.051604e+00","7":"68257","8":"2.456676e+02","9":"87491","10":"14.06363843","11":"2011","12":"ARICEPT","13":"DONEPEZIL HCL"},{"1":"5920","2":"1.529608e+06","3":"2006","4":"7.625165e+02","5":"1.857210e+05","6":"8.236028e+00","7":"617","8":"1.883488e+02","9":"1389","10":"5.20508999","11":"2011","12":"ARICEPT ODT","13":"DONEPEZIL HCL"},{"1":"39615","2":"2.005907e+07","3":"8677","4":"2.311752e+03","5":"1.538773e+06","6":"1.303576e+01","7":"4483","8":"3.989406e+02","9":"4194","10":"24.94182642","11":"2011","12":"ARIMIDEX","13":"ANASTROZOLE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARIPIPRAZOLE","13":"ARIPIPRAZOLE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARIPIPRAZOLE ODT","13":"ARIPIPRAZOLE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARISTADA","13":"ARIPIPRAZOLE LAUROXIL"},{"1":"50","2":"6.875440e+03","3":"32","4":"2.148575e+02","5":"1.753000e+03","6":"8.436704e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARISTOSPAN","13":"TRIAMCINOLONE HEXACETONIDE"},{"1":"40847","2":"5.750353e+07","3":"19725","4":"2.915261e+03","5":"3.406769e+05","6":"1.589625e+02","7":"11641","8":"2.315696e+02","9":"8084","10":"13.85740228","11":"2011","12":"ARIXTRA","13":"FONDAPARINUX SODIUM"},{"1":"199116","2":"2.066347e+06","3":"40901","4":"5.052071e+01","5":"1.273336e+07","6":"1.668992e-01","7":"32062","8":"4.569838e+01","9":"8839","10":"16.16783120","11":"2011","12":"ARMOUR THYROID","13":"THYROID,PORK"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARNUITY ELLIPTA","13":"FLUTICASONE FUROATE"},{"1":"49887","2":"2.370311e+07","3":"14571","4":"1.626732e+03","5":"1.878562e+06","6":"1.261769e+01","7":"9149","8":"3.038587e+02","9":"5422","10":"24.94527850","11":"2011","12":"AROMASIN","13":"EXEMESTANE"},{"1":"46552","2":"8.993669e+06","3":"15715","4":"5.722984e+02","5":"3.210701e+06","6":"2.801154e+00","7":"8425","8":"2.115140e+02","9":"7290","10":"15.01519342","11":"2011","12":"ARTHROTEC 50","13":"DICLOFENAC SODIUM/MISOPROSTOL"},{"1":"106034","2":"2.019236e+07","3":"30968","4":"6.520394e+02","5":"7.235150e+06","6":"2.790869e+00","7":"17249","8":"2.582055e+02","9":"13719","10":"16.79611050","11":"2011","12":"ARTHROTEC 75","13":"DICLOFENAC SODIUM/MISOPROSTOL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ARZERRA","13":"OFATUMUMAB"},{"1":"367076","2":"1.474134e+08","3":"73691","4":"2.000426e+03","5":"8.070210e+07","6":"1.826636e+00","7":"49779","8":"3.873420e+02","9":"23912","10":"30.96224281","11":"2011","12":"ASACOL","13":"MESALAMINE"},{"1":"41664","2":"2.005057e+07","3":"12190","4":"1.644837e+03","5":"5.488333e+06","6":"3.653307e+00","7":"8800","8":"3.415265e+02","9":"3390","10":"23.29850737","11":"2011","12":"ASACOL HD","13":"MESALAMINE"},{"1":"35015","2":"2.332572e+06","3":"7116","4":"3.277926e+02","5":"2.695023e+06","6":"8.655111e-01","7":"4417","8":"8.828286e+01","9":"2699","10":"12.33300852","11":"2011","12":"ASCOMP WITH CODEINE","13":"CODEINE/BUTALBITAL/ASA/CAFFEIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ASHLYNA","13":"L-NORGEST/E.ESTRADION-E.ESTRAD"},{"1":"225313","2":"4.165080e+07","3":"66852","4":"6.230300e+02","5":"9.775374e+04","6":"4.424691e+02","7":"38936","8":"1.678788e+02","9":"27916","10":"14.66141926","11":"2011","12":"ASMANEX","13":"MOMETASONE FUROATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ASMANEX HFA","13":"MOMETASONE FUROATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ASPIRIN-CAFFEINE-DIHYDROCODEIN","13":"DIHYDROCODEINE/ASPIRIN/CAFFEIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ASPIRIN-DIPYRIDAMOLE ER","13":"ASPIRIN/DIPYRIDAMOLE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ASSURE ID INSULIN SAFETY","13":"SYRINGE,NEEDLE,INSULN,SAFE,1ML"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ASSURE ID INSULIN SAFETY","13":"SYRINGE,NEEDLE,INSULN,SF 0.5ML"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ASTAGRAF XL","13":"TACROLIMUS"},{"1":"25969","2":"3.190517e+06","3":"12370","4":"2.579238e+02","5":"9.027782e+05","6":"3.534109e+00","7":"6236","8":"9.090964e+01","9":"6134","10":"6.47857026","11":"2011","12":"ASTELIN","13":"AZELASTINE HCL"},{"1":"175354","2":"1.905437e+07","3":"91129","4":"2.090922e+02","5":"5.868002e+06","6":"3.247104e+00","7":"60978","8":"7.574632e+01","9":"30151","10":"8.12486452","11":"2011","12":"ASTEPRO","13":"AZELASTINE HCL"},{"1":"35","2":"4.179120e+03","3":"14","4":"2.985086e+02","5":"2.333000e+03","6":"2.633731e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ASTRAMORPH-PF","13":"MORPHINE SULFATE/PF"},{"1":"13","2":"1.636900e+02","3":"NA","4":"NA","5":"3.900000e+02","6":"4.197179e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ATABEX EC","13":"PNV COMB.NO43/IRON,CARB/FA/DSS"},{"1":"201506","2":"2.330481e+07","3":"44150","4":"5.278552e+02","5":"8.848525e+06","6":"2.645165e+00","7":"31864","8":"2.794894e+02","9":"12286","10":"23.84192089","11":"2011","12":"ATACAND","13":"CANDESARTAN CILEXETIL"},{"1":"64901","2":"8.898964e+06","3":"14140","4":"6.293468e+02","5":"2.846257e+06","6":"3.128551e+00","7":"10632","8":"3.026935e+02","9":"3508","10":"26.44055017","11":"2011","12":"ATACAND HCT","13":"CANDESARTAN/HYDROCHLOROTHIAZID"},{"1":"95580","2":"1.300142e+07","3":"34577","4":"3.760135e+02","5":"4.684406e+05","6":"2.775467e+01","7":"13764","8":"1.383279e+02","9":"20813","10":"9.21256907","11":"2011","12":"ATELVIA","13":"RISEDRONATE SODIUM"},{"1":"13977090","2":"1.063617e+08","3":"2465351","4":"4.314262e+01","5":"8.169391e+08","6":"1.305171e-01","7":"1691088","8":"2.878088e+01","9":"774263","10":"8.23335104","11":"2011","12":"ATENOLOL","13":"ATENOLOL"},{"1":"758267","2":"6.681725e+06","3":"135750","4":"4.922081e+01","5":"3.578518e+07","6":"1.869754e-01","7":"92262","8":"3.134886e+01","9":"43488","10":"9.43880013","11":"2011","12":"ATENOLOL-CHLORTHALIDONE","13":"ATENOLOL/CHLORTHALIDONE"},{"1":"2185","2":"5.482405e+05","3":"494","4":"1.109799e+03","5":"1.840510e+05","6":"3.002957e+00","7":"475","8":"2.610577e+02","9":"19","10":"402.81000000","11":"2011","12":"ATIVAN","13":"LORAZEPAM"},{"1":"730402","2":"1.241706e+08","3":"704841","4":"1.761683e+02","5":"3.226325e+07","6":"3.854438e+00","7":"462526","8":"4.582579e+01","9":"242315","10":"2.13554349","11":"2011","12":"ATORVASTATIN CALCIUM","13":"ATORVASTATIN CALCIUM"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ATOVAQUONE","13":"ATOVAQUONE"},{"1":"4032","2":"6.646506e+05","3":"3914","4":"1.698137e+02","5":"1.138920e+05","6":"5.835075e+00","7":"3686","8":"5.229925e+01","9":"228","10":"2.28140351","11":"2011","12":"ATOVAQUONE-PROGUANIL HCL","13":"ATOVAQUONE/PROGUANIL HCL"},{"1":"16","2":"2.245100e+02","3":"16","4":"1.403187e+01","5":"1.870000e+02","6":"1.200588e+00","7":"0","8":"NA","9":"16","10":"0.43125000","11":"2011","12":"ATRACURIUM BESYLATE","13":"ATRACURIUM BESYLATE"},{"1":"844","2":"1.811453e+05","3":"633","4":"2.861695e+02","5":"3.993000e+04","6":"4.536571e+00","7":"451","8":"8.841796e+01","9":"182","10":"7.23890110","11":"2011","12":"ATRALIN","13":"TRETINOIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"ATRAPRO DERMAL SPRAY","13":"HYPOC ACID/SOD HYPO/NACL/WATER"},{"1":"225063","2":"3.914440e+08","3":"26665","4":"1.468007e+04","5":"7.067292e+06","6":"5.538812e+01","7":"3959","8":"1.725432e+03","9":"22706","10":"42.76447018","11":"2011","12":"ATRIPLA","13":"EFAVIRENZ/EMTRICITAB/TENOFOVIR"},{"1":"767","2":"7.672140e+03","3":"607","4":"1.263944e+01","5":"2.761000e+03","6":"2.778754e+00","7":"387","8":"6.381628e+00","9":"220","10":"0.88772727","11":"2011","12":"ATROPINE CARE","13":"ATROPINE SULFATE"},{"1":"49405","2":"9.981756e+05","3":"31673","4":"3.151503e+01","5":"4.231175e+05","6":"2.392163e+00","7":"16985","8":"9.557320e+00","9":"14688","10":"1.22590754","11":"2011","12":"ATROPINE SULFATE","13":"ATROPINE SULFATE"},{"1":"257","2":"3.136490e+03","3":"146","4":"2.148281e+01","5":"7.950000e+02","6":"3.945270e+00","7":"73","8":"9.669726e+00","9":"73","10":"0.97342466","11":"2011","12":"ATROPINE SULFATE","13":"ATROPINE SULFATE/PF"},{"1":"970","2":"9.889394e+04","3":"470","4":"2.104126e+02","5":"2.616700e+04","6":"4.029270e+00","7":"315","8":"1.087917e+02","9":"155","10":"5.45019355","11":"2011","12":"ATROVENT","13":"IPRATROPIUM BROMIDE"},{"1":"413830","2":"8.445756e+07","3":"123677","4":"6.828881e+02","5":"6.679005e+06","6":"1.264523e+01","7":"53109","8":"1.624168e+02","9":"70568","10":"16.14314817","11":"2011","12":"ATROVENT HFA","13":"IPRATROPIUM BROMIDE"},{"1":"21","2":"1.654770e+03","3":"20","4":"8.273850e+01","5":"3.003000e+03","6":"5.510390e-01","7":"20","8":"NA","9":"0","10":"NA","11":"2011","12":"ATUSS DS","13":"CHLORPHEN/PSEUDOEPH/DM TANNATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AUBAGIO","13":"TERIFLUNOMIDE"},{"1":"1669","2":"2.132488e+05","3":"1381","4":"1.544162e+02","5":"1.239610e+05","6":"4.182693e+00","7":"488","8":"6.456689e+01","9":"893","10":"3.29873460","11":"2011","12":"AUGMENTIN","13":"AMOXICILLIN/POTASSIUM CLAV"},{"1":"1302","2":"1.546679e+05","3":"1022","4":"1.513385e+02","5":"4.242800e+04","6":"3.645421e+00","7":"479","8":"7.563363e+01","9":"543","10":"5.55600368","11":"2011","12":"AUGMENTIN XR","13":"AMOXICILLIN/POTASSIUM CLAV"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AURAX","13":"ANTIPYRINE/BENZOCAINE"},{"1":"363","2":"4.031180e+03","3":"307","4":"1.313088e+01","5":"3.694600e+03","6":"1.091101e+00","7":"112","8":"7.108839e+00","9":"195","10":"1.21528205","11":"2011","12":"AURODEX","13":"ANTIPYRINE/BENZOCAINE"},{"1":"20","2":"2.471500e+02","3":"16","4":"1.544688e+01","5":"3.000000e+02","6":"8.238333e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AURODEX EAR DROPS","13":"ANTIPYRINE/BENZOCAINE"},{"1":"547","2":"6.844650e+03","3":"473","4":"1.447072e+01","5":"8.099530e+03","6":"8.450676e-01","7":"273","8":"3.077363e+00","9":"200","10":"1.54870000","11":"2011","12":"AUROGUARD","13":"ANTIPYRINE/BENZOCAINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AURYXIA","13":"FERRIC CITRATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AUTOSHIELD DUO PEN NEEDLE","13":"PEN NEEDLE,DUAL SAFETY,DIABETC"},{"1":"25091","2":"1.271065e+06","3":"8335","4":"1.524973e+02","5":"2.412265e+06","6":"5.269285e-01","7":"1537","8":"8.303142e+01","9":"6798","10":"2.39677699","11":"2011","12":"AUTOSHIELD PEN NEEDLE","13":"PEN NEEDLE, DIABETIC, SAFETY"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AUVI-Q","13":"EPINEPHRINE"},{"1":"12","2":"2.431540e+03","3":"NA","4":"NA","5":"3.600000e+02","6":"6.754278e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AVAGE","13":"TAZAROTENE"},{"1":"16","2":"7.187600e+02","3":"NA","4":"NA","5":"1.200000e+03","6":"5.989667e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AVAILNEX","13":"CARBOCYSTEINE"},{"1":"242647","2":"3.457098e+07","3":"70636","4":"4.894243e+02","5":"1.066439e+07","6":"3.245657e+00","7":"52704","8":"1.748516e+02","9":"17932","10":"19.35465815","11":"2011","12":"AVALIDE","13":"IRBESARTAN/HYDROCHLOROTHIAZIDE"},{"1":"73653","2":"1.605403e+07","3":"16297","4":"9.850910e+02","5":"5.007603e+06","6":"3.208828e+00","7":"9120","8":"2.349101e+02","9":"7177","10":"26.34010171","11":"2011","12":"AVANDAMET","13":"ROSIGLITAZONE/METFORMIN HCL"},{"1":"22620","2":"4.717011e+06","3":"4761","4":"9.907607e+02","5":"1.024479e+06","6":"4.615269e+00","7":"2689","8":"2.352765e+02","9":"2072","10":"30.18297297","11":"2011","12":"AVANDARYL","13":"ROSIGLITAZONE/GLIMEPIRIDE"},{"1":"161604","2":"3.478229e+07","3":"36133","4":"9.626183e+02","5":"7.238526e+06","6":"4.946250e+00","7":"17231","8":"2.532792e+02","9":"18902","10":"23.02425034","11":"2011","12":"AVANDIA","13":"ROSIGLITAZONE MALEATE"},{"1":"1196248","2":"1.515340e+08","3":"233818","4":"6.480851e+02","5":"5.134321e+07","6":"2.956727e+00","7":"174759","8":"2.385556e+02","9":"59059","10":"28.14181920","11":"2011","12":"AVAPRO","13":"IRBESARTAN"},{"1":"11","2":"1.514240e+03","3":"NA","4":"NA","5":"1.767600e+03","6":"1.640245e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AVAR","13":"SULFACETAMIDE SODIUM/SULFUR"},{"1":"32","2":"4.576420e+03","3":"25","4":"1.830568e+02","5":"1.620000e+03","6":"2.824951e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AVAR-E","13":"SULFACETAMIDE SODIUM/SULFUR"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AVAR-E LS","13":"SULFACETAMIDE SODIUM/SULFUR"},{"1":"2945","2":"1.350518e+07","3":"671","4":"2.012695e+04","5":"8.957436e+04","6":"1.507707e+02","7":"247","8":"8.749119e+02","9":"424","10":"51.85408019","11":"2011","12":"AVASTIN","13":"BEVACIZUMAB"},{"1":"385","2":"5.168452e+04","3":"279","4":"1.852492e+02","5":"4.682400e+04","6":"1.103804e+00","7":"164","8":"4.804152e+01","9":"115","10":"4.92147826","11":"2011","12":"AVC","13":"SULFANILAMIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AVEED","13":"TESTOSTERONE UNDECANOATE"},{"1":"625538","2":"8.636538e+07","3":"495326","4":"1.743607e+02","5":"5.150919e+06","6":"1.676698e+01","7":"275738","8":"5.487715e+01","9":"219588","10":"5.32372142","11":"2011","12":"AVELOX","13":"MOXIFLOXACIN HCL"},{"1":"9636","2":"1.272061e+06","3":"8169","4":"1.557181e+02","5":"7.561000e+04","6":"1.682398e+01","7":"3492","8":"4.966308e+01","9":"4677","10":"4.59206543","11":"2011","12":"AVELOX ABC PACK","13":"MOXIFLOXACIN HCL"},{"1":"1996","2":"3.285820e+05","3":"1141","4":"2.879772e+02","5":"2.138109e+06","6":"1.536788e-01","7":"162","8":"1.102051e+02","9":"979","10":"2.39552605","11":"2011","12":"AVELOX IV","13":"MOXIFLOXACIN IN NACL (ISO-OSM)"},{"1":"21437","2":"6.122335e+05","3":"3642","4":"1.681037e+02","5":"7.194230e+05","6":"8.510063e-01","7":"345","8":"4.814017e+01","9":"3297","10":"7.35496209","11":"2011","12":"AVIANE","13":"LEVONORGESTREL-ETHIN ESTRADIOL"},{"1":"61978","2":"2.440658e+07","3":"8741","4":"2.792196e+03","5":"2.560443e+06","6":"9.156164e+00","7":"3200","8":"4.492900e+02","9":"5541","10":"35.79887024","11":"2011","12":"AVINZA","13":"MORPHINE SULFATE"},{"1":"179","2":"1.049322e+04","3":"104","4":"1.008963e+02","5":"6.810000e+03","6":"1.497568e+00","7":"67","8":"2.979463e+01","9":"37","10":"1.83513514","11":"2011","12":"AVITA","13":"TRETINOIN"},{"1":"1631984","2":"2.529732e+08","3":"300083","4":"8.430108e+02","5":"6.899748e+07","6":"3.666412e+00","7":"200809","8":"2.700937e+02","9":"99274","10":"25.87386506","11":"2011","12":"AVODART","13":"DUTASTERIDE"},{"1":"96310","2":"3.166700e+08","3":"10953","4":"2.891171e+04","5":"4.071178e+05","6":"7.778356e+02","7":"3931","8":"2.792146e+03","9":"7022","10":"75.22741099","11":"2011","12":"AVONEX","13":"INTERFERON BETA-1A"},{"1":"9992","2":"3.243823e+07","3":"1361","4":"2.383412e+04","5":"4.159949e+04","6":"7.797748e+02","7":"431","8":"2.318489e+03","9":"930","10":"54.45367742","11":"2011","12":"AVONEX ADMINISTRATION PACK","13":"INTERFERON BETA-1A/ALBUMIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AVONEX PEN","13":"INTERFERON BETA-1A"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AVYCAZ","13":"CEFTAZIDIME/AVIBACTAM"},{"1":"5504","2":"1.539378e+06","3":"1554","4":"9.905905e+02","5":"6.166600e+04","6":"2.496333e+01","7":"737","8":"2.436336e+02","9":"817","10":"15.33462668","11":"2011","12":"AXERT","13":"ALMOTRIPTAN MALATE"},{"1":"42","2":"1.666936e+04","3":"13","4":"1.282258e+03","5":"2.038900e+04","6":"1.297625e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AXID","13":"NIZATIDINE"},{"1":"2457","2":"7.825283e+05","3":"1454","4":"5.381900e+02","5":"2.459788e+05","6":"3.181284e+00","7":"1016","8":"1.378357e+02","9":"438","10":"10.23267123","11":"2011","12":"AXIRON","13":"TESTOSTERONE"},{"1":"2238","2":"1.944044e+05","3":"652","4":"2.981662e+02","5":"9.052100e+04","6":"2.147616e+00","7":"575","8":"2.462874e+02","9":"77","10":"191.30909091","11":"2011","12":"AXONA","13":"NUT.TX, METAB.DIS, MV & MIN #2"},{"1":"161","2":"1.620033e+04","3":"59","4":"2.745819e+02","5":"5.493000e+03","6":"2.949268e+00","7":"39","8":"1.649310e+02","9":"20","10":"13.78000000","11":"2011","12":"AYGESTIN","13":"NORETHINDRONE ACETATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AZACITIDINE","13":"AZACITIDINE"},{"1":"1690","2":"8.362152e+05","3":"785","4":"1.065242e+03","5":"1.056672e+05","6":"9.232912e+00","7":"175","8":"2.576762e+02","9":"610","10":"3.77539344","11":"2011","12":"AZACTAM","13":"AZTREONAM"},{"1":"1862","2":"7.646515e+05","3":"661","4":"1.156810e+03","5":"8.003915e+05","6":"9.221410e-01","7":"105","8":"3.185197e+02","9":"556","10":"5.26178058","11":"2011","12":"AZACTAM-ISO-OSMOTIC DEXTROSE","13":"AZTREONAM/DEXTROSE-WATER"},{"1":"2054","2":"4.364855e+05","3":"391","4":"1.116331e+03","5":"1.030470e+05","6":"4.288568e+00","7":"225","8":"4.318702e+02","9":"166","10":"10.89873494","11":"2011","12":"AZASAN","13":"AZATHIOPRINE"},{"1":"199721","2":"2.070760e+07","3":"99697","4":"2.077053e+02","5":"6.185151e+05","6":"3.347954e+01","7":"59703","8":"7.253853e+01","9":"39994","10":"8.00132345","11":"2011","12":"AZASITE","13":"AZITHROMYCIN"},{"1":"329488","2":"1.104584e+07","3":"58600","4":"1.884956e+02","5":"2.822643e+07","6":"3.913298e-01","7":"36874","8":"5.527734e+01","9":"21726","10":"8.75112124","11":"2011","12":"AZATHIOPRINE","13":"AZATHIOPRINE"},{"1":"418278","2":"3.952594e+07","3":"184412","4":"2.143350e+02","5":"1.245869e+07","6":"4.706362e+00","7":"108155","8":"5.311192e+01","9":"76257","10":"3.71455643","11":"2011","12":"AZELASTINE HCL","13":"AZELASTINE HCL"},{"1":"3338","2":"7.762414e+05","3":"1873","4":"4.144375e+02","5":"1.385110e+05","6":"5.604186e+00","7":"1179","8":"9.825131e+01","9":"694","10":"7.72142651","11":"2011","12":"AZELEX","13":"AZELAIC ACID"},{"1":"154212","2":"6.836401e+07","3":"27934","4":"2.447341e+03","5":"6.031930e+06","6":"1.133484e+01","7":"21083","8":"5.083575e+02","9":"6851","10":"34.63775361","11":"2011","12":"AZILECT","13":"RASAGILINE MESYLATE"},{"1":"7082555","2":"9.967539e+07","3":"4968615","4":"2.006100e+01","5":"4.612221e+07","6":"2.267107e+00","7":"2956489","8":"9.331856e+00","9":"2012126","10":"1.92915689","11":"2011","12":"AZITHROMYCIN","13":"AZITHROMYCIN"},{"1":"19","2":"2.349330e+03","3":"15","4":"1.566220e+02","5":"3.411000e+03","6":"1.061264e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AZITHROMYCIN","13":"AZITHROMYCIN HYDROGEN CITRATE"},{"1":"33","2":"5.100790e+03","3":"28","4":"1.821711e+02","5":"7.000000e+02","6":"7.286843e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"AZMACORT","13":"TRIAMCINOLONE ACETONIDE"},{"1":"480765","2":"5.887336e+07","3":"125064","4":"4.707459e+02","5":"5.562816e+06","6":"1.058337e+01","7":"76304","8":"1.778865e+02","9":"48760","10":"17.49971801","11":"2011","12":"AZOPT","13":"BRINZOLAMIDE"},{"1":"324824","2":"4.921395e+07","3":"63280","4":"7.777173e+02","5":"1.279484e+07","6":"3.847511e+00","7":"37678","8":"2.813173e+02","9":"25602","10":"26.62013319","11":"2011","12":"AZOR","13":"AMLODIPINE BES/OLMESARTAN MED"},{"1":"3236","2":"1.965179e+06","3":"1353","4":"1.452461e+03","5":"3.533342e+05","6":"6.102201e+00","7":"331","8":"4.038941e+02","9":"1022","10":"5.36543053","11":"2011","12":"AZTREONAM","13":"AZTREONAM"},{"1":"1596","2":"1.895473e+05","3":"419","4":"4.523802e+02","5":"2.949380e+05","6":"6.429125e-01","7":"324","8":"2.402292e+02","9":"95","10":"12.17621053","11":"2011","12":"AZULFIDINE","13":"SULFASALAZINE"},{"1":"3947","2":"2.152505e+05","3":"782","4":"2.752564e+02","5":"1.477530e+05","6":"1.456826e+00","7":"83","8":"7.107084e+01","9":"699","10":"6.86230329","11":"2011","12":"AZURETTE","13":"DESOG-E.ESTRADIOL/E.ESTRADIOL"},{"1":"305","2":"5.213292e+04","3":"40","4":"1.303323e+03","5":"4.855110e+05","6":"1.073774e-01","7":"16","8":"2.573075e+02","9":"24","10":"13.13750000","11":"2011","12":"BACIIM","13":"BACITRACIN"},{"1":"86744","2":"4.665373e+06","3":"58374","4":"7.992210e+01","5":"1.073087e+06","6":"1.444764e+01","7":"35122","8":"1.419369e+01","9":"23252","10":"1.93825907","11":"2011","12":"BACITRACIN","13":"BACITRACIN"},{"1":"36760","2":"9.352569e+05","3":"25394","4":"3.682984e+01","5":"1.349210e+05","6":"6.931887e+00","7":"16126","8":"1.084844e+01","9":"9268","10":"1.79199072","11":"2011","12":"BACITRACIN-POLYMYXIN","13":"BACITRACIN/POLYMYXIN B SULFATE"},{"1":"1894114","2":"2.975104e+07","3":"380777","4":"7.813245e+01","5":"1.892672e+08","6":"1.545696e-01","7":"136864","8":"2.343793e+01","9":"243913","10":"5.08594179","11":"2011","12":"BACLOFEN","13":"BACLOFEN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BACMIN","13":"MULTIVIT, MIN CMB#20/IRON/FA"},{"1":"75","2":"3.208070e+03","3":"26","4":"1.233873e+02","5":"2.215000e+03","6":"1.448339e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BACTRIM","13":"SULFAMETHOXAZOLE/TRIMETHOPRIM"},{"1":"889","2":"6.347807e+04","3":"586","4":"1.083244e+02","5":"2.428700e+04","6":"2.613665e+00","7":"357","8":"5.437521e+01","9":"229","10":"4.58545852","11":"2011","12":"BACTRIM DS","13":"SULFAMETHOXAZOLE/TRIMETHOPRIM"},{"1":"1209","2":"1.235306e+05","3":"815","4":"1.515713e+02","5":"6.054232e+04","6":"2.040401e+00","7":"460","8":"5.603715e+01","9":"355","10":"3.65746479","11":"2011","12":"BACTROBAN","13":"MUPIROCIN"},{"1":"145930","2":"1.222243e+07","3":"100669","4":"1.214121e+02","5":"4.256857e+06","6":"2.871233e+00","7":"49789","8":"5.075913e+01","9":"50880","10":"5.35512028","11":"2011","12":"BACTROBAN","13":"MUPIROCIN CALCIUM"},{"1":"23925","2":"2.505804e+06","3":"20248","4":"1.237557e+02","5":"2.833607e+05","6":"8.843162e+00","7":"10053","8":"4.793993e+01","9":"10195","10":"3.58728985","11":"2011","12":"BACTROBAN NASAL","13":"MUPIROCIN CALCIUM"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BAL-CARE DHA","13":"PNV81/SOD IRON EDTA& PS/FA/OM3"},{"1":"56513","2":"8.211571e+06","3":"12009","4":"6.837848e+02","5":"1.636819e+07","6":"5.016787e-01","7":"9616","8":"1.862286e+02","9":"2393","10":"14.21463435","11":"2011","12":"BALSALAZIDE DISODIUM","13":"BALSALAZIDE DISODIUM"},{"1":"6050","2":"2.386825e+05","3":"923","4":"2.585942e+02","5":"1.939880e+05","6":"1.230398e+00","7":"76","8":"8.051171e+01","9":"847","10":"8.11094451","11":"2011","12":"BALZIVA","13":"NORETHINDRONE-ETHINYL ESTRAD"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BAND-AID GAUZE PADS","13":"GAUZE BANDAGE"},{"1":"15955","2":"1.447213e+07","3":"1627","4":"8.894979e+03","5":"2.413018e+06","6":"6.013403e+00","7":"47","8":"8.251734e+02","9":"1580","10":"13.61320886","11":"2011","12":"BANZEL","13":"RUFINAMIDE"},{"1":"44275","2":"3.959674e+07","3":"6047","4":"6.548162e+03","5":"1.491382e+06","6":"2.720691e+01","7":"1491","8":"9.747453e+02","9":"4556","10":"28.30756146","11":"2011","12":"BARACLUDE","13":"ENTECAVIR"},{"1":"11","2":"4.486300e+02","3":"NA","4":"NA","5":"2.480000e+03","6":"1.808992e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BAYCADRON","13":"DEXAMETHASONE"},{"1":"163","2":"7.765924e+04","3":"91","4":"8.533982e+02","5":"6.670000e+02","6":"1.164306e+02","7":"69","8":"1.871564e+02","9":"22","10":"17.72409091","11":"2011","12":"BCG (TICE STRAIN)","13":"BCG LIVE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BCG VACCINE (TICE STRAIN)","13":"BCG VACCINE, LIVE/PF"},{"1":"62","2":"1.254170e+03","3":"27","4":"4.645074e+01","5":"5.575000e+03","6":"2.249632e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BD INSULIN SYRINGE","13":"SYRINGE AND NEEDLE,INSULIN,1ML"},{"1":"38","2":"8.012600e+02","3":"28","4":"2.861643e+01","5":"3.260000e+03","6":"2.457853e-01","7":"11","8":"1.804727e+01","9":"17","10":"3.89235294","11":"2011","12":"BD INSULIN SYRINGE MICRO-FINE","13":"SYRING W-NDL,DISP,INSUL,0.3 ML"},{"1":"322","2":"7.067460e+03","3":"162","4":"4.362630e+01","5":"2.807700e+04","6":"2.517171e-01","7":"31","8":"1.425355e+01","9":"131","10":"6.52610687","11":"2011","12":"BD INSULIN SYRINGE MICRO-FINE","13":"SYRING W-NDL,DISP,INSUL,0.5 ML"},{"1":"76","2":"1.311440e+03","3":"46","4":"2.850957e+01","5":"5.211000e+03","6":"2.516676e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BD INSULIN SYRINGE MICRO-FINE","13":"SYRINGE AND NEEDLE,INSULIN,1ML"},{"1":"116","2":"3.034740e+03","3":"82","4":"3.700902e+01","5":"1.192000e+04","6":"2.545923e-01","7":"40","8":"2.856550e+01","9":"42","10":"6.24976190","11":"2011","12":"BD INSULIN SYRINGE ULT-FINE II","13":"SYRING W-NDL,DISP,INSUL,0.3 ML"},{"1":"105","2":"2.729300e+03","3":"73","4":"3.738767e+01","5":"1.092000e+04","6":"2.499359e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BD INSULIN SYRINGE ULT-FINE II","13":"SYRING W-NDL,DISP,INSUL,0.5 ML"},{"1":"203","2":"5.093310e+03","3":"138","4":"3.690804e+01","5":"2.018000e+04","6":"2.523940e-01","7":"44","8":"2.593205e+01","9":"94","10":"6.64617021","11":"2011","12":"BD INSULIN SYRINGE ULT-FINE II","13":"SYRINGE AND NEEDLE,INSULIN,1ML"},{"1":"71","2":"1.640200e+03","3":"50","4":"3.280400e+01","5":"6.624000e+03","6":"2.476147e-01","7":"18","8":"2.882167e+01","9":"32","10":"5.40843750","11":"2011","12":"BD INSULIN SYRINGE ULTRA-FINE","13":"SYRING W-NDL,DISP,INSUL,0.3 ML"},{"1":"45","2":"1.025820e+03","3":"30","4":"3.419400e+01","5":"4.050000e+03","6":"2.532889e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BD INSULIN SYRINGE ULTRA-FINE","13":"SYRING W-NDL,DISP,INSUL,0.5 ML"},{"1":"247","2":"1.050140e+03","3":"89","4":"1.179933e+01","5":"2.588800e+04","6":"4.056474e-02","7":"17","8":"3.732353e+00","9":"72","10":"4.18958333","11":"2011","12":"B-D SINGLE USE ALCOHOL SWAB","13":"ALCOHOL ANTISEPTIC PADS"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BD ULTRA-FINE II","13":"LANCETS"},{"1":"1779985","2":"6.549858e+07","3":"576588","4":"1.135969e+02","5":"2.162408e+08","6":"3.029337e-01","7":"279127","8":"6.638102e+01","9":"297461","10":"9.93122248","11":"2011","12":"BD ULTRA-FINE PEN NEEDLE","13":"PEN NEEDLE, DIABETIC"},{"1":"9291","2":"1.600995e+06","3":"3843","4":"4.166002e+02","5":"2.877510e+05","6":"5.563819e+00","7":"2608","8":"1.434628e+02","9":"1235","10":"10.30111741","11":"2011","12":"BECONASE AQ","13":"BECLOMETHASONE DIPROPIONATE"},{"1":"313","2":"5.608360e+03","3":"189","4":"2.967386e+01","5":"1.718800e+04","6":"3.262951e-01","7":"130","8":"7.423385e+00","9":"59","10":"4.09322034","11":"2011","12":"BE-FLEX PLUS","13":"SAL-AMIDE/ACETAMINOPHN/P-TLOX"},{"1":"1333","2":"6.720018e+05","3":"745","4":"9.020158e+02","5":"3.162603e+04","6":"2.111630e+01","7":"491","8":"6.509621e+01","9":"254","10":"3.73015748","11":"2011","12":"BELLADONNA-OPIUM","13":"OPIUM/BELLADONNA ALKALOIDS"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BELSOMRA","13":"SUVOREXANT"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BELVIQ","13":"LORCASERIN HCL"},{"1":"3239291","2":"3.651528e+07","3":"561090","4":"6.507919e+01","5":"1.685804e+08","6":"2.169076e-01","7":"349138","8":"3.461729e+01","9":"211952","10":"7.71181409","11":"2011","12":"BENAZEPRIL HCL","13":"BENAZEPRIL HCL"},{"1":"21","2":"2.038100e+02","3":"NA","4":"NA","5":"7.800000e+02","6":"2.569495e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENAZEPRIL HCL-HCTZ","13":"BENAZEPRIL/HYDROCHLOROTHIAZIDE"},{"1":"628977","2":"1.143138e+07","3":"110140","4":"1.037895e+02","5":"3.401343e+07","6":"3.365045e-01","7":"76391","8":"4.792395e+01","9":"33749","10":"9.82012237","11":"2011","12":"BENAZEPRIL-HYDROCHLOROTHIAZIDE","13":"BENAZEPRIL/HYDROCHLOROTHIAZIDE"},{"1":"1607769","2":"2.109555e+08","3":"318694","4":"6.619375e+02","5":"6.778688e+07","6":"3.119325e+00","7":"204715","8":"2.703863e+02","9":"113979","10":"26.01128199","11":"2011","12":"BENICAR","13":"OLMESARTAN MEDOXOMIL"},{"1":"1030256","2":"1.440560e+08","3":"202727","4":"7.105909e+02","5":"4.310252e+07","6":"3.342654e+00","7":"132310","8":"2.795138e+02","9":"70417","10":"28.54428888","11":"2011","12":"BENICAR HCT","13":"OLMESARTAN/HYDROCHLOROTHIAZIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENLYSTA","13":"BELIMUMAB"},{"1":"37","2":"5.759560e+03","3":"30","4":"1.919853e+02","5":"5.420000e+02","6":"1.062649e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENSAL HP","13":"BENZOIC ACID/SALICYLIC ACID"},{"1":"38","2":"1.645804e+04","3":"24","4":"6.857517e+02","5":"1.886600e+03","6":"8.723651e+00","7":"12","8":"3.925000e+01","9":"12","10":"1.96666667","11":"2011","12":"BENSAL HP","13":"SALICYLIC ACID"},{"1":"1554","2":"9.415244e+04","3":"622","4":"1.513705e+02","5":"2.375200e+05","6":"1.408192e+00","7":"424","8":"7.978057e+01","9":"198","10":"8.97803030","11":"2011","12":"BENTYL","13":"DICYCLOMINE HCL"},{"1":"3193","2":"5.177612e+05","3":"1821","4":"2.843280e+02","5":"1.410676e+05","6":"3.712616e+00","7":"542","8":"9.318446e+01","9":"1279","10":"5.70009382","11":"2011","12":"BENZACLIN","13":"CLINDAMYCIN PHOS/BENZOYL PEROX"},{"1":"78","2":"1.503225e+04","3":"54","4":"2.783750e+02","5":"3.681200e+03","6":"4.083519e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENZAMYCIN","13":"ERYTHROMYCIN/BENZOYL PEROXIDE"},{"1":"119","2":"1.687129e+04","3":"73","4":"2.311136e+02","5":"7.579600e+03","6":"2.225881e+00","7":"11","8":"9.991636e+01","9":"62","10":"5.51580645","11":"2011","12":"BENZAMYCINPAK","13":"ERYTHROMYCIN/BENZOYL PEROXIDE"},{"1":"18","2":"3.789760e+03","3":"12","4":"3.158133e+02","5":"1.500000e+03","6":"2.526507e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENZEFOAM","13":"BENZOYL PEROXIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENZEFOAM ULTRA","13":"BENZOYL PEROXIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENZEPRO","13":"BENZOYL PEROXIDE"},{"1":"62684","2":"1.015217e+06","3":"44568","4":"2.277905e+01","5":"2.661009e+06","6":"3.878590e-01","7":"39018","8":"9.046502e+00","9":"5550","10":"6.56980000","11":"2011","12":"BENZONATATE","13":"BENZONATATE"},{"1":"20","2":"4.789400e+02","3":"18","4":"2.660778e+01","5":"3.000000e+02","6":"1.596467e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENZOTIC","13":"BENZOCAINE"},{"1":"7471","2":"1.920086e+05","3":"3586","4":"5.354394e+01","5":"1.113953e+06","6":"2.380843e-01","7":"1112","8":"1.151693e+01","9":"2474","10":"2.44869846","11":"2011","12":"BENZOYL PEROXIDE","13":"BENZOYL PEROXIDE"},{"1":"38","2":"4.162260e+03","3":"27","4":"1.541578e+02","5":"2.565000e+03","6":"1.995911e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENZOYL PEROXIDE","13":"BENZOYL PEROXIDE MICROSPHERES"},{"1":"100","2":"5.845670e+03","3":"65","4":"8.993338e+01","5":"1.060000e+02","6":"5.506044e+01","7":"27","8":"1.852444e+01","9":"38","10":"2.13052632","11":"2011","12":"BENZOYL PEROXIDE","13":"BENZOYL PEROXIDE&SKIN CLEANSR5"},{"1":"70","2":"4.448000e+03","3":"42","4":"1.059048e+02","5":"2.850300e+04","6":"1.849133e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENZOYL PEROXIDE","13":"BENZOYL PEROXIDE/UREA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BENZPHETAMINE HCL","13":"BENZPHETAMINE HCL"},{"1":"2265226","2":"1.809074e+07","3":"291012","4":"6.216492e+01","5":"1.184315e+08","6":"1.926740e-01","7":"34061","8":"2.669206e+01","9":"256951","10":"6.89844433","11":"2011","12":"BENZTROPINE MESYLATE","13":"BENZTROPINE MESYLATE"},{"1":"39381","2":"5.790688e+06","3":"21137","4":"2.739598e+02","5":"3.096007e+05","6":"1.870373e+01","7":"7640","8":"7.891958e+01","9":"13497","10":"6.16757502","11":"2011","12":"BEPREVE","13":"BEPOTASTINE BESILATE"},{"1":"227","2":"4.194214e+06","3":"32","4":"1.310692e+05","5":"2.125000e+03","6":"1.973748e+03","7":"17","8":"5.504192e+03","9":"15","10":"3.48000000","11":"2011","12":"BERINERT","13":"C1 ESTERASE INHIBITOR"},{"1":"89386","2":"7.467909e+06","3":"67767","4":"1.101998e+02","5":"4.550505e+05","6":"1.641117e+01","7":"48895","8":"5.757346e+01","9":"18872","10":"6.38735958","11":"2011","12":"BESIVANCE","13":"BESIFLOXACIN HCL"},{"1":"66","2":"8.487800e+02","3":"49","4":"1.732204e+01","5":"1.694000e+03","6":"5.010508e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BETADINE","13":"POVIDONE-IODINE"},{"1":"1069","2":"6.226746e+04","3":"384","4":"1.621548e+02","5":"1.106500e+04","6":"5.627425e+00","7":"247","8":"1.406214e+02","9":"137","10":"8.10306569","11":"2011","12":"BETAGAN","13":"LEVOBUNOLOL HCL"},{"1":"678","2":"2.741430e+04","3":"542","4":"5.057989e+01","5":"5.911000e+03","6":"4.637845e+00","7":"150","8":"1.505367e+01","9":"392","10":"0.88813776","11":"2011","12":"BETAMETHASONE ACETATE-SOD PHOS","13":"BETAMET ACET/BETAMET NA PH"},{"1":"342767","2":"1.694307e+07","3":"185278","4":"9.144675e+01","5":"1.766899e+07","6":"9.778454e-01","7":"116093","8":"1.307818e+01","9":"69185","10":"2.67671995","11":"2011","12":"BETAMETHASONE DIPROPIONATE","13":"BETAMETHASONE DIPROPIONATE"},{"1":"212952","2":"1.360792e+07","3":"124190","4":"1.095734e+02","5":"1.070936e+07","6":"1.264445e+00","7":"79498","8":"1.628108e+01","9":"44692","10":"2.71237626","11":"2011","12":"BETAMETHASONE DIPROPIONATE","13":"BETAMETHASONE/PROPYLENE GLYC"},{"1":"188820","2":"4.289353e+06","3":"106088","4":"4.043203e+01","5":"9.824249e+06","6":"4.453493e-01","7":"68056","8":"1.026080e+01","9":"38032","10":"2.52670146","11":"2011","12":"BETAMETHASONE VALERATE","13":"BETAMETHASONE VALERATE"},{"1":"2449","2":"7.924076e+05","3":"433","4":"1.830041e+03","5":"2.002120e+05","6":"3.940515e+00","7":"319","8":"4.995988e+02","9":"114","10":"30.82526316","11":"2011","12":"BETAPACE","13":"SOTALOL HCL"},{"1":"1694","2":"5.102295e+05","3":"289","4":"1.765500e+03","5":"1.353220e+05","6":"3.766066e+00","7":"223","8":"5.502680e+02","9":"66","10":"21.47742424","11":"2011","12":"BETAPACE AF","13":"SOTALOL HCL"},{"1":"47873","2":"1.559813e+08","3":"5830","4":"2.675495e+04","5":"6.906930e+05","6":"2.258328e+02","7":"1042","8":"2.190532e+03","9":"4788","10":"21.74544904","11":"2011","12":"BETASERON","13":"INTERFERON BETA-1B"},{"1":"15978","2":"1.375766e+05","3":"12063","4":"1.140484e+01","5":"8.258097e+05","6":"1.678047e-01","7":"8160","8":"7.158189e+00","9":"3903","10":"2.05512426","11":"2011","12":"BETA-VAL","13":"BETAMETHASONE VALERATE"},{"1":"44155","2":"2.831357e+06","3":"10017","4":"2.826552e+02","5":"1.157198e+06","6":"4.871226e+00","7":"7791","8":"6.466425e+01","9":"2226","10":"7.13990117","11":"2011","12":"BETAXOLOL HCL","13":"BETAXOLOL HCL"},{"1":"215514","2":"1.480727e+07","3":"46306","4":"3.197699e+02","5":"2.035602e+07","6":"7.253264e-01","7":"24245","8":"6.919641e+01","9":"22061","10":"6.12510856","11":"2011","12":"BETHANECHOL CHLORIDE","13":"BETHANECHOL CHLORIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BETHKIS","13":"TOBRAMYCIN"},{"1":"71088","2":"5.873224e+06","3":"21081","4":"2.786027e+02","5":"5.902550e+05","6":"9.939818e+00","7":"15559","8":"1.802703e+02","9":"5522","10":"18.21048714","11":"2011","12":"BETIMOL","13":"TIMOLOL"},{"1":"69170","2":"1.134197e+07","3":"16829","4":"6.739536e+02","5":"8.564166e+05","6":"1.324351e+01","7":"10604","8":"2.758428e+02","9":"6225","10":"19.42513253","11":"2011","12":"BETOPTIC S","13":"BETAXOLOL HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BEXAROTENE","13":"BEXAROTENE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BEXSERO","13":"MENINGOCOCCAL B VACC,4-COMP/PF"},{"1":"434","2":"3.768234e+04","3":"201","4":"1.874743e+02","5":"1.377600e+04","6":"2.735361e+00","7":"21","8":"1.639814e+02","9":"180","10":"7.76255556","11":"2011","12":"BEYAZ","13":"DROSPIR/ETH ESTRA/LEVOMEFOL CA"},{"1":"995","2":"1.524968e+05","3":"676","4":"2.255870e+02","5":"3.275700e+04","6":"5.341472e+00","7":"395","8":"7.317970e+01","9":"281","10":"5.06398577","11":"2011","12":"BIAXIN","13":"CLARITHROMYCIN"},{"1":"515","2":"7.939214e+04","3":"289","4":"2.747133e+02","5":"1.304800e+04","6":"6.084621e+00","7":"196","8":"1.003112e+02","9":"93","10":"6.65795699","11":"2011","12":"BIAXIN XL","13":"CLARITHROMYCIN"},{"1":"283275","2":"2.153589e+07","3":"64519","4":"3.337915e+02","5":"1.122278e+07","6":"1.918944e+00","7":"46030","8":"5.485061e+01","9":"18489","10":"8.36793120","11":"2011","12":"BICALUTAMIDE","13":"BICALUTAMIDE"},{"1":"1481","2":"1.221225e+05","3":"1005","4":"1.215149e+02","5":"5.450000e+03","6":"2.239706e+01","7":"908","8":"2.363170e+01","9":"97","10":"4.19670103","11":"2011","12":"BICILLIN C-R","13":"PEN G BENZ/PEN G PROCAINE"},{"1":"4547","2":"9.232579e+05","3":"2402","4":"3.843705e+02","5":"3.403080e+04","6":"2.710188e+01","7":"927","8":"9.770028e+01","9":"1475","10":"6.58943051","11":"2011","12":"BICILLIN L-A","13":"PENICILLIN G BENZATHINE"},{"1":"56","2":"1.752209e+04","3":"23","4":"7.618300e+02","5":"1.852800e+04","6":"9.457087e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BICNU","13":"CARMUSTINE"},{"1":"48612","2":"9.048338e+06","3":"10537","4":"8.587205e+02","5":"4.475327e+06","6":"2.021827e+00","7":"3191","8":"2.127625e+02","9":"7346","10":"21.93095154","11":"2011","12":"BIDIL","13":"ISOSORB DINIT/HYDRALAZINE HCL"},{"1":"102","2":"7.591030e+03","3":"43","4":"1.765356e+02","5":"5.550000e+03","6":"1.367753e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BIFERA RX","13":"IRON POLYSAC/IRON HEME/FA/B12"},{"1":"593","2":"7.863190e+04","3":"419","4":"1.876656e+02","5":"5.933000e+03","6":"1.325331e+01","7":"227","8":"6.031709e+01","9":"192","10":"6.60692708","11":"2011","12":"BILTRICIDE","13":"PRAZIQUANTEL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BIMATOPROST","13":"BIMATOPROST"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BINOSTO","13":"ALENDRONATE SODIUM"},{"1":"512039","2":"2.048225e+07","3":"92404","4":"2.216597e+02","5":"2.399501e+07","6":"8.526394e-01","7":"65217","8":"6.094703e+01","9":"27187","10":"9.57582153","11":"2011","12":"BISOPROLOL FUMARATE","13":"BISOPROLOL FUMARATE"},{"1":"491","2":"4.877160e+03","3":"159","4":"3.067396e+01","5":"1.623100e+04","6":"2.995128e-01","7":"91","8":"1.055242e+01","9":"68","10":"4.00764706","11":"2011","12":"BISOPROLOL FUMARATE-HCTZ","13":"BISOPROLOL FUMARATE/HCTZ"},{"1":"889705","2":"1.125609e+07","3":"152331","4":"7.389229e+01","5":"4.630950e+07","6":"2.430483e-01","7":"116973","8":"3.891804e+01","9":"35358","10":"10.68879603","11":"2011","12":"BISOPROLOL-HYDROCHLOROTHIAZIDE","13":"BISOPROLOL FUMARATE/HCTZ"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BIVIGAM","13":"IMMUN GLOB G (IGG)/GLY/IGA 50+"},{"1":"16","2":"1.636960e+03","3":"NA","4":"NA","5":"2.600000e+01","6":"6.255342e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BLEOMYCIN SULFATE","13":"BLEOMYCIN SULFATE"},{"1":"745","2":"1.257453e+04","3":"625","4":"2.011925e+01","5":"4.375000e+03","6":"2.874178e+00","7":"384","8":"1.636456e+01","9":"241","10":"2.72643154","11":"2011","12":"BLEPH-10","13":"SULFACETAMIDE SODIUM"},{"1":"16935","2":"1.255636e+06","3":"11404","4":"1.101049e+02","5":"1.110270e+05","6":"1.130928e+01","7":"7174","8":"5.837934e+01","9":"4230","10":"6.01539243","11":"2011","12":"BLEPHAMIDE","13":"SULFACETM NA/PREDNISOL AC"},{"1":"14222","2":"8.974709e+05","3":"10145","4":"8.846436e+01","5":"5.141219e+04","6":"1.745638e+01","7":"6753","8":"4.088487e+01","9":"3392","10":"3.20763561","11":"2011","12":"BLEPHAMIDE S.O.P.","13":"SULFACETM NA/PREDNISOL AC"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BLINCYTO","13":"BLINATUMOMAB"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"B-NEXA","13":"PNV/FA/B6/CALCIUM PHOS/GINGER"},{"1":"1371590","2":"2.278119e+08","3":"276841","4":"8.228980e+02","5":"1.917740e+06","6":"1.183751e+02","7":"154907","8":"2.681914e+02","9":"121934","10":"22.65426116","11":"2011","12":"BONIVA","13":"IBANDRONATE SODIUM"},{"1":"4480","2":"3.077474e+05","3":"4466","4":"6.890896e+01","5":"3.745983e+03","6":"8.215398e+01","7":"3548","8":"3.323497e+01","9":"918","10":"3.45668845","11":"2011","12":"BOOSTRIX","13":"DIPHTH,PERTUSS(ACELL),TET VAC"},{"1":"6823","2":"3.905836e+05","3":"6794","4":"5.748949e+01","5":"4.158410e+03","6":"9.382937e+01","7":"4464","8":"3.658508e+01","9":"2330","10":"2.86821888","11":"2011","12":"BOOSTRIX TDAP","13":"DIPHTH,PERTUSS(ACELL),TET VAC"},{"1":"47","2":"2.340420e+03","3":"31","4":"7.549742e+01","5":"2.820000e+03","6":"8.299362e-01","7":"14","8":"4.928571e+00","9":"17","10":"1.92941176","11":"2011","12":"BOROFAIR","13":"ACETIC ACID/ALUMINUM ACETATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BOSULIF","13":"BOSUTINIB"},{"1":"5587","2":"6.611011e+06","3":"3021","4":"2.188352e+03","5":"1.171300e+04","6":"5.841860e+02","7":"1294","8":"3.771507e+02","9":"1727","10":"14.69133179","11":"2011","12":"BOTOX","13":"ONABOTULINUMTOXINA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BOTOX COSMETIC","13":"ONABOTULINUMTOXINA"},{"1":"122","2":"9.336700e+03","3":"68","4":"1.373044e+02","5":"2.198250e+04","6":"4.247333e-01","7":"54","8":"2.062870e+01","9":"14","10":"4.25714286","11":"2011","12":"BP 10-1","13":"SULFACETAMIDE SODIUM/SULFUR"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BP WASH","13":"BENZOYL PEROXIDE"},{"1":"73","2":"1.077136e+04","3":"35","4":"3.077531e+02","5":"2.181800e+04","6":"4.936914e-01","7":"16","8":"1.811437e+01","9":"19","10":"2.77894737","11":"2011","12":"BP-50% UREA","13":"UREA/LACTIC AC/ZN UNDECYLENATE"},{"1":"69","2":"1.272700e+02","3":"56","4":"2.272679e+00","5":"2.280000e+03","6":"5.582018e-02","7":"21","8":"9.347619e-01","9":"35","10":"0.09028571","11":"2011","12":"B-PLEX","13":"FOLIC ACID/VIT BCOMP,C"},{"1":"81","2":"2.183800e+02","3":"45","4":"4.852889e+00","5":"2.429000e+03","6":"8.990531e-02","7":"26","8":"2.278846e+00","9":"19","10":"0.28736842","11":"2011","12":"B-PLEX PLUS","13":"MULTIVITS,THERAP W-FE,HEMATIN"},{"1":"122","2":"1.771290e+03","3":"109","4":"1.625037e+01","5":"5.203000e+03","6":"3.404363e-01","7":"65","8":"8.855385e+00","9":"44","10":"2.28545455","11":"2011","12":"BPM","13":"BROMPHENIRAMINE MALEATE"},{"1":"2148","2":"3.062044e+04","3":"1760","4":"1.739798e+01","5":"7.587000e+04","6":"4.035909e-01","7":"1054","8":"1.634755e+01","9":"706","10":"2.74932011","11":"2011","12":"BPM PSEUDO","13":"BROMPHENIRAMIN/PSEUDOEPHEDRINE"},{"1":"171","2":"1.750723e+04","3":"115","4":"1.522368e+02","5":"7.721600e+03","6":"2.730382e+00","7":"48","8":"2.004854e+01","9":"67","10":"2.13805970","11":"2011","12":"BPO","13":"BENZOYL PEROXIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BREO ELLIPTA","13":"FLUTICASONE/VILANTEROL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BREVICON","13":"NORETHINDRONE-ETHINYL ESTRAD"},{"1":"100","2":"4.144290e+03","3":"41","4":"1.010802e+02","5":"3.556000e+03","6":"1.165436e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BRIELLYN","13":"NORETHINDRONE-ETHINYL ESTRAD"},{"1":"539","2":"1.390637e+05","3":"361","4":"3.852180e+02","5":"3.743800e+04","6":"3.714507e+00","7":"221","8":"1.145325e+02","9":"140","10":"5.68507143","11":"2011","12":"BRILINTA","13":"TICAGRELOR"},{"1":"976926","2":"5.737203e+07","3":"231480","4":"2.478488e+02","5":"8.645542e+06","6":"6.762811e+00","7":"133948","8":"5.354376e+01","9":"97532","10":"5.65380285","11":"2011","12":"BRIMONIDINE TARTRATE","13":"BRIMONIDINE TARTRATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BRINTELLIX","13":"VORTIOXETINE HYDROBROMIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BRISDELLE","13":"PAROXETINE MESYLATE"},{"1":"103","2":"4.020560e+03","3":"78","4":"5.154564e+01","5":"3.772000e+03","6":"1.065896e+00","7":"49","8":"3.930429e+01","9":"29","10":"7.69275862","11":"2011","12":"BROMAX","13":"BROMPHENIRAMINE MALEATE"},{"1":"14","2":"8.553000e+02","3":"13","4":"6.579231e+01","5":"9.640000e+02","6":"8.872407e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BROMAX D","13":"BROMPHENIRAMIN/PHENYLEPHRINE"},{"1":"178168","2":"2.605733e+07","3":"112909","4":"2.307817e+02","5":"3.238937e+05","6":"8.045024e+01","7":"73604","8":"9.209492e+01","9":"39305","10":"7.45138328","11":"2011","12":"BROMDAY","13":"BROMFENAC SODIUM"},{"1":"727","2":"2.349836e+04","3":"621","4":"3.783955e+01","5":"1.275810e+05","6":"1.841839e-01","7":"591","8":"2.162008e+01","9":"30","10":"16.58333333","11":"2011","12":"BROMFED DM","13":"BROMPHENIRAMINE/PSEUDOEPHED/DM"},{"1":"23284","2":"2.944176e+06","3":"13881","4":"2.121012e+02","5":"6.794186e+04","6":"4.333377e+01","7":"9551","8":"5.595414e+01","9":"4330","10":"2.91393533","11":"2011","12":"BROMFENAC SODIUM","13":"BROMFENAC SODIUM"},{"1":"53856","2":"7.929582e+06","3":"8868","4":"8.941793e+02","5":"3.968851e+06","6":"1.943168e+00","7":"4078","8":"1.789145e+02","9":"4790","10":"10.05967223","11":"2011","12":"BROMOCRIPTINE MESYLATE","13":"BROMOCRIPTINE MESYLATE"},{"1":"27","2":"4.746300e+02","3":"20","4":"2.373150e+01","5":"5.650000e+03","6":"8.400531e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BRONCOMAR-1","13":"GUAIFEN/THEOP ANHYD/P-EPHED"},{"1":"12736","2":"3.887051e+06","3":"3726","4":"1.043224e+03","5":"1.151594e+06","6":"3.375366e+00","7":"874","8":"2.417915e+02","9":"2852","10":"6.50768934","11":"2011","12":"BROVANA","13":"ARFORMOTEROL TARTRATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BROVEX PSE","13":"BROMPHENIRAMIN/PSEUDOEPHEDRINE"},{"1":"125","2":"3.001850e+03","3":"47","4":"6.386915e+01","5":"4.764000e+03","6":"6.301113e-01","7":"33","8":"5.009121e+01","9":"14","10":"12.20142857","11":"2011","12":"BSS","13":"BALANCED SALT IRRIG SOLN NO.2"},{"1":"42","2":"6.625200e+02","3":"42","4":"1.577429e+01","5":"1.260000e+03","6":"5.258095e-01","7":"42","8":"NA","9":"0","10":"NA","11":"2011","12":"BUCALSEP","13":"B-CAINE/ZINC CL/PINE/CPYRD"},{"1":"87297","2":"4.476503e+06","3":"26342","4":"1.699379e+02","5":"5.659436e+06","6":"7.908426e-01","7":"12056","8":"3.841775e+01","9":"14286","10":"5.07091208","11":"2011","12":"BUDEPRION SR","13":"BUPROPION HCL"},{"1":"222820","2":"1.317709e+07","3":"58363","4":"2.257781e+02","5":"8.272089e+06","6":"1.637671e+00","7":"22082","8":"5.021899e+01","9":"36281","10":"5.40274055","11":"2011","12":"BUDEPRION XL","13":"BUPROPION HCL"},{"1":"119392","2":"2.790058e+07","3":"25516","4":"1.093454e+03","5":"9.101753e+06","6":"3.066493e+00","7":"5661","8":"2.346224e+02","9":"19855","10":"5.48219340","11":"2011","12":"BUDESONIDE","13":"BUDESONIDE"},{"1":"34371","2":"3.609411e+07","3":"15521","4":"2.325502e+03","5":"2.826788e+06","6":"1.276859e+01","7":"10957","8":"2.606901e+02","9":"4564","10":"8.67812007","11":"2011","12":"BUDESONIDE EC","13":"BUDESONIDE"},{"1":"1207790","2":"1.748177e+07","3":"239401","4":"7.302296e+01","5":"6.756168e+07","6":"2.551093e-01","7":"133812","8":"3.094111e+01","9":"105589","10":"6.14773243","11":"2011","12":"BUMETANIDE","13":"BUMETANIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BUNAVAIL","13":"BUPRENORPHINE HCL/NALOXONE HCL"},{"1":"246","2":"6.460050e+03","3":"135","4":"4.785222e+01","5":"1.263500e+04","6":"5.112822e-01","7":"105","8":"1.630733e+01","9":"30","10":"16.12466667","11":"2011","12":"BUPAP","13":"BUTALBITAL/ACETAMINOPHEN"},{"1":"544","2":"3.386130e+06","3":"55","4":"6.156600e+04","5":"3.205050e+05","6":"1.085525e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BUPHENYL","13":"SODIUM PHENYLBUTYRATE"},{"1":"63","2":"6.514300e+02","3":"38","4":"1.714289e+01","5":"9.446500e+03","6":"9.239365e-02","7":"13","8":"9.509231e+00","9":"25","10":"1.43000000","11":"2011","12":"BUPIVACAINE HCL","13":"BUPIVACAINE HCL"},{"1":"241","2":"2.808000e+03","3":"170","4":"1.651765e+01","5":"3.431000e+04","6":"8.556399e-02","7":"39","8":"9.810000e+00","9":"131","10":"0.69633588","11":"2011","12":"BUPIVACAINE HCL","13":"BUPIVACAINE HCL/PF"},{"1":"601","2":"7.030119e+05","3":"80","4":"8.787649e+03","5":"9.552400e+04","6":"7.359532e+00","7":"31","8":"9.818671e+02","9":"49","10":"48.41612245","11":"2011","12":"BUPRENEX","13":"BUPRENORPHINE HCL"},{"1":"26403","2":"6.145508e+06","3":"4936","4":"1.245038e+03","5":"1.697258e+06","6":"3.783864e+00","7":"1745","8":"3.518082e+02","9":"3191","10":"16.04434347","11":"2011","12":"BUPRENORPHINE HCL","13":"BUPRENORPHINE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BUPRENORPHINE-NALOXONE","13":"BUPRENORPHINE HCL/NALOXONE HCL"},{"1":"9165","2":"5.433964e+05","3":"4315","4":"1.259320e+02","5":"5.859011e+05","6":"9.274541e-01","7":"1535","8":"3.454293e+01","9":"2780","10":"3.19047122","11":"2011","12":"BUPROBAN","13":"BUPROPION HCL"},{"1":"468988","2":"1.328185e+07","3":"108365","4":"1.225658e+02","5":"3.367993e+07","6":"3.929478e-01","7":"49776","8":"3.595425e+01","9":"58589","10":"4.93140316","11":"2011","12":"BUPROPION HCL","13":"BUPROPION HCL"},{"1":"1918022","2":"1.015966e+08","3":"397123","4":"2.558316e+02","5":"1.211603e+08","6":"8.432139e-01","7":"180122","8":"6.505122e+01","9":"217001","10":"7.52491071","11":"2011","12":"BUPROPION HCL SR","13":"BUPROPION HCL"},{"1":"1632103","2":"1.087798e+08","3":"304497","4":"3.572442e+02","5":"7.044171e+07","6":"1.585858e+00","7":"148177","8":"8.749007e+01","9":"156320","10":"8.90437071","11":"2011","12":"BUPROPION XL","13":"BUPROPION HCL"},{"1":"13","2":"1.089200e+03","3":"11","4":"9.901818e+01","5":"8.090000e+02","6":"1.310235e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BUSPAR","13":"BUSPIRONE HCL"},{"1":"1953363","2":"3.520276e+07","3":"356079","4":"9.886221e+01","5":"1.554413e+08","6":"2.369800e-01","7":"132127","8":"3.171148e+01","9":"223952","10":"6.26098298","11":"2011","12":"BUSPIRONE HCL","13":"BUSPIRONE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BUTALB-ACETAMINOPH-CAFF-CODEIN","13":"BUTALBIT/ACETAMIN/CAFF/CODEINE"},{"1":"74950","2":"3.133206e+06","3":"15992","4":"1.959233e+02","5":"5.660096e+06","6":"5.535606e-01","7":"7577","8":"5.077064e+01","9":"8415","10":"7.67750802","11":"2011","12":"BUTALB-CAFF-ACETAMINOPH-CODEIN","13":"BUTALBIT/ACETAMIN/CAFF/CODEINE"},{"1":"144","2":"1.970480e+03","3":"44","4":"4.478364e+01","5":"7.554000e+03","6":"2.608525e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BUTALBITAL COMPOUND","13":"BUTALBITAL/ASPIRIN/CAFFEINE"},{"1":"45281","2":"3.063468e+06","3":"9636","4":"3.179191e+02","5":"3.461168e+06","6":"8.850967e-01","7":"5606","8":"8.256206e+01","9":"4030","10":"10.35722581","11":"2011","12":"BUTALBITAL COMPOUND-CODEINE","13":"CODEINE/BUTALBITAL/ASA/CAFFEIN"},{"1":"558","2":"1.424382e+04","3":"188","4":"7.576500e+01","5":"4.610300e+04","6":"3.089565e-01","7":"161","8":"2.651261e+01","9":"27","10":"22.42629630","11":"2011","12":"BUTALBITAL-ACETAMINOPHEN","13":"BUTALBITAL/ACETAMINOPHEN"},{"1":"58859","2":"8.198540e+05","3":"16877","4":"4.857819e+01","5":"3.705261e+06","6":"2.201685e-01","7":"14130","8":"1.530847e+01","9":"2747","10":"10.30028395","11":"2011","12":"BUTALBITAL-ACETAMINOPHEN-CAFFE","13":"BUTALB/ACETAMINOPHEN/CAFFEINE"},{"1":"9035","2":"3.091709e+05","3":"2545","4":"1.214817e+02","5":"6.405550e+05","6":"4.857453e-01","7":"2302","8":"3.288299e+01","9":"243","10":"25.60555556","11":"2011","12":"BUTALBITAL-ASPIRIN-CAFFEINE","13":"BUTALBITAL/ASPIRIN/CAFFEINE"},{"1":"217","2":"3.390930e+04","3":"56","4":"6.055232e+02","5":"2.105100e+04","6":"1.875126e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BUTISOL SODIUM","13":"BUTABARBITAL SODIUM"},{"1":"46409","2":"3.175370e+06","3":"5946","4":"5.340346e+02","5":"2.906507e+05","6":"1.333000e+01","7":"2145","8":"1.731902e+02","9":"3801","10":"16.47431465","11":"2011","12":"BUTORPHANOL TARTRATE","13":"BUTORPHANOL TARTRATE"},{"1":"24408","2":"5.063266e+06","3":"10496","4":"4.823996e+02","5":"9.899700e+04","6":"5.105827e+01","7":"4379","8":"1.510905e+02","9":"6117","10":"9.28682197","11":"2011","12":"BUTRANS","13":"BUPRENORPHINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BYDUREON","13":"EXENATIDE MICROSPHERES"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"BYDUREON PEN","13":"EXENATIDE MICROSPHERES"},{"1":"378677","2":"1.358257e+08","3":"80895","4":"1.679037e+03","5":"9.933026e+05","6":"1.497649e+02","7":"42552","8":"3.712711e+02","9":"38343","10":"23.53611976","11":"2011","12":"BYETTA","13":"EXENATIDE"},{"1":"1483851","2":"1.136239e+08","3":"277848","4":"4.089427e+02","5":"6.118020e+07","6":"1.857102e+00","7":"171628","8":"2.191851e+02","9":"106220","10":"24.64334683","11":"2011","12":"BYSTOLIC","13":"NEBIVOLOL HCL"},{"1":"36475","2":"9.556379e+06","3":"6602","4":"1.447498e+03","5":"4.213921e+05","6":"2.267812e+01","7":"3592","8":"2.491495e+02","9":"3010","10":"12.32756478","11":"2011","12":"CABERGOLINE","13":"CABERGOLINE"},{"1":"239610","2":"5.778883e+07","3":"45780","4":"1.262316e+03","5":"1.013869e+07","6":"5.709603e+00","7":"29280","8":"3.704968e+02","9":"16500","10":"34.44338000","11":"2011","12":"CADUET","13":"AMLODIPINE/ATORVASTATIN"},{"1":"5512","2":"7.361717e+05","3":"2035","4":"3.617551e+02","5":"2.563410e+05","6":"2.871845e+00","7":"1317","8":"1.520105e+02","9":"718","10":"6.72791086","11":"2011","12":"CAFERGOT","13":"ERGOTAMINE TARTRATE/CAFFEINE"},{"1":"40","2":"7.371523e+04","3":"NA","4":"NA","5":"5.730000e+03","6":"1.286479e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAFFEINE CITRATE","13":"CAFFEINE CITRATED"},{"1":"200","2":"7.148310e+03","3":"93","4":"7.686355e+01","5":"1.378300e+04","6":"5.186324e-01","7":"51","8":"2.408157e+01","9":"42","10":"3.57785714","11":"2011","12":"CAFGESIC","13":"SAL-AMIDE/ACETAMIN/P-TLOX/CAFF"},{"1":"19","2":"8.153200e+02","3":"15","4":"5.435467e+01","5":"1.037000e+03","6":"7.862295e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAFGESIC FORTE","13":"MG SAL/ACETAMINOPHN/P-TLOX/CAF"},{"1":"453","2":"6.338994e+04","3":"97","4":"6.535045e+02","5":"4.979300e+04","6":"1.279298e+00","7":"76","8":"2.963472e+02","9":"21","10":"16.66047619","11":"2011","12":"CALAN","13":"VERAPAMIL HCL"},{"1":"7190","2":"1.154076e+06","3":"1407","4":"8.202385e+02","5":"3.936670e+05","6":"2.935008e+00","7":"1078","8":"3.753187e+02","9":"329","10":"26.49981763","11":"2011","12":"CALAN SR","13":"VERAPAMIL HCL"},{"1":"16","2":"1.173940e+03","3":"NA","4":"NA","5":"1.500000e+03","6":"7.826267e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CALCIFOLIC-D","13":"CALCIUM/MAG/D3/B12/FA/B6/BORON"},{"1":"27189","2":"6.808497e+06","3":"13491","4":"5.046696e+02","5":"1.937047e+06","6":"3.491166e+00","7":"7736","8":"5.982939e+01","9":"5755","10":"4.02315378","11":"2011","12":"CALCIPOTRIENE","13":"CALCIPOTRIENE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CALCIPOTRIENE-BETAMETHASONE DP","13":"CALCIPOTRIENE/BETAMETHASONE"},{"1":"376350","2":"3.375423e+07","3":"98541","4":"3.425399e+02","5":"1.685845e+06","6":"2.002214e+01","7":"58804","8":"9.464670e+01","9":"39737","10":"6.03047487","11":"2011","12":"CALCITONIN-SALMON","13":"CALCITONIN,SALMON,SYNTHETIC"},{"1":"299","2":"1.041700e+05","3":"206","4":"5.056798e+02","5":"2.292000e+04","6":"4.544940e+00","7":"145","8":"5.598572e+01","9":"61","10":"4.06245902","11":"2011","12":"CALCITRENE","13":"CALCIPOTRIENE"},{"1":"897469","2":"4.007250e+07","3":"177101","4":"2.262692e+02","5":"3.578676e+07","6":"1.122980e+00","7":"93692","8":"5.425517e+01","9":"83409","10":"7.68230239","11":"2011","12":"CALCITRIOL","13":"CALCITRIOL"},{"1":"572268","2":"7.119979e+07","3":"132521","4":"5.372718e+02","5":"1.163280e+08","6":"6.120752e-01","7":"40374","8":"1.129875e+02","9":"92147","10":"7.72021477","11":"2011","12":"CALCIUM ACETATE","13":"CALCIUM ACETATE"},{"1":"68","2":"3.463790e+03","3":"15","4":"2.309193e+02","5":"3.032589e+04","6":"1.435995e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CALCIUM CHLORIDE","13":"CALCIUM CHLORIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CALCIUM FOLINATE","13":"LEUCOVORIN CALCIUM"},{"1":"315","2":"9.229240e+03","3":"68","4":"1.357241e+02","5":"1.293896e+05","6":"1.853504e-01","7":"24","8":"7.161542e+01","9":"44","10":"1.68977273","11":"2011","12":"CALCIUM GLUCONATE","13":"CALCIUM GLUCONATE"},{"1":"18","2":"1.137470e+03","3":"NA","4":"NA","5":"2.010000e+03","6":"5.659055e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CALCIUM-FOLIC ACID PLUS D","13":"CALCIUM/MAG/D3/B12/FA/B6/BORON"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAMBIA","13":"DICLOFENAC POTASSIUM"},{"1":"10913","2":"3.321084e+05","3":"2407","4":"1.379761e+02","5":"3.619090e+05","6":"9.176573e-01","7":"300","8":"4.306113e+01","9":"2107","10":"5.87549597","11":"2011","12":"CAMILA","13":"NORETHINDRONE"},{"1":"30","2":"3.644726e+05","3":"12","4":"3.037272e+04","5":"2.020000e+02","6":"1.804320e+03","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAMPATH","13":"ALEMTUZUMAB"},{"1":"31025","2":"4.349524e+06","3":"9068","4":"4.796564e+02","5":"4.962636e+06","6":"8.764971e-01","7":"2503","8":"1.549870e+02","9":"6565","10":"12.44847068","11":"2011","12":"CAMPRAL","13":"ACAMPROSATE CALCIUM"},{"1":"27","2":"1.473138e+04","3":"13","4":"1.133183e+03","5":"4.820000e+02","6":"3.048186e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAMPTOSAR","13":"IRINOTECAN HCL"},{"1":"531","2":"1.115395e+05","3":"415","4":"2.687700e+02","5":"4.830900e+04","6":"2.308877e+00","7":"29","8":"6.020793e+01","9":"386","10":"1.88137306","11":"2011","12":"CAMRESE","13":"L-NORGEST/E.ESTRADION-E.ESTRAD"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAMRESE LO","13":"L-NORGEST/E.ESTRADION-E.ESTRAD"},{"1":"38157","2":"1.853446e+07","3":"16955","4":"1.093156e+03","5":"1.233870e+06","6":"1.502140e+01","7":"11040","8":"1.541692e+02","9":"5915","10":"11.28971090","11":"2011","12":"CANASA","13":"MESALAMINE"},{"1":"1374","2":"2.669213e+06","3":"350","4":"7.626323e+03","5":"1.743536e+05","6":"1.734257e+01","7":"89","8":"1.270112e+03","9":"261","10":"6.68708812","11":"2011","12":"CANCIDAS","13":"CASPOFUNGIN ACETATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CANDESARTAN CILEXETIL","13":"CANDESARTAN CILEXETIL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CANDESARTAN-HYDROCHLOROTHIAZID","13":"CANDESARTAN/HYDROCHLOROTHIAZID"},{"1":"393","2":"5.883708e+04","3":"135","4":"4.358302e+02","5":"3.965500e+04","6":"1.483724e+00","7":"105","8":"1.922625e+02","9":"30","10":"19.05866667","11":"2011","12":"CANTIL","13":"MEPENZOLATE BROMIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAPACET","13":"BUTALB/ACETAMINOPHEN/CAFFEINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAPASTAT SULFATE","13":"CAPREOMYCIN SULFATE"},{"1":"141","2":"1.393840e+03","3":"116","4":"1.201586e+01","5":"2.054800e+04","6":"6.783337e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAPCOF","13":"CHLORPHENIRAMINE/PE/CODEINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAPECITABINE","13":"CAPECITABINE"},{"1":"7933","2":"2.086934e+06","3":"3748","4":"5.568127e+02","5":"1.045090e+06","6":"1.996893e+00","7":"1869","8":"1.026193e+02","9":"1879","10":"7.42094731","11":"2011","12":"CAPEX SHAMPOO","13":"FLUOCINOLONE ACETONIDE"},{"1":"101","2":"5.584882e+04","3":"62","4":"9.007874e+02","5":"2.662300e+05","6":"2.097766e-01","7":"48","8":"1.158504e+02","9":"14","10":"6.78571429","11":"2011","12":"CAPHOSOL","13":"SALIVA SUBSTITUTE COMBO NO.2"},{"1":"37","2":"9.538070e+03","3":"28","4":"3.406454e+02","5":"1.210200e+04","6":"7.881400e-01","7":"16","8":"5.797937e+01","9":"12","10":"2.52916667","11":"2011","12":"CAPITAL W-CODEINE","13":"ACETAMINOPHEN WITH CODEINE"},{"1":"112","2":"1.135497e+06","3":"46","4":"2.468472e+04","5":"4.422000e+03","6":"2.838788e+02","7":"30","8":"2.344793e+03","9":"16","10":"2.04375000","11":"2011","12":"CAPRELSA","13":"VANDETANIB"},{"1":"689501","2":"5.142140e+06","3":"112875","4":"4.555606e+01","5":"6.052965e+07","6":"8.423793e-02","7":"71430","8":"2.141389e+01","9":"41445","10":"7.43173459","11":"2011","12":"CAPTOPRIL","13":"CAPTOPRIL"},{"1":"51489","2":"1.009788e+06","3":"8417","4":"1.199701e+02","5":"3.431883e+06","6":"2.941764e-01","7":"5694","8":"4.680143e+01","9":"2723","10":"10.63390745","11":"2011","12":"CAPTOPRIL-HYDROCHLOROTHIAZIDE","13":"CAPTOPRIL/HYDROCHLOROTHIAZIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAPTRACIN","13":"CAPSAICIN/MENTHOL"},{"1":"56216","2":"1.175431e+07","3":"45546","4":"2.580755e+02","5":"1.813738e+06","6":"6.480709e+00","7":"40899","8":"8.837305e+01","9":"4647","10":"9.39948354","11":"2011","12":"CARAC","13":"FLUOROURACIL"},{"1":"337874","2":"4.115328e+07","3":"131169","4":"3.137424e+02","5":"2.213025e+08","6":"1.923780e-01","7":"67049","8":"9.088998e+01","9":"64120","10":"9.05025265","11":"2011","12":"CARAFATE","13":"SUCRALFATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARBAGLU","13":"CARGLUMIC ACID"},{"1":"1210226","2":"2.039576e+07","3":"171699","4":"1.187879e+02","5":"1.655152e+08","6":"1.219686e-01","7":"55959","8":"3.444659e+01","9":"115740","10":"7.18773302","11":"2011","12":"CARBAMAZEPINE","13":"CARBAMAZEPINE"},{"1":"182761","2":"1.984749e+07","3":"34325","4":"5.782226e+02","5":"1.677100e+07","6":"1.218182e+00","7":"9498","8":"1.266784e+02","9":"24827","10":"6.99401539","11":"2011","12":"CARBAMAZEPINE ER","13":"CARBAMAZEPINE"},{"1":"78279","2":"7.651715e+06","3":"13840","4":"5.528696e+02","5":"6.986340e+06","6":"1.150268e+00","7":"3676","8":"9.860197e+01","9":"10164","10":"7.41453266","11":"2011","12":"CARBAMAZEPINE XR","13":"CARBAMAZEPINE"},{"1":"142182","2":"2.500789e+07","3":"19978","4":"1.251771e+03","5":"1.457750e+07","6":"1.715865e+00","7":"5300","8":"3.516782e+02","9":"14678","10":"26.12194713","11":"2011","12":"CARBATROL","13":"CARBAMAZEPINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARBIDOPA","13":"CARBIDOPA"},{"1":"2267738","2":"9.702641e+07","3":"349395","4":"2.776983e+02","5":"3.070291e+08","6":"3.164271e-01","7":"206223","8":"8.783522e+01","9":"143172","10":"7.58970476","11":"2011","12":"CARBIDOPA-LEVODOPA","13":"CARBIDOPA/LEVODOPA"},{"1":"513069","2":"3.555929e+07","3":"84930","4":"4.186894e+02","5":"5.368026e+07","6":"6.658855e-01","7":"53586","8":"1.025803e+02","9":"31344","10":"9.28192254","11":"2011","12":"CARBIDOPA-LEVODOPA ER","13":"CARBIDOPA/LEVODOPA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARBIDOPA-LEVODOPA-ENTACAPONE","13":"CARBIDOPA/LEVODOPA/ENTACAPONE"},{"1":"10488","2":"3.807381e+05","3":"4354","4":"8.744560e+01","5":"6.505533e+05","6":"6.432952e-01","7":"2441","8":"2.275077e+01","9":"1913","10":"4.16754835","11":"2011","12":"CARBINOXAMINE MALEATE","13":"CARBINOXAMINE MALEATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARBOCAINE","13":"MEPIVACAINE HCL/PF"},{"1":"22","2":"2.781800e+02","3":"18","4":"1.545444e+01","5":"4.230000e+03","6":"6.576359e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARBOFED DM","13":"BROMPHENIRAMINE/PSEUDOEPHED/DM"},{"1":"1877","2":"2.333420e+05","3":"554","4":"4.211950e+02","5":"8.844500e+04","6":"1.245665e+01","7":"238","8":"8.429525e+01","9":"316","10":"5.27161392","11":"2011","12":"CARBOPLATIN","13":"CARBOPLATIN"},{"1":"33","2":"3.239020e+03","3":"18","4":"1.799456e+02","5":"2.114000e+03","6":"1.566386e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARDENE SR","13":"NICARDIPINE HCL"},{"1":"73","2":"2.778620e+03","3":"13","4":"2.137400e+02","5":"3.630000e+03","6":"7.654601e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARDIOTEK-RX","13":"FA/ARGININE HCL/B12/B6/PEP EX"},{"1":"1093","2":"1.941254e+05","3":"240","4":"8.088558e+02","5":"1.222910e+05","6":"1.651444e+00","7":"152","8":"2.787868e+02","9":"88","10":"21.47022727","11":"2011","12":"CARDIZEM","13":"DILTIAZEM HCL"},{"1":"75927","2":"2.417218e+07","3":"16463","4":"1.468273e+03","5":"3.183068e+06","6":"7.723831e+00","7":"8998","8":"3.230234e+02","9":"7465","10":"24.58994508","11":"2011","12":"CARDIZEM CD","13":"DILTIAZEM HCL"},{"1":"25284","2":"4.215738e+06","3":"7858","4":"5.364899e+02","5":"1.290445e+06","6":"3.262402e+00","7":"5363","8":"1.899765e+02","9":"2495","10":"14.44588778","11":"2011","12":"CARDIZEM LA","13":"DILTIAZEM HCL"},{"1":"4821","2":"4.051658e+05","3":"1151","4":"3.520120e+02","5":"2.518580e+05","6":"1.613135e+00","7":"826","8":"1.901111e+02","9":"325","10":"17.62443077","11":"2011","12":"CARDURA","13":"DOXAZOSIN MESYLATE"},{"1":"2105","2":"1.699767e+05","3":"648","4":"2.623097e+02","5":"9.436000e+04","6":"1.800993e+00","7":"437","8":"1.685612e+02","9":"211","10":"13.86322275","11":"2011","12":"CARDURA XL","13":"DOXAZOSIN MESYLATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAREFINE PEN NEEDLE","13":"PEN NEEDLE, DIABETIC"},{"1":"12","2":"2.748000e+02","3":"NA","4":"NA","5":"1.200000e+03","6":"2.290000e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAREONE","13":"SYR-ND,INS,0.5/CONTAINER,EMPTY"},{"1":"1537","2":"7.471578e+06","3":"139","4":"5.375236e+04","5":"5.944750e+04","6":"1.263269e+02","7":"46","8":"3.786123e+03","9":"93","10":"99.43817204","11":"2011","12":"CARIMUNE NF NANOFILTERED","13":"IMMUN GLOB G(IGG)/SUCR/IGA 50+"},{"1":"2644079","2":"3.445699e+07","3":"458310","4":"7.518273e+01","5":"2.113089e+08","6":"1.684543e-01","7":"171854","8":"2.631306e+01","9":"286456","10":"9.28354466","11":"2011","12":"CARISOPRODOL","13":"CARISOPRODOL"},{"1":"3084","2":"3.630634e+05","3":"1262","4":"2.876889e+02","5":"2.219720e+05","6":"1.635627e+00","7":"679","8":"3.475997e+01","9":"583","10":"4.40998285","11":"2011","12":"CARISOPRODOL COMPOUND","13":"CARISOPRODOL/ASPIRIN"},{"1":"1865","2":"2.995080e+05","3":"536","4":"5.587836e+02","5":"1.518390e+05","6":"1.972537e+00","7":"298","8":"1.236207e+02","9":"238","10":"10.46163865","11":"2011","12":"CARISOPRODOL COMPOUND-CODEINE","13":"CODEINE/CARISOPRODOL/ASPIRIN"},{"1":"203","2":"2.884565e+04","3":"111","4":"2.598707e+02","5":"1.811300e+04","6":"1.592539e+00","7":"70","8":"1.999571e+01","9":"41","10":"1.83902439","11":"2011","12":"CARISOPRODOL-ASPIRIN","13":"CARISOPRODOL/ASPIRIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARISOPRODOL-ASPIRIN-CODEINE","13":"CODEINE/CARISOPRODOL/ASPIRIN"},{"1":"191","2":"3.282377e+04","3":"157","4":"2.090686e+02","5":"2.229339e+04","6":"1.881716e+00","7":"82","8":"2.635585e+01","9":"75","10":"2.75013333","11":"2011","12":"CARMOL 40","13":"UREA"},{"1":"126","2":"2.889188e+04","3":"77","4":"3.752192e+02","5":"1.238390e+04","6":"2.333019e+00","7":"24","8":"6.440125e+01","9":"53","10":"1.73962264","11":"2011","12":"CARMOL HC","13":"HYDROCORTISONE ACETATE/UREA"},{"1":"873","2":"1.821893e+05","3":"163","4":"1.117726e+03","5":"8.481175e+04","6":"4.101543e+00","7":"37","8":"2.687927e+02","9":"126","10":"6.30214286","11":"2011","12":"CARNITOR","13":"LEVOCARNITINE"},{"1":"127","2":"1.587006e+04","3":"29","4":"5.472434e+02","5":"6.476500e+04","6":"2.450407e-01","7":"0","8":"NA","9":"29","10":"6.82068966","11":"2011","12":"CARNITOR","13":"LEVOCARNITINE (WITH SUGAR)"},{"1":"40","2":"3.297510e+03","3":"14","4":"2.355364e+02","5":"1.341600e+04","6":"2.457894e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CARNITOR SF","13":"LEVOCARNITINE"},{"1":"31088","2":"7.521199e+05","3":"7225","4":"1.040996e+02","5":"2.882501e+05","6":"2.609262e+00","7":"5363","8":"4.025942e+01","9":"1862","10":"6.33277658","11":"2011","12":"CARTEOLOL HCL","13":"CARTEOLOL HCL"},{"1":"1043317","2":"4.550667e+07","3":"219340","4":"2.074709e+02","5":"4.902395e+07","6":"9.356274e-01","7":"148514","8":"6.241870e+01","9":"70826","10":"8.84755302","11":"2011","12":"CARTIA XT","13":"DILTIAZEM HCL"},{"1":"10535381","2":"1.535977e+08","3":"1763656","4":"8.709053e+01","5":"8.582646e+08","6":"1.789986e-01","7":"1008092","8":"3.728096e+01","9":"755564","10":"8.09605687","11":"2011","12":"CARVEDILOL","13":"CARVEDILOL"},{"1":"4589","2":"3.044696e+06","3":"1290","4":"2.360229e+03","5":"1.802640e+05","6":"1.689020e+01","7":"747","8":"3.957219e+02","9":"543","10":"19.28226519","11":"2011","12":"CASODEX","13":"BICALUTAMIDE"},{"1":"255","2":"8.210712e+04","3":"128","4":"6.414619e+02","5":"2.038500e+04","6":"4.027820e+00","7":"103","8":"1.052991e+02","9":"25","10":"12.01320000","11":"2011","12":"CATAFLAM","13":"DICLOFENAC POTASSIUM"},{"1":"2915","2":"5.979442e+05","3":"609","4":"9.818460e+02","5":"3.042850e+05","6":"1.985915e+00","7":"374","8":"3.090941e+02","9":"235","10":"20.87200000","11":"2011","12":"CATAPRES","13":"CLONIDINE HCL"},{"1":"13703","2":"2.245791e+06","3":"3347","4":"6.709864e+02","5":"6.624500e+04","6":"3.390130e+01","7":"1515","8":"2.773562e+02","9":"1832","10":"14.47452511","11":"2011","12":"CATAPRES-TTS 1","13":"CLONIDINE"},{"1":"21188","2":"6.107416e+06","3":"4494","4":"1.359016e+03","5":"1.070809e+05","6":"5.703553e+01","7":"1842","8":"3.899660e+02","9":"2652","10":"19.00288461","11":"2011","12":"CATAPRES-TTS 2","13":"CLONIDINE"},{"1":"30695","2":"1.232277e+07","3":"5693","4":"2.164548e+03","5":"1.564312e+05","6":"7.877438e+01","7":"1887","8":"4.835079e+02","9":"3806","10":"22.73986863","11":"2011","12":"CATAPRES-TTS 3","13":"CLONIDINE"},{"1":"25","2":"1.282460e+03","3":"NA","4":"NA","5":"1.200000e+03","6":"1.068717e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVAN ONE OMEGA","13":"PNV W-CA NO.37/IRON/FA/OMEGA-3"},{"1":"52","2":"2.026220e+03","3":"20","4":"1.013110e+02","5":"3.480000e+03","6":"5.822471e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVAN-ALPHA KIT","13":"PNV67/SOD IRON EDTA& PS/FA/OM3"},{"1":"99","2":"3.968070e+03","3":"32","4":"1.240022e+02","5":"6.510000e+03","6":"6.095346e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVAN-EC SOD DHA","13":"PNV48/IRON NA FEREDETAT/FA/OM3"},{"1":"23","2":"8.259400e+02","3":"15","4":"5.506267e+01","5":"1.470000e+03","6":"5.618639e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVAN-FOLATE DHA","13":"PRENAT VIT COMB.10/IRON/FA/DHA"},{"1":"16","2":"3.516700e+02","3":"NA","4":"NA","5":"6.970000e+02","6":"5.045481e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVAN-FOLATE OB","13":"PRENATAL VIT COMB.10/IRON/FA"},{"1":"24","2":"7.813100e+02","3":"NA","4":"NA","5":"8.510000e+02","6":"9.181081e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVAN-HEME OB","13":"PNV #8/IRON PS & HEME POLYP/FA"},{"1":"20","2":"8.467400e+02","3":"15","4":"5.644933e+01","5":"1.230000e+03","6":"6.884065e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVAN-HEME OMEGA","13":"PNV COMBO #8/IRON/FOLIC AC/DHA"},{"1":"473","2":"1.172535e+04","3":"174","4":"6.738707e+01","5":"1.992500e+04","6":"5.884743e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVAN-X","13":"CYANOCOBALAMIN/FA/PYRIDOXINE"},{"1":"259","2":"7.599583e+04","3":"102","4":"7.450572e+02","5":"1.604250e+03","6":"4.666925e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CAVERJECT","13":"ALPROSTADIL"},{"1":"1779","2":"8.930756e+06","3":"639","4":"1.397614e+04","5":"1.494270e+05","6":"5.976668e+01","7":"100","8":"1.943424e+03","9":"539","10":"25.71571429","11":"2011","12":"CAYSTON","13":"AZTREONAM LYSINE"},{"1":"547","2":"1.751145e+04","3":"93","4":"1.882952e+02","5":"1.879000e+04","6":"9.319558e-01","7":"12","8":"5.073417e+01","9":"81","10":"7.72469136","11":"2011","12":"CAZIANT","13":"DESOGESTREL-ETHINYL ESTRADIOL"},{"1":"986","2":"1.789746e+05","3":"809","4":"2.212294e+02","5":"1.384500e+04","6":"1.461616e+01","7":"419","8":"8.437768e+01","9":"390","10":"5.13282051","11":"2011","12":"CEDAX","13":"CEFTIBUTEN"},{"1":"502","2":"4.100902e+04","3":"164","4":"2.500550e+02","5":"1.736000e+03","6":"3.089702e+01","7":"108","8":"1.012076e+02","9":"56","10":"15.59321429","11":"2011","12":"CEENU","13":"LOMUSTINE"},{"1":"30937","2":"1.741839e+06","3":"22611","4":"7.703504e+01","5":"8.375993e+05","6":"2.114761e+00","7":"13477","8":"1.427430e+01","9":"9134","10":"2.26269542","11":"2011","12":"CEFACLOR","13":"CEFACLOR"},{"1":"221","2":"1.468368e+04","3":"177","4":"8.295864e+01","5":"4.388000e+03","6":"3.346326e+00","7":"104","8":"2.085058e+01","9":"73","10":"2.27424658","11":"2011","12":"CEFACLOR ER","13":"CEFACLOR"},{"1":"192841","2":"4.022822e+06","3":"150053","4":"2.680934e+01","5":"3.966245e+06","6":"1.047128e+00","7":"110137","8":"8.144061e+00","9":"39916","10":"1.81970764","11":"2011","12":"CEFADROXIL","13":"CEFADROXIL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEFAZOLIN","13":"CEFAZOLIN SODIUM/DEXTROSE,ISO"},{"1":"20953","2":"1.346504e+06","3":"7005","4":"1.922205e+02","5":"1.694824e+06","6":"1.155718e+00","7":"2806","8":"6.237715e+01","9":"4199","10":"3.17806621","11":"2011","12":"CEFAZOLIN SODIUM","13":"CEFAZOLIN SODIUM"},{"1":"95","2":"2.908024e+04","3":"37","4":"7.859524e+02","5":"8.731000e+03","6":"3.330688e+00","7":"12","8":"5.564667e+01","9":"25","10":"2.41600000","11":"2011","12":"CEFAZOLIN SODIUM","13":"CEFAZOLIN SODIUM/DEXTROSE,ISO"},{"1":"1121","2":"7.310092e+04","3":"450","4":"1.624465e+02","5":"6.255250e+05","6":"1.168633e-01","7":"58","8":"3.940931e+01","9":"392","10":"1.34020408","11":"2011","12":"CEFAZOLIN SODIUM-DEXTROSE","13":"CEFAZOLIN SODIUM/DEXTROSE,ISO"},{"1":"499596","2":"2.168963e+07","3":"402631","4":"5.386975e+01","5":"1.016426e+07","6":"2.239363e+00","7":"240961","8":"1.515539e+01","9":"161670","10":"2.13289980","11":"2011","12":"CEFDINIR","13":"CEFDINIR"},{"1":"1862","2":"4.185453e+05","3":"1622","4":"2.580427e+02","5":"3.528400e+04","6":"1.184798e+01","7":"897","8":"5.971547e+01","9":"725","10":"4.07943448","11":"2011","12":"CEFDITOREN PIVOXIL","13":"CEFDITOREN PIVOXIL"},{"1":"3475","2":"7.850632e+05","3":"1232","4":"6.372266e+02","5":"1.606851e+06","6":"5.187770e-01","7":"160","8":"1.816321e+02","9":"1072","10":"2.65625933","11":"2011","12":"CEFEPIME","13":"CEFEPIME HCL/DEXTROSE, ISO-OSM"},{"1":"36557","2":"7.993336e+06","3":"14289","4":"5.594048e+02","5":"3.490350e+06","6":"2.448263e+00","7":"3862","8":"1.735496e+02","9":"10427","10":"3.23340270","11":"2011","12":"CEFEPIME HCL","13":"CEFEPIME HCL"},{"1":"30","2":"6.650220e+03","3":"19","4":"3.500116e+02","5":"1.096800e+04","6":"6.219347e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEFEPIME-DEXTROSE","13":"CEFEPIME HCL/D5W"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEFIXIME","13":"CEFIXIME"},{"1":"624","2":"6.609250e+04","3":"320","4":"2.065391e+02","5":"7.883840e+04","6":"6.593569e+00","7":"45","8":"5.328400e+01","9":"275","10":"0.87381818","11":"2011","12":"CEFOTAXIME SODIUM","13":"CEFOTAXIME SODIUM"},{"1":"377","2":"5.190151e+04","3":"217","4":"2.391775e+02","5":"3.924950e+04","6":"1.903144e+00","7":"30","8":"1.386867e+02","9":"187","10":"2.35197861","11":"2011","12":"CEFOTETAN","13":"CEFOTETAN DISODIUM"},{"1":"32","2":"3.948460e+03","3":"16","4":"2.467788e+02","5":"9.670000e+02","6":"8.520589e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEFOTETAN & DEXTROSE","13":"CEFOTETAN DISOD/DEXTROSE,ISO"},{"1":"1933","2":"4.045680e+05","3":"731","4":"5.534445e+02","5":"3.661458e+05","6":"2.964381e+00","7":"105","8":"2.598581e+02","9":"626","10":"5.62276358","11":"2011","12":"CEFOXITIN","13":"CEFOXITIN SODIUM"},{"1":"24","2":"5.977360e+03","3":"12","4":"4.981133e+02","5":"4.766000e+03","6":"2.377084e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEFOXITIN SODIUM","13":"CEFOXITIN SODIUM/DEXTROSE,ISO"},{"1":"91236","2":"7.630556e+06","3":"73487","4":"1.038355e+02","5":"1.678952e+06","6":"4.835696e+00","7":"38325","8":"3.116463e+01","9":"35162","10":"2.13263296","11":"2011","12":"CEFPODOXIME PROXETIL","13":"CEFPODOXIME PROXETIL"},{"1":"75371","2":"4.791458e+06","3":"61466","4":"7.795298e+01","5":"1.795830e+06","6":"3.188076e+00","7":"37127","8":"2.121413e+01","9":"24339","10":"2.38477629","11":"2011","12":"CEFPROZIL","13":"CEFPROZIL"},{"1":"14747","2":"2.143706e+06","3":"6400","4":"3.349540e+02","5":"1.620716e+06","6":"1.857847e+00","7":"1560","8":"1.023508e+02","9":"4840","10":"2.18672521","11":"2011","12":"CEFTAZIDIME","13":"CEFTAZIDIME"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEFTAZIDIME","13":"CEFTAZIDIME IN DEXTROSE5%WATER"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEFTIBUTEN","13":"CEFTIBUTEN"},{"1":"2520","2":"4.881509e+05","3":"2084","4":"2.342375e+02","5":"3.273190e+05","6":"2.817518e+00","7":"729","8":"7.057820e+01","9":"1355","10":"3.07728413","11":"2011","12":"CEFTIN","13":"CEFUROXIME AXETIL"},{"1":"10450","2":"2.449898e+06","3":"5337","4":"4.590403e+02","5":"2.461244e+06","6":"1.012932e+00","7":"852","8":"1.853045e+02","9":"4485","10":"2.46538684","11":"2011","12":"CEFTRIAXONE","13":"CEFTRIAXONE NA/DEXTROSE,ISO"},{"1":"253073","2":"2.518571e+07","3":"146664","4":"1.717239e+02","5":"5.730264e+06","6":"4.421977e+00","7":"29939","8":"6.784391e+01","9":"116725","10":"1.14851566","11":"2011","12":"CEFTRIAXONE","13":"CEFTRIAXONE SODIUM"},{"1":"737921","2":"1.211175e+07","3":"571540","4":"2.119142e+01","5":"1.360207e+07","6":"8.898978e-01","7":"344660","8":"9.365339e+00","9":"226880","10":"1.62679769","11":"2011","12":"CEFUROXIME","13":"CEFUROXIME AXETIL"},{"1":"65","2":"8.214770e+03","3":"63","4":"1.303932e+02","5":"8.669000e+03","6":"9.688022e-01","7":"14","8":"2.794071e+01","9":"49","10":"0.30408163","11":"2011","12":"CEFUROXIME AXETIL","13":"CEFUROXIME AXETIL"},{"1":"270","2":"2.685786e+04","3":"147","4":"1.827065e+02","5":"1.734500e+04","6":"3.087718e+00","7":"47","8":"8.014787e+01","9":"100","10":"1.19950000","11":"2011","12":"CEFUROXIME SODIUM","13":"CEFUROXIME SODIUM"},{"1":"3053004","2":"5.738764e+08","3":"737552","4":"7.780826e+02","5":"1.446409e+08","6":"3.987649e+00","7":"419576","8":"2.136298e+02","9":"317976","10":"19.78919359","11":"2011","12":"CELEBREX","13":"CELECOXIB"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CELECOXIB","13":"CELECOXIB"},{"1":"140","2":"8.499890e+03","3":"111","4":"7.657559e+01","5":"3.178000e+03","6":"2.674604e+00","7":"46","8":"7.349000e+01","9":"65","10":"4.02000000","11":"2011","12":"CELESTONE","13":"BETAMET ACET/BETAMET NA PH"},{"1":"2982","2":"1.716275e+05","3":"2437","4":"7.042573e+01","5":"4.943814e+05","6":"3.471561e-01","7":"2360","8":"2.541775e+01","9":"77","10":"9.60649351","11":"2011","12":"CELESTONE","13":"BETAMETHASONE"},{"1":"9237","2":"1.517180e+06","3":"2100","4":"7.224667e+02","5":"4.335258e+05","6":"3.504479e+00","7":"1172","8":"2.782830e+02","9":"928","10":"18.55512931","11":"2011","12":"CELEXA","13":"CITALOPRAM HYDROBROMIDE"},{"1":"22368","2":"2.177258e+07","3":"3982","4":"5.467751e+03","5":"3.452903e+06","6":"6.884488e+00","7":"1649","8":"6.088382e+02","9":"2333","10":"24.76667381","11":"2011","12":"CELLCEPT","13":"MYCOPHENOLATE MOFETIL"},{"1":"49","2":"7.801800e+03","3":"NA","4":"NA","5":"4.900000e+02","6":"1.592204e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CELLCEPT","13":"MYCOPHENOLATE MOFETIL HCL"},{"1":"3206","2":"4.528417e+05","3":"370","4":"1.223896e+03","5":"2.880650e+05","6":"1.572012e+00","7":"124","8":"4.698389e+02","9":"246","10":"31.09520325","11":"2011","12":"CELONTIN","13":"METHSUXIMIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEM-UREA","13":"UREA"},{"1":"31421","2":"3.662529e+06","3":"6182","4":"5.924506e+02","5":"1.338359e+06","6":"2.736619e+00","7":"4396","8":"3.190650e+02","9":"1786","10":"30.69396976","11":"2011","12":"CENESTIN","13":"ESTROGENS,CONJ.,SYNTHETIC A"},{"1":"1372","2":"5.764295e+04","3":"1193","4":"4.831764e+01","5":"4.279400e+04","6":"1.346987e+00","7":"857","8":"1.989289e+01","9":"336","10":"2.79776786","11":"2011","12":"CENTANY","13":"MUPIROCIN"},{"1":"251","2":"3.227041e+04","3":"241","4":"1.339021e+02","5":"5.450000e+02","6":"5.921176e+01","7":"165","8":"4.950867e+01","9":"76","10":"5.29105263","11":"2011","12":"CENTANY AT","13":"MUPIROCIN"},{"1":"33","2":"6.270000e+02","3":"18","4":"3.483333e+01","5":"1.037000e+03","6":"6.046287e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CENTRATEX","13":"FE FUMARATE/FA/MV, MIN COMB#15"},{"1":"200","2":"3.908690e+03","3":"89","4":"4.391787e+01","5":"8.070000e+03","6":"4.843482e-01","7":"63","8":"1.785825e+01","9":"26","10":"12.68000000","11":"2011","12":"CEPHADYN","13":"BUTALBITAL/ACETAMINOPHEN"},{"1":"3937748","2":"3.527407e+07","3":"2763234","4":"1.276550e+01","5":"1.170561e+08","6":"3.154691e-01","7":"1625159","8":"7.302561e+00","9":"1138075","10":"1.67444082","11":"2011","12":"CEPHALEXIN","13":"CEPHALEXIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CERDELGA","13":"ELIGLUSTAT TARTRATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEREBYX","13":"FOSPHENYTOIN SODIUM"},{"1":"1120","2":"1.410934e+05","3":"298","4":"4.734678e+02","5":"6.780400e+04","6":"2.080901e+00","7":"285","8":"2.320736e+02","9":"13","10":"192.23538462","11":"2011","12":"CEREFOLIN","13":"VIT B12/LMEFOLATE CA/VIT B6/B2"},{"1":"2799","2":"3.006158e+05","3":"726","4":"4.140713e+02","5":"1.597450e+05","6":"1.881848e+00","7":"702","8":"1.954880e+02","9":"24","10":"146.14708333","11":"2011","12":"CEREFOLIN NAC","13":"ACETYL/METHYL-B12/LMEFOLATE CA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEREFOLIN NAC","13":"LMFOL CA/ACETYL/MB12/ALGAL OIL"},{"1":"323","2":"5.984837e+06","3":"24","4":"2.493682e+05","5":"2.861800e+04","6":"2.091284e+02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEREZYME","13":"IMIGLUCERASE"},{"1":"23","2":"3.763100e+02","3":"20","4":"1.881550e+01","5":"3.943000e+03","6":"9.543748e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CERON","13":"CHLORPHENIRAMINE/PHENYLEPHRINE"},{"1":"153","2":"2.073040e+03","3":"144","4":"1.439611e+01","5":"2.603600e+04","6":"7.962206e-02","7":"125","8":"8.145680e+00","9":"19","10":"10.20052632","11":"2011","12":"CERON-DM","13":"CHLORPHENIRAMINE/PHENYLEPH/DM"},{"1":"60","2":"7.245332e+04","3":"22","4":"3.293333e+03","5":"3.440000e+03","6":"2.106201e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CESAMET","13":"NABILONE"},{"1":"14","2":"3.299200e+02","3":"NA","4":"NA","5":"3.940000e+02","6":"8.373604e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CESIA","13":"DESOGESTREL-ETHINYL ESTRADIOL"},{"1":"7260","2":"1.824620e+05","3":"2883","4":"6.328895e+01","5":"1.732571e+06","6":"1.053129e-01","7":"1193","8":"6.167997e+00","9":"1690","10":"2.87320710","11":"2011","12":"CETIRIZINE HCL","13":"CETIRIZINE HCL"},{"1":"35","2":"4.780570e+03","3":"31","4":"1.542119e+02","5":"5.320000e+02","6":"8.986034e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CETRAXAL","13":"CIPROFLOXACIN HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CEVIMELINE HCL","13":"CEVIMELINE HCL"},{"1":"386180","2":"5.856041e+07","3":"177942","4":"3.290983e+02","5":"2.160731e+07","6":"2.713151e+00","7":"55872","8":"1.348166e+02","9":"122070","10":"9.88406857","11":"2011","12":"CHANTIX","13":"VARENICLINE TARTRATE"},{"1":"213","2":"1.206064e+05","3":"117","4":"1.030824e+03","5":"1.633900e+04","6":"7.381507e+00","7":"81","8":"1.963521e+02","9":"36","10":"8.16000000","11":"2011","12":"CHEMET","13":"SUCCIMER"},{"1":"169","2":"1.142711e+06","3":"18","4":"6.348396e+04","5":"1.608000e+04","6":"7.106413e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CHENODAL","13":"CHENODIOL"},{"1":"5076","2":"2.024068e+04","3":"3802","4":"5.323693e+00","5":"1.024649e+06","6":"1.975376e-02","7":"3471","8":"4.621420e+00","9":"331","10":"4.94830816","11":"2011","12":"CHERATUSSIN AC","13":"GUAIFENESIN/CODEINE PHOSPHATE"},{"1":"4855","2":"6.338319e+04","3":"1597","4":"3.968891e+01","5":"1.080378e+06","6":"5.866758e-02","7":"360","8":"2.135986e+01","9":"1237","10":"2.67227971","11":"2011","12":"CHLORAL HYDRATE","13":"CHLORAL HYDRATE"},{"1":"66","2":"1.673649e+04","3":"13","4":"1.287422e+03","5":"6.193140e+03","6":"2.702424e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CHLORAMPHENICOL SOD SUCCINATE","13":"CHLORAMPHENICOL SOD SUCC"},{"1":"21823","2":"2.196974e+05","3":"5230","4":"4.200715e+01","5":"1.454091e+06","6":"1.510867e-01","7":"3832","8":"1.825605e+01","9":"1398","10":"6.41819027","11":"2011","12":"CHLORDIAZEPOXIDE HCL","13":"CHLORDIAZEPOXIDE HCL"},{"1":"44973","2":"2.326626e+06","3":"7893","4":"2.947708e+02","5":"2.867450e+06","6":"8.135638e-01","7":"5000","8":"6.901553e+01","9":"2893","10":"12.21920152","11":"2011","12":"CHLORDIAZEPOXIDE-AMITRIPTYLINE","13":"AMITRIP HCL/CHLORDIAZEPOXIDE"},{"1":"896447","2":"6.899079e+06","3":"458810","4":"1.503690e+01","5":"4.725499e+08","6":"1.459968e-02","7":"288800","8":"7.938503e+00","9":"170010","10":"2.19081566","11":"2011","12":"CHLORHEXIDINE GLUCONATE","13":"CHLORHEXIDINE GLUCONATE"},{"1":"26","2":"1.611100e+02","3":"23","4":"7.004783e+00","5":"5.430000e+03","6":"2.967035e-02","7":"12","8":"7.075000e+00","9":"11","10":"1.96363636","11":"2011","12":"CHLOR-MES D","13":"CHLOR-MAL/PHENYLEPH/METHSCOP"},{"1":"9072","2":"4.789442e+05","3":"4469","4":"1.071703e+02","5":"2.086455e+05","6":"2.734947e+00","7":"3468","8":"2.316663e+01","9":"1001","10":"4.66872128","11":"2011","12":"CHLOROQUINE PHOSPHATE","13":"CHLOROQUINE PHOSPHATE"},{"1":"21842","2":"2.054817e+05","3":"4212","4":"4.878482e+01","5":"1.136502e+06","6":"1.809453e-01","7":"3194","8":"3.403345e+01","9":"1018","10":"7.59369352","11":"2011","12":"CHLOROTHIAZIDE","13":"CHLOROTHIAZIDE"},{"1":"20","2":"3.133703e+04","3":"NA","4":"NA","5":"1.654000e+03","6":"1.894621e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CHLOROTHIAZIDE SODIUM","13":"CHLOROTHIAZIDE SODIUM"},{"1":"31","2":"5.687600e+02","3":"28","4":"2.031286e+01","5":"4.000000e+02","6":"1.421900e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CHLOROXYLENOL-PRAMOXINE HCL","13":"CHLOROXYLENOL/PRAMOXINE HCL"},{"1":"21","2":"1.409540e+03","3":"18","4":"7.830778e+01","5":"3.500000e+03","6":"4.027257e-01","7":"18","8":"NA","9":"0","10":"NA","11":"2011","12":"CHLORPHEN-PSE-DM TANNATE","13":"CHLORPHEN/PSEUDOEPH/DM TANNATE"},{"1":"300265","2":"1.024962e+07","3":"51144","4":"2.004070e+02","5":"2.003849e+07","6":"5.735097e-01","7":"15373","8":"2.539700e+01","9":"35771","10":"6.51881412","11":"2011","12":"CHLORPROMAZINE HCL","13":"CHLORPROMAZINE HCL"},{"1":"10328","2":"4.267780e+05","3":"1934","4":"2.206712e+02","5":"7.393250e+05","6":"5.704828e-01","7":"1342","8":"5.694714e+01","9":"592","10":"10.51344595","11":"2011","12":"CHLORPROPAMIDE","13":"CHLORPROPAMIDE"},{"1":"656661","2":"8.936576e+06","3":"148121","4":"6.033294e+01","5":"2.914651e+07","6":"3.062729e-01","7":"97228","8":"3.336822e+01","9":"50893","10":"6.77036881","11":"2011","12":"CHLORTHALIDONE","13":"CHLORTHALIDONE"},{"1":"133131","2":"1.430357e+06","3":"47971","4":"2.981712e+01","5":"9.998593e+06","6":"1.430561e-01","7":"25958","8":"1.208296e+01","9":"22013","10":"4.25062872","11":"2011","12":"CHLORZOXAZONE","13":"CHLORZOXAZONE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CHOICE-OB + DHA","13":"PRENATAL VITS #33/IRON/FA/DHA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CHOICE-TABS","13":"MV,MIN #10/FA/D3/ALIP ACID/LUT"},{"1":"364658","2":"2.555525e+07","3":"134083","4":"1.905928e+02","5":"8.732626e+07","6":"8.476021e-01","7":"82525","8":"4.383095e+01","9":"51558","10":"3.91189263","11":"2011","12":"CHOLESTYRAMINE","13":"CHOLESTYRAMINE (WITH SUGAR)"},{"1":"71524","2":"4.770963e+06","3":"27135","4":"1.758232e+02","5":"1.347526e+07","6":"7.053537e-01","7":"17482","8":"4.289179e+01","9":"9653","10":"4.05798405","11":"2011","12":"CHOLESTYRAMINE LIGHT","13":"CHOLESTYRAMINE/ASPARTAME"},{"1":"1412","2":"9.385234e+04","3":"345","4":"2.720358e+02","5":"4.846000e+05","6":"1.968090e-01","7":"143","8":"3.518615e+01","9":"202","10":"2.03277228","11":"2011","12":"CHOLINE MAG TRISALICYLATE","13":"CHOLINE SAL/MAG SALICYLATE"},{"1":"481","2":"1.684956e+05","3":"134","4":"1.257430e+03","5":"1.365300e+03","6":"1.234129e+02","7":"56","8":"1.400059e+02","9":"78","10":"4.19487179","11":"2011","12":"CHORIONIC GONADOTROPIN","13":"CHORIONIC GONADOTROPIN, HUMAN"},{"1":"90826","2":"9.597602e+06","3":"26986","4":"3.556512e+02","5":"6.234750e+05","6":"1.700402e+01","7":"23332","8":"9.862592e+01","9":"3654","10":"23.16249316","11":"2011","12":"CIALIS","13":"TADALAFIL"},{"1":"20","2":"6.086000e+02","3":"20","4":"3.043000e+01","5":"1.264000e+02","6":"4.814873e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CICLODAN","13":"CICLOPIROX"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CICLODAN","13":"CICLOPIROX OLAMINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CICLODAN","13":"CICLOPIROX/SKIN CLEANSER NO.28"},{"1":"64","2":"1.062532e+04","3":"55","4":"1.931876e+02","5":"2.284000e+03","6":"4.652067e+00","7":"39","8":"6.958282e+01","9":"16","10":"5.23125000","11":"2011","12":"CICLODAN","13":"CICLOPIROX/URE/CAMPH/MENTH/EUC"},{"1":"248673","2":"1.274818e+07","3":"134349","4":"9.488857e+01","5":"7.357973e+06","6":"2.754538e+00","7":"76425","8":"2.189481e+01","9":"57924","10":"2.32107917","11":"2011","12":"CICLOPIROX","13":"CICLOPIROX"},{"1":"221119","2":"1.075252e+07","3":"109780","4":"9.794605e+01","5":"1.269812e+07","6":"8.503428e-01","7":"56019","8":"1.713489e+01","9":"53761","10":"2.49079537","11":"2011","12":"CICLOPIROX","13":"CICLOPIROX OLAMINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CICLOPIROX","13":"CICLOPIROX/URE/CAMPH/MENTH/EUC"},{"1":"917","2":"1.492543e+05","3":"680","4":"2.194916e+02","5":"9.666000e+02","6":"1.544116e+02","7":"396","8":"4.247449e+01","9":"284","10":"2.32845070","11":"2011","12":"CICLOPIROX","13":"CICLOPIROX/VITE/NAIL LACQ REMO"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CIDOFOVIR","13":"CIDOFOVIR"},{"1":"1029328","2":"3.742309e+07","3":"191576","4":"1.953433e+02","5":"7.410695e+07","6":"5.052662e-01","7":"104862","8":"4.890531e+01","9":"86714","10":"7.97096939","11":"2011","12":"CILOSTAZOL","13":"CILOSTAZOL"},{"1":"18657","2":"1.815507e+06","3":"11258","4":"1.612637e+02","5":"6.895550e+04","6":"2.643731e+01","7":"6028","8":"7.612915e+01","9":"5230","10":"5.77177055","11":"2011","12":"CILOXAN","13":"CIPROFLOXACIN HCL"},{"1":"207618","2":"2.530533e+06","3":"55296","4":"4.576339e+01","5":"1.446244e+07","6":"1.787276e-01","7":"32415","8":"2.142637e+01","9":"22881","10":"5.33346925","11":"2011","12":"CIMETIDINE","13":"CIMETIDINE"},{"1":"1657","2":"5.117388e+04","3":"436","4":"1.173713e+02","5":"5.239380e+05","6":"1.012142e-01","7":"200","8":"1.715130e+01","9":"236","10":"4.83224576","11":"2011","12":"CIMETIDINE","13":"CIMETIDINE HCL"},{"1":"18668","2":"3.900755e+07","3":"3174","4":"1.228971e+04","5":"2.198108e+04","6":"1.774604e+03","7":"790","8":"1.403819e+03","9":"2384","10":"33.50547819","11":"2011","12":"CIMZIA","13":"CERTOLIZUMAB PEGOL"},{"1":"936","2":"3.420552e+07","3":"89","4":"3.843317e+05","5":"1.752900e+04","6":"1.951367e+03","7":"36","8":"1.790679e+04","9":"53","10":"23.35226415","11":"2011","12":"CINRYZE","13":"C1 ESTERASE INHIBITOR"},{"1":"8626","2":"1.122010e+06","3":"6962","4":"1.611620e+02","5":"1.013780e+06","6":"1.114007e+00","7":"2622","8":"6.945217e+01","9":"4340","10":"3.95129954","11":"2011","12":"CIPRO","13":"CIPROFLOXACIN"},{"1":"2589","2":"2.425898e+05","3":"1933","4":"1.254991e+02","5":"5.007100e+04","6":"4.849633e+00","7":"1264","8":"5.812104e+01","9":"669","10":"4.88535127","11":"2011","12":"CIPRO","13":"CIPROFLOXACIN HCL"},{"1":"29973","2":"4.083952e+06","3":"26187","4":"1.559534e+02","5":"3.020157e+05","6":"1.352232e+01","7":"11750","8":"6.564343e+01","9":"14437","10":"4.63416361","11":"2011","12":"CIPRO HC","13":"CIPROFLOXACIN/HYDROCORTISONE"},{"1":"227","2":"3.504364e+04","3":"149","4":"2.351922e+02","5":"2.693720e+05","6":"1.311791e-01","7":"26","8":"8.226423e+01","9":"123","10":"1.08577236","11":"2011","12":"CIPRO I.V.","13":"CIPROFLOXACIN LACTATE/D5W"},{"1":"179836","2":"2.386751e+07","3":"133618","4":"1.786250e+02","5":"1.372672e+06","6":"1.738763e+01","7":"69860","8":"5.919140e+01","9":"63758","10":"5.56157251","11":"2011","12":"CIPRODEX","13":"CIPROFLOXACIN HCL/DEXAMETH"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CIPROFLOXACIN","13":"CIPROFLOXACIN"},{"1":"850","2":"4.100604e+04","3":"385","4":"1.065092e+02","5":"5.386390e+05","6":"7.479442e-02","7":"130","8":"2.321100e+01","9":"255","10":"5.64443137","11":"2011","12":"CIPROFLOXACIN","13":"CIPROFLOXACIN LACTATE"},{"1":"5542","2":"4.251008e+05","3":"4716","4":"9.014011e+01","5":"5.226100e+04","6":"8.129843e+00","7":"3326","8":"1.994835e+01","9":"1390","10":"1.89566187","11":"2011","12":"CIPROFLOXACIN ER","13":"CIPROFLOXACIN/CIPROFLOXA HCL"},{"1":"6348878","2":"5.015751e+07","3":"4236767","4":"1.183863e+01","5":"1.088948e+08","6":"5.389441e-01","7":"2540037","8":"6.865141e+00","9":"1696730","10":"1.76799636","11":"2011","12":"CIPROFLOXACIN HCL","13":"CIPROFLOXACIN HCL"},{"1":"4477","2":"2.985886e+05","3":"2055","4":"1.452986e+02","5":"7.385135e+06","6":"4.181790e-02","7":"395","8":"4.229506e+01","9":"1660","10":"1.81346988","11":"2011","12":"CIPROFLOXACIN-D5W","13":"CIPROFLOXACIN LACTATE/D5W"},{"1":"478","2":"2.654581e+04","3":"169","4":"1.570758e+02","5":"7.771200e+04","6":"3.415922e-01","7":"67","8":"4.991791e+01","9":"102","10":"2.09705882","11":"2011","12":"CISPLATIN","13":"CISPLATIN"},{"1":"16","2":"8.078800e+02","3":"NA","4":"NA","5":"2.610000e+03","6":"3.095326e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITALOPRAM","13":"CITALOPRAM HYDROBROMIDE"},{"1":"10115390","2":"1.068451e+08","3":"1789937","4":"5.969208e+01","5":"4.134122e+08","6":"2.577917e-01","7":"943326","8":"2.988825e+01","9":"846611","10":"6.41656027","11":"2011","12":"CITALOPRAM HBR","13":"CITALOPRAM HYDROBROMIDE"},{"1":"163","2":"1.000149e+04","3":"78","4":"1.282242e+02","5":"1.122000e+04","6":"8.913984e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL 90 DHA","13":"PN W-CA64/IRON CB&GL/FA/DSS/DH"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL 90 DHA","13":"PNV72/IRON,CARB&GLU/FA/DSS/DHA"},{"1":"276","2":"1.647599e+04","3":"136","4":"1.211470e+02","5":"1.821000e+04","6":"9.047770e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL ASSURE","13":"PNV38/IRON CBN&GLUC/FA/DSS/DHA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL ASSURE","13":"PNV73/IRON,CARB&GLU/FA/DSS/DHA"},{"1":"27","2":"1.255110e+03","3":"17","4":"7.383000e+01","5":"2.370000e+03","6":"5.295823e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL B-CALM","13":"PNV WITH CA,NO63/IRON/FA/B6"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL B-CALM","13":"PRENATAL #48/IRON CB,GLU/FA/B6"},{"1":"155","2":"9.235510e+03","3":"62","4":"1.489598e+02","5":"1.089000e+04","6":"8.480725e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL DHA","13":"PNV22/IRON CBN&GLUC/FA/DSS/DHA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL DHA","13":"PNV76/IRON,CARB&GLU/FA/DSS/DHA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL HARMONY","13":"PNV34/IRON,CARBONYL/FA/DSS/DHA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL HARMONY","13":"PNV59/IRON,CARB&FUM/FA/DSS/DHA"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL HARMONY","13":"PNV59/IRON,CARBONYL/FA/DSS/DHA"},{"1":"66","2":"5.714070e+03","3":"43","4":"1.328853e+02","5":"3.123000e+03","6":"1.825321e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL HARMONY","13":"PNV69/IRON,CARBONYL/FA/DSS/DHA"},{"1":"58","2":"3.490910e+03","3":"24","4":"1.454546e+02","5":"2.767000e+03","6":"1.261623e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL RX","13":"PNV NO.22/IRON CBN&GLUC/FA/DSS"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CITRANATAL RX","13":"PNV NO.81/IRON CBN&GLUC/FA/DSS"},{"1":"158","2":"7.527330e+03","3":"95","4":"7.923505e+01","5":"1.092000e+04","6":"1.115539e+00","7":"17","8":"5.137706e+01","9":"78","10":"1.57115385","11":"2011","12":"CLAFORAN","13":"CEFOTAXIME SODIUM"},{"1":"3366","2":"1.568641e+06","3":"1081","4":"1.451102e+03","5":"1.552630e+05","6":"1.005363e+01","7":"489","8":"1.908676e+02","9":"592","10":"7.33978041","11":"2011","12":"CLARAVIS","13":"ISOTRETINOIN"},{"1":"36","2":"6.825930e+03","3":"32","4":"2.133103e+02","5":"3.320000e+03","6":"2.056003e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLARIFOAM EF","13":"SULFACETAMIDE SODIUM/SULFUR"},{"1":"88571","2":"1.472705e+07","3":"30432","4":"4.839330e+02","5":"3.570001e+06","6":"4.211256e+00","7":"15298","8":"1.392332e+02","9":"15134","10":"12.30514801","11":"2011","12":"CLARINEX","13":"DESLORATADINE"},{"1":"3573","2":"5.298167e+05","3":"1920","4":"2.759462e+02","5":"1.794830e+05","6":"2.951904e+00","7":"1087","8":"5.802923e+01","9":"833","10":"9.36901561","11":"2011","12":"CLARINEX-D 12 HOUR","13":"DESLORATADINE/PSEUDOEPHEDRINE"},{"1":"5469","2":"9.097013e+05","3":"2209","4":"4.118159e+02","5":"1.992600e+05","6":"4.565398e+00","7":"919","8":"9.635616e+01","9":"1290","10":"10.91379070","11":"2011","12":"CLARINEX-D 24 HOUR","13":"DESLORATADINE/PSEUDOEPHEDRINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLARIS","13":"SULFACETAMIDE SOD/SULFUR/UREA"},{"1":"423268","2":"1.816506e+07","3":"343795","4":"5.283688e+01","5":"1.039856e+07","6":"1.810911e+00","7":"200240","8":"1.250402e+01","9":"143555","10":"1.88199478","11":"2011","12":"CLARITHROMYCIN","13":"CLARITHROMYCIN"},{"1":"88491","2":"6.229534e+06","3":"73398","4":"8.487334e+01","5":"1.813966e+06","6":"3.434206e+00","7":"50506","8":"1.829496e+01","9":"22892","10":"2.38596802","11":"2011","12":"CLARITHROMYCIN ER","13":"CLARITHROMYCIN"},{"1":"49","2":"5.835620e+03","3":"36","4":"1.621006e+02","5":"2.413000e+04","6":"2.418409e-01","7":"25","8":"1.333000e+01","9":"11","10":"1.53636364","11":"2011","12":"CLEANSING WASH","13":"SULFACETAMIDE SOD/SULFUR/UREA"},{"1":"22171","2":"3.827588e+05","3":"5964","4":"6.417821e+01","5":"1.438528e+06","6":"2.944668e-01","7":"1886","8":"2.591864e+01","9":"4078","10":"4.46306032","11":"2011","12":"CLEMASTINE FUMARATE","13":"CLEMASTINE FUMARATE"},{"1":"486","2":"4.462669e+04","3":"329","4":"1.356434e+02","5":"9.134810e+04","6":"9.606968e-01","7":"293","8":"2.848201e+01","9":"36","10":"8.14083333","11":"2011","12":"CLENIA","13":"SULFACETAMIDE SODIUM/SULFUR"},{"1":"3908","2":"3.402442e+05","3":"3146","4":"1.081514e+02","5":"1.834026e+04","6":"2.278788e+01","7":"1738","8":"5.789685e+01","9":"1408","10":"6.29661222","11":"2011","12":"CLEOCIN","13":"CLINDAMYCIN PHOSPHATE"},{"1":"323","2":"3.927323e+04","3":"232","4":"1.692812e+02","5":"1.159700e+04","6":"3.612022e+00","7":"140","8":"6.808064e+01","9":"92","10":"5.18119565","11":"2011","12":"CLEOCIN HCL","13":"CLINDAMYCIN HCL"},{"1":"629","2":"1.417704e+05","3":"484","4":"2.929139e+02","5":"2.405780e+05","6":"5.892906e-01","7":"145","8":"6.196745e+01","9":"339","10":"2.06858407","11":"2011","12":"CLEOCIN PALMITATE","13":"CLINDAMYCIN PALMITATE HCL"},{"1":"369","2":"4.598797e+04","3":"164","4":"2.804145e+02","5":"8.096295e+04","6":"5.733380e-01","7":"58","8":"1.297224e+02","9":"106","10":"3.28820755","11":"2011","12":"CLEOCIN PHOSPHATE","13":"CLINDAMYCIN PHOSPHATE"},{"1":"654","2":"9.593028e+04","3":"331","4":"2.898196e+02","5":"3.597090e+05","6":"2.712337e-01","7":"47","8":"1.242923e+02","9":"284","10":"2.98683099","11":"2011","12":"CLEOCIN PHOSPHATE IN D5W","13":"CLINDAMYCIN PHOSPHATE/D5W"},{"1":"208","2":"1.680336e+04","3":"125","4":"1.344269e+02","5":"1.692000e+04","6":"1.194960e+00","7":"78","8":"5.950731e+01","9":"47","10":"5.17255319","11":"2011","12":"CLEOCIN T","13":"CLINDAMYCIN PHOSPHATE"},{"1":"17414","2":"3.361151e+05","3":"7574","4":"4.437749e+01","5":"1.891496e+06","6":"1.777049e-01","7":"3629","8":"3.121067e+01","9":"3945","10":"6.47682129","11":"2011","12":"CLICKFINE","13":"PEN NEEDLE, DIABETIC"},{"1":"29316","2":"3.103722e+06","3":"8179","4":"3.794745e+02","5":"2.524580e+05","6":"1.234928e+01","7":"7079","8":"1.314049e+02","9":"1100","10":"16.73206364","11":"2011","12":"CLIMARA","13":"ESTRADIOL"},{"1":"8902","2":"9.193838e+05","3":"2043","4":"4.500166e+02","5":"5.039800e+04","6":"1.824247e+01","7":"1475","8":"2.974115e+02","9":"568","10":"18.13772887","11":"2011","12":"CLIMARA PRO","13":"ESTRADIOL/LEVONORGESTREL"},{"1":"18","2":"2.162840e+03","3":"13","4":"1.663723e+02","5":"1.125000e+03","6":"1.922524e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINAC BPO","13":"BENZOYL PEROXIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDACIN ETZ","13":"CLINDAMYCIN PHOS/SKIN CLNSR 19"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDACIN ETZ","13":"CLINDAMYCIN PHOSPHATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDACIN P","13":"CLINDAMYCIN PHOSPHATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDACIN PAC","13":"CLINDAMYCIN PHOS/SKIN CLNSR 19"},{"1":"1990","2":"6.101444e+05","3":"1307","4":"4.668281e+02","5":"1.222650e+05","6":"4.990344e+00","7":"685","8":"9.037788e+01","9":"622","10":"6.85659164","11":"2011","12":"CLINDAGEL","13":"CLINDAMYCIN PHOSPHATE"},{"1":"129","2":"6.558540e+03","3":"95","4":"6.903726e+01","5":"6.062400e+03","6":"1.095740e+00","7":"22","8":"1.358182e+01","9":"73","10":"1.21712329","11":"2011","12":"CLINDAMAX","13":"CLINDAMYCIN PHOSPHATE"},{"1":"1418021","2":"2.270878e+07","3":"1032744","4":"2.198878e+01","5":"4.238911e+07","6":"5.561005e-01","7":"624561","8":"8.594052e+00","9":"408183","10":"1.76292121","11":"2011","12":"CLINDAMYCIN HCL","13":"CLINDAMYCIN HCL"},{"1":"4272","2":"9.540807e+05","3":"3519","4":"2.711227e+02","5":"1.887450e+06","6":"5.054866e-01","7":"1476","8":"4.066123e+01","9":"2043","10":"2.18677925","11":"2011","12":"CLINDAMYCIN PALMITATE HCL","13":"CLINDAMYCIN PALMITATE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDAMYCIN PEDIATRIC","13":"CLINDAMYCIN PALMITATE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDAMYCIN PHOS-BENZOYL PEROX","13":"CLINDAMYCIN PHOS/BENZOYL PEROX"},{"1":"254474","2":"8.220254e+06","3":"134840","4":"6.096302e+01","5":"1.572610e+07","6":"5.567222e-01","7":"69670","8":"1.273141e+01","9":"65170","10":"2.39990717","11":"2011","12":"CLINDAMYCIN PHOSPHATE","13":"CLINDAMYCIN PHOSPHATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDAMYCIN PHOSPHATE-D5W","13":"CLINDAMYCIN PHOSPHATE/D5W"},{"1":"11115","2":"1.573275e+06","3":"5887","4":"2.672456e+02","5":"5.754367e+05","6":"2.734054e+00","7":"2022","8":"3.884251e+01","9":"3865","10":"2.79993273","11":"2011","12":"CLINDAMYCIN-BENZOYL PEROXIDE","13":"CLINDAMYCIN PHOS/BENZOYL PEROX"},{"1":"16","2":"2.631870e+03","3":"12","4":"2.193225e+02","5":"1.600000e+01","6":"1.644919e+02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDAREACH","13":"CLINDAMYCIN PHOSPHATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINDESSE","13":"CLINDAMYCIN PHOSPHATE"},{"1":"20","2":"9.590030e+03","3":"NA","4":"NA","5":"2.280000e+05","6":"4.206154e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX","13":"AMINO ACID 4.25 %/DEXTROSE 25%"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX","13":"AMINO ACIDS 4.25 %/DEXTROSE 5%"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX","13":"AMINO ACIDS 4.25%/DEXTROSE 10%"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX","13":"AMINO ACIDS 5 %/DEXTROSE 15 %"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX","13":"AMINO ACIDS 5 %/DEXTROSE 20 %"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX","13":"AMINO ACIDS 5 %/DEXTROSE 25 %"},{"1":"36","2":"8.441180e+03","3":"NA","4":"NA","5":"1.429104e+05","6":"5.906624e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX E","13":"AA 4.25%/CALCIUM/LYTES/D25W"},{"1":"19","2":"1.648971e+04","3":"NA","4":"NA","5":"2.488190e+05","6":"6.627191e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX E","13":"AA 4.25%/CALCIUM/LYTES/D5W"},{"1":"47","2":"1.520298e+04","3":"13","4":"1.169460e+03","5":"2.725490e+05","6":"5.578072e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX E","13":"AA 4.25%/CALCIUM/LYTES/DEX 10%"},{"1":"71","2":"4.353318e+04","3":"16","4":"2.720824e+03","5":"6.703280e+05","6":"6.494310e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX E","13":"AA 5 %/CALCIUM/LYTES/DEXT 15 %"},{"1":"35","2":"1.436446e+04","3":"12","4":"1.197038e+03","5":"2.129503e+05","6":"6.745452e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX E","13":"AA 5 %/CALCIUM/LYTES/DEXT 20 %"},{"1":"20","2":"3.531220e+03","3":"NA","4":"NA","5":"1.070000e+05","6":"3.300206e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINIMIX E","13":"AA 5 %/CALCIUM/LYTES/DEXT 25 %"},{"1":"44244","2":"1.531139e+07","3":"2263","4":"6.765970e+03","5":"9.759210e+07","6":"1.568917e-01","7":"321","8":"1.750704e+03","9":"1942","10":"38.54545314","11":"2011","12":"CLINISOL","13":"PARENTERAL AMINO ACID 15% NO.1"},{"1":"46","2":"1.653670e+03","3":"35","4":"4.724771e+01","5":"1.534000e+03","6":"1.078012e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLINORIL","13":"SULINDAC"},{"1":"116","2":"2.186160e+03","3":"90","4":"2.429067e+01","5":"1.523600e+04","6":"1.434865e-01","7":"70","8":"1.791829e+01","9":"20","10":"1.01400000","11":"2011","12":"CLINPRO 5000","13":"SODIUM FLUORIDE"},{"1":"11","2":"2.943520e+03","3":"NA","4":"NA","5":"1.200000e+01","6":"2.453738e+02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLOBETA + PLUS","13":"CLOBETASOL PROPIONATE/COAL TAR"},{"1":"39492","2":"1.349887e+06","3":"22726","4":"5.939833e+01","5":"2.460493e+06","6":"5.486245e-01","7":"15012","8":"1.317293e+01","9":"7714","10":"2.53902515","11":"2011","12":"CLOBETASOL EMOLLIENT","13":"CLOBETASOL PROPIONATE/EMOLL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLOBETASOL EMULSION","13":"CLOBETASOL PROPIONATE/EMOLL"},{"1":"1220897","2":"3.417967e+07","3":"617494","4":"5.535223e+01","5":"7.010616e+07","6":"4.485903e-01","7":"420543","8":"1.554318e+01","9":"196951","10":"2.96823220","11":"2011","12":"CLOBETASOL PROPIONATE","13":"CLOBETASOL PROPIONATE"},{"1":"38797","2":"1.560946e+07","3":"20850","4":"7.486553e+02","5":"4.427392e+06","6":"3.572806e+00","7":"13925","8":"1.267754e+02","9":"6925","10":"10.45886065","11":"2011","12":"CLOBEX","13":"CLOBETASOL PROPIONATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLOCORTOLONE PIVALATE","13":"CLOCORTOLONE PIVALATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLODAN","13":"CLOBETASOL PROPIONATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLODAN","13":"CLOBETASOL/SKIN CLEANSER #28"},{"1":"5488","2":"1.016126e+06","3":"3734","4":"2.721281e+02","5":"2.886021e+05","6":"3.520855e+00","7":"2824","8":"8.778378e+01","9":"910","10":"7.76386813","11":"2011","12":"CLODERM","13":"CLOCORTOLONE PIVALATE"},{"1":"23","2":"9.266000e+02","3":"15","4":"6.177333e+01","5":"4.650000e+02","6":"1.992688e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLOMIPHENE CITRATE","13":"CLOMIPHENE CITRATE"},{"1":"133707","2":"3.351112e+06","3":"16906","4":"1.982203e+02","5":"1.022152e+07","6":"3.306195e-01","7":"5156","8":"5.451250e+01","9":"11750","10":"8.88567489","11":"2011","12":"CLOMIPRAMINE HCL","13":"CLOMIPRAMINE HCL"},{"1":"587601","2":"6.813947e+06","3":"110816","4":"6.148884e+01","5":"3.639518e+07","6":"1.872331e-01","7":"88266","8":"2.153260e+01","9":"22550","10":"16.54133836","11":"2011","12":"CLONAZEPAM","13":"CLONAZEPAM"},{"1":"445964","2":"8.606138e+07","3":"90570","4":"9.502196e+02","5":"2.138621e+06","6":"3.992325e+01","7":"35410","8":"1.742739e+02","9":"55160","10":"8.07464322","11":"2011","12":"CLONIDINE","13":"CLONIDINE"},{"1":"4606990","2":"4.127979e+07","3":"862356","4":"4.786862e+01","5":"3.669100e+08","6":"1.114748e-01","7":"397737","8":"2.699079e+01","9":"464619","10":"6.55886546","11":"2011","12":"CLONIDINE HCL","13":"CLONIDINE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLONIDINE HCL","13":"CLONIDINE HCL/PF"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLONIDINE HCL ER","13":"CLONIDINE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLOPIDOGREL","13":"CLOPIDOGREL BISULFATE"},{"1":"50621","2":"9.381333e+05","3":"10695","4":"8.771700e+01","5":"2.889813e+06","6":"3.231039e-01","7":"8612","8":"1.721026e+01","9":"2083","10":"7.16837734","11":"2011","12":"CLORAZEPATE DIPOTASSIUM","13":"CLORAZEPATE DIPOTASSIUM"},{"1":"1719","2":"1.637769e+05","3":"326","4":"5.023832e+02","5":"1.027420e+05","6":"1.587735e+00","7":"213","8":"2.540144e+02","9":"113","10":"16.62513274","11":"2011","12":"CLORPRES","13":"CLONIDINE HCL/CHLORTHALIDONE"},{"1":"501744","2":"1.662495e+07","3":"287640","4":"5.779776e+01","5":"2.293130e+07","6":"6.975055e-01","7":"119249","8":"1.260021e+01","9":"168391","10":"1.91653984","11":"2011","12":"CLOTRIMAZOLE","13":"CLOTRIMAZOLE"},{"1":"1466693","2":"6.112053e+07","3":"783329","4":"7.802664e+01","5":"6.204102e+07","6":"9.883988e-01","7":"438682","8":"1.326238e+01","9":"344647","10":"2.39506585","11":"2011","12":"CLOTRIMAZOLE-BETAMETHASONE","13":"CLOTRIMAZOLE/BETAMETHASONE DIP"},{"1":"1089579","2":"1.121867e+08","3":"58469","4":"1.918738e+03","5":"7.220331e+07","6":"1.641577e+00","7":"4842","8":"3.602961e+02","9":"53627","10":"22.13180711","11":"2011","12":"CLOZAPINE","13":"CLOZAPINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CLOZAPINE ODT","13":"CLOZAPINE"},{"1":"24501","2":"1.627045e+07","3":"1854","4":"8.775863e+03","5":"2.507358e+06","6":"6.171279e+00","7":"154","8":"7.273564e+02","9":"1700","10":"33.32282941","11":"2011","12":"CLOZARIL","13":"CLOZAPINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"C-NATE DHA","13":"PNV 11-IRON FUM-FOLIC ACID-OM3"},{"1":"193","2":"3.916072e+04","3":"143","4":"2.738512e+02","5":"2.160000e+02","6":"1.812996e+02","7":"73","8":"8.641041e+01","9":"70","10":"1.68857143","11":"2011","12":"CNL 8","13":"CICLOPIROX/NAIL LACQUER REMOVR"},{"1":"77","2":"9.238050e+03","3":"48","4":"1.924594e+02","5":"3.110000e+03","6":"2.970434e+00","7":"37","8":"8.589027e+01","9":"11","10":"4.69090909","11":"2011","12":"COARTEM","13":"ARTEMETHER/LUMEFANTRINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COCAINE HCL","13":"COCAINE HCL"},{"1":"29284","2":"1.449142e+06","3":"9815","4":"1.476456e+02","5":"3.456119e+06","6":"4.117113e-01","7":"5478","8":"3.794076e+01","9":"4337","10":"4.75962186","11":"2011","12":"CODEINE SULFATE","13":"CODEINE SULFATE"},{"1":"199","2":"7.829607e+04","3":"111","4":"7.053700e+02","5":"1.332000e+03","6":"5.878083e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COGENTIN","13":"BENZTROPINE MESYLATE"},{"1":"20","2":"1.656500e+02","3":"NA","4":"NA","5":"1.625000e+03","6":"1.019385e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CO-GESIC","13":"HYDROCODONE/ACETAMINOPHEN"},{"1":"3221","2":"9.599005e+05","3":"1270","4":"7.558271e+02","5":"1.516967e+06","6":"6.327761e-01","7":"1129","8":"9.133552e+01","9":"141","10":"23.16992908","11":"2011","12":"COLAZAL","13":"BALSALAZIDE DISODIUM"},{"1":"91000","2":"2.002478e+06","3":"55034","4":"3.638619e+01","5":"4.142408e+06","6":"4.834091e-01","7":"34811","8":"1.370902e+01","9":"20223","10":"3.14075310","11":"2011","12":"COLCHICINE","13":"COLCHICINE"},{"1":"923418","2":"1.920304e+08","3":"300666","4":"6.386834e+02","5":"3.820067e+07","6":"5.026885e+00","7":"161808","8":"1.376932e+02","9":"138858","10":"16.81092785","11":"2011","12":"COLCRYS","13":"COLCHICINE"},{"1":"2195","2":"2.665662e+05","3":"799","4":"3.336248e+02","5":"3.864690e+05","6":"1.147678e+00","7":"498","8":"1.533891e+02","9":"301","10":"7.72166113","11":"2011","12":"COLESTID","13":"COLESTIPOL HCL"},{"1":"183275","2":"1.207461e+07","3":"47586","4":"2.537430e+02","5":"2.167089e+07","6":"6.029813e-01","7":"32205","8":"5.818567e+01","9":"15381","10":"7.17024511","11":"2011","12":"COLESTIPOL HCL","13":"COLESTIPOL HCL"},{"1":"2998","2":"2.664987e+06","3":"1042","4":"2.557569e+03","5":"1.868403e+05","6":"1.426345e+01","7":"196","8":"6.536882e+02","9":"846","10":"3.36017731","11":"2011","12":"COLISTIMETHATE","13":"COLISTIN (COLISTIMETHATE NA)"},{"1":"2629","2":"4.379802e+05","3":"1316","4":"3.328117e+02","5":"3.361120e+06","6":"1.303078e-01","7":"956","8":"6.366813e+01","9":"360","10":"4.36163889","11":"2011","12":"COLOCORT","13":"HYDROCORTISONE"},{"1":"88","2":"2.566340e+04","3":"51","4":"5.032039e+02","5":"9.526000e+03","6":"2.694037e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COLY-MYCIN M PARENTERAL","13":"COLISTIN (COLISTIMETHATE NA)"},{"1":"1285","2":"6.542778e+04","3":"1047","4":"6.249072e+01","5":"8.115000e+03","6":"8.062573e+00","7":"534","8":"4.431882e+01","9":"513","10":"4.91222222","11":"2011","12":"COLY-MYCIN S","13":"NEOMYCIN SU/COLIST/HC/THONZON"},{"1":"35","2":"7.392500e+02","3":"35","4":"2.112143e+01","5":"1.440000e+05","6":"5.133681e-03","7":"12","8":"1.328333e+01","9":"23","10":"1.56521739","11":"2011","12":"COLYTE","13":"PEG 3350/NA SULF,BICARB,CL/KCL"},{"1":"10060","2":"2.200247e+05","3":"9749","4":"2.256895e+01","5":"4.048866e+07","6":"5.434229e-03","7":"7236","8":"1.744069e+01","9":"2513","10":"3.07742141","11":"2011","12":"COLYTE WITH FLAVOR PACKETS","13":"PEG 3350/NA SULF,BICARB,CL/KCL"},{"1":"3262","2":"1.014947e+05","3":"3231","4":"3.141278e+01","5":"1.237891e+07","6":"8.199002e-03","7":"2446","8":"2.805307e+01","9":"785","10":"5.58304459","11":"2011","12":"COLYTE WITH FLAVOR PACKS","13":"PEG 3350/NA SULF,BICARB,CL/KCL"},{"1":"783756","2":"7.946400e+07","3":"170680","4":"4.655730e+02","5":"5.185647e+06","6":"1.532384e+01","7":"104702","8":"1.864705e+02","9":"65978","10":"20.88606839","11":"2011","12":"COMBIGAN","13":"BRIMONIDINE TARTRATE/TIMOLOL"},{"1":"20126","2":"1.604314e+06","3":"4772","4":"3.361933e+02","5":"2.144410e+05","6":"7.481586e+00","7":"3256","8":"2.458954e+02","9":"1516","10":"19.14548153","11":"2011","12":"COMBIPATCH","13":"ESTRADIOL/NORETHINDRONE ACET"},{"1":"2128397","2":"4.770053e+08","3":"542486","4":"8.792951e+02","5":"3.927919e+07","6":"1.214397e+01","7":"228580","8":"1.877820e+02","9":"313906","10":"19.90463043","11":"2011","12":"COMBIVENT","13":"IPRATROPIUM/ALBUTEROL SULFATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMBIVENT RESPIMAT","13":"IPRATROPIUM/ALBUTEROL SULFATE"},{"1":"85971","2":"7.851435e+07","3":"10660","4":"7.365324e+03","5":"5.390325e+06","6":"1.456579e+01","7":"1923","8":"7.593926e+02","9":"8737","10":"25.63364427","11":"2011","12":"COMBIVIR","13":"LAMIVUDINE/ZIDOVUDINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMETRIQ","13":"CABOZANTINIB S-MALATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMFORT EZ","13":"PEN NEEDLE, DIABETIC"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMFORT EZ","13":"SYRING W-NDL,DISP,INSUL,0.3 ML"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMFORT EZ","13":"SYRING W-NDL,DISP,INSUL,0.5 ML"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMFORT EZ","13":"SYRINGE AND NEEDLE,INSULIN,1ML"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMPAZINE","13":"PROCHLORPERAZINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMPAZINE","13":"PROCHLORPERAZINE MALEATE"},{"1":"1970","2":"3.536816e+06","3":"861","4":"4.107800e+03","5":"6.009300e+04","6":"5.885571e+01","7":"92","8":"3.069517e+02","9":"769","10":"4.89665800","11":"2011","12":"COMPLERA","13":"EMTRICITAB/RILPIVIRINE/TENOFOV"},{"1":"81","2":"2.407370e+03","3":"28","4":"8.597750e+01","5":"5.250000e+03","6":"4.585467e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMPLETE NATAL DHA","13":"PNV2/IRON B-G SUC-P/FA/OMEGA-3"},{"1":"167","2":"4.135990e+03","3":"77","4":"5.371416e+01","5":"7.236000e+03","6":"5.715851e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMPLETENATE","13":"PNV #14/FERROUS FUM/FOLIC ACID"},{"1":"40","2":"4.623200e+02","3":"NA","4":"NA","5":"1.373000e+03","6":"3.367225e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMPLETE-RF PRENATAL","13":"PRENATAL VIT 17/IRON CB/FA/DSS"},{"1":"30465","2":"8.721047e+05","3":"24587","4":"3.547015e+01","5":"4.073557e+05","6":"2.140892e+00","7":"8766","8":"9.712660e+00","9":"15821","10":"0.74295304","11":"2011","12":"COMPRO","13":"PROCHLORPERAZINE"},{"1":"141078","2":"5.552423e+07","3":"21962","4":"2.528196e+03","5":"1.678508e+07","6":"3.307952e+00","7":"11982","8":"5.086744e+02","9":"9980","10":"28.12544990","11":"2011","12":"COMTAN","13":"ENTACAPONE"},{"1":"22","2":"1.214690e+03","3":"15","4":"8.097933e+01","5":"2.150000e+01","6":"5.649721e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COMVAX","13":"HEP B VACCINE/HIB CONJ-MENG/PF"},{"1":"178","2":"5.489260e+03","3":"77","4":"7.128909e+01","5":"6.243000e+03","6":"8.792664e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CONCEPT DHA","13":"PNV#16/IRON FUM & PS/FA/OM-3"},{"1":"83","2":"2.407080e+03","3":"48","4":"5.014750e+01","5":"3.112000e+03","6":"7.734833e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CONCEPT OB","13":"PNV #15/IRON FUM,PS/FOLIC ACID"},{"1":"29390","2":"6.951873e+06","3":"8264","4":"8.412237e+02","5":"1.143638e+06","6":"6.096017e+00","7":"2210","8":"2.250731e+02","9":"6054","10":"16.05598778","11":"2011","12":"CONCERTA","13":"METHYLPHENIDATE HCL"},{"1":"2031","2":"5.952947e+05","3":"1465","4":"4.063445e+02","5":"7.621000e+03","6":"7.808549e+01","7":"515","8":"7.462555e+01","9":"950","10":"6.12808421","11":"2011","12":"CONDYLOX","13":"PODOFILOX"},{"1":"7605","2":"2.100308e+05","3":"2849","4":"7.372087e+01","5":"7.979363e+06","6":"2.632174e-02","7":"765","8":"1.760094e+01","9":"2084","10":"2.10811420","11":"2011","12":"CONSTULOSE","13":"LACTULOSE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CONTRAVE","13":"NALTREXONE HCL/BUPROPION HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CONTROL RX","13":"SODIUM FLUORIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CONZIP","13":"TRAMADOL HCL"},{"1":"188828","2":"7.077777e+08","3":"22731","4":"3.113711e+04","5":"1.981888e+05","6":"3.571218e+03","7":"8415","8":"3.318096e+03","9":"14316","10":"108.23678402","11":"2011","12":"COPAXONE","13":"GLATIRAMER ACETATE"},{"1":"81","2":"1.658467e+05","3":"28","4":"5.923096e+03","5":"1.185200e+04","6":"1.399314e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COPEGUS","13":"RIBAVIRIN"},{"1":"1131","2":"1.970529e+05","3":"233","4":"8.457208e+02","5":"4.972200e+04","6":"3.963094e+00","7":"166","8":"3.696245e+02","9":"67","10":"14.77552239","11":"2011","12":"CORDARONE","13":"AMIODARONE HCL"},{"1":"19283","2":"2.831766e+06","3":"11036","4":"2.565935e+02","5":"2.721020e+05","6":"6.989391e+01","7":"7693","8":"8.068818e+01","9":"3343","10":"8.73917739","11":"2011","12":"CORDRAN","13":"FLURANDRENOLIDE"},{"1":"19584","2":"3.529079e+06","3":"4221","4":"8.360766e+02","5":"1.607379e+06","6":"2.195334e+00","7":"2402","8":"2.912314e+02","9":"1819","10":"21.78359538","11":"2011","12":"COREG","13":"CARVEDILOL"},{"1":"397603","2":"6.816120e+07","3":"67444","4":"1.010634e+03","5":"1.647899e+07","6":"4.136275e+00","7":"34012","8":"3.139645e+02","9":"33432","10":"27.29019442","11":"2011","12":"COREG CR","13":"CARVEDILOL PHOSPHATE"},{"1":"36","2":"2.195210e+03","3":"19","4":"1.155374e+02","5":"2.850000e+03","6":"7.702491e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORENATE-DHA","13":"PNV38/IRON CBN&GLUC/FA/DSS/DHA"},{"1":"11","2":"1.290800e+02","3":"NA","4":"NA","5":"1.770000e+03","6":"7.292655e-02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORFEN-DM","13":"CHLORPHENIRAMINE/PHENYLEPH/DM"},{"1":"3269","2":"6.236080e+05","3":"650","4":"9.593970e+02","5":"1.953020e+05","6":"3.244147e+00","7":"530","8":"3.693959e+02","9":"120","10":"39.58208333","11":"2011","12":"CORGARD","13":"NADOLOL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORLANOR","13":"IVABRADINE HCL"},{"1":"1271","2":"5.974799e+04","3":"744","4":"8.030644e+01","5":"1.180500e+05","6":"5.054272e-01","7":"639","8":"2.230610e+01","9":"105","10":"2.47295238","11":"2011","12":"CORMAX","13":"CLOBETASOL PROPIONATE"},{"1":"8255","2":"4.679324e+05","3":"1759","4":"2.660218e+02","5":"1.039580e+06","6":"4.642124e-01","7":"1062","8":"1.846736e+02","9":"697","10":"15.48371593","11":"2011","12":"CORTEF","13":"HYDROCORTISONE"},{"1":"79","2":"1.423271e+04","3":"60","4":"2.372118e+02","5":"9.132000e+04","6":"1.558553e-01","7":"38","8":"9.198579e+01","9":"22","10":"3.75909091","11":"2011","12":"CORTENEMA","13":"HYDROCORTISONE"},{"1":"3278","2":"1.242926e+06","3":"1619","4":"7.677119e+02","5":"7.180200e+04","6":"1.731046e+01","7":"970","8":"1.405530e+02","9":"649","10":"9.84993837","11":"2011","12":"CORTIFOAM","13":"HYDROCORTISONE ACETATE"},{"1":"95","2":"2.170420e+03","3":"46","4":"4.718304e+01","5":"5.632000e+03","6":"3.853729e-01","7":"24","8":"1.591083e+01","9":"22","10":"2.52636364","11":"2011","12":"CORTISONE","13":"CORTISONE ACETATE"},{"1":"16784","2":"4.471689e+05","3":"2787","4":"1.604481e+02","5":"1.120192e+06","6":"3.991894e-01","7":"1900","8":"4.841143e+01","9":"887","10":"8.94720406","11":"2011","12":"CORTISONE ACETATE","13":"CORTISONE ACETATE"},{"1":"3663","2":"3.009191e+05","3":"2594","4":"1.160058e+02","5":"6.639850e+04","6":"4.532016e+00","7":"1341","8":"6.101530e+01","9":"1253","10":"5.85293695","11":"2011","12":"CORTISPORIN","13":"NEOMYCIN/BACITRA/POLYMYXIN/HC"},{"1":"1893","2":"1.316228e+05","3":"1264","4":"1.041319e+02","5":"2.001169e+04","6":"6.575514e+00","7":"484","8":"5.394353e+01","9":"780","10":"4.77415385","11":"2011","12":"CORTISPORIN","13":"NEOMYCIN/POLYMYXIN B SULF/HC"},{"1":"6952","2":"5.200355e+05","3":"6412","4":"8.110348e+01","5":"7.087600e+04","6":"7.337258e+00","7":"3419","8":"5.582114e+01","9":"2993","10":"4.67040094","11":"2011","12":"CORTISPORIN-TC","13":"NEOMYCIN SU/COLIST/HC/THONZON"},{"1":"1707","2":"3.170559e+04","3":"1491","4":"2.126465e+01","5":"1.764206e+04","6":"1.793842e+00","7":"421","8":"7.311211e+00","9":"1070","10":"1.26172897","11":"2011","12":"CORTOMYCIN","13":"NEOMYCIN/POLYMYXIN B SULF/HC"},{"1":"49","2":"1.307690e+03","3":"17","4":"7.692294e+01","5":"2.284000e+03","6":"5.725438e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORVITA","13":"FA/MVI THER-MIN/LYCOPENE/LUT"},{"1":"115","2":"5.590480e+03","3":"40","4":"1.397620e+02","5":"5.110000e+03","6":"1.094027e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORVITA 150","13":"IRON, CARBONYL/FA/C/B-6/B12/ZN"},{"1":"46","2":"1.880600e+03","3":"18","4":"1.044778e+02","5":"3.090000e+03","6":"6.086084e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORVITE","13":"FA/MVI THER-MIN/LYCOPENE/LUT"},{"1":"98","2":"7.585450e+03","3":"37","4":"2.050122e+02","5":"5.577000e+03","6":"1.360131e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORVITE 150","13":"IRON, CARBONYL/FA/C/B-6/B12/ZN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORVITE 150","13":"IRON,CARB/FA#6/MV, MIN NO.41"},{"1":"80","2":"9.096250e+03","3":"40","4":"2.274062e+02","5":"3.568000e+03","6":"2.549397e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORVITE FE","13":"IRON &IRON ASP GLY/FA/MV,MIN27"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORVITE FE","13":"IRON,CARB/FA#6/MV, MIN NO.40"},{"1":"73","2":"2.373520e+03","3":"18","4":"1.318622e+02","5":"3.934000e+03","6":"6.033350e-01","7":"18","8":"NA","9":"0","10":"NA","11":"2011","12":"CORVITE FREE","13":"MV, MIN CMB #6/FA/LUT/LYCO/Q10"},{"1":"24","2":"9.010100e+02","3":"20","4":"4.505050e+01","5":"3.910000e+03","6":"2.304373e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORZALL PLUS","13":"PYRILAMINE/PSEUDOEPHED/CARBETA"},{"1":"11","2":"3.572200e+02","3":"NA","4":"NA","5":"1.680000e+03","6":"2.126310e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CORZALL-PE","13":"DEXCHLORPHENIRAM-PE-CARBETAPEN"},{"1":"612","2":"7.575465e+04","3":"110","4":"6.886786e+02","5":"2.329000e+04","6":"3.253493e+00","7":"81","8":"3.950460e+02","9":"29","10":"32.31000000","11":"2011","12":"CORZIDE","13":"NADOLOL/BENDROFLUMETHIAZIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COSENTYX (2 SYRINGES)","13":"SECUKINUMAB"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COSENTYX PEN","13":"SECUKINUMAB"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COSENTYX PEN (2 PENS)","13":"SECUKINUMAB"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COSENTYX SYRINGE","13":"SECUKINUMAB"},{"1":"29426","2":"3.933862e+06","3":"8405","4":"4.680383e+02","5":"3.365130e+05","6":"1.169008e+01","7":"5044","8":"2.051480e+02","9":"3361","10":"15.21526034","11":"2011","12":"COSOPT","13":"DORZOLAMIDE HCL/TIMOLOL MALEAT"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COSOPT PF","13":"DORZOLAMIDE/TIMOLOL/PF"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"COTELLIC","13":"COBIMETINIB FUMARATE"},{"1":"862509","2":"5.094827e+07","3":"140553","4":"3.624844e+02","5":"4.091108e+07","6":"1.255873e+00","7":"99593","8":"2.264066e+02","9":"40960","10":"25.39784692","11":"2011","12":"COUMADIN","13":"WARFARIN SODIUM"},{"1":"1377","2":"1.498526e+05","3":"423","4":"3.542614e+02","5":"6.919300e+04","6":"2.169333e+00","7":"254","8":"2.125746e+02","9":"169","10":"18.73846154","11":"2011","12":"COVERA-HS","13":"VERAPAMIL HCL"},{"1":"74974","2":"9.020651e+06","3":"24086","4":"3.745185e+02","5":"3.687736e+06","6":"2.518446e+00","7":"11451","8":"1.918883e+02","9":"12635","10":"10.69814484","11":"2011","12":"COZAAR","13":"LOSARTAN POTASSIUM"},{"1":"54","2":"1.315700e+03","3":"53","4":"2.482453e+01","5":"9.242375e+03","6":"1.423552e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"C-PHEN DM","13":"CHLORPHENIRAMINE/PHENYLEPH/DM"},{"1":"324485","2":"1.152135e+08","3":"71126","4":"1.619850e+03","5":"5.169420e+07","6":"2.217792e+00","7":"24680","8":"3.079940e+02","9":"46446","10":"15.46744176","11":"2011","12":"CREON","13":"LIPASE/PROTEASE/AMYLASE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CRESEMBA","13":"ISAVUCONAZONIUM SULFATE"},{"1":"7826872","2":"1.416315e+09","3":"1496100","4":"9.466714e+02","5":"3.187148e+08","6":"4.443867e+00","7":"894600","8":"2.651215e+02","9":"601500","10":"25.68457526","11":"2011","12":"CRESTOR","13":"ROSUVASTATIN CALCIUM"},{"1":"157","2":"3.438520e+03","3":"144","4":"2.387861e+01","5":"2.355000e+03","6":"1.460093e+00","7":"117","8":"1.829974e+01","9":"27","10":"4.15703704","11":"2011","12":"CRESYLATE","13":"CRESYL ACETATE"},{"1":"348","2":"5.220607e+04","3":"141","4":"3.702558e+02","5":"7.039010e+03","6":"6.895335e+00","7":"93","8":"1.420680e+02","9":"48","10":"6.82187500","11":"2011","12":"CRINONE","13":"PROGESTERONE,MICRONIZED"},{"1":"4639","2":"2.057053e+06","3":"582","4":"3.534456e+03","5":"7.953030e+05","6":"2.576280e+00","7":"157","8":"4.247825e+02","9":"425","10":"20.77741177","11":"2011","12":"CRIXIVAN","13":"INDINAVIR SULFATE"},{"1":"26","2":"4.520200e+02","3":"12","4":"3.766833e+01","5":"2.600000e+02","6":"1.738538e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CROLOM","13":"CROMOLYN SODIUM"},{"1":"54144","2":"1.181217e+06","3":"24538","4":"4.813826e+01","5":"6.170160e+05","6":"1.994523e+00","7":"7560","8":"1.181293e+01","9":"16978","10":"1.97311639","11":"2011","12":"CROMOLYN SODIUM","13":"CROMOLYN SODIUM"},{"1":"22907","2":"6.370031e+05","3":"3839","4":"1.659294e+02","5":"7.485290e+05","6":"8.510066e-01","7":"363","8":"4.771741e+01","9":"3476","10":"6.83037975","11":"2011","12":"CRYSELLE","13":"NORGESTREL-ETHINYL ESTRADIOL"},{"1":"34213","2":"4.987347e+07","3":"7831","4":"6.368723e+03","5":"1.937503e+06","6":"2.574110e+01","7":"2334","8":"1.210072e+03","9":"5497","10":"23.58026742","11":"2011","12":"CUBICIN","13":"DAPTOMYCIN"},{"1":"3368","2":"1.851843e+06","3":"641","4":"2.888990e+03","5":"3.062580e+05","6":"6.046676e+00","7":"358","8":"4.952951e+02","9":"283","10":"51.61197880","11":"2011","12":"CUPRIMINE","13":"PENICILLAMINE"},{"1":"12","2":"7.020000e+01","3":"12","4":"5.850000e+00","5":"2.100000e+02","6":"3.342857e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CURAD GAUZE PADS","13":"GAUZE BANDAGE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CURITY","13":"GAUZE BANDAGE"},{"1":"1781","2":"5.747370e+03","3":"643","4":"8.938367e+00","5":"2.561510e+05","6":"2.243743e-02","7":"96","8":"4.839062e+00","9":"547","10":"3.52733090","11":"2011","12":"CURITY ALCOHOL PREPS","13":"ALCOHOL ANTISEPTIC PADS"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CURITY AMD","13":"POLYHEXAM BIGUAN/GAUZE BANDAGE"},{"1":"4508","2":"2.019449e+06","3":"3087","4":"6.541784e+02","5":"5.486200e+05","6":"3.676606e+00","7":"1886","8":"9.704870e+01","9":"1201","10":"5.94415487","11":"2011","12":"CUTIVATE","13":"FLUTICASONE PROPIONATE"},{"1":"34","2":"1.310086e+04","3":"24","4":"5.458692e+02","5":"1.544800e+04","6":"8.480619e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CUVPOSA","13":"GLYCOPYRROLATE"},{"1":"47319","2":"2.214056e+05","3":"18136","4":"1.220807e+01","5":"2.236000e+05","6":"9.901859e-01","7":"15890","8":"7.125172e+00","9":"2246","10":"8.65344167","11":"2011","12":"CYANOCOBALAMIN INJECTION","13":"CYANOCOBALAMIN (VITAMIN B-12)"},{"1":"595","2":"1.703407e+04","3":"233","4":"7.310760e+01","5":"2.031300e+04","6":"8.398482e-01","7":"30","8":"3.356667e+01","9":"203","10":"2.71832512","11":"2011","12":"CYCLAFEM","13":"NORETHINDRONE-ETHINYL ESTRAD"},{"1":"71","2":"4.595470e+03","3":"14","4":"3.282479e+02","5":"2.604000e+03","6":"1.764773e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYCLESSA","13":"DESOGESTREL-ETHINYL ESTRADIOL"},{"1":"5043614","2":"4.781817e+07","3":"1771193","4":"2.699772e+01","5":"2.898052e+08","6":"1.680893e-01","7":"828800","8":"1.204374e+01","9":"942393","10":"4.37956272","11":"2011","12":"CYCLOBENZAPRINE HCL","13":"CYCLOBENZAPRINE HCL"},{"1":"2679","2":"8.855556e+04","3":"2115","4":"4.187024e+01","5":"1.497900e+04","6":"6.394520e+00","7":"1250","8":"2.699115e+01","9":"865","10":"2.48317919","11":"2011","12":"CYCLOGYL","13":"CYCLOPENTOLATE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYCLOMYDRIL","13":"CYCLOPENTOLATE/PHENYLEPHRINE"},{"1":"18213","2":"2.821101e+05","3":"13725","4":"2.055447e+01","5":"1.564152e+05","6":"1.803598e+00","7":"8762","8":"9.307313e+00","9":"4963","10":"1.81191013","11":"2011","12":"CYCLOPENTOLATE HCL","13":"CYCLOPENTOLATE HCL"},{"1":"11755","2":"1.821664e+06","3":"3188","4":"5.714127e+02","5":"6.243047e+05","6":"6.415189e+00","7":"2041","8":"1.040722e+02","9":"1147","10":"11.20668701","11":"2011","12":"CYCLOPHOSPHAMIDE","13":"CYCLOPHOSPHAMIDE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYCLOSERINE","13":"CYCLOSERINE"},{"1":"2646","2":"6.133147e+05","3":"958","4":"6.402032e+02","5":"3.592900e+05","6":"1.707018e+00","7":"556","8":"1.987036e+02","9":"402","10":"8.65303483","11":"2011","12":"CYCLOSET","13":"BROMOCRIPTINE MESYLATE"},{"1":"1378","2":"3.990661e+05","3":"514","4":"7.763932e+02","5":"1.112980e+05","6":"4.049379e+00","7":"267","8":"1.238902e+02","9":"247","10":"5.21105263","11":"2011","12":"CYCLOSPORINE","13":"CYCLOSPORINE"},{"1":"726","2":"2.177537e+05","3":"199","4":"1.094240e+03","5":"5.389425e+04","6":"4.127924e+00","7":"104","8":"1.568861e+02","9":"95","10":"4.69789474","11":"2011","12":"CYCLOSPORINE","13":"CYCLOSPORINE, MODIFIED"},{"1":"40655","2":"8.350557e+06","3":"7104","4":"1.175473e+03","5":"4.990642e+06","6":"2.173122e+00","7":"4210","8":"1.822134e+02","9":"2894","10":"14.93304423","11":"2011","12":"CYCLOSPORINE MODIFIED","13":"CYCLOSPORINE, MODIFIED"},{"1":"42","2":"1.174062e+04","3":"21","4":"5.590771e+02","5":"3.490000e+03","6":"3.364074e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYKLOKAPRON","13":"TRANEXAMIC ACID"},{"1":"4930036","2":"1.020322e+09","3":"780792","4":"1.306778e+03","5":"2.028801e+08","6":"5.032389e+00","7":"311293","8":"3.092033e+02","9":"469499","10":"26.35659676","11":"2011","12":"CYMBALTA","13":"DULOXETINE HCL"},{"1":"306556","2":"4.598965e+06","3":"93280","4":"4.930280e+01","5":"2.284896e+07","6":"2.193519e-01","7":"30755","8":"1.782960e+01","9":"62525","10":"3.64665430","11":"2011","12":"CYPROHEPTADINE HCL","13":"CYPROHEPTADINE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYRAMZA","13":"RAMUCIRUMAB"},{"1":"421","2":"6.760033e+05","3":"41","4":"1.648788e+04","5":"1.612200e+05","6":"4.193048e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYSTADANE","13":"BETAINE"},{"1":"688","2":"2.085599e+05","3":"77","4":"2.708570e+03","5":"2.623960e+05","6":"7.354680e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYSTAGON","13":"CYSTEAMINE BITARTRATE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYSTARAN","13":"CYSTEAMINE HCL"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYSTEX","13":"METHENAM/BENZ AC/SALICY/SAL-AM"},{"1":"21","2":"2.233500e+02","3":"NA","4":"NA","5":"4.350000e+02","6":"5.134483e-01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYTARABINE","13":"CYTARABINE"},{"1":"128","2":"3.492450e+03","3":"31","4":"1.126597e+02","5":"2.758000e+03","6":"3.096375e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYTARABINE","13":"CYTARABINE/PF"},{"1":"31","2":"1.609099e+05","3":"NA","4":"NA","5":"6.804000e+03","6":"2.364930e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"CYTOGAM","13":"CYTOMEGALOVIRUS IMMUNE GLOBULN"},{"1":"20556","2":"1.274557e+06","3":"5508","4":"2.314010e+02","5":"1.368548e+06","6":"9.568049e-01","7":"4105","8":"1.548690e+02","9":"1403","10":"13.26090520","11":"2011","12":"CYTOMEL","13":"LIOTHYRONINE SODIUM"},{"1":"344","2":"5.742218e+04","3":"113","4":"5.081609e+02","5":"3.276800e+04","6":"1.716726e+00","7":"59","8":"1.637136e+02","9":"54","10":"5.00703704","11":"2011","12":"CYTOTEC","13":"MISOPROSTOL"},{"1":"216","2":"9.287804e+04","3":"67","4":"1.386239e+03","5":"2.538435e+04","6":"3.658870e+00","7":"32","8":"3.642206e+02","9":"35","10":"20.95114286","11":"2011","12":"CYTOVENE","13":"GANCICLOVIR SODIUM"},{"1":"6795","2":"1.259526e+05","3":"2057","4":"6.123120e+01","5":"7.228789e+06","6":"1.742375e-02","7":"1200","8":"1.573266e+01","9":"857","10":"2.83850642","11":"2011","12":"CYTRA-2","13":"CITRIC ACID/SODIUM CITRATE"},{"1":"800","2":"2.723264e+04","3":"179","4":"1.521377e+02","5":"8.958360e+05","6":"3.039914e-02","7":"127","8":"3.430354e+01","9":"52","10":"5.29500000","11":"2011","12":"CYTRA-3","13":"SOD/POT/K CIT/SOD CIT/CIT ACID"},{"1":"3487","2":"1.908722e+05","3":"966","4":"1.975902e+02","5":"1.289659e+06","6":"4.571055e-01","7":"711","8":"7.446416e+01","9":"255","10":"5.18141176","11":"2011","12":"CYTRA-K","13":"POTASSIUM CITRATE/CITRIC ACID"},{"1":"32","2":"4.352222e+04","3":"17","4":"2.560131e+03","5":"3.880000e+02","6":"1.121707e+02","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"D.H.E.45","13":"DIHYDROERGOTAMINE MESYLATE"},{"1":"50","2":"4.962100e+03","3":"NA","4":"NA","5":"3.300000e+02","6":"1.503667e+01","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"DACARBAZINE","13":"DACARBAZINE"},{"1":"175","2":"1.429351e+06","3":"46","4":"3.107285e+04","5":"8.870000e+02","6":"1.611444e+03","7":"21","8":"1.687094e+03","9":"25","10":"2.58000000","11":"2011","12":"DACOGEN","13":"DECITABINE"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"DAKLINZA","13":"DACLATASVIR DIHYDROCHLORIDE"},{"1":"19647","2":"3.817900e+06","3":"10119","4":"3.773002e+02","5":"6.393805e+05","6":"5.971249e+00","7":"4084","8":"1.118930e+02","9":"6035","10":"5.69194035","11":"2011","12":"DALIRESP","13":"ROFLUMILAST"},{"1":"196","2":"1.005627e+04","3":"153","4":"6.572725e+01","5":"1.067500e+04","6":"1.152084e+00","7":"122","8":"4.788730e+01","9":"31","10":"6.53419355","11":"2011","12":"DALLERGY","13":"CHLOR-MAL/PHENYLEPH/METHSCOP"},{"1":"70","2":"7.393990e+03","3":"36","4":"2.053886e+02","5":"5.877000e+03","6":"1.409375e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"DALLERGY PE","13":"CHLOR-MAL/PHENYLEPH/METHSCOP"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"DALVANCE","13":"DALBAVANCIN HCL"},{"1":"11129","2":"2.303525e+06","3":"2320","4":"9.928987e+02","5":"7.465390e+05","6":"3.062382e+00","7":"1398","8":"1.829640e+02","9":"922","10":"11.03528200","11":"2011","12":"DANAZOL","13":"DANAZOL"},{"1":"1134","2":"1.683158e+05","3":"235","4":"7.162372e+02","5":"1.338180e+05","6":"1.310188e+00","7":"43","8":"2.373621e+02","9":"192","10":"12.43614583","11":"2011","12":"DANTRIUM","13":"DANTROLENE SODIUM"},{"1":"43035","2":"5.060203e+06","3":"5927","4":"8.537545e+02","5":"4.685657e+06","6":"1.092813e+00","7":"1495","8":"1.712229e+02","9":"4432","10":"8.62117780","11":"2011","12":"DANTROLENE SODIUM","13":"DANTROLENE SODIUM"},{"1":"83941","2":"4.061544e+06","3":"17438","4":"2.329134e+02","5":"3.957619e+06","6":"1.074589e+00","7":"8185","8":"1.266465e+02","9":"9253","10":"6.04685291","11":"2011","12":"DAPSONE","13":"DAPSONE"},{"1":"130","2":"5.923750e+03","3":"130","4":"4.556731e+01","5":"9.450000e+01","6":"6.268519e+01","7":"64","8":"3.941047e+01","9":"66","10":"2.87242424","11":"2011","12":"DAPTACEL DTAP","13":"DIPH,PERTUSS(ACELL),TET PED/PF"},{"1":"3519","2":"1.051090e+06","3":"745","4":"1.410859e+03","5":"1.838480e+05","6":"5.717170e+00","7":"203","8":"1.186355e+02","9":"542","10":"9.72332103","11":"2011","12":"DARAPRIM","13":"PYRIMETHAMINE"},{"1":"61","2":"2.347930e+03","3":"53","4":"4.430057e+01","5":"2.155000e+03","6":"1.089527e+00","7":"40","8":"8.905500e+00","9":"13","10":"1.61153846","11":"2011","12":"DARCALMA","13":"MTH/ME BLUE/SOD PHOS/PHEN/HYOS"},{"1":"36","2":"2.664980e+03","3":"30","4":"8.883267e+01","5":"1.488000e+03","6":"1.790981e+00","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"DARPAZ","13":"MTH/ME BLUE/SOD PHOS/PHEN/HYOS"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"DARZALEX","13":"DARATUMUMAB"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"DASETTA","13":"NORETHINDRONE-ETHINYL ESTRAD"},{"1":"664","2":"1.507117e+05","3":"274","4":"5.500426e+02","5":"5.421300e+04","6":"2.779992e+00","7":"152","8":"1.950724e+02","9":"122","10":"9.18459016","11":"2011","12":"DAYPRO","13":"OXAPROZIN"},{"1":"NA","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"NA","9":"NA","10":"NA","11":"2011","12":"DAYSEE","13":"L-NORGEST/E.ESTRADION-E.ESTRAD"},{"1":"1367","2":"2.588824e+05","3":"290","4":"8.926980e+02","5":"4.636100e+04","6":"5.584405e+00","7":"101","8":"2.423990e+02","9":"189","10":"18.38899471","11":"2011","12":"DAYTRANA","13":"METHYLPHENIDATE"}],"options":{"columns":{"min":{},"max":[10],"total":[13]},"rows":{"min":[10],"max":[10],"total":[22490]},"pages":{}}}
  </script>
</div>
<!-- rnb-frame-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>## -- Combine data by year for all brand names for the same generic --------------------------------
spending.data.bygeneric &lt;- spending.data %&gt;%
  group_by(drug_year, drugname_generic) %&gt;%
  summarise(claim_count = sum(claim_count, na.rm = TRUE),
            total_spending = sum(total_spending, na.rm = TRUE),
            user_count = sum(user_count, na.rm = TRUE),
            total_spending_per_user = sum(total_spending_per_user, na.rm = TRUE),
            unit_count = sum(unit_count, na.rm = TRUE),
            user_count_non_lowincome = sum(user_count_non_lowincome, na.rm = TRUE),
            out_of_pocket_avg_non_lowincome = sum(out_of_pocket_avg_non_lowincome, na.rm = TRUE),
            user_count_lowincome = sum(user_count_lowincome, na.rm = TRUE),
            out_of_pocket_avg_lowincome = sum(out_of_pocket_avg_lowincome, na.rm = TRUE))</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<div id="out-of-pocket-cost-over-time-for-low-income-vs-non-low-income-users-of-aripiprazole-aricept" class="section level1">
<h1>Out-of-pocket cost over time for low-income vs non-low-income users of aripiprazole (Aricept)</h1>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>plotdata &lt;- spending.data.bygeneric %&gt;%
  filter(drugname_generic == 'ARIPIPRAZOLE ') %&gt;%
  select(drug_year, out_of_pocket_avg_lowincome, out_of_pocket_avg_non_lowincome) %&gt;%
  gather(key = income_level, value = out_of_pocket,
         out_of_pocket_avg_lowincome:out_of_pocket_avg_non_lowincome) %&gt;%
  mutate(income_level = gsub('out_of_pocket_avg_', '', income_level, fixed = TRUE))
ggplot(data = plotdata, aes(x = drug_year, y = out_of_pocket)) +
  geom_line(aes(group = income_level, colour = income_level)) +
  geom_point(aes(group = income_level, colour = income_level)) +
  scale_colour_manual(values = c('#003D79', '#258CF0')) +
  theme_minimal()</code></pre>
<!-- rnb-source-end -->
<!-- rnb-plot-begin eyJjb25kaXRpb25zIjpbXSwiaGVpZ2h0Ijo0MDEuNzMwNSwic2l6ZV9iZWhhdmlvciI6MCwid2lkdGgiOjY1MH0= -->
<p><img src="data:image/png;base64,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" /></p>
<!-- rnb-plot-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin 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 -->
<pre class="r"><code>## -- Therapeutic areas ----------------------------------------------------------------------------
## Read in JSON
therapeutic.areas &lt;- read_json('data/drug_list.json', simplifyDataFrame = TRUE)
all.areas &lt;- unique(flatten_chr(therapeutic.areas$therapeutic_areas))
area.abbrevs &lt;- c('cardiology', 'immunology', 'otolaryngology', 'pulmonary', 'family', 'infection',
                  'neurology', 'sleep', 'musculoskeletal', 'orthopedic', 'gastroenterology',
                  'pediatrics', 'vaccine', 'hepatology', 'oncology', 'ophthalmology', 'nephrology',
                  'urology', 'genetic', 'endocrinology', 'rheumatology', 'psychiatry', 'hematology',
                  'pharmacology', 'nutrition', 'dermatology', 'podiatry', 'obgyn', 'healthyvols',
                  'trauma', 'device', 'internal', 'dental')
## Create indicators for whether each drug is in each unique therapeutic area
## Areas are lists in column therapeutic_areas; write function to determine if a given area is
## included for a particular drug
in_this_area &lt;- function(area, df){
  indicator.col &lt;- rep(FALSE, nrow(df))
  indicator.col[grep(area, df$therapeutic_areas, fixed = TRUE)] &lt;- TRUE
  indicator.col
}
## Iterate over all unique therapeutic areas and combine into a matrix -&gt; data.frame
area.indicators &lt;- do.call(cbind,
                           map(all.areas, in_this_area, df = therapeutic.areas)) %&gt;%
  as.data.frame()
## Give useful column names
names(area.indicators) &lt;- paste0('used.', area.abbrevs)
## Bind indicators with original data set
therapeutic.areas &lt;- bind_cols(therapeutic.areas, area.indicators)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxudGhlcmFwZXV0aWMuYXJlYXNcbmBgYCJ9 -->
<pre class="r"><code>therapeutic.areas</code></pre>
<!-- rnb-source-end -->
<!-- rnb-frame-begin {"metadata":{"classes":["data.frame"],"ncol":38,"nrow":1253},"rdf":"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"} -->
<div data-pagedtable>
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["therapeutic_areas"],"name":[1],"type":["list"],"align":["right"]},{"label":["name"],"name":[2],"type":["chr"],"align":["left"]},{"label":["approval_status"],"name":[3],"type":["chr"],"align":["left"]},{"label":["company"],"name":[4],"type":["chr"],"align":["left"]},{"label":["specific_treatment"],"name":[5],"type":["chr"],"align":["left"]},{"label":["used.cardiology"],"name":[6],"type":["lgl"],"align":["right"]},{"label":["used.immunology"],"name":[7],"type":["lgl"],"align":["right"]},{"label":["used.otolaryngology"],"name":[8],"type":["lgl"],"align":["right"]},{"label":["used.pulmonary"],"name":[9],"type":["lgl"],"align":["right"]},{"label":["used.family"],"name":[10],"type":["lgl"],"align":["right"]},{"label":["used.infection"],"name":[11],"type":["lgl"],"align":["right"]},{"label":["used.neurology"],"name":[12],"type":["lgl"],"align":["right"]},{"label":["used.sleep"],"name":[13],"type":["lgl"],"align":["right"]},{"label":["used.musculoskeletal"],"name":[14],"type":["lgl"],"align":["right"]},{"label":["used.orthopedic"],"name":[15],"type":["lgl"],"align":["right"]},{"label":["used.gastroenterology"],"name":[16],"type":["lgl"],"align":["right"]},{"label":["used.pediatrics"],"name":[17],"type":["lgl"],"align":["right"]},{"label":["used.vaccine"],"name":[18],"type":["lgl"],"align":["right"]},{"label":["used.hepatology"],"name":[19],"type":["lgl"],"align":["right"]},{"label":["used.oncology"],"name":[20],"type":["lgl"],"align":["right"]},{"label":["used.ophthalmology"],"name":[21],"type":["lgl"],"align":["right"]},{"label":["used.nephrology"],"name":[22],"type":["lgl"],"align":["right"]},{"label":["used.urology"],"name":[23],"type":["lgl"],"align":["right"]},{"label":["used.genetic"],"name":[24],"type":["lgl"],"align":["right"]},{"label":["used.endocrinology"],"name":[25],"type":["lgl"],"align":["right"]},{"label":["used.rheumatology"],"name":[26],"type":["lgl"],"align":["right"]},{"label":["used.psychiatry"],"name":[27],"type":["lgl"],"align":["right"]},{"label":["used.hematology"],"name":[28],"type":["lgl"],"align":["right"]},{"label":["used.pharmacology"],"name":[29],"type":["lgl"],"align":["right"]},{"label":["used.nutrition"],"name":[30],"type":["lgl"],"align":["right"]},{"label":["used.dermatology"],"name":[31],"type":["lgl"],"align":["right"]},{"label":["used.podiatry"],"name":[32],"type":["lgl"],"align":["right"]},{"label":["used.obgyn"],"name":[33],"type":["lgl"],"align":["right"]},{"label":["used.healthyvols"],"name":[34],"type":["lgl"],"align":["right"]},{"label":["used.trauma"],"name":[35],"type":["lgl"],"align":["right"]},{"label":["used.device"],"name":[36],"type":["lgl"],"align":["right"]},{"label":["used.internal"],"name":[37],"type":["lgl"],"align":["right"]},{"label":["used.dental"],"name":[38],"type":["lgl"],"align":["right"]}],"data":[{"1":"<chr [1]>","2":"Niaspan","3":"October 28, 1999","4":"Kos Pharmaceuticals","5":"Treatment for increasing HDL cholesterol (\"good cholesterol\") in patients with dyslipidemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Cedax (ceftibuten)","3":"Approved December 1995","4":"Schering-Plough","5":"chronic bronchitis, infection of the middle ear, pharyngitis/tonsillitis","6":"FALSE","7":"TRUE","8":"TRUE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Silenor (doxepin)","3":"Approved March 2010","4":"Somaxon Pharma","5":"insomnia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"TRUE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Amrix (cyclobenzaprine hydrochloride extended release)","3":"Approved February 2007","4":"Cephalon","5":"muscle spasm associated with acute, painful musculoskeletal conditions","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"TRUE","15":"TRUE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Zyrtec (cetirizine HCl)","3":"Approved December 1995","4":"Pfizer","5":"allergy","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Bactroban Nasal 2% (mupirocin calcium ointment)","3":"Approved April 1996","4":"SmithKline Beecham","5":"nasal bacteria","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Merrem I.V. (meropenem)","3":"Approved June 1996","4":"AstraZeneca","5":"intra-abdominal infections and bacterial meningitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"TRUE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Havrix","3":"Approved March 1996","4":"SmithKline Beecham","5":"hepatitis A","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"TRUE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Intron A (Interferon alfa-2b, recombinant)","3":"Approved December 1995","4":"Schering-Plough","5":"malignant melanoma","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vitrasert Implant","3":"Approved March 1996","4":"Chiron","5":"cytomegalovirus (CMV)","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vistide (cidofovir)","3":"Approved June 1996","4":"Gilead","5":"CMV retinitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ocuflox (ofloxacin opthalmic solution) 0.3%","3":"Approved May 1996","4":"Allergan","5":"corneal ulcers","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Floxin otic","3":"Approved December 1997","4":"Daiichi Sankyo","5":"otitis media (ear infections)","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Caverject (alprostadil)","3":"Approved on July 6, 1995","4":"Upjohn","5":"impotence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Monurol","3":"Approved December 1996","4":"Forest Laboratories","5":"uncomplicated urinary tract infection","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Alphagan (brimonidine)","3":"Approved September 1996","4":"Allergan","5":"open-angle glaucoma and ocular hypertension","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"AK-Con-A (naphazoline ophthalmic)","3":"Approved January 1996","4":"Akorn","5":"antihistamine product","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"FLOMAX","3":"Approved October 1997","4":"Boehringer Ingelheim","5":"benign prostatic hypertrophy (BPH)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Tegretol (carbamazepine)","3":"Approved March 1996","4":"Ciba Pharmaceuticals","5":"epilepsy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Children's Advil (pediatric ibuprofen)","3":"Approved July 1996","4":"Whitehall-Robins Healthcare","5":"pain due to colds, flu, sore throat, headache, and toothache","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Naprelan (naproxen sodium)","3":"Approved January 1996","4":"Elan Pharmaceuticals, Wyeth","5":"osteoarthritis, rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lodine (etodolac)","3":"Approved July 1996","4":"Wyeth","5":"rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Azulfidine EN-tabs Tablets (sulfasalazine delayed release tablets, USP)","3":"Approved October 1996","4":"Pharmacia & Upjohn","5":"rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tolmetin Sodium","3":"Approved March 1997","4":"Teva Pharmaceutical","5":"arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Nuplazid (pimavanserin)","3":"Approved May 2016","4":"Acadia Pharmaceuticals","5":"hallucinations and delusions associated with Parkinson’s disease psychosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Zyprexa","3":"Approved September 1996","4":"Eli Lilly","5":"psychotic disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Risperdal Oral Formulation","3":"Approved July 1996","4":"Janssen Pharmaceuticals","5":"schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"SPORANOX (itraconazole)","3":"Approved March 1997","4":"Janssen Pharmaceuticals","5":"oral thrush","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [7]>","2":"Nascobal Gel (Cyanocobalamin, USP)","3":"Approved November 1996","4":"Questcor Pharmaceuticals","5":"vitamin B-12 deficiency","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"TRUE","29":"TRUE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Interstim Continence Control Therapy","3":"Approved September 1997","4":"Medtronic","5":"urinary incontinence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Paxil (paroxetine hydrochloride)","3":"Approved May 1996","4":"SmithKline Beecham","5":"panic disorder, obsessive-compulsive disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Nicorette (nicotine polacrilex)","3":"Approved February 1996","4":"SmithKline Beecham","5":"smoking cessation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"NicoDerm CQ","3":"Approved August 1996","4":"SmithKline Beecham, Hoechst Marion Roussel, Alza","5":"smoking cessation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lithobid (Lithium Carbonate)","3":"Approved January 1996","4":"Solvay Pharmaceuticals","5":"manic depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Depakote (divalproex sodium)","3":"Approved March 1996","4":"Abbott Laboratories","5":"migraine headaches","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"ARICEPT (donepezil hydrochloride)","3":"Approved December 1996","4":"Eisai","5":"Alzheimer's Disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Zyban Sustained-Release Tablets","3":"Approved May 1997","4":"GlaxoSmithKline","5":"smoking cessation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zoloft (sertraline HCl)","3":"Approved July 1997","4":"Pfizer","5":"panic disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Trazadone 150mg","3":"Approved  May 1997","4":"Teva Pharmaceutical","5":"depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Seroquel (R)  (quetiapine fumarate) Tablets","3":"Approved September 1997","4":"AstraZeneca","5":"psychotic disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Redux (dexfenfluramine hydrochloride)","3":"Approved May 1996","4":"Wyeth","5":"obesity","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Remeron (Mirtazapine)","3":"Approved June 1996","4":"Organon","5":"depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Nicotrol nasal spray","3":"Approved March 1996","4":"Pharmacia & Upjohn","5":"smoking cessation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Prochlorperazine","3":"Approved January 1998","4":"IVAX","5":"Severe nausea and vomiting, and management of psychotic disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Naltrexone Hydrochloride Tablets","3":"Approved May 1998","4":"Barr Laboratories","5":"alcohol dependence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Marplan Tablets","3":"Approved August 1998","4":"Roche","5":"Depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Clomipramine hydrochloride","3":"Approved April 1998","4":"Mylan Laboratories","5":"depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Celexa","3":"Approved July 1998","4":"Forest Laboratories","5":"Depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Sonata","3":"Approved August 1999","4":"American Home Products","5":"Neurology; Psychiatry","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Paxil CR (paroxetine hydrochloride)","3":"Approved March 1999","4":"SmithKline Beecham","5":"Psychiatry","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Effexor (venlafaxin HCL)","3":"Approved March 1999","4":"Wyeth","5":"Psychiatry/Psychology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Concerta","3":"Approved August 2000","4":"Alza","5":"For the treatment of Attention Deficit Hyperactivity Disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ziprasidone (ziprasidone hydrochloride)","3":"Approved February 2001","4":"Pfizer","5":"Schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Generic Transdermal Nicotine Patch","3":"Approved October 1997","4":"Sano","5":"smoking cessation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Remeron SolTab (mirtazapine)","3":"Approved January 2001","4":"Organon","5":"Depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Prozac Weekly (fluoxetine HCl)","3":"Approved February 2001","4":"Eli Lilly","5":"Depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Paxil CR (paroxetine hydrochloride)","3":"Approved February 2002","4":"GlaxoSmithKline","5":"Depression, panic disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Lexapro (escitalopram oxalate)","3":"Approved August 2002","4":"Forest Laboratories","5":"major depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Geodon (ziprasidone mesylate)","3":"Approved June 2002","4":"Pfizer","5":"Schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Abilify (aripiprazole)","3":"Approved November 2002","4":"Bristol-Myers Squibb, Otsuka America Pharmaceutical","5":"Schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cymbalta (duloxetine)","3":"Approved August 2004","4":"Eli Lilly","5":"Depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Invega (paliperidone)","3":"Approved December 2006","4":"Janssen Pharmaceuticals","5":"Schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Chantix (varenicline)","3":"Approved May 2006","4":"Pfizer","5":"Smoking Cessation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vivitrol (naltrexone for extended-release injectable suspension)","3":"Approved April 2006","4":"Alkermes","5":"alcohol dependence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Stavzor (valproic acid delayed release)","3":"Approved July 2008","4":"Banner Pharmacaps","5":"bipolar manic disorder, seizures and migraine headaches","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Aplenzin (bupropion hydrobromide)","3":"Approved April 2008","4":"Biovail Laboratories","5":"Major depressive disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Saphris (asenapine)","3":"Approved August of 2009","4":"Schering-Plough","5":"schizophrenia and manic or mixed bipolar 1 episodes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"LUVOX  (fluvoxamine maleate)","3":"Approved April 1997","4":"Solvay Pharmaceuticals, Pharmacia & Upjohn","5":"obsessive compulsive disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Edluar (zolpidem tartrate)","3":"Approved March 2009","4":"Orexo","5":"insomnia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vivitrol (naltrexone for extended-release injectable suspension)","3":"Approved October 2010","4":"Alkermes","5":"opioid dependence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Latuda (lurasidone)","3":"Approved October 2010","4":"Sunovion","5":"schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Viibryd (vilazodone hydrochloride)","3":"Approved January 2011","4":"Clinical Data","5":"major depressive disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zubsolv (buprenorphine and naloxone)","3":"Approved July 2013","4":"Orexo AB","5":"maintenance treatment of opioid dependence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Fetzima (levomilnacipran)","3":"Approved July 2013","4":"Forest Laboratories","5":"major depressive disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Brintellix (vortioxetine)","3":"Approved October 2013","4":"Takeda Pharmaceuticals USA","5":"Major Depressive Disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Vraylar (cariprazine)","3":"Approved September 2015","4":"Allergan","5":"schizophrenia and bipolar disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Rexulti (brexpiprazole)","3":"Approved July 2015","4":"Otsuka","5":"depression and schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Aristada (aripiprazole lauroxil) extended-release injectable","3":"Approved October 2015","4":"Alkermes","5":"schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Synvisc, Synvisc-One (Hylan GF 20)","3":"Approved August 1997","4":"Genzyme","5":"pain associated with osteoarthritis of the knee","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"REGRANEX (becaplermin) Gel","3":"Approved December 1997","4":"RW Johnson","5":"diabetic foot ulcers","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"TRUE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Leukine (sargramostim)","3":"Approved on November 24, 1995","4":"Immunex","5":"transplantation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Etodolac","3":"Approved April 1997","4":"Royce Laboratories","5":"rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Effexor XR (venlafaxin HCI)","3":"Approved October 1997","4":"Wyeth","5":"depression","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Oleptro (trazodone hydrochloride)","3":"Approved February 2010","4":"Labopharm","5":"major depressive disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Arthrotec","3":"Approved December 1997","4":"Searle","5":"arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lodine XL (etodolac)","3":"Approved February 1998","4":"Wyeth","5":"arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lodine XL (etodolac)","3":"Approved May 1999","4":"Wyeth","5":"Rheumatology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Mobic (meloxicam) Tablets","3":"Approved April 2000","4":"Boehringer Ingelheim","5":"For relief of the signs and symptoms of osteoarthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Supartz","3":"Approved January 2001","4":"Smith & Nephew Orthopaedics","5":"Osteoarthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Remicade (infliximab)","3":"Approved January 2001","4":"Centocor Ortho Biotech","5":"Rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kineret","3":"Approved November 2001","4":"Amgen","5":"Rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Remicade (infliximab)","3":"Approved February 2002","4":"Centocor Ortho Biotech","5":"Rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Humira (adalimumab)","3":"Approved December 2002","4":"Abbott Laboratories","5":"Rheumatoid Arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Enbrel (etanercept)","3":"Approved January 2002","4":"Immunex","5":"Psoriatic arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vioxx (rofecoxib)","3":"Approved April 2002 -- UPDATED: WITHDRAWN OCTOBER 2004","4":"Merck","5":"Rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Orencia (abatacept)","3":"Approved December 2005","4":"Bristol-Myers Squibb","5":"Rheumatoid Arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Fanapt (iloperidone)","3":"Approved May of 2009","4":"Vanda","5":"schizophrenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Stelara (ustekinumab)","3":"Approved September 2009","4":"Janssen Biotech","5":"plaque psoriasis, psoriatic arthritis and Crohn's disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Simponi (golimumab)","3":"Approved April 2009","4":"Centocor Ortho Biotech","5":"rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Pennsaid (diclofenac sodium topical solution)","3":"Approved November 2009","4":"Nuvo Research","5":"osteoarthritis of the knee","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Nicotrol transdermal patch","3":"Approved July 1996","4":"McNeil Consumer Products","5":"smoking cessation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Etodolac","3":"Approved December 1997","4":"Royce Laboratories","5":"osteoarthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Vimovo (naproxen + esomeprazole)","3":"Approved April 2010","4":"AstraZeneca","5":"arthritis in patients at risk for NSAID-associated ulcers","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Krystexxa (pegloticase)","3":"Approved September 2010","4":"Savient Pharma","5":"chronic gout (hyperuricemia)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Arava","3":"Approved September 1998","4":"Hoechst Marion Roussel","5":"Rheumatoid Arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Actemra (tocilizumab)","3":"Approved January 2010","4":"Genentech","5":"rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Xeljanz (tofacitinib)","3":"Approved November 2012","4":"Pfizer","5":"moderately to severely active rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Adderall (mixed salts of a single-entity amphetamine)","3":"Supplemental NDA Approved February 1996","4":"Richwood Pharmaceutical","5":"Attention Deficit/Hyperactivity Disorder (ADHD)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Zerit (stavudine)","3":"Approved January 1997","4":"Bristol-Myers Squibb","5":"HIV","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"VIRACEPT (nelfinavir mesylate)","3":"Approved March 1997","4":"Agouron Pharmaceuticals","5":"HIV infection","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"VERSED (midazolam HCI)","3":"Approved March 1997","4":"Roche","5":"sedative for children undergoing painful surgeries","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Timentin","3":"Approved December 1997","4":"SmithKline Beecham","5":"septicemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Norvir (ritonavir)","3":"Approved March 1996/March 1997","4":"Abbott Laboratories","5":"HIV infection","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Uloric (febuxostat)","3":"Approved February 2009","4":"Takeda","5":"hyperuricemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Timentin","3":"Approved January 1998","4":"SmithKline Beecham","5":"Infections in children","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Desmopressin Acetate (DDAVP)","3":"Approved March 1998","4":"Rhone Poulenc Rorer","5":"nocturnal enuresis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cimzia (certolizumab pegol)","3":"Approved May of 2009","4":"UCB","5":"rheumatoid arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Topamax (topiramate)","3":"Approved July 1999","4":"Ortho-McNeil Pharmaceutical","5":"Neurology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Amoxil (amoxicillin)","3":"Approved July 1999","4":"SmithKline Beecham","5":"Pediatrics","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Zoloft (sertraline HCl)","3":"Approved October 1997","4":"Pfizer","5":"panic disorder/obsessive compulsive disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Neurontin (gabapentin) oral solution","3":"Approved October 2000","4":"Parke-Davis","5":"As an adjunctive therapy in the treatment of partial seizures in pediatric patients three years of age and older","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lantus (insulin glargine [rDNA origin] injection)","3":"Approved April 2000","4":"Sanofi-aventis","5":"For adults and children w/Type 1 diabetes, or adults w/Type 2 diabetes requiring basal insulin to control hyperglycemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lantus (insulin glargine [rDNA origin] injection)","3":"Approved April 2000","4":"Sanofi-aventis","5":"type I and type II diabetes mellitus in adults and pediatrics","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kogenate FS (Antihemophilic Factor Recombinant)","3":"Approved June 2000","4":"Bayer","5":"hemophilia A","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ketoprofen","3":"Approved December 1997","4":"Schein Pharmaceutical","5":"anti-inflammatory","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cylert","3":"Approved October 1998","4":"Abbott Laboratories","5":"Neurology, Pediatrics, Psychiatry","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Duexis (ibuprofen and famotidine)","3":"Approved April 2011","4":"Horizon Pharma","5":"relief of rheumatoid arthritis and osteoarthritis and prevention of gastric ulcers","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Strattera (atomoxetine HCl)","3":"December 2002","4":"Eli Lilly","5":"Attention-Deficit/Hyperactivity Disorder (ADHD)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Ritalin LA (methylphenidate HCl)","3":"Approved June 2002","4":"Novartis","5":"Attention-Deficit/Hyperactivity Disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Metadate CD","3":"Approved April 2001","4":"Celltech Pharmaceuticals","5":"Attention Deficit Hyperactivity Disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Orfadin (nitisinone)","3":"Approved January 2002","4":"Orphan Pharmaceuticals","5":"Hereditary tyrosinemia type I","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Genotropin (somatropin) injection","3":"Approved July 2001","4":"Pharmacia & Upjohn","5":"Growth failure in children who were born small for gestational age (SGA)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Alinia (nitazoxanide)","3":"December 2002","4":"Romark Laboratories","5":"Diarrhea caused by Cryptosporidium and Giardia in children.","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Focalin (dexmethylphenidate HCl)","3":"Approved November 2001","4":"Celgene","5":"Attention deficit hyperactivity disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Myozyme (alglucosidase alfa)","3":"Approved April 2006","4":"Genzyme","5":"Pompe disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Elaprase (idursulfase)","3":"Approved July 2006","4":"Shire Pharmaceuticals","5":"Mucopolysaccharidosis II","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Adderall XR","3":"Approved October 2001","4":"Shire Pharmaceuticals","5":"Attention deficit/hyperactivity disorder (ADHD)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zingo (lidocaine hydrochloride monohydrate)","3":"Approved August 2007","4":"Powder Pharmaceuticals","5":"local analgesia prior to venipuncture or peripheral intravenous cannulation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Vyvanse (Lisdexamfetamine Dimesylate)","3":"Approved February 2007","4":"New River","5":"Attention-Deficit/Hyperactivity Disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Supprelin LA (histrelin acetate)","3":"Approved May 2007","4":"Indevus Pharmaceuticals","5":"central precocious puberty","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Trileptal (oxcarbazepine) Tablets","3":"Approved January 2000","4":"Novartis","5":"Adjunctive & monotherapy in adults; adjunctive therapy for children ages 4-16 with partial epileptic seizures","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Altabax (retapamulin)","3":"Approved April 2007","4":"GlaxoSmithKline","5":"impetigo due to Staphylococcus aureus or Streptococcus pyogenes","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Orencia (abatacept)","3":"Approved April 2008","4":"Bristol-Myers Squibb","5":"Juvenile Idiopathic Arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cinryze (C1 Inhibitor (Human))","3":"Approved October 2008","4":"Lev Pharmaceuticals","5":"angioedema attacks in adolescents/adults with Hereditary Angioedema","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Banzel (rufinamide)","3":"Approved November 2008","4":"Elan Pharmaceuticals","5":"seizures associated with Lennox-Gastaut syndrome in pediatrics and adults","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Aptivus (tipranavir)","3":"Approved June 2008","4":"Boehringer Ingelheim","5":"HIV","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Geref (sermorelin acetate for injection)","3":"Approved October 1997","4":"Serono Laboratories","5":"pediatric growth disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Sabril (vigabatrin)","3":"Approved August 2009","4":"Lundbeck","5":"infantile spasms and complex partial seizures","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Intuniv (guanfacine extended-release)","3":"Approved September 2009","4":"Shire Pharmaceuticals","5":"ADHD in children and adolescents","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Daptacel","3":"Approved May 2002","4":"Sanofi Pasteur","5":"Pediatric Immunology","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Berinert (C1 Esterase Inhibitor (Human))","3":"Approved October 2009","4":"CSL Behring","5":"abdominal or facial attacks of hereditary angioedema","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Veltin (clindamycin phosphate and tretinoin)","3":"Approved July 2010","4":"Stiefel","5":"acne vulgaris","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Rotarix (Rotavirus Vaccine, Live, Oral)","3":"Approved April 2008","4":"GlaxoSmithKline","5":"rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in pediatrics","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cuvposa (glycopyrrolate)","3":"Approved July 2010","4":"Shionogi","5":"chronic severe drooling in pediatrics with neurologic conditions","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Onfi (clobazam)","3":"Approved October 2011","4":"Lundbeck","5":"seizures associated with Lennox-Gastaut syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Accretropin (somatropin rDNA Original)","3":"Approved January 2008","4":"Cangene","5":"growth failure in pediatrics","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Sklice (ivermectin) lotion","3":"Approved February 2012","4":"Sanofi Pasteur","5":"head lice","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Quillivant XR (methylphenidate hydrochloride)","3":"Approved September 2012","4":"NextWave Pharmaceuticals","5":"Attention Deficit Hyperactivity Disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Oxtellar XR (oxcarbazepine extended release)","3":"Approved October 2012","4":"Supernus Pharmaceuticals","5":"partial seizures in adults and in children 6 years to 17 years of age","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Fycompa (perampanel)","3":"Approved October 2012","4":"Eisai","5":"partial-onset seizures with or without secondarily generalized seizures","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Trokendi XR (topiramate)","3":"Approved August 2013","4":"Supernus Pharmaceuticals","5":"partial onset, tonic-clonic and Lennox-Gastaut Syndrome seizures","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tivicay (dolutegravir)","3":"Approved August 2013","4":"ViiV HealthCare","5":"HIV-1 in adults and children over 12 years of age","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kapvay (clonidine hydrochloride)","3":"Approved October 2010","4":"Shionogi","5":"attention deficit hyperactivity disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kineret, anakinra","3":"Approved January 2013","4":"Swedish Orphan Biovitrum","5":"Cryopyrin-Associated Periodic Syndromes","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Ilaris (canakinumab)","3":"Approved May 2013","4":"Novartis","5":"Systemic Juvenile Idiopathic Arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Actemra (tocilizumab)","3":"Approved April 2011","4":"Genentech","5":"systemic juvenile idiopathic arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Norditropin  (somatropin (rDNA origin) for injection)","3":"Approved February 1997","4":"Novo Nordisk","5":"Growth failure in children","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vimizim (elosulfase alfa)","3":"Approved February 2014","4":"BioMarin","5":"Mucopolysaccharidosis type IVA","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Qudexy XR (topiramate)","3":"Approved March 2014","4":"Upsher-Smith Laboratories","5":"partial onset and primary generalized tonic-clonic seizures and Lennox-Gastaut Syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Alprolix [Coagulation Factor IX (Recombinant), Fc Fusion Protein]","3":"Approved March 2014","4":"Biogen Idec","5":"hemophilia B","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cholbam (cholic acid)","3":"Approved March 2015","4":"Asklepion Pharmaceuticals","5":"bile acid synthesis and peroxisomal disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"TRUE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Kovaltry [Antihemophilic Factor (Recombinant)]","3":"Approved March 2016","4":"Bayer","5":"hemophillia A","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Exondys 51 (eteplirsen)","3":"Approved September 2016","4":"Sarepta Therapeutics","5":"Duchenne muscular dystrophy with mutated DMD gene amenable to exon 51 skipping","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"INFANRIX (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)","3":"January 1997","4":"SmithKline Beecham","5":"diphtheria, tetanus and pertussis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Dutasteride","3":"Approved November 2001","4":"GlaxoSmithKline","5":"Symptomatic benign prostatic hyperplasia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cialis (tadalafil)","3":"Approved December 2003","4":"Eli Lilly","5":"Erectile Dysfunction","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Doribax (doripenem)","3":"Approved October 2007","4":"Johnson & Johnson","5":"intra-abdominal infections and urinary tract infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Ravicti (glycerol phenylbutyrate)","3":"Approved February 2013","4":"Hyperion Therapeutics","5":"pediatrics and adults with urea cycle disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Jalyn (dutasteride + tamsulosin)","3":"Approved June 2010","4":"GlaxoSmithKline","5":"benign prostatic hyperplasia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Anturol (oxybutynin) Gel","3":"Approved December 2011","4":"Antares Pharma","5":"overactive bladder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Stendra (avanafil)","3":"Approved April 2012","4":"Vivus","5":"erectile dysfunction","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Myrbetriq (mirabegron)","3":"Approved June 2012","4":"Astellas Pharma US, Inc","5":"overactive bladder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Bio-T-Gel (testosterone gel)","3":"Approved February 2012","4":"Teva Pharmaceutical","5":"hypogonadism","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xiaflex (collagenase clostridium histolyticum)","3":"Approved December of 2013","4":"Auxilium","5":"Peyronie's disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Zerbaxa (ceftolozane + tazobactam)","3":"Approved December 2014","4":"Cubist Pharmaceuticals","5":"complicated intra-abdominal and urinary tract infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xuriden (uridine triacetate)","3":"Approved September 2015","4":"Wellstat Therapeutics","5":"hereditary orotic aciduria","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Actemra (ocilizumab)","3":"Approved May 2013","4":"Genentech","5":"Polyarticular Juvenile Idiopathic Arthritis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Acular (ketorolac tromethamine ophthalmic solution) 0.5%","3":"Approved November 1997","4":"Allergan","5":"post-surgical inflammation following cataract extraction","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Acular (ketorolac tromethamine ophthalmic solution) 0.5%","3":"Approved January 1997","4":"Allergan","5":"Treatment for postoperative inflammation in patients who have undergone cataract extraction","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Viroptic","3":"Approved February 1998","4":"King Pharmaceuticals","5":"inflammation of the cornea due to herpes simplex virus","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Salagen Tablets","3":"Approved February 1998","4":"MGI Pharma","5":"Sjogren's Syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lotemax","3":"Approved March 1998","4":"Bausch & Lomb,  Pharmos","5":"post-operative eye inflammation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cosopt","3":"Approved April 1998","4":"Merck","5":"glaucoma or ocular hypertension","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Alrex","3":"Approved March 1998","4":"Bausch & Lomb,  Pharmos","5":"seasonal allergic conjunctivitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"ZADITOR","3":"Approved July 1999","4":"Ciba Vision","5":"Ophthalmology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Alamast","3":"Approved September 1999","4":"Santen","5":"Ophthalmology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Visudyne (verteporfin for injection)","3":"Approved April 2000","4":"QLT","5":"For the treatment of wet age-related macular degeneration (wet AMD)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Rescula (unoprostone isopropyl ophthalmic solution) 0.15%","3":"Approved August 2000","4":"Ciba Vision","5":"For the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Avycaz  (ceftazidime-avibactam)","3":"Approved February 2015","4":"Actavis","5":"complicated intra-abdominal and urinary tract infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Quixin (levofloxacin)","3":"Approved August 2000","4":"Santen","5":"Antibacterial agent approved for the treatment of bacterial conjunctivitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"BSS Sterile Irrigating Solution","3":"Approved December 1997","4":"Alcon","5":"irrigating solution during ocular surgical procedures","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Betaxon","3":"Approved February 2000","4":"Alcon","5":"For lowering intraocular pressure (IOP) in patients with chronic open-angle glaucoma or ocular hypertension","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Valcyte (valganciclovir HCl)","3":"Approved March 2001","4":"Roche","5":"Cytomegalovirus retinitis in patients with AIDS","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Travatan (travoprost ophthalmic solution)","3":"Approved March 2001","4":"Alcon","5":"Glaucoma or ocular hypertension","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Lumigan (bimatoprost ophthalmic solution)","3":"Approved March 2001","4":"Allergan","5":"Glaucoma or ocular hypertension","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Restasis (cyclosporine ophthalmic emulsion)","3":"December 2002","4":"Allergan","5":"Low tear production due to ocular inflammation associated with keratoconjunctivitis sicca.","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Macugen (pegaptanib)","3":"Approved December 2004","4":"Pfizer / Eyetech Pharmaceuticals","5":"Macular Degeneration","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lucentis (ranibizumab)","3":"Approved June 2006","4":"Genentech","5":"Wet Age-Related Macular Degeneration","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"AzaSite (azithromycin)","3":"Approved April 2007","4":"InSite Vision","5":"bacterial conjunctivitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ilaris (canakinumab)","3":"Approved June 2009","4":"Novartis","5":"Cryopyrin-Associated Periodic Syndromes","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Durezol (difluprednate)","3":"Approved June 2008","4":"Sirion Therapeutics","5":"inflammation and pain associated with ocular surgery","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ozurdex (dexamethasone)","3":"Approved June 2009","4":"Allergan","5":"macular edema following branch retinal vein occlusion or central retinal vein occlusion","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Bepreve (bepotastine besilate ophthalmic solution)","3":"Approved September 2009","4":"Ista Pharmaceuticals","5":"itching associated with allergic conjunctivitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Acuvail (ketorolac tromethamine)","3":"Approved July 2009","4":"Allergan","5":"pain and inflammation following cataract surgery","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Zymaxid (gatifloxacin ophthalmic solution)","3":"Approved May 2010","4":"Allergan","5":"bacterial conjunctivitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Eylea (aflibercept)","3":"Approved November 2011","4":"Regeneron Pharmaceuticals","5":"neovascular (wet) age-related macular degeneration","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zioptan (tafluprost ophthalmic solution)","3":"Approved February 2012","4":"Merck","5":"elevated intraocular pressure","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lucentis (ranibizumab injection)","3":"Approved August 2012","4":"Genentech","5":"diabetic macular edema","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Jetrea (ocriplasmin)","3":"Approved October 2012","4":"Thrombogenics","5":"symptomatic vitreomacular adhesion","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Omidria (phenylephrine and ketorolac injection)","3":"Approved June 2014","4":"Omeros","5":"For use during eye surgery to prevent intraoperative miosis and reduce post-operative pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Xiidra (lifitegrast)","3":"Approved July 2016","4":"Shire","5":"dry eye disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Vitravene Injection","3":"Approved August 1998","4":"Isis Pharmaceuticals","5":"CMV Retinitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Humira (adalimumab)","3":"Approved July 2016","4":"Abbvie","5":"uveitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Zoladex (10.8 mg goserelin acetate implant)","3":"Approved January 1996","4":"AstraZeneca","5":"prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"UltraJect","3":"Approved August 1996","4":"Mallinckrodt Group","5":"chronic pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Colcrys (colchicine)","3":"Approved October 2009","4":"Mutual Pharmaceuticals","5":"gout flares and familial Mediterranean fever","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Lupron Depot (leuprolide acetate for depot suspension)","3":"Approved January 1996","4":"Abbott Laboratories","5":"prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Besivance (besifloxacin ophthalmic suspension)","3":"Approved June 2009","4":"Bausch & Lomb","5":"bacterial conjunctivitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Kadian","3":"Approved July 1996","4":"Purepac Pharmaceutical","5":"chronic pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Gemzar (gemcitabine HCL)","3":"Approved May 1996","4":"Eli Lilly","5":"pancreatic cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"GastroMARK","3":"Approved May 1996","4":"Advanced Magnetics","5":"gastrointestinal forms of cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Feridex I.V.","3":"Approved February 1996","4":"Advanced Magnetics","5":"liver cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Eulexin (flutamide)","3":"Approved June 1996","4":"Schering-Plough","5":"prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Elliotts B Solution (buffered intrathecal electrolyte/dextrose injection)","3":"Approved October 1996","4":"Orphan Medical","5":"meningeal leukemia or lymphocytic lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"CEA-Scan","3":"Approved April 1996","4":"Immunomedics","5":"colorectal cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Campostar","3":"Approved June 1996","4":"Pharmacia & Upjohn","5":"metastatic colorectal cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Anexsia","3":"Approved August 1996","4":"Mallinckrodt Group","5":"chronic pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Taxol","3":"Approved August 1997","4":"Bristol-Myers Squibb","5":"Kaposi's Sarcoma","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Rituxan","3":"Approved November 1997","4":"Biogen IDEC, Genentech","5":"non-hodgkin's lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Quadramet (Samarium Sm 153 Lexidronam Injection)","3":"Approved March 1997","4":"DuPont Merck Pharmaceutical Company","5":"pain associated with bone cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Neumega","3":"Approved November 1997","4":"Genetics Institute","5":"platelet deficiency","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Intron A (interferon alfa-2b, recombinant)","3":"Approved December 1997","4":"Schering-Plough","5":"non-Hodgkin's lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Photodynamic Therapy","3":"Approved January, 1996","4":"Sanofi-aventis","5":"esophageal cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Gliadel Wafer (polifeprosan 20 with carmustine implant)","3":"Approved February 1997","4":"Rhone-Poulenc Rorer, Guilford Pharmaceuticals","5":"brain cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zirgan (ganciclovir ophthalmic gel)","3":"Approved September 2009","4":"Sirion Therapeutics","5":"acute herpetic keratitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Leukine (sargramostim)","3":"Approved November 1996","4":"Immunex","5":"replenishment of white blood cells, fungal infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Bromfenac","3":"Approved July 1997","4":"Duract, Wyeth-Ayerst Laboratories","5":"acute pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Zofran","3":"Approved April 1998","4":"GlaxoSmithKline","5":"postoperative vomiting and nausea in adults","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Valstar","3":"Approved October 1998","4":"Anthra Pharmaceuticals","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Photofrin","3":"Approved January 1998","4":"QLT","5":"Non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Nolvadex","3":"Approved October 1998","4":"AstraZeneca","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Neupogen","3":"Approval April 1998","4":"Amgen","5":"slow white blood cell recovery following chemotherapy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Gemzar (gemcitabine HCL)","3":"Approved August 1998","4":"Eli Lilly","5":"Lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Anzemet","3":"Approved February 1998","4":"Hoechst Marion Roussel","5":"prevention of nausea and vomiting associated with chemotherapy and surgery","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Actiq","3":"Approved November 1998","4":"Anesta Corporation","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Zofran","3":"Approved January 1999","4":"GlaxoSmithKline","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"UVADEX Sterile Solution","3":"Approved February 1999","4":"Therakos","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Temodar","3":"Approved August 1999","4":"Schering-Plough","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Desonate (desonide)","3":"Approved October 2006","4":"Dow Pharm","5":"atopic dermatitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Busulflex","3":"Approved February 1999","4":"Orphan Medical","5":"Oncology/Hematology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Viadur (leuprolide acetate implant)","3":"Approved March 2000","4":"Alza","5":"For the palliative treatment of advanced prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Anzemet","3":"Approved September 1997","4":"Hoechst Marion Roussel","5":"Treatment for chemotherapy induced emesis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Trisenox (arsenic trioxide)","3":"Approved September 2000","4":"Cell Therapeutics","5":"Acute Promyelocytic Leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Trelstar Depot (triptorelin pamoate)","3":"Approved June 2000","4":"Debio Rechereche Pharmaceutique, Target Research Associates","5":"For the palliative treatment of advanced prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Proleukin","3":"Approved January 1998","4":"Chiron","5":"Metastatic melanoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zometa (zoledronic acid)","3":"Approved August 2001","4":"Novartis","5":"Hypercalcemia of malignancy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Trelstar LA (triptorelin pamoate)","3":"Approved June 2001","4":"Debiopharm","5":"Prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Gleevec (imatinib mesylate)","3":"Approved May 2001","4":"Novartis","5":"chronic myeloid leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Camptosar","3":"Approved October 1998","4":"Pharmacia & Upjohn","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Campath","3":"Approved May 2001","4":"Berlex Laboratories","5":"Leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Zometa (zoledronic acid)","3":"Approved February 2002","4":"Novartis","5":"Multiple myeloma; bone metastases from solid tumors","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Zevalin (ibritumomab tiuxetan)","3":"Approved February 2002","4":"Biogen IDEC","5":"Non-Hodgkin's lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"SecreFlo (secretin)","3":"Approved April 2002","4":"Repligen","5":"Pancreatic dysfunction and gastrinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Neulasta","3":"Approved January 2002","4":"Amgen","5":"Neutropenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lupron Depot (leuprolide acetate for depot suspension)","3":"Approved July 1997","4":"TAP Pharmaceuticals","5":"prostrate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Faslodex (fulvestrant)","3":"Approved April 2002","4":"AstraZeneca","5":"Hormone receptor positive metastatic breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Eloxatin (oxaliplatin/5-fluorouracil/leucovorin)","3":"Approved August 2002","4":"Sanofi-aventis","5":"Metastatic colon or rectum carcinomas that have recurred or progressed within six months folowing first-line treatment","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Eligard (leuprolide acetate)","3":"Approved January 2002","4":"Atrix Laboratories","5":"Advanced prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Velcade (bortezomib)","3":"Approved May 2003","4":"Millennium Pharmaceuticals","5":"Multiple Myeloma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"UroXatral (alfuzosin HCl extended-release tablets)","3":"Approved June 2003","4":"Sanofi-aventis","5":"Benign Prostatic Hyperplasia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Mylotarg (gemtuzumab ozogamicin)","3":"Approved May 2000","4":"Wyeth","5":"Acute Myeloid Leukemia (AML)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Emend (aprepitant)","3":"Approved March 2003","4":"Merck","5":"Chemotherapy-induced Nausea and Vomiting","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Xeloda","3":"Approved May 2001","4":"Roche","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Bexxar","3":"Approved  June 2003","4":"Corixa","5":"Non-Hodgkin's Lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Kytril (granisetron) solution","3":"Approved June 2001","4":"Roche","5":"Nausea and vomiting associated with cancer therapy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tarceva (erlotinib, OSI 774)","3":"Approved November, 2004","4":"Genentech, OSI Pharmaceuticals","5":"Non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Sensipar (cinacalcet)","3":"Approved March 2004","4":"Amgen","5":"Hyperparathyroidism / Hypercalcemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Erbitux (cetuximab)","3":"Approved February 2004","4":"Imclone, Bristol-Myers Squibb","5":"Colorectal Cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Clolar (clofarabine)","3":"Approved December, 2004","4":"Genzyme","5":"Lymphoblastic Leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Nexavar (sorafenib)","3":"Approved December 2005","4":"Bayer/Onyx","5":"Renal Cell Carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Avastin (bevacizumab)","3":"Approved February 2004","4":"Genentech","5":"Colorectal Cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Arranon (nelarabine)","3":"Approved October 2005","4":"GlaxoSmithKline","5":"Lymphoblastic Leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Gleevec (imatinib mesylate)","3":"Approved February 2002","4":"Novartis","5":"Gastrointestinal stromal tumors (GISTs)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Vectibix (panitumumab)","3":"Approved September 2006","4":"Amgen","5":"colorectal cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine)","3":"Approved June 2006","4":"Merck","5":"Cervical Cancer Caused by Human Papillomavirus","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tykerb (lapatinib)","3":"Approved March 2007","4":"GlaxoSmithKline","5":"breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Torisel (temsirolimus)","3":"Approved May 2007","4":"Wyeth","5":"renal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Tasigna (nilotinib hydrochloride monohydrate)","3":"Approved October 2007","4":"Novartis","5":"chronic myelogenous leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Aloxi (palonosetron)","3":"Approved August 2003","4":"MGI Pharma, Helsinn Healthcare","5":"Chemotherapy side effects","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Hycamtin (topotecan hydrochloride)","3":"Approved October 2007","4":"GlaxoSmithKline","5":"small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cystaran (cysteamine hydrochloride)","3":"Approved October 2012","4":"Sigma Tau Pharmaceuticals","5":"corneal cystine crystal accumulation due to cystinosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Mozobil (plerixafor injection)","3":"Approved December 2008","4":"Genzyme","5":"non-Hodgkin’s lymphoma and multiple myeloma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Alimta (pemetrexed for injection)","3":"Approved February 2004","4":"Eli Lilly","5":"Mesothelioma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Degarelix (degarelix for injection)","3":"Approved December of 2008","4":"Ferring Pharmaceuticals","5":"Prostate Cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Votrient (pazopanib)","3":"Approved October of 2009","4":"GlaxoSmithKline","5":"renal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Onsolis (fentanyl buccal)","3":"Approved July 2009","4":"BioDelivery Sciences","5":"breakthrough cancer pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Sutent (sunitinib)","3":"Approved January 2006","4":"Pfizer","5":"Kidney Cancer/Gastrointestinal Stromal Tumors","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Sprycel (dasatinib)","3":"Approved June 2006","4":"Bristol-Myers Squibb","5":"Chronic Myeloid Leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Folotyn (pralatrexate injection)","3":"Approved September 2009","4":"Allos Therapeutics","5":"peripheral T-cell lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Avastin (bevacizumab)","3":"Approved July 2009","4":"Genentech","5":"renal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Afinitor (everolimus)","3":"Approved March 2009","4":"Novartis","5":"renal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Plenaxis (abarelix for injectable suspension)","3":"Approved December 2003","4":"Praecis Pharmaceuticals","5":"Prostate Cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xgeva (denosumab)","3":"Approved November 2010","4":"Amgen","5":"prevention of skeletal-related events in patients with bone metastases from solid tumors","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Provenge (sipuleucel-T)","3":"Approved May 2010","4":"Dendreon","5":"hormone refractory prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ixempra (ixabepilone)","3":"Approved October 2007","4":"Bristol-Myers Squibb","5":"Breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Jevtana (cabazitaxel)","3":"Approved June 2010","4":"sanofi aventis","5":"prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Herceptin (trastuzumab)","3":"Approved October 2010","4":"Genentech","5":"gastric cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Zytiga (abiraterone acetate)","3":"Approved May 2011","4":"Centocor Ortho Biotech","5":"prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Zelboraf (vemurafenib)","3":"Approved August of 2011","4":"Roche","5":"BRAF + melanoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Yervoy (ipilimumab)","3":"Approved March 2011","4":"Bristol-Myers Squibb","5":"metastatic melanoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Sylatron (peginterferon alfa-2b)","3":"Approved April 2011","4":"Merck","5":"melanoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Sutent (sunitinib malate)","3":"Approved May 2011","4":"Pfizer","5":"pancreatic neuroendocrine tumors","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lazanda (fentanyl citrate) nasal spray","3":"Approved June 2011","4":"Archimedes","5":"breakthrough cancer pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Afinitor (everolimus)","3":"Approved May 2011","4":"Novartis","5":"advanced pancreatic neuroendocrine tumors","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Adcetris (brentuximab vedotin)","3":"Approved August 2011","4":"Seattle Genetics","5":"Hodgkin lymphoma and anaplastic large cell lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Istodax (romidepsin)","3":"Approved November 2009","4":"Gloucester Pharmaceuticals","5":"cutaneous T-cell lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Zaltrap (ziv-aflibercept)","3":"Approved August 2012","4":"Sanofi-aventis","5":"metastatic colorectal cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Elitek (rasburicase)","3":"Approved October 2009","4":"sanofi-aventis","5":"management of plasma uric acid levels in adults with malignancies","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Xtandi (enzalutamide)","3":"Approved August 2012","4":"Medivation","5":"metastatic castration-resistant prostate cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Votrient (pazopanib)","3":"Approved April 2012","4":"GlaxoSmithKline","5":"soft tissue sarcoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Synribo (omacetaxine mepesuccinate)","3":"Approved October 2012","4":"Teva Pharmaceutical","5":"chronic or accelerated phase chronic myeloid leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Subsys (fentanyl sublingual spray)","3":"Approved January of 2012","4":"Insys Therapeutics","5":"breakthrough cancer pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Picato (ingenol mebutate) gel","3":"Approved January 2012","4":"LEO Pharma","5":"actinic keratosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Neutroval (tbo-filgrastim)","3":"Approved August 2012","4":"Teva Pharmaceutical","5":"severe chemotherapy-induced neutropenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Marqibo (vinCRIStine sulfate LIPOSOME injection)","3":"Approved August 2012","4":"Talon Therapeutics","5":"Ph- acute lymphoblastic leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kyprolis (carfilzomib)","3":"Approved July 2012","4":"Onyx Pharmaceuticals","5":"multiple myeloma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Inlyta (axitinib)","3":"Approved January 2012","4":"Pfizer","5":"advanced renal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Iclusig (ponatinib)","3":"Approved December 2012","4":"Ariad Pharmaceuticals","5":"chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Erivedge (vismodegib)","3":"Approved January 2012","4":"Genentech","5":"basal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cometriq (cabozantinib)","3":"Approved November 2012","4":"Exelixis","5":"thyroid cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Bosulif (bosutinib)","3":"Approved September 2012","4":"Pfizer","5":"Ph+ chronic myelogenous leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Erwinaze (asparaginase Erwinia chrysanthemi)","3":"Approved November of 2011","4":"Eusa Pharma","5":"acute lymphoblastic leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xofigo (radium Ra 223 dichloride)","3":"Approved May 2013","4":"Bayer Healthcare Pharmaceuticals","5":"prostate cancer with bone metastases","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Valchlor (mechlorethamine) gel","3":"Approved August 2013","4":"Ceptaris Therapeutics","5":"Stage IA/IB mycosisfungoides-type cutaneous T-cell lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Abstral (fentanyl sublingual tablets)","3":"Approved January 2011","4":"ProStrakan","5":"breakthrough cancer pain in opioid-tolerant patients","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tafinlar (dabrafenib)","3":"Approved May 2013","4":"GlaxoSmithKline","5":"unresectable or metastatic melanoma with BRAF V600E mutation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Stivarga (regorafenib)","3":"Approved February 2013","4":"Bayer","5":"gastrointestinal stromal tumor","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Pomalyst (pomalidomide)","3":"Approved February 2013","4":"Celgene","5":"relapsed and refractory multiple myeloma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Mekinist (trametinib)","3":"Approved May of 2013","4":"GlaxoSmithKline","5":"unresectable or metastatic melanoma with BRAF V600E or V600K mutations","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Stivarga (regorafenib)","3":"Approved September 2012","4":"Bayer HealthCare Pharmaceuticals","5":"metastatic colorectal cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Imbruvica (ibrutinib)","3":"Approved November of 2013","4":"Pharmacyclics","5":"mantle cell lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Gazyva (obinutuzumab)","3":"Approved October of 2013","4":"Genentech","5":"previously untreated chronic lymphocytic leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zydelig (idelalisib)","3":"Approved July 2014","4":"Gilead","5":"relapsed CLL, follicular B-cell NHL and small lymphocytic lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Opdivo (nivolumab)","3":"Approved December 2014","4":"Bristol-Myers Squibb","5":"unresectable or metastatic melanoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Keytruda (pembrolizumab)","3":"Approved September 2014","4":"Merck","5":"unresectable or metastatic melanoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Imbruvica (ibrutinib)","3":"Approved February 2014","4":"Pharmacyclics","5":"chronic lymphocytic leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Treanda (bendamustine hydrochloride)","3":"Approved October 2008","4":"Cephalon","5":"Chronic lymphocytic leukemia and B-cell non-Hodgkin’s lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cyramza (ramucirumab)","3":"Approved April 2014","4":"Eli Lilly","5":"gastric cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Blincyto (blinatumomab)","3":"Approved December 2014","4":"Amgen","5":"Philadelphia chromosome-negative relapsed /refractory B cell precursor acute lymphoblastic leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Beleodaq (belinostat)","3":"Approved July 2014","4":"Spectrum Pharmaceuticals","5":"relapsed or refractory peripheral T-cell lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Yondelis (trabectedin)","3":"Approved October 2015","4":"Janssen","5":"liposarcoma or leiomyosarcoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Vistogard (uridine triacetate)","3":"Approved December 2015","4":"Wellstat Therapeutics","5":"fluorouracil or capecitabine overdose","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Afinitor (everolimus)","3":"Approved April 2012","4":"Novartis","5":"renal angiomyolipoma associated with tuberous sclerosis complex","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Unituxin (dinutuximab)","3":"Approved March 2015","4":"United Therapeutics","5":"pediatrics with high-risk neuroblastoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Onivyde (irinotecan liposome injection)","3":"Approved October 2015","4":"Merrimack","5":"metastatic pancreatic cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Odomzo (sonidegib)","3":"July 2015","4":"Novartis","5":"locally advanced basal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ninlaro (ixazomib)","3":"Approved November 2015","4":"Millennium Pharmaceuticals","5":"Multiple myeloma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Lonsurf (trifluridine and tipiracil)","3":"Approved September 2015","4":"Taiho Oncology","5":"metastatic colorectal cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lenvima (lenvatinib)","3":"Approved February 2015","4":"Eisai","5":"thyroid cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Imlygic (talimogene laherparepvec)","3":"Approved October 2015","4":"Amgen","5":"unresectable recurrent melanoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Farydak (panobinostat)","3":"Approved February 2015","4":"Novartis","5":"Multiple myeloma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Empliciti (elotuzumab)","3":"Approved November 2015","4":"Bristol-Myers Squibb","5":"multiple myeloma patients who have received prior therapies","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Darzalex (daratumumab)","3":"Approved November 2015","4":"Janssen Biotech","5":"multiple myeloma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cotellic (cobimetinib)","3":"Approved November 2015","4":"Genentech","5":"BRAF V600E or V600K melanoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Venclexta (venetoclax)","3":"Approved April 2016","4":"AbbVie","5":"chronic lymphocytic leukemia with 17p deletion","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Syndros (dronabinol oral solution)","3":"Approved July 2016","4":"Insys Therapeutics","5":"anorexia associated with AIDS and nausea and vomiting associated with cancer chemotherapy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Opdivo (nivolumab)","3":"Approved November 2016","4":"Bristol-Myers Squibb","5":"recurrent or metastatic squamous cell carcinoma of the head and neck","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Opdivo (nivolumab)","3":"Approved May 2016","4":"Bristol-Myers Squibb","5":"classical Hodgkin lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Lenvima (lenvatinib)","3":"Approved May 2016","4":"Eisai","5":"advanced renal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Varubi (rolapitant)","3":"Approved September 2015","4":"Tesaro","5":"chemotherapy-induced nausea and vomiting","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Keytruda (pembrolizumab)","3":"Approved August 2016","4":"Merck","5":"head and neck squamous cell cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Opdivo (nivolumab)","3":"Approved November 2015","4":"Bristol-Myers Squibb","5":"advanced renal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"MERIDIA","3":"Approved November 1997","4":"Knoll Pharmaceutical","5":"obesity","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Qsymia (phentermine + topiramate extended-release)","3":"Approved July 2012","4":"Vivus","5":"chronic weight management","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Arzerra (ofatumumab)","3":"Approved October 2009","4":"GlaxoSmithKline","5":"chronic lymphocytic leukemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Bydureon (exenatide extended-release for injectable suspension)","3":"Approved January 2012","4":"Amylin","5":"glycemic control in adults with type II daibetesmellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Belviq (lorcaserin hydrochloride)","3":"Approved June 2012","4":"Arena Pharmaceuticals","5":"weight loss management","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Nesina (alogliptin)","3":"Approved January 2013","4":"Takeda","5":"type II diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tanzeum (albiglutide)","3":"Approved April 2014","4":"GlaxoSmithKline","5":"type II diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Saxenda (liraglutide [rDNA origin] injection)","3":"Approved December 2014","4":"Novo Nordisk","5":"chronic weight management","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Jardiance (empagliflozin)","3":"Approved August 2014","4":"Boehringer Ingelheim","5":"type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Contrave (naltrexone HCl and bupropion HCl)","3":"Approved September 2014","4":"Takeda Pharmaceuticals U.S.A.","5":"chronic  weight management","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Self-examination breast pad","3":"Approved on December 22, 1995","4":"Inventive Products","5":"breast self-examination","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Prempro & Premphase (conjugated estrogens/medroxyprogesterone acetate tablets)","3":"Approved November 1995","4":"Wyeth","5":"postmenopausal hormone replacement, postmenopausal osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Miacalcin (calcitonin-salmon) Nasal Spray","3":"Approved on August 17, 1995","4":"Sandoz Pharmaceuticals","5":"post-menopausal osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Fosamax (alendronate sodium)","3":"Approved on September 29, 1995","4":"Merck","5":"Post-menopausal osteoporosis, Paget's disease of bone","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Ethyol (amifostine)","3":"Approved December 8, 1995","4":"Alza","5":"ovarian cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cabometyx (cabozantinib)","3":"Approved April 2016","4":"Exelixis","5":"advanced renal cell carcinoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vivelle (estradiol transdermal system)","3":"Approved March 1996","4":"Ciba Pharmaceuticals","5":"menopausal symptoms","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Taxotere (Docetaxel)","3":"Approved May 1996","4":"Rhone Poulenc Rorer","5":"breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Revlimid (lenalidomide)","3":"Approved June 2013","4":"Celgene","5":"mantle cell lymphoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Monistat 3 (miconazole nitrate)","3":"Approved April 1996","4":"Johnson & Johnson","5":"vaginal yeast infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Hycamtin (topotecan hydrochloride)","3":"Approved May 1996","4":"SmithKline Beecham","5":"ovarian cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Trulicity (dulaglutide)","3":"Approved September 2014","4":"Eli Lilly","5":"To improve glycemic control in type II diabetics","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"TRUE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"FemPatch","3":"Approved December 1996","4":"Parke-Davis","5":"menopausal symptoms","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Estrostep (norethindrone acetate and ethinyl estradiol)","3":"Approved October 1996","4":"Parke-Davis","5":"oral contraceptive","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Arimidex (anastrozole)","3":"Approved January 1996","4":"AstraZeneca","5":"post menopausal breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Aredia (pamidronate disodium for injection)","3":"Approved August 1996","4":"Chiron","5":"osteolytic bone metastases of breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Trivora-21 and Trivora-28","3":"Approved December 1997","4":"Watson Pharmaceuticals","5":"oral contraceptives","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Ortho Tri-Cyclen Tablets (norgestimate/ethinyl estradiol)","3":"Approved January 1997","4":"Ortho-McNeil Pharmaceutical","5":"acne","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Miraluma test","3":"Approved May 1997","4":"DuPont Merck Pharmaceutical Company","5":"breast imaging","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Gonal-F (follitropin alfa for injection)","3":"Approved September 1997","4":"Serono Laboratories","5":"infertility","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Follistim (TM) (follitropin beta for injection)","3":"Approved September 1997","4":"Organon","5":"infertility","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Floxin Tablets (ofloxacin tablets)","3":"Approved January 1997","4":"Ortho-McNeil Pharmaceutical","5":"pelvic inflammatory disease (PID)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"FEMSTAT One","3":"Approved Februrary 1997","4":"Roche","5":"vaginal yeast infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Femara (letrozole)","3":"Approved July 1997","4":"Novartis","5":"breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Evista (raloxifene hydrochloride)","3":"Approved December 1997","4":"Eli Lilly","5":"osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Seprafilm","3":"Approved August 1996","4":"Genzyme","5":"reduction of scar tissue as a result of abdominal or pelvic surgery","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Fertinex (urofollitropin for injection, purified)","3":"Approved September 1996","4":"Serono Laboratories","5":"For patients undergoing infertility treatments","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Gilotrif (afatinib)","3":"Approved July 2013","4":"Boehringer Ingelheim","5":"metastatic non-small cell lung cancer with EGFR mutations","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Estradiol tablets","3":"Approved October 1997","4":"Barr Laboratories","5":"post-menopausal osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Crinone 8% (progesterone gel)","3":"Approved May 1997","4":"Wyeth","5":"progesterone deficiency","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Alesse (100 mcg levonorgestrel/20 mcg ethinyl estradiol tablets)","3":"Approved April 1997","4":"Wyeth","5":"birth control","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Xeloda","3":"Approved April 1998","4":"Roche","5":"breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prometrium","3":"Approved May 1998","4":"Solvay Pharmaceuticals","5":"amenorrhea","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prometrium","3":"Approved December 1998","4":"Schering-Plough","5":"Gynecology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"PREVEN ; Emergency Contraceptive Kit","3":"Approved September 1998","4":"Gynetics","5":"Ob/Gyn","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Prempro","3":"Approved January 1998","4":"Wyeth","5":"Hormone replacement therapy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Mircette","3":"Approved April 1998","4":"Organon","5":"oral contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Flagyl ER","3":"Approved December 1997","4":"Searle","5":"bacterial vaginosis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Herceptin","3":"Approved October 1998","4":"Genentech","5":"Breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Estratab (.3 mg )","3":"Approved March 1998","4":"Solvay Pharmaceuticals","5":"prevention of osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Esclim","3":"Approved August 1998","4":"Fournier Research","5":"Menopause","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cleocin (clindamycin phosphate)","3":"Approved March 1998","4":"Pharmacia & Upjohn","5":"bacterial vaginosis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Ortho-Prefest","3":"October 22, 1999","4":"Ortho-McNeil Pharmaceutical, RW Johnson","5":"Treatment of vasomotor symptoms assoc. w/menopause; vulvar, vaginal atrophy; prevention of osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lupron Depot (leuprolide acetate for depot suspension)","3":"Approved June 1999","4":"TAP Pharmaceuticals","5":"Gynecology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Femhrt Tablets","3":"October 15, 1999","4":"Parke-Davis","5":"For the treatment of moderate to severe vasomotor symptoms associated with menopause, and the prevention of osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Evista (raloxifene hydrochloride)","3":"Approved September 1999","4":"Eli Lilly","5":"For the treatment of osteoporosis in postmenopausal women.","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Estradiol tablets","3":"Approved December 1997","4":"Duramed Pharmaceuticals","5":"hormone replacement","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Ellence","3":"Approved September 1999","4":"Pharmacia & Upjohn","5":"Component of adjuvant therapy in patients with evidence of axillary node tumor involvement for primary breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Doxil (doxorubicin HCl liposome injection)","3":"Approved June 1999","4":"Alza","5":"Oncology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Climara","3":"Approved June 1999","4":"Berlex Laboratories","5":"Obstetrics/Gynecology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cleocin (clindamycin phosphate)","3":"Approved August 1999","4":"Pharmacia & Upjohn","5":"Immunology; Ob/Gyn","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cenestin","3":"Approved July 1999","4":"Duramed Pharmaceuticals","5":"Obstetrics/Gynecology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Cenestin","3":"Approved March 1999","4":"Duramed Pharmaceuticals","5":"Obstetrics/Gynecology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Aromasin Tablets","3":"October 21, 1999","4":"Pharmacia & Upjohn","5":"Treatment of advanced breast cancer in postmenopausal women whose disease has progressed following tamoxifen therapy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Vivelle (estradiol transdermal system)","3":"Approved August 2000","4":"Novartis","5":"For the prevention of osteoporosis and treatment of other menopausal symptoms","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Trivagizole 3 (clotrimazole) Vaginal Cream","3":"Approved April 2000","4":"Taro Pharmaceuticals","5":"For the treatment of vaginal yeast infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Ovidrel (gonadotropin, chorionic human recombinant)","3":"Approved September 2000","4":"Serono Laboratories","5":"Infertility","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Mirena (levonorgestrel-releasing intrauterine system)","3":"Approved December 2000","4":"Berlex Laboratories","5":"Hormone-releasing system for intrauterine contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cetrotide","3":"Approved August 2000","4":"Asta Medica","5":"For the prevention of premature ovulation in women undergoing controlled ovarian stimulation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Activella (Estradiol/Norethindrone Acetate) Tablets","3":"Approved April 2000","4":"Novo Nordisk","5":"Combination hormone replacement therapy for the prevention of osteoporosis and other symptoms associated with Menopause.","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Yasmin (drospirenone/ethinyl estradiol)","3":"Approved May 2001","4":"Berlex Laboratories","5":"Contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ortho Evra","3":"Approved November 2001","4":"Ortho-McNeil Pharmaceutical","5":"Contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Estrostep (norethindrone acetate and ethinyl estradiol)","3":"Approved March 1997","4":"Warner-Lambert","5":"oral contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Monistat 3 (miconazole nitrate)","3":"Approved February 2001","4":"Advanced Care Products","5":"Vaginal yeast infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Estradiol Transdermal System","3":"Approved September 1999","4":"Wyeth","5":"Treatment of vulvar vaginal atrophy and vasomotor symptoms","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Bextra","3":"Approved November 2001","4":"Pharmacia, Pfizer","5":"Osteoarthritis, rheumatoid arthritis and menstrual pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zoloft (sertraline HCl)","3":"Approved May 2002","4":"Pfizer","5":"Mood disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Vivelle-Dot (estradiol transdermal system)","3":"Approved May 2002","4":"Novartis","5":"Post-menopausal osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Forteo (teriparatide)","3":"December 2002","4":"Eli Lilly","5":"Osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Bravelle (urofollitropin for injection, purified)","3":"Approved May 2002","4":"Ferring Pharmaceuticals","5":"Ovulation induction / infertility","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Alora","3":"Approved April 2002","4":"Watson Pharmaceuticals","5":"Postmenopausal osteoporosis, Vasomotor menopausal symptoms","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Premarin (conjugated estrogens)","3":"Approved July of 2003","4":"Wyeth","5":"prevention of postmenopausal osteoporosis and treatment of vasomotor menopause symptoms","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Inform HER-2/neu breast cancer test","3":"Approved January 1998","4":"Oncor","5":"breast cancer prediction","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"EstroGel (estradiol gel 0.06%)","3":"Approved April 2004","4":"Solvay Pharmaceuticals","5":"Menopause","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Elestrin (estradiol gel)","3":"Approved December 2006","4":"BioSante","5":"Vasomotor symptoms associated with menopause","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Reclast (zoledronic acid)","3":"Approved August 2007","4":"Novartis","5":"postmenopausal osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Evista (raloxifene hydrochloride)","3":"Approved September 2007","4":"Eli Lilly","5":"the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Evamist (estradiol)","3":"Approved July 2007","4":"Vivus","5":"moderate to severe vasomotor symptoms due to menopause","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lysteda (tranexamic acid)","3":"Approved November 2009","4":"Xanodyne Pharmaceuticals","5":"heavy menstrual bleeding","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Prolia (denosumab)","3":"Approved June 2010","4":"Amgen","5":"postmenopausal women with osteoporosis at high risk for fracture","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Natazia (estradiol valerate + dienogest)","3":"Approved May 2010","4":"Bayer","5":"contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Halaven (eribulin mesylate)","3":"Approved November 2010","4":"Eisai","5":"metastatic breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"ella (ulipristal acetate)","3":"Approved August 2010","4":"HRA Pharma","5":"emergency contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Makena (hydroxyprogesterone caproate injection)","3":"Approved February 2011","4":"Hologic","5":"preterm birth","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Seasonale, Lo Seasonale, Seasonique (ethinylestradiol + levonorgestrel)","3":"Approved September 2003","4":"Duramed Pharmaceuticals","5":"contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Femstat 3 (butoconazole nitrate 2%)","3":"Approved December 1995","4":"Procter & Gamble, Roche","5":"vaginal yeast infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Perjeta (pertuzumab)","3":"Approved June 2012","4":"Genentech","5":"HER2+ metastatic breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lartruvo (olaratumab)","3":"Approved October 2016","4":"Eli Lilly","5":"soft tissue sarcoma","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Afinitor (everolimus)","3":"Approved July 2012","4":"Novartis","5":"hormone receptor-positive, HER2-negative breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol)","3":"Approved April 2013","4":"Teva Pharmaceutical","5":"contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Osphena (ospemifene)","3":"Approved March 2013","4":"Shionogi","5":"dyspareunia and vulvar and vaginal atrophy due to menopause","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lo Minastrin, (norethindrone acetate, ethinyl estradiol, ferrous fumarate)","3":"Approved July 2013","4":"Warner Chilcott","5":"prevention of pregnancy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Kadcyla (ado-trastuzumab emtansine)","3":"Approved February 2013","4":"Genentech","5":"HER2-positive metastatic breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Diclegis (doxylamine succinate + pyridoxine hydrochloride DR tablets)","3":"Approved April 2013","4":"Duchesnay USA","5":"nausea and vomiting of pregnancy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Brisdelle (low-dose paroxetine mesylate)","3":"Approved July 2013","4":"Noven Pharmaceuticals","5":"vasomotor symptoms of menopause","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Metronidazole 1.3% Vaginal Gel","3":"Approved April 2014","4":"Actavis, Inc.","5":"bacterial vaginosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Cervarix [Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant","3":"Approved October 2009","4":"GlaxoSmithKline","5":"prevention of cervical cancer and cervical intraepithelial neoplasia caused by HPV types 16 and 18","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Lynparza (olaparib)","3":"Approved December 2014","4":"AstraZeneca","5":"previously treated BRCA mutated advanced ovarian cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ibrance (palbociclib)","3":"Approved February 2015","4":"Pfizer","5":"ER-positive, HER2-negative breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Intrarosa (prasterone vaginal inser\\177t)","3":"Approved November 2016","4":"Endoceutics","5":"moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tamiflu  capsule","3":"October 27, 1999","4":"Roche","5":"For the treatment of all common strains of influenza","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Synercid I.V.","3":"Approved September 1999","4":"Rhone Poulenc Rorer","5":"For serious or life-threatening infections associated w/ vancomycin-resistant Enterococcus faecium (VREF) bacteremia.","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Twinrix","3":"Approved May 2001","4":"GlaxoSmithKline","5":"Hepatitis A and B","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"TRUE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Spectracef","3":"Approved August 2001","4":"TAP Pharmaceuticals","5":"Bacterial infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Pediarix Vaccine","3":"Approved December 2002","4":"GlaxoSmithKline","5":"Diphtheria, Tetanus,  Acellular Pertussis , Hepatitis  B, Polio","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"TRUE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Neurontin (gabapentin)","3":"Approved May 2002","4":"Pfizer","5":"Post-herpetic neuralgia (PHN)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Fluzone Preservative-free","3":"Approved September 2002","4":"Sanofi Pasteur","5":"Influenza immunization in infants","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"FluMist ( Influenza Virus Vaccine)","3":"Approved June 2003","4":"MedImmune","5":"Influenza","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Hiberix (Haemophilus b Conjugate Vaccine; Tetanus Toxoid Conjugate)","3":"August of 2009","4":"GlaxoSmithKline","5":"invasive disease caused by Haemophilus influenzae type b","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine)","3":"Approved February 2010","4":"Wyeth","5":"invasive disease caused by Streptococcus pneumoniae","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Duavee (conjugated estrogens/bazedoxifene)","3":"Approved October 2013","4":"Pfizer","5":"vasomotor symptoms associated with menopause and postmenopausal osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Menveo (meningitis vaccine)","3":"Approved February 2010","4":"Novartis","5":"invasive meningococcal disease","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Horizant (gabapentin enacarbil)","3":"Approved April 2011","4":"GlaxoSmithKline","5":"restless legs syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Horizant (gabapentin enacarbil)","3":"Approved June 2012","4":"GlaxoSmithKline","5":"postherpetic neuralgia","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"NuvaRing","3":"Approved October 2001","4":"Organon","5":"Female contraception","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"VariZIG, Varicella Zoster Immune Globulin (Human)","3":"Approved January 2013","4":"Cangene","5":"varicella zoster (chickenpox)","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Flublok (seasonal influenza vaccine)","3":"Approved January 2013","4":"Protein Sciences","5":"influenza virus subtypes A and type B","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"TRUE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Bexsero (Meningococcal Group B Vaccine)","3":"Approved January 2015","4":"Novartis","5":"invasive meningococcal disease caused by serogroup B","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Rocephin","3":"Approved January 1998","4":"Roche","5":"Pediatric otitis media","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Ethyol (amifostine)","3":"Approved June 1999","4":"US Bioscience, Alza","5":"Oncology","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Protonix (pantoprazole sodium) Delayed-Release Tablets","3":"Approved February 2000","4":"Wyeth","5":"Short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD)","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Depakote ER (divalproex sodium)","3":"Approved August 2000","4":"Abbott Laboratories","5":"For the prophylaxis (prevention) of migraine headaches in adults","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Veramyst (fluticasone furoate)","3":"Approved April 2007","4":"GlaxoSmithKline","5":"seasonal and perennial allergic rhinitis","6":"FALSE","7":"TRUE","8":"TRUE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Moxatag (amoxicillin)","3":"Approved January 2008","4":"MiddleBrooke Pharmaceuticals","5":"tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics","6":"FALSE","7":"TRUE","8":"TRUE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Astepro (azelastine hydrochloride nasal spray)","3":"Approved October 2008","4":"Meda Pharmaceuticals Inc","5":"seasonal and perennial allergic rhinitis","6":"FALSE","7":"TRUE","8":"TRUE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Oravig (miconazole)","3":"Approved April 2010","4":"Strativa Pharmaceuticals","5":"oropharyngeal candidiasis","6":"FALSE","7":"TRUE","8":"TRUE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vandetanib (vandetanib)","3":"Approved April 2011","4":"AstraZeneca","5":"thyroid cancer","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Xtoro (finafloxacin otic suspension) 0.3%","3":"Approved December 2014","4":"Alcon","5":"acute otitis externa","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Otiprio (ciprofloxacin otic suspension)","3":"Approved December 2015","4":"Otonomy","5":"pediatrics with bilateral otitis media with effusion undergoing tympanostomy tube placement","6":"FALSE","7":"FALSE","8":"TRUE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xgeva (denosumab)","3":"Approved June 2013","4":"Amgen","5":"giant cell tumor of bone","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"TRUE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Otezla (apremilast)","3":"Approved March 2014","4":"Celgene","5":"psoriatic arthritis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"TRUE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Strensiq (asfotase alfa)","3":"Approved October 2015","4":"Alexion","5":"hypophosphatasia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"TRUE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Flucelvax, Influenza Virus Vaccine","3":"Approved November 2012","4":"Novartis","5":"influenza virus subtypes A and type B","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Hetlioz (tasimelteon)","3":"January 2014","4":"Vanda Pharmaceuticals","5":"non-24-hour sleep-wake disorder in the totally blind","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"TRUE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Femara (letrozole)","3":"Approved January 2001","4":"Novartis","5":"Hormone receptor positive or hormone receptor unknown locally advanced or metastatic breast cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Vaxchora (Cholera Vaccine, Live, Oral)","3":"Approved June 2016","4":"PaxVax","5":"Cholera","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Addyi (flibanserin)","3":"Approved August 2015","4":"Sprout Pharmaceuticals","5":"premenopausal women with generalized hypoactive sexual desire disorder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Wilate (von Willebrand Factor/Coagulation Factor VIII Complex (Human)","3":"Approved December of 2009","4":"Octapharma","5":"von Willebrand disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"TRUE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Lyrica (pregabalin)","3":"Approved June 2012","4":"Pfizer","5":"neuropathic pain associated with spinal cord injury","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"TRUE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zosyn (sterile piperacillin sodium/tazobactam sodium)","3":"Approved May 1996","4":"Wyeth","5":"pneumonia","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Vancenase AQ 84 mcg Double Strength","3":"Approved June 1996","4":"Schering-Plough","5":"allergic and non-allergic rhinitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tripedia (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed)","3":"Approved August 1996","4":"Connaught Laboratories","5":"whooping cough","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tavist (clemastine fumarate)","3":"Approved November 1996","4":"Sandoz Pharmaceuticals","5":"cold symptoms, including sneezing and runny nose","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"RespiGam (Respiratory Syncitial Virus Immune Globulin Intravenous)","3":"Approved January 1996","4":"MedImmune","5":"RSV, bronchopulmonary dysplasia","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Pulmozyme (dornase alfa)","3":"Approved December 1996","4":"Genentech","5":"cystic fibrosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Nasacort AQ (triamcinolone acetonide) Nasal Spray","3":"Approved May 1996","4":"Rhone Poulenc Rorer","5":"allergic rhinitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate)","3":"Approved August 1996","4":"Schering-Plough","5":"nasal congestion","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Claritin Syrup (loratadine)","3":"Approved October 1996","4":"Schering-Plough","5":"seasonal allergies in children","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Intermezzo (zolpidem tartrate sublingual tablet)","3":"Approved November 2011","4":"Transcept Pharmaceuticals","5":"insomnia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"TRUE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Azmacort (triamcinolone acetonide) Inhalation Aerosol","3":"Approved November 1996","4":"Rhone Poulenc Rorer","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Augmentin (amoxicillin/clavulanate)","3":"Approved February 1996","4":"SmithKline Beecham","5":"sinusitis, bronchitis, pneumonia","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Exparel (bupivacaine liposome injectable suspension)","3":"Approved November 2011","4":"Pacira Pharmaceuticals","5":"postsurgical analgesia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"TRUE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Astelin nasal spray","3":"Approved November 1996","4":"Wallace Laboratories","5":"seasonal allergic rhinitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Allegra (fexofenadine hydrochloride)","3":"Approved July 1996","4":"Hoechst Marion Roussel","5":"seasonal allergic rhinitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Accolate","3":"Approved October 1996","4":"AstraZeneca","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zyflo (Zileuton)","3":"Approved January 1997","4":"Abbott Laboratories","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Vanceril 84 mcg Double Strength (beclomethasone dipropionate, 84 mcg) Inhalation Aerosol","3":"Approved January 1997","4":"Schering-Plough","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Breathe Right","3":"Approved June 1996","4":"CNS","5":"breathing difficulties due to deviated nasal septum","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"OsmoCyte Pillow Wound Dressing","3":"Approved December 1996","4":"ProCyte","5":"chronic and acute wounds","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"TRUE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Iamin","3":"Approved February 1996","4":"ProCyte","5":"wounds","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"TRUE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Atrovent (ipratropium bromide)","3":"Approved January 1996","4":"Boehringer Ingelheim","5":"runny nose due to allergies and the common cold","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Serevent","3":"Approved September 1997","4":"GlaxoSmithKline","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Zagam (sparfloxacin) tablets","3":"Approved January 1997","4":"Rhone Poulenc Rorer","5":"community-acquired pneumonia (CAP) and chronic bronchitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Raxar (grepafloxacin)","3":"Approved November 1997","4":"GlaxoSmithKline","5":"chronic bronchitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Metaprotereol Sulfate Inhalation Solution, 5%","3":"Approved March 1997","4":"Morton Grove Pharmaceuticals","5":"bronchial asthma and reversible bronchospasm","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Flovent Rotadisk","3":"Approved November 1997","4":"GlaxoSmithKline","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Tobi","3":"Approved December 1997","4":"PathoGenesis","5":"cystic fibrosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Claritin RediTabs (10 mg loratadine rapidly-disintegrating tablet)","3":"Approved January 1997","4":"Schering-Plough","5":"seasonal allergy symptoms","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tilade (nedocromil sodium)","3":"Approved November 1997","4":"Rhone Poulenc Rorer","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Synagis","3":"Approved June 1998","4":"MedImmune","5":"respiratory syncytial virus (RSV)","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tilade (nedocromil sodium)","3":"Approved April 1997","4":"Rhone Poulenc Rorer","5":"mild-to-moderate bronchial asthma in children ages six to eleven","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Singulair","3":"Approved February 1998","4":"Merck","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Sclerosol Intrapleural Aerosol","3":"Approved January 1998","4":"Bryan Corporation","5":"malignant pleural effusions","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"OcuHist","3":"Approved January 1996","4":"Pfizer","5":"itching and redness of the eye","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Infasurf","3":"Approved July 1998.","4":"ONY","5":"Respiratory Distress Syndrome (RDS)","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Flonase Nasal Spray","3":"Approved November 1997","4":"GlaxoSmithKline","5":"allergic rhinitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Dynabac","3":"Approved March 1998","4":"Sanofi-aventis","5":"acute bacterial exacerbations","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Curosurf","3":"Approved October 1998","4":"Dey Laboratories","5":"Pediatric Respiratory Distress Syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cipro (ciprofloxacin HCl)","3":"Approved June 1997","4":"Bayer","5":"acute sinusitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Clemastine fumarate syrup","3":"Approved March 1998","4":"Morton Grove Pharmaceuticals","5":"allergic rhinitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Allegra-D","3":"Approved March 1998","4":"Hoechst Marion Roussel","5":"nasal congestion due to seasonal allergy","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Ceftin (cefuroxime axetil)","3":"Approved September 1997","4":"GlaxoSmithKline","5":"acute bronchitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Tikosyn Capsules","3":"Approved October 1999","4":"Pfizer","5":"For the maintenance of normal sinus rhythm in patients with atrial fibrillation/atrial flutter.","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tilade (nedocromil sodium)","3":"Approved April 1997","4":"Rhone Poulenc Rorer","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Rhinocort Aqua Nasal Spray","3":"Approved October 1999","4":"AstraZeneca","5":"Management of nasal symptoms of seasonal or perennial allergic rhinitis in adults and children six years of age or older","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Proventil HFA Inhalation Aerosol","3":"Approved June 1999","4":"3M Pharmaceuticals","5":"Pulmonary/Respiratory Diseases","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Accolate","3":"Approved September 1999","4":"AstraZeneca","5":"Asthma in pediatric patients","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Tri-Nasal Spray (triamcinolone acetonide spray)","3":"Approved February 2000","4":"Muro Pharmaceutical","5":"Allergic rhinitis","6":"FALSE","7":"TRUE","8":"TRUE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [7]>","2":"Cefazolin and Dextrose USP","3":"Approved July 2000","4":"B Braun Medical","5":"Various bacterial infections, septicemia, endocarditis, and perioperative prophylaxis","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Pulmozyme (dornase alfa)","3":"Approved March 1998","4":"Genentech","5":"cystic fibrosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Priftin","3":"Approved June 1998","4":"Hoechst Marion Roussel","5":"pulmonary tuberculosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Advair (fluticasone propionate and salmeterol)","3":"Approved August 2000","4":"GlaxoSmithKline","5":"asthma and chronic obstructive pulmonary disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ventolin HFA (albuterol sulfate inhalation aerosol)","3":"Approved April 2001","4":"GlaxoSmithKline","5":"Asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tracleer (bosentan)","3":"Approved November 2001","4":"Actelion","5":"Pulmonary arterial hypertension","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"NasalCrom Nasal Spray","3":"Approved April 2001","4":"Pharmacia & Upjohn","5":"Allergic Rhinitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [7]>","2":"Invanz","3":"Approved November 2001","4":"Merck","5":"Bacterial infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Foradil Aerolizer (formoterol fumarate inhalation powder)","3":"Approved February 2001 (asthma, bronchospasm); September 2001 (COPD)","4":"Novartis","5":"COPD, asthma and bronchospasm","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"DuoNeb (albuterol sulfate and ipratropium bromide)","3":"Approved March 2001","4":"Dey Laboratories","5":"Bronchospasm associated with COPD for patients who require more than one bronchodilator","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Avelox I.V. (moxifloxacin hydrochloride)","3":"Approved November 2001","4":"Bayer","5":"Susceptible strains of sinusitis, bronchitis, pneumonia, skin structure infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Xopenex","3":"Approved February 2002","4":"Sepracor","5":"Reversible obstructive airway disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Qvar (beclomethasone dipropionate)","3":"Approved May 2002","4":"Ivax","5":"Asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Clarinex","3":"Approved February 2002","4":"Schering-Plough","5":"Allergic rhinitis; Chronic ideopathic urticaria","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zemaira (alpha1-proteinase inhibitor)","3":"Approved July 2003","4":"Aventis Behring","5":"Alpha1-proteinase inhibitor deficiency","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xolair (omalizumab)","3":"Approved June 2003","4":"Genentech","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Cafcit Injection","3":"Approved September 1999","4":"Roxane Laboratories","5":"For the short term treatment of apnea of prematurity in infants between 28 and","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Iressa (gefitinib)","3":"Approved May 2003","4":"AstraZeneca","5":"Non-Small-Cell Lung Cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Aldurazyme (laronidase)","3":"Approved May 2003","4":"Genzyme","5":"Mucopolysaccharidosis I","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Spiriva HandiHaler (tiotropium bromide)","3":"Approved February 2004","4":"Boehringer Ingelheim","5":"Chronic Obstructive Pulmonary Disease (COPD)","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ketek (telithromycin)","3":"Approved April 2004","4":"Sanofi-aventis","5":"Respiratory Infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Biaxin XL (clarithromycin extended-release tablets)","3":"Approved March 2000","4":"Abbott Laboratories","5":"Acute Bacterial Exacerbation of Chronic Bronchitis (AECB) and Acute Maxillary Sinusitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [6]>","2":"Xyzal (levocetirizine dihydrochloride)","3":"Approved May 2007","4":"UCB","5":"seasonal and perennial allergic rhinitis and urticaria","6":"FALSE","7":"TRUE","8":"TRUE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Patanase (olopatadine hydrochloride)","3":"Approved April 2008","4":"Alcon","5":"seasonal allergic rhinitis","6":"FALSE","7":"FALSE","8":"TRUE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Alvesco (ciclesonide)","3":"Approved January 2008","4":"Nycomed","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [6]>","2":"Teflaro (ceftaroline fosamil)","3":"November 2010","4":"Cerexa","5":"bacterial skin infections and bacterial pneumonia","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Dulera (mometasone furoate + formoterol fumarate dihydrate)","3":"Approved June 2010","4":"Merck","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Xalkori (crizotinib)","3":"Approved August of 2011","4":"Pfizer","5":"ALK+ non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Daliresp (roflumilast)","3":"Approved February 2011","4":"Forest Pharmaceuticals","5":"chronic obstructive pulmonary disease","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Arcapta (indacaterol maleate inhalation powder)","3":"Approved July 2011","4":"Novartis","5":"airflow obstruction resulting from chronic obstructive pulmonary disease","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tequin","3":"December, 1999","4":"Bristol-Myers Squibb","5":"Community-acquired respiratory tract infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Tudorza Pressair (aclidinium bromide inhalation powder)","3":"Approved July 2012","4":"Forest Laboratories","5":"maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Surfaxin (lucinactant)","3":"Approved March 2012","4":"Discovery Laboratories","5":"respiratory distress syndrome in premature infants","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Sirturo (bedaquiline)","3":"Approved December 2012","4":"Janssen Therapeutics","5":"multi-drug resistant tuberculosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [6]>","2":"Rayos (prednisone) delayed-release tablets","3":"Approved July of 2012","4":"Horizon Pharma","5":"certain inflammatory diseases, including arthritis, COPD, asthma and  psoriatic conditions","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"TRUE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"TRUE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Natazia (estradiol valerate and estradiol valerate/dienogest)","3":"Approved March 2012","4":"Bayer","5":"heavy menstrual bleeding","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kalydeco (ivacaftor)","3":"Approved January of 2012","4":"Vertex Pharmaceuticals","5":"cystic fibrosis with the G551D mutation in the CFTR gene","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Brovana (arformoterol tartrate)","3":"Approved in October 2006","4":"Sepracor","5":"Chronic Obstructive Pulmonary Disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Dymista (azelastine hydrochloride and fluticasone propionate)","3":"Approved May 2012","4":"Meda Pharmaceuticals Inc","5":"seasonal allergic rhinitis","6":"FALSE","7":"FALSE","8":"TRUE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Vibativ (telavancin)","3":"Approved June 2013","4":"Theravance","5":"hospital-acquired and ventilator-associated bacterial pneumonia caused by","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Anoro Ellipta (umeclidinium and vilanterol inhalation powder)","3":"Approved December of 2013","4":"GlaxoSmithKline","5":"chronic obstructive pulmonary disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Cayston (aztreonam for inhalation solution)","3":"Approved February 2010","4":"Gilead","5":"cystic fibrosis patients with Pseudomonas aeruginosa","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zykadia (ceritinib)","3":"Approved April 2014","4":"Novartis","5":"ALK+ metastatic non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Striverdi Respimat (olodaterol)","3":"Approved July 2014","4":"Boehringer Ingelheim","5":"chronic obstructive pulmonary  disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Ragwitek (Short Ragweed Pollen Allergen Extract)","3":"Approved April 2014","4":"Merck","5":"short ragweed pollen-induced allergic rhinitis","6":"FALSE","7":"TRUE","8":"TRUE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ofev (nintedanib)","3":"Approved October 2014","4":"Boehringer Ingelheim","5":"idiopathic pulmonary  fibrosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Incruse Ellipta (umeclidinium inhalation powder)","3":"Approved May 2014","4":"GlaxoSmithKline","5":"chronic obstructive pulmonary disease","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Grastek (Timothy Grass Pollen Allergen Extract)","3":"Approved April 2014","4":"Merck","5":"grass pollen-induced allergic rhinitis","6":"FALSE","7":"TRUE","8":"TRUE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Esbriet (pirfenidone)","3":"Approved October 2014","4":"InterMune","5":"idiopathic pulmonary  fibrosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Arnuity Ellipta (fluticasone furoate inhalation powder)","3":"Approved August 2014","4":"GlaxoSmithKline","5":"asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Utibron Neohaler (indacaterol and glycopyrrolate)","3":"Approved October 2015","4":"Novartis","5":"long term, maintenance treatment of airflow obstruction in patients with COPD","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Abraxane (paclitaxel protein-bound particles for injectable suspension)","3":"Approved October 2012","4":"Celgene","5":"non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Breo Ellipta (fluticasone furoate and vilanterol inhalation powder)","3":"Approved May 2013","4":"GlaxoSmithKline","5":"chronic obstructive pulmonary disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"TRUE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Portrazza (necitumumab)","3":"Approved November 2015","4":"Eli Lilly","5":"metastatic squamous non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Orkambi (lumacaftor and ivacaftor)","3":"Approved July 2015","4":"Vertex Pharmaceuticals","5":"cystic fibrosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Opdivo (nivolumab)","3":"Approved March 2015","4":"Bristol-Myers Squibb","5":"metastatic squamous non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [6]>","2":"Oralair (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract)","3":"Approved April 2014","4":"Greer Labs","5":"grass pollen-induced allergic rhinitis with or without conjunctivitis","6":"FALSE","7":"TRUE","8":"TRUE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"TRUE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Keytruda (pembrolizumab)","3":"Approved October 2015","4":"Merck","5":"PD-L1 positive advanced non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Alecensa (alectinib)","3":"Approved December 2015","4":"Roche","5":"ALK-positive, metastatic non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tecentriq (atezolizumab)","3":"Approved May 2016","4":"Genentech","5":"urothelial carcinoma and metastatic non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Cinqair (reslizumab)","3":"Approved March 2016","4":"Teva Pharmaceuticals","5":"severe asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [6]>","2":"Qnasl (beclomethasone dipropionate) nasal aerosol","3":"Approved March 2012","4":"Teva Pharmaceutical","5":"seasonal and perennial allergic rhinitis","6":"FALSE","7":"TRUE","8":"TRUE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Bevespi Aerosphere (glycopyrrolate and formoterol fumarate)","3":"Approved April 2016","4":"AstraZeneca","5":"chronic obstructive pulmonary disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Lamisil (terbinafine hydrochloride) Tablets","3":"Approved May 1996","4":"Sandoz Pharmaceuticals","5":"nail fungal infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Iontocaine","3":"Approved May 1996","4":"Iomed","5":"dermal surgery","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Stiolto Respimat (tiotropium bromide and olodaterol)","3":"Approved May 2015","4":"Boehringer Ingelheim","5":"maintenance of  chronic obstructive pulmonary disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Oxycodone with Acetaminophen 5mg/325mg","3":"Approved November 1997","4":"Watson Pharmaceuticals","5":"analgesic","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [8]>","2":"Omnicef","3":"Approved December 1997","4":"Warner-Lambert","5":"bacteria causing pulmonary, throat, and skin infections","6":"FALSE","7":"FALSE","8":"TRUE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Galzin (zinc acetate)","3":"Approved January 1997","4":"Teva Pharmaceutical","5":"Wilson’s disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Antizol Injection","3":"Approved December 1997","4":"Orphan Medical","5":"ethylene glycol poisoning","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"AneuVysion Assay","3":"Approved October 1997","4":"Vysis","5":"chromosomal abnormalities","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Raplon","3":"Approved August 1999","4":"Organon","5":"Pharmacology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Subutex/Suboxone (buprenorphine/naloxone)","3":"Approved October 2002","4":"Reckitt Benckiser","5":"Opiate Dependence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Mesnex","3":"Approved March 2002","4":"Bristol-Myers Squibb, Baxter Healthcare","5":"Bladder complications caused by Ifex (ifosfamide)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Campral (acamprosate calcium)","3":"Approved August, 2004","4":"Forest Laboratories","5":"Alcohol dependence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Tygacil (tigecycline)","3":"Approved 2005","4":"Wyeth","5":"complicated skin and skin structure and intra-abdominal infections and bacterial pneumonia","6":"FALSE","7":"TRUE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Sancuso (granisetron)","3":"Approved September 2008","4":"ProStrakan","5":"chemotherapy-induced nausea and vomiting","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Fusilev (levoleucovorin)","3":"Approved March of 2008","4":"Spectrum Pharmaceuticals","5":"For rescue after high-dose methotrexate therapy in osteosarcoma and to reduce the toxicity of methotrexate","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Akten (lidocaine hydrochloride)","3":"Approved October 2008","4":"Akorn","5":"anesthesia during ophthalmologic procedures","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"TRUE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Trovan","3":"Approved December 1997","4":"Pfizer","5":"bacterial infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"TRUE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tavist (clemastine fumarate)","3":"Approved March 2001","4":"Novartis","5":"Cold and Allergy","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Egrifta (tesamorelin for injection)","3":"Approved November 2010","4":"Theratechnologies","5":"reduction of excess abdominal fat in HIV-infected patients with lipodystrophy","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Oxecta (oxycodone HCl)","3":"Approved June 2011","4":"Pfizer","5":"acute and chronic moderate to severe pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Voraxaze (glucarpidase)","3":"Approved January 2012","4":"BTG International","5":"toxic plasma methotrexate concentrations in patients with impaired renal function","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kcentra (Prothrombin Complex Concentrate)","3":"Approved May 2013","4":"CSL Behring","5":"reversal of vitamin K antagonist therapy-induced coagulation factor deficiency","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"TRUE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Myalept (metreleptin for injection)","3":"Approved February of 2014","4":"Bristol-Myers Squibb","5":"lipodystrophy","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Movantik (naloxegol)","3":"Approved September 2014","4":"AstraZeneca","5":"opiod-induced constipation in adults with chronic non-cancer pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Bunavail (buprenorphine and naloxone)","3":"Approved June 2014","4":"BioDelivery Sciences","5":"maintenance treatment of opioid dependence","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"TRUE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Nucala (mepolizumab)","3":"Approved November 2015","4":"GlaxoSmithKline","5":"severe asthma","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Bridion (sugammadex)","3":"Approved December 2015","4":"Merck","5":"reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults undergoing surgery","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Sustol (granisetron)","3":"Approved August 2016","4":"Heron Therapeutics","5":"prevention of chemotherapy-induced nausea and vomiting","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Mentax (1% butenafine HCl cream)","3":"Approved December 1997","4":"Penederm","5":"athlete's foot","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"TRUE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Condylox Gel 0.5% (pokofilox)","3":"Approved March 1997","4":"Oclassen Pharmaceuticals","5":"external genital and perianal warts","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"TRUE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Aldara (imiquimod)","3":"Approved March 1997","4":"3M Pharmaceuticals","5":"external genital and perianal warts","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"TRUE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Lotrisone (clotrimazole/betamethasone diproprionate) lotion","3":"Approved December 2000","4":"Schering-Plough","5":"Symptomatic inflammatory tinea pedis, tinea cruris, and tinea corporis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"TRUE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Lamisil (terbinafine hydrochloride) Solution, 1%","3":"Approved March 2000","4":"Novartis","5":"For the treatment of interdigital-type pedis (athlete's foot), tinea cruris (jock itch) and tinea corporis (ringworm)","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"TRUE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Veregen (kunecatechins)","3":"Approved October 2006","4":"Medigene","5":"External genital and perianal warts","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"TRUE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Luzu (luliconazole) Cream 1%","3":"November of 2013","4":"Valeant Pharmaceuticals","5":"interdigital tinea pedis, tinea cruris, and tinea corporis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"TRUE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Prinivil or Zestril (Lisinopril)","3":"Approved November 24, 1995","4":"Merck, Zeneca","5":"hypertension, heart failure, acute myocardial infarction","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Corvert Injection (ibutilide fumarate injection)","3":"Approved December 1995","4":"Pharmacia & Upjohn","5":"irregular contractions of the heart","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Androderm (Testosterone Transdermal System)","3":"Approved on September 29, 1995","4":"TheraTech","5":"hypogonadism","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Zuplenz (ondansetron oral soluble film)","3":"Approved July 2010","4":"Strativa Pharmaceuticals","5":"post-operative, chemotherapy and radiotherapy induced nausea and vomiting","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"TRUE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tiazac (diltiazem hydrochloride)","3":"Approved February 1996","4":"Forest Laboratories","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Teczem (enalapril maleate/diltiazem malate)","3":"Approved October 1996","4":"Hoechst Marion Roussel","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Kytril (granisetron) tablets","3":"Approved November 1997","4":"SmithKline Beecham","5":"nausea and vomiting associated with chemotherapy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Procanbid (procainamide hydrochloride extended-release tablets)","3":"Approved January 1996","4":"Warner-Lambert","5":"ventricular arrhythmias","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Pravachol (pravastatin sodium)","3":"Approved April 1996","4":"Bristol-Myers Squibb","5":"heart disease","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Pravachol (pravastatin sodium)","3":"Approved July 1996","4":"Bristol-Myers Squibb","5":"cholesterol-lowering","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Mavik (trandolapril)","3":"Approved May 1996","4":"Knoll Pharmaceutical","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Toprol-XL (metoprolol succinate)","3":"Approved January 1995","4":"AstraZeneca","5":"hypertension, angina pectoris and heart failure","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lipitor (atorvastatin calcium)","3":"Approved December 1996","4":"Pfizer","5":"cardiovascular disease, hyperlipidemia and dyslipidemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Covera-HS (verapamil)","3":"Approved January 1996","4":"GD Searle, Alza","5":"hypertension, angina","6":"TRUE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Zocor","3":"Approved November 1997","4":"Merck","5":"high triglyceride levels","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [7]>","2":"Visipaque (iodixanol)","3":"Approved April 1996","4":"Nycomed","5":"diagnosis of disease in major organs","6":"TRUE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Warfarin Sodium tablets","3":"Approved March 1997","4":"Barr Laboratories","5":"Anticoagulant, or \"blood thinner\" to keep blood clots from forming or getting larger","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Retavase (reteplase)","3":"Approved November 1996","4":"Boehringer Mannheim Corporation","5":"patients suffering from heart attack","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"REPRONEX(menotropins for injection, USP)","3":"Approved February 1997","4":"Ferring Pharmaceuticals","5":"Treatment for infertility","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Akynzeo (netupitant and palonosetron)","3":"Approved October 2014","4":"Helsinn","5":"chemotherapy-induced nausea and vomiting","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"TRUE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Posicor","3":"Approved June 1997","4":"Roche","5":"hypertension and chronic stable angina pectoris","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Plavix (clopidogrel bisulfate)","3":"Approved November 1997","4":"Sanofi-aventis, Bristol-Myers Squibb","5":"atherosclerosis","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Pindolol","3":"Approved April 1997","4":"Teva Pharmaceutical","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Pentoxifylline","3":"Approved July 1997","4":"Faulding, Mylan Laboratories","5":"chronic occlusive arterial disease","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Normiflo","3":"Approved May 1997","4":"Wyeth","5":"Deep venous thrombosis","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Microzide (hydrochlorothiazide)","3":"Approved January 1997","4":"Watson Pharmaceuticals","5":"mild-to moderate hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tagrisso (osimertinib)","3":"Approved November 2015","4":"AstraZeneca","5":"EGFR T790M mutation positive non-small cell lung cancer","6":"FALSE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"TRUE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lexxel (enalapril maleate-felodipine ER)","3":"Approved January 1997","4":"Astra Merck","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lescol (fluvastatin sodium)","3":"Approved September 1997","4":"Novartis","5":"coronary atherosclerosis","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"EDEX","3":"Approved June 1997","4":"Schwarz Pharma","5":"erectile dysfunction","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Teveten (eprosartan mesylate)","3":"Approved December 1997","4":"SmithKline Beecham","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Diovan (valsartan)","3":"Approved January 1997","4":"Ciba Pharmaceuticals","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"ProAmatine (midodrine)","3":"Approved September 1996","4":"Roberts Pharmaceutical","5":"hypotension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"ReoPro","3":"Approved November 1997","4":"Centocor Ortho Biotech","5":"cardiac ischemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Cardizem (R)  (Diltiazem HC1 for injection) Monvial (R)","3":"Approved September 1997","4":"Hoechst Marion Roussel","5":"atrial fibrillation","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Captopril and hydrochlorotiazide","3":"Approved May 1997","4":"Mylan Laboratories","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Baycol (cerivastatin sodium)","3":"Approved June 1997; withdrawn 8/8/01","4":"Bayer","5":"Hypercholesterolemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Muse","3":"Approved October 1996","4":"Vivus","5":"impotence","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Tricor (fenofibrate)","3":"Approved February 1998","4":"Abbott Laboratories","5":"high triglyceride levels","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tiazac (diltiazem hydrochloride)","3":"Approved February 1998","4":"Forest Laboratories","5":"chronic stable angina","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Rythmol","3":"Approved January 1998","4":"Knoll Pharmaceutical","5":"Paroxysmal atrial fibrillation","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Integrilin","3":"Approved May 1998","4":"COR Therapeutics, Key Pharmaceuticals","5":"For the treatment of acute coronary syndrome","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Diovan HCT (valsartan)","3":"Approved March 1998","4":"Novartis","5":"second-line treatment of hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"CellCept","3":"Approved February 1998","4":"Roche","5":"prevention of organ rejection inpatients undergoing heart transplants","6":"TRUE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Agrylin (anagrelide HCL)","3":"Approved December 1998","4":"Roberts Pharmaceutical","5":"Cardiology","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Mevacor (lovastatin) tablets","3":"Approved March 1999","4":"Merck","5":"Cardiology","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lescol (fluvastatin sodium) capsules, Rx","3":"Approved June 1999","4":"Novartis","5":"Cardiology","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Nitrostat (nitroglycerin) Tablets","3":"Approved May 2000","4":"Parke-Davis","5":"For the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lescol XL (fluvastatin sodium) tablet, extended release","3":"Approved October 2000","4":"Novartis","5":"For the use as an adjunct to diet to reduce elevated total cholesterol","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"DynaCirc CR","3":"Approved February 1997","4":"Novartis","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Innohep (tinzaparin sodium) injectable","3":"Approved July 2000","4":"DuPont Merck Pharmaceutical Company","5":"Deep vein thrombosis with or without pulmonary embolism when administered in conjunction with warfarin sodium","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Corlopam","3":"Approved September 1997","4":"Neurex","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Betapace AF Tablet","3":"Approved February 2000","4":"Berlex Laboratories","5":"For the prolongation of time to recurrence of symptomatic AFIB/AFL","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Atacand (candesartan cilexetil)","3":"Approved September 2000","4":"AstraZeneca","5":"For the treatment of hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Viagra","3":"Approved March 1998","4":"Pfizer","5":"impotence","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Argatroban Injection","3":"Approved June 2000","4":"Texas Biotechnology Corporation, SmithKline Beecham","5":"Heparin-induced thrombocytopenia and thrombosis syndrome","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Angiomax (bivalirudin)","3":"Approved December 2000","4":"The Medicines Company","5":"As an anticoagulant in conjunction with aspirin","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tricor (fenofibrate)","3":"Approved September 2001","4":"Abbott Laboratories","5":"Primary hypercholesterolemia, mixed lipidemia and hypertriglyceridemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Micardis (telmisartan)","3":"Approved November 1998","4":"Boehringer Ingelheim","5":"Cardiology","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"TRUE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Natrecor (nesiritide)","3":"Approved August 2001","4":"Scios","5":"Acutely decompensated congestive heart failure","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Diovan (valsartan)","3":"Approved January 1997 (capsules); July 2001 (tablets)","4":"Novartis","5":"Hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Advicor (extended-release niacin/lovastatin)","3":"Approved December 2001","4":"Kos Pharmaceuticals","5":"Cholesterol disorders","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Remodulin (treprostinil)","3":"Approved May 2002","4":"United Therapeutics","5":"pulmonary arterial hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Plavix (clopidogrel bisulfate)","3":"Approved February 2002","4":"Sanofi-aventis","5":"Acute coronary syndrome","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Inspra (eplerenone tablets)","3":"Approved September 2002","4":"Pharmacia & Upjohn","5":"Hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Imagent (perflexane lipid microspheres)","3":"Approved June 2002","4":"Alliance Pharmaceutical","5":"Ultrasound contrast agent","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Altocor (lovastatin) Extended-Release Tablets","3":"Approved June 2002","4":"Andrx","5":"Hypercholesterolemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Micardis HCT (telmisartan and hydrochlorothiazide)","3":"Approved November 2000","4":"Boehringer Ingelheim","5":"Hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Crestor (rosuvastatin  calcium)","3":"Approved August 2003","4":"AstraZeneca","5":"Hypercholesterolemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Caduet (amlodipine/atorvastatin)","3":"Approved January 2004","4":"Pfizer","5":"Hypertension/Angina","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Verapamil","3":"Approved December 1997","4":"IVAX","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"BiDil (isosorbide dinitrate/hydralazine hydrochloride)","3":"Approved June, 2005","4":"NitroMed","5":"Heart Failure","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ranexa (ranolazine)","3":"Approved January 2006","4":"CV Therapeutics","5":"Chronic Angina","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tekturna (aliskiren)","3":"Approved March 2007","4":"Novartis","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Soliris (eculizumab)","3":"Approved March 2007","4":"Alexion","5":"paroxysmal nocturnal hemoglobinuria","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Letairis (ambrisentan)","3":"Approved June 2007","4":"Gilead","5":"pulmonary arterial hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Fenofibrate","3":"Approved August 2007","4":"LifeCycle Pharma","5":"hyperlipidemia, dyslipidemia and hypertriglyceridemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Azor (amlodipine besylate; olmesartan medoxomil)","3":"Approved September 2007","4":"Daiichi Sankyo","5":"Hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Trilipix (fenofibric acid)","3":"Approved December 2008","4":"Abbott Laboratories","5":"dyslipidemia, hypertriglyceridemia and hyperlipidemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cleviprex (clevidipine)","3":"Approved August 2008","4":"The Medicines Company","5":"hypertension when oral therapy is not feasible or not desirable","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Teveten (eprosartan mesylate plus hydrochlorothiazide)","3":"Approved November 2001","4":"Unimed Pharmaceuticals","5":"Hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Multaq (dronedarone)","3":"Approved July 2009","4":"Sanofi-aventis","5":"paroxysmal or persistent atrial fibrillation or atrial flutter","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Livalo (pitavastatin)","3":"Approved August 2009","4":"Kowa Company","5":"primary hyperlipidemia and mixed dyslipidemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Efient (prasugrel)","3":"Approved July 2009","4":"Eli Lilly","5":"prevention of thrombotic cardiovascular complications in acute coronary syndromes","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Atryn (antithrombin recombinant lyophilized powder for reconstitution)","3":"Approved January 2009","4":"GTC BioTherapeutics","5":"peri-operative and peri-partum thromboembolic events","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"TRUE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Adcirca (tadalafil)","3":"Approved May 2009","4":"Eli Lilly","5":"pulmonary arterial hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tribenzor (olmesartan medoxomil + amlodipine + hydrochlorothiazide)","3":"Approved July 2010","4":"Daiichi Sankyo","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tekamlo (aliskiren + amlodipine)","3":"Approved August 2010","4":"Novartis","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Pradaxa (dabigatran etexilate mesylate)","3":"Approved October 2010","4":"Boehringer Ingelheim","5":"risk reduction of stroke and embolism due to atrial fibrillation","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Amturnide (aliskiren + amlodipine + hydrochlorothiazide)","3":"Approved December 2010","4":"Novartis","5":"uncontrolled hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [5]>","2":"Levitra (vardenafil)","3":"Approved September 2003","4":"Bayer, GlaxoSmithKline","5":"Erectile Dysfunction","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"TRUE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Xarelto (rivaroxaban)","3":"Approved July 2011","4":"Bayer","5":"prophylaxis of deep vein thrombosis during knee or hip replacement surgery","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Edarbyclor (azilsartan medoxomil and chlorthalidone)","3":"Approved December of 2011","4":"Takeda","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Edarbi (azilsartan medoxomil)","3":"Approved February 2011","4":"Takeda","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Brilinta (ticagrelor)","3":"Approved July 2011","4":"AstraZeneca","5":"reduction of thrombotic events in patients with acute coronary syndrome","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Vascepa (icosapent ethyl)","3":"Approved July of 2012","4":"Amarin Pharmaceuticals","5":"hypertriglyceridemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Juxtapid (lomitapide)","3":"Approved December of 2012","4":"Aegerion Pharmaceuticals","5":"homozygous familial hypercholesterolemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Diltiazem HCL, Extended-Release Capsules","3":"Approved January 2000","4":"Biovail Laboratories","5":"Indicated for the treatment of hypertension; for use alone or in combination with other anti-hypertensive medications","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Varithena (polidocanol injectable foam)","3":"November 2013","4":"BTG plc","5":"varicose veins","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Opsumit (macitentan)","3":"Approved October 2013","4":"Actelion Pharmaceuticals","5":"pulmonary arterial hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Nymalize (nimodipine)","3":"Approved May 2013","4":"Arbor Pharmaceuticals","5":"reduction of incidence and severity of ischemic deficits following subarachnoid hemorrhage","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kynamro (mipomersen sodium)","3":"Approved January 2013","4":"Genzyme","5":"homozygous familial hypercholesterolemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tyvaso (treprostinil)","3":"Approved July 2009","4":"United Therapeutics","5":"pulmonary arterial hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"TRUE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zontivity (vorapaxar)","3":"Approved May 2014","4":"Merck","5":"reduction of thrombotic cardiovascular events","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Epanova (omega-3-carboxylic acids)","3":"Approved May 2014","4":"AstraZeneca","5":"hypertriglyceridemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Uptravi (selexipag)","3":"Approved December 2015","4":"Actelion Pharmaceuticals","5":"pulmonary arterial hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Savaysa (edoxaban)","3":"Approved January 2015","4":"Daiichi Sankyo","5":"deep vein thrombosis, pulmonary embolism and risk of stroke and embolism due to atrial fibrillation","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Repatha (evolocumab)","3":"Approved August 2015","4":"Amgen","5":"high cholesterol","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Benicar","3":"Approved April 2002","4":"Daiichi Sankyo","5":"Hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Praluent (alirocumab)","3":"Approved July 2015","4":"Sanofi Aventis","5":"heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xarelto (rivaroxaban)","3":"Approved November 2011","4":"Janssen Pharmaceuticals","5":"stroke and systemic embolism resulting from atrial fibrillation","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Kanuma (sebelipase alfa)","3":"Approved December 2015","4":"Alexion","5":"Lysosomal Acid Lipase (LAL) deficiency","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"TRUE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Entresto (sacubitril and valsartan)","3":"Approved July 2015","4":"Novartis","5":"chronic heart failure","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Corlanor (ivabradine)","3":"Approved April 2015","4":"Amgen","5":"chronic heart failure","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Yosprala (aspirin and omeprazole)","3":"Approved September 2016","4":"Aralez Pharmaceuticals","5":"prevention of cardiovascular and cerebrovascular events","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Eliquis (apixaban)","3":"Approved December 2012","4":"Bristol-Myers Squibb","5":"stroke and systemic embolism resulting from nonvalvular atrial fibrillation","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Kengreal (cangrelor)","3":"Approved June 2015","4":"The Medicines Company","5":"For reducing periprocedural thrombotic events","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Prestalia (perindopril arginine and amlodipine besylate)","3":"Approved January 2015","4":"Symplmed Pharmaceuticals","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Liptruzet (ezetimibe and atorvastatin)","3":"Approved May 2013","4":"Merck","5":"hyperlipidemia","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Adempas (riociguat)","3":"Approved October 2013","4":"Bayer Healthcare Pharmaceuticals","5":"Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"TRUE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Briviact (brivaracetam)","3":"Approved February 2016","4":"UCB","5":"partial onset seizures related to epilepsy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Byvalson (nebivolol and valsartan)","3":"Approved June 2016","4":"Allergan","5":"hypertension","6":"TRUE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Nasonex Nasal Spray","3":"Approved January 1999","4":"Schering-Plough","5":"Immunology/Allergy","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"TRUE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Rilutek (riluzole)","3":"Approved December 1995","4":"Rhone Poulenc Rorer","5":"amyotrophic lateral sclerosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cerdelga (eliglustat)","3":"Approved August 2014","4":"Genzyme","5":"certain adult patients with Gaucher disease type 1","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"TRUE","38":"FALSE"},{"1":"<chr [2]>","2":"Protonix (pantoprazole sodium) Delayed Release Tablets","3":"Approved April 2002","4":"Wyeth","5":"Gastroesophageal disorders","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xifaxan (rifaximin)","3":"Approved May 2004","4":"Salix Pharmaceuticals","5":"Travelers’ Diarrhea","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Zenpep (pancrelipase)","3":"Approved August 2009","4":"Eurand","5":"pancreatic insufficiency due to cystic fibrosis or other conditions","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Cipro (ciprofloxacin HCl)","3":"Approved April 1996","4":"Bayer","5":"cystitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Prilosec (omeprazole)","3":"Approved March 1996","4":"Astra Merck","5":"gastric ulcers","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Oral Cytovene","3":"Approved December 1996","4":"Roche","5":"CMV","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Vidaza (azacitidine)","3":"Approved May 2004","4":"Pharmion Corporation","5":"Myelodysplastic Syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Glyburide Tablets","3":"Approved December 1997","4":"Mova Pharmaceutical","5":"blood-glucose lowering agent","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"OxyContin (oxycodone HCl controlled-release)","3":"Approved May 1996","4":"Purdue Pharma","5":"pain associated with musculoskeletal conditions","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"AlphaNine SD Coagulation Factor IX (Human)","3":"Approved July 1996","4":"Alpha Therapeutic Corporation","5":"Hemophilia B","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Skelid (tiludronate disodium)","3":"Approved March 1997","4":"Sanofi-aventis","5":"Paget’s disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Etodolac","3":"Approved May 1998","4":"Faulding","5":"osteoarthritis and pain","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Saizen","3":"Approved May 1996","4":"Ares-Serono","5":"growth hormone deficiency, Turner Syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Testim","3":"Approved October 2002","4":"Auxilium Pharmaceuticals","5":"Low Testosterone","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Naglazyme (galsulfase)","3":"Approved May 2005","4":"BioMarin Pharmaceuticals","5":"Mucopolysaccharidosis VI","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prilosec (omeprazole)/Biaxin (clarithromycin) Combination Therapy","3":"Approved April 1996","4":"Astra Merck, Abbott Laboratories","5":"duodenal ulcers","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prilosec (omeprazole)","3":"Approved December 1996","4":"Astra Merck","5":"symptoms associated with gastroesophageal reflux disease (GERD)","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Avonex (Interferon Beta 1-A)","3":"Recommended for Approval in December 1995","4":"Biogen IDEC","5":"multiple sclerosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"TRUE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Urso","3":"Approved December 1997","4":"Axcan","5":"primary biliary cirrhosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ranitidine Tablets","3":"Approved September 1997","4":"Apotex","5":"ulcers","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Ranitidine Capsules","3":"Approved October 1997","4":"Geneva Pharmaceuticals","5":"heartburn","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Prochloroperazine","3":"Approved May 1997","4":"Duramed Pharmaceuticals","5":"nausea","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prevpac","3":"Approved December 1997","4":"TAP Pharmaceuticals","5":"duodenal ulcers","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Atracurium Besylate Injection","3":"Approved April 1997","4":"Faulding","5":"muscle relaxant","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Somavert (pegvisomant)","3":"Approved March 2003","4":"Pharmacia & Upjohn","5":"Acromegaly","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zantac 75 Efferdose","3":"Approved March 1998","4":"GlaxoSmithKline","5":"heartburn","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tazorac topical gel","3":"Approved June 1997","4":"Allergan","5":"psoriasis, acne vulgaris","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Precose (acarbose)","3":"Approved September 6, 1995","4":"Bayer","5":"non-insulin-dependent diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Axid AR (nizatidine","3":"Approved May 1996","4":"Whitehall-Robins Healthcare","5":"heartburn, acid indigestion, sour stomach","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Amaryl (Glimepiride)","3":"Approved December 1995","4":"Hoechst Marion Roussel","5":"type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Humalog (insulin lispro)","3":"Approved June 1996","4":"Eli Lilly","5":"type 1 and type 2 diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Glyset (miglitol)","3":"Approved December 1996","4":"Bayer","5":"type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Differin (adapalene gel) Gel, 0.1%","3":"Approved June 1996","4":"Galderma Laboratories","5":"acne","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"DentiPatch (lidocaine transoral delivery system)","3":"Approved May 1996","4":"Noven Pharmaceuticals","5":"pain from oral injections, soft tissue dental procedures","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"TRUE"},{"1":"<chr [2]>","2":"Retin-A Micro (tretinoin gel) microsphere, 0.1%","3":"Approved February 1997","4":"Advanced Polymer Systems","5":"acne","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Propecia","3":"Approved December 1997","4":"Merck","5":"male baldness","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prandin","3":"Approved December 1997","4":"Novo Nordisk","5":"Type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Minoxidil Topical Solution 2% for Women","3":"Approved April 1997","4":"Alpharma","5":"general thinning of scalp hair","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cimetidine Hydrochloride Oral Solution","3":"Approved October 1997","4":"Hi-Tech Pharmacal","5":"heartburn","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Glipizide Tablets","3":"Approved September 1997","4":"Duramed Pharmaceuticals","5":"diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Dermagraft-TC","3":"Approved October 1997","4":"Advanced Tissue Sciences","5":"burns","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Asacol (mesalamine)","3":"Approved August 1997","4":"Procter & Gamble","5":"ulcerative colitits","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Clindamycin Phosphate Topical Solution USP 1%","3":"Approved July 1997","4":"Morton Grove Pharmaceuticals","5":"acne vulgaris","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Avita Gel","3":"Approved January 1997","4":"Penederm","5":"acne","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Sulfamylon","3":"Approved June 1998","4":"Mylan Laboratories","5":"Burn Wounds","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Noritate","3":"Approved January 1998","4":"Dermik Laboratories","5":"Rosacea","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Glyburide Tablets","3":"Approved July 1998.","4":"Mylan Laboratories","5":"Diabetes Mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Glucagon","3":"Approved October 1998","4":"Eli Lilly","5":"Diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Protopic (tacrolimus) ointment","3":"Approved December 2000","4":"Fujisawa Healthcare","5":"Moderate to severe atopic dermatitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"NovoLog (insulin aspart)","3":"Approved June 2000","4":"Novo Nordisk","5":"Diabetes Mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Clindamycin phosphate topical gel","3":"Approved November 2000","4":"Target Research Associates","5":"Acne vulgaris","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Benzamycin (erythromycin 3%-benzoyl peroxide 5% topical gel)","3":"Approved November 2000","4":"Dermik Laboratories","5":"Acne vulgaris","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Novolog Mix 70/30","3":"Approved November 2001","4":"Novo Nordisk","5":"Diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Finevin","3":"Approved May 2001","4":"Berlex Laboratories","5":"Acne","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Estrostep (norethindrone acetate and ethinyl estradiol)","3":"Approved July 2001","4":"Pfizer","5":"Acne vulgaris","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Elidel","3":"Approved December 2001","4":"Novartis","5":"Atopic dermatitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Metaglip (glipizide/metformin HCl)","3":"Approved October 2002","4":"Bristol-Myers Squibb","5":"Type 2 Diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Finacea (azelaic acid) Gel, 15%","3":"January 2003","4":"Berlex Laboratories","5":"Inflammatory papules and pustules of mild to moderate rosacea.","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Symlin (pramlintide)","3":"Approved March 2005","4":"Amylin Pharmaceuticals","5":"Diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Byetta (exenatide)","3":"Approved April, 2005","4":"Amylin/Eli Lilly","5":"Type 2 Diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"ACTOplus met (pioglitazone hydrochloride and metformin hydrochloride)","3":"Approved August of 2005","4":"Takeda","5":"type 2 diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Verdeso (desonide)","3":"Approved September 2006","4":"Connetics Corporation","5":"atopic dermatitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Januvia (sitagliptin phosphate)","3":"Approved October 2006","4":"Merck","5":"type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Welchol (colesevelam hydrochloride)","3":"Approved January 2008","4":"Daiichi Sankyo","5":"glycemic control in type 2 diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Onglyza (saxagliptin)","3":"Approved July 2009","4":"Bristol-Myers Squibb","5":"type 2 diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cycloset, bromocriptine mesylate","3":"Approved May 2009","4":"VeroScience","5":"type 2 diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Victoza (liraglutide)","3":"Approved January 2010","4":"Novo Nordisk","5":"type 2 diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tradjenta (linagliptin)","3":"Approved May 2011","4":"Boehringer Ingelheim","5":"type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Juvisync (sitagliptin and simvastatin)","3":"Approved October 2011","4":"Merck","5":"type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Korlym (mifepristone)","3":"Approved February 2012","4":"Corcept Therapeutics","5":"hyperglycemia in adults with endogenous Cushing’s syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Jentadueto (linagliptin plus metformin hydrochloride)","3":"Approved February 2012","4":"Eli Lilly","5":"type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Invokana (canagliflozin)","3":"Approved April 2013","4":"Janssen Pharmaceuticals","5":"type II diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Natesto, (testosterone) nasal gel","3":"Approved May 2014","4":"Trimel Pharmaceuticals","5":"deficiency or absence of endogenous testosterone","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Farxiga (dapagliflozin)","3":"January of 2014","4":"Bristol-Myers Squibb","5":"type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Aveed (testosterone undecanoate) injection","3":"Approved March 2014","4":"Endo Pharmaceuticals","5":"hypogonadism","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Afrezza (insulin human) Inhalation Powder","3":"Approved June 2014","4":"Mannkind","5":"diabetes mellitus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Kybella  (deoxycholic acid)","3":"Approved April 2015","4":"Kythera Biopharma","5":"submental fat","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Enstilar (calcipotriene and betamethasone dipropionate)","3":"Approved October 2015","4":"LEO Pharmaceuticals","5":"psoriasis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xultophy 100/3.6 (insulin degludec and liraglutide injection)","3":"Approved November 2016","4":"Novo Nordisk","5":"inadequately controlled type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Soliqua 100/33 (insulin glargine and lixisenatide injection)","3":"Approved November 2016","4":"Sanofi Aventis","5":"inadequately controlled type II diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prilosec (omeprazole)","3":"Approved January 1998","4":"Astra Merck","5":"Heartburn","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"PREVACID(R) (lansopraxole)","3":"Approved April 1998","4":"TAP Pharmaceuticals","5":"heartburn","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cimetidine Hydrochloride Oral Solution","3":"Approved June 1998","4":"Pharmaceutical Formulations","5":"heartburn","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Prevpac","3":"Approved February 1999","4":"TAP Pharmaceuticals","5":"Gastroenterology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Visicol Tablet","3":"Approved September 2000","4":"Inkine Pharmaceutical","5":"For cleansing of the bowel as a preparation for colonoscopy, in adults 18 years of age and older","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Pepcid Complete","3":"Approved October 2000","4":"Merck","5":"Heartburn associated with acid indigestion and sour stomach","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Colazal (balsalazide disodium)","3":"Approved July 2000","4":"Salix Pharmaceuticals","5":"Mild to moderately active ulcerative colitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Protonix (pantoprazole sodium) Intravenous Formulation","3":"Approved March 2001","4":"Wyeth","5":"Gastroesophageal reflux disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Nexium (esomeprazole magnesium)","3":"Approved February 2001","4":"AstraZeneca","5":"Duodenal ulcer disease, erosive esophagitis, and gastroesophageal reflux disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Entocort EC (budesonide)","3":"Approved October 2001","4":"AstraZeneca","5":"Crohn's disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Canasa (mesalamine)","3":"Approved January 2001","4":"Axcan","5":"Ulcerative proctitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Avandamet (rosiglitazone maleate and metformin HCl)","3":"Approved October 2002","4":"GlaxoSmithKline","5":"Type 2 Diabetes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Amitiza (lubiprostone)","3":"Approved January 2006","4":"Sucampo/Takeda","5":"Constipation","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Entereg (alvimopan)","3":"Approved May 2008","4":"GlaxoSmithKline","5":"postoperative ileus","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Cimzia (certolizumab pegol)","3":"Approved April 2008","4":"UCB","5":"Crohn's disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Klaron (sodium sulfacet amide lotion ) Lotion, 10%","3":"Approved February 1997","4":"Dermik Laboratories","5":"acne","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Metozolv ODT (metoclopramide hydrochloride)","3":"Approved September of 2009","4":"Salix Pharmaceuticals","5":"gastroesophageal reflux and diabetic gastroparesis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Pancreaze (pancrelipase)","3":"Approved April of 2010","4":"Johnson & Johnson","5":"exocrine pancreatic insufficiency","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cimetadine Hydrochloride Oral Solution 300mg/5ml","3":"Approved October 1997","4":"Morton Grove Pharmaceuticals","5":"gastric ulcer and GERD","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Gattex (teduglutide)","3":"Approved December 2012","4":"NPS Pharmaceuticals","5":"short bowel syndrome","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Uceris (budesonide)","3":"Approved January 2013","4":"Santarus","5":"ulcerative colitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Xifaxan (rifaximin)","3":"Approved May 2015","4":"Salix Pharmaceuticals","5":"irritable bowel syndrome with diarrhea","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Viberzi (eluxadoline)","3":"Approved May 2015","4":"Actavis","5":"irritable bowel syndrome with diarrhea","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Boniva (ibandronate)","3":"Approved May, 2003 -- UPDATED: NEW FORMULATION APPROVED MARCH, 2005","4":"Roche / GlaxoSmithKline","5":"Osteoporosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Somatuline Depot (lanreotide acetate)","3":"Approved August 2007","4":"Beaufour Ipsen","5":"acromegaly","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Cipro (ciprofloxacin) I.V. and Cipro (ciprofloxacin HCI) tablets","3":"Approved December 1996","4":"Bayer","5":"complicated intra-abdominal infections","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Savella (milnacipran hydrochloride)","3":"Approved January 2009","4":"Forest Laboratories","5":"fibromyalgia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Xiaflex (collagenase clostridium histolyticum)","3":"Approved February 2010","4":"Auxilium Pharmaceuticals","5":"Dupuytren’s contracture","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Xeomin (incobotulinumtoxinA)","3":"Approved July 2010","4":"Merz Pharmaceutical","5":"cervical dystonia and blepharospasm","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Gilenya (fingolimod)","3":"Approved September 2010","4":"Novartis","5":"relapsing multiple sclerosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Aubagio (teriflunomide)","3":"Approved September 2012","4":"Sanofi Aventis","5":"multiple sclerosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"BeneFIX (coagulation Factor IX (recombinant))","3":"Approved February 1997","4":"Genetics Institute","5":"hemophilia B","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Glyburide Tablets","3":"Approved December 1997","4":"Roche","5":"blood-glucose lowering agent","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Agrylin (anagrelide HCL)","3":"Approved March 1997","4":"Roberts Pharmaceutical","5":"thrombocythemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Refludan","3":"Approved March 1998","4":"Hoechst Marion Roussel","5":"heparin-induced thrombocytopenia type II","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Lovenox (enoxaparin sodium) Injection","3":"Approved February 1998","4":"Rhone Poulenc Rorer","5":"prevention of blood clots following hip-replacement surgery","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lovenox (enoxaparin sodium) Injection","3":"Approved May 1997","4":"Rhone Poulenc Rorer","5":"deep vein thrombosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Lovenox (enoxaparin sodium) Injection","3":"Approved January 1999","4":"Rhone Poulenc Rorer","5":"Hematology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Fragmin","3":"Approved March 1999","4":"Pharmacia & Upjohn","5":"Hematology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ferrlecit","3":"Approved February 1999","4":"R&D Laboratories","5":"Anemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Arixtra","3":"Approved December 2001","4":"Organon, Sanofi-Synthelabo","5":"Deep vein thrombosis prophylaxis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Reclast (zoledronic acid)","3":"Approved April 2007","4":"Novartis","5":"Paget's disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Revlimid (lenalidomide)","3":"Approved December 2005","4":"Celgene","5":"Myelodysplastic Syndromes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Dacogen (decitabine)","3":"Approved May 2006","4":"MGI Pharma","5":"Myelodysplastic Syndromes","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Kuvan (sapropterin dihydrochloride)","3":"Approved December 2007","4":"BioMarin Pharmaceuticals","5":"hyperphenylalaninemia due to tetrahydrobiopterin- (BH4-) responsive Phenylketonuria","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Nplate (romiplostim)","3":"Approved August 2008","4":"Amgen","5":"thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Samsca (tolvaptan)","3":"Approved May of 2009","4":"Otsuka","5":"hyponatremia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Jakafi (ruxolitinib)","3":"Approved November 2011","4":"Incyte","5":"myelofibrosis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Droxia","3":"Approved March 1998","4":"Bristol-Myers Squibb","5":"sickle-cell anemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Actonel","3":"Approved April 1998","4":"Procter & Gamble, Hoechst Marion Roussel","5":"Paget's Disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Tretten (Coagulation Factor XIII A-Subunit [Recombinant])","3":"Approved December of 2013","4":"Novo Nordisk","5":"congenital factor XIII (FXIII) A-subunit deficiency","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Rixubis (Coagulation Factor IX (Recombinant)]","3":"Approved June 2013","4":"Baxter International","5":"routine prophylaxis and control of hemophilia B","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ruconest (C1 esterase inhibitor [recombinant])","3":"Approved July 2014","4":"Pharming Group","5":"hereditary  angioedema","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence]","3":"Approved October 2014","4":"Baxter","5":"acquired hemophilia A","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Eloctate [Antihemophilic Factor (Recombinant), Fc Fusion  Protein]","3":"Approved June 2014","4":"Biogen IDEC.","5":"hemophillia A","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Veltassa (patiromer)","3":"Approved October 2015","4":"Relypsa","5":"hyperkalemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Promacta (eltrombopag)","3":"Approved November 2008","4":"GlaxoSmithKline","5":"thrombocytopenia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Aciphex (rabeprazole sodium)","3":"Approved February 2002","4":"Elan Pharmaceuticals","5":"Symptomatic gastroesophageal reflux disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Natpara (parathyroid hormone)","3":"Approved January 2015","4":"NPS Pharmaceuticals","5":"hypocalcemia in patients with hypoparathyroidism","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Ferriprox (deferiprone)","3":"Approved October 2011","4":"Apotex","5":"transfusional iron overload due to thalassemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [6]>","2":"Elelyso (taliglucerase alfa)","3":"Approved May 2012","4":"Pfizer","5":"Gaucher disease","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"TRUE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Rectiv (nitroglycerin) ointment 0.4%","3":"Approved June 2011","4":"ProStrakan","5":"chronic anal fissure","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Albenza (albendazole)","3":"Approved June 1996","4":"SmithKline Beecham","5":"parasitic infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Stromectol (ivermectin)","3":"Approved March 1997","4":"Merck","5":"nondisseminated intestinal threadworm","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Nuwiq (recombinant Factor VIII)","3":"Approved September 2015","4":"Octapharma","5":"hemophilia A","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Acyclovir Capsules","3":"Approved April 1997","4":"Teva Pharmaceutical","5":"anti-viral treatment","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Idelvion (Coagulation Factor IX (Recombinant), Albumin Fusion Protein)","3":"Approved March 2016","4":"CSL Behring","5":"hemophilia B","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Vistide (cidofovir)","3":"Approved March 1999","4":"Gilead","5":"Infectious Diseases","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Relenza","3":"Approved July 1999","4":"GlaxoSmithKline","5":"Immunology/Infectious Diseases","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Panretin Gel","3":"Approved June 1999","4":"Ligand Pharmaceuticals","5":"Infectious Diseases","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Norvir (ritonavir)","3":"Approved June 1999","4":"Abbott Laboratories","5":"Immunology/Infectious Diseases","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Famvir (famciclovir)","3":"Approved January 1999","4":"SmithKline Beecham","5":"Infectious Diseases","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Agenerase  (amprenavir)","3":"Approved April 1999","4":"GlaxoSmithKline","5":"Immunology/Infectious Diseases","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Glucagon","3":"Approved September 1998","4":"Eli Lilly","5":"Endocrinology, Hematology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Gastrocrom Oral Concentrate (cromolyn sodium)","3":"Approved April 1996","4":"Rhone Poulenc Rorer","5":"mastocytosis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Rapamune (sirolimus) oral solution","3":"Approved September 1999","4":"Wyeth","5":"To prevent organ rejection in patients receiving renal transplants","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Evoxac","3":"Approved January 2000","4":"SnowBrand Pharmaceuticals","5":"Indicated for the symptoms of dry mouth in patients with Sjogren's Syndrome","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Amevive (alefacept)","3":"Approved January 2003","4":"Biogen IDEC","5":"Psoriasis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Tindamax, tinidazole","3":"Approved May, 2004","4":"Presutti Laboratories","5":"Protozoal infections","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Rotateq (rotavirus vaccine, live oral pentavalent)","3":"Approved February 2006","4":"Merck","5":"Rotavirus","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Extina (ketoconazole)","3":"Approved June 2007","4":"Stiefel","5":"seborrheic dermatitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tysabri (natalizumab)","3":"Approved January 2008","4":"Biogen IDEC","5":"Crohn's disease","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Kalbitor (ecallantide)","3":"Approved November 2009","4":"Dyax","5":"hereditary angioedema","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ixiaro (Japanese Encephalitis Vaccine, Inactivated, Adsorbed)","3":"Approved March 2009","4":"Intercell AG","5":"Japanese encephalitis virus","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Coartem (artemether/lumefantrine)","3":"Approved April 2009","4":"Novartis","5":"malaria infections due to Plasmodium falciparum","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Rid Mousse","3":"Approved March 2000","4":"Soltec Research","5":"For the treatment of head, pubic (crab), and body lice","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Tecfidera (dimethyl fumarate)","3":"Approved March 2013","4":"Biogen Idec","5":"relapsing multiple sclerosis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"TRUE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Malarone (atovaquone; proguanil hydrochloride) Tablet","3":"Approved July 2000","4":"GlaxoSmithKline","5":"Malaria","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Sylvant (siltuximab)","3":"Approved April 2014","4":"Janssen Biotech","5":"multicentric Castleman’s disease","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Otezla (apremilast)","3":"Approved September 2014","4":"Celgene","5":"moderate to severe plaque psoriasis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"HyQvia [Immune Globulin Infusion 10% (Human) with Recombinant  Human Hyaluronidase]","3":"Approved September 2014","4":"Baxter","5":"Primary Immunodeficiency","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Entyvio (vedolizumab)","3":"Approved May of 2014","4":"Millenium Pharmaceuticals","5":"adults with ulcerative colitis and Crohn's disease","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Cosentyx (secukinumab)","3":"Approved January 2015","4":"Novartis","5":"plaque psoriasis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Taltz (ixekizumab)","3":"Approved March 2016","4":"Eli Lilly","5":"plaque psoriasis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"TRUE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Aphthasol","3":"Approved December 1997","4":"Block Drug Company","5":"canker sores","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"TRUE"},{"1":"<chr [2]>","2":"Afstyla (Antihemophilic Factor (Recombinant), Single Chain)","3":"Approved May 2016","4":"CSL Behring","5":"hemophillia A","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Viokace (pancrelipase) tablets","3":"Approved March 2012","4":"Aptalis Pharma","5":"NA","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [4]>","2":"Ultresa (pancrelipase) delayed-release capsules","3":"Approved March 2012","4":"Aptalis Pharma","5":"exocrine pancreatic insufficiency","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"TRUE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ocaliva (obeticholic acid)","3":"Approved May 2016","4":"Intercept Pharmaceuticals","5":"primary biliary cholangitis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Defitelio (defibrotide sodium)","3":"Approved March 2016","4":"Jazz Pharmaceuticals","5":"hepatic veno-occlusive disease  with renal or pulmonary dysfunction following HSCT","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"TRUE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Zenapax","3":"Approved December 1997","4":"Roche","5":"rejection of kidney transplants","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Prograf","3":"Approved April 1997","4":"Fujisawa Healthcare","5":"kidney transplant rejection","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Simponi (golimumab)","3":"Aproved May 2013","4":"Janssen Biotech","5":"ulcerative colitis","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"TRUE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Simulect","3":"Approved May 1998","4":"Novartis","5":"acute organ transplant rejection","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"RenaGelRenagel (sevelamer hydrochloride)","3":"Approved November 1998","4":"GelTex Pharmaceuticals","5":"Urology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Proscar","3":"Approved April 1998","4":"Merck","5":"reducing the need for prostate surgery","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ditropan XL (oxybutynin chloride)","3":"Approved December 1998","4":"Alza","5":"Urology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Detrol (tolterodine tartrate)","3":"Approved March 1998","4":"Pharmacia & Upjohn","5":"overactive bladder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Levaquin","3":"Approved July 1999","4":"RW Johnson","5":"Urology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Ditropan XL (oxybutynin chloride)","3":"Approved June 1999","4":"Alza","5":"Urology","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Venofer (iron sucrose injection)","3":"Approved November 2000","4":"Luitpold Pharmaceuticals","5":"Iron deficiency anemia in patients undergoing chronic hemodialysis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [3]>","2":"Renagel (sevelamer hydrochloride)","3":"Approved July of 2000","4":"Genzyme","5":"the control of serum phosphorus in patients with chronic kidney disease on dialysis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"TRUE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Praxbind (idarucizumab)","3":"Approved October 2015","4":"Boehringer Ingelheim","5":"reversal of the anticoagulant effects of dabigatran","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"FALSE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"TRUE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Rapamune (sirolimus) Tablets","3":"Approved August 2000","4":"Wyeth","5":"Prevention of organ rejection in patients receiving kidney transplants","6":"FALSE","7":"TRUE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [2]>","2":"Hectorol (Doxercalciferol) Injection","3":"Approved April 2000","4":"Bone Care International","5":"For the reduction of iPTH levels in mgmt. of secondary hyperparathyroidism in patients undergoing chronic renal dialysis","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"TRUE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"Detrol LA (tolterodine tartrate)","3":"Approved December 2000","4":"Pharmacia & Upjohn","5":"Overactive Bladder","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"},{"1":"<chr [1]>","2":"PhosLo","3":"Approved April 2001","4":"Braintree Laboratories","5":"Hyperphosphetemia","6":"FALSE","7":"FALSE","8":"FALSE","9":"FALSE","10":"FALSE","11":"FALSE","12":"FALSE","13":"FALSE","14":"FALSE","15":"FALSE","16":"FALSE","17":"FALSE","18":"FALSE","19":"FALSE","20":"FALSE","21":"FALSE","22":"TRUE","23":"FALSE","24":"FALSE","25":"FALSE","26":"FALSE","27":"FALSE","28":"FALSE","29":"FALSE","30":"FALSE","31":"FALSE","32":"FALSE","33":"FALSE","34":"FALSE","35":"FALSE","36":"FALSE","37":"FALSE","38":"FALSE"}],"options":{"columns":{"min":{},"max":[10],"total":[38]},"rows":{"min":[10],"max":[10],"total":[1253]},"pages":{}}}
  </script>
</div>
<!-- rnb-frame-end -->
<!-- rnb-chunk-end -->
</div>

<div id="rmd-source-code">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</div>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});

$(document).ready(function () {
  $('.knitsql-table').addClass('kable-table');
  var container = $('.kable-table');
  container.each(function() {

    // move the caption out of the table
    var table = $(this).children('table');
    var caption = table.children('caption').detach();
    caption.insertBefore($(this)).css('display', 'inherit');
  });
});

</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
